PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jacobson, TA				Jacobson, TA			"The lower the better" in hypercholesterolemia therapy: A reliable clinical guideline?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CORONARY-ARTERY DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; FACTOR INTERVENTION TRIAL; HEART-DISEASE; PRIMARY PREVENTION; SERUM-CHOLESTEROL; UNITED-STATES; RISK; PRAVASTATIN; EVENTS	Since the publication of the second set of guidelines by the National Cholesterol Education Program, a solid body of data from landmark clinical studies has demonstrated that reduction in low-density lipoprotein (LDL) cholesterol with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor ("statin") therapy sharply diminishes the risk for coronary artery disease. These trials include the Scandinavian Simvastatin Survival Study, the West of Scotland Coronary Prevention Study, the Air Force/Texas Coronary Atherosclerosis Prevention Study, the Cholesterol and Recurrent Events investigation, and the Long-Term Intervention with Pravastatin in Ischaemic Disease trial. Coronary event rates and, in some cases, all-cause mortality decreased significantly after about 5 years of statin therapy in patients at risk for and those who had coronary artery disease at baseline. In contrast, recent subgroup analyses of these pivotal studies have in the aggregate challenged the premise that lower LDL cholesterol levels necessarily lead to further declines in risk for coronary artery disease, particularly among the patients most likely to be seen by the clinician: those with moderately elevated or normal cholesterol profiles. Indeed, when LDL cholesterol levels are in this range, further lowering with statin therapy elicits diminishing returns in terms of coronary event rates. These findings are readily accommodated by the curvilinear, or log-linear, model between serum cholesterol level and risk for coronary artery disease, which is predicated on data from large epidemiologic studies. In light of the current climate involving competing health care costs, the pursuit of progressively diminishing returns in terms of reductions in coronary artery disease risk through more aggressive lowering of LDL cholesterol levels appears to be unwarranted. Until data are published from ongoing randomized, clinical trials that can more effectively resolve the clinical utility of aggressive lipid-lowering strategies to improve coronary event rates, a prudent, evidence-based strategy seems warranted.	Emory Univ, Off Hlth Informat & Dis Prevent, Dept Med, Atlanta, GA 30303 USA	Emory University	Jacobson, TA (corresponding author), Emory Univ, Off Hlth Informat & Dis Prevent, Dept Med, Thomas Glenn Bldg,69 Butler St SE, Atlanta, GA 30303 USA.	tjaco02@emory.edu	Jacobson, Terry/AAK-4757-2020	Jacobson, Terry/0000-0002-9926-2179				ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; Campeau L, 1997, NEW ENGL J MED, V336, P153; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fager G, 1997, ARTERIOSCL THROM VAS, V17, P3527, DOI 10.1161/01.ATV.17.12.3527; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Haffner SM, 2000, DIABETES CARE, V23, pS57; Harper CR, 1999, ARCH INTERN MED, V159, P1049, DOI 10.1001/archinte.159.10.1049; Jacobson TA, 2000, ARCH INTERN MED, V160, P1361, DOI 10.1001/archinte.160.9.1361; Jacobson TA, 1998, ARCH INTERN MED, V158, P1977, DOI 10.1001/archinte.158.18.1977; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; KANNEL WB, 1995, AM J CARDIOL, V76, pC69, DOI 10.1016/S0002-9149(99)80474-3; Knatterud GL, 2000, CIRCULATION, V102, P157, DOI 10.1161/01.CIR.102.2.157; Packard CJ, 1998, CIRCULATION, V97, P1440; Pedersen T. R., 1998, European Heart Journal, V19, pM15; PEDERSEN TR, 1995, LANCET, V345, P1274; PEDERSEN TR, 1994, LANCET, V344, P1383; Perreault S, 1998, ARCH INTERN MED, V158, P375, DOI 10.1001/archinte.158.4.375; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Sacks FM, 1998, CIRCULATION, V97, P1446; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schectman G, 1996, ANN INTERN MED, V125, P990, DOI 10.7326/0003-4819-125-12-199612150-00011; SEMPOS CT, 1993, JAMA-J AM MED ASSOC, V269, P3009, DOI 10.1001/jama.269.23.3009; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; WITTELS EH, 1990, AM J CARDIOL, V65, P432, DOI 10.1016/0002-9149(90)90806-C; Wood D, 1998, EUR HEART J, V19, P1434	31	31	34	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					549	+		10.7326/0003-4819-133-7-200010030-00015	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00015			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015169				2022-12-28	WOS:000089678300008
J	Saltz, LB; Cox, JV; Blanke, C; Rosen, LS; Fehrenbacher, L; Moore, MJ; Maroun, JA; Ackland, SP; Locker, PK; Pirotta, N; Elfring, GL; Miller, LL				Saltz, LB; Cox, JV; Blanke, C; Rosen, LS; Fehrenbacher, L; Moore, MJ; Maroun, JA; Ackland, SP; Locker, PK; Pirotta, N; Elfring, GL; Miller, LL		Irinotecan Study Group	Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	35th Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 13-18, 1999	ATLANTA, GA	Amer Soc Clin Oncol			PHASE-II TRIAL; HEPATIC METASTASES; TOPOISOMERASE-I; CPT-11; CAMPTOTHECIN; CARCINOMA; MODULATION	Background: The combination of fluorouracil and leucovorin has until recently been standard therapy for metastatic colorectal cancer. Irinotecan prolongs survival in patients with colorectal cancer that is refractory to treatment with fluorouracil and leucovorin. In a multicenter trial, we compared a combination of irinotecan, fluorouracil, and leucovorin with bolus doses of fluorouracil and leucovorin as first-line therapy for metastatic colorectal cancer. A third group of patients received irinotecan alone. Methods: Patients were randomly assigned to receive irinotecan (125 mg per square meter of body-surface area intravenously), fluorouracil (500 mg per square meter as an intravenous bolus), and leucovorin (20 mg per square meter as an intravenous bolus) weekly for four weeks every six weeks; fluorouracil (425 mg per square meter as an intravenous bolus) and leucovorin (20 mg per square meter as an intravenous bolus) daily for five consecutive days every four weeks; or irinotecan alone (125 mg per square meter intravenously) weekly for four weeks every six weeks. End points included progression-free survival and overall survival. Results: Of 683 patients, 231 were assigned to receive irinotecan, fluorouracil, and leucovorin; 226 to receive fluorouracil and leucovorin; and 226 to receive irinotecan alone. In an intention-to-treat analysis, as compared with treatment with fluorouracil and leucovorin, treatment with irinotecan, fluorouracil, and leucovorin resulted in significantly longer progression-free survival (median, 7.0 vs. 4.3 months; P = 0.004), a higher rate of confirmed response (39 percent vs. 21 percent, P<0.001), and longer overall survival (median, 14.8 vs. 12.6 months; P = 0.04). Results for irinotecan alone were similar to those for fluorouracil and leucovorin. Grade 3 (severe) diarrhea was more common during treatment with irinotecan, fluorouracil, and leucovorin than during treatment with fluorouracil and leucovorin, but the incidence of grade 4 (life-threatening) diarrhea was similar in the two groups (<8 percent). Grade 3 or 4 mucositis, grade 4 neutropenia, and neutropenic fever were less frequent during treatment with irinotecan, fluorouracil, and leucovorin. Adding irinotecan to the regimen of fluorouracil and leucovorin did not compromise the quality of life. Conclusions: Weekly treatment with irinotecan plus fluorouracil and leucovorin is superior to a widely used regimen of fluorouracil and leucovorin for metastatic colorectal cancer in terms of progression-free survival and overall survival. (N Engl J Med 2000;343:905-14.) (C) 2000, Massachusetts Medical Society.	Mem Sloan Kettering Canc Ctr, Gastroenterol Oncol Serv, New York, NY 10021 USA; US Oncol, Dallas, TX USA; Vanderbilt Canc Ctr, Nashville, TN USA; Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA; Kaiser Permanente Med Ctr, Vallejo, CA USA; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Ottawa Reg Canc Ctr, Ottawa, ON K1Y 4K7, Canada; Newcastle Mater Misericordiae Hosp, Waratah, NSW, Australia; Pharmacia Corp, Peapack, NJ USA	Memorial Sloan Kettering Cancer Center; US Oncology Network; Vanderbilt University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Kaiser Permanente; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital Research Institute; Calvary Mater Newcastle Hospital; Pfizer	Saltz, LB (corresponding author), Mem Sloan Kettering Canc Ctr, Gastroenterol Oncol Serv, 1275 York Ave, New York, NY 10021 USA.		Goldberg, Richard/O-1871-2017; Ackland, Stephen P./G-7460-2013; Ducreux, Michel/L-7012-2019; Krieger, Gerhard/D-5164-2012; Goldberg, Richard M/M-1311-2013; Messori, Andrea/U-6903-2019	Goldberg, Richard/0000-0003-3713-6895; Ackland, Stephen P./0000-0001-5303-0017; Krieger, Gerhard/0000-0002-4548-0285; Saltz, Leonard/0000-0001-8353-4670				ABIGERGES D, 1994, J NATL CANCER I, V86, P446, DOI 10.1093/jnci/86.6.446; BUROKER TR, 1994, J CLIN ONCOL, V12, P14, DOI 10.1200/JCO.1994.12.1.14; Conti JA, 1996, J CLIN ONCOL, V14, P709, DOI 10.1200/JCO.1996.14.3.709; Cunningham D, 1998, LANCET, V352, P1413, DOI 10.1016/S0140-6736(98)02309-5; Douillard JY, 2000, LANCET, V355, P1372; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; GANDIA D, 1993, J CLIN ONCOL, V11, P196, DOI 10.1200/JCO.1993.11.1.196; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; GREM JL, 1996, CANC CHEMOTHERAPY BI, P149; HSIANG YH, 1989, CANCER RES, V49, P5077; JAXEL C, 1989, CANCER RES, V49, P1465; KAWATO Y, 1991, CANCER RES, V51, P4187; KEMENY N, 1989, CANCER, V63, P742, DOI 10.1002/1097-0142(19890215)63:4<742::AID-CNCR2820630423>3.0.CO;2-T; LEICHMAN CG, 1995, J CLIN ONCOL, V13, P1303, DOI 10.1200/JCO.1995.13.6.1303; MILLER LL, 1998, P AN M AM SOC CLIN, V17, pA297; PAZDUR R, 1997, P AN M AM SOC CLIN, V16, pA260; PETIT RG, 1997, P AN M AM SOC CLIN, V16, pA268; Pitot HC, 1997, J CLIN ONCOL, V15, P2910, DOI 10.1200/JCO.1997.15.8.2910; POON MA, 1989, J CLIN ONCOL, V7, P1407, DOI 10.1200/JCO.1989.7.10.1407; Rothenberg ML, 1996, J CLIN ONCOL, V14, P1128, DOI 10.1200/JCO.1996.14.4.1128; ROTHENBERG ML, 1993, J CLIN ONCOL, V11, P2194, DOI 10.1200/JCO.1993.11.11.2194; Rothenberg ML, 1999, CANCER-AM CANCER SOC, V85, P786, DOI 10.1002/(SICI)1097-0142(19990215)85:4<786::AID-CNCR5>3.0.CO;2-9; ROTHENBERG ML, 1998, P AN M AM SOC CLIN, V17, pA284; ROUGIER P, 1995, BRIT J SURG, V82, P1397, DOI 10.1002/bjs.1800821034; Rougier P, 1997, J CLIN ONCOL, V15, P251, DOI 10.1200/JCO.1997.15.1.251; Rougier P, 1998, LANCET, V352, P1634; Saltz LB, 1996, J CLIN ONCOL, V14, P2959, DOI 10.1200/JCO.1996.14.11.2959; SHIMADA Y, 1993, J CLIN ONCOL, V11, P909, DOI 10.1200/JCO.1993.11.5.909; VANCUTSEM E, 1997, P AN M AM SOC CLIN, V16, pA268; VONHOFF DD, 1997, P AN M AM SOC CLIN, V16, pA228	30	2448	2544	1	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2000	343	13					905	914		10.1056/NEJM200009283431302	http://dx.doi.org/10.1056/NEJM200009283431302			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	357KT	11006366	Bronze			2022-12-28	WOS:000089501400002
J	Lowe, M				Lowe, M			Evidence-based medicine - the view from Fiji	LANCET			English	Editorial Material									Lautoka Hosp, Fiji Sch Med, Lautoka, Fiji		Lowe, M (corresponding author), Lautoka Hosp, Fiji Sch Med, Lautoka, Fiji.							ALEXANDER T, 1991, INT J CARDIOL, V32, P361, DOI 10.1016/0167-5273(91)90299-5; Dickson R, 1998, WORLD HEALTH FORUM, V19, P311; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Garner P, 1998, BRIT MED J, V317, P531; Hirst GHL, 2000, MED J AUSTRALIA, V172, P287, DOI 10.5694/j.1326-5377.2000.tb123949.x; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Urdahl KB, 1996, AUST NZ J MED, V26, P49, DOI 10.1111/j.1445-5994.1996.tb02906.x	7	10	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1105	1107		10.1016/S0140-6736(00)02743-4	http://dx.doi.org/10.1016/S0140-6736(00)02743-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009161				2022-12-28	WOS:000089430500041
J	Sainsbury, JRC; Anderson, TJ; Morgan, DAL				Sainsbury, JRC; Anderson, TJ; Morgan, DAL			ABC of breast diseases - Breast cancer	BRITISH MEDICAL JOURNAL			English	Review							POSTOPERATIVE RADIOTHERAPY; RANDOMIZED TRIAL; CONSERVATION; LUMPECTOMY; RISK; THERAPY		Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England; Univ Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland; City Hosp Nottingham, Nottingham, England	University of Edinburgh; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Sainsbury, JRC (corresponding author), Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England.			Morgan, David/0000-0002-2291-1740				ABE O, 1995, NEW ENGL J MED, V333, P1444; Abner Anthony, 1992, International Journal of Radiation Oncology Biology Physics, V24, P130; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; Forrest AP, 1996, LANCET, V348, P708, DOI 10.1016/S0140-6736(96)02133-2; Gage I, 1996, CANCER-AM CANCER SOC, V78, P1921, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1921::AID-CNCR12>3.0.CO;2-#; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; SMITT MC, 1995, CANCER-AM CANCER SOC, V76, P259, DOI 10.1002/1097-0142(19950715)76:2<259::AID-CNCR2820760216>3.0.CO;2-2; VERONESI U, 1990, EUR J CANCER, V26, P671, DOI 10.1016/0277-5379(90)90114-9; VERONESI U, 1990, EUR J CANCER, V26, P668, DOI 10.1016/0277-5379(90)90113-8	10	42	42	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					745	750		10.1136/bmj.321.7263.745	http://dx.doi.org/10.1136/bmj.321.7263.745			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999911	Green Published			2022-12-28	WOS:000089546600030
J	Yeomans, DK; Antreasian, PG; Barriot, JP; Chesley, SR; Dunham, DW; Farquhar, RW; Giorgini, JD; Helfrich, CE; Konopliv, AS; McAdams, JV; Miller, JK; Owen, WM; Scheeres, DJ; Thomas, PC; Veverka, J; Williams, BG				Yeomans, DK; Antreasian, PG; Barriot, JP; Chesley, SR; Dunham, DW; Farquhar, RW; Giorgini, JD; Helfrich, CE; Konopliv, AS; McAdams, JV; Miller, JK; Owen, WM; Scheeres, DJ; Thomas, PC; Veverka, J; Williams, BG			Radio science results during the NEAR-Shoemaker spacecraft rendezvous with Eros	SCIENCE			English	Article							ASTEROID-433 EROS; ORBIT; FLYBY	We determined the mass of asteroid 433 Eros, its lower order gravitational harmonics, and rotation state, using ground-based Doppler and range tracking of the Near Earth Asteroid Rendezvous (NEAR)-Shoemaker spacecraft and images of the asteroid's surface Landmarks. The mass of Eros is (6.687 +/- 0.003) x 10(18) grams, which, coupled with our volume estimate, implies a bulk density of 2.67 +/- 0.03 grams per cubic centimeter. The asteroid appears to have a uniform density distribution. The right ascension and declination of the rotation pole are 11.37 +/- 0.05 and 17.22 +/- 0.05 degrees, respectively, and at Least over the short term, the rotation state of Eros is stable with no measurable free precession of the spin pole. Escape velocities on the surface vary from 3.1 to 17.2 meters per second. The dynamical environment of Eros suggests that it is covered with regolith and that one might expect material transport. toward the deepest potential wells in the saddle and 5.5-kilometer crater regions.	CALTECH, Jet Prop Lab, Navigat & Mission Design Sect, Pasadena, CA 91109 USA; Ctr Natl Etud Spatiales, Dept Terr & Planetary Geodesy, F-31055 Toulouse, France; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Cornell Univ, Ithaca, NY 14853 USA; Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Cornell University; University of Michigan System; University of Michigan	Yeomans, DK (corresponding author), CALTECH, Jet Prop Lab, Navigat & Mission Design Sect, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.		Dunham, David W/A-5214-2014; Barriot, Jean-Pierre/AAD-6709-2021	Dunham, David W/0000-0001-7527-4207; Barriot, Jean-Pierre/0000-0002-2112-9685; Antreasian, Peter/0000-0001-9040-310X; SCHEERES, DANIEL/0000-0003-0558-3842				BELTON MJS, 1995, NATURE, V374, P785, DOI 10.1038/374785a0; Bierman G. J., 1977, FACTORIZATION METHOD; DOBROVOLSKIS AR, 1980, ICARUS, V42, P422, DOI 10.1016/0019-1035(80)90105-0; Kaula W.M., 1966, THEORY SATELLITE GEO; Miller JK, 1995, J ASTRONAUT SCI, V43, P453; MILLER JK, 1990, J GUID CONTROL DYNAM, V13, P775, DOI 10.2514/3.25402; Scheeres DJ, 1998, ICARUS, V132, P53, DOI 10.1006/icar.1997.5870; Scheeres DJ, 1996, ICARUS, V121, P67, DOI 10.1006/icar.1996.0072; Veverka J, 2000, SCIENCE, V289, P2088, DOI 10.1126/science.289.5487.2088; Veverka J, 1999, SCIENCE, V285, P562, DOI 10.1126/science.285.5427.562; Werner R. A., 1996, Celestial Mechanics and Dynamical Astronomy, V65, P313, DOI 10.1007/BF00053511; Yeomans DK, 1999, SCIENCE, V285, P560, DOI 10.1126/science.285.5427.560; ZELLNER B, 1976, ICARUS, V28, P149, DOI 10.1016/0019-1035(76)90097-X; Zuber MT, 2000, SCIENCE, V289, P2097, DOI 10.1126/science.289.5487.2097	14	154	157	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2085	2088		10.1126/science.289.5487.2085	http://dx.doi.org/10.1126/science.289.5487.2085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000104				2022-12-28	WOS:000089430900034
J	Flower, HM				Flower, HM			A moving oxygen story	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England	Imperial College London	Flower, HM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.							Chen GZ, 2000, NATURE, V407, P361, DOI 10.1038/35030069; GINATTA MV, 1998, P 6 WORLD C TIT, V2, P753; Hartman AD, 1998, JOM-J MIN MET MAT S, V50, P16, DOI 10.1007/s11837-998-0408-1; [No title captured]	4	19	26	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					305	306		10.1038/35030266	http://dx.doi.org/10.1038/35030266			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014169				2022-12-28	WOS:000089390700023
J	Boquet, I; Boujemaa, R; Carlier, MF; Preat, T				Boquet, I; Boujemaa, R; Carlier, MF; Preat, T			Ciboulot regulates actin assembly during Drosophila brain metamorphosis	CELL			English	Article							MUSHROOM BODIES; ACANTHAMOEBA ACTOBINDIN; FILAMENT TURNOVER; THYMOSIN BETA-4; CENTRAL COMPLEX; NERVOUS-SYSTEM; GLIAL-CELLS; PROFILIN; MOTILITY; BODY	A dynamic actin cytoskeleton is essential for the remodeling of cell shape during development, but the specific roles of many actin partners remain unclear. Here we characterize a novel actin binding protein, Ciboulot (Cib), which plays a major role in axonal growth during Drosophila brain metamorphosis. Loss of Cib function leads to axonal growth defects in the central brain, while overexpression of the gene during development leads to overgrown projections. The Cib protein displays strong sequence similarity to beta-thymosins but has biochemical properties like profilin: the Cib-actin complex participates in actin filament assembly exclusively at the barbed end, and Cib enhances actin-based motility in vitro. Genetic experiments show that Cib and the Drosophila profilin protein Chickadee (Chic) cooperate in central brain metamorphosis.	CNRS, Inst Neurobiol Alfred Fessard, Lab Dev Evolut & Plast Syst Nerveux, F-91190 Gif Sur Yvette, France; CNRS, Lab Enzymol & Biochim Struct, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, Lab Dev Evolut & Plast Syst Nerveux, F-91190 Gif Sur Yvette, France.	preat@iaf.cnrs-gif.fr		Boujemaa-Paterski, Rajaa/0000-0001-9645-387X; Preat, Thomas/0000-0001-9976-1763				Armstrong JD, 1998, LEARN MEMORY, V5, P102; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Boquet I, 2000, J NEUROBIOL, V42, P33; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUBB MR, 1991, J BIOL CHEM, V266, P3820; BUBB MR, 1995, BIOCHEMISTRY-US, V34, P3921, DOI 10.1021/bi00012a008; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Carlsen KH, 1994, EUR RESPIR REV, V4, P5; CASELLA JF, 1995, CELL MOTIL CYTOSKEL, V30, P164, DOI 10.1002/cm.970300208; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; ERICKSONVIITANEN S, 1983, ARCH BIOCHEM BIOPHYS, V221, P570, DOI 10.1016/0003-9861(83)90177-7; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; HANESCH U, 1986, THESIS J MAXIMILIANS; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; Ito K, 1997, DEVELOPMENT, V124, P761; Korey CA, 2000, J NEUROBIOL, V44, P184, DOI 10.1002/1097-4695(200008)44:2<184::AID-NEU8>3.0.CO;2-N; Kraft R, 1998, J NEUROSCI, V18, P8886; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lee T, 1999, DEVELOPMENT, V126, P4065; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; Nachmias VT, 1993, CURR OPIN CELL BIOL, V5, P56, DOI 10.1016/S0955-0674(05)80008-0; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; POECK B, 1993, DEVELOPMENT, V117, P1017; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Renn SCP, 1999, J NEUROBIOL, V41, P189; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Roth LWA, 1999, DEVELOPMENT, V126, P1365; Safer D, 1997, CELL MOTIL CYTOSKEL, V38, P163, DOI 10.1002/(SICI)1097-0169(1997)38:2<163::AID-CM5>3.0.CO;2-8; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; Simon AF, 1998, MECH DEVELOP, V76, P45, DOI 10.1016/S0925-4773(98)00104-X; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Tettamanti M, 1997, DEV GENES EVOL, V207, P242, DOI 10.1007/s004270050112; Truman James W., 1993, P1245; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Vaduva G, 1997, J CELL BIOL, V139, P1821, DOI 10.1083/jcb.139.7.1821; Vaduva G, 1999, J BIOL CHEM, V274, P17103, DOI 10.1074/jbc.274.24.17103; VANDEKERCKHOVE J, 1990, J BIOL CHEM, V265, P12801; VanTroys M, 1996, EMBO J, V15, P201, DOI 10.1002/j.1460-2075.1996.tb00350.x; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; YU FX, 1993, J BIOL CHEM, V268, P502	58	98	101	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					797	808		10.1016/S0092-8674(00)00068-4	http://dx.doi.org/10.1016/S0092-8674(00)00068-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030623	Bronze			2022-12-28	WOS:000089395200011
J	Hope, S				Hope, S			10-minute consultation - Menorrhagia	BRITISH MEDICAL JOURNAL			English	Article									The Surg, Woodstock OX20 1UD, England		Hope, S (corresponding author), The Surg, Pk Lane, Woodstock OX20 1UD, England.								0	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					935	935		10.1136/bmj.321.7266.935	http://dx.doi.org/10.1136/bmj.321.7266.935			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030684	Green Published, Bronze			2022-12-28	WOS:000089975100025
J	Walker-Bone, K; Javaid, K; Arden, N; Cooper, C				Walker-Bone, K; Javaid, K; Arden, N; Cooper, C			Regular review - Medical management of osteoarthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CONTROLLED TRIAL; KNEE OSTEOARTHRITIS; INTRAARTICULAR INJECTIONS; EDUCATION INTERVENTIONS; RHEUMATOID-ARTHRITIS; FUNCTIONAL STATUS; HYALURONIC-ACID; OSTEO-ARTHRITIS; SOCIAL SUPPORT		Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England	University of Southampton	Cooper, C (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.	cc@mrc.soton.ac.uk	Walker-Bone, Karen/AAE-5255-2019					Abatangelo G., 1995, European Journal of Rheumatology and Inflammation, V15, P9; Adams ME, 1995, OSTEOARTHR CARTILAGE, V3, P213, DOI 10.1016/S1063-4584(05)80013-5; Altman RD, 1998, J RHEUMATOL, V25, P2203; Borjesson M, 1996, Physiother Res Int, V1, P89; Calfas K J, 1992, Arthritis Care Res, V5, P202, DOI 10.1002/art.1790050404; CHANG RW, 1993, ARTHRITIS RHEUM, V36, P289, DOI 10.1002/art.1780360302; Cronan TA, 1997, ARTHRIT CARE RES, V10, P99, DOI 10.1002/art.1790100205; CUSHNAGHAN J, 1994, BRIT MED J, V308, P753, DOI 10.1136/bmj.308.6931.753; DAHLBERG L, 1994, ARTHRITIS RHEUM, V37, P521, DOI 10.1002/art.1780370412; DIEPPE P, 2000, CLIN EVIDENCE, V3, P529; Dougados M, 1993, Osteoarthritis Cartilage, V1, P97, DOI 10.1016/S1063-4584(05)80024-X; DOUGADOS M, 2000, ANN RHEUM DIS S1, V59, P16; Eccles M, 1998, BRIT MED J, V317, P526; Ernst E, 1997, SCAND J RHEUMATOL, V26, P444, DOI 10.3109/03009749709065717; ETTINGER WH, 1992, JAMA-J AM MED ASSOC, V116, P529; GRIFFIN MR, 1988, ANN INTERN MED, V109, P359, DOI 10.7326/0003-4819-109-5-359; Hawkey CJ, 1999, LANCET, V353, P307, DOI 10.1016/S0140-6736(98)12154-2; HENDERSON EB, 1994, ANN RHEUM DIS, V53, P529, DOI 10.1136/ard.53.8.529; Huskisson EC, 1999, RHEUMATOLOGY, V38, P602, DOI 10.1093/rheumatology/38.7.602; IKE RW, 1992, J RHEUMATOL, V19, P772; Jones AC, 1995, OSTEOARTHR CARTILAGE, V3, P269, DOI 10.1016/S1063-4584(05)80018-4; Keefe FJ, 1996, ARTHRIT CARE RES, V9, P279, DOI 10.1002/1529-0131(199608)9:4<279::AID-ANR1790090413>3.0.CO;2-6; KOVAR PA, 1992, ANN INTERN MED, V116, P529, DOI 10.7326/0003-4819-116-7-529; Lane NE, 1997, AM J MED, V103, P25, DOI 10.1016/S0002-9343(97)90005-X; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; LOHMANDER LS, 1995, ACTA ORTHOP SCA S265, V66, P35; Lussier A, 1996, J RHEUMATOL, V23, P1579; Mazzuca SA, 1997, ARTHRITIS RHEUM-US, V40, P1466, DOI 10.1002/art.1780400815; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; MINOR MA, 1989, ARTHRITIS RHEUM, V32, P1396, DOI 10.1002/anr.1780321108; Moore RA, 1998, BRIT MED J, V316, P333, DOI 10.1136/bmj.316.7128.333; MORATZ V, 1986, CLIN THER, V9, P24; MURRAY C, 1997, GLOBAL BURDEN DIS; O'Reilly SC, 1999, ANN RHEUM DIS, V58, P15, DOI 10.1136/ard.58.1.15; PATARNELLO F, 1997, RHEUMATOL EUROPE S2, V26, P73; PUETT DW, 1994, ANN INTERN MED, V121, P133, DOI 10.7326/0003-4819-121-2-199407150-00010; RENE J, 1992, ARTHRITIS RHEUM, V35, P511, DOI 10.1002/art.1780350504; SuperioCabuslay E, 1996, ARTHRIT CARE RES, V9, P292, DOI 10.1002/1529-0131(199608)9:4<292::AID-ANR1790090414>3.0.CO;2-4; WEINBERGER M, 1989, ARTHRITIS RHEUM, V32, P1577, DOI 10.1002/anr.1780321212; WEINBERGER M, 1986, SOC SCI MED, V23, P899, DOI 10.1016/0277-9536(86)90218-2; Wobig M, 1998, CLIN THER, V20, P410, DOI 10.1016/S0149-2918(98)80052-0; ZHANG WY, 1994, EUR J CLIN PHARMACOL, V46, P517	42	83	86	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2000	321	7266					936	940		10.1136/bmj.321.7266.936	http://dx.doi.org/10.1136/bmj.321.7266.936			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030685	Green Published			2022-12-28	WOS:000089975100026
J	Agertoft, L; Pedersen, S				Agertoft, L; Pedersen, S			Effect of long-term treatment with inhaled budesonide on adult height in children with asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SKELETAL MATURATION; PREPUBERTAL CHILDREN; BECLOMETHASONE DIPROPIONATE; CORTICOSTEROID TREATMENT; CHILDHOOD ASTHMA; TARGET HEIGHT; GROWTH; DEFLAZACORT; PREDNISONE; VELOCITY	Background: Short-term studies have shown that inhaled corticosteroids may reduce the growth of children with asthma. However, the effect of long-term treatment on adult height is uncertain. Methods: We conducted a prospective study in children with asthma to examine the effect of long-term treatment with inhaled budesonide on adult height. We report on 211 children who have attained adult height: 142 budesonide-treated children with asthma, 18 control patients with asthma who have never received inhaled corticosteroids, and 51 healthy siblings of patients in the budesonide group, who also served as controls. Results: The children in the budesonide group attained adult height after a mean of 9.2 years of budesonide treatment (range, 3 to 13) at a mean daily dose of 412 microg (range, 110 to 877). The mean cumulative dose of budesonide was 1.35 g (range, 0.41 to 3.99). The mean differences between the measured and target adult heights were +0.3 cm (95 percent confidence interval, -0.6 to +1.2) for the budesonide-treated children, -0.2 cm (95 percent confidence interval, -2.4 to +2.1) for the control children with asthma, and +0.9 cm (95 percent confidence interval, -0.4 to +2.2) for the healthy siblings. The adult height depended significantly (P<0.001) on the child's height before budesonide treatment. Although growth rates were significantly reduced during the first years of budesonide treatment, these changes in growth rate were not significantly associated with adult height. Conclusions: Children with asthma who have received long-term treatment with budesonide attain normal adult height. (N Engl J Med 2000;343:1064-9.) (C) 2000, Massachusetts Medical Society.	Kolding Cty Hosp, Dept Pediat, DK-6000 Kolding, Denmark; Univ So Denmark, Dept Pediat, Kolding, Denmark	Kolding Hospital; University of Southern Denmark; University of Southern Denmark	Agertoft, L (corresponding author), Kolding Cty Hosp, Dept Pediat, DK-6000 Kolding, Denmark.	lone_agertoft@dadlnet.dk		Agertoft, Lone/0000-0001-6840-7921				Agertoft L, 1998, EUR RESPIR J, V12, P130, DOI 10.1183/09031936.98.12010130; AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; Agertoft L, 1998, AM J RESP CRIT CARE, V157, P178, DOI 10.1164/ajrccm.157.1.9707072; AICARDI G, 1993, BRIT J RHEUMATOL, V32, P39; Allen DB, 1999, ALLERGY, V54, P29, DOI 10.1111/j.1398-9995.1999.tb04385.x; BALFOURLYNN L, 1986, ARCH DIS CHILD, V61, P1049, DOI 10.1136/adc.61.11.1049; BARNES PJ, 1993, AM REV RESPIR DIS, V148, pS1, DOI 10.1164/ajrccm/148.4_Pt_2.S1; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; BUTLER GE, 1990, ANN HUM BIOL, V17, P177, DOI 10.1080/03014469000000952; CLISSOLD SP, 1984, DRUGS, V28, P485, DOI 10.2165/00003495-198428060-00001; DOULL IJM, 1995, AM J RESP CRIT CARE, V151, P1715, DOI 10.1164/ajrccm.151.6.7767512; Doull IJM, 1998, ARCH DIS CHILD, V78, P172, DOI 10.1136/adc.78.2.172; FERGUSON AC, 1982, J ALLERGY CLIN IMMUN, V69, P461, DOI 10.1016/0091-6749(82)90122-1; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; GELANDER L, 1994, ACTA PAEDIATR, V83, P1249, DOI 10.1111/j.1651-2227.1994.tb13006.x; HAUSPIE R, 1977, J ALLERGY CLIN IMMUN, V59, P200, DOI 10.1016/0091-6749(77)90150-6; HENRIKSEN JM, 1985, BRIT MED J, V291, P248, DOI 10.1136/bmj.291.6490.248-a; KARLBERG J, 1994, ACTA PAEDIATR, V83, P777, DOI 10.1111/j.1651-2227.1994.tb13138.x; Luo ZC, 1999, ACTA PAEDIATR, V88, P248, DOI 10.1080/08035259950169972; Luo ZC, 1998, PEDIATR RES, V44, P563, DOI 10.1203/00006450-199810000-00016; MARSHALL WA, 1971, ARCH DIS CHILD, V46, P414, DOI 10.1136/adc.46.248.414; MARTIN AJ, 1981, ACTA PAEDIATR SCAND, V70, P683, DOI 10.1111/j.1651-2227.1981.tb05768.x; McCowan C, 1998, BMJ-BRIT MED J, V316, P668, DOI 10.1136/bmj.316.7132.668; MORRIS HG, 1975, PEDIATR RES, V9, P579, DOI 10.1203/00006450-197507000-00005; NINAN TK, 1992, ARCH DIS CHILD, V67, P703, DOI 10.1136/adc.67.6.703; OBERGER E, 1986, ACTA PAEDIATR SCAND, V75, P744, DOI 10.1111/j.1651-2227.1986.tb10284.x; Saha MT, 1997, ACTA PAEDIATR, V86, P138, DOI 10.1111/j.1651-2227.1997.tb08854.x; Silverstein MD, 1997, J ALLERGY CLIN IMMUN, V99, P466, DOI 10.1016/S0091-6749(97)70072-1; Simons FER, 1997, NEW ENGL J MED, V337, P1659, DOI 10.1056/NEJM199712043372304; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; TINKELMAN DG, 1993, PEDIATRICS, V92, P64; VANBEVER HP, 1999, PEDIAT PULMONOL, V27, P69; Verberne AAPH, 1997, AM J RESP CRIT CARE, V156, P688, DOI 10.1164/ajrccm.156.3.9611067; VIGNOLO M, 1991, CLIN EXP RHEUMATOL, V9, P41; VOSS LD, 1991, ARCH DIS CHILD, V66, P833, DOI 10.1136/adc.66.7.833; WARNER JO, 1989, ARCH DIS CHILD, V64, P1065, DOI 10.1136/adc.64.7.1065	36	369	399	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2000	343	15					1064	1069		10.1056/NEJM200010123431502	http://dx.doi.org/10.1056/NEJM200010123431502			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362FA	11027740				2022-12-28	WOS:000089766900002
J	McKinstry, B				McKinstry, B			Do patients wish to be involved in decision making in the consultation? A cross sectional survey with video vignettes	BRITISH MEDICAL JOURNAL			English	Article							SATISFACTION	Objective To determine patients' preferences for a shared or directed style of consultation in the decision making part of the general practice consultation. Design Structured interview with video vignettes of acted consultations. Setting 5 practices in Lothian, Scotland. Participants 410 patients (adults and adults accompanying children) attending surgery appointments. Main outcome measures Preference for shared or directed form of video vignette for live different presenting conditions. Results Patients varied in their preference for involvement in decision making in the consultation. Under multiple regression analysis, patients' preference was found to be independently predicted by the problem viewed (patients presented with physical problems preferred a directed approach), patients' age (patients aged 61 or older were more likely to prefer the directed approach), social class (social classes I and II were more likely to prefer the shared approach), and smoking status (smokers more likely to prefer the shared approach). Those patients who were able to answer (or who thought their doctor's style similar to those in the vignettes) were more likely to describe their own doctor's style as similar to their preferred style. No major association in preference was found with sex, frequency of attendance, or perceived chronic ill health. Conclusion Patients may vary in their desire for involvement in decision making in consultations. Although this variation seems to depend on the presenting problem, age, social class, and smoking status, these associations are not absolute, with large minorities in each group. Doctors need the skills, knowledge of their patients, and the time to determine on which occasions, with which illnesses, and at which level their patients wish to be involved in decision making.	Ashgrove Hlth Ctr, Blackburn EH47 7LL, W Lothian, Scotland; Univ Edinburgh, Dept Gen Practice, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh	McKinstry, B (corresponding author), Ashgrove Hlth Ctr, Blackburn EH47 7LL, W Lothian, Scotland.			McKinstry, Brian/0000-0001-9581-0468				BAIN DJG, 1982, MED EDUC, V11, P347; BOTELHO RJ, 1992, FAM PRACT, V9, P210, DOI 10.1093/fampra/9.2.210; BOULTON M, 1986, SOCIOL HLTH ILLNESS, V8, P323; BRODY DS, 1980, ANN INTERN MED, V93, P718, DOI 10.7326/0003-4819-93-5-718; BUCHAN IC, 1978, PRACTITIONER, V221, P298; BYRNE PS, 1980, DOCTORS TALKING PATI; CARTWRIGHT A, 1976, SOCIOL REV MONOGR, V22, P77; CASSILETH BR, 1980, ANN INTERN MED, V92, P832, DOI 10.7326/0003-4819-92-6-832; Coulter A, 1997, J Health Serv Res Policy, V2, P112; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; HEATON PB, 1981, J FAM PRACTICE, V13, P845; *OFF POP CENS SURV, 1991, GEN HOUS SURV, P150; PENDLETON D, 1984, CONSULTATION APPROAC, P97; PENDLETON DA, 1980, SOC SCI MED-MED SOC, V14, P669, DOI 10.1016/S0271-7123(80)80077-0; PORTER M, 1984, SOC SCI MED, V19, P1197, DOI 10.1016/0277-9536(84)90370-8; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; ROTER D, 1987, J GEN INTERNAL MED, V2, P326; SACKETT DL, 1975, LANCET, V1, P1205; SAVAGE R, 1990, BRIT MED J, V301, P968, DOI 10.1136/bmj.301.6758.968; SHAPIRO J, 1979, NEW ENGL J MED, V295, P939; Stewart M., 1995, PATIENT CTR MED PATIENT CTR MED; STILES WB, 1979, MED CARE, V17, P667, DOI 10.1097/00005650-197906000-00010; SZASZ TS, 1956, ARCH INTERN MED, V97, P585, DOI 10.1001/archinte.1956.00250230079008; Tuckett D., 1985, M EXP	24	203	209	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					867	871		10.1136/bmj.321.7265.867	http://dx.doi.org/10.1136/bmj.321.7265.867			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	363VC	11021866	Green Published, Bronze			2022-12-28	WOS:000089857500023
J	Willmot, M; Sullivan, F				Willmot, M; Sullivan, F			NHSnet in Scottish primary care: lessons for the future	BRITISH MEDICAL JOURNAL			English	Article							EVIDENCE BASED MEDICINE; INFORMATION; KNOWLEDGE; INTERNET	Objective To evaluate the primary care communications initiative, which introduced NHSnet to primary care in Scotland. Design Semi-structured telephone interviews, postal questionnaire. Setting All 15 Scottish health boards, random sample of 1 in 3 of all Scottish general practices. Participants Information management and technology managers of health boards, 355 practice managers in the general practices. Main outcome measures Variations between health boards in styles of project management, means of connection to NHSnet, costs to general practices, and training provided. Practices' levels of participation in initiative, initial use of NHSnet, and factors acting as incentives and disincentives to use of NHSnet Results 99% of Scottish general practices agreed to participate in initiative. Health boards varied significantly in project management styles (from minimal to total control), the nature of the networks they established (intranets or direct connections), costs to practices (from nothing to pound 125 per general practitioner per par), and training provided (from none to an extensive programme). In 56% of practices someone accessed NHSnet at least once a week. Practices varied considerably in amount of internet training received and staff groups targeted and in the intention to protide desktop access to NHSnet through a practice network. Conclusion The initiative has successfully introduced a network that links Scottish general practices,heaIth boards, and hospital trusts. However local variation in this "national" initiative may affect its use in primary care. Health authorities and general practices in England and Wales may wish to note these findings in order to avoid unhelpful variation.	Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4AD, Scotland; Forth Valley Hlth Board, Stirling FK8 1DX, Scotland	University of Dundee	Willmot, M (corresponding author), Forth Valley Hlth Board, 33 Spittal St, Stirling FK8 1DX, Scotland.		Sullivan, Frank/L-8286-2019; Sullivan, Frank m/A-7767-2009	Sullivan, Frank/0000-0002-6623-4964; 				ATKINSON C, 1993, CHANGE TEAMWORK PRIM, P16; BROOME A, 1990, MANGING CHANGE; DAVIDOFF F, 1995, BRIT MED J, V310, P1085, DOI 10.1136/bmj.310.6987.1085; de Lusignan S, 1998, BRIT MED J, V317, P1319, DOI 10.1136/bmj.317.7168.1319; Department of Health, 1997, NEW NHS; DUNMORE T, 1997, PRIMARY CARE COMPUTE; Farmer J, 1997, Health Libr Rev, V14, P97, DOI 10.1046/j.1365-2532.1997.1420097.x; Glanville J, 1998, BRIT MED J, V317, P200, DOI 10.1136/bmj.317.7152.200; Gray JAM, 1998, BRIT MED J, V317, P832, DOI 10.1136/bmj.317.7162.832; KIDD M, 1998, EVIDENCE BASED PRACT, P123; KLERCKER T, 1998, FAMILY PRACTITIONER, V15, P205; *NHS, 1996, PRIM CAR WAY AH DISC; *NHS EX INF MAN GR, 1995, NHS WID NETW; *NHS TELB RANCH, 1997, PRACT TECHN REQ CONN; ROSENBERG W, 1995, BMJ-BRIT MED J, V310, P1122, DOI 10.1136/bmj.310.6987.1122; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; *SCOTT HLTH CAR SU, 1997, NAT IN PROM PRIM CAR; *SCOTT LIB INF COU, 1998, EN ACC KNOWL BAS HEA; *SCOTT OFF, 1998, DES CAR REN NAT HLTH; *SCOTT OFF DEP HLT, 1997, SCOTT HLTH SERV READ; *SCOTT OFF DEP HLT, 1997, INV PRIM CAR IM T PR; SILAGY C, 1998, EVIDENCE BASED PRACT; Steiner B D, 1996, Fam Med, V28, P128; Weed LL, 1997, BRIT MED J, V315, P231, DOI 10.1136/bmj.315.7102.231; Westberg EE, 1999, J AM MED INFORM ASSN, V6, P6, DOI 10.1136/jamia.1999.0060006; Wyatt J, 1998, BRIT MED J, V317, P900	26	6	7	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					878	881		10.1136/bmj.321.7265.878	http://dx.doi.org/10.1136/bmj.321.7265.878			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021870	Green Published, Bronze			2022-12-28	WOS:000089857500026
J	Alberts, MJ				Alberts, MJ			Issues in establishing primary stroke centers - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Alberts, MJ (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.								0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1647	1647						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015786				2022-12-28	WOS:000089501900015
J	Bhutta, ZA				Bhutta, ZA			Why has so little changed in maternal and child health in south Asia?	BRITISH MEDICAL JOURNAL			English	Article							DEVELOPING-COUNTRIES; PAKISTAN; TRIAL	Despite south Asia's nuclear capability and technological skills, indicators of maternal and child health rank among the worst in the world The health of mothers and children is intertwined with the poor status of women in society and with economic inequity Few research programmes are aimed at understanding and tackling the basic determinants of health, and there is little applied research Funds available for health care and health related research are limited and subject to structural adjustments dictated by international financial institutions In future, research projects and intervention programmes should involve national groups and be based on evidence not political expediency.	Aga Khan Univ, Dept Paediat, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Dept Paediat, Stadium Rd,POB 3500, Karachi 74800, Pakistan.							[Anonymous], 1992, NAT EV INT CHILD DEV; ATKINS M, 2000, BID CUT STRINGS ATTA; BEATTIE A, 2000, FINANCIAL TIMES 0615; Bhutta Z. A., 1999, JCPSP, Journal of the College of Physicians and Surgeons - Pakistan, V9, P117; Bhutta Z A, 1997, J Perinatol, V17, P54; BHUTTA ZA, 2000, J COLL PHYSICIANS SU, V10, P43; Chatterjee M, 1993, REACHING HLTH ALL, P342; Chavasse DC, 1999, LANCET, V353, P22, DOI 10.1016/S0140-6736(98)03366-2; DOLLAR D, 2000, GROWTH IS GOOD POOR; GIBBS W., 1995, SCI AM           AUG, P76; Gillespie S, 1997, MALNUTRITION S ASIA; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Howson CP, 1998, LANCET, V351, P586, DOI 10.1016/S0140-6736(97)11452-0; *HUM DEV CTR, 1998, HUM DEV S AS ED CHAL; KHAN SR, 1993, ACTA PAEDIATR, V82, P109, DOI 10.1111/j.1651-2227.1993.tb12911.x; *MAHB HUM DEV CTR, 1999, HUM DEV S AS CRIS GO; Maine D, 1999, AM J PUBLIC HEALTH, V89, P480, DOI 10.2105/AJPH.89.4.480; MEASHAM AR, 1999, WASTING CRISIS MALNU; MICHAUD C, 1994, B WORLD HEALTH ORGAN, V72, P639; Murdoch DA, 1998, LANCET, V351, P339, DOI 10.1016/S0140-6736(05)78338-0; MURRAY CJL, 1990, J TROP MED HYG, V93, P229; Ramalingaswami V., 1996, PROGR NATIONS, P11; SACHS J, 1999, ECONOMIST       0814, P17; *SOC POL DEV CTR, 1999, SOC DEV PAK ANN REV, P161; *SOC POL DEV CTR, 1999, SOC DEV PAK ANN REV; Straus WL, 1998, LANCET, V352, P270, DOI 10.1016/S0140-6736(97)10294-X; ULHAQ M, 1997, HUMAN DEV S ASIA, P2; *UN, 2000, PROGR NAT 2000; *UN, 2000, 4 UN; Unicef (United Nations Children's Fund), 2000, STAT WORLDS CHILDR 2; Walt G, 1998, LANCET, V351, P434, DOI 10.1016/S0140-6736(97)05546-3; *WHO, 1998, ALM AT YEAR 2000 REF; *WHO, 1999, CONT ANT RES; World Health Organization, 2000, WORLD HLTH REP 2000; YUSUFZAI M, 2000, CONT ISSUES CHILDHOO, P1	35	45	46	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					809	812		10.1136/bmj.321.7264.809	http://dx.doi.org/10.1136/bmj.321.7264.809			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009524	Green Published, Green Submitted			2022-12-28	WOS:000089696600026
J	Ruepp, A; Graml, W; Santos-Martinez, ML; Koretle, KK; Volker, C; Mewes, HW; Frishman, D; Stocker, S; Lupas, AN; Baumeister, W				Ruepp, A; Graml, W; Santos-Martinez, ML; Koretle, KK; Volker, C; Mewes, HW; Frishman, D; Stocker, S; Lupas, AN; Baumeister, W			The genome sequence of the thermoacidophilic scavenger Thermoplasma acidophilum	NATURE			English	Article							PROTEIN; EXPRESSION; GLUCOSE; MACHINE; VAT	Thermoplasma acidophilum is a thermoacidophilic archaeon that thrives at 59 degrees C and pH 2, which was isolated from self-heating coal refuse piles and solfatara fields(1,2). Species of the genus Thermoplasma do not possess a rigid cell wall, but are only delimited by a plasma membrane. Many macromolecular assemblies from Thermoplasma, primarily proteases and chaperones, have been pivotal in elucidating the structure and function of their more complex eukaryotic homologues(3,4). Our interest in protein folding and degradation led us to seek a more complete representation of the proteins involved in these pathways by determining the genome sequence of the organism. Here we have sequenced the 1,564,905-base-pair genome in just 7,855 sequencing reactions by using a new strategy. The 1,509 open reading frames identify Thermoplasma as a typical euryarchaeon with a substantial complement of bacteria-related genes; however, evidence indicates that there has been much lateral gene transfer between Thermoplasma and Sulfolobus solfataricus, a phylogenetically distant crenarchaeon inhabiting the same environment. At least 252 open reading frames, including a complete protein degradation pathway and various transport proteins, resemble Sulfolobus proteins most closely.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; SmithKline Beecham Pharmaceut, Bioinformat, Collegeville, PA 19426 USA; GSF Forschungszentrum Umwelt & Gesundheit, Munich Informat Ctr Prot Sequences, D-82152 Martinsried, Germany	Max Planck Society; GlaxoSmithKline; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Baumeister, W (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	baumeist@biochem.mpg.de	Frishman, Dmitrij/AAT-7815-2020; Mewes, Hans-Werner/A-8204-2019	Santos, Leticia/0000-0002-7992-7487; Mewes, Hans-Werner/0000-0002-9713-6398				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARRETT AJ, 1999, HDB PROTEOLYTIC ENZY; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BUDGEN N, 1986, FEBS LETT, V196, P207, DOI 10.1016/0014-5793(86)80247-2; Coles M, 1999, CURR BIOL, V9, P1158, DOI 10.1016/S0960-9822(00)80017-2; DARLAND G, 1970, SCIENCE, V170, P1416, DOI 10.1126/science.170.3965.1416; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Frishman D, 1997, TRENDS GENET, V13, P415, DOI 10.1016/S0168-9525(97)01224-9; Frishman D, 1998, NUCLEIC ACIDS RES, V26, P2941, DOI 10.1093/nar/26.12.2941; Golbik R, 1999, BIOL CHEM, V380, P1049, DOI 10.1515/BC.1999.131; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; HIXON WG, 1993, BIOSYSTEMS, V29, P151, DOI 10.1016/0303-2647(93)90091-P; HUANG CJ, 1991, J BACTERIOL, V173, P1544, DOI 10.1128/jb.173.4.1544-1553.1991; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Koretke KK, 1999, PROTEINS, P141; Lopez P, 1999, MOL MICROBIOL, V32, P883, DOI 10.1046/j.1365-2958.1999.01370.x; Luebben Mathias, 1995, Biochimica et Biophysica Acta, V1229, P1; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; REE HK, 1990, NUCLEIC ACIDS RES, V18, P4471, DOI 10.1093/nar/18.15.4471; RUDOLPH J, 1995, EMBO J, V14, P667, DOI 10.1002/j.1460-2075.1995.tb07045.x; SEARCY DG, 1984, SYST APPL MICROBIOL, V5, P30; Segerer A., 1992, PROKARYOTES, P712; SMITH PF, 1975, J BACTERIOL, V124, P884, DOI 10.1128/JB.124.2.884-892.1975; STEIN DB, 1978, SCIENCE, V202, P219, DOI 10.1126/science.694528; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WOLF S, 1993, FEBS LETT, V326, P42, DOI 10.1016/0014-5793(93)81757-Q; YASUDA M, 1995, FEMS MICROBIOL LETT, V128, P157, DOI 10.1111/j.1574-6968.1995.tb07516.x; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	30	333	706	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					508	513		10.1038/35035069	http://dx.doi.org/10.1038/35035069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029001	Bronze			2022-12-28	WOS:000089727400049
J	Watt, G; Kantipong, P; Jongsakul, K; Watcharapichat, P; Phulsuksombati, D; Strickman, D				Watt, G; Kantipong, P; Jongsakul, K; Watcharapichat, P; Phulsuksombati, D; Strickman, D			Doxycycline and rifampicin for mild scrub-typhus infections in northern Thailand: a randomised trial	LANCET			English	Article								Background Some strains of scrub typhus in northern Thailand are poorly responsive to standard antirickettsial drugs. We therefore did a mashed, randomised trial to compare rifampicin with standard doxycycline therapy for patients with scrub typhus. Methods Adult patients with strictly defined, mild scrub typhus were initially randomly assigned 1 week of daily oral treatment with 200 mg doxycycline (n=40), 600 mg rifampicin (n=38), or doxycycline with rifampicin (n=11), During the first year of treatment, the combined regimen was withdrawn because of lack of efficacy and the regimen was replaced with 900 mg rifampicin (n=37). Treatment outcome was assessed by fever clearance time (the time for oral temperature to fall below 37.3 degrees C). Findings About 12 800 fever patients were screened during the 3-year study to recruit 126 patients with confirmed scrub typhus and no other infection, of whom 86 completed therapy. Eight. individuals received the combined regimen that was discontinued after 1 year. The median duration of pyrexia was significantly shorter (p=0.01) in the 24 patients treated with 900 mg daily rifampicin (fever clearance time 22.5 h) and in the 26 patients who received 600 mg rifampicin (fever clearance time 27.5 h) than in the 28 patients given doxycycline monotherapy (fever clearance time 52 h), Fever resolved in a significantly higher proportion of patients within 48 h of starting rifampicin (900 mg=79% [19 of 24], 600 mg=77% [20 of 26]) than in patients treated with doxycycline (46% [13 of 28]; p=0.02). Severe gastrointestinal events warranted exclusion of two patients on doxycyline. There were two relapses after doxycycline therapy, but none after rifampicin therapy. Interpretation Rifampicin is more effective than doxycycline against scrub-typhus infections acquired in northern Thailand, where strains with reduced susceptibility to antibiotics can occur.	AFRIMS, US Army Component, Dept Med, Bangkok, Thailand; Chiangral Reg Hosp, Dept Med, Chiangrai, Thailand; AFRIMS, Royal thai Army Component, Analyt Div, Bangkok, Thailand; Walter Reed Army Med Ctr, Walter Reed Army Inst Res, Div Entomol, Washington, DC 20307 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter Reed National Military Medical Center	Watt, G (corresponding author), AFRIMS, Dept Retrovirol, HIV Interact Sect, APO, AP 96546 USA.							ARIZA J, 1985, ANTIMICROB AGENTS CH, V28, P548, DOI 10.1128/AAC.28.4.548; BAYARD PJ, 1992, J ACQ IMMUN DEF SYND, V5, P1237; BERMAN SJ, 1973, ANN INTERN MED, V79, P26, DOI 10.7326/0003-4819-79-1-26; Brown GW, 1988, BIOL RICKETTSIAL DIS, V1, P94; FARR BM, 1990, PRINCIPLES PRACTICE, P295; MCCLAIN JB, 1988, ANTIMICROB AGENTS CH, V32, P285, DOI 10.1128/AAC.32.2.285; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rosenberg R, 1997, PARASITOL TODAY, V13, P131, DOI 10.1016/S0169-4758(97)01020-X; Silpapojakul Khachornsakdi, 1997, Annals Academy of Medicine Singapore, V26, P794; SIRISANTHANA V, 1989, J INFECT DIS ANTIMIC, V6, P22; WATT G, 1994, CLIN INFECT DIS, V18, P624, DOI 10.1093/clinids/18.4.624; Watt G, 1996, LANCET, V348, P86, DOI 10.1016/S0140-6736(96)02501-9; Watt G, 1998, J INFECT DIS, V177, P800, DOI 10.1086/517813	13	94	95	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1057	1061		10.1016/S0140-6736(00)02728-8	http://dx.doi.org/10.1016/S0140-6736(00)02728-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009140				2022-12-28	WOS:000089430500009
J	Fayrer-Hosken, RA; Grobler, D; Van Altena, JJ; Bertschinger, HJ; Kirkpatrick, JF				Fayrer-Hosken, RA; Grobler, D; Van Altena, JJ; Bertschinger, HJ; Kirkpatrick, JF			Immunocontraception of African elephants - A humane method to control elephant populations without behavioural side effects.	NATURE			English	Article							PORCINE ZONA-PELLUCIDA		Univ Georgia, Coll Vet Med, Athens, GA 30602 USA; Kruger Natl Pk, ZA-1350 Skukuza, South Africa; Univ Pretoria, Dept Theriogenol, ZA-0110 Onderstepoort, South Africa; ZooMontana, Billings, MT 59106 USA	University System of Georgia; University of Georgia; University of Pretoria	Fayrer-Hosken, RA (corresponding author), Univ Georgia, Coll Vet Med, Athens, GA 30602 USA.							AYRERHOSKEN RA, 1997, THERIOGENOLOGY, V47, P397; Fayrer-Hosken RA, 1999, THERIOGENOLOGY, V52, P835, DOI 10.1016/S0093-691X(99)00176-4; FayrerHosken RA, 1997, WILDLIFE SOC B, V25, P18; Kirkpatrick JF, 1997, REPROD FERT DEVELOP, V9, P105, DOI 10.1071/R96052; WILLIS P, 1994, J EQUINE VET SCI, V14, P364, DOI 10.1016/S0737-0806(06)81753-3	5	88	101	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					149	149		10.1038/35025136	http://dx.doi.org/10.1038/35025136			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001042	Bronze			2022-12-28	WOS:000089241000032
J	Douglas, CD; Macpherson, NE; Davidson, PM; Gani, JS				Douglas, CD; Macpherson, NE; Davidson, PM; Gani, JS			Randomised controlled trial of ultrasonography in diagnosis of acute appendicitis, incorporating the Alvarado score	BRITISH MEDICAL JOURNAL			English	Article							ACUTE ABDOMINAL-PAIN; GRADED COMPRESSION; QUADRANT PAIN; ULTRASOUND; CHILDHOOD; CHILDREN	Objectives To determine whether diagnosis by graded compression ultrasonography improves clinical outcomes for patients with suspected appendicitis. Design A randomised controlled trial comparing clinical diagnosis (control) with a diagnostic protocol incorporating ultrasonography and the Alvarado score (intervention group). Setting Single tertiary referral centre. Participants 302 patients (age 5-82 years) referred to the surgical service with suspected appendicitis. 160 patients were randomised to the intervention group, of whom 129 underwent ultrasonography Ultrasonography was omitted for patients with extreme Alvarado scores (1-3, 9, or 10) unless requested by the admitting surgical team. Main outcome measures Time to operation, duration of hospital stay, and adverse outcomes, including non-therapeutic operations and delayed treatment in association with perforation. Results Sensitivity and specificity of ultrasonography were measured at 95% and 89%, respectively. Patients in the intervention group who underwent therapeutic operation had a significantly shorter mean time to operation than patients in the control group (7 v 10 hours, P = 0.02). There were no differences between groups in mean duration of hospital stay (53 v 55 hours, P = 0.84), proportion of patients undergoing a non-therapeutic operation (9% v 11%, P = 0.59) or delayed treatment in association with perforation (3% v 1%, P = 0.45). Conclusion Graded compression ultrasonography is an accurate procedure that leads to the prompt diagnosis and early treatment of many cases of appendicitis, although it does not prevent adverse outcomes or reduce length of hospital stay.	Univ Newcastle, Fac Med & Hlth Sci, Callaghan, NSW 2308, Australia	University of Newcastle			Gani, Jon/V-4960-2019; Douglas, Charles/G-7756-2013	Gani, Jon/0000-0003-0655-1877; Douglas, Charles/0000-0001-7952-068X; Davidson, Patricia M./0000-0003-2050-1534				ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; BALTHAZAR EJ, 1991, RADIOLOGY, V180, P21, DOI 10.1148/radiology.180.1.2052696; Davidson PM, 1999, PEDIATR SURG INT, V15, P32, DOI 10.1007/s003830050506; DEDOMBAL FT, 1972, BMJ-BRIT MED J, V2, P9, DOI 10.1136/bmj.2.5804.9; FORD RD, 1994, AM SURGEON, V60, P895; HELLER MB, 1993, AM J EMERG MED, V11, P51, DOI 10.1016/0735-6757(93)90060-O; HOFFMANN J, 1989, BRIT J SURG, V76, P774, DOI 10.1002/bjs.1800760803; Incesu L, 1997, AM J ROENTGENOL, V168, P669, DOI 10.2214/ajr.168.3.9057512; JONES PF, 1976, BRIT MED J, V2, P551, DOI 10.1136/bmj.2.6035.551; Macklin CP, 1997, ANN ROY COLL SURG, V79, P203; Moberg AC, 1998, EUR J SURG, V164, P833; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; OHMANN C, 1995, EUR J SURG, V161, P273; Olsen JB, 1993, BRIT J SURG, V80; PUYLAERT JBCM, 1986, RADIOLOGY, V158, P355, DOI 10.1148/radiology.158.2.2934762; Rao PM, 1998, CLIN RADIOL, V53, P639, DOI 10.1016/S0009-9260(98)80290-0; Sivit CJ, 1997, PEDIATR CLIN N AM, V44, P575, DOI 10.1016/S0031-3955(05)70494-6; TEICHER I, 1983, ANN SURG, V198, P753, DOI 10.1097/00000658-198312000-00014; TOBIAS M, 1992, J ROY SOC MED, V85, P585; VELANOVICH V, 1992, AM SURGEON, V58, P264	20	126	139	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					919	922A		10.1136/bmj.321.7266.919	http://dx.doi.org/10.1136/bmj.321.7266.919			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030676	Green Published, Bronze			2022-12-28	WOS:000089975100018
J	Larson, VD; Williams, DW; Henderson, WG; Luethke, LE; Beck, LB; Noffsinger, D; Wilson, RH; Dobie, RA; Haskell, GB; Bratt, GW; Shanks, JE; Stelmachowicz, P; Studebaker, GA; Boysen, AE; Donahue, A; Canalis, R; Fausti, SA; Rappaport, BZ				Larson, VD; Williams, DW; Henderson, WG; Luethke, LE; Beck, LB; Noffsinger, D; Wilson, RH; Dobie, RA; Haskell, GB; Bratt, GW; Shanks, JE; Stelmachowicz, P; Studebaker, GA; Boysen, AE; Donahue, A; Canalis, R; Fausti, SA; Rappaport, BZ		NIDCD VA Hearing Aid Clin Trial Gr	Efficacy of 3 commonly used hearing aid circuits - A crossover trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPRESSION; IMPAIRMENT; BENEFIT; PERFORMANCE; PROFILE; QUALITY; GAIN; LIFE	Context Numerous studies have demonstrated that hearing aids provide significant benefit for a wide range of sensorineural hearing loss, but no carefully controlled, multicenter clinical trials comparing hearing aid efficacy have been conducted. Objective To compare the benefits provided to patients with sensorineural hearing loss by 3 commonly used hearing aid circuits. Design Double-blind, 3-period, 3-treatment crossover trial conducted from May 1996 to February 1998. Setting Eight audiology laboratories at Department of Veterans Affairs medical centers across the United States. Patients A sample of 360 patients with bilateral sensorineural hearing loss (mean age, 67.2 years; 57% male, 78.6% white). Intervention Patients were randomly assigned to 1 of 6 sequences of linear peak clipper (PC), compression limiter (CL), and wide dynamic range compressor (WDRC) hearing aid circuits. All patients wore each of the 3 bearing aids, which were installed in identical casements, for 3 months, Main Outcome Measures Results of tests of speech recognition, sound quality, and subjective hearing aid benefit, administered at baseline and after each 3-month intervention with and without a hearing aid. At the end of the experiment, patients ranked the 3 hearing aid circuits. Results Each circuit markedly improved speech recognition, with greater improvement observed for soft and conversationally loud speech (all 52-dB and 62-dB conditions, P less than or equal to .001). All 3 circuits significantly reduced the frequency of problems encountered in verbal communication. Some test results suggested that CL and WDRC circuits provided a significantly better listening experience than PC circuits in word recognition (P = .002), loudness (P = .003), overall liking (P = .001), aversiveness of environmental sounds (P = .02), and distortion (P = .02). In the rank-order ratings, patients preferred the CL hearing aid circuits more frequently (41.6%) than the WDRC (29.8%) and the PC (28.6%) (P = .001 for CL vs both WDRC and PC). Conclusions Each circuit provided significant benefit in quiet and noisy listening situations. The CL and WDRC circuits appeared to provide superior benefits compared with the PC, although the differences between them were much less than the differences between the aided vs unaided conditions.	Dept Vet Affairs Med Ctr, Washington, DC USA; Hines VA Cooperat Studies Program, Coordinating Ctr, Hines, IL USA; Natl Inst Deafness & Other Commun Disorders, Bethesda, MD USA; Greater Los Angeles VA Hlth Care Syst, Los Angeles, CA USA; Dept Vet Affairs Med Ctr, Mountain Home, TN USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; Dept Vet Affairs Med Ctr, Long Beach, CA USA; Boys Town Natl Res Hosp, Omaha, NE 68131 USA; Univ Memphis, Memphis, TN 38152 USA; Univ Calif Los Angeles, Harborview Med Ctr, Los Angeles, CA USA; Dept Vet Affairs Med Ctr, Portland, OR USA; Dept Vet Affairs Med Ctr, Albuquerque, NM USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Boys Town National Research Hospital; University of Memphis; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Larson, VD (corresponding author), Howard Leight Ind, 7828 Waterville Rd, San Diego, CA 92154 USA.	vlarson@howardleight.com		dobie, robert/0000-0003-3833-1772				American National Standards Institute, 1987, S3221987 ANSI; ANDERSON BA, 1996, HEAR REV, V69, P18; Braida L D, 1979, ASHA Monogr, P1; BYRNE D, 1986, EAR HEARING, V7, P257, DOI 10.1097/00003446-198608000-00007; Collins J G, 1997, Vital Health Stat 10, P1; COX RM, 1987, EAR HEARING, V8, pS119, DOI 10.1097/00003446-198710001-00010; COX RM, 1988, EAR HEARING, V9, P198, DOI 10.1097/00003446-198808000-00005; COX RM, 1990, J SPEECH HEAR RES, V33, P343, DOI 10.1044/jshr.3302.343; COX RM, 1995, EAR HEARING, V16, P176, DOI 10.1097/00003446-199504000-00005; Dillon H, 1996, EAR HEARING, V17, P287, DOI 10.1097/00003446-199608000-00001; Dillon H., 1999, J AM ACAD AUDIOL, V10, P67; Goldstein D P, 1984, ASHA, V26, P24; Goldstein D. P., 1984, ASHA, V26, P38; HAVLIK RJ, 1986, VITAL HLTH STATISTIC, V125, P1; Hawkins D B, 1993, J Am Acad Audiol, V4, P221; HAWKINS DB, 1987, EAR HEARING, V8, P162, DOI 10.1097/00003446-198706000-00006; Hickson L M, 1994, Am J Audiol, V3, P51, DOI 10.1044/1059-0889.0303.51; Humes LE, 1999, J SPEECH LANG HEAR R, V42, P65, DOI 10.1044/jslhr.4201.65; Humes LE, 1997, J SPEECH LANG HEAR R, V40, P666, DOI 10.1044/jslhr.4003.666; KOCHKIN S, 1996, HEAR J, V49, P16; Kochkin S, 1992, HEARING J, V45, P47; Kochkin S., 1992, HEARING J, V45, P44; KREBS DF, 1972, SCAND AUDIOL, V1, P167; Leske M C, 1981, ASHA, V23, P229; MOORE CJ, 1993, RECENT DEV HEART INS, P147; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; MULROW CD, 1990, J AM GERIATR SOC, V38, P45, DOI 10.1111/j.1532-5415.1990.tb01595.x; Palmer CV, 1999, J SPEECH LANG HEAR R, V42, P312, DOI 10.1044/jslhr.4202.312; PLOMP R, 1988, J ACOUST SOC AM, V83, P2322, DOI 10.1121/1.396363; RIES PW, 1994, VITAL HLTH STAT, V10, P1; RUSSELL JN, 1997, VITAL HLTH STAT, V292, P1; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Teder H, 1993, Am J Audiol, V2, P41, DOI 10.1044/1059-0889.0202.41; UHLMANN RF, 1986, J AM GERIATR SOC, V34, P207, DOI 10.1111/j.1532-5415.1986.tb04204.x; WILSON RH, 1993, J REHABIL RES DEV, V30, P342	35	61	63	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1806	1813		10.1001/jama.284.14.1806	http://dx.doi.org/10.1001/jama.284.14.1806			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	359PW	11025833				2022-12-28	WOS:000089622100032
J	Anandalakshmi, R; Marathe, R; Ge, X; Herr, JM; Mau, C; Mallory, A; Pruss, G; Bowman, L; Vance, VB				Anandalakshmi, R; Marathe, R; Ge, X; Herr, JM; Mau, C; Mallory, A; Pruss, G; Bowman, L; Vance, VB			A calmodulin-related protein that suppresses posttranscriptional gene silencing in plants	SCIENCE			English	Article							RNA; VIRUSES; EXPRESSION; STRATEGY	Posttranscriptional gene silencing (PTGS) is an ancient eukaryotic regulatory mechanism in which a particular RNA sequence is targeted and destroyed. The helper component-proteinase (HC-Pro) of plant potyviruses suppresses PTGS in plants; Using a yeast two-hybrid system, we identified a calmodulin-related protein (termed rgs-CaM) that interacts with HC-Pro. Here we report that rgs-CaM, like HC-Pro itself, suppresses gene silencing. Our work is the first report identifying a cellular suppressor of PTGS.	Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Univ Calif Davis, CEPRAP, Davis, CA 95616 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California Davis	Vance, VB (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.							AN G, 1987, PLANT MOL BIOL MANUA, pA3; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Beclin C, 1998, VIROLOGY, V252, P313, DOI 10.1006/viro.1998.9457; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; CARRINGTON JC, 1990, EMBO J, V9, P1347, DOI 10.1002/j.1460-2075.1990.tb08249.x; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Grant SR, 1999, CELL, V96, P303, DOI 10.1016/S0092-8674(00)80541-3; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Sharp PA, 2000, SCIENCE, V287, P2431, DOI 10.1126/science.287.5462.2431; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; SNEDDEN WA, 1999, PLANT SCI, V3, P299; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	25	256	299	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					142	144		10.1126/science.290.5489.142	http://dx.doi.org/10.1126/science.290.5489.142			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021800				2022-12-28	WOS:000089724800053
J	Burmester, T; Weich, B; Reinhardt, S; Hankeln, T				Burmester, T; Weich, B; Reinhardt, S; Hankeln, T			A vertebrate globin expressed in the brain	NATURE			English	Article							AMINO-ACID-SEQUENCE; GLYCERA-DIBRANCHIATA; INTRACELLULAR HEMOGLOBIN; INTRON GAIN; GENE; MYOGLOBIN; EVOLUTION; TISSUE; RNA	Haemoglobins and myoglobins constitute related protein families that function in oxygen transport and storage in humans and other vertebrates(1,2). Here we report the identification of a third globin type in man and mouse. This protein is predominantly expressed in the brain, and therefore we have called it neuroglobin. Mouse neuroglobin is a monomer with a high oxygen affinity (half saturation pressure, P(50) approximate to 2 torr). Analogous to myoglobin, neuroglobin may increase the availability of oxygen to brain tissue. The human neuroglobin gene (NGB), located on chromosome 14q24, has a unique exon-intron structure. Neuroglobin represents a distinct protein family that diverged early in metazoan evolution, probably before the Protostomia/Deuterostomia split.	Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Mol Genet Biosafety Res & Consulting, D-55099 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Physiol Chem, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Burmester, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany.	burmeste@mail.uni-mainz.de	Burmester, Thorsten/I-7225-2013	Burmester, Thorsten/0000-0002-5772-7863				BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Burmester T, 1999, MOL BIOL EVOL, V16, P1809, DOI 10.1093/oxfordjournals.molbev.a026093; Dewilde S, 1996, J BIOL CHEM, V271, P19865, DOI 10.1074/jbc.271.33.19865; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; DIXON B, 1992, TRENDS BIOCHEM SCI, V17, P486; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELSENSTEIN J, 1993, PHYLIP VERSION 3 5C; GO M, 1981, NATURE, V291, P90, DOI 10.1038/291090a0; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; GOODMAN M, 1975, NATURE, V253, P603, DOI 10.1038/253603a0; Hankeln T, 1997, GENE, V205, P151, DOI 10.1016/S0378-1119(97)00518-0; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; KRAUS DW, 1986, SCIENCE, V232, P90, DOI 10.1126/science.232.4746.90; Logsdon JM, 1998, CURR BIOL, V8, pR560, DOI 10.1016/S0960-9822(07)00361-2; Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846; RENTROP M, 1986, HISTOCHEM J, V18, P271, DOI 10.1007/BF01676237; Schmidt R. F., 1997, PHYSL MENSCHEN, V27; SIMONS PC, 1989, BIOCHEMISTRY-US, V28, P8525, DOI 10.1021/bi00447a038; STRITTMATTER P, 1963, BIOCHIM BIOPHYS ACTA, V78, P562, DOI 10.1016/0006-3002(63)90928-4; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandergon TL, 1998, J BIOL CHEM, V273, P16998, DOI 10.1074/jbc.273.27.16998; Waterman M R, 1978, Methods Enzymol, V52, P456; WITTENBERG BA, 1965, BIOCHEM J, V96, P363, DOI 10.1042/bj0960363; ZAFAR RS, 1990, BIOCHIM BIOPHYS ACTA, V1041, P117, DOI 10.1016/0167-4838(90)90053-I; ZAFAR RS, 1990, J BIOL CHEM, V265, P21843; [No title captured]	28	838	1003	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					520	523		10.1038/35035093	http://dx.doi.org/10.1038/35035093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029004				2022-12-28	WOS:000089727400052
J	Jacobs, LD; Beck, RW; Simon, JH; Kinkel, RP; Brownscheidle, CM; Murray, TJ; Simonian, NA; Slasor, PJ; Sandrock, AW				Jacobs, LD; Beck, RW; Simon, JH; Kinkel, RP; Brownscheidle, CM; Murray, TJ; Simonian, NA; Slasor, PJ; Sandrock, AW		CHAMPS Study Grp	Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICALLY ISOLATED SYNDROMES; MAGNETIC-RESONANCE; FOLLOW-UP; MRI	Background: Treatment with interferon beta has been shown to help patients with established multiple sclerosis, but it is not known whether initiating treatment at the time of a first clinical demyelinating event is of value. Methods: We conducted a randomized, double-blind trial of 383 patients who had a first acute clinical demyelinating event (optic neuritis, incomplete transverse myelitis, or a brain-stem or cerebellar syndrome) and evidence of prior subclinical demyelination on magnetic resonance imaging (MRI) of the brain. After initial treatment with corticosteroids, 193 patients were randomly assigned to receive weekly intramuscular injections of 30 microg of interferon beta-1a and 190 were assigned to receive weekly injections of placebo. The study end points were the development of clinically definite multiple sclerosis and changes in findings on MRI of the brain. The trial was stopped after a preplanned interim efficacy analysis. Results: During three years of follow-up, the cumulative probability of the development of clinically definite multiple sclerosis was significantly lower in the interferon beta-1a group than in the placebo group (rate ratio, 0.56; 95 percent confidence interval, 0.38 to 0.81; P = 0.002). As compared with the patients in the placebo group, patients in the interferon beta-1a group had a relative reduction in the volume of brain lesions (P<0.001), fewer new or enlarging lesions (P<0.001), and fewer gadolinium-enhancing lesions (P<0.001) at 18 months. Conclusions: Initiating treatment with interferon beta-1a at the time of a first demyelinating event is beneficial for patients with brain lesions on MRI that indicate a high risk of clinically definite multiple sclerosis. (N Engl J Med 2000;343:898-904.) (C)2000, Massachusetts Medical Society.	Buffalo Gen Hosp, Dept Neurol, Buffalo, NY 14203 USA; SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA; Jaeb Ctr Hlth Res, Tampa, FL 33620 USA; Univ Colorado, Hlth Sci Ctr, Dept Radiol MRI, Denver, CO 80262 USA; Cleveland Clin Fdn, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44195 USA; Victoria Gen Hosp, Queen Elizabeth II Hlth Sci Ctr, Clin Res Ctr, Multiple Sclerosis Res Unit, Halifax, NS B3H 2Y9, Canada; Biogen, Cambridge, MA 02139 USA	Buffalo General Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; JAEB Center For Health Research; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Cleveland Clinic Foundation; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Victoria; Biogen	Jacobs, LD (corresponding author), Buffalo Gen Hosp, Dept Neurol, 100 High St, Buffalo, NY 14203 USA.	ljacobs@kaleidahealth.org	Macedo, Ana/L-9912-2018	Macedo, Ana/0000-0002-6978-8989				BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Brodsky M, 1997, NEUROLOGY, V49, P1404; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 1999, LANCET, V353, P678; Fazekas F, 1999, NEUROLOGY, V53, P448, DOI 10.1212/WNL.53.3.448; Jacobs LD, 1996, ANN NEUROL, V40, P480; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jacobs LD, 1997, ANN NEUROL, V41, P392, DOI 10.1002/ana.410410315; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; MORRISSEY SP, 1993, BRAIN, V116, P135, DOI 10.1093/brain/116.1.135; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; ORMEROD IEC, 1987, BRAIN, V110, P1579, DOI 10.1093/brain/110.6.1579; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rudick RA, 1998, NEUROLOGY, V50, P1266, DOI 10.1212/WNL.50.5.1266; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Sailer M, 1999, NEUROLOGY, V52, P599, DOI 10.1212/WNL.52.3.599; Simon JH, 1998, ANN NEUROL, V43, P79, DOI 10.1002/ana.410430114; TAVES DR, 1974, CLIN PHARMACOL THER, V15, P443	19	1145	1179	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2000	343	13					898	904		10.1056/NEJM200009283431301	http://dx.doi.org/10.1056/NEJM200009283431301			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KT	11006365	Bronze			2022-12-28	WOS:000089501400001
J	Livingston, JD				Livingston, JD			An electromagnetic personality - An Elizabethan experimentalist and spirited foe of pseudoscience.	NATURE			English	Editorial Material									MIT, Dept Mat Sci & Engn, Cambridge, MA USA	Massachusetts Institute of Technology (MIT)	Livingston, JD (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA USA.								0	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					453	453		10.1038/35035167	http://dx.doi.org/10.1038/35035167			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028979				2022-12-28	WOS:000089727400023
J	Mullikin, JC; Hunt, SE; Cole, CG; Mortimore, BJ; Rice, CM; Burton, J; Matthews, LH; Pavitt, R; Plumb, RW; Sims, SK; Ainscough, RMR; Attwood, J; Bailey, JM; Barlow, K; Bruskiewich, RMM; Butcher, PN; Carter, NP; Chen, Y; Clee, CM; Coggill, PC; Davies, J; Davies, RM; Dawson, E; Francis, MD; Joy, AA; Lamble, RG; Langford, CF; Macarthy, J; Mall, V; Moreland, A; Overton-Larty, EK; Ross, MT; Smith, LC; Steward, CA; Sulston, JE; Tinsley, EJ; Turney, KJ; Willey, DL; Wilson, GD; McMurray, AA; Dunham, I; Rogers, J; Bentley, DR				Mullikin, JC; Hunt, SE; Cole, CG; Mortimore, BJ; Rice, CM; Burton, J; Matthews, LH; Pavitt, R; Plumb, RW; Sims, SK; Ainscough, RMR; Attwood, J; Bailey, JM; Barlow, K; Bruskiewich, RMM; Butcher, PN; Carter, NP; Chen, Y; Clee, CM; Coggill, PC; Davies, J; Davies, RM; Dawson, E; Francis, MD; Joy, AA; Lamble, RG; Langford, CF; Macarthy, J; Mall, V; Moreland, A; Overton-Larty, EK; Ross, MT; Smith, LC; Steward, CA; Sulston, JE; Tinsley, EJ; Turney, KJ; Willey, DL; Wilson, GD; McMurray, AA; Dunham, I; Rogers, J; Bentley, DR			An SNP map of human chromosome 22	NATURE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DNA-SEQUENCE; GEL-ELECTROPHORESIS; HUMAN GENOME; GENES; IDENTIFICATION; MUTATION; QUALITY	The human genome sequence will provide a reference for measuring DNA sequence variation in human populations. Sequence variants are responsible for the genetic component of individuality, including complex characteristics such as disease susceptibility and drug response. Most sequence variants are single nucleotide polymorphisms (SNPs), where two alternate bases occur at one position (1-3). Comparison of any two genomes reveals around 1 SNP per kilobase(1,3). A sufficiently dense map of SNPs would allow the detection of sequence variants responsible for particular characteristics on the basis that they are associated with a specific SNP allele(4-6). Here we have evaluated large-scale sequencing approaches to obtaining SNPs, and have constructed a map of 2,730 SNPs on human chromosome 22. Most of the SNPs are within 25 kilobases of a transcribed exon, and are valuable for association studies. We have scaled up the process, detecting over 65,000 SNPs in the genome as part of The SNP Consortium programme, which is on target to build a map of 1 SNP every 5 kilobases that is integrated with the human genome sequence and that is freely available in the public domain.	Sanger Ctr, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Bentley, DR (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.			Dunham, Ian/0000-0003-2525-5598; Carter, Emma/0000-0002-0825-2793; Hunt, Sarah/0000-0002-8350-1235; Davies, Robert/0000-0002-9983-1378; Steward, Charles/0000-0001-8829-5349				Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bouck J, 1998, GENOME RES, V8, P1074, DOI 10.1101/gr.8.10.1074; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsenfeld A, 1999, GENOME RES, V9, P1; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; *SANG CTR WASH U G, 1998, GENOME RES, V8, P1097; Taillon-Miller P, 1998, GENOME RES, V8, P748, DOI 10.1101/gr.8.7.748; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	25	104	129	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					516	520		10.1038/35035089	http://dx.doi.org/10.1038/35035089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029003	hybrid			2022-12-28	WOS:000089727400051
J	Wang, MH; vom Saal, FS				Wang, MH; vom Saal, FS			Maternal age and traits in offspring - The timing of a mouse's first litter influences the development of her pups.	NATURE			English	Article							ESTRADIOL; PREGNANCY; EXPOSURE		Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Wang, MH (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	vomsaalf@missouri.edu						BERNSTEIN L, 1986, J NATL CANCER I, V76, P1035; BERNSTEIN L, 1988, BRIT J CANCER, V58, P379, DOI 10.1038/bjc.1988.223; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Finch C, 2000, CHANCE DEV AGING; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Key TJA, 1996, BRIT J CANCER, V73, P698, DOI 10.1038/bjc.1996.121; MATT DW, 1986, BIOL REPROD, V34, P478, DOI 10.1095/biolreprod34.3.478; SAAL FSV, 1989, J ANIM SCI, V67, P1824; Vom Saal FS, 1994, PHYSL REPRODUCTION, P1213; vomSaal FS, 1997, P NATL ACAD SCI USA, V94, P2056	11	57	58	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					469	470		10.1038/35035156	http://dx.doi.org/10.1038/35035156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028989				2022-12-28	WOS:000089727400037
J	Carman, WF; Wallace, LA; Walker, J; McIntyre, S; Noone, A; Christie, P; Millar, J; Douglas, JD				Carman, WF; Wallace, LA; Walker, J; McIntyre, S; Noone, A; Christie, P; Millar, J; Douglas, JD			Rapid virological surveillance of community influenza infection in general practice	BRITISH MEDICAL JOURNAL			English	Article							REVERSE TRANSCRIPTION-PCR	The annual outbreak of influenza in Scotland is monitored by sentinel general practices, which report influenza-like illness. We piloted real time virological surveillance to investigate whether polymerase chain reaction (PCR)(1 2) is useful for monitoring an outbreak while it is evolving; to compare PCR wit tow standard techniques-culture and serology; and to compare two media for submitting samples.	Gartnavel Gen Hosp, W Scotland Reg Virus Lab, Glasgow G12 0YN, Lanark, Scotland; Tweeddale Med Practice, Ft William PH33 6EU, Scotland		Carman, WF (corresponding author), Gartnavel Gen Hosp, W Scotland Reg Virus Lab, Glasgow G12 0YN, Lanark, Scotland.							Atmar RL, 1996, J CLIN MICROBIOL, V34, P2604, DOI 10.1128/JCM.34.10.2604-2606.1996; Grondahl B, 1999, J CLIN MICROBIOL, V37, P1; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998; Wallace LA, 1999, J INFECTION, V39, P221, DOI 10.1016/S0163-4453(99)90053-1	4	47	49	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					736	737		10.1136/bmj.321.7263.736	http://dx.doi.org/10.1136/bmj.321.7263.736			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999907	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000089546600027
J	Easterling, DR; Meehl, GA; Parmesan, C; Changnon, SA; Karl, TR; Mearns, LO				Easterling, DR; Meehl, GA; Parmesan, C; Changnon, SA; Karl, TR; Mearns, LO			Climate extremes: Observations, modeling, and impacts	SCIENCE			English	Review							TROPICAL CYCLONE ACTIVITY; LONG-TERM TRENDS; UNITED-STATES; EUPHYDRYAS-EDITHA; BUTTERFLY METAPOPULATION; ENVIRONMENTAL VARIATION; PRECIPITATION EVENTS; POPULATION-DYNAMICS; ATLANTIC HURRICANES; AUSTRALIAN REGION	One of the major concerns with a potential change in climate is that an increase in extreme events will occur. Results of observational studies suggest that in many areas That have been analyzed, changes in total precipitation are amplified at the tails, and changes in some temperature extremes have been observed. Model output has been analyzed that shows changes in extreme events for future climates, such as increases in extreme high temperatures. decreases in extreme Low temperatures, and increases in intense precipitation events. In addition, the societal infrastructure is becoming more sensitive to weather and climate extremes, which would be exacerbated by climate change. In wild plants and animals, climate-induced extinctions, distributional and phenological changes, and species' range shifts are being documented at an increasing rate. Several apparently gradual biological changes are Linked to responses to extreme weather and climate events.	NOAA, Natl Climate Data Ctr, Asheville, NC 28801 USA; Natl Ctr Atmospher Res, Boulder, CO 80303 USA; Univ Texas, Austin, TX 78712 USA; Illinois State Water Survey, Champaign, IL 61820 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Center Atmospheric Research (NCAR) - USA; University of Texas System; University of Texas Austin; Illinois State Water Survey	Easterling, DR (corresponding author), NOAA, Natl Climate Data Ctr, 151 Patton Ave, Asheville, NC 28801 USA.	david.r.easterling@noaa.gov	Parmesan, Camille/GVT-5674-2022	Parmesan, Camille/0000-0002-1515-274X				Akinremi OO, 1999, J CLIMATE, V12, P2996, DOI 10.1175/1520-0442(1999)012<2996:PTOTCP>2.0.CO;2; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; Bengtsson L, 1996, TELLUS A, V48, P57, DOI 10.1034/j.1600-0870.1996.00004.x; BOAG PT, 1984, BIOL J LINN SOC, V22, P243, DOI 10.1111/j.1095-8312.1984.tb01679.x; BOER GJ, IN PRESS CLIM DYN; Boughton DA, 1999, ECOLOGY, V80, P2727; BULL JJ, 1980, Q REV BIOL, V55, P3, DOI 10.1086/411613; Bumpus H.C., 1899, BIOL LECT WOODS HOLE, P209; CAMELL R, 1998, CLIM DYNAM, V14, P369; Chan JCL, 1996, GEOPHYS RES LETT, V23, P2765, DOI 10.1029/96GL02637; CHANGNON S, IN PRESS NAT HAZARDS; CHANGNON S, 1997, TRENDS HAIL US, P19; CHANGNON S, 1998, METEOROL APPL, V5, P125; Changnon SA, 2000, B AM METEOROL SOC, V81, P437, DOI 10.1175/1520-0477(2000)081<0437:HFETIL>2.3.CO;2; Changnon SA, 1996, B AM METEOROL SOC, V77, P1497, DOI 10.1175/1520-0477(1996)077<1497:IARTTH>2.0.CO;2; CHANGON S, 1996, IMPACTS RESPONSES IN; Christianson GE, 1999, GREENHOUSE 200 YEAR; COFFROTH MA, 1990, GLOBAL ECOLOGICAL CO, pCH3; COLLINS M, IN PRESS J CLIM; COOPE GR, 1995, EXTINCTION RATES, pCH4; COOTER EJ, 1995, INT J CLIMATOL, V15, P65, DOI 10.1002/joc.3370150108; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; CURRY RL, 1989, J ANIM ECOL, V58, P441, DOI 10.2307/4841; Dai A, 1998, GEOPHYS RES LETT, V25, P3367, DOI 10.1029/98GL52511; DAVIS MB, 1992, GLOBAL WARMING BIOL, pCH22; DeGaetano AT, 1996, J CLIMATE, V9, P1646, DOI 10.1175/1520-0442(1996)009<1646:RTIMAM>2.0.CO;2; DELWORTH TL, IN PRESS CLIM CHANGE; DOBKIN DS, 1987, OECOLOGIA, V71, P161, DOI 10.1007/BF00377280; DURMAN CF, IN PRESS Q J R METEO; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; EHRLICH PR, 1980, OECOLOGIA, V46, P101, DOI 10.1007/BF00346973; EVANS JL, 1999, P 23 AM MET SOC HURR, P803; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Gaffen DJ, 1998, NATURE, V396, P529, DOI 10.1038/25030; GLYNN PW, 1990, GLOBAL ECOLOGICAL CO, pCH3; GRAY WM, 1997, HURRICANE CLIMATE SO; Gregory JM, 1997, J CLIMATE, V10, P662, DOI 10.1175/1520-0442(1997)010<0662:SDINMI>2.0.CO;2; GROISMAN P, IN PRESS B AM METEOR; Groisman PY, 1999, CLIMATIC CHANGE, V42, P243, DOI 10.1023/A:1005432803188; Hadly EA, 1997, BIOL J LINN SOC, V60, P277; Hawkins BA, 1998, AM NAT, V152, P480, DOI 10.1086/286184; Heino R, 1999, CLIMATIC CHANGE, V42, P151, DOI 10.1023/A:1005420400462; Henderson-Sellers A, 1998, B AM METEOROL SOC, V79, P19, DOI 10.1175/1520-0477(1998)079<0019:TCAGCC>2.0.CO;2; Hoffman A.A., 1997, EXTREME ENV CHANGE E; HU ZZ, IN PRESS CLIM DYN; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; IWASHIMA T, 1993, J METEOROL SOC JPN, V71, P637, DOI 10.2151/jmsj1965.71.5_637; Jankowsky H.-D., 1973, TEMPERATURE LIFE, P293; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; KARL TR, 1991, GEOPHYS RES LETT, V18, P2253, DOI 10.1029/91GL02900; Karl TR, 1997, B AM METEOROL SOC, V78, P1107, DOI 10.1175/1520-0477(1997)078<1107:TCHWHL>2.0.CO;2; Karl TR, 1996, B AM METEOROL SOC, V77, P279, DOI 10.1175/1520-0477(1996)077<0279:IOCCFT>2.0.CO;2; Karl TR, 1998, B AM METEOROL SOC, V79, P231, DOI 10.1175/1520-0477(1998)079<0231:STOPAF>2.0.CO;2; Kattenberg A., 1996, CLIMATE CHANGE 1995, P285; KINGSOLVER JG, 1995, EVOLUTION, V49, P932, DOI [10.2307/2410415, 10.1111/j.1558-5646.1995.tb02328.x]; Kitoh A, 1997, J METEOROL SOC JPN, V75, P1019, DOI 10.2151/jmsj1965.75.6_1019; KNIPPERTZ P, IN PRESS CLIM RES; Knutson TR, 1997, J CLIMATE, V10, P138, DOI 10.1175/1520-0442(1997)010<0138:SEIAGC>2.0.CO;2; Knutson TR, 1998, SCIENCE, V279, P1018, DOI 10.1126/science.279.5353.1018; Knutson TR, 1998, J CLIMATE, V11, P2273, DOI 10.1175/1520-0442(1998)011<2273:MAODVA>2.0.CO;2; KNUTSON TR, IN PRESS CLIM DYN; Kothavala Z, 1999, ENVIRON MODELL SOFTW, V14, P243, DOI 10.1016/S1364-8152(98)00076-0; Kothavala Z, 1997, MATH COMPUT SIMULAT, V43, P261, DOI 10.1016/S0378-4754(97)00008-6; Krishnamurti TN, 1998, TELLUS A, V50, P186, DOI 10.1034/j.1600-0870.1998.t01-1-00003.x; KUNKEL K, 1996, B AM METEOROL SOC, V77, P1508; Kunkel KE, 1999, B AM METEOROL SOC, V80, P1077, DOI 10.1175/1520-0477(1999)080<1077:TFIWAC>2.0.CO;2; Kunkel KE, 1999, J CLIMATE, V12, P2515, DOI 10.1175/1520-0442(1999)012<2515:LTTIEP>2.0.CO;2; LAL M, IN PRESS REG ENV CHA; Landsea CW, 1999, CLIMATIC CHANGE, V42, P89, DOI 10.1023/A:1005416332322; Landsea CW, 1996, GEOPHYS RES LETT, V23, P1697, DOI 10.1029/96GL01029; LATIF M, UNPUB; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Meehl GA, 2000, J CLIMATE, V13, P1879, DOI 10.1175/1520-0442(2000)013<1879:ROTNCS>2.0.CO;2; MURPHY DD, 1984, PAN-PAC ENTOMOL, V60, P350; Nicholls N, 1998, METEOROL ATMOS PHYS, V65, P197, DOI 10.1007/BF01030788; Nicholls N, 1995, CLIMATIC CHANGE, V31, P231, DOI 10.1007/BF01095148; NICHOLLS N, 1996, CLIMATE CHANGE 1995, P133; Osborn TJ, 2000, INT J CLIMATOL, V20, P347, DOI [10.1002/(SICI)1097-0088(20000330)20:4<347::AID-JOC475>3.0.CO;2-C, 10.1002/(SICI)1097-0088(20000330)20:4&lt;347::AID-JOC475&gt;3.0.CO;2-C]; Palevitz BA, 1999, SCIENTIST, V13, P1; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; PARMESAN C, EVOLUTION ECOLOGY TA; PARMESAN C, 1999, IN PRESS INSECT MOVE; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; PIELKE R, 1998, WEATHER FORECAST, V12, P387; Pielke RA, 1999, CLIMATIC CHANGE, V42, P413; Plummer N, 1999, CLIMATIC CHANGE, V42, P183, DOI 10.1023/A:1005472418209; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; Post E, 1999, P NATL ACAD SCI USA, V96, P4467, DOI 10.1073/pnas.96.8.4467; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; ROOT TL, 1995, SCIENCE, V269, P334, DOI 10.1126/science.269.5222.334; Ross RJ, 1996, J CLIMATE, V9, P3561, DOI 10.1175/1520-0442(1996)009<3561:TWVCAT>2.0.CO;2; RUBENSTEIN DI, 1992, GLOBAL WARMING BIOL, pCH14; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Schneider SH, 1996, BIODIVERS CONSERV, V5, P1109, DOI 10.1007/BF00052720; SCHNEIDER SH, 1993, BIOTIC INTERACTIONS, pCH2; Schubert M, 1998, CLIM DYNAM, V14, P827, DOI 10.1007/s003820050258; Sinclair MR, 1999, J CLIMATE, V12, P3467, DOI 10.1175/1520-0442(1999)012<3467:OAOEWS>2.0.CO;2; Singer MC, 1996, AM NAT, V148, pS9, DOI 10.1086/285900; SINGER MC, 1972, SCIENCE, V176, P75, DOI 10.1126/science.176.4030.75; SINGER MC, 1979, FORTS ZOOL, V25, P53; Stone DA, 2000, ATMOS OCEAN, V38, P321, DOI 10.1080/07055900.2000.9649651; Suppiah R, 1998, INT J CLIMATOL, V18, P1141, DOI 10.1002/(SICI)1097-0088(199808)18:10<1141::AID-JOC286>3.0.CO;2-P; SYLVES R, 1998, DISASTERS COASTAL ZO; Szinell CS, 1998, INT J CLIMATOL, V18, P1479, DOI 10.1002/(SICI)1097-0088(19981115)18:13&lt;1479::AID-JOC325&gt;3.0.CO;2-P; Tarhule A, 1998, INT J CLIMATOL, V18, P1261, DOI [10.1002/(SICI)1097-0088(199809)18:11<1261::AID-JOC302>3.0.CO;2-Z, 10.1002/(SICI)1097-0088(199809)18:11&lt;1261::AID-JOC302&gt;3.0.CO;2-Z]; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth KE, 1999, CLIMATIC CHANGE, V42, P327, DOI 10.1023/A:1005488920935; WALKER LR, 1999, ECOLOGY DISTURBED GR; WALSH KJ, 1999, 23 C HURR TROP MET A; WASHINGTON WM, IN PRESS CLIM DYN; Weiser W., 1973, EFFECTS TEMPERATURE; WEISS SB, 1988, ECOLOGY, V69, P1486, DOI 10.2307/1941646; Wetherald RT, 1999, CLIMATIC CHANGE, V43, P495, DOI 10.1023/A:1005499220385; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Wuethrich B, 2000, SCIENCE, V287, P793, DOI 10.1126/science.287.5454.793; YE R, 1996, STUDY PATTERNS CAUSE; Yoshimura J., 1999, 10 S GLOB CHANG STUD, P555; Zhai PM, 1999, CLIMATIC CHANGE, V42, P203, DOI 10.1023/A:1005428602279; Zwiers FW, 1998, J CLIMATE, V11, P2200, DOI 10.1175/1520-0442(1998)011<2200:CITEOT>2.0.CO;2	130	3285	3472	138	2009	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2068	2074		10.1126/science.289.5487.2068	http://dx.doi.org/10.1126/science.289.5487.2068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000103				2022-12-28	WOS:000089430900033
J	Blackwell, M				Blackwell, M			Evolution - Terrestrial life - Fungal from the start?	SCIENCE			English	Editorial Material									Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Blackwell, M (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	btblac@unix1.sncc.lsu.edu						Alexopoulos C. J., 1996; ALLEN MF, 1980, CAN J BOT, V58, P371, DOI 10.1139/b80-038; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Berbee ML, 2001, MYCOTA, V7, P229; Camacho FJ, 1997, MOL ECOL, V6, P983, DOI 10.1046/j.1365-294X.1997.00266.x; CANTRILL DJ, 1988, AUST J BOT, V36, P257, DOI 10.1071/BT9880257; CONNOR RC, 1995, BIOL REV, V70, P427, DOI 10.1111/j.1469-185X.1995.tb01196.x; Gardes M, 1996, CAN J BOT, V74, P1572, DOI 10.1139/b96-190; HAWKSWORTH DL, 1996, CAB INT; Lee MSY, 1999, J MOL EVOL, V49, P385, DOI 10.1007/PL00006562; MISRA JK, 2000, ILLUSTRATED GENERA T; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; PRICE PW, 1988, AGR ECOSYST ENVIRON, V24, P369, DOI 10.1016/0167-8809(88)90080-1; Read DJ, 2000, PHILOS T R SOC B, V355, P815, DOI 10.1098/rstb.2000.0617; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Selosse MA, 1998, TRENDS ECOL EVOL, V13, P15, DOI 10.1016/S0169-5347(97)01230-5; SUH SO, UNPUB; TAYLOR TN, 1995, MYCOLOGIA, V87, P560, DOI 10.2307/3760776; VANDOVER CL, 1986, BIOL BULL, V171, P461, DOI 10.2307/1541687; Weir A, 1997, BIODIVERS CONSERV, V6, P701, DOI 10.1023/A:1018318320019; Wellman CH, 2000, PHILOS T R SOC B, V355, P717, DOI 10.1098/rstb.2000.0612; WETZEL JM, 1992, J CHEM ECOL, V18, P2083, DOI 10.1007/BF00981929; Zhang WP, 1997, MOL PHYLOGENET EVOL, V8, P205, DOI 10.1006/mpev.1997.0422	23	53	57	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2000	289	5486					1884	1885		10.1126/science.289.5486.1884	http://dx.doi.org/10.1126/science.289.5486.1884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	11012361				2022-12-28	WOS:000089355800027
J	Seale, P; Sabourin, LA; Girgis-Gabardo, A; Mansouri, A; Gruss, P; Rudnicki, MA				Seale, P; Sabourin, LA; Girgis-Gabardo, A; Mansouri, A; Gruss, P; Rudnicki, MA			Pax7 is required for the specification of myogenic satellite cells	CELL			English	Article							SKELETAL-MUSCLE REGENERATION; HEMATOPOIETIC STEM-CELLS; ADHESION MOLECULE; MDX MOUSE; IN-VIVO; EXPRESSION; DIFFERENTIATION; GENES; MYOD; MICE	The paired box transcription factor Pax7 was isolated by representational difference analysis as a gene specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization revealed that Pax7 was also expressed in satellite cells residing in adult muscle. Cell culture and electron microscopic analysis revealed a complete absence of satellite cells in Pax7(-/-) skeletal muscle. Surprisingly, fluorescence-activated cell sorting analysis indicated that the proportion of muscle-derived stem cells was unaffected. Importantly, stem cells from Pax7(-/-) muscle displayed almost a 10-fold increase in their ability to form hematopoietic colonies. These results demonstrate that satellite cells and muscle-derived stem cells represent distinct cell populations. Together these studies suggest that induction of Pax7 in muscle-derived stem cells induces satellite cell specification by restricting alternate developmental programs.	McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; McMaster Univ, Dept Pathol, Hamilton, ON L8S 4K1, Canada; McMaster Univ, Inst Mol Biol & Biotechnol, Hamilton, ON L8S 4K1, Canada; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	McMaster University; McMaster University; McMaster University; Max Planck Society	Rudnicki, MA (corresponding author), Ottawa Hosp Res Inst, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ottawahospital.on.ca						ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; APPELL HJ, 1988, INT J SPORTS MED, V9, P297, DOI 10.1055/s-2007-1025026; Bancroft JD, 1990, THEORY PRACTICE HIST; Bennicelli JL, 1999, ONCOGENE, V18, P4348, DOI 10.1038/sj.onc.1202812; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; Borycki AG, 1997, CURR BIOL, V7, pR620, DOI 10.1016/S0960-9822(06)00317-4; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Daston G, 1996, DEVELOPMENT, V122, P1017; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; GEORGEWEINSTEIN M, 1993, DEV BIOL, V156, P209, DOI 10.1006/dbio.1993.1071; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Grounds M D, 1993, Mol Cell Biol Hum Dis Ser, V3, P210; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Holst BD, 1997, P NATL ACAD SCI USA, V94, P1465, DOI 10.1073/pnas.94.4.1465; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; HURKO O, 1983, NEUROLOGY, V33, P737, DOI 10.1212/WNL.33.6.737; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; KABLAR B, 1995, TISSUE CELL, V27, P309, DOI 10.1016/S0040-8166(95)80051-4; Kay PH, 1998, INT J BIOCHEM CELL B, V30, P261, DOI 10.1016/S1357-2725(97)00108-8; KAY PH, 1995, GENE, V163, P171, DOI 10.1016/0378-1119(95)00368-G; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Maniatis T., 1982, MOL CLONING; Mansouri A, 1996, DEVELOPMENT, V122, P831; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; Mansouri A, 1999, CANCER RES, V59, p1707S; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; MORLET K, 1989, ANAT EMBRYOL, V180, P471, DOI 10.1007/BF00305122; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Relaix F, 1999, GENE DEV, V13, P3171, DOI 10.1101/gad.13.24.3171; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; SCHAFER BW, 1994, NUCLEIC ACIDS RES, V22, P4574, DOI 10.1093/nar/22.22.4574; SCHULTZ E, 1985, MECH AGEING DEV, V30, P63, DOI 10.1016/0047-6374(85)90059-4; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785	56	1547	1615	4	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					777	786		10.1016/S0092-8674(00)00066-0	http://dx.doi.org/10.1016/S0092-8674(00)00066-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030621	Green Published, Bronze			2022-12-28	WOS:000089395200009
J	Gleeson, H; Hughes, T; Northridge, D; Prendergast, BD				Gleeson, H; Hughes, T; Northridge, D; Prendergast, BD			Bulbar palsies and chest pain	LANCET			English	Article							AORTIC DISSECTION		Western Gen Hosp, Dept Med, Edinburgh EH4 2XU, Midlothian, Scotland; Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; Western Gen Hosp, Dept Cardiol, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Prendergast, BD (corresponding author), Royal Infirm Edinburgh, Dept Cardiol, Lauriston Pl, Edinburgh EH3 9YW, Midlothian, Scotland.							DESANCTIS RW, 1987, NEW ENGL J MED, V317, P1060, DOI 10.1056/NEJM198710223171705; Martin PJ, 1997, POSTGRAD MED J, V73, P8, DOI 10.1136/pgmj.73.855.8; Mokri B, 1996, NEUROLOGY, V46, P356, DOI 10.1212/WNL.46.2.356; PATTEN J, 1995, NEUROLOGICAL DIFFERE, P84; Pretre R, 1997, LANCET, V349, P1461, DOI 10.1016/S0140-6736(96)09372-5	5	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					826	826		10.1016/S0140-6736(00)02658-1	http://dx.doi.org/10.1016/S0140-6736(00)02658-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022931				2022-12-28	WOS:000089101800014
J	Rees, J				Rees, J			Patents and intellectual property: a salvation for patient-oriented research?	LANCET			English	Editorial Material							PHYSICIAN-SCIENTIST; INVESTIGATORS; DISCOVERY		Univ Edinburgh, Royal Infirm, Dept Dermatol, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Rees, J (corresponding author), Univ Edinburgh, Royal Infirm, Dept Dermatol, Lauriston Bldg,Lauriston Pl, Edinburgh EH3 9YW, Midlothian, Scotland.							BRESLOW A, 1975, ANN SURG, V182, P572, DOI 10.1097/00000658-197511000-00007; Brown MS, 1996, J INVEST MED, V44, P14; FARR PM, 1985, LANCET, V2, P921; GALLAGHER RP, 1998, CUTANEOUS ONCOLOGY, P225; GOLDSTEIN JL, 1986, J CLIN INVEST, V78, P848, DOI 10.1172/JCI112652; Goldstein JL, 1997, J CLIN INVEST, V99, P2803, DOI 10.1172/JCI119470; GOLDSTEIN JL, 1993, A GARROD INDIVIDUALI, pR7; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Gutterman JU, 1997, NAT BIOTECHNOL, V15, P598, DOI 10.1038/nbt0797-598; MARSHALL BJ, 1984, LANCET, V1, P1311; Rockey DC, 1999, J INVEST MED, V47, P25; Rosenberg LE, 1999, J CLIN INVEST, V103, P1621, DOI 10.1172/JCI7304; STEERE AC, 1977, ARTHRITIS RHEUM, V20, P7, DOI 10.1002/art.1780200102; WURTMAN RJ, 1995, NAT MED, V1, P1122, DOI 10.1038/nm1195-1122	14	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					849	850		10.1016/S0140-6736(00)02666-0	http://dx.doi.org/10.1016/S0140-6736(00)02666-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022945				2022-12-28	WOS:000089101800038
J	Joazeiro, CAP; Weissman, AM				Joazeiro, CAP; Weissman, AM			RING finger proteins: Mediators of ubiquitin ligase activity	CELL			English	Review							GROWTH-FACTOR RECEPTOR; C-CBL		Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA; NCI, Lab Immune Cell Biol, Div Basic Sci, Bethesda, MD 20892 USA	Salk Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Joazeiro, CAP (corresponding author), Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA.							Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Everett RD, 1999, EMBO J, V18, P1526, DOI 10.1093/emboj/18.6.1526; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	21	1015	1069	6	73	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					549	552		10.1016/S0092-8674(00)00077-5	http://dx.doi.org/10.1016/S0092-8674(00)00077-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007473	Bronze			2022-12-28	WOS:000089105200003
J	Al Suwaidi, J; Berger, PB; Holmes, DR				Al Suwaidi, J; Berger, PB; Holmes, DR			Coronary artery stents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE MYOCARDIAL-INFARCTION; INTRAVASCULAR ULTRASOUND GUIDANCE; CONVENTIONAL BALLOON ANGIOPLASTY; CHRONIC TOTAL OCCLUSIONS; ANGIOGRAPHIC FOLLOW-UP; LOCAL-DRUG DELIVERY; ANTIPLATELET THERAPY; THREATENED CLOSURE; PERCUTANEOUS TREATMENT; MULTICENTER-REGISTRY	Context Intracoronary stents are now used for the majority of patients undergoing percutaneous coronary revascularization, and the body of scientific knowledge about stents has expanded rapidly in the last several years. Objective To review the evidence supporting the widespread use of intracoronary stents. Data Sources The MEDLINE database was searched for articles from 1990 through January 2000 using the indexing terms stents, coronary artery disease, and angioplasty. Additional data sources included bibliographies of articles identified on MEDLINE, bibliographies in textbooks on percutaneous coronary interventions, and preliminary data presented at recent national and international cardiology conferences, Study Selection We selected for review studies that assessed the effects of stenting on the immediate and long-term outcome of patients undergoing percutaneous coronary revascularization. If data from randomized controlled trials were not available for specific patient subsets or lesion characteristics, observational studies were included. Data Extraction The methodologic characteristics of studies in coronary stenting were extracted and summarized according to key components of research design, including lesion type, location, and adjunctive therapy used. Studies were classified according to the strength of the available data into proven and unproven indications for stent use. Data Synthesis Coronary artery stents increase the safety of interventional procedures, increase procedure success rates, and decrease the need for emergency coronary artery bypass graft surgery. Conclusions Intracoronary stents have become an essential component of the catheter-based treatment of coronary artery disease. The evidence indicates that elective stenting, rather than provisional stenting or balloon angioplasty atone, improves clinical outcomes in the months following percutaneous coronary revascularization in a wide variety of clinical settings and lesion types.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Holmes, DR (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, SMH MB 4-523,200 1st St SW, Rochester, MN 55905 USA.	holmes.david@mayo.edu		al suwaidi, MB, ChB, FACC, FESC, FSCAI, jassim/0000-0002-5299-9106				AAMOLS HI, 1999, CARDIOVASC RAD MED, V1, P270; Akiyama T, 1998, J AM COLL CARDIOL, V32, P1610, DOI 10.1016/S0735-1097(98)00444-6; Al Suwaidi J, 2000, J AM COLL CARDIOL, V35, P929, DOI 10.1016/S0735-1097(99)00648-8; Al Suwaidi J, 2000, J AM COLL CARDIOL, V35, p63A; Albiero R, 2000, CIRCULATION, V101, P18, DOI 10.1161/01.CIR.101.1.18; AMBROSE JA, 1997, CIRCULATION S1, V96, P592; Antoniucci D, 1998, J AM COLL CARDIOL, V31, P1234, DOI 10.1016/S0735-1097(98)00097-7; Axel DI, 1997, CIRCULATION, V96, P636; BALM DS, 1996, CATHETER CARDIOVASC, V37, P314; Barsness GW, 2000, AM HEART J, V139, P824, DOI 10.1016/S0002-8703(00)90014-0; Baumbach A, 1999, CATHETER CARDIO INTE, V47, P102, DOI 10.1002/(SICI)1522-726X(199905)47:1<102::AID-CCD22>3.0.CO;2-G; Bauters C, 1998, CIRCULATION, V97, P318; Bauters C, 1998, J AM COLL CARDIOL, V31, P1291, DOI 10.1016/S0735-1097(98)00076-X; *BEN 1 STUD GROUP, 1999, CIRCULATION, V100, P233; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Bennett CL, 1998, ANN INTERN MED, V128, P541, DOI 10.7326/0003-4819-128-7-199804010-00004; Berger PB, 1999, J AM COLL CARDIOL, V34, P1891, DOI 10.1016/S0735-1097(99)00442-8; Bertrand ME, 1998, CIRCULATION, V98, P1597, DOI 10.1161/01.CIR.98.16.1597; Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7; Betriu A, 1999, J AM COLL CARDIOL, V34, P1498, DOI 10.1016/S0735-1097(99)00366-6; Bhargava B, 2000, J AM COLL CARDIOL, V35, P389, DOI 10.1016/S0735-1097(99)00564-1; Bilodeau L., 1998, European Heart Journal, V19, P48; Bottner RK, 1997, CATHETER CARDIO DIAG, V40, P144, DOI 10.1002/(SICI)1097-0304(199702)40:2<144::AID-CCD4>3.0.CO;2-B; Brener SJ, 1997, AM J CARDIOL, V79, P13, DOI 10.1016/S0002-9149(96)00668-6; Buller CE, 1999, CIRCULATION, V100, P236, DOI 10.1161/01.CIR.100.3.236; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; CALVER AL, IN PRESS AM HEART J; Caputo RP, 2000, J AM COLL CARDIOL, V35, p56A; Carter AJ, 1996, CIRCULATION, V94, P2364, DOI 10.1161/01.CIR.94.10.2364; CHAN CNS, 1995, AM J CARDIOL, V75, P23, DOI 10.1016/S0002-9149(99)80520-7; Cohen MG, 2000, AM J CARDIOL, V85, P446, DOI 10.1016/S0002-9149(99)00770-5; COLOMBO A, 1995, CIRCULATION, V91, P1676, DOI 10.1161/01.CIR.91.6.1676; DAHL JV, 2000, J AM COLL CARDIOL  S, V35, pA63; Dauerman HL, 1998, AM J CARDIOL, V82, P277, DOI 10.1016/S0002-9149(98)00311-7; DEFEYTER PIMJ, 1993, J AM COLL CARDIOL, V21, P1539, DOI 10.1016/0735-1097(93)90366-9; Di Mario Carlo, 1999, Journal of the American College of Cardiology, V33, p47A; DiMario C, 1997, CATHETER CARDIO DIAG, V41, P197, DOI 10.1002/(SICI)1097-0304(199706)41:2<197::AID-CCD20>3.0.CO;2-M; DORROS G, 1984, J THORAC CARDIOV SUR, V87, P17; Doucet S, 2000, J AM COLL CARDIOL, V35, p8A; ELDAR M, 1991, AM J CARDIOL, V68, P255, DOI 10.1016/0002-9149(91)90755-A; Elezi S, 1998, CIRCULATION, V98, P1875, DOI 10.1161/01.CIR.98.18.1875; Ellis SG, 1997, CIRCULATION, V96, P3867; ELLIS SG, 1999, STRATEGIC APPROACHES; Erbel R, 1998, NEW ENGL J MED, V339, P1672, DOI 10.1056/NEJM199812033392304; Ferguson JJ, 1999, CIRCULATION, V100, P570, DOI 10.1161/01.CIR.100.6.570; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; GEORGE BS, 1993, J AM COLL CARDIOL, V22, P135, DOI 10.1016/0735-1097(93)90827-N; George CJ, 1998, AM J CARDIOL, V81, P860, DOI 10.1016/S0002-9149(98)00004-6; GOLDBERG SL, 1997, CIRCULATION S1, V96, P88; GORDON PC, 1993, J AM COLL CARDIOL, V21, P1166, DOI 10.1016/0735-1097(93)90241-R; GREENBAUM AB, 1999, J AM COLL CARDIOL  S, V32, pA68; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Hall P, 1996, CIRCULATION, V93, P215, DOI 10.1161/01.CIR.93.2.215; Hanekamp CEE, 2000, J AM COLL CARDIOL, V35, p9A; HANKE H, 1994, EUR HEART J, V15, P691, DOI 10.1093/oxfordjournals.eurheartj.a060569; HARTZLER GO, 1988, AM J CARDIOL, V61, pG33, DOI 10.1016/S0002-9149(88)80030-4; Hayase M, 1998, J AM COLL CARDIOL, V31, p386A, DOI 10.1016/S0735-1097(97)85384-3; Hehrlein C, 1996, CIRCULATION, V93, P641, DOI 10.1161/01.CIR.93.4.641; Herdeg C, 1998, Semin Interv Cardiol, V3, P197; HIRSHFELD JW, 1991, J AM COLL CARDIOL, V18, P647, DOI 10.1016/0735-1097(91)90783-6; Hoffmann R, 1998, J AM COLL CARDIOL, V31, P43, DOI 10.1016/S0735-1097(97)00438-5; Hoher M, 1999, J AM COLL CARDIOL, V34, P722, DOI 10.1016/S0735-1097(99)00254-5; Holmes DR, 1998, CIRCULATION, V98, P660; Holmes DR, 1997, CATHETER CARDIO DIAG, V40, P133, DOI 10.1002/(SICI)1097-0304(199702)40:2<133::AID-CCD1>3.0.CO;2-C; Holmes DR, 1998, J AM COLL CARDIOL, V32, P1471, DOI 10.1016/S0735-1097(98)00427-6; Holmes DR, 1998, J AM COLL CARDIOL, V32, P590, DOI 10.1016/S0735-1097(98)00285-X; Horstkotte D., 1996, European Heart Journal, V17, P297; Huang P, 2000, CATHETER CARDIO INTE, V49, P121, DOI 10.1002/(SICI)1522-726X(200002)49:2<121::AID-CCD1>3.0.CO;2-X; Ikeda S, 2000, J INVASIVE CARDIOL, V12, P194; ISHIZAKA N, 1994, AM HEART J, V127, P8, DOI 10.1016/0002-8703(94)90503-7; IVANHOE RJ, 1992, CIRCULATION, V85, P106, DOI 10.1161/01.CIR.85.1.106; Karrillon GJ, 1996, CIRCULATION, V94, P1519, DOI 10.1161/01.CIR.94.7.1519; Kastrati A, 1999, CIRCULATION, V100, P1285, DOI 10.1161/01.CIR.100.12.1285; Kawashima A, 1999, CIRCULATION, V100, P856; Keane D, 1996, Semin Interv Cardiol, V1, P255; Kleiman NS, 2000, J AM COLL CARDIOL, V36, P310, DOI 10.1016/S0735-1097(00)00805-6; Kobayashi Y, 1999, J AM COLL CARDIOL, V34, P651, DOI 10.1016/S0735-1097(99)00303-4; Koning R, 1999, CIRCULATION, V100, P503; Koning R, 1998, CATHETER CARDIO DIAG, V45, P235, DOI 10.1002/(SICI)1097-0304(199811)45:3<235::AID-CCD3>3.0.CO;2-G; Koster R, 1999, J AM COLL CARDIOL, V34, P25, DOI 10.1016/S0735-1097(99)00167-9; Kosuga K, 1999, CIRCULATION, V100, P436; KUNTZ RE, 1992, CIRCULATION, V86, P1827, DOI 10.1161/01.CIR.86.6.1827; KUNTZ RE, 1993, J AM COLL CARDIOL, V21, P15, DOI 10.1016/0735-1097(93)90712-A; L'Allier PL, 2000, J AM COLL CARDIOL, V35, p66A; Lafont A, 2000, J AM COLL CARDIOL, V36, P404, DOI 10.1016/S0735-1097(00)00747-6; Lansky Alexandra J., 1999, Journal of the American College of Cardiology, V33, p17A; Lau KW, 1997, CLIN CARDIOL, V20, P711, DOI 10.1002/clc.4960200809; LEFEVRE T, 1997, CIRCULATION S1, V96, P88; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; LEON MB, 1999, 11 TRANSC CARD THER; Lincoff AM, 1999, NEW ENGL J MED, V341, P319, DOI 10.1056/NEJM199907293410503; Lopez JJ, 1997, J AM COLL CARDIOL, V29, P345, DOI 10.1016/S0735-1097(96)00488-3; Lotan C., 1999, Journal of the American College of Cardiology, V33, p28A; Maillard L, 1998, CIRCULATION, V98, P21; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Mehran R, 1997, CIRCULATION, V96, P2183; MEHRAN R, 1999, 11 TRANSC CARD THER; Mintz GS, 1998, AM J CARDIOL, V81, p7E, DOI 10.1016/S0002-9149(98)00190-8; Mishkel GJ, 1999, J AM COLL CARDIOL, V34, P1884, DOI 10.1016/S0735-1097(99)00443-X; Morice MC, 1999, J INVASIVE CARDIOL, V11, P337; Moses JW, 1998, J AM COLL CARDIOL, V31, p350A, DOI 10.1016/S0735-1097(97)85231-X; Moussa I, 1999, CIRCULATION, V99, P2364, DOI 10.1161/01.CIR.99.18.2364; Muller C, 2000, CIRCULATION, V101, P590, DOI 10.1161/01.CIR.101.6.590; Muller D, 1999, CIRCULATION, V100, P503; OKEEFE JH, 1989, AM J CARDIOL, V64, P144, DOI 10.1016/0002-9149(89)90447-5; Pan M, 1999, AM J CARDIOL, V83, P1320, DOI 10.1016/S0002-9149(99)00093-4; Park SJ, 1998, J AM COLL CARDIOL, V31, P37, DOI 10.1016/S0735-1097(97)00425-7; PENN IM, 1995, CIRCULATION, V92, P1327; Pepine CJ, 1996, J AM COLL CARDIOL, V28, P782; Peterson ED, 1999, J AM COLL CARDIOL, V33, P1610, DOI 10.1016/S0735-1097(99)00051-0; PIANA RN, 1994, J AM COLL CARDIOL, V23, P1296, DOI 10.1016/0735-1097(94)90370-0; PIANA RN, 1994, CIRCULATION, V89, P2514, DOI 10.1161/01.CIR.89.6.2514; Plucinski DA, 2000, J AM COLL CARDIOL, V35, p67A; RAY SG, 1998, EUR HEART J SUPPL, V19, P471; Rocha-Singh KJ, 2000, CATHETER CARDIO INTE, V49, P135; Rodriguez A, 1998, AM J CARDIOL, V81, P1286, DOI 10.1016/S0002-9149(98)00154-4; Rodriguez A, 1998, J AM COLL CARDIOL, V32, P1351, DOI 10.1016/S0735-1097(98)00388-X; ROGERS C, 1993, CIRCULATION, V88, P1215, DOI 10.1161/01.CIR.88.3.1215; ROUBIN GS, 1992, CIRCULATION, V85, P916, DOI 10.1161/01.CIR.85.3.916; Rubartelli P, 1998, J AM COLL CARDIOL, V32, P90, DOI 10.1016/S0735-1097(98)00193-4; Ruygrok PN, 1999, J AM COLL CARDIOL, V34, P1507, DOI 10.1016/S0735-1097(99)00380-0; Safian Robert D., 1999, Journal of the American College of Cardiology, V33, p37A; Saito S, 1999, CATHETER CARDIO INTE, V48, P262, DOI 10.1002/(SICI)1522-726X(199911)48:3<262::AID-CCD5>3.0.CO;2-4; Savage MP, 1999, CIRCULATION, V100, P503; Savage MP, 1997, NEW ENGL J MED, V337, P740, DOI 10.1056/NEJM199709113371103; Savage MP, 1998, J AM COLL CARDIOL, V31, P307, DOI 10.1016/S0735-1097(97)00511-1; Scheller Bruno, 1999, Journal of the American College of Cardiology, V33, p29A; Schiele F, 1998, J AM COLL CARDIOL, V32, P320, DOI 10.1016/S0735-1097(98)00249-6; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; SCHOMIG A, 1994, J AM COLL CARDIOL, V23, P1053, DOI 10.1016/0735-1097(94)90589-4; Schomig A, 1997, CIRCULATION, V96, P3880; Schumaker JR, 1997, J FOREST, V95, P20; Schwartz RS, 1996, J INVASIVE CARDIOL, V8, P386; Serruys P. W., 1999, European Heart Journal, V20, P371; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Sievert H, 1999, AM J CARDIOL, V84, P386, DOI 10.1016/S0002-9149(99)00320-3; Simoons ML, 1997, LANCET, V349, P1429; Sirnes PA, 1996, J AM COLL CARDIOL, V28, P1444, DOI 10.1016/S0735-1097(96)00349-X; Suryapranata H, 1998, CIRCULATION, V97, P2502, DOI 10.1161/01.CIR.97.25.2502; TANIUCHI M, 2000, CATHETER CARDIOVASC, V50, P128; Teirstein PS, 2000, CIRCULATION, V101, P360, DOI 10.1161/01.CIR.101.4.360; Teirstein PS, 1997, NEW ENGL J MED, V336, P1697, DOI 10.1056/NEJM199706123362402; Thomas Martyn, 1996, Journal of the American College of Cardiology, V27, p153A; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Urban P, 1999, CIRCULATION, V100, P379; Urban P, 1998, CIRCULATION, V98, P2126, DOI 10.1161/01.CIR.98.20.2126; Versaci F, 1997, NEW ENGL J MED, V336, P817, DOI 10.1056/NEJM199703203361201; VIOLARIS AG, 1995, CIRCULATION, V91, P2140, DOI 10.1161/01.CIR.91.8.2140; Wong P, 1999, CATHETER CARDIO INTE, V46, P153, DOI 10.1002/(SICI)1522-726X(199902)46:2<153::AID-CCD8>3.0.CO;2-7; Yamashita T, 2000, J AM COLL CARDIOL, V35, P1145, DOI 10.1016/S0735-1097(00)00534-9	153	127	131	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1828	1836		10.1001/jama.284.14.1828	http://dx.doi.org/10.1001/jama.284.14.1828			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025836	Bronze			2022-12-28	WOS:000089622100035
J	Hardy, RG; Meltzer, SJ; Jankowski, JA				Hardy, RG; Meltzer, SJ; Jankowski, JA			ABC of colorectal cancer - Molecular basis for risk factors	BRITISH MEDICAL JOURNAL			English	Review							TUMORIGENESIS		Univ Hosp, Dept Med, Birmingham, W Midlands, England; Univ Hosp, Dept Surg, Birmingham, W Midlands, England; Univ Maryland, Greenbarn Canc Ctr, Funct Genom Lab, Baltimore, MD 21201 USA; Imperial Canc Res Fund, London WC2A 3PX, England	University of Birmingham; University of Birmingham; University System of Maryland; University of Maryland Baltimore; Cancer Research UK	Hardy, RG (corresponding author), Univ Hosp, Dept Med, Birmingham, W Midlands, England.		Jankowski, Janusz/H-2706-2012	Jankowski, Janusz/0000-0003-2130-9181	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Jankowski JAZ, 1998, LAB INVEST, V78, P1155; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; OATES GD, 1997, HDB CLINICOPATHOLOGI; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Tomlinson I, 1999, NAT MED, V5, P11, DOI 10.1038/4687	7	74	79	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					886	889		10.1136/bmj.321.7265.886	http://dx.doi.org/10.1136/bmj.321.7265.886			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021873	Green Published			2022-12-28	WOS:000089857500028
J	Boucher, TJ; Okuse, K; Bennett, DLH; Munson, JB; Wood, JN; McMahon, SB				Boucher, TJ; Okuse, K; Bennett, DLH; Munson, JB; Wood, JN; McMahon, SB			Potent analgesic effects of GDNF in neuropathic pain states	SCIENCE			English	Article							NERVE INJURY; NEUROTROPHIC FACTOR; SENSORY NEURONS; DRG NEURONS; RAT MODEL; AFFERENTS; LIGATION	Neuropathic pain arises as a debilitating consequence of nerve injury. The etiology of such pain is poorly understood, and existing treatment is largely ineffective. We demonstrate here that glial cell line-derived neurotrophic factor (GDNF) both prevented and reversed sensory abnormalities that developed in neuropathic pain models, without affecting pain-related behavior in normal animals. GDNF reduces ectopic discharges within sensory neurons after nerve injury. This may arise as a consequence of the reversal by GDNF of the injury-induced plasticity of several sodium channel subunits. Together these findings provide a rational basis for the use of GDNF as a therapeutic treatment for neuropathic pain states.	Kings Coll London, Ctr Res Neurosci, London SE1 7EH, England; UCL, Dept Biol, London WC1E 6BT, England	University of London; King's College London; University of London; University College London	McMahon, SB (corresponding author), Kings Coll London, Ctr Res Neurosci, London SE1 7EH, England.	stephen.mcmahon@kcl.ac.uk		Bennett, David/0000-0002-7996-2696; McMahon, Stephen/0000-0003-4656-5536				Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bian D, 1998, NEUROSCI LETT, V241, P79, DOI 10.1016/S0304-3940(98)00051-2; Black JA, 1999, J NEUROPHYSIOL, V82, P2776, DOI 10.1152/jn.1999.82.5.2776; Boucher TJ, 2000, PROG PAIN RES MANAG, V16, P175; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; Gold MS, 2000, PAIN, V84, P117, DOI 10.1016/S0304-3959(99)00309-7; KERR BJ, UNPUB; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Lai J, 2000, METHOD ENZYMOL, V314, P201; Leclere P, 1998, NEUROSCIENCE, V82, P545; Li YB, 2000, PAIN, V85, P493, DOI 10.1016/S0304-3959(00)00250-5; Liu XG, 2000, PAIN, V84, P309, DOI 10.1016/S0304-3959(99)00211-0; Michaelis M, 2000, J NEUROSCI, V20, P2742; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Ogun-Muyiwa P, 1999, NEUROREPORT, V10, P2107, DOI 10.1097/00001756-199907130-00021; OmanaZapata I, 1997, PAIN, V72, P41, DOI 10.1016/S0304-3959(97)00012-2; Ossipov MH, 1999, PAIN, V79, P127, DOI 10.1016/S0304-3959(98)00187-0; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; SHEEN K, 1993, BRAIN RES, V610, P62, DOI 10.1016/0006-8993(93)91217-G; Waxman SG, 1999, PAIN, pS133, DOI 10.1016/S0304-3959(99)00147-5; Yoon YW, 1996, PAIN, V64, P27, DOI 10.1016/0304-3959(95)00096-8	25	414	452	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					124	127		10.1126/science.290.5489.124	http://dx.doi.org/10.1126/science.290.5489.124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021795				2022-12-28	WOS:000089724800048
J	Seidel, S; Seppelt, K				Seidel, S; Seppelt, K			Xenon as a complex ligand: The tetra xenono gold(II) cation in AuXe42+(Sb2F11-)(2)	SCIENCE			English	Article							METAL-CARBONYL-COMPLEXES; RESOLVED IR SPECTROSCOPY; H BOND ACTIVATION; LIQUID RARE-GASES; KINETICS; XE; KRYPTON; ATOMS; KR	The first metal-xenon compound with direct gold-xenon bonds is achieved by reduction of AuF3 with elemental xenon. The square planar AuXe42+ cation is established by a single-crystal structure determination, with a gold-xenon bond Length of approximately 274 picometers. The bonding between gold and xenon is of the a donor type, resulting in a charge of approximately 0.4 per xenon atom.	Free Univ Berlin, Inst Chem, D-14195 Berlin, Germany	Free University of Berlin	Seppelt, K (corresponding author), Free Univ Berlin, Inst Chem, Fabeckstr 34-36, D-14195 Berlin, Germany.							BARTLETT N, 1962, P CHEM SOC LONDON, P218; BARTLETT N, 1973, COMPREHENSIVE INORGA, V1, P226; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BENGALI AA, 1995, J AM CHEM SOC, V117, P3879, DOI 10.1021/ja00118a029; BENGALI AA, 1994, J AM CHEM SOC, V116, P9585, DOI 10.1021/ja00100a024; Drews T, 1997, ANGEW CHEM INT EDIT, V36, P273, DOI 10.1002/anie.199702731; Ehlers AW, 1997, ORGANOMETALLICS, V16, P4896, DOI 10.1021/om9704962; Elder SH, 1997, J AM CHEM SOC, V119, P1020, DOI 10.1021/ja9630654; Evans CJ, 2000, J AM CHEM SOC, V122, P6100, DOI 10.1021/ja000874l; FAIRHURST SA, 1984, ORGANOMETALLICS, V3, P1389, DOI 10.1021/om00087a012; Graham L, 2000, COORDIN CHEM REV, V197, P321, DOI 10.1016/S0010-8545(99)00190-3; Kuster R, 2000, Z ANORG ALLG CHEM, V626, P236; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; McNamara BK, 1999, J AM CHEM SOC, V121, P6437, DOI 10.1021/ja9904282; PYYKKO P, 1979, ACCOUNTS CHEM RES, V12, P276, DOI 10.1021/ar50140a002; PYYKKO P, 1995, J AM CHEM SOC, V117, P2067, DOI 10.1021/ja00112a021; Schroder D, 1998, INORG CHEM, V37, P624, DOI 10.1021/ic970986m; SCHULTZ RH, 1994, J AM CHEM SOC, V116, P7369, DOI 10.1021/ja00095a047; SIMPSON MB, 1983, J CHEM SOC CHEM COMM, P1355, DOI 10.1039/c39830001355; Sun XZ, 1997, J AM CHEM SOC, V119, P7521, DOI 10.1021/ja962939j; WEILLER BH, 1993, J AM CHEM SOC, V115, P4326, DOI 10.1021/ja00063a058; WEILLER BH, 1989, J AM CHEM SOC, V111, P8288, DOI 10.1021/ja00203a045; WEILLER BH, 1992, J AM CHEM SOC, V114, P10911; WELLS JR, 1992, J AM CHEM SOC, V114, P2783, DOI 10.1021/ja00034a003	24	261	262	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					117	118		10.1126/science.290.5489.117	http://dx.doi.org/10.1126/science.290.5489.117			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021792				2022-12-28	WOS:000089724800045
J	von Andrian, UH; Mackay, CR				von Andrian, UH; Mackay, CR			Advances in immunology: T-cell function and migration - Two sides of the same coin	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HIGH ENDOTHELIAL VENULES; LEUKOCYTE ADHESION DEFICIENCY; CHEMOKINE RECEPTOR EXPRESSION; SECONDARY LYMPHOID ORGANS; P-SELECTIN; RHEUMATOID-ARTHRITIS; T-HELPER-2 CELLS; DENDRITIC CELLS; EOSINOPHIL CHEMOATTRACTANT; PHYSIOLOGICAL FLOW		Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, Boston, MA 02115 USA; Garvan Inst Med Res, Darlinghurst, NSW, Australia	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Garvan Institute of Medical Research	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Mackay, Charles R/A-9673-2008	Mackay, Charles R/0000-0002-6338-7340				Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Andrew DP, 1998, EUR J IMMUNOL, V28, P1959, DOI 10.1002/(SICI)1521-4141(199806)28:06<1959::AID-IMMU1959>3.0.CO;2-4; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Baggiolini M, 1997, J EXP MED, V186, P1189, DOI 10.1084/jem.186.8.1189; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Borges E, 1997, J EXP MED, V185, P573, DOI 10.1084/jem.185.3.573; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; CARLOS TM, 1994, BLOOD, V84, P2068; Cerwenka A, 1999, J EXP MED, V189, P423, DOI 10.1084/jem.189.2.423; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fuggle SV, 1998, TRANSPLANTATION, V65, P763, DOI 10.1097/00007890-199803270-00001; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; Gomez-Reino JJ, 1999, ARTHRITIS RHEUM-US, V42, P989, DOI 10.1002/1529-0131(199905)42:5<989::AID-ANR18>3.0.CO;2-U; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Gutierrez-Ramos JC, 1999, IMMUNOL TODAY, V20, P500, DOI 10.1016/S0167-5699(99)01522-4; Homey B, 1999, CURR OPIN IMMUNOL, V11, P626, DOI 10.1016/S0952-7915(99)00028-X; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Jung S, 1999, CURR OPIN IMMUNOL, V11, P319, DOI 10.1016/S0952-7915(99)80051-X; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kantele A, 1999, J IMMUNOL, V162, P5173; Kevil CG, 1999, AM J MED, V106, P677, DOI 10.1016/S0002-9343(99)00132-1; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kunkel EJ, 1998, J IMMUNOL, V161, P2449; Lalani AS, 2000, IMMUNOL TODAY, V21, P100, DOI 10.1016/S0167-5699(99)01556-X; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Lim YC, 1999, J IMMUNOL, V162, P3193; Lin KC, 1999, J MED CHEM, V42, P920, DOI 10.1021/jm980673g; Loetscher P, 2000, Adv Immunol, V74, P127; Lukacs NW, 1999, J CLIN INVEST, V104, P995, DOI 10.1172/JCI8125; MacDermott RP, 1999, J CLIN IMMUNOL, V19, P266, DOI 10.1023/A:1020583306627; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Oberlin E, 1996, NATURE, V384, P288, DOI 10.1038/384288a0; Oppenheimer-Marks N, 1998, SPRINGER SEMIN IMMUN, V20, P95, DOI 10.1007/BF00832001; Orme IM, 1999, IMMUNOL TODAY, V20, P307, DOI 10.1016/S0167-5699(98)01438-8; Paxton WA, 1998, SEMIN IMMUNOL, V10, P187, DOI 10.1006/smim.1998.0132; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Price DA, 1999, IMMUNOL TODAY, V20, P212, DOI 10.1016/S0167-5699(99)01447-4; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Ransohoff RM, 1999, J NEUROIMMUNOL, V98, P57, DOI 10.1016/S0165-5728(99)00082-X; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Sallusto F, 1999, CURR TOP MICROBIOL, V246, P123; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; SALMI M, 1992, P NATL ACAD SCI USA, V89, P11436, DOI 10.1073/pnas.89.23.11436; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Stein JV, 1999, J EXP MED, V189, P37, DOI 10.1084/jem.189.1.37; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Strieter RM, 1996, J IMMUNOL, V156, P3583; Syrbe U, 1999, SPRINGER SEMIN IMMUN, V21, P263, DOI 10.1007/BF00812257; Thurston G, 2000, MICROCIRCULATION, V7, P67, DOI 10.1038/sj.mn.7300155; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; Wagers AJ, 1998, J EXP MED, V188, P2225, DOI 10.1084/jem.188.12.2225; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wagner UG, 1998, P NATL ACAD SCI USA, V95, P14447, DOI 10.1073/pnas.95.24.14447; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; WEISS AA, 1986, ANNU REV MICROBIOL, V40, P661, DOI 10.1146/annurev.micro.40.1.661; Xie HJ, 1999, J EXP MED, V189, P1765, DOI 10.1084/jem.189.11.1765; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	109	1111	1176	1	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					1020	1033		10.1056/NEJM200010053431407	http://dx.doi.org/10.1056/NEJM200010053431407			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018170				2022-12-28	WOS:000089619900007
J	Sitthi-amorn, C; Somrongthong, R				Sitthi-amorn, C; Somrongthong, R			Strengthening health research capacity in developing countries: a critical element for achieving health equity	BRITISH MEDICAL JOURNAL			English	Article								Health inequity is widening between and within countries Research capacity in developing countries is weak As a result developing countries are unable to participate effectively in national and international health policy development International and national cooperation and collaboration is needed to strengthen research capacity for health development Health policy should be informed by a wide range of stakeholders and underpinned by sound evidence Greater solidarity and commitment to tackling global health inequity is needed.	Chulalongkorn Univ, Coll Publ Hlth, Bangkok 10330, Thailand	Chulalongkorn University	Sitthi-amorn, C (corresponding author), Chulalongkorn Univ, Coll Publ Hlth, Inst Bldg 3,10th Floor,Soi Chula 62,Phyathair Rd, Bangkok 10330, Thailand.		Somrongthong, Ratana/D-6814-2015	Somrongthong, Ratana/0000-0003-4425-1760				*COMM HLTH RES DEV, 1990, HLTH RES ES LINK EQ; Global Forum for Health Research, 2000, 10 90 REP HLTH RES 2; HALSTEAD SB, 1991, J CLIN EPIDEMIOL, V44, P579, DOI 10.1016/0895-4356(91)90222-U; Kaul I., 1999, GLOBAL PUBLIC GOODS; Lucas A, 1997, COOPERATION HLTH DEV; Mervis J, 1998, SCIENCE, V279, P1466, DOI 10.1126/science.279.5356.1466; *OV DEV COUNC, 1998, RX GLOB HLTH COOP 20; Perry BD, 1999, VET PARASITOL, V84, P145, DOI 10.1016/S0304-4017(99)00040-0; PICARD J, 1992, T ROY SOC TROP MED H, V86, P580, DOI 10.1016/0035-9203(92)90135-Y; Simon J, 2000, WHO M RES CAP STRENG; SITTHIAMORN C, 1999, M EFF EQ OR HLTH CAR; SITTHIAMORN C, 1996, EVALUATION HLTH SYST; SITTHIAMORN C, 2000, AS FOR HLTH RES MAN; TENDLER J, 1994, WORLD DEV, V22, P1771, DOI 10.1016/0305-750X(94)90173-2; *THAIL RAT INF SER, 2000, REP SIT RES SUPP GOV; *UN DEV PROGR, 1992, HUM DEV REP; UN Development Programme, 1994, HUM DEV REP; UNITED NATIONS DEVELOPMENT PROGRAM, 1996, HUM DEV REP; United Nations Development Programme, 1995, HUM DEV REP; United Nations Development Programme, 1993, HUM DEV REP	21	87	90	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					813	815		10.1136/bmj.321.7264.813	http://dx.doi.org/10.1136/bmj.321.7264.813			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009525	Green Published			2022-12-28	WOS:000089696600027
J	Pham, AD; Sauer, F				Pham, AD; Sauer, F			Ubiquitin-activating/conjugating activity of TAF(II)250, a mediator of activation of gene expression in Drosophila	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATION; MACRONUCLEI; NUCLEOSOME; SUBUNIT; PROTEIN; TAFS	Ubiquitination of histones has been linked to the complex processes that regulate the activation of eukaryotic transcription. However, the cellular factors that interpose this histone modification during the processes of transcriptional activation are not well characterized. A biochemical approach identified the Drosophila coactivator TAF(II)250, the central subunit within the general transcription factor TFIID, as a histone-specific ubiquitin-activating/conjugating enzyme (ubac). TAF(II)250 mediates monoubiquitination of histone H1 in vitro. Point mutations within the putative ubac domain of TAF(II)250 abolished H1-specific ubiquitination in vitro. In the Drosophila embryo, inactivation of the TAF(II)250 ubac activity reduces the cellular level of monoubiquitinated histone H1 and the expression of genes targeted by the maternal activator Dorsal. Thus, coactivator-mediated ubiquitination of proteins within the transactivation pathway may contribute to the processes directing activation of eukaryotic transcription.	Univ Heidelberg ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sauer, F (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.							Austin RJ, 1996, P NATL ACAD SCI USA, V93, P5788, DOI 10.1073/pnas.93.12.5788; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; DAVIE JR, 1991, BIOCHEM CELL BIOL, V69, P66, DOI 10.1139/o91-009; DAVIE JR, 1990, BIOCHEMISTRY-US, V29, P4752, DOI 10.1021/bi00472a002; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Georgel PT, 1997, EMBO J, V16, P4717, DOI 10.1093/emboj/16.15.4717; HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Howe L, 1999, CRIT REV EUKAR GENE, V9, P231, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.80; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Pham AD, 1999, MECH DEVELOP, V84, P3, DOI 10.1016/S0925-4773(99)00051-9; PHARN AD, UNPUB; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; VANHOLDE KE, 1988, CHROMATIN, P111; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Wassarman DA, 2000, P NATL ACAD SCI USA, V97, P1154, DOI 10.1073/pnas.97.3.1154; WEINZIERL ROJ, 1993, NATURE, V362, P511, DOI 10.1038/362511a0; Wimmer EA, 1996, MECH DEVELOP, V59, P53, DOI 10.1016/0925-4773(96)00575-8	21	190	200	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2357	2360		10.1126/science.289.5488.2357	http://dx.doi.org/10.1126/science.289.5488.2357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009423				2022-12-28	WOS:000089593500055
J	Lounis, B; Moerner, WE				Lounis, B; Moerner, WE			Single photons on demand from a single molecule at room temperature	NATURE			English	Article							TURNSTILE DEVICE; P-TERPHENYL; FLUORESCENCE; GENERATION; CAVITY; SPECTROSCOPY; STATISTICS; TERRYLENE; SURFACE; SYSTEM	The generation of non-classical states of light(1) is of fundamental scientific and technological interest. For example, `squeezed' states(2) enable measurements to be performed at lower noise levels than possible using classical light. Deterministic (or triggered) single-photon sources exhibit non-classical behaviour in that they emit, with a high degree of certainty, just one photon at a user-specified time. (In contrast, a classical source such as an attenuated pulsed laser emits photons according to Poisson statistics.) A deterministic source of single photons could rnd applications in quantum information processing(3), quantum cryptography(4) and certain quantum computation problems(5). Here we realize a controllable source of single photons using optical pumping of a single molecule in a solid. Triggered single photons are produced at a high rate, whereas the probability of simultaneous emission of two photons is nearly zero-a useful property for secure quantum cryptography. Our approach is characterized by simplicity, room temperature operation and improved performance compared to other triggered sources of single photons.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France	Stanford University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Moerner, WE (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.		Lounis, Brahim/I-7862-2016; Moerner, William E/C-3260-2008	Lounis, Brahim/0000-0001-7501-0236; Moerner, William E/0000-0002-2830-209X				Ambrose WP, 1997, CHEM PHYS LETT, V269, P365, DOI 10.1016/S0009-2614(97)00266-2; AMBROSE WP, 1994, PHYS REV LETT, V72, P160, DOI 10.1103/PhysRevLett.72.160; BASCHE T, 1992, PHYS REV LETT, V69, P1516, DOI 10.1103/PhysRevLett.69.1516; BENNETT CH, 1992, SCI AM, V267, P50, DOI 10.1038/scientificamerican1092-50; Brunel C, 1999, PHYS REV LETT, V83, P2722, DOI 10.1103/PhysRevLett.83.2722; Buttler WT, 1998, PHYS REV LETT, V81, P3283, DOI 10.1103/PhysRevLett.81.3283; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; De Martini F, 1996, PHYS REV LETT, V76, P900, DOI 10.1103/PhysRevLett.76.900; DRUMMOND PD, 1999, QUANTUM SQUEEZING; Fleury L, 1998, MOL PHYS, V95, P1333, DOI 10.1080/00268979809483263; Fleury L, 2000, PHYS REV LETT, V84, P1148, DOI 10.1103/PhysRevLett.84.1148; IMAMOGLU A, 1994, PHYS REV LETT, V72, P210, DOI 10.1103/PhysRevLett.72.210; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; Kim J, 1999, NATURE, V397, P500, DOI 10.1038/17295; KISTON SC, 1998, PHYS REV A, V58, P620; Kuhn A, 1999, APPL PHYS B-LASERS O, V69, P373, DOI 10.1007/s003400050822; Kulzer F, 1999, CHEM PHYS, V247, P23, DOI 10.1016/S0301-0104(99)00100-7; KUMMER S, 1994, CHEM PHYS LETT, V229, P309, DOI 10.1016/0009-2614(94)01043-9; MANDEL L, 1979, OPT LETT, V4, P205, DOI 10.1364/OL.4.000205; Meystre P, 1991, ELEMENTS QUANTUM OPT; Miller GD, 1997, OPT LETT, V22, P1834, DOI 10.1364/OL.22.001834; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; PARKINS AS, 1995, PHYS REV A, V51, P1578, DOI 10.1103/PhysRevA.51.1578; PLAKHOTNIK T, 1995, OPT COMMUN, V114, P83, DOI 10.1016/0030-4018(94)00594-K; SHORT R, 1983, PHYS REV LETT, V51, P384, DOI 10.1103/PhysRevLett.51.384; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; 1998, PHYS WORLD, V11	28	654	671	3	201	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					491	493		10.1038/35035032	http://dx.doi.org/10.1038/35035032			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028995				2022-12-28	WOS:000089727400043
J	Neumann, CJ; Nuesslein-Volhard, C				Neumann, CJ; Nuesslein-Volhard, C			Patterning of the zebrafish retina by a wave of sonic hedgehog activity	SCIENCE			English	Article							POLARITY GENE HEDGEHOG; TRANSGENIC ZEBRAFISH; DROSOPHILA EYE; FLOOR PLATE; DIFFERENTIATION; EXPRESSION; ACTIVATION; INDUCTION; TISSUES; CELLS	The Drosophila retina is patterned by a morphogenetic wave driven by the Hedgehog signaling protein. Hedgehog, secreted by the first neurons, induces neuronal differentiation and hedgehog expression in nearby uncommitted cells, thereby propagating the wave. Evidence is presented here that the zebrafish Hedgehog homolog, Sonic Hedgehog, is also expressed in the first retinal neurons, and that Sonic Hedgehog drives a wave of neurogenesis across the retina, strikingly similar to the wave in Drosophila. The conservation of this patterning mechanism is unexpected, given the highly divergent structures of vertebrate and invertebrate eyes, and supports a common evolutionary origin of the animal visual system.	Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany	Max Planck Society	Neumann, CJ (corresponding author), Max Planck Inst Entwicklungsbiol, Spemannstr 35-III, D-72076 Tubingen, Germany.							Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Greenwood S, 1999, DEVELOPMENT, V126, P5795; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; HEBERLEIN U, 1995, NATURE, V373, P709, DOI 10.1038/373709a0; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jensen AM, 1997, DEVELOPMENT, V124, P363; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Levine EM, 1997, J NEUROSCI, V17, P6277; Long QM, 1997, DEVELOPMENT, V124, P4105; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Malicki J, 1996, DEVELOPMENT, V123, P263; McCabe KL, 1999, DEVELOPMENT, V126, P5713; Muller F, 1999, DEVELOPMENT, V126, P2103; Neumann C.C M., UNPUB; Neumann CJ, 1999, DEVELOPMENT, V126, P4817; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Stenkamp DL, 2000, DEV BIOL, V220, P238, DOI 10.1006/dbio.2000.9629; Takabatake T, 1997, FEBS LETT, V410, P485, DOI 10.1016/S0014-5793(97)00645-5; Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8; WESTERFIELD M, 1992, GENE DEV, V6, P591, DOI 10.1101/gad.6.4.591	26	282	284	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2137	2139		10.1126/science.289.5487.2137	http://dx.doi.org/10.1126/science.289.5487.2137			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000118				2022-12-28	WOS:000089430900048
J	Parlati, F; McNew, JA; Fukuda, R; Miller, R; Sollner, TH; Rothman, JE				Parlati, F; McNew, JA; Fukuda, R; Miller, R; Sollner, TH; Rothman, JE			Topological restriction of SNARE-dependent membrane fusion	NATURE			English	Article							YEAST SECRETORY PATHWAY; GOLGI-COMPLEX; V-SNARE; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; PROTEIN; VESICLES; IDENTIFICATION; ACTIVATION; ENCODES	To fuse transport vesicles with target membranes, proteins of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) complex must be located on both the vesicle (v-SNARE) and the target membrane (t-SNARE)(1). In yeast, four integral membrane proteins, Sed5, Bos1, Sec22 and Bet1 (refs 2-6), each probably contribute a single helix to form the SNARE complex that is needed for transport from endoplasmic reticulum to Golgi(7-11). This generates a four-helix bundle(12), which ultimately mediates the actual fusion event(13). Here we explore how the anchoring arrangement of the four helices affects their ability to mediate fusion. We reconstituted two populations of phospholipid bilayer vesicles, with the individual SNARE proteins distributed in all possible combinations between them. Of the eight non-redundant permutations of four subunits distributed over two vesicle populations, only one results in membrane fusion. Fusion only occurs when the v-SNARE Bet1 is on one membrane and the syntaxin heavy chain Sed5 and its two light chains, Bos1 and Sec22, are on the other membrane where they form a functional t-SNARE. Thus, each SNARE protein is topologically restricted by design to function either as a v-SNARE or as part of a t-SNARE complex.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Rothman, JE (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave,Box 251, New York, NY 10021 USA.		McNew, James/ABD-8081-2020; McNew, James/AAV-4911-2020	McNew, James/0000-0001-8459-3664				Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; BOEHM J, 1994, EMBO J, V13, P3696, DOI 10.1002/j.1460-2075.1994.tb06679.x; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; NEWMAN AP, 1987, J CELL BIOL, V105, P1587, DOI 10.1083/jcb.105.4.1587; NEWMAN AP, 1990, MOL CELL BIOL, V10, P3405, DOI 10.1128/MCB.10.7.3405; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Sacher M, 1997, J BIOL CHEM, V272, P17134, DOI 10.1074/jbc.272.27.17134; SHIM J, 1991, J CELL BIOL, V113, P55, DOI 10.1083/jcb.113.1.55; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stone S, 1997, MOL BIOL CELL, V8, P1175, DOI 10.1091/mbc.8.7.1175; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEBER T, 2000, J CELL BIOL, V149; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	30	195	206	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					194	198		10.1038/35025076	http://dx.doi.org/10.1038/35025076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001058				2022-12-28	WOS:000089241000050
J	Simeonov, A; Matsushita, M; Juban, EA; Thompson, EHZ; Hoffman, TZ; Beuscher, AE; Taylor, MJ; Wirsching, P; Rettig, W; McCusker, JK; Stevens, RC; Millar, DP; Schultz, PG; Lerner, RA; Janda, KD				Simeonov, A; Matsushita, M; Juban, EA; Thompson, EHZ; Hoffman, TZ; Beuscher, AE; Taylor, MJ; Wirsching, P; Rettig, W; McCusker, JK; Stevens, RC; Millar, DP; Schultz, PG; Lerner, RA; Janda, KD			Blue-fluorescent antibodies	SCIENCE			English	Article							COHERENT REACTION DYNAMICS; CIS-STILBENE FLUORESCENCE; EXCIMER FLUORESCENCE; TRANS-STILBENE; QUANTUM YIELDS; PHOTOISOMERIZATION; PHOTOCHEMISTRY; ISOMERIZATION; CYCLODEXTRIN; PHOTOPHYSICS	The forte of catalytic antibodies has resided in the control of the ground-state reaction coordinate. A principle and method are now described in which antibodies can direct the outcome of photophysical and photochemical events that take place on excited-state potential energy surfaces. The key component is a chemically reactive optical sensor that provides a direct report of the dynamic interplay between protein and Ligand at the active site. To illustrate the concept, we used a trans-stilbene hapten to elicit a panel of monoclonal antibodies that displayed a range of fluorescent spectral behavior when bound to a trans-stilbene substrate. Several antibodies yielded a blue fluorescence indicative of an excited-state complex or "exciplex" between trans-stilbene and the antibody. The antibodies controlled the isomerization coordinate of trans-stilbene and dynamically coupled this manifold with an active-site residue. A step was taken toward the use of antibody-based photochemical sensors for diagnostic and clinical applications.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Humboldt Univ, Inst Phys & Theoret Chem, D-10117 Berlin, Germany	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Berkeley; Scripps Research Institute; Humboldt University of Berlin	Simeonov, A (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Stevens, Raymond/K-7272-2015	Stevens, Raymond/0000-0002-4522-8725	NCI NIH HHS [P01CA27489] Funding Source: Medline; NIAID NIH HHS [AI39089] Funding Source: Medline; NIGMS NIH HHS [GM43858] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA027489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039089, R01AI039089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM043858, R01GM043858] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGBARIA RA, 1995, J PHYS CHEM-US, V99, P10056, DOI 10.1021/j100024a057; BIRKS JB, 1975, CHEM PHYS LETT, V31, P608, DOI 10.1016/0009-2614(75)85098-6; COURTNEIDGE JL, 1987, J CHEM SOC PERK T 2, P1527, DOI 10.1039/p29870001527; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; DUVENECK GL, 1989, J PHYS CHEM-US, V93, P7166, DOI 10.1021/j100357a028; Exner O., 1988, CORRELATION ANAL CHE; GOMER H, 1995, ADV PHOTOCHEM, V19, P1; GUEST CR, 1991, BIOCHEMISTRY-US, V30, P3271, DOI 10.1021/bi00227a015; Kistiakowsky GB, 1934, J AM CHEM SOC, V56, P638, DOI 10.1021/ja01318a029; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LAARHOVEN WH, 1990, PHOTOCHROMISM MOL SY, P282; LEWIS FD, 1995, J AM CHEM SOC, V117, P8785, DOI 10.1021/ja00139a011; LEWIS FD, 1995, J AM CHEM SOC, V117, P660, DOI 10.1021/ja00107a010; Liebl U, 1999, NATURE, V401, P181, DOI 10.1038/43699; MALKIN S, 1964, J PHYS CHEM-US, V68, P1153, DOI 10.1021/j100787a032; OGAWA K, 1988, J CHEM SOC PERK T 2, P39, DOI 10.1039/p29880000039; PALMANS JP, 1984, J AM CHEM SOC, V106, P7721, DOI 10.1021/ja00337a014; PETEK H, 1990, J PHYS CHEM-US, V94, P7539, DOI 10.1021/j100382a043; RETTIG W, 1993, PURE APPL CHEM, V65, P1699, DOI 10.1351/pac199365081699; SALTIEL J, 1972, J AM CHEM SOC, V94, P6445, DOI 10.1021/ja00773a031; SALTIEL J, 1990, J AM CHEM SOC, V112, P4580, DOI 10.1021/ja00167a086; SALTIEL J, 1967, J AM CHEM SOC, V89, P1036, DOI 10.1021/ja00980a057; SALTIEL J, 1993, J AM CHEM SOC, V115, P2453, DOI 10.1021/ja00059a047; SALTIEL J, 1979, J AM CHEM SOC, V101, P2982, DOI 10.1021/ja00505a027; SALTIEL J, 1993, J PHYS CHEM-US, V97, P2516, DOI 10.1021/j100113a009; SALTIEL J, 1990, STUD ORG CHEM, V40, P64; SALTIEL J, 1968, J AM CHEM SOC, V90, P4759, DOI 10.1021/ja01019a063; SCHULTZ PG, 1995, SCIENCE, V269, P1835, DOI 10.1126/science.7569920; SIMEONOV AM, UNPUB; SYAMALA MS, 1986, J PHOTOCHEM, V34, P219, DOI 10.1016/0047-2670(86)85021-3; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; WALDECK DH, 1991, CHEM REV, V91, P415, DOI 10.1021/cr00003a007; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; Wentworth P, 1998, CURR OPIN CHEM BIOL, V2, P138, DOI 10.1016/S1367-5931(98)80046-X; ZHU LY, 1994, SCIENCE, V266, P629, DOI 10.1126/science.7939716	36	94	99	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					307	313		10.1126/science.290.5490.307	http://dx.doi.org/10.1126/science.290.5490.307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030644				2022-12-28	WOS:000089818100036
J	Gabrick, DM; Hartmann, LC; Cerhan, JR; Vierkant, RA; Therneau, TM; Vachon, CM; Olson, JE; Couch, FJ; Anderson, KE; Pankratz, VS; Sellers, TA				Gabrick, DM; Hartmann, LC; Cerhan, JR; Vierkant, RA; Therneau, TM; Vachon, CM; Olson, JE; Couch, FJ; Anderson, KE; Pankratz, VS; Sellers, TA			Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEREDITARY OVARIAN-CANCER; FINAL REPORT; FOLLOW-UP	Context Oral contraceptive (OC) use is weakly associated with breast cancer risk in the general population, but the association among women with a familial predisposition to breast cancer is less clear. Objective To determine whether the association between OC use and risk of breast cancer is influenced by family history of the disease. Design and Setting Historical cohort study of 426 families of breast cancer probands diagnosed between 1944 and 1952 at the Tumor Clinic of the University of Minnesota Hospital. Follow-up data on families were collected by telephone interview between 1991 and 1996. Participants A total of 394 sisters and daughters of the probands, 3002 grand daughters and nieces, and 2754 women who married into the families. Main Outcome Measure Relative risk (RR) of breast cancer associated with history of OC use by relationship to proband. Results After accounting for age and birth cohort, ever having used OCs was associated with significantly increased risk of breast cancer among sisters and daughters of the probands (RR, 3.3; 95% confidence interval [CI], 1.6-6.7), but not among granddaughters and nieces of the probands (RR, 1.2, 95% CI, 0.8-2.0) or among marry-ins (RR, 1.2, 95% CI, 0.8-1.9). Results were essentially unchanged after adjustment for parity, age at first birth, age at menarche, age at menopause, oophorectomy, smoking, and education. The elevated risk among women with a first-degree family history of breast cancer was most evident for OC use during or prior to 1975, when formulations were likely to contain higher dosages of estrogen and progestins (RR, 3.3; 95% CI, 1.5-7.2). A small number of breast cancer cases (n = 2) limited the statistical power to detect risk among women with a first-degree relative with breast cancer and OC use after 1975. Conclusions These results suggest that women who have ever used earlier formulations of OCs and who also have a first-degree relative with breast cancer may be at particularly high risk for breast cancer. Further studies of women with a strong family history who have used more recent lower-dosage formulations of OCs are needed to determine how women with a familial predisposition to breast cancer should be advised regarding OC use today.	Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin, Dept Med Oncol, Rochester, MN USA; Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; Mayo Clin, Dept Biochem, Rochester, MN USA; Mayo Clin, Dept Mol Biol, Rochester, MN USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Canc, Minneapolis, MN USA; Mayo Clin, Ctr Canc, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Sellers, TA (corresponding author), Mayo Clin, Dept Hlth Sci Res, 200 1st St SW, Rochester, MN 55905 USA.		Vierkant, Robert/AAP-4927-2020	Vierkant, Robert/0000-0001-6242-5221; Cerhan, James/0000-0002-7482-178X	NATIONAL CANCER INSTITUTE [K07CA064220, R01CA055747] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA55747, K07-CA64220] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON VE, 1958, VARIABLES RELATED HU; BLACK MM, 1980, CANCER, V46, P27247; BRINTON LA, 1995, J NATL CANCER I, V87, P827, DOI 10.1093/jnci/87.11.827; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; *CDC CANC STER HOR, 1983, JAMA-J AM MED ASSOC, V249, P1591; CHILVERS CED, 1990, LANCET, V335, P1507, DOI 10.1016/0140-6736(90)93038-Q; Colditz GA, 1996, J NATL CANCER I, V88, P365, DOI 10.1093/jnci/88.6.365; Cox DR, 1972, J ROYAL STAT SOC B, V34, P87; Egan KM, 1998, CANCER EPIDEM BIOMAR, V7, P359; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; HARRIS RE, 1990, INT J EPIDEMIOL, V19, P240, DOI 10.1093/ije/19.2.240; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; LIPNICK RJ, 1986, JAMA-J AM MED ASSOC, V255, P58, DOI 10.1001/jama.255.1.58; Little R. J. A., 1987, STAT ANAL MISSING DA; LITTLE RJA, 1998, ENCY BIOSTATISTICS, P2272; MILLER DR, 1989, AM J EPIDEMIOL, V129, P269, DOI 10.1093/oxfordjournals.aje.a115132; MISHELL DR, 1997, TXB INFERTILITY CONT, P800; MURRAY PP, 1989, OBSTET GYNECOL, V73, P977; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; NISCHAN P, 1993, AM J EPIDEMIOL, V138, P697, DOI 10.1093/oxfordjournals.aje.a116907; PAUL C, 1990, INT J CANCER, V46, P366, DOI 10.1002/ijc.2910460305; PUGH M, 1992, INFERENCE COX PROPOR; RAVNIHAR B, 1988, NEOPLASMA, V35, P109; ROHAN TE, 1988, MED J AUSTRALIA, V149, P520, DOI 10.5694/j.1326-5377.1988.tb120759.x; Rosenberg L, 1996, AM J EPIDEMIOL, V143, P25; Rubin SC, 1998, NEW ENGL J MED, V339, P469, DOI 10.1056/NEJM199808133390710; SELLERS TA, 1995, GENET EPIDEMIOL, V12, P417, DOI 10.1002/gepi.1370120409; TAVANI A, 1993, BRIT J CANCER, V68, P568, DOI 10.1038/bjc.1993.387; Ursin G, 1998, BREAST CANCER RES TR, V50, P175, DOI 10.1023/A:1006037823178; Ursin G, 1997, CANCER RES, V57, P3678; VESSEY M, 1983, BRIT J CANCER, V47, P455, DOI 10.1038/bjc.1983.74	32	143	146	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1791	1798		10.1001/jama.284.14.1791	http://dx.doi.org/10.1001/jama.284.14.1791			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025831	Bronze			2022-12-28	WOS:000089622100030
J	Low, K; Crestani, F; Keist, R; Benke, D; Brunig, I; Benson, JA; Fritschy, JM; Rulicke, T; Bluethmann, H; Mohler, H; Rudolph, U				Low, K; Crestani, F; Keist, R; Benke, D; Brunig, I; Benson, JA; Fritschy, JM; Rulicke, T; Bluethmann, H; Mohler, H; Rudolph, U			Molecular and neuronal substrate for the selective attenuation of anxiety	SCIENCE			English	Article							ALPHA-SUBUNITS; LOCALIZATION; RECEPTORS; MOUSE	Benzodiazepine tranquilizers are used in the treatment of anxiety disorders. To identify the molecular and neuronal target mediating the anxiolytic action of benzodiazepines, we generated and analyzed two mouse lines in which the alpha 2 or alpha 3 GABA(A) (gamma-aminobutyric acid type A) receptors, respectively, were rendered insensitive to diazepam by a knock-in point mutation. The anxiolytic action of diazepam was absent in mice with the alpha 2(H101R) point mutation but present in mice with the alpha 3(H126R) point mutation. These findings indicate that the anxiolytic effect of benzodiazepine drugs is mediated by alpha 2 GABA(A) receptors, which are largely expressed in the limbic system, but not by alpha 3 GABA(A) receptors, which predominate in the reticular activating system.	Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland; Univ Zurich Hosp, Biol Cent Lab, CH-8091 Zurich, Switzerland; F Hoffmann La Roche & Co Ltd, Dept Pharma Res Gene Technol, CH-4002 Basel, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; Roche Holding	Rudolph, U (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Low, Karin/0000-0002-5052-3892; Fritschy, Jean-Marc/0000-0002-8552-3702				Benson JA, 1998, FEBS LETT, V431, P400, DOI 10.1016/S0014-5793(98)00803-5; BONETTI EP, 1988, PHARMACOL BIOCHEM BE, V31, P733, DOI 10.1016/0091-3057(88)90259-6; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; MISSLIN R, 1989, BEHAV PROCESS, V18, P119, DOI 10.1016/S0376-6357(89)80010-5; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; SHADER RI, 1993, NEW ENGL J MED, V328, P1398; WIELAND HA, 1992, J BIOL CHEM, V267, P1426	12	740	768	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					131	134		10.1126/science.290.5489.131	http://dx.doi.org/10.1126/science.290.5489.131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021797				2022-12-28	WOS:000089724800050
J	Kurlemann, G; Debus, O				Kurlemann, G; Debus, O			A medical mystery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Munster, D-48129 Munster, Germany	University of Munster	Kurlemann, G (corresponding author), Univ Munster, D-48129 Munster, Germany.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					1019	1019		10.1056/NEJM200010053431406	http://dx.doi.org/10.1056/NEJM200010053431406			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018169				2022-12-28	WOS:000089619900006
J	Khan, AS; Morse, S; Lillibridge, S				Khan, AS; Morse, S; Lillibridge, S			Public-health preparedness for biological terrorism in the USA	LANCET			English	Review							MANAGEMENT; EMERGENCY; PROGRAMS; OUTBREAK; ANTHRAX; WEAPON; IMPACT; ATTACK		Ctr Dis Control & Prevent, Bioterrorism Preparedness & Response Program, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Khan, AS (corresponding author), Ctr Dis Control & Prevent, Bioterrorism Preparedness & Response Program, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.							Alibek K, 1999, BIOHAZARD CHILLING T; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; BROAD WJ, 1999, NY TIME         0613; *COMM RD NEEDS IMP, 1999, CHEM BIOL TERR RES D; Davis CJ, 1999, EMERG INFECT DIS, V5, P509, DOI 10.3201/eid0504.990408; Departments of the Army Navy and Air Force, 1996, NATO HDB MED ASP NBC; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Hogan DE, 1999, ANN EMERG MED, V34, P160, DOI 10.1016/S0196-0644(99)70224-6; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; JANOFSKY M, 1995, NY TIMES        0524, pA12; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; LANGMUIR AD, 1952, AM J PUBLIC HEALTH, V42, P235; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; Okumura T, 1998, ACAD EMERG MED, V5, P613, DOI 10.1111/j.1553-2712.1998.tb02470.x; PRESTON R, 1997, COBRA EVENT; *ROYAL SOC GROUP, 2000, MEAS CONTR THREAT BI; Stephenson J, 1997, JAMA-J AM MED ASSOC, V277, P1337, DOI 10.1001/jama.277.17.1337; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; TUCKER JB, 1996, POLIT LIFE SCI, P170	20	114	121	2	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2000	356	9236					1179	1182		10.1016/S0140-6736(00)02769-0	http://dx.doi.org/10.1016/S0140-6736(00)02769-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	359CQ	11030310				2022-12-28	WOS:000089594300041
J	Eom, J; Cho, H; Kang, W; Campman, KL; Gossard, AC; Bichler, T; Wegscheider, W				Eom, J; Cho, H; Kang, W; Campman, KL; Gossard, AC; Bichler, T; Wegscheider, W			Quantum Hall ferromagnetism in a two-dimensional electron system	SCIENCE			English	Article							PHASE-TRANSITIONS; MAGNETIC-RELAXATION; GROUND-STATES; LANDAU-LEVEL; SPIN; HETEROSTRUCTURES	Experiments on a nearly spin degenerate two-dimensional electron system reveals unusual hysteretic and relaxational transport in the fractional quantum Hall effect regime. The transition between the spin-polarized (with fill fraction nu = 1/3) and spin-unpolarized (nu = 2/5) states is accompanied by a complicated series of hysteresis. loops reminiscent of a classical, ferromagnet, In correlation with the hysteresis, magnetoresistance can either grow or decay Logarithmically in time with remarkable persistence and does not saturate. In contrast to the established models of relaxation, the relaxation rate exhibits an anomalous divergence as temperature is reduced. These results indicate the presence of novel two-dimensional ferromagnetism with a complicated magnetic domain dynamic.	Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Calif Santa Barbara, Dept Elect Engn, Santa Barbara, CA 93106 USA; Tech Univ Munich, Walter Schottky Inst, D-85748 Garching, Germany; Univ Regensburg, D-8400 Regensburg, Germany	University of Chicago; University of Chicago; University of California System; University of California Santa Barbara; Technical University of Munich; University of Regensburg	Kang, W (corresponding author), Univ Chicago, James Franck Inst, Chicago, IL 60637 USA.	wkang@midway.uchicago.edu	Wegscheider, Werner H/D-1493-2010					Alberici-Kious F, 1998, PHYS REV LETT, V81, P4987, DOI 10.1103/PhysRevLett.81.4987; Bayot V, 1997, PHYS REV LETT, V79, P1718, DOI 10.1103/PhysRevLett.79.1718; BROWN WF, 1963, PHYS REV, V130, P1677, DOI 10.1103/PhysRev.130.1677; Cho H, 1998, PHYS REV LETT, V81, P2522, DOI 10.1103/PhysRevLett.81.2522; CHUDNOVSKY EM, 1988, PHYS REV LETT, V60, P661, DOI 10.1103/PhysRevLett.60.661; CLARK RG, 1989, PHYS REV LETT, V62, P1536, DOI 10.1103/PhysRevLett.62.1536; DOBERS M, 1988, PHYS REV LETT, V61, P1650, DOI 10.1103/PhysRevLett.61.1650; DU RR, 1995, PHYS REV LETT, V75, P3926, DOI 10.1103/PhysRevLett.75.3926; EISENSTEIN JP, 1990, PHYS REV B, V41, P7910, DOI 10.1103/PhysRevB.41.7910; EISENSTEIN JP, 1989, PHYS REV LETT, V62, P1540, DOI 10.1103/PhysRevLett.62.1540; ENGEL LW, 1992, PHYS REV B, V45, P3418, DOI 10.1103/PhysRevB.45.3418; ENZ M, 1986, J PHYS C SOLID STATE, V19, P1765, DOI 10.1088/0022-3719/19/11/014; EOM J, UNPUB; GUNTHER L, 1995, QUANTUM TUNNELING E, V301; Jungwirth T, 1998, PHYS REV LETT, V81, P2328, DOI 10.1103/PhysRevLett.81.2328; LOTTIS DK, 1991, PHYS REV LETT, V67, P362, DOI 10.1103/PhysRevLett.67.362; MacDonald AH, 1999, PHYS REV B, V60, P8817, DOI 10.1103/PhysRevB.60.8817; Melinte S, 1999, PHYS REV LETT, V82, P2764, DOI 10.1103/PhysRevLett.82.2764; MURPHY SQ, 1994, PHYS REV LETT, V72, P728, DOI 10.1103/PhysRevLett.72.728; Piazza V, 1999, NATURE, V402, P638, DOI 10.1038/45189; Prange R. E., 1990, QUANTUM HALL EFFECT; PREJEAN JJ, 1980, J PHYS-PARIS, V41, P1335, DOI 10.1051/jphys:0198000410110133500; Sarma Sankar Das, 1997, PERSPECTIVES QUANTUM; Sawada A, 1998, PHYS REV LETT, V80, P4534, DOI 10.1103/PhysRevLett.80.4534; Sondhi SL, 1997, REV MOD PHYS, V69, P315, DOI 10.1103/RevModPhys.69.315; VANHEMMEN JL, 1986, EUROPHYS LETT, V1, P481, DOI 10.1209/0295-5075/1/10/001; Vincent E, 1997, LECT NOTES PHYS, V492, P184; WEGROWE JE, 1995, PHYS REV B, V52, P3466, DOI 10.1103/PhysRevB.52.3466; Wegrowe JE, 1997, EUROPHYS LETT, V38, P329, DOI 10.1209/epl/i1997-00247-9; WEI HP, 1988, PHYS REV LETT, V61, P1294, DOI 10.1103/PhysRevLett.61.1294; WEI HP, 1986, PHYS REV B, V33, P1488, DOI 10.1103/PhysRevB.33.1488; WIEGERS SAJ, 1997, PHYS REV LETT, V79, P3228; Yamazaki H, 1996, J MAGN MAGN MATER, V156, P135, DOI 10.1016/0304-8853(95)00816-0; YANG K, 1994, PHYS REV LETT, V72, P732, DOI 10.1103/PhysRevLett.72.732	34	63	63	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2320	2323		10.1126/science.289.5488.2320	http://dx.doi.org/10.1126/science.289.5488.2320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009411	Green Submitted			2022-12-28	WOS:000089593500043
J	Larson, DG; Tobin, DR				Larson, DG; Tobin, DR			End-of-life conversations - Evolving practice and theory	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVANCE DIRECTIVES; PALLIATIVE MEDICINE; DECISION-MAKING; SELF-EFFICACY; CARE; CANCER; COMMUNICATION; PERSPECTIVES; QUALITY	This article examines the evolution of and need for "end-of-life conversations." Barriers to end-of-life discussions that have been identified in patients and families, health care professionals, and health cave systems can seriously interfere with the quality of remaining life for terminally ill patients. Strategies for enhancing end-of-life discussions are most productively linked to (1) physicians' interpersonal communication skills, (2) a patient-centered model of care, (3) a focus on quality of remaining life, and (4) innovative clinical models for implementing these discussions earlier in the care process. We conclude that end-of-life conversations must become a routine, structured intervention in health care and that advance care planning is best viewed as one component in a series of ongoing end-of-life discussions. Randomized trials are needed to examine new approaches and models for enhancing end-of-life conversations.	Vet Affairs Hlth Care Network Upstate New York, Albany, NY 12208 USA; Santa Clara Univ, Dept Counseling Psychol, Santa Clara, CA 95053 USA	Santa Clara University	Tobin, DR (corresponding author), Vet Affairs Hlth Care Network Upstate New York, 113 Holland Ave,111T, Albany, NY 12208 USA.	daniel.tobin@med.va.gov						Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Becker Ernest, 1973, DENIAL DEATH; Beckham JC, 1997, BEHAV MED, V23, P138, DOI 10.1080/08964289709596370; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; Buckman R., 1992, BREAK BAD NEWS GUIDE; BURGER JM, 1989, J PERS SOC PSYCHOL, V56, P246, DOI 10.1037/0022-3514.56.2.246; Byock I, 1997, DYING WELL PROSPECT; Byock IR, 1996, CLIN GERIATR MED, V12, P237; CASSEL EJ, 1989, NEW ENGL J MED, V306, P639; Chen A., 2000, BEST PRACTICES COORD; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Connor S, 1998, HOSPICE PRACTICE PIT; Connor S R, 1999, Hosp J, V14, P193; Cugliari AM, 1999, AM J HEALTH BEHAV, V23, P105, DOI 10.5993/AJHB.23.2.3; EMANUEL L, 1999, ED PHYSICIANS END LI; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; EMANUEL LL, 1995, STRUCTURED DELIBRA S; EPSTEIN RM, 1993, J FAM PRACTICE, V37, P377; FAULKNER A, 1991, PATIENT EDUC COUNS, V18, P3, DOI 10.1016/0738-3991(91)90073-E; Field MJ, 1997, APPROACHING DEATH IM; Fins JJ, 1999, J PAIN SYMPTOM MANAG, V17, P6, DOI 10.1016/S0885-3924(98)00109-2; FORD S, 1994, BRIT J CANCER, V70, P767, DOI 10.1038/bjc.1994.393; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Gallagher TH, 1999, TEACH LEARN MED, V11, P142, DOI 10.1207/S15328015TL110304; GERTEIS M, 1993, PATIENTS EYES, P1; GOLDSTEIN MG, 1998, HDB HLTH BEHAV CHANG, P85; Greene MG, 1996, RES AGING, V18, P84, DOI 10.1177/0164027596181006; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; HAVERMANS T, 1994, CHILD CARE HLTH DEV, V20, P309, DOI 10.1111/j.1365-2214.1994.tb00393.x; Heaven CM, 1997, PALLIATIVE MED, V11, P283, DOI 10.1177/026921639701100404; Hinton J, 1998, J PALLIATIVE CARE, V14, P15, DOI 10.1177/082585979801400305; Hockley JM, 1998, HOSP BASED PALLIATIV; JARRETT N, 1995, J ADV NURS, V22, P72, DOI 10.1046/j.1365-2648.1995.22010072.x; Kleinman A., 1988, ILLNESS NARRATIVES; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Laine C, 1996, JAMA-J AM MED ASSOC, V275, P152, DOI 10.1001/jama.275.2.152; Larson D. G., 1993, HELPERS JOURNEY WORK; Larson Dale G., 1993, Journal of Psychosocial Oncology, V11, P1; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; LO B, 1995, JAMA-J AM MED ASSOC, V274, P1634, DOI 10.1001/jama.274.20.1634; Lynn J, 2000, J AM GERIATR SOC, V48, pS214, DOI 10.1111/j.1532-5415.2000.tb03135.x; MCCANN R, 1998, GERONTOL GERIATR ED, V18, P3; Merluzzi TV, 1997, HEALTH PSYCHOL, V16, P163, DOI 10.1037/0278-6133.16.2.163; Morrison M.F., 1998, END OF LIFE DECISION, P109; Murphy P, 2000, J AM GERIATR SOC, V48, pS154, DOI 10.1111/j.1532-5415.2000.tb03125.x; National Hospice Organization Standards and Accreditation Committee, 1997, PATHW PAT FAM FAC TE; PEARLMAN RA, 1995, PATIENT EDUC COUNS, V26, P353, DOI 10.1016/0738-3991(95)00739-M; Rabow MW, 2000, JAMA-J AM MED ASSOC, V283, P771, DOI 10.1001/jama.283.6.771; Rando T.A., 2000, CLIN DIMENSIONS ANTI; ROTER D, 1998, PSYCHO-ONCOLOGY, P1074; ROTHCHILD E, 1994, GEN HOSP PSYCHIAT, V16, P251, DOI 10.1016/0163-8343(94)90004-3; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; SMITH RA, 1984, J PERS SOC PSYCHOL, V47, P415, DOI 10.1037/0022-3514.47.2.415; Solomon M Z, 1993, J Law Med Ethics, V21, P231, DOI 10.1111/j.1748-720X.1993.tb01245.x; STRULL WM, 1984, JAMA-J AM MED ASSOC, V252, P2990, DOI 10.1001/jama.252.21.2990; Teno JM, 1999, J PAIN SYMPTOM MANAG, V17, P75, DOI 10.1016/S0885-3924(98)00134-1; TOBIN DR, 2000, ADV ILLNES COORDINAT; TOBIN DR, 1999, PEACEFUL DYING; TOBIN DR, 1999, PATIENT FAMILY ED MA, P193; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; Weissman DE, 1998, J PAIN SYMPTOM MANAG, V15, P195, DOI 10.1016/S0885-3924(97)00265-0; Weissman DE, 1998, J PAIN SYMPTOM MANAG, V15, P82, DOI 10.1016/S0885-3924(97)00253-4; Wilkinson A M, 1998, Hosp J, V13, P165; Yuen K, 1998, J PALLIATIVE CARE, V14, P79, DOI 10.1177/082585979801400316; Zuckerman C, 1999, Hosp J, V14, P85; [No title captured]	67	185	187	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1573	1578		10.1001/jama.284.12.1573	http://dx.doi.org/10.1001/jama.284.12.1573			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355HF	11000655	Bronze			2022-12-28	WOS:000089379700037
J	Cosgrove, DJ				Cosgrove, DJ			Loosening of plant cell walls by expansins	NATURE			English	Review							DEEP-WATER RICE; GROWING CUCUMBER HYPOCOTYLS; GROUP-I ALLERGENS; TOMATO FRUIT; GRASS-POLLEN; GENE; GROWTH; EXTENSION; EXPRESSION; ENZYMES	Plant cell walls are the starting materials for many commercial products, from lumber, paper and textiles to thickeners, films and explosives, The cell wall is secreted by each cell in the plant body, forming a thin fibreglass-like network with remarkable strength and flexibility. During growth, plant cells secrete a protein called expansin, which unlocks the network of wall polysaccharides, permitting turgor-driven cell enlargement. Germinating grass pollen also secretes an unusual expansin that loosens maternal cell walls to aid penetration of the stigma by the pollen tube. Expansin's action has puzzling implications for plant cell-wall structure. The recent explosion of gene sequences and expression data has given new hints of additional biological functions for expansins.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cosgrove, DJ (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	dCosgrove@psu.edu	/AAE-9630-2019					Brummell DA, 1999, PLANT MOL BIOL, V40, P615, DOI 10.1023/A:1006269031452; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Brummell DA, 1999, PLANT MOL BIOL, V39, P161, DOI 10.1023/A:1006130018931; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Catala C, 2000, PLANT PHYSIOL, V122, P527, DOI 10.1104/pp.122.2.527; Cho HT, 1997, PLANT PHYSIOL, V113, P1145, DOI 10.1104/pp.113.4.1145; Cho HT, 1997, PLANT CELL, V9, P1661, DOI 10.1105/tpc.9.9.1661; CHO HT, IN PRESS P NATL ACAD; Civello PM, 1999, PLANT PHYSIOL, V121, P1273, DOI 10.1104/pp.121.4.1273; COSGROVE D, 1986, ANNU REV PLANT PHYS, V37, P377, DOI 10.1146/annurev.arplant.37.1.377; COSGROVE D J, 1989, Planta (Heidelberg), V177, P121, DOI 10.1007/BF00392162; COSGROVE DJ, 1994, J EXP BOT, V45, P1711, DOI 10.1093/jxb/45.Special_Issue.1711; COSGROVE DJ, 1993, PLANT PHYSIOL, V103, P1321, DOI 10.1104/pp.103.4.1321; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; Cosgrove DJ, 1997, PLANT CELL, V9, P1031, DOI 10.1105/tpc.9.7.1031; COSGROVE DJ, 1993, INT J PLANT SCI, V154, P10, DOI 10.1086/297087; Cosgrove DJ, 1998, ANN M AM SOC PLANT P, P171; CROWELL DN, 1994, PLANT MOL BIOL, V25, P829, DOI 10.1007/BF00028877; DAVIES GJ, 1993, NATURE, V365, P362, DOI 10.1038/365362a0; De Marino S, 1999, STRUCT FOLD DES, V7, P943; Downes BP, 1998, PLANT MOL BIOL, V37, P437, DOI 10.1023/A:1005920732211; DURACHKO DM, 1999, ANN M AM SOC PLANT P, P56; Fedorov AA, 1997, INT ARCH ALLERGY IMM, V113, P109, DOI 10.1159/000237520; Fenwick KM, 1999, PHYTOCHEMISTRY, V51, P17, DOI 10.1016/S0031-9422(98)00723-7; FISCHER RL, 1991, ANNU REV PLANT PHYS, V42, P675, DOI 10.1146/annurev.pp.42.060191.003331; Fleming AJ, 1999, PLANTA, V208, P166, DOI 10.1007/s004250050546; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; FRY SC, 1995, ANNU REV PLANT PHYS, V46, P497, DOI 10.1146/annurev.pp.46.060195.002433; GIOVANNONI JJ, 1989, PLANT CELL, V1, P53, DOI 10.1105/tpc.1.1.53; Green PB, 1997, TRENDS PLANT SCI, V2, P365, DOI 10.1016/S1360-1385(97)01104-7; Grobe K, 1999, EUR J BIOCHEM, V263, P33, DOI 10.1046/j.1432-1327.1999.00462.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henrissat B, 1998, FEBS LETT, V425, P352, DOI 10.1016/S0014-5793(98)00265-8; HESLOPHARRISON Y, 1984, ACTA BOT NEERL, V33, P81, DOI 10.1111/j.1438-8677.1984.tb01774.x; Hutchison KW, 1999, PLANT PHYSIOL, V120, P827, DOI 10.1104/pp.120.3.827; Im KH, 2000, PLANT PHYSIOL, V123, P463, DOI 10.1104/pp.123.2.463; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Keller E, 1995, PLANT J, V8, P795, DOI 10.1046/j.1365-313X.1995.8060795.x; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Knox B, 1996, TRENDS PLANT SCI, V1, P156, DOI 10.1016/S1360-1385(96)80051-3; Link BM, 1998, PLANT PHYSIOL, V118, P907, DOI 10.1104/pp.118.3.907; Mattinen ML, 1998, EUR J BIOCHEM, V256, P279, DOI 10.1046/j.1432-1327.1998.2560279.x; MCCANN MC, 1990, J CELL SCI, V96, P323; MCCANN MC, 1992, J MICROSC-OXFORD, V166, P123, DOI 10.1111/j.1365-2818.1992.tb01511.x; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; MCQUEENMASON SJ, 1993, PLANTA, V190, P327, DOI 10.1007/BF00196961; MOORE RC, 1995, J CELL BIOCHEM, P457; Orford SJ, 1998, BBA-GENE STRUCT EXPR, V1398, P342, DOI 10.1016/S0167-4781(98)00065-7; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; Reinhardt D, 1998, PLANT CELL, V10, P1427, DOI 10.1105/tpc.10.9.1427; ROBERTS K, 1994, CURR OPIN CELL BIOL, V6, P688, DOI 10.1016/0955-0674(94)90095-7; Rose JKC, 1999, TRENDS PLANT SCI, V4, P176, DOI 10.1016/S1360-1385(99)01405-3; Rose JKC, 1997, P NATL ACAD SCI USA, V94, P5955, DOI 10.1073/pnas.94.11.5955; ROSE JKC, IN PRESS PLANT PHYSL; SHCHERBAN TY, 1995, P NATL ACAD SCI USA, V92, P9245, DOI 10.1073/pnas.92.20.9245; Shimizu Y, 1997, PLANT CELL PHYSIOL, V38, P375, DOI 10.1093/oxfordjournals.pcp.a029178; Smith Penelope M., 1996, P125; TALBOTT LD, 1992, PLANT PHYSIOL, V98, P357, DOI 10.1104/pp.98.1.357; TIEMAN DM, 1992, PLANT CELL, V4, P667, DOI 10.1105/tpc.4.6.667; TOONE EJ, 1994, CURR OPIN STRUC BIOL, V4, P719, DOI 10.1016/S0959-440X(94)90170-8; VARNER JE, 1989, CELL, V56, P231, DOI 10.1016/0092-8674(89)90896-9; Vriezen WH, 2000, PLANTA, V210, P956, DOI 10.1007/s004250050703; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x; Wu YJ, 1996, PLANT PHYSIOL, V111, P765, DOI 10.1104/pp.111.3.765	68	1052	1159	20	307	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					321	326		10.1038/35030000	http://dx.doi.org/10.1038/35030000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014181				2022-12-28	WOS:000089390700035
J	Hernandez, ER				Hernandez, ER			No room on the carousel for meeting of like minds	NATURE			English	Letter									Univ Complutense, Fac Farm, Inst Bioquim, CSIC,UCM, E-28040 Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Hernandez, ER (corresponding author), Univ Complutense, Fac Farm, Inst Bioquim, CSIC,UCM, E-28040 Madrid, Spain.								0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					285	285		10.1038/35030196	http://dx.doi.org/10.1038/35030196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014162	Bronze			2022-12-28	WOS:000089390700015
J	Dye, C; Reiter, P				Dye, C; Reiter, P			Climate chance and malaria - Temperatures without fevers?	SCIENCE			English	Editorial Material									WHO, Dept Communicable Dis Control Prevent & Eradicat, CH-1211 Geneva 27, Switzerland; Ctr Dis Control & Prevent, Entomol Sect, Dengue Branch, San Juan, PR 00920 USA	World Health Organization; Centers for Disease Control & Prevention - USA	Dye, C (corresponding author), WHO, Dept Communicable Dis Control Prevent & Eradicat, CH-1211 Geneva 27, Switzerland.							Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; Bruce-Chwatt LJ, 1980, RISE FALL MALARIA EU; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50; Faust Ernest, 1941, S HUM MAL SPEC REF N, P8; *INDEPTH, 2000, INDEPTH NETW; Kovats RS, 1999, BRIT MED J, V318, P1682, DOI 10.1136/bmj.318.7199.1682; McMichael A.J., 1996, CLIMATE CHANGE HUMAN; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Reiter P, 2000, EMERG INFECT DIS, V6, P1; Reiter P, 1998, LANCET, V351, P839, DOI 10.1016/S0140-6736(05)78979-0; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; WATSON RT, 1996, IMPACTS ADAPTATIONS	13	13	13	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1697	1698						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	11001735				2022-12-28	WOS:000089195200030
J	Mant, J; Carter, J; Wade, DT; Winner, S				Mant, J; Carter, J; Wade, DT; Winner, S			Family support for stroke: a randomised controlled trial	LANCET			English	Article							SPECIALIST NURSE SUPPORT; QUESTIONNAIRE; INTERVENTION; VERSION; CONSENT; PEOPLE; INDEX; SF-36	Background Attention is currently focused on family care of stroke survivors, but the effectiveness of support services is unclear. We did a single-blind, randomised, controlled trial to assess the impact of family support on stroke patients and their carers. Methods Patients with acute stroke admitted to hospitals in Oxford. UK, were assigned family support or normal care within 6 weeks of stroke. After 6 months, we assessed, for carers, knowledge about stroke, Frenchay activities index, general health questionnaire-28 scores, caregiver strain index, Dartmouth co-op charts, short form 36 (SF-36), and satisfaction scores, and, for patients, knowledge about stroke and use of services, Barthel index, Rivermead mobility index. Frenchay activities index, London handicap scale, hospital anxiety and depression scales, Dartmouth co-op charts, and satisfaction. Findings 323 patients and 267 carers were followed up. Carers in the intervention group had significantly better Frenchay activities indices (p=0.03), SF-36 scores (energy p=0.02. mental health p=0.004, pain p=0.03, physical function p=0.025, and general health perception p=0.02), quality of life on the Dartmouth co-op chart (p=0.01), and satisfaction with understanding of stroke (82 vs 71.%, p=0.04) than those in the control group. Patients' knowledge about stroke, disability, handicap, quality of life, and satisfaction with services and understanding of stroke did not differ between groups. Fewer patients in the intervention group than in the control group saw a physiotherapist after discharge (44 vs 56%, p=0.04), but use of other services was similar. Interpretation Family support significantly increased social activities and improved quality of life for carers, with no significant effects on patients.	Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Rivermead Rehabil Ctr, Oxford OX1 4XD, England; Radcliffe Infirm, Dept Clin Geratol, Oxford OX2 6HE, England	University of Birmingham; Radcliffe Infirmary	Mant, J (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.		Tanne, David/F-2560-2010	Tanne, David/0000-0002-6699-2220; Wade, Derick/0000-0002-1188-8442				BOSANQUET N, 1998, STROKE CARE REDUCING; CARNWATH TCM, 1987, BMJ-BRIT MED J, V294, P409, DOI 10.1136/bmj.294.6569.409; Carter J, 1997, CLIN REHABIL, V11, P131, DOI 10.1177/026921559701100206; CHRISTIE D, 1984, COMMUNITY HEALTH ST, V8, P26; Dennis M, 1997, BRIT MED J, V314, P1077, DOI 10.1136/bmj.314.7087.1077; Dennis M, 1998, STROKE, V29, P1867, DOI 10.1161/01.STR.29.9.1867; Dennis M, 1997, BRIT MED J, V314, P1071, DOI 10.1136/bmj.314.7087.1071; Dorman PJ, 1999, STROKE, V30, P2146, DOI 10.1161/01.STR.30.10.2146; Dowswell G, 1997, CLIN REHABIL, V11, P293, DOI 10.1177/026921559701100405; EVANS RL, 1988, STROKE, V19, P1243, DOI 10.1161/01.STR.19.10.1243; Forster A, 1996, BRIT MED J, V312, P1642, DOI 10.1136/bmj.312.7047.1642; FRIEDLAND JF, 1992, ARCH PHYS MED REHAB, V73, P573; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Han B, 1999, STROKE, V30, P1478, DOI 10.1161/01.STR.30.7.1478; Harwood RH, 1995, MANUAL LONDON HANDIC; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Mant J, 1998, CLIN REHABIL, V12, P465, DOI 10.1191/026921598668972226; MANT J, 1998, HLTH TRENDS, V29, P96; McLean S, 1997, BRIT MED J, V314, P1076, DOI 10.1136/bmj.314.7087.1076; POUND P, 1993, J EPIDEMIOL COMMUN H, V47, P500, DOI 10.1136/jech.47.6.500; POUND P, 1994, CLIN REHABIL, V8, P7, DOI DOI 10.1177/026921559400800102; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; ROWAN K, 1994, MEASURING HLTH MED O; *STROK ASS, 1997, FAM SUPP OV APR 1996; TOWLE D, 1989, CLIN REHABIL, V3, P89; Trigg R, 1997, BRIT MED J, V315, P607; Wade D T, 1988, Int Disabil Stud, V10, P64; Wade DT., 1992, MEASUREMENT NEUROLOG; Walker MF, 1999, LANCET, V354, P278, DOI 10.1016/S0140-6736(98)11128-5; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	166	171	0	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					808	813		10.1016/S0140-6736(00)02655-6	http://dx.doi.org/10.1016/S0140-6736(00)02655-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022928				2022-12-28	WOS:000089101800011
J	Reed, JC; Bischoff, JR				Reed, JC; Bischoff, JR			BIRinging chromosomes through cell division - And survivin' the experience	CELL			English	Review							INHIBITOR; SEGREGATION; CYTOKINESIS; YEAST; FAMILY		Burnham Inst, La Jolla, CA 92037 USA; Pharmacia Corp, Discovery Res Oncol, I-20014 Nerviano, MI, Italy	Sanford Burnham Prebys Medical Discovery Institute; Pfizer	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Altieri DC, 1999, LAB INVEST, V79, P1327; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fraser AG, 1999, CURR BIOL, V9, P292, DOI 10.1016/S0960-9822(99)80137-7; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jones G, 2000, J BIOL CHEM, V275, P22157, DOI 10.1074/jbc.M000369200; Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170; VERDECIA MA, 2000, NAT STRUCT BIOL, V7, P1; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208	19	131	134	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					545	548		10.1016/S0092-8674(00)00076-3	http://dx.doi.org/10.1016/S0092-8674(00)00076-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007472	Bronze			2022-12-28	WOS:000089105200002
J	Diggle, L; Deeks, J				Diggle, L; Deeks, J			Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article								Objective To compare rates of local reactions associated with two needle sizes used to administer routine immunisations to infants. Design Randomised controlled trial. Setting Routine immunisation clinics in eight general practices in Buckinghamshire. Participants Healthy infants attending for third primary immunisation due at 16 weeks of age: 119 infants were recruited, and 110 diary cards were analysed. Interventions Immunisation with 25 gauge, 16 mm, orange hub needle or 23 gauge, 25 mm, blue hub needle. Main outcome measures Parental recordings of redness, swelling, and tenderness for three days after immunisation. Results Rate of redness with the longer needle was initially two thirds the rate with the smaller needle (relative risk 0.66 (95% confidence interval 0.45 to 0.99), P = 0.04), and by the third day this had decreased to a seventh (relative risk 0.13 (0.03 to 0.56), P = 0.0006). Rate of swelling with the longer needle was initially about a third that with the smaller needle (relative risk 0.39 (0.23 to 0.67), P = 0.0002), and this difference remained for all three days. Rates of tenderness were also lower with the longer needle throughout follow up, but not significantly (relative risk 0.60 (0.29 to 1.25), P = 0.17). Conclusions Use of 25 mm needles significantly reduced rates of local reaction to routine infant immunisation. On average, for every five infants vaccinated, use of the longer needle instead of the shorter needle would prevent one infant from experiencing any local reaction. Vaccine manufacturers should review their policy of supplying the shorter needle in vaccine packs.	Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 9DU, England; Univ Oxford, Inst Hlth Sci, Imperial Canc Res Fund, NHS Ctr Stat Med, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Diggle, L (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 9DU, England.		Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971				*DEP HLTH, 1999, PLCMO995 DOH; Diggle LE, 1999, THESIS ROYAL COLL NU; HMSO, 1996, IMM INF DIS; Lieu TA, 2000, VACCINE, V19, P33, DOI 10.1016/S0264-410X(00)00154-7; Mark A, 1999, VACCINE, V17, P2067, DOI 10.1016/S0264-410X(98)00410-1; SCHEIFELE DW, 1994, CAN MED ASSOC J, V150, P14; *WHO, 1998, IMM PRACT MOD 8 SESS	7	43	47	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					931	933		10.1136/bmj.321.7266.931	http://dx.doi.org/10.1136/bmj.321.7266.931			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030682	Green Published, Bronze			2022-12-28	WOS:000089975100023
J	Mehilli, J; Kastrati, A; Dirschinger, J; Bollwein, H; Neumann, FJ; Schomig, A				Mehilli, J; Kastrati, A; Dirschinger, J; Bollwein, H; Neumann, FJ; Schomig, A			Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; IN-HOSPITAL MORTALITY; BALLOON ANGIOPLASTY; SEX-DIFFERENCES; HEART-DISEASE; PLACEMENT; BYPASS; REGISTRY; MULTICENTER; RESTENOSIS	Context Women with coronary artery disease (CAD) are believed to have a higher risk for adverse outcomes than men after conventional coronary interventions. The increasing use of coronary stenting has improved the outcome of patients undergoing coronary interventions, but little is known about the nature of outcomes in men vs women after this procedure. Objective To examine whether there are sex-based differences in prognostic factors and in early and late outcomes among CAD patients undergoing coronary stent placement. Design, Setting, and Patients Inception cohort study, at 2 tertiary referral institu tions in Germany. Consecutive series of 1001 women and 3263 men with symptomatic CAD who were treated with stenting between May 1992 and December 1998. Patients who underwent stenting in the setting of acute myocardial infarction were excluded. Main Outcome Measure The combined event rates of death and nonfatal myocardial infarction, assessed at 30 days and 1 year after stenting and compared by sex, Results Compared with men, women undergoing coronary stenting were significantly older (mean age, 69 vs 63 years) and more likely to present with diabetes, arterial hypertension, or hypercholesterolemia. Women had less extensive CAD, a less frequent history of myocardial infarction and better preserved left ventricular function than men. Women presented an excess risk of death or nonfatal myocardial infarction only during the early period after stenting: the 30-day combined event rate of death or myocardial infarction was 3.1% in women and 1.8% in men (P = .02) and the multivariate-adjusted hazard ratio (HR) for women was 2.02 (95% confidence interval [CI], 1.27-3.19). At 1 year, the outcome was similar for both women and men (combined event rate for women, 6.0%, and for men, 5.8% (P = .77); multivariate-adjusted HR for women, 1.06 [95% CI, 0.75-1.48]). There was a sex difference in the prognostic value of baseline characteristics: the strongest prognostic factors were diabetes in women and age in men. Conclusions The results of this study indicate that 1-year outcomes of women with CAD undergoing coronary artery stenting are similar to those of men. Despite the similarity in outcomes, there are several sex-specific differences in baseline characteristics, clinical course after the intervention, and relative weight of prognostic factors.	Deutsch Herzzentrum Munich, D-80636 Munich, Germany; Tech Univ Munich, Med Klin Rechts Isar 1, D-8000 Munich, Germany	German Heart Centre Munich; Technical University of Munich	Kastrati, A (corresponding author), Deutsch Herzzentrum Munich, Lazarettstr 36, D-80636 Munich, Germany.	kastrati@dhm.mhn.de	Mehilli, Julinda/F-2629-2016; , Kastrati/Y-2389-2019					AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; BARRETTCONNOR E, 1991, JAMA-J AM MED ASSOC, V265, P1861, DOI 10.1001/jama.265.14.1861; BECKER RC, 1994, ANN INTERN MED, V120, P638, DOI 10.7326/0003-4819-120-8-199404150-00003; BELL MR, 1995, CIRCULATION, V91, P2876, DOI 10.1161/01.CIR.91.12.2876; BELL MR, 1993, JAMA-J AM MED ASSOC, V269, P2091, DOI 10.1001/jama.269.16.2091; CASTELLI WP, 1988, AM J OBSTET GYNECOL, V158, P1566; CASTELLI WP, 1988, AM J OBSTET GYNECOL, V158, P1553, DOI 10.1016/0002-9378(88)90189-5; COWLEY MJ, 1985, CIRCULATION, V71, P90, DOI 10.1161/01.CIR.71.1.90; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; Erbel R, 1998, NEW ENGL J MED, V339, P1672, DOI 10.1056/NEJM199812033392304; FIEBACH NH, 1990, JAMA-J AM MED ASSOC, V263, P1092, DOI 10.1001/jama.263.8.1092; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; FISHER LD, 1982, J THORAC CARDIOV SUR, V84, P334; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Jacobs AK, 1997, AM J CARDIOL, V80, P979, DOI 10.1016/S0002-9149(97)00588-2; Jacobs AK, 1998, CIRCULATION, V98, P1279, DOI 10.1161/01.CIR.98.13.1279; JAYES RL, 1992, J CLIN EPIDEMIOL, V45, P621, DOI 10.1016/0895-4356(92)90134-9; Kastrati A, 1999, CIRCULATION, V100, P1285, DOI 10.1161/01.CIR.100.12.1285; Kastrati A, 1999, CIRCULATION, V99, P1005, DOI 10.1161/01.CIR.99.8.1005; KELSEY SF, 1993, CIRCULATION, V87, P720, DOI 10.1161/01.CIR.87.3.720; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Malacrida R, 1998, NEW ENGL J MED, V338, P8, DOI 10.1056/NEJM199801013380102; Malenka DJ, 1996, CIRCULATION, V94, P99; Mark DB, 2000, JAMA-J AM MED ASSOC, V283, P659, DOI 10.1001/jama.283.5.659; MARK DB, 1994, NEW ENGL J MED, V330, P1101, DOI 10.1056/NEJM199404213301601; Marso SP, 1999, CIRCULATION, V100, P2477, DOI 10.1161/01.CIR.100.25.2477; *MATHS INC, 1999, S PLUS 2000 GUID STA, P369; Maynard C, 1996, CIRCULATION, V94, P93; OCONNOR GT, 1993, CIRCULATION, V88, P2104, DOI 10.1161/01.CIR.88.5.2104; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; RAHIMTOOLA SH, 1993, CIRCULATION, V88, P71; Roger VL, 2000, JAMA-J AM MED ASSOC, V283, P646, DOI 10.1001/jama.283.5.646; RUTHERFORD JD, 1988, HEART DISEASE TXB CA, P1314; Savage MP, 1997, NEW ENGL J MED, V337, P740, DOI 10.1056/NEJM199709113371103; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; SCHOMIG A, 1994, CIRCULATION, V90, P2716, DOI 10.1161/01.CIR.90.6.2716; Schuhlen H, 1998, CIRCULATION, V98, P104, DOI 10.1161/01.CIR.98.2.104; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Topol EJ, 1999, LANCET, V354, P2019, DOI 10.1016/S0140-6736(99)10018-7; Topol EJ, 1998, NEW ENGL J MED, V339, P1702, DOI 10.1056/NEJM199812033392311; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; VanBelle E, 1997, CIRCULATION, V96, P1454, DOI 10.1161/01.CIR.96.5.1454; Versaci F, 1997, NEW ENGL J MED, V336, P817, DOI 10.1056/NEJM199703203361201; WEINTRAUB WS, 1994, J AM COLL CARDIOL, V24, P81, DOI 10.1016/0735-1097(94)90545-2; WENGER NK, 1993, NEW ENGL J MED, V329, P247, DOI 10.1056/NEJM199307223290406; WHITE HD, 1993, CIRCULATION, V88, P2097, DOI 10.1161/01.CIR.88.5.2097	51	137	147	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1799	1805		10.1001/jama.284.14.1799	http://dx.doi.org/10.1001/jama.284.14.1799			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025832	Bronze			2022-12-28	WOS:000089622100031
J	Huang, YH; Rettner, CT; Auerbach, DJ; Wodtke, AM				Huang, YH; Rettner, CT; Auerbach, DJ; Wodtke, AM			Vibrational promotion of electron transfer	SCIENCE			English	Article							MOLECULE-SURFACE COLLISIONS; EXCITED MOLECULES; CHARGE-TRANSFER; POLAR-SOLVENTS; EXCITATION; SCATTERING; NO; DYNAMICS; INTERPLAY; SOLVATION	By using laser methods to prepare specific quantum states of gas-phase nitric oxide molecules, we examined the role of vibrational motion in electron transfer to a molecule from a metal surface free from the complicating influence of solvation effects. The signature of the electron transfer process is a highly efficient multiquantum vibrational relaxation event, where the nitrogen oxide loses hundreds of kilojoules per mole of energy on a subpicosecond time scale. These results cannot be explained simply on the basis of Franck-Condon factors. The large-amplitude vibrational motion associated;with molecules in high vibrational states strongly modulates the energetic driving force of the electron transfer reaction. These results show the importance of molecular vibration in promoting electron transfer reactions, a class of chemistry important to molecular electronics devices, solar energy conversion, and many biological processes.	Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA; IBM Corp, Almaden Res Ctr, Div Res, San Jose, CA 95120 USA	University of California System; University of California Santa Barbara; International Business Machines (IBM)	Huang, YH (corresponding author), Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA.		Auerbach, Daniel J/J-7109-2014; Wodtke, Alec M/I-4848-2012	Auerbach, Daniel J/0000-0001-9494-3066; Wodtke, Alec/0000-0002-6509-2183				Bagchi B, 1999, ADV CHEM PHYS, V107, P1, DOI 10.1002/9780470141663.ch1; Barbara PF, 1996, J PHYS CHEM-US, V100, P13148, DOI 10.1021/jp9605663; CHANG HC, 1990, PHYS REV LETT, V65, P2125, DOI 10.1103/PhysRevLett.65.2125; EFRIMA S, 1976, CHEM PHYS, V13, P447, DOI 10.1016/0301-0104(76)87014-0; EFRIMA S, 1974, CHEM PHYS LETT, V25, P34, DOI 10.1016/0009-2614(74)80325-8; EWING GE, 1992, ACCOUNTS CHEM RES, V25, P292, DOI 10.1021/ar00019a004; GADZUK JW, 1985, PHYS SCRIPTA, V32, P413, DOI 10.1088/0031-8949/32/4/028; GADZUK JW, 1986, PHYS REV B, V33, P4298, DOI 10.1103/PhysRevB.33.4298; GADZUK JW, 1983, J CHEM PHYS, V79, P6341, DOI 10.1063/1.445742; Gadzuk JW, 1996, PHYS REV LETT, V76, P4234, DOI 10.1103/PhysRevLett.76.4234; Gayathri N, 1999, J PHYS CHEM A, V103, P8496, DOI 10.1021/jp991357w; GROSS A, 1993, SURF SCI, V289, P335, DOI 10.1016/0039-6028(93)90664-6; HOLLOWAY S, 1985, SURF SCI, V152, P838, DOI 10.1016/0039-6028(85)90495-9; Hou H, 1999, SCIENCE, V284, P1647, DOI 10.1126/science.284.5420.1647; Huang Y, 2000, PHYS REV LETT, V84, P2985, DOI 10.1103/PhysRevLett.84.2985; HUXLEY P, 1983, J CHEM SOC FARAD T 2, V79, P323, DOI 10.1039/f29837900323; JONG KT, 1990, CHEM PHYS, V149, P81; KAHLOW MA, 1989, J CHEM PHYS, V90, P151, DOI 10.1063/1.456520; KESTNER NR, 1974, J PHYS CHEM-US, V78, P2148, DOI 10.1021/j100614a017; KIRSON Z, 1985, SURF SCI, V151, P531, DOI 10.1016/0039-6028(85)90391-7; LUCCHESE RR, 1984, J CHEM PHYS, V80, P3451, DOI 10.1063/1.447101; MARCUS RA, 1964, ANNU REV PHYS CHEM, V15, P155, DOI 10.1146/annurev.pc.15.100164.001103; McCarthy MC, 1998, CHEM PHYS LETT, V289, P156, DOI 10.1016/S0009-2614(98)00408-4; MISEWICH J, 1985, PHYS REV LETT, V55, P1919, DOI 10.1103/PhysRevLett.55.1919; NEUMARK DM, 1985, PHYS REV A, V32, P1890, DOI 10.1103/PhysRevA.32.1890; NEWNS DM, 1986, SURF SCI, V171, P600, DOI 10.1016/0039-6028(86)91062-9; PHELPS DK, 1992, J PHYS CHEM-US, V96, P7187, DOI 10.1021/j100197a013; RETTNER CT, 1985, PHYS REV LETT, V55, P1904, DOI 10.1103/PhysRevLett.55.1904; Spears KG, 1996, J PHYS CHEM-US, V100, P10206, DOI 10.1021/jp960444a; SUMI H, 1986, J CHEM PHYS, V84, P4272, DOI 10.1063/1.450804; Sutin N, 1999, ADV CHEM PHYS, V106, P7, DOI 10.1002/9780470141656.ch2; WALKER GC, 1992, J PHYS CHEM-US, V96, P3728, DOI 10.1021/j100188a032; Watts EK, 1997, SURF SCI, V374, P191, DOI 10.1016/S0039-6028(96)01194-6; Wight AC, 1998, J CHEM PHYS, V109, P8626, DOI 10.1063/1.477529	34	246	251	6	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					111	114		10.1126/science.290.5489.111	http://dx.doi.org/10.1126/science.290.5489.111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021790				2022-12-28	WOS:000089724800043
J	Wolkow, CA; Kimura, KD; Lee, MS; Ruvkun, G				Wolkow, CA; Kimura, KD; Lee, MS; Ruvkun, G			Regulation of C-elegans life-span by insulinlike signaling in the nervous system	SCIENCE			English	Article							AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; METABOLIC-RATE; LONGEVITY; DIAPAUSE; RECEPTOR; DAF-2	An insulinlike signaling pathway controls Caenorhabditis elegans aging. metabolism, and development. Mutations in the daf-2 insulin receptor-like gene or the downstream age-1 phosphoinositide 3-kinase gene extend adult life-span by two- to threefold. To identify tissues where this pathway regulates aging and metabolism, we restored daf-2 pathway signaling to only neurons, muscle, or intestine. Insulinlike signaling in neurons alone was sufficient to specify wild-type life-span, but muscle or intestinal signaling was not. However, restoring daf-2 pathway signaling to muscle rescued metabolic defects, thus decoupling regulation of life-span and metabolism. These findings point to the nervous system as a central regulator of animal longevity.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Nagoya Univ, Div Biol Sci, Nagoya, Aichi 4648602, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nagoya University	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@frodo.mgh.harvard.edu	Kimura, Koutarou D./T-9645-2019	Kimura, Koutarou D./0000-0002-3359-1578	NIA NIH HHS [AG14161] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG014161, R01AG014161] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Finch CE, 1990, LONGEVITY SENESCENCE; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; HSU DR, 1995, DEVELOPMENT, V121, P3323; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMURA K, UNPUB; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LARSEN PL, 1995, GENETICS, V139, P1567; MADURO M, 1995, GENETICS, V141, P977; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; OKKEMA PG, 1993, GENETICS, V135, P385; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; WOLKOW CA, UNPUB	27	502	527	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					147	150		10.1126/science.290.5489.147	http://dx.doi.org/10.1126/science.290.5489.147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021802				2022-12-28	WOS:000089724800055
J	Edejer, TTT				Edejer, TTT			Disseminating health information in developing countries: the role of the internet	BRITISH MEDICAL JOURNAL			English	Article							FULL	Information and communication technologies have not been harnessed systematically to improve the health of populations in developing countries These technologies empower those who use information by providing them with a choice of information to be accessed in their own time and by allowing them to put their own information on the web The current digital divide is more dramatic than any other inequity in health or income The quality of health information available on the web is inconsistent, and the visibility of research from developing countries is limited The way forward is to exploit the full interactivity of the internet, which allows rapid feedback and change to continuously mould information into useful knowledge.	WHO, Global Programme Evidence Hlth Policy, CH-1211 Geneva 27, Switzerland	World Health Organization	Edejer, TTT (corresponding author), WHO, Global Programme Evidence Hlth Policy, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.			Edejer, Tessa/0000-0003-1068-332X				DEANE J, 2000, INFORMATION KNOWLEDG; Delamothe T, 1999, BRIT MED J, V319, P1515, DOI 10.1136/bmj.319.7224.1515; Delamothe T, 1998, BMJ-BRIT MED J, V316, P1109, DOI 10.1136/bmj.316.7138.1109; Fraser HSF, 2000, BRIT MED J, V321, P465, DOI 10.1136/bmj.321.7259.465; GIBBS WW, 1995, SCI AM           AUG, P92; Global Forum for Health Research, 2000, 10 90 REP HLTH RES 2; GREENOP D, 2000, INVENTING FUTURE COM; Groves T, 1996, BRIT MED J, V313, P1606, DOI 10.1136/bmj.313.7072.1606; Jadad AR, 2000, CAN MED ASSOC J, V162, P362; JENSEN M, 2000, AFRICAN INTERNET CON; Kim P, 1999, BMJ-BRIT MED J, V318, P647, DOI 10.1136/bmj.318.7184.647; LOWN B, 1998, LANCET S2, V352, pS34; MARKOFF J, 1995, NY TIMES        0216, pA1; MARKOFF J, 1995, NY TIMES        1120, pC5; McConnell J, 1999, LANCET, V354, P2, DOI 10.1016/S0140-6736(99)00226-3; McLellan F, 1998, LANCET S2, V352, pS1139, DOI DOI 10.1016/S0140-6736(98)90301-4]; *NIH, 2000, PUBM CENTR NIH OP SI; *ORG EC COOP DEV, 1996, KNOWL BAS EC, P7; *PARTN INF COMM TE, 2000, AI AIMS AFR ICT ACT; *PHIL RES NETW, 2000, LINK PEOPL INF; Rosselli D, 1998, MED EDUC, V32, P274, DOI 10.1046/j.1365-2923.1998.00214.x; Sundram F X, 1998, Ann Acad Med Singap, V27, P147; *UN DEV PROGR, 2000, M HIGH LEV PAN EXP I; WILLIAMS M, 2000, G8 M DEV NATIONS DIG; World Bank, 1998, WORLD DEV REP KNOWL; ZIELINSKI C, 1995, BRIT MED J, V310, P1480, DOI 10.1136/bmj.310.6993.1480	26	110	113	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					797	800		10.1136/bmj.321.7264.797	http://dx.doi.org/10.1136/bmj.321.7264.797			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009519	Bronze, Green Published			2022-12-28	WOS:000089696600023
J	Rickwood, AMK; Kenny, SE; Donnell, SC				Rickwood, AMK; Kenny, SE; Donnell, SC			Towards evidence based circumcision of English boys: survey of trends in practice	BRITISH MEDICAL JOURNAL			English	Article							PHIMOSIS		Childrens Hosp, Dept Paediat Surg, Birmingham B16 8ET, W Midlands, England; Alder Hey Childrens Hosp, Dept Urol, Liverpool L12 2AP, Merseyside, England; Univ Liverpool, Alder Hey Childrens Hosp, Inst Child Hlth, Dept Child Hlth, Liverpool L69 3BX, Merseyside, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool	Rickwood, AMK (corresponding author), Alder Hey Childrens Hosp, Dept Urol, Liverpool L12 2AP, Merseyside, England.			Kenny, Simon/0000-0002-5917-8554				ESCALA JM, 1989, BRIT J UROL, V63, P196, DOI 10.1111/j.1464-410X.1989.tb05164.x; FRISCH M, 1995, BRIT MED J, V311, P1471, DOI 10.1136/bmj.311.7018.1471; Kenney N, 1999, BRIT MED J, V319, P619, DOI 10.1136/bmj.319.7210.619; RICKWOOD AMK, 1989, ANN ROY COLL SURG, V71, P275; Shankar KR, 1999, BJU INT, V84, P101	5	44	44	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					792	793		10.1136/bmj.321.7264.792	http://dx.doi.org/10.1136/bmj.321.7264.792			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009516	Bronze, Green Published			2022-12-28	WOS:000089696600021
J	Haffner, D; Schaefer, F; Nissel, R; Wuhl, E; Tonshoff, B; Mehls, O				Haffner, D; Schaefer, F; Nissel, R; Wuhl, E; Tonshoff, B; Mehls, O		German Study Grp Growth Hormone T	Effect of growth hormone treatment on the adult height of children with chronic renal failure.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FINAL HEIGHT; SHORT STATURE; THERAPY; TRANSPLANTATION; DEFICIENCY; EXPERIENCE; MATURATION; EFFICACY; TERM	Background: Growth hormone treatment stimulates growth in short children with chronic renal failure. However, the extent to which this therapy increases final adult height is not known. Methods: We followed 38 initially prepubertal children with chronic renal failure treated with growth hormone for a mean of 5.3 years until they reached their final adult height. The mean (+/-SD) age at the start of treatment was 10.4+/-2.2 years, the mean bone age was 7.1+/-2.3 years, and the mean height was 3.1+/-1.2 SD below normal. Fifty matched children with chronic renal failure who were not treated with growth hormone served as controls. Results: The children treated with growth hormone had sustained catch-up growth, whereas the control children had progressive growth failure. The mean final height of the growth hormone-treated children was 165 cm for boys and 156 cm for girls. The mean final adult height of the growth hormone-treated children was 1.6+/-1.2 SD below normal, which was 1.4 SD above their standardized height at base line (P<0.001). In contrast, the final height of the untreated children (2.1+/-1.2 SD below normal) was 0.6 SD below their standardized height at base line (P<0.001). Although prepubertal bone maturation was accelerated in growth hormone-treated children, treatment was not associated with a shortening of the pubertal growth spurt. The total height gain was positively associated with the initial target-height deficit and the duration of growth hormone therapy and was negatively associated with the percentage of the observation period spent receiving dialysis treatment. Conclusions: Long-term growth hormone treatment of children with chronic renal failure induces persistent catch-up growth, and the majority of patients achieve normal adult height. (N Engl J Med 2000;343:923-30.) (C)2000, Massachusetts Medical Society.	Univ Childrens Hosp, Div Pediat Nephrol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Mehls, O (corresponding author), Univ Childrens Hosp, Div Pediat Nephrol, Neuenheimer Feld 150, D-69120 Heidelberg, Germany.	otto_mehls@med.uni-heidelberg.de	Schaefer, Franz/G-4365-2010					August GP, 1998, PEDIATRICS, V102, P512; DARENDELILER F, 1990, ACTA ENDOCRINOL-COP, V122, P414, DOI 10.1530/acta.0.1220414; Donaldson MDC, 1997, HORM RES, V48, P35, DOI 10.1159/000191327; Fine RN, 1996, KIDNEY INT, V49, P781, DOI 10.1038/ki.1996.108; GASSER T, 1991, PEDIATR NEPHROL, V5, P447, DOI 10.1007/BF01453679; GASSER T, 1990, ANN HUM BIOL, V17, P459, DOI 10.1080/03014469000001242; Haffner D, 1998, J AM SOC NEPHROL, V9, P1899; Hindmarsh PC, 1996, LANCET, V348, P13, DOI 10.1016/S0140-6736(96)01038-0; Hintz RL, 1999, NEW ENGL J MED, V340, P502, DOI 10.1056/NEJM199902183400702; HOCHBERG Z, 1994, CLIN ENDOCRINOL, V41, P331, DOI 10.1111/j.1365-2265.1994.tb02553.x; HOKKENKOELEGA ACS, 1994, PEDIATR RES, V36, P323, DOI 10.1203/00006450-199409000-00009; Kawai M, 1997, J PEDIATR-US, V130, P205, DOI 10.1016/S0022-3476(97)70344-5; LOCHE S, 1994, J PEDIATR-US, V125, P196, DOI 10.1016/S0022-3476(94)70192-X; McCaughey ES, 1998, LANCET, V351, P940; Molinari L, 1985, HUMAN GROWTH DEV, P193; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; SCHAEFER F, 1990, PEDIATR RES, V28, P5, DOI 10.1203/00006450-199007000-00002; SCHAEFER F, 1991, ACTA PAEDIATR, P3; Schaefer F, 1999, PEDIAT NEPHROLOGY, P1197; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Tanner JM., 1983, ASSESSMENT SKELETAL; Tejani A, 1996, KIDNEY INT, V49, pS103; TONSHOFF B, 1993, KIDNEY INT, V44, P199, DOI 10.1038/ki.1993.231; VANDIEMENSTEENVOORDE R, 1987, J PEDIATR-US, V110, P351, DOI 10.1016/S0022-3476(87)80493-6; Wuhl E, 1996, PEDIATR NEPHROL, V10, P294	25	196	200	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2000	343	13					923	930		10.1056/NEJM200009283431304	http://dx.doi.org/10.1056/NEJM200009283431304			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KT	11006368				2022-12-28	WOS:000089501400004
J	Pines, D				Pines, D			Science-based security under threat - Los Alamos National Laboratory is an endangered national treasure.	NATURE			English	Editorial Material									Univ Calif Los Alamos Natl Lab, Inst Complex Adapt Matter, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Pines, D (corresponding author), Univ Calif Los Alamos Natl Lab, Inst Complex Adapt Matter, POB 1663, Los Alamos, NM 87545 USA.								0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					447	448		10.1038/35035219	http://dx.doi.org/10.1038/35035219			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028978				2022-12-28	WOS:000089727400018
J	Rotblat, J				Rotblat, J			Mark Oliphant (1901-2000) - Obituary	NATURE			English	Biographical-Item									Pugwash Conferences Sci & World Affairs, London WC1B 3BJ, England		Rotblat, J (corresponding author), Pugwash Conferences Sci & World Affairs, 63A Great Russell St, London WC1B 3BJ, England.								0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					468	468		10.1038/35035202	http://dx.doi.org/10.1038/35035202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028988				2022-12-28	WOS:000089727400036
J	Piccirillo, JF; Duntley, S; Schotland, H				Piccirillo, JF; Duntley, S; Schotland, H			Obstructive sleep apnea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSITIVE AIRWAY PRESSURE; DAYTIME SLEEPINESS; THERAPY; FRAGMENTATION; DEPRIVATION; DIAGNOSIS; OBESITY; ADULTS		Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Clin Outcomes Res Off, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Piccirillo, JF (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Clin Outcomes Res Off, Campus Box 8115,660 Euclid Ave, St Louis, MO 63110 USA.							*AG HLTHCAR POL RE, 1999, 1 US DEP HLTH HUM SE; Ball EM, 1997, ARCH INTERN MED, V157, P419, DOI 10.1001/archinte.157.4.419; CHARUZI I, 1992, American Journal of Clinical Nutrition, V55, p594S, DOI 10.1093/ajcn/55.2.594s; Cohen R, 1998, ORAL SURG ORAL MED O, V85, P388, DOI 10.1016/S1079-2104(98)90062-2; Conradt R, 1998, J SLEEP RES, V7, P217, DOI 10.1046/j.1365-2869.1998.00116.x; Douketis JD, 1999, CAN MED ASSOC J, V160, P513; GUILLEMINAULT C, 1981, CLIN RES PROC, V17, P341; GUILLEMINAULT C, 1993, CHEST, V104, P781, DOI 10.1378/chest.104.3.781; Haponik EF, 1996, J GEN INTERN MED, V11, P759, DOI 10.1007/BF02598994; Hoy CJ, 1999, AM J RESP CRIT CARE, V159, P1096, DOI 10.1164/ajrccm.159.4.9808008; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jokic R, 1999, CHEST, V115, P771, DOI 10.1378/chest.115.3.771; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; KRIEGER J, 1983, LANCET, V2, P1429; Li KK, 2000, OTOLARYNG HEAD NECK, V122, P410, DOI 10.1016/S0194-5998(00)70057-X; Loube DI, 1999, CHEST, V115, P863, DOI 10.1378/chest.115.3.863; Man GCW, 1996, MED CLIN N AM, V80, P803, DOI 10.1016/S0025-7125(05)70468-5; Marklund M, 1998, CHEST, V113, P707, DOI 10.1378/chest.113.3.707; Mickelson SA, 1996, LARYNGOSCOPE, V106, P10, DOI 10.1097/00005537-199601000-00003; NINOMURCIA G, 1989, WESTERN J MED, V150, P165; PACK AI, 1994, ADV INTERNAL MED, V39, P517; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Persson HE, 1996, CHEST, V109, P645, DOI 10.1378/chest.109.3.645; Powell NB, 1998, CLIN CHEST MED, V19, P77, DOI 10.1016/S0272-5231(05)70433-0; Powell NB, 1999, OTOLARYNG HEAD NECK, V120, P656, DOI 10.1053/hn.1999.v120.a96956; ROCHESTER DF, 1974, AM J MED, V57, P402, DOI 10.1016/0002-9343(74)90135-1; Ryan CF, 2000, THORAX, V55, P399, DOI 10.1136/thorax.55.5.399; Sher AE, 1996, SLEEP, V19, P156, DOI 10.1093/sleep/19.2.156; Strollo PJ, 1998, CLIN CHEST MED, V19, P55, DOI 10.1016/S0272-5231(05)70431-7; SURATT PM, 1987, CHEST, V92, P631, DOI 10.1378/chest.92.4.631; THORPY M, 1994, SLEEP, V17, P372; WETTER DW, 1994, ARCH INTERN MED, V154, P2219, DOI 10.1001/archinte.154.19.2219; Woodson BT, 2000, OTOLARYNG HEAD NECK, V122, P395, DOI 10.1016/S0194-5998(00)70055-6; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	35	9	9	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1492	1494		10.1001/jama.284.12.1492	http://dx.doi.org/10.1001/jama.284.12.1492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000621				2022-12-28	WOS:000089379700002
J	Plancoulaine, S; Abel, L; van Beveren, M; Tregouet, DA; Joubert, M; Tortevoye, P; de The, G; Gessain, A				Plancoulaine, S; Abel, L; van Beveren, M; Tregouet, DA; Joubert, M; Tortevoye, P; de The, G; Gessain, A			Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population	LANCET			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; ESTIMATING EQUATIONS; HUMAN-HERPESVIRUS-8 INFECTION; SEXUAL TRANSMISSION; HIGH SEROPREVALENCE; SEROLOGIC EVIDENCE; HOMOSEXUAL MEN; ODDS-RATIO; ANTIBODIES	Background Transmission or human herpesvirus 8 (HHV-8), the aetiological agent of Kaposi's sarcoma, is known to occur during sex among homosexual men. However, other modes of HHV-8 transmission remain to be elucidated in endemic populations. Methods We did a population-based seroepidemiological survey in a village in French Guiana among 1337 individuals of African origin (age 2-91 years) who had reliable genealogical data. Plasma samples were taken and tested for HHV-8-specific IgG by immunofluorescence assay. Risk factors and familial correlations for HHV-8 seropositivity were modelled by logistic regression analysis by use of the estimating equations approach, which expresses familial dependences in terms of odds ratios. Familial odds ratios were also acquired by use of the distribution of all possible pairs of a given familiar dependence. Findings The overall HHV-8 seroprevalence was 13.2% with no difference according to sex. HHV-8 seropositivity was strongly age;dependent: at 1.2% under 5 years, HHV-8 seroprevalence rose up to a plateau around 15% between 15 and 40 years, and showed a seroprevalence of more than 27% in individuals older than 40 years. Strong familial aggregation in HHV-8 seroprevalence was found with high mother-child (odd ratio 2.8 [95% CI 1.6-5.0]) and sib-sib (3.8 [1.6-9.5]) correlations. By:contrast, no significant correlation between spouses (0.6 [0.2-1.9]) was seen. Interpretation This pattern of familiar aggregation, together with the variation of HHV-8 seroprevalence with age, indicate that, in endemic populations, HHV-8 transmission mainly occurs from mother to child and between siblings during childhood and adolescence.	Fac Med Necker Enfants Malad, Inst Pasteur, Unite Oncol Virale, Dept SIDA & Retrovirus,Lab Genet Humaine Malad In, F-75015 Paris, France; Fac Med Necker Enfants Malad, Inst Pasteur, CNRS,URA 1930, Lab Genet Humaine Malad Infect, F-75015 Paris, France; Fac Med Necker Enfants Malad, Inst Pasteur, INSERM,U436, Lab Genet Humaine Malad Infect, F-75015 Paris, France; Fac Med Necker Enfants Malad, Inst Pasteur, Unite Epidemiol Virus Oncogenes, Lab Genet Humaine Malad Infect, F-75015 Paris, France; INSERM, U525, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gessain, A (corresponding author), Fac Med Necker Enfants Malad, Inst Pasteur, Unite Oncol Virale, Dept SIDA & Retrovirus,Lab Genet Humaine Malad In, 28 Rue Dr Roux, F-75015 Paris, France.	agessain@pasteur.fr	Trégouët, David-Alexandre/P-9210-2019; Abel, Laurent/H-8888-2017; Tregouet, David-Alexandre/E-3961-2016; PLANCOULAINE, Sabine/E-2824-2017	Trégouët, David-Alexandre/0000-0001-9084-7800; Abel, Laurent/0000-0001-7016-6493; PLANCOULAINE, Sabine/0000-0003-0725-8306				Andreoni M, 1999, J NATL CANCER I, V91, P465, DOI 10.1093/jnci/91.5.465; Angeloni A, 1998, J INFECT DIS, V177, P1715, DOI 10.1086/517429; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Bestetti G, 1998, AIDS, V12, P541; Blackbourn DJ, 1998, J INFECT DIS, V177, P213, DOI 10.1086/517356; Blackbourn DJ, 1999, J INFECT DIS, V179, P237, DOI 10.1086/314570; Boshoff C, 1998, ADV CANCER RES, V75, P57, DOI 10.1016/S0065-230X(08)60739-3; Bourboulia D, 1998, JAMA-J AM MED ASSOC, V280, P31, DOI 10.1001/jama.280.1.31-a; Calabro M L, 1998, J Hum Virol, V1, P207; Calabro ML, 1999, J INFECT DIS, V179, P1534, DOI 10.1086/314765; Chatlynne LG, 1998, BLOOD, V92, P53, DOI 10.1182/blood.V92.1.53.413k30_53_58; de-The G, 1999, J NATL CANCER I, V91, P1888, DOI 10.1093/jnci/91.21.1888; DEMENAIS FM, 1991, AM J HUM GENET, V49, P773; Gessain A, 1999, INT J CANCER, V81, P189, DOI 10.1002/(SICI)1097-0215(19990412)81:2&lt;189::AID-IJC4&gt;3.0.CO;2-E; Kaslow, 1997, VIRAL INFECT HUMANS, P253; Kasolo FC, 1997, J GEN VIROL, V78, P847, DOI 10.1099/0022-1317-78-4-847; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Koelle DM, 1997, J INFECT DIS, V176, P94, DOI 10.1086/514045; Lennette ET, 1996, LANCET, V348, P858, DOI 10.1016/S0140-6736(96)03240-0; LIANG KY, 1991, GENET EPIDEMIOL, V8, P361, DOI 10.1002/gepi.1370080602; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIPSITZ SR, 1991, BIOMETRIKA, V78, P153; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;817::AID-IJC2&gt;3.0.CO;2-X; Melbye M, 1998, INT J CANCER, V77, P543, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;543::AID-IJC12&gt;3.0.CO;2-7; Plancoulaine S, 1998, INT J CANCER, V76, P331, DOI 10.1002/(SICI)1097-0215(19980504)76:3&lt;331::AID-IJC8&gt;3.0.CO;2-W; PRENTICE RL, 1991, BIOMETRICS, V47, P825, DOI 10.2307/2532642; Schulz TF, 1998, J GEN VIROL, V79, P1573, DOI 10.1099/0022-1317-79-7-1573; Sitas F, 1999, NEW ENGL J MED, V340, P1923, DOI 10.1056/NEJM199906173402414; Smith NA, 1999, J INFECT DIS, V180, P600, DOI 10.1086/314926; SPERDUTO RD, 1994, AM J EPIDEMIOL, V140, P555; Tregouet DA, 2000, ANN HUM GENET, V64, P1, DOI 10.1046/j.1469-1809.2000.6410001.x; Tregouet DA, 1999, GENET EPIDEMIOL, V16, P69, DOI 10.1002/(SICI)1098-2272(1999)16:1<69::AID-GEPI6>3.0.CO;2-H; Vieira J, 1997, J VIROL, V71, P7083, DOI 10.1128/JVI.71.9.7083-7087.1997; Whitby D, 1999, J INFECT DIS, V179, P234, DOI 10.1086/314563; ZHAO LP, 1990, BIOMETRIKA, V77, P642, DOI 10.1093/biomet/77.3.642; Ziegler JL, 1996, INT J CANCER, V65, P200, DOI 10.1002/(SICI)1097-0215(19960117)65:2&lt;200::AID-IJC12&gt;3.0.CO;2-H	37	189	200	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2000	356	9235					1062	1065		10.1016/S0140-6736(00)02729-X	http://dx.doi.org/10.1016/S0140-6736(00)02729-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009141				2022-12-28	WOS:000089430500010
J	Froeschle, C; Guzzo, M; Lega, E				Froeschle, C; Guzzo, M; Lega, E			Graphical evolution of the Arnold web: From order to chaos	SCIENCE			English	Article							SYSTEMS; ORBITS; MOTION	We represent graphically the evolution of the set of resonances of a quasi-integrable dynamical system, the so-called Arnold web, whose structure is crucial for the stability properties of the system. The basis of our representation is the use of an original numerical method, whose definition is directly related to the dynamics of orbits, and the careful choice of a model system. We also show the transition from the Nekhoroshev stability regime to the Chirikov diffusive one, which is a generic nontrivial phenomenon occurring in many physical processes, such as slow chaotic transport in the asteroid belt and beam-beam interaction.	Observ Nice, F-06304 Nice 4, France	UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Froeschle, C (corresponding author), Observ Nice, Blvd Observ,Boite Postale 4229, F-06304 Nice 4, France.		Elena, Lega/AAR-4207-2021	Elena, Lega/0000-0001-6086-0545				Arnold V.I., 1978, MATH METHODS CLASSIC, DOI 10.1007/978-1-4757-1693-1; Benettin G, 1996, NONLINEARITY, V9, P137, DOI 10.1088/0951-7715/9/1/005; BENETTIN G, 1998, REGUL CHAOTIC DYN, V3, P3; CHIRIKOV BV, 1979, PHYS REP, V52, P263, DOI 10.1016/0370-1573(79)90023-1; Contopoulos G, 1997, ASTRON ASTROPHYS, V317, P73; Froeschle C, 1998, ASTRON ASTROPHYS, V334, P355; Froeschle C, 1997, CELEST MECH DYN ASTR, V67, P41, DOI 10.1023/A:1008276418601; Froeschle C, 1996, CELEST MECH DYN ASTR, V64, P21, DOI 10.1007/BF00051602; Guzzo M, 1997, CELEST MECH DYN ASTR, V66, P255, DOI 10.1007/BF00049382; LASKAR J, 1992, PHYSICA D, V56, P253, DOI 10.1016/0167-2789(92)90028-L; LASKAR J, 1993, PHYSICA D, V67, P257, DOI 10.1016/0167-2789(93)90210-R; LASKAR J, 1995, 11 ICMP C PAR; LEGA E, 1996, 4 A VONH C CEL MECH; MONTH M, 1979, NONLINEAR DYNAMICS B; MOSER J, 1958, COMMUN PUR APPL MATH, V11, P81, DOI 10.1002/cpa.3160110105; Nesvorny D, 1997, ICARUS, V130, P247, DOI 10.1006/icar.1997.5807; Oseledec VI., 1968, T MOSKOV MAT OBSC, V19, P179; [No title captured]	21	118	119	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2108	2110		10.1126/science.289.5487.2108	http://dx.doi.org/10.1126/science.289.5487.2108			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000109				2022-12-28	WOS:000089430900039
J	Loder, N				Loder, N			Case of the stolen Enigma machine takes cryptic turn	NATURE			English	News Item																			0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					278	278		10.1038/35030382	http://dx.doi.org/10.1038/35030382			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014158	Bronze			2022-12-28	WOS:000089390700009
J	Wickware, P				Wickware, P			Postdocs reject academic research	NATURE			English	Article																			0	1	1	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					429	430		10.1038/35030316	http://dx.doi.org/10.1038/35030316			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014203				2022-12-28	WOS:000089390700061
J	Jepsen, K; Hermanson, O; Onami, TM; Gleiberman, AS; Lunyak, V; McEvilly, RJ; Kurokawa, R; Kumar, V; Liu, F; Seto, E; Hedrick, SM; Mandel, G; Glass, CK; Rose, DW; Rosenfeld, MG				Jepsen, K; Hermanson, O; Onami, TM; Gleiberman, AS; Lunyak, V; McEvilly, RJ; Kurokawa, R; Kumar, V; Liu, F; Seto, E; Hedrick, SM; Mandel, G; Glass, CK; Rose, DW; Rosenfeld, MG			Combinatorial roles of the nuclear receptor corepressor in transcription and development	CELL			English	Article							HISTONE DEACETYLASE; N-COR; NEURONAL DIFFERENTIATION; SILENCER ELEMENT; GENE-EXPRESSION; TARGET GENES; REPRESSION; COMPLEX; MSIN3; REST	Transcriptional repression plays crucial roles in diverse aspects of metazoan development, implying critical regulatory roles for corepressors such as N-CoR and SMRT. Altered patterns of transcription in tissues and cells derived from N-CoR gene-deleted mice and the resulting block at specific points in CNS, erythrocyte, and thymocyte development indicated that N-CoR was a required component of short-term active repression by nuclear receptors and MAD and of a subset of long-term repression events mediated by REST/NRSF. Unexpectedly, N-CoR and a specific deacetylase were also required for transcriptional activation of one class of retinoic acid response element. Together, these findings suggest that specific combinations of corepressors and histone deacetylases mediate the gene-specific actions of DNA-bound repressors in development of multiple organ systems.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; SUNY Stony Brook, Howard Hughes Med Inst, Stony Brook, NY 11794 USA; Univ Calif San Diego, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Glass, Christopher/AAI-3933-2021; Hedrick, Stephen M/E-9171-2010; lunyak, victoria/R-3765-2017; Kumar, Vivek/P-8749-2014	Glass, Christopher/0000-0003-4344-3592; lunyak, victoria/0000-0001-9093-2714; Hermanson, Ola/0000-0001-9320-7921; Kumar, Vivek/0000-0001-6643-7465; Hedrick, Stephen/0000-0002-6345-8751; gleiberman, anatoli/0000-0001-8491-0826	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054802] Funding Source: NIH RePORTER; NIDDK NIH HHS [1 RO1 DK54802-O1A1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Bauer A, 1998, EMBO J, V17, P4291, DOI 10.1093/emboj/17.15.4291; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; Glass CK, 2000, GENE DEV, V14, P121; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; GREGORY CJ, 1978, BLOOD, V51, P527; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Guenther MG, 2000, GENE DEV, V14, P1048; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HERMANSON O, 1994, J HISTOCHEM CYTOCHEM, V42, P827, DOI 10.1177/42.6.7514627; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Huang EY, 2000, GENE DEV, V14, P45; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kallunki P, 1997, J CELL BIOL, V138, P1343, DOI 10.1083/jcb.138.6.1343; Kao HY, 2000, GENE DEV, V14, P55; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; NEUMAN K, 1995, J NEUROSCI RES, V41, P39, DOI 10.1002/jnr.490410106; PAIN B, 1990, New Biologist, V2, P284; RAMSDELL F, 1992, CURRENT PROTOCOLS IM; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Seol W, 1996, MOL ENDOCRINOL, V10, P1646, DOI 10.1210/me.10.12.1646; Smith WL, 1997, ACAD RADIOL, V4, P657, DOI 10.1016/S1076-6332(05)80273-9; Struhl K, 1998, COLD SPRING HARB SYM, V63, P413, DOI 10.1101/sqb.1998.63.413; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Xu JM, 1996, P NATL ACAD SCI USA, V93, P12195, DOI 10.1073/pnas.93.22.12195; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zamir I, 1996, MOL CELL BIOL, V16, P5458	55	402	410	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					753	763		10.1016/S0092-8674(00)00064-7	http://dx.doi.org/10.1016/S0092-8674(00)00064-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030619	Bronze			2022-12-28	WOS:000089395200007
J	Carmeliet, P; Jain, RK				Carmeliet, P; Jain, RK			Angiogenesis in cancer and other diseases	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; HUMAN COLON ADENOCARCINOMA; TUMOR ANGIOGENESIS; DRUG-DELIVERY; SOLID TUMORS; MICE; VESSELS; CELLS; MICROENVIRONMENT; PLASMINOGEN	Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti- angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.	Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Massachusetts Gen Hosp, Dept Radiat Oncol, Steele Lab Tumor Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Flanders Institute for Biotechnology (VIB); KU Leuven; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.ac.be; jain@steele.mgh.harvard.edu	Carmeliet, Peter/AAQ-5140-2020; Jain, Rakesh K/I-1384-2017; Yin, ming/F-3737-2012; Zinn, Pascal O/A-6667-2010	Carmeliet, Peter/0000-0001-7961-1821; Jain, Rakesh K/0000-0001-7571-3548; 				Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; ALGIRE GH, 1945, J NATL CANCER I, V6, P73, DOI 10.1093/jnci/6.1.73; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Asahara T, 2000, GENE THER, V7, P451, DOI 10.1038/sj.gt.3301142; Baish JW, 2000, CANCER RES, V60, P3683; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bellamy WT, 1999, CANCER RES, V59, P728; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Boulton AJM, 1998, MED CLIN N AM, V82, P909, DOI 10.1016/S0025-7125(05)70029-8; Buschmann I, 2000, J PATHOL, V190, P338, DOI 10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 1998, THROMB RES, V91, P255, DOI 10.1016/S0049-3848(98)00122-4; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 1999, NATURE, V401, P657, DOI 10.1038/44304; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2000, J PATHOL, V190, P387; CHANG YS, IN PRESS P AM ASS CA; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Eberhard A, 2000, CANCER RES, V60, P1388; EHRMANN RL, 1968, J NATL CANCER I, V41, P1329; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FIDLER IJ, 1995, J NATL CANCER I, V87, P1588, DOI 10.1093/jnci/87.21.1588; Fidler IJ, 2000, NAT MED, V6, P500, DOI 10.1038/74969; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; FOLKMAN J, 2000, CANC MED, P132; Fukumura D, 1997, AM J PATHOL, V151, P679; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Giaccia AJ, 1996, SEMIN RADIAT ONCOL, V6, P46, DOI 10.1016/S1053-4296(96)80035-X; Gohongi T, 1999, NAT MED, V5, P1203, DOI 10.1038/13524; Goldmann E, 1907, LANCET, V2, P1236; GREENBLATT M, 1968, JNCI-J NATL CANCER I, V41, P111; GULLINO PM, 1978, JNCI-J NATL CANCER I, V61, P639; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartford AC, 2000, CANCER RES, V60, P2128; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Huang XM, 1997, SCIENCE, V275, P547, DOI 10.1126/science.275.5299.547; IDE A. GORDON, 1939, AMER JOUR ROENTGENOL AND RADIUM THERAP, V42, P891; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Jain RK, 1998, P NATL ACAD SCI USA, V95, P10820, DOI 10.1073/pnas.95.18.10820; Jain RK, 1996, CANCER METAST REV, V15, P195, DOI 10.1007/BF00437472; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; Jain RK, 1997, NAT MED, V3, P1203, DOI 10.1038/nm1197-1203; JAIN RK, 1988, CANCER RES, V48, P2641; Jain RK, 2000, NAT MED, V6, P131, DOI 10.1038/72212; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Leu AJ, 2000, CANCER RES, V60, P4324; LEUNIG M, 1992, CANCER RES, V52, P6553; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Patan S, 1996, MICROVASC RES, V51, P260, DOI 10.1006/mvre.1996.0025; PerezAtayde AR, 1997, AM J PATHOL, V150, P815; Pinedo HM, 1998, LANCET, V352, P1775, DOI 10.1016/S0140-6736(98)05095-8; Rabinovitch M, 1999, J HEART LUNG TRANSPL, V18, P1041, DOI 10.1016/S1053-2498(99)00015-7; Rafii S, 2000, J CLIN INVEST, V105, P17, DOI 10.1172/JCI8774; Ramanujan S, 2000, CANCER RES, V60, P1442; Rohan RM, 2000, FASEB J, V14, P871, DOI 10.1096/fasebj.14.7.871; Schaper W, 1996, CIRC RES, V79, P911, DOI 10.1161/01.RES.79.5.911; Seljelid R, 1999, ANTICANCER RES, V19, P4809; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; SILVERMAN KJ, 1988, BIOCHEM BIOPH RES CO, V153, P347, DOI 10.1016/S0006-291X(88)81229-4; TSUZUKI Y, IN PRESS CANC RES; Vikkula M, 1998, TRENDS CARDIOVAS MED, V8, P281, DOI 10.1016/S1050-1738(98)00024-3	75	6845	7371	30	1530	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					249	257		10.1038/35025220	http://dx.doi.org/10.1038/35025220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001068				2022-12-28	WOS:000089241000061
J	Berger, HM; de Waard, F; Molenaar, Y				Berger, HM; de Waard, F; Molenaar, Y			A case of twin-to-twin transfusion in 1617	LANCET			English	Article									Leiden Univ, Med Ctr, Dept Pediat, Neonatal Ctr, NL-2300 RC Leiden, Netherlands; Rijksmuseum Muiderslot, Muiden, Netherlands; Univ Utrecht, Dept Epidemiol, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University	Berger, HM (corresponding author), Leiden Univ, Med Ctr, Dept Pediat, Neonatal Ctr, NL-2300 RC Leiden, Netherlands.							BEDAUX JB, 1998, NAAT LIJK NEDERLAAND, P86; *CAT RIJKSM AMST, 1996, A981 NOORDN SCH CAT, P675; Crowther C. A., 1999, HIGH RISK PREGNANCY, P129; FISK NM, 1990, ARCH DIS CHILD-FETAL, V65, P657, DOI 10.1136/adc.65.7_Spec_No.657; *INT FERT ASS, 1959, 3 WORLD C FERT STER; KLOOSTERMAN G J, 1963, Ned Tijdschr Verloskd Gynaecol, V63, P395; LIPTON EL, 1965, PEDIATRICS, V35, P521; LOPRIORE E, 1995, J PEDIATR-US, V127, P675, DOI 10.1016/S0022-3476(95)70152-4; MEAKINS JL, 1991, ARCH SURG-CHICAGO, V131, P1289; Sharma P, 1997, LANCET, V349, P1470, DOI 10.1016/S0140-6736(96)12216-9; SHARMA P, 1990, BRIT MED J, V300, P333, DOI 10.1136/bmj.300.6720.333-b; Strong S.J, 1967, PLACENTA TWIN PREGNA; Ville Y, 1997, ULTRASOUND OBST GYN, V10, P82, DOI 10.1046/j.1469-0705.1997.10020082.x; YURDAKOK K, 1990, AM J PUBLIC HEALTH, V80, P873, DOI 10.2105/AJPH.80.7.873	14	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					847	848		10.1016/S0140-6736(00)02665-9	http://dx.doi.org/10.1016/S0140-6736(00)02665-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022944				2022-12-28	WOS:000089101800037
J	Doshi, DA; Huesing, NK; Lu, MC; Fan, HY; Lu, YF; Simmons-Potter, K; Potter, BG; Hurd, AJ; Brinker, CJ				Doshi, DA; Huesing, NK; Lu, MC; Fan, HY; Lu, YF; Simmons-Potter, K; Potter, BG; Hurd, AJ; Brinker, CJ			Optically, defined multifunctional patterning of photosensitive thin-film silica mesophases	SCIENCE			English	Article							GEL; GRATINGS	Photosensitive films incorporating molecular photoacid generators compartmentalized within a silica-surfactant mesophase were prepared by an evaporation-induced self-assembly process. Ultraviolet exposure promoted localized acid-catalyzed siloxane condensation, which can be used for selective etching of unexposed regions; for "gray-scale" patterning of refractive index, pore size, surface area, and wetting behavior; and for optically defining a mesophase transformation (from hexagonal to tetragonal) within the film. The ability to optically define and continuously central both structure and function on the macro- and mesoscales is of interest for sensor arrays, nanoreactors, photonic and fluidic devices, and low-dielectric-constant films.	Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87106 USA; Univ New Mexico, Ctr Microengineered Mat, Adv Mat Lab, Albuquerque, NM 87106 USA; Univ New Mexico, Dept Chem, Albuquerque, NM 87131 USA; Vienna Univ Technol, Inst Inorgan Chem, Vienna, Austria; Appl Mat Inc, Santa Clara, CA 95054 USA; Sandia Natl Labs, Albuquerque, NM 87185 USA	University of New Mexico; University of New Mexico; University of New Mexico; Technische Universitat Wien; Applied Materials Inc; United States Department of Energy (DOE); Sandia National Laboratories	Brinker, CJ (corresponding author), Univ New Mexico, Dept Chem & Nucl Engn, 1001 Univ Blvd SE, Albuquerque, NM 87106 USA.	cjbrink@sandia.gov	Huesing, Nicola K/E-7296-2011	Huesing, Nicola K/0000-0003-2274-9779				Blanc D, 1999, ADV MATER, V11, P1508, DOI 10.1002/(SICI)1521-4095(199912)11:18<1508::AID-ADMA1508>3.0.CO;2-V; Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R; BRINKER CJ, 1995, ACCESS NANOPOROUS MA, P123; BRINKER CJ, 1990, SOL GEL SCI, P139; Coudray P, 1997, OPT ENG, V36, P1234, DOI 10.1117/1.601243; CRIVELLO JV, 1977, MACROMOLECULES, V10, P1307, DOI 10.1021/ma60060a028; DOSHI DA, UNPUB; Fan HY, 2000, NATURE, V405, P56, DOI 10.1038/35011026; FRYE GC, 1988, MATER RES SOC S P, V121, P349; Gupta VK, 1997, SCIENCE, V276, P1533, DOI 10.1126/science.276.5318.1533; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P341, DOI 10.1016/B978-0-12-375182-9.10015-6; ISRAELACHVILI JN, 1976, J CHEM SOC FARAD T 2, V72, P1525, DOI 10.1039/f29767201525; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Lu MC, 2000, MATER RES SOC SYMP P, V594, P463; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; Miller RD, 1999, SCIENCE, V286, P421, DOI 10.1126/science.286.5439.421; MONNIER A, 1993, SCIENCE, V261, P1299, DOI 10.1126/science.261.5126.1299; Moreau Y, 1998, OPT ENG, V37, P1130, DOI 10.1117/1.601946; Sakya P, 1997, LANGMUIR, V13, P3706, DOI 10.1021/la9701844; Samuel J, 1998, LANGMUIR, V14, P2602, DOI 10.1021/la980073k; Simmons-Potter K, 1998, JPN J APPL PHYS 1, V37, P8, DOI 10.7567/JJAPS.37S1.8; Trau M, 1997, NATURE, V390, P674, DOI 10.1038/37764; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244	24	173	178	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					107	111		10.1126/science.290.5489.107	http://dx.doi.org/10.1126/science.290.5489.107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021789	Green Submitted			2022-12-28	WOS:000089724800042
J	Greenberger, NJ				Greenberger, NJ			Update in gastroenterology	ANNALS OF INTERNAL MEDICINE			English	Review							TRIAL; INFECTION		Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Greenberger, NJ (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.							Bardhan KD, 2000, ALIMENT PHARM THERAP, V14, P23; Bond JH, 1999, NEW ENGL J MED, V341, P1540, DOI 10.1056/NEJM199911113412010; Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; Cody SH, 1999, ANN INTERN MED, V130, P202, DOI 10.7326/0003-4819-130-3-199902020-00005; Colombel JF, 1999, AM J GASTROENTEROL, V94, P674, DOI 10.1111/j.1572-0241.1999.935_q.x; Daniel S, 1999, AM J GASTROENTEROL, V94, P3010, DOI 10.1111/j.1572-0241.1999.01451.x; Ferrer M, 1999, ANN INTERN MED, V130, P991, DOI 10.7326/0003-4819-130-12-199906150-00007; Peterson WL, 1999, JAMA-J AM MED ASSOC, V282, P1961, DOI 10.1001/jama.282.20.1961; Prantera C, 1999, GASTROENTEROLOGY, V116, P521, DOI 10.1016/S0016-5085(99)70172-1; Reddy KR, 1999, GASTROINTEST ENDOSC, V49, P498, DOI 10.1016/S0016-5107(99)70050-7; Steinbach G, 1999, ANN INTERN MED, V131, P88, DOI 10.7326/0003-4819-131-2-199907200-00003; Vaezi MF, 1999, GUT, V44, P231, DOI 10.1136/gut.44.2.231; Vaira D, 1999, LANCET, V354, P30, DOI 10.1016/S0140-6736(98)08103-3	13	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					542	548		10.7326/0003-4819-133-7-200010030-00014	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00014			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015168				2022-12-28	WOS:000089678300007
J	Suzuki, T; Katoh, H; Tsuchio, Y; Hasegawa, A; Kurabayashi, M; Ohira, A; Hiramori, K; Sakomura, Y; Kasanuki, H; Hori, S; Aikawa, N; Abe, S; Tei, C; Nakagawa, Y; Nobuyoshi, M; Misu, K; Sumiyoshi, T; Nagai, R				Suzuki, T; Katoh, H; Tsuchio, Y; Hasegawa, A; Kurabayashi, M; Ohira, A; Hiramori, K; Sakomura, Y; Kasanuki, H; Hori, S; Aikawa, N; Abe, S; Tei, C; Nakagawa, Y; Nobuyoshi, M; Misu, K; Sumiyoshi, T; Nagai, R			Diagnostic implications of elevated levels of smooth-muscle myosin heavy-chain protein in acute aortic dissection - The smooth muscle myosin heavy chain study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; STENT-GRAFT PLACEMENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; IMMUNOASSAY; SERUM	Background: A rapid 30-minute assay of circulating smooth-muscle myosin heavy-chain protein has been developed as a biochemical diagnostic tool for aortic dissection. Objective: To determine the sensitivity and specificity of this assay. Design: Cross-sectional study. Setting: 8 major cardiovascular centers in Japan. Patients: 95 patients with acute aortic dissection, 48 patients with acute myocardial infarction, and 131 healthy volunteers. Measurements: Levels of circulating smooth-muscle myosin heavy-chain protein. Results: Patients with acute aortic dissection who presented within 3 hours after onset had elevated levels of circulating smooth-muscle myosin heavy-chain protein, In these patients, the assay had a sensitivity of 90.9%, a specificity of 98% compared with healthy volunteers, and a specificity of 83% compared with patients who had acute myocardial infarction; the clinical decision limit was 2.5 mu g/L. All patients with proximal lesions had elevated levels of smooth-muscle myosin heavy-chain protein, and only patients with distal lesions had decreased levels (<2.5 mu g/L). Conclusions: Levels of smooth-muscle myosin heavy-chain protein can be used to diagnose aortic dissection soon after symptom onset. The assay had the greatest diagnostic value in patients with proximal lesions.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Tokyo Womens Med Univ, Tokyo, Japan; Keio Univ, Tokyo, Japan; Sakakibara Heart Inst, Tokyo, Japan; Gunma Univ, Gunma, Japan; Iwate Med Univ, Morioka, Iwate 020, Japan; Kagoshima Univ, Kagoshima 890, Japan; Kokura Mem Hosp, Kokurakita Ku, Kokura, Japan	University of Tokyo; Tokyo Women's Medical University; Keio University; Gunma University; Iwate Medical University; Kagoshima University; Kokura Memorial Hospital	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	torusuzu-tky@umin.ac.jp						Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; DEBAKEY ME, 1955, ANN SURG, V142, P586, DOI 10.1097/00000658-195510000-00005; ERBEL R, 1989, LANCET, V1, P457; ERBEL R, 1993, CIRCULATION, V87, P1604, DOI 10.1161/01.CIR.87.5.1604; GROS BJ, 1996, CARDIOL REV, V4, P112; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; HAMM CW, 1994, NEW ENGL J MED, V331, P607, DOI 10.1056/NEJM199409013310910; ISSELBACHER EM, 1997, HEART DIS TXB CARDIO; KATOH H, 1995, J IMMUNOL METHODS, V185, P57, DOI 10.1016/0022-1759(95)00104-I; KATOH H, 1995, LANCET, V345, P191, DOI 10.1016/S0140-6736(95)90194-9; KATUS HA, 1989, J MOL CELL CARDIOL, V21, P1349, DOI 10.1016/0022-2828(89)90680-9; KERSTINGSOMMERHOFF BA, 1988, RADIOLOGY, V166, P651, DOI 10.1148/radiology.166.3.3340758; Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003; NIENABER CA, 1992, CIRCULATION, V85, P434, DOI 10.1161/01.CIR.85.2.434; NIENABER CA, 1993, NEW ENGL J MED, V328, P1, DOI 10.1056/NEJM199301073280101; Sebastia C, 1999, RADIOGRAPHICS, V19, P45, DOI 10.1148/radiographics.19.1.g99ja0945; SPITTELL PC, 1993, MAYO CLIN PROC, V68, P642, DOI 10.1016/S0025-6196(12)60599-0; Suzuki T, 1996, CIRCULATION, V93, P1244, DOI 10.1161/01.CIR.93.6.1244; vonKodolitsch Y, 1997, Z KARDIOL, V86, P469; WHEAT MW, 1965, J THORAC CARDIOV SUR, V50, P364, DOI 10.1016/S0022-5223(19)33192-7	20	85	92	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					537	541		10.7326/0003-4819-133-7-200010030-00013	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015167				2022-12-28	WOS:000089678300006
J	Fehn, U; Snyder, G; Egeberg, PK				Fehn, U; Snyder, G; Egeberg, PK			Dating of pore waters with I-129: Relevance for the origin of marine gas hydrates	SCIENCE			English	Article							ANTHROPOGENIC I-129; SOURCE AGES; SEDIMENTS; FLUIDS	Pore waters associated with gas hydrates at Blake Ridge in the Atlantic Ocean were dated by measuring their iodine-129/iodine-129/iodine ratios. Samples collected from sediments with ages between 1.8 and 6 million years ago consistently yield ages around 55 million years ago. These ages, together with the strong iodine enrichment observed in the pore waters, suggest that the origin of iodine is related to organic material of early Tertiary age, which probably is also the source of the methane in the gas hydrates at this location.	Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; Agder Coll, Dept Chem, N-4604 Kristiansand, Norway	University of Rochester; University of Agder	Fehn, U (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.		Snyder, Glen/ABG-7762-2021; Snyder, Glen T/E-7873-2017	Snyder, Glen T/0000-0001-5289-7903				Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; Egeberg PK, 1999, CHEM GEOL, V153, P53, DOI 10.1016/S0009-2541(98)00152-1; Elmore D, 1997, NUCL INSTRUM METH B, V123, P69, DOI 10.1016/S0168-583X(96)00621-0; FABRYKAMARTIN J, 1985, GEOCHIM COSMOCHIM AC, V49, P337, DOI 10.1016/0016-7037(85)90027-4; FEHN U, 1992, GEOCHIM COSMOCHIM AC, V56, P2069, DOI 10.1016/0016-7037(92)90330-L; FEHN U, 1986, GEOPHYS RES LETT, V13, P137, DOI 10.1029/GL013i002p00137; FEHN U, IN PRESS NUCL INSTRU; Hesse R., 2000, P OCEAN DRILL PROG B, V164, P129, DOI DOI 10.2973/0DP.PR0C.SR.164.238.2000; Hutchinson D. R., 1982, AAPG BULL, V34, P129; Kvenvolden KA, 1999, P NATL ACAD SCI USA, V96, P3420, DOI 10.1073/pnas.96.7.3420; MARTIN JB, 1993, GEOCHIM COSMOCHIM AC, V57, P4377, DOI 10.1016/0016-7037(93)90489-J; Matsumoto R, 2000, P ODP SCI RESULTS, V164, P59, DOI DOI 10.2973/0DP.PR0C.SR.164.206.2000; Moran JE, 1998, CHEM GEOL, V152, P193, DOI 10.1016/S0009-2541(98)00106-5; Moran JE, 1995, GEOCHIM COSMOCHIM AC, V59, P5055, DOI 10.1016/0016-7037(95)00360-6; Okada Hisatake, 2000, Proceedings of the Ocean Drilling Program Scientific Results, V164, P331; Rao US, 1999, GEOCHIM COSMOCHIM AC, V63, P1927, DOI 10.1016/S0016-7037(99)00133-7; RIESE WC, 1999, AM ASS PET GEOL, pA116; SCHINK DR, 1995, EARTH PLANET SC LETT, V135, P131, DOI 10.1016/0012-821X(95)00153-4; Sloan E. D., 1990, CLATHRATE HYDRATES N; SNYDER GT, 2000, EOS, V81, P178; SNYDER GT, IN PRESS NUCL INSTRU; Xu WY, 1999, J GEOPHYS RES-SOL EA, V104, P5081, DOI 10.1029/1998JB900092; 2000, GEOCHEMICAL EARTH RE	23	144	153	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2332	2335		10.1126/science.289.5488.2332	http://dx.doi.org/10.1126/science.289.5488.2332			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009415				2022-12-28	WOS:000089593500047
J	Topinka, MA; LeRoy, BJ; Shaw, SEJ; Heller, EJ; Westervelt, RM; Maranowski, KD; Cossard, AC				Topinka, MA; LeRoy, BJ; Shaw, SEJ; Heller, EJ; Westervelt, RM; Maranowski, KD; Cossard, AC			Imaging coherent electron flow from a quantum point contact	SCIENCE			English	Article							SEMICONDUCTOR NANOSTRUCTURES; MICROSCOPY; CORRALS; SURFACE	Scanning a charged tip above the two-dimensional electron gas inside a gallium arsenide/aluminum gallium arsenide nanostructure allows the coherent electron flow from the lowest quantized modes of a quantum point contact at liquid helium temperatures to be imaged. As the width of the quantum point contact is increased, its electrical conductance increases in quantized steps of 2 e(2)/h, where e is the electron charge and h is Planck's constant. The angular dependence of the electron flow on each step agrees with theory, and fringes separated by half the electron wavelength are observed. Placing the tip so that it interrupts the flow from particular modes of the quantum point contact causes a reduction in the conductance of those particular conduction channels below 2 e(2)/h without affecting other channels.	Harvard Univ, Dept Phys, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Harvard University; Harvard University; University of California System; University of California Santa Barbara	Westervelt, RM (corresponding author), Harvard Univ, Dept Phys, Div Engn & Appl Sci, Cambridge, MA 02138 USA.	westervelt@deas.harvard.edu	LeRoy, Brian J/J-9112-2012	LeRoy, Brian J/0000-0003-1610-5424				BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Crook R, 2000, J PHYS-CONDENS MAT, V12, pL167, DOI 10.1088/0953-8984/12/8/102; Divincenzo DP, 1997, NATO ADV SCI I E-APP, V345, P657; Eriksson MA, 1996, APPL PHYS LETT, V69, P671, DOI 10.1063/1.117801; Finkelstein G, 2000, SCIENCE, V289, P90, DOI 10.1126/science.289.5476.90; Gurevich L, 2000, APPL PHYS LETT, V76, P384, DOI 10.1063/1.125761; HELLER EJ, 1994, NATURE, V369, P464, DOI 10.1038/369464a0; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; McCormick KL, 1999, PHYS REV B, V59, P4654, DOI 10.1103/PhysRevB.59.4654; MOLENKAMP LW, 1990, PHYS REV B, V41, P1274, DOI 10.1103/PhysRevB.41.1274; SHEPARD KL, 1992, PHYS REV LETT, V68, P2660, DOI 10.1103/PhysRevLett.68.2660; TORTONESE M, 1993, APPL PHYS LETT, V62, P834, DOI 10.1063/1.108593; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002; Yoo MJ, 1997, SCIENCE, V276, P579, DOI 10.1126/science.276.5312.579; Zhitenev NB, 2000, NATURE, V404, P473, DOI 10.1038/35006591	18	326	331	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2000	289	5488					2323	2326		10.1126/science.289.5488.2323	http://dx.doi.org/10.1126/science.289.5488.2323			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009412				2022-12-28	WOS:000089593500044
J	Thompson, RN; Gibson, SA				Thompson, RN; Gibson, SA			Transient high temperatures in mantle plume heads inferred from magnesian olivines in Phanerozoic picrites	NATURE			English	Article							HAWAIIAN VOLCANISM; ICELAND PLUME; BASALTS; ORIGIN; KOMATIITES; MAGMAS; MELT; GPA	Both scaled laboratory experiments and numerical models of terrestrial mantle plumes produce `balloon-on-a-string' structures, with a bulbous head followed by a stem-like tail. Discussions have focused on whether their initial upwelling heads are hotter than the tails or cooler, as a result of entrainment of ambient mantle during ascent(1-3), and also on whether initial plume upwelling is a newtonian or non-newtonian process(4,5). The temperature of the mantle delivered to the base of the lithosphere is a critical parameter in such debates. Dry continental magmas can normally contribute little to this topic because their hottest (ultramafic) examples can be expected to be trapped, owing to their density, beneath the Moho. Here we report a rare case in which olivine (with 93.3% forsterite; Mg(2)SiO(4)) phenocrysts, precipitated from an unerupted komatiitic melt (similar to 24% MgO) of the Tristan mantle plume head 132 Myr ago, were carried to upper-crust levels in northwest Namibia by less Mg-rich (9.6-18.5% MgO) magmas. We infer that the hidden melt, generated when the plume impinged on the base of the lithosphere, originated in the mantle with a potential temperature of 1,700 degrees C. This is similar to 400 degrees C above ambient and much hotter than the temperatures previously calculated for steady-state Phanerozoic mantle plumes(3,6-8). Published data show that the same conclusion can be reached for the initial Iceland and Galapagos plumes.	Univ Durham, Dept Geol Sci, Durham DH1 3LE, England; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	Durham University; University of Cambridge	Thompson, RN (corresponding author), Univ Durham, Dept Geol Sci, South Rd, Durham DH1 3LE, England.	r.n.thompson@durham.ac.uk		Gibson, Sally/0000-0002-4835-2908				Arndt N, 1998, CONTRIB MINERAL PETR, V133, P297, DOI 10.1007/s004100050453; Arndt NT, 1997, EARTH PLANET SC LETT, V146, P289, DOI 10.1016/S0012-821X(96)00219-1; BYERS CD, 1985, GEOCHIM COSMOCHIM AC, V49, P1887, DOI 10.1016/0016-7037(85)90083-3; DUNCAN AR, 1990, INT GEOL C, P119; ECHEVERRIA LM, 1986, CONTRIB MINERAL PETR, V92, P428, DOI 10.1007/BF00374425; Falloon TJ, 1999, J PETROL, V40, P1343, DOI 10.1093/petrology/40.9.1343; FARNETANI CG, 1994, J GEOPHYS RES-SOL EA, V99, P13813, DOI 10.1029/94JB00649; FRANCIS D, 1985, CONTRIB MINERAL PETR, V89, P144, DOI 10.1007/BF00379449; GARCIA MO, 1995, GEOPHYS MONOGR SER, V92, P219; Gibson SA, 2000, EARTH PLANET SC LETT, V174, P355, DOI 10.1016/S0012-821X(99)00274-5; GILL RCO, 1992, GEOL SOC SPEC PUBL, P335; Gladczenko TP, 1997, J GEOL SOC LONDON, V154, P465, DOI 10.1144/gsjgs.154.3.0465; GRIFFITHS RW, 1990, EARTH PLANET SC LETT, V99, P66, DOI 10.1016/0012-821X(90)90071-5; HARDS VL, 1995, J GEOL SOC LONDON, V152, P1003, DOI 10.1144/GSL.JGS.1995.152.01.21; Hauri EH, 1996, NATURE, V382, P415, DOI 10.1038/382415a0; Herzberg C, 1996, J GEOPHYS RES-SOL EA, V101, P8271, DOI 10.1029/96JB00170; Larsen TB, 1999, TECTONOPHYSICS, V311, P31, DOI 10.1016/S0040-1951(99)00163-8; LEBAS MJ, IN PRESS J PETROL; LI JP, 1995, J PETROL, V36, P107, DOI 10.1093/petrology/36.1.107; Libourel G, 1999, CONTRIB MINERAL PETR, V136, P63, DOI 10.1007/s004100050524; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; Miller R.McG., 1983, GEOLOGICAL SOC S AFR, V11, P431; MONIERTH C, 1995, GEOPHYS MONOGR, V92, P207; NISBET EG, 1993, LITHOS, V30, P291, DOI 10.1016/0024-4937(93)90042-B; Ribe NM, 1999, EARTH PLANET SC LETT, V171, P517, DOI 10.1016/S0012-821X(99)00179-X; SACK RO, 1991, AM MINERAL, V76, P827; Schmitt AK, 2000, J PETROL, V41, P1207, DOI 10.1093/petrology/41.8.1207; Shen Y, 1998, NATURE, V395, P62, DOI 10.1038/25714; TAKAHASHI E, 1993, PHILOS T ROY SOC A, V342, P105, DOI 10.1098/rsta.1993.0008; ULMER P, 1989, CONTRIB MINERAL PETR, V101, P261, DOI 10.1007/BF00375311; vanKeken P, 1997, EARTH PLANET SC LETT, V148, P1, DOI 10.1016/S0012-821X(97)00042-3; WATSON S, 1991, J PETROL, V32, P501, DOI 10.1093/petrology/32.3.501; WHITE RS, 1995, J GEOPHYS RES-SOL EA, V100, P17543, DOI 10.1029/95JB01585	33	217	246	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					502	506		10.1038/35035058	http://dx.doi.org/10.1038/35035058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028999				2022-12-28	WOS:000089727400047
J	Wikoff, WR; Liljas, L; Duda, RL; Tsuruta, H; Hendrix, RW; Johnson, JE				Wikoff, WR; Liljas, L; Duda, RL; Tsuruta, H; Hendrix, RW; Johnson, JE			Topologically linked protein rings in the bacteriophage HK97 capsid	SCIENCE			English	Article							3-DIMENSIONAL STRUCTURE; CONFORMATIONAL-CHANGES; BACTERIAL-VIRUS; CROSS-LINKING; MATURATION; TRANSITIONS; DEAMIDATION; ASPARAGINYL; MOLSCRIPT; RESIDUES	The crystal structure of the double-stranded DNA bacteriophage HK97 mature empty capsid was determined at 3.6 angstrom resolution. The 660 angstrom diameter icosahedral particle contains 420 subunits with a new fold. The final capsid maturation step is an autocatalytic reaction that creates 420 isopeptide bonds between proteins. Each subunit is joined to two of its neighbors by Ligation of the side-chain Lysine 169 to asparagine 356. This generates 12 pentameric and 60 hexameric rings of covalently joined subunits that loop through each other, creating protein chainmail: topologically linked protein catenanes arranged with icosahedral symmetry. Catenanes have not been previously observed in proteins and provide a stabilization mechanism for the very thin HK97 capsid.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Uppsala Univ, Ctr Biomed, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA	Scripps Research Institute; Uppsala University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Johnson, JE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Duda, Robert/0000-0002-9517-2731	NIAID NIH HHS [R01 AI040101, AI40101] Funding Source: Medline; NIGMS NIH HHS [GM47795, R01 GM047795] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047795] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Casjens S., 1988, BACTERIOPHAGES, V1, P16; CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4; CONWAY JF, 1995, J MOL BIOL, V253, P86, DOI 10.1006/jmbi.1995.0538; DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545; DUDA RL, 1995, J MOL BIOL, V247, P636, DOI 10.1006/jmbi.1994.0169; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; EARNSHAW WC, 1979, J MOL BIOL, V131, P14; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gilakjan ZA, 1999, J BACTERIOL, V181, P7221, DOI 10.1128/JB.181.23.7221-7227.1999; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lata R, 2000, CELL, V100, P253, DOI 10.1016/S0092-8674(00)81563-9; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; LURA R, 1988, BIOCHEMISTRY-US, V27, P7671, DOI 10.1021/bi00420a015; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POPA MP, 1991, J VIROL, V65, P3227, DOI 10.1128/JVI.65.6.3227-3237.1991; Sauvage, 1999, MOL CATENANES ROTAXA; Seeman NC, 1998, ANNU REV BIOPH BIOM, V27, P225, DOI 10.1146/annurev.biophys.27.1.225; STEVEN AC, 1992, J MOL BIOL, V228, P870, DOI 10.1016/0022-2836(92)90871-G; STEVEN AC, 1983, VIROLOGY, V124, P109, DOI 10.1016/0042-6822(83)90294-5; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; ThumanCommike PA, 1996, J MOL BIOL, V260, P85, DOI 10.1006/jmbi.1996.0383; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0; WHITE JH, 1984, P NATL ACAD SCI-BIOL, V81, P3322, DOI 10.1073/pnas.81.11.3322; Wikoff WR, 1998, VIROLOGY, V243, P113, DOI 10.1006/viro.1998.9040; Wikoff WR, 1999, ACTA CRYSTALLOGR D, V55, P763, DOI 10.1107/S0907444998017661; Wikoff WR, 2000, ACTA CRYSTALLOGR D, V56, P890, DOI 10.1107/S0907444900005941; WIKOFF WR, UNPUB; WILLIAMS RC, 1974, J MOL BIOL, V88, P547, DOI 10.1016/0022-2836(74)90501-4; XIE ZH, 1995, J MOL BIOL, V253, P74, DOI 10.1006/jmbi.1995.0537; Yang F, 2000, NAT STRUCT BIOL, V7, P230; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	42	536	546	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2129	2133		10.1126/science.289.5487.2129	http://dx.doi.org/10.1126/science.289.5487.2129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000116				2022-12-28	WOS:000089430900046
J	Burks, DJ; de Mora, JF; Schubert, M; Withers, DJ; Myers, MG; Towery, HH; Altamuro, SL; Flint, CL; White, MF				Burks, DJ; de Mora, JF; Schubert, M; Withers, DJ; Myers, MG; Towery, HH; Altamuro, SL; Flint, CL; White, MF			IRS-2 pathways integrate female reproduction and energy homeostasis	NATURE			English	Article							RECEPTOR SUBSTRATE FAMILY; PHOSPHOTYROSINE PROTEIN; CAENORHABDITIS-ELEGANS; INSULIN-RECEPTORS; LEPTIN RECEPTOR; FOOD-INTAKE; DB/DB MICE; SYSTEM; CELL; HYPOTHALAMUS	Severe dietary restriction, catabolic states and even short-term caloric deprivation impair fertility in mammals. Likewise, obesity is associated with infertile conditions such as polycystic ovary syndrome(1,2). The reproductive status of lower organisms such as Caenorhabditis elegans is also modulated by availability of nutrients(3,4). Thus, fertility requires the integration of reproductive and metabolic signals. Here we show that deletion of insulin receptor substrate-2 (IRS-2), a component of the insulin/insulin-like growth factor-1 signalling cascade, causes female infertility. Mice lacking IRS-2 have small, anovulatory ovaries with reduced numbers of follicles. Plasma concentrations of luteinizing hormone, prolactin and sex steroids are low in these animals. Pituitaries are decreased in size and contain reduced numbers of gonadotrophs. Females lacking IRS-2 have increased food intake and obesity, despite elevated levels of leptin. Our findings indicate that insulin, together with leptin and other neuropeptides, may modulate hypothalamic control of appetite and reproductive endocrinology. Coupled with findings on the role of insulin-signalling pathways in the regulation of fertility, metabolism and longevity in C. elegans and Drosophila(3-5), we have identified an evolutionarily conserved mechanism in mammals that regulates both reproduction and energy homeostasis.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA; Univ Salamanca, Fac Med, Ctr Invest Canc, Salamanca 37007, Spain	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	White, MF (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, 1 Joslin Pl, Boston, MA 02215 USA.		de Mora, Jaime Font/H-6304-2015; Schubert, Markus/F-5150-2010; de Mora, Jaime Font/AAK-7591-2021; Withers, Dominic J/D-7671-2014	de Mora, Jaime Font/0000-0002-6816-2095; de Mora, Jaime Font/0000-0002-6816-2095; Withers, Dominic J/0000-0002-8009-7521				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Berti L, 1997, DIABETOLOGIA, V40, P606, DOI 10.1007/s001250050722; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; FOSTER LA, 1991, PHYSIOL BEHAV, V50, P745, DOI 10.1016/0031-9384(91)90012-D; Franks S, 1999, ENDOCRIN METAB CLIN, V28, P361, DOI 10.1016/S0889-8529(05)70074-8; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Legro RS, 1998, RECENT PROG HORM RES, V53, P217; McCowen KC, 1998, ENDOCRINOLOGY, V139, P4442, DOI 10.1210/en.139.11.4442; Morita Y, 1999, ENDOCRINOLOGY, V140, P941, DOI 10.1210/en.140.2.941; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Richards RG, 1996, P NATL ACAD SCI USA, V93, P12002, DOI 10.1073/pnas.93.21.12002; Schwartz MW, 1997, NEW ENGL J MED, V336, P1802, DOI 10.1056/NEJM199706193362507; Schwartz MW, 1999, AM J CLIN NUTR, V69, P584; Szanto I, 2000, P NATL ACAD SCI USA, V97, P2355, DOI 10.1073/pnas.050580497; Tissenbaum HA, 1998, GENETICS, V148, P703; Unger JW, 1997, CELL TISSUE RES, V288, P471, DOI 10.1007/s004410050833; Unger JW, 1998, HISTOL HISTOPATHOL, V13, P1215, DOI 10.14670/HH-13.1215; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Vassen L, 1999, MOL ENDOCRINOL, V13, P485; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0	30	360	375	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					377	382		10.1038/35030105	http://dx.doi.org/10.1038/35030105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014193				2022-12-28	WOS:000089390700047
J	Prather, RS				Prather, RS			Cloning - Pigs is pigs	SCIENCE			English	Editorial Material									Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Prather, RS (corresponding author), Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA.	pratherR@missouri.edu		Prather, Randall/0000-0002-6012-4035				ABEYDEERA L, IN PRESS THERIOGENOL; Obata Y, 1998, DEVELOPMENT, V125, P1553; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; POLEJAEVA IA, 2000, NATURE, V407, P505; VANDERLAAN LJW, 2000, NATURE, V406, P501; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615	6	24	29	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2000	289	5486					1886	1887		10.1126/science.289.5486.1886	http://dx.doi.org/10.1126/science.289.5486.1886			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	11012362				2022-12-28	WOS:000089355800028
J	Fukuda, R; McNew, JA; Weber, T; Parlati, F; Engel, T; Nickel, W; Rothman, JE; Sollner, TH				Fukuda, R; McNew, JA; Weber, T; Parlati, F; Engel, T; Nickel, W; Rothman, JE; Sollner, TH			Functional architecture of an intracellular membrane t-SNARE	NATURE			English	Article							V-SNARE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; TRANSPORT PATHWAYS; VESICLE TRANSPORT; SECRETORY PATHWAY; GOLGI-APPARATUS; SNAP-25 HOMOLOG; FUSION; YEAST	Lipid bilayer fusion is mediated by SNAREs (soluble N-ethyl-maleimide-sensitive factor attachment protein receptors) located on the vesicle membrane (v-SNAREs) and the target membrane (t-SNAREs)(1,2). The assembled v-SNARE/t-SNARE complex consists of a bundle of four helices, of which one is supplied by the v-SNARE and the other three by the t-SNARE(3). For t-SNAREs on the plasma membrane, the protein syntaxin(4) supplies one helix and a SNAP-25 protein(5) contributes the other two. Although there are numerous homologues of syntaxin on intracellular membranes(6), there are only two SNAP-25-related proteins in yeast, Sec9 and Spo20, both of which are localized to the plasma membrane and function in secretion(7) and sporulation(8), respectively. What replaces SNAP-25 in t-SNAREs of intracellular membranes? Here we show that an intracellular t-SNARE is built from a `heavy chain' homologous to syntaxin and two separate nonsyntaxin `light chains'. SNAP-25 may thus be the exception rather than the rule, having been derived from genes that encoded separate light chains that fused during evolution to produce a single gene encoding one protein with two helices.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sollner, TH (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave,Box 519, New York, NY 10021 USA.		McNew, James/ABD-8081-2020; Weber, Thomas/A-2363-2008; Weber, Thomas/GLS-9125-2022; McNew, James/AAV-4911-2020	Weber, Thomas/0000-0002-0494-0484; Weber, Thomas/0000-0002-0494-0484; McNew, James/0000-0001-8459-3664				BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Nichols BJ, 1998, BBA-MOL CELL RES, V1404, P9, DOI 10.1016/S0167-4889(98)00044-5; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEBER T, IN PESS J CELL BIOL; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	30	184	187	1	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					198	202		10.1038/35025084	http://dx.doi.org/10.1038/35025084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001059				2022-12-28	WOS:000089241000051
J	Trauger, JW; Kohli, RM; Mootz, HD; Marahiel, MA; Walsh, CT				Trauger, JW; Kohli, RM; Mootz, HD; Marahiel, MA; Walsh, CT			Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase	NATURE			English	Article							ERYTHROMYCIN POLYKETIDE SYNTHASE; NUCLEOTIDE-SEQUENCE; VIBRIO-HARVEYI; BIOSYNTHESIS; SUPERFAMILY	In the biosynthesis of many macrocyclic natural products by multidomain megasynthases, a carboxy-terminal thioesterase (TE) domain is involved in cyclization and product release(1,2); however, it has not been determined whether TE domains can catalyse macrocyclization (and elongation in the case of symmetric cyclic peptides) independently of upstream domains. The inability to decouple the TE cyclization step from earlier chain assembly steps has precluded determination of TE substrate specificity, which is important for the engineered biosynthesis of new compounds(1). Here we report that the excised TE domain from tyrocidine synthetase efficiently catalyses cyclization of a decapeptide-thioester to form the antibiotic tyrocidine A, and can catalyse pentapeptide-thioester dimerization followed by cyclization to form the antibiotic gramicidin S. By systematically varying the decapeptide-thioester substrate and comparing cyclization rates, we also show that only two residues (one near each end of the decapeptide) are critical for cyclization. This specificity profile indicates that the tyrocidine synthetase TE, and by analogy many other TE domains, will be able to cyclize and release a broad range of new substrates and products produced by engineered enzymatic assembly lines.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Marburg, Biochem Fachbereich Chem, D-35032 Marburg, Germany	Harvard University; Harvard Medical School; Philipps University Marburg	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.			Kohli, Rahul/0000-0002-7689-5678				AGGARWAL R, 1995, J CHEM SOC CHEM COMM, P1519, DOI 10.1039/c39950001519; Belshaw PJ, 1999, SCIENCE, V284, P486, DOI 10.1126/science.284.5413.486; Boger DL, 2000, J AM CHEM SOC, V122, P2956, DOI 10.1021/ja0001660; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; CORTES J, 1995, SCIENCE, V268, P1487, DOI 10.1126/science.7770773; deFerra F, 1997, J BIOL CHEM, V272, P25304, DOI 10.1074/jbc.272.40.25304; Gokhale RS, 1999, CHEM BIOL, V6, P117, DOI 10.1016/S1074-5521(99)80008-8; HORI K, 1989, J BIOCHEM-TOKYO, V106, P639, DOI 10.1093/oxfordjournals.jbchem.a122909; JACKSON DY, 1994, SCIENCE, V266, P243, DOI 10.1126/science.7939659; Jacobsen JR, 1997, SCIENCE, V277, P367, DOI 10.1126/science.277.5324.367; Kao CM, 1997, J AM CHEM SOC, V119, P11339, DOI 10.1021/ja972609e; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAWSON DM, 1994, BIOCHEMISTRY-US, V33, P9382, DOI 10.1021/bi00198a003; Li J, 1996, BIOCHEMISTRY-US, V35, P9967, DOI 10.1021/bi9605292; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Mootz HD, 2000, P NATL ACAD SCI USA, V97, P5848, DOI 10.1073/pnas.100075897; ROSKOSKI R, 1970, BIOCHEMISTRY-US, V9, P4846; Shaw-Reid CA, 1999, CHEM BIOL, V6, P385, DOI 10.1016/S1074-5521(99)80050-7; STACHELHAUS T, 1995, SCIENCE, V269, P69, DOI 10.1126/science.7604280; Tang L, 2000, CHEM BIOL, V7, P77, DOI 10.1016/S1074-5521(00)00073-9; TURGAY K, 1992, MOL MICROBIOL, V6, P529, DOI 10.1111/j.1365-2958.1992.tb01498.x; Xue YQ, 2000, NATURE, V403, P571, DOI 10.1038/35000624	24	249	265	2	48	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					215	218		10.1038/35025116	http://dx.doi.org/10.1038/35025116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001063				2022-12-28	WOS:000089241000055
J	Murch, SH				Murch, SH			Diarrhoea, diagnostic delay, and appendicitis	LANCET			English	Editorial Material									UCL Royal Free & Univ Coll Med Sch, Univ Dept Paediat Gastroenterol, London NW3 2PF, England	University of London; University College London; UCL Medical School	Murch, SH (corresponding author), UCL Royal Free & Univ Coll Med Sch, Univ Dept Paediat Gastroenterol, London NW3 2PF, England.							ANDERSSON R, 1995, INT J EPIDEMIOL, V24, P829, DOI 10.1093/ije/24.4.829; Cappendijk VC, 2000, ARCH DIS CHILD, V83, P64, DOI 10.1136/adc.83.1.64; Hashimoto H, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.1.e2; Phillips AD, 2000, GUT, V47, P377, DOI 10.1136/gut.47.3.377; Saxen H, 1996, CLIN INFECT DIS, V23, P1038, DOI 10.1093/clinids/23.5.1038; WALKERSMITH JA, 1999, DIS SMALL INTESTINE, P119	6	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					787	787		10.1016/S0140-6736(00)02650-7	http://dx.doi.org/10.1016/S0140-6736(00)02650-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022923				2022-12-28	WOS:000089101800006
J	Brunner, D; Nurse, P				Brunner, D; Nurse, P			CLIP170-like tip1p spatially organizes microtubular dynamics in fission yeast	CELL			English	Article							OSCILLATORY NUCLEAR-MOVEMENT; SCHIZOSACCHAROMYCES-POMBE; CYTOPLASMIC DYNEIN; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; MEIOTIC PROPHASE; DYNACTIN COMPLEX; BINDING PROTEIN; LIVING CELLS; CLIP-170	Rod-shaped fission yeast cells grow in a polarized manner, and unlike budding yeast, the correct positioning of the growth sites at cell ends requires interphase microtubules. Here we describe a microtubule guidance mechanism that orients microtubules in the intracellular space along the long axis of the cell, guiding them to their target region at the cell ends. This mechanism involves tip1p, a CLIP170-like protein that localizes to distal tips of cytoplasmic microtubules. In the absence of tip1p, microtubular catastrophe is no longer restricted to cell ends but occurs when microtubules reach any region of the cellular cortex. Thus, tip1p enables microtubules to discriminate different cortical regions and regulates their dynamics accordingly.	Imperial Canc Res Fund, London WC2A 3PX, England	Cancer Research UK	Nurse, P (corresponding author), Imperial Canc Res Fund, 44 Lincolns Inn Fields, London WC2A 3PX, England.	p.nurse@icrf.icnet.uk	Brunner, Damian/F-2024-2011	Brunner, Damian/0000-0001-5250-492X				Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; BRUNNER D, 2000, IN PRESS PHILOS T B; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Ding DQ, 1998, J CELL SCI, V111, P701; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; HAGAN IM, 1988, J CELL SCI, V89, P343; Hagan IM, 1998, J CELL SCI, V111, P1603; HAROLD FM, 1990, MICROBIOL REV, V54, P381, DOI 10.1128/MMBR.54.4.381-431.1990; HIRAOKA N, 1984, PLANT CELL TISS ORG, V3, P349, DOI 10.1007/BF00043087; Hirata D, 1998, J CELL SCI, V111, P149; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Jannatipour M, 1998, BBA-GENE STRUCT EXPR, V1399, P67, DOI 10.1016/S0167-4781(98)00097-9; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Mata J, 1998, TRENDS CELL BIOL, V8, P163, DOI 10.1016/S0962-8924(98)01224-0; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MITCHISON JM, 1985, J CELL SCI, V75, P357; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Nakaseko Y, 1996, GENES CELLS, V1, P633, DOI 10.1046/j.1365-2443.1996.00253.x; NURSE P, 1994, MOL BIOL CELL, V5, P613, DOI 10.1091/mbc.5.6.613; PerezPriego MA, 1996, INSULA, V51, P7; PIERRE P, 1994, J CELL SCI, V107, P1909; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Pruyne D, 2000, J CELL SCI, V113, P365; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; SNELL V, 1993, DEVELOPMENT, P289; TODA T, 1983, J MOL BIOL, V168, P251, DOI 10.1016/S0022-2836(83)80017-5; TODA T, 1984, CELL, V37, P233, DOI 10.1016/0092-8674(84)90319-2; Tran PT, 1999, BIOL BULL, V197, P262, DOI 10.2307/1542640; UMESONO K, 1983, J MOL BIOL, V168, P271, DOI 10.1016/S0022-2836(83)80018-7; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; VASILIEV JM, 1991, J CELL SCI, V98, P1; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan KT, 1999, J CELL SCI, V112, P1437; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; WACKER IU, 1992, J CELL BIOL, V117, P813, DOI 10.1083/jcb.117.4.813; Wadsworth P, 1999, CELL MOTIL CYTOSKEL, V42, P48, DOI 10.1002/(SICI)1097-0169(1999)42:1<48::AID-CM5>3.3.CO;2-#; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Wilson EB., 1925, CELL DEV HEREDITY, V3rd edition; WOODS A, 1989, J CELL SCI, V93, P491; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamashita A, 1997, GENES CELLS, V2, P155, DOI 10.1046/j.1365-2443.1997.1100307.x	56	227	230	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					695	704		10.1016/S0092-8674(00)00091-X	http://dx.doi.org/10.1016/S0092-8674(00)00091-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007487	Bronze			2022-12-28	WOS:000089105200017
J	Bennett, KD; Haberle, SG; Lumley, SH				Bennett, KD; Haberle, SG; Lumley, SH			The last glacial-holocene transition in southern Chile	SCIENCE			English	Article							YOUNGER DRYAS; NORTH-ATLANTIC; ICE-CORE; CLIMATE; VEGETATION; ANTARCTICA; EVENT; ARGENTINA; HISTORY; AMERICA	Warming at the Last glacial termination in the North Atlantic region was interrupted by a period of renewed glacial activity during the Younger Dryas chronozone (YDC). The underlying mechanism of this cooling remains elusive, but hypotheses turn on whether it was a global or a North Atlantic phenomenon. Chronological, sedimentological, and palaeoecological records from sediments of small Lakes in oceanic southern Chile demonstrate that there was no YDC cooling in southern Chile. It is therefore Likely that there was little or no cooling in southern Pacific surface waters and hence that YDC cooling in the North Atlantic was a regional, rather than global, phenomenon.	Uppsala Univ, Dept Earth Sci, S-75236 Uppsala, Sweden; Monash Univ, Dept Geog & Environm Sci, Clayton, Vic 3168, Australia	Uppsala University; Monash University	Bennett, KD (corresponding author), Uppsala Univ, Dept Earth Sci, Villavagen 16, S-75236 Uppsala, Sweden.		Haberle, Simon/U-4118-2019; Bennett, Keith D/C-8619-2009	Bennett, Keith D/0000-0002-3423-1531; Haberle, Simon/0000-0001-5802-6535				ANDRIEU V, 1993, QUATERNARY SCI REV, V12, P681, DOI 10.1016/0277-3791(93)90007-9; Ariztegui D, 1997, J QUATERNARY SCI, V12, P333, DOI 10.1002/(SICI)1099-1417(199707/08)12:4<333::AID-JQS312>3.3.CO;2-S; ASHWORTH AC, 1991, J QUATERNARY SCI, V6, P279, DOI 10.1002/jqs.3390060403; Bjorck S, 1998, J QUATERNARY SCI, V13, P283, DOI 10.1002/(SICI)1099-1417(199807/08)13:4<283::AID-JQS386>3.0.CO;2-A; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Blunier T, 1997, GEOPHYS RES LETT, V24, P2683, DOI 10.1029/97GL02658; BRIKS HJB, 1981, CLIMATE HIST STUDIES, P111; Clapperton CM, 1993, QUATERNARY GEOLOGY G; Haberle SG, 1998, J VOLCANOL GEOTH RES, V84, P239, DOI 10.1016/S0377-0273(98)00037-7; HEUSSER CJ, 1990, REV PALAEOBOT PALYNO, V65, P9, DOI 10.1016/0034-6667(90)90051-J; Heusser CJ., 1971, POLLEN SPORES CHILE; JOUZEL J, 1995, CLIM DYNAM, V11, P151, DOI 10.1007/BF00223498; KRISTIANSEN IL, 1988, REV PALAEOBOT PALYNO, V53, P185, DOI 10.1016/0034-6667(88)90033-4; LLIBOUTRY L, 1998, SATELLITE IMAGE ATLA, P148; LOWE J J, 1986, Transactions of the Royal Society of Edinburgh Earth Sciences, V77, P1; LUMLEY SH, 1993, J QUATERNARY SCI, V8, P161, DOI 10.1002/jqs.3390080208; LUMLEY SH, 1993, THESIS U CAMBRIDGE; MANGERUD J, 1974, Boreas (Oslo), V3, P109; MARKGRAF V, 1991, BOREAS, V20, P63; Marticorena C, 1995, FLORA DE CHILE, V1; Mayle FE, 1995, QUATERNARY SCI REV, V14, P813, DOI 10.1016/0277-3791(95)00063-1; Moore D. M., 1983, FLORA TIERRA FUEGO; Moreno PI, 1999, GEOGR ANN A, V81A, P285, DOI 10.1111/1468-0459.00059; NIEMEYER H, 1984, 6061 SERV NACION GEO; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Singer C, 1998, SCIENCE, V281, P812, DOI 10.1126/science.281.5378.812; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; STRETEN NA, 1984, CLIMATES OCEANS WORL, V0015, P00263; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Troels-Smith J, 1955, DANMARKS GEOLOGISKE, VIV, P73; Villagran C., 1995, ECOLOGIA BOSQUES NAT, P51; Watts WA, 1980, STUDIES LATEGLACIAL, P1; Wenzens G, 1999, QUATERNARY RES, V51, P238, DOI 10.1006/qres.1999.2043	33	151	161	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					325	328		10.1126/science.290.5490.325	http://dx.doi.org/10.1126/science.290.5490.325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030648				2022-12-28	WOS:000089818100040
J	Phipps, KR; Orwoll, ES; Mason, JD; Cauley, JA				Phipps, KR; Orwoll, ES; Mason, JD; Cauley, JA			Community water fluoridation, bone mineral density, and fractures: prospective study of effects in older women	BRITISH MEDICAL JOURNAL			English	Article							HIP FRACTURE; DRINKING-WATER; OSTEOPOROTIC FRACTURES; RISK-FACTORS; WHITE WOMEN; MASS; POPULATION	Objective To determine whether fluoridation influences bone mineral density and fractures in older women. Design Multicentre prospective study on risk factors for osteoporosis and fractures. Setting Four community based centres in the United States. Participants 9704 ambulatory women without bilateral hip replacements enrolled during 1986-8; 7129 provided information on exposure to fluoride. Main outcome measures Bone mineral density of the lumbar spine, proximal femur, radius, and calcaneus plus incident fractures (fractures that occurred during the study) of vertebrae, hip, wrist, and humerus. Results Women were classified as exposed or not exposed or having unknown exposure to fluoride for each pear from 1950 to 1994. Outcomes were compared in women with continuous exposure ro fluoridated water for the past 20 years (n=3218) and women with. no exposure during the past 20 years (n = 2563). Ln women with continuous exposure mean bone mineral density was 2.6% higher at the femoral neck (0.017 g/cm(2), P < 0.001), 2.5% higher at the lumbar spine (0.022 g/cm(2), P < 0.001), and 1.9% lower at the distal radius (0.007 g/cm(2), P = 0.002). In women with. continuous exposure the multivariable adjusted risk of hip fracture nas slightly reduced (risk ratio 0.69, 95% confidence interval 0.50 to 0.96, P = 0.028) as was the risk of vertebral fracture (0.13, 0.55 to 0.97, P = 0.033). There was a non-significant trend toward an increased risk of wrist fracture (1.32, 1.00 to 1.71, P = 0.051) and no difference in risk of humerus fracture (0.85, 0.58 to 1.23, P = 0.378). Conclusions Long term exposure to fluoridated drinking water does not increase the risk of fracture.	Oregon Hlth Sci Univ, Sch Dent, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Sch Med, Portland, OR 97201 USA; Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA	Oregon Health & Science University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Phipps, KR (corresponding author), Oregon Hlth Sci Univ, Sch Dent, 611 Sw Campus Dr, Portland, OR 97201 USA.		Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408; Orwoll, Eric/0000-0002-8520-7355	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035582, R01AR035583, R01AR035584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005407, R01AG005394] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR35582, R01 AR035583, R01 AR035584, R01 AR035582] Funding Source: Medline; NIA NIH HHS [R01 AG005394, R01 AG005407, AG0407] Funding Source: Medline; NIDCR NIH HHS [DE10814] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		*AD HOC SUBC FLUOR, 1991, REV FLUOR BEN RISKS, P17; ANSELL BM, 1966, ANN RHEUM DIS, V25, P67; ARNALA I, 1986, ACTA ORTHOP SCAND, V57, P344, DOI 10.3109/17453678608994408; AVORN J, 1986, GERODONTICS, V2, P175; BAUER DC, 1993, ANN INTERN MED, V118, P657, DOI 10.7326/0003-4819-118-9-199305010-00001; BERNSTEI.DS, 1966, J AMER MED ASSOC, V198, P499, DOI 10.1001/jama.198.5.499; BLACK DM, 1995, J BONE MINER RES, V10, P890; Burt BA, 1992, DENT DENT PRACTICE C; CAULEY JA, 1995, J BONE MINER RES, V10, P1076; COOPER C, 1990, J EPIDEMIOL COMMUN H, V44, P17, DOI 10.1136/jech.44.1.17; CUMMINGS SR, 1987, AM J EPIDEMIOL, V126, P796, DOI 10.1093/oxfordjournals.aje.a114716; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Dabeka RW, 1995, J AOAC INT, V78, P897; DANIELSON C, 1992, JAMA-J AM MED ASSOC, V268, P746; FARLEY JR, 1988, METABOLISM, V37, P988, DOI 10.1016/0026-0495(88)90158-8; Hillier S, 2000, LANCET, V355, P265, DOI 10.1016/S0140-6736(99)07161-5; Jacobsen S J, 1992, Ann Epidemiol, V2, P617, DOI 10.1016/1047-2797(92)90006-C; JACOBSEN SJ, 1993, AM J PUBLIC HEALTH, V83, P743, DOI 10.2105/AJPH.83.5.743; JACOBSEN SJ, 1990, JAMA-J AM MED ASSOC, V264, P500, DOI 10.1001/jama.264.4.500; Karagas MR, 1996, ANN EPIDEMIOL, V6, P209, DOI 10.1016/1047-2797(96)00006-3; KELSEY JL, 1992, AM J EPIDEMIOL, V135, P477, DOI 10.1093/oxfordjournals.aje.a116314; KROGER H, 1994, BONE MINER, V27, P33, DOI 10.1016/S0169-6009(08)80184-5; Lahti S M, 1995, Adv Dent Res, V9, P21; LEONE NC, 1962, DHEW PUBL PHS; MADANS J, 1983, AM J PUBLIC HEALTH, V73, P296, DOI 10.2105/AJPH.73.3.296; Orwoll ES, 1996, ANN INTERN MED, V124, P187, DOI 10.7326/0003-4819-124-2-199601150-00001; *PHS CDC, 1993, FLUOR CENS 1992; SILBERGELD EK, 1994, CLIN CHEM, V40, P1363; SIMONEN O, 1985, LANCET, V2, P432; Whitford GM, 1996, MONOGR ORAL SCI, V16, P1	30	41	43	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					860	864		10.1136/bmj.321.7265.860	http://dx.doi.org/10.1136/bmj.321.7265.860			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021862	Green Published, Bronze			2022-12-28	WOS:000089857500020
J	Ravetch, JV; Lanier, LL				Ravetch, JV; Lanier, LL			Immune inhibitory receptors	SCIENCE			English	Review							PROTEIN-TYROSINE-PHOSPHATASE; FC-GAMMA-RIIB; NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-LIKE RECEPTORS; CLASS-I MOLECULES; B-CELL; NEGATIVE REGULATION; MYELOID CELLS; CUTTING EDGE; PIR-B	With the detailed description and analysis of several inhibitory receptor systems on Lymphoid and myeloid cells, a central paradigm has emerged in which the pairing of activation and inhibition is necessary to initiate, amplify, and then terminate immune responses. In some cases, the activating and inhibitory receptors recognize similar Ligands, and the net outcome is determined by the relative strength of these opposing signals. The importance of this modulation is demonstrated by the sometimes fatal autoimmune disorders observed in mice with targeted disruption of inhibitory receptors. The significance of these receptors is further evidenced by the conservation of immunoreceptor tyrosine-based inhibitory motifs during their evolution.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	Rockefeller University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.		Ravetch, Jeffrey/Z-1596-2019; Lanier, Lewis L/E-2139-2014	Ravetch, Jeffrey/0000-0003-2024-9041; Lanier, Lewis L/0000-0003-1308-3952				Adachi T, 1998, J IMMUNOL, V160, P4662; ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; Aman MJ, 1998, J BIOL CHEM, V273, P33922, DOI 10.1074/jbc.273.51.33922; AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; BAKKER ABH, IN PRESS IMMUNOL TOD; Baroja ML, 2000, J IMMUNOL, V164, P49, DOI 10.4049/jimmunol.164.1.49; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Binstadt BA, 1996, IMMUNITY, V5, P629, DOI 10.1016/S1074-7613(00)80276-9; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Carretero M, 1998, EUR J IMMUNOL, V28, P1280, DOI 10.1002/(SICI)1521-4141(199804)28:04<1280::AID-IMMU1280>3.0.CO;2-O; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; CHAN PL, 1971, IMMUNOLOGY, V21, P967; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Cinek T, 2000, J IMMUNOL, V164, P5, DOI 10.4049/jimmunol.164.1.5; Clark GJ, 2000, TISSUE ANTIGENS, V55, P101, DOI 10.1034/j.1399-0039.2000.550201.x; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Colonna M, 1998, J IMMUNOL, V160, P3096; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Gary-Gouy H, 2000, J BIOL CHEM, V275, P548, DOI 10.1074/jbc.275.1.548; GUTHMANN MD, 1995, P NATL ACAD SCI USA, V92, P9397, DOI 10.1073/pnas.92.20.9397; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Helgason CD, 2000, J EXP MED, V191, P781, DOI 10.1084/jem.191.5.781; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hua CT, 1998, J BIOL CHEM, V273, P28332, DOI 10.1074/jbc.273.43.28332; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kubagawa H, 1999, J EXP MED, V189, P309, DOI 10.1084/jem.189.2.309; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Maeda A, 1998, J EXP MED, V188, P991, DOI 10.1084/jem.188.5.991; Malbec O, 1998, J IMMUNOL, V160, P1647; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Moller MJ, 1996, INT J CANCER, V65, P740, DOI 10.1002/(SICI)1097-0215(19960315)65:6<740::AID-IJC5>3.0.CO;2-Z; Mousseau DD, 2000, J BIOL CHEM, V275, P4467, DOI 10.1074/jbc.275.6.4467; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Nadler MJS, 1997, J BIOL CHEM, V272, P20038, DOI 10.1074/jbc.272.32.20038; Nakajima H, 1999, J IMMUNOL, V162, P5; Nakamura A, 2000, J EXP MED, V191, P899, DOI 10.1084/jem.191.5.899; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Olcese L, 1996, J IMMUNOL, V156, P4531; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; Poe JC, 2000, J BIOL CHEM, V275, P17420, DOI 10.1074/jbc.M001892200; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RAVETCH JV, 1986, SCIENCE, V234, P718, DOI 10.1126/science.2946078; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rohrschneider LR, 2000, GENE DEV, V14, P505; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Sen G, 1999, EUR J IMMUNOL, V29, P3319; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; Smith KGC, 1998, J EXP MED, V187, P807, DOI 10.1084/jem.187.5.807; Suzuki Y, 1998, KIDNEY INT, V54, P1166, DOI 10.1046/j.1523-1755.1998.00108.x; Sylvestre D, 1996, J EXP MED, V184, P2385, DOI 10.1084/jem.184.6.2385; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tamir I, 2000, CURR OPIN IMMUNOL, V12, P307, DOI 10.1016/S0952-7915(00)00092-3; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; TITUS JA, 1987, J IMMUNOL, V139, P3153; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Valiante NM, 1996, J EXP MED, V184, P2243, DOI 10.1084/jem.184.6.2243; Vely F, 1997, J IMMUNOL, V159, P2075; Vitale C, 1999, P NATL ACAD SCI USA, V96, P15091, DOI 10.1073/pnas.96.26.15091; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6; Yamanashi Y, 2000, GENE DEV, V14, P11; YOUNG JDE, 1984, P NATL ACAD SCI-BIOL, V81, P5430, DOI 10.1073/pnas.81.17.5430; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187	99	1001	1165	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					84	89		10.1126/science.290.5489.84	http://dx.doi.org/10.1126/science.290.5489.84			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021804				2022-12-28	WOS:000089724800037
J	Stiff, PJ; Veum-Stone, J; Lazarus, HM; Ayash, L; Edwards, JR; Keating, A; Klein, JP; Oblon, DJ; Shea, TC; Thome, S; Horowitz, MM				Stiff, PJ; Veum-Stone, J; Lazarus, HM; Ayash, L; Edwards, JR; Keating, A; Klein, JP; Oblon, DJ; Shea, TC; Thome, S; Horowitz, MM			High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: An autologous blood and marrow transplant registry report	ANNALS OF INTERNAL MEDICINE			English	Article							PHASE-II TRIAL; STAGE-III; MULTIVARIATE-ANALYSIS; ALKYLATING-AGENTS; CYCLOPHOSPHAMIDE; CARCINOMA; CARBOPLATIN; PACLITAXEL; CISPLATIN; THERAPY	Background: Autologous transplantation is increasingly used to treat epithelial ovarian cancer. However, it is not clear which patients may benefit. Objective: To determine overall and progression-free survival and factors associated with favorable outcome after autotransplantation for ovarian cancer. Design: Observational cohort study. Setting: 57 centers reporting to the Autologous Blood and Marrow Transplant Registry (ABMTR). Patients: 421 women who received transplants between 1989 and 1996. Interventions: High-dose chemotherapy using diverse regimens with hematopoietic stem-cell rescue. Measurements: Primary outcomes were progression-free survival and overall survival. Multivariate analyses using Cox proportional hazards regression considered the following factors: age, Kamofsky performance score, initial stage, histologic characteristics, previous therapy, remission status, extent of disease, graft source, transplant regimen, and year of transplantation. Results: Most patients had extensive previous chemotherapy. Forty-one percent had platinum-resistant tumors, and 38% had tumors at least 1 cm in diameter. Only 34 patients (8%) received transplants as part of initial therapy. The probability of death within 100 days was 11% (95% CI, 8% to 14%). Two-year progression-free survival was 12% (CI, 9% to 16%), and 2-year overall survival was 35% (CI, 30% to 41%). Younger age, Karnofsky performance score of at least 90%, non-clear-cell disease, remission at transplantation, and platinum sensitivity were associated with better outcomes. Progression-free and overall survival were 22% (CI, 12% to 33%) and 55% (CI, 42% to 66%), respectively, for women with a high Karnofsky performance score and non-clear-cell, platinum-sensitive tumors. Conclusions: Some subgroups of patients with ovarian cancer seem to have good outcomes after autotransplantation, although several biases may have affected these observations. Phase III trials are needed to compare such outcomes with outcomes of conventional chemotherapy.	Med Coll Wisconsin, Hlth Policy Inst, Autologous Blood & Marrow Transplant Registry, Ctr Stat, Milwaukee, WI 53226 USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA; Walt Disney Mem Canc Inst, Orlando, FL USA; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Sharp Hlth Care, San Diego, CA USA; Sidney Kimmel Canc Ctr, San Diego, CA USA; Univ N Carolina, Chapel Hill, NC USA; Mayo Clin, Rochester, MN USA	Medical College of Wisconsin; Loyola University Chicago; Case Western Reserve University; University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic	Horowitz, MM (corresponding author), Med Coll Wisconsin, Hlth Policy Inst, Autologous Blood & Marrow Transplant Registry, Ctr Stat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	marymh@mcw.edu	Stiff, Patrick/S-2676-2019; horowitz, Mary/ABH-2173-2021		NATIONAL CANCER INSTITUTE [P01CA040053] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA-40053] Funding Source: Medline; PHS HHS [U24-76518] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBERTS DS, 1985, SEMIN ONCOL, V12, P38; Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; Andersen PK, 1999, STAT MED, V18, P1489, DOI 10.1002/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#; CALDAS C, 1994, OBSTET GYN CLIN N AM, V21, P179; DUSKA L, 1998, P AN M AM SOC CLIN, V17, pA355; Eisenhauer EA, 1997, ANN ONCOL, V8, P963, DOI 10.1023/A:1008240421028; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; GRAVES EJ, 1991, VITAL HLTH STAT 13; Huinink WTB, 1997, J CLIN ONCOL, V15, P2183, DOI 10.1200/JCO.1997.15.6.2183; Kaufmann M, 1997, EUR J CANCER, V33, pS31, DOI 10.1016/S0959-8049(96)00338-3; Kristensen GB, 1997, LANCET, V349, P113, DOI 10.1016/S0140-6736(96)06071-0; Legros M, 1997, J CLIN ONCOL, V15, P1302, DOI 10.1200/JCO.1997.15.4.1302; LIDOR Y, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P401; LIDOR YJ, 1991, INT J CANCER, V49, P704, DOI 10.1002/ijc.2910490513; MARKMAN M, 1991, J CLIN ONCOL, V9, P389, DOI 10.1200/JCO.1991.9.3.389; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Muggia FM, 1997, J CLIN ONCOL, V15, P987, DOI 10.1200/JCO.1997.15.3.987; ROSE PG, 1996, P AN M AM SOC CLIN, V15, P282; SHEA TC, 1989, J CLIN ONCOL, V7, P651, DOI 10.1200/JCO.1989.7.5.651; SHPALL EJ, 1990, GYNECOL ONCOL, V38, P386, DOI 10.1016/0090-8258(90)90079-Z; STIFF P, 1995, GYNECOL ONCOL, V57, P278, DOI 10.1006/gyno.1995.1143; Stiff P., 1997, Blood, V90, p591A; STIFF PJ, 1994, J CLIN ONCOL, V12, P176, DOI 10.1200/JCO.1994.12.1.176; Stiff PJ, 1997, J CLIN ONCOL, V15, P1309, DOI 10.1200/JCO.1997.15.4.1309; TEICHER BA, 1989, CANCER CHEMOTH PHARM, V25, P161, DOI 10.1007/BF00689576; THIGPEN JT, 1994, J CLIN ONCOL, V12, P1748, DOI 10.1200/JCO.1994.12.9.1748; TROPE C, 1997, SEMIN ONCOL S15, V24; *US DEP HHS PHS CD, 1992, NAT HOSP DISCH SURV; VERGOTE I, 1992, GYNECOL ONCOL, V47, P282, DOI 10.1016/0090-8258(92)90127-5	29	34	34	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					504	515		10.7326/0003-4819-133-7-200010030-00009	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00009			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015163				2022-12-28	WOS:000089678300002
J	Allen, GJ; Chu, SP; Schumacher, K; Shimazaki, CT; Vafeados, D; Kemper, A; Hawke, SD; Tallman, G; Tsien, RY; Harper, JF; Chory, J; Schroeder, JI				Allen, GJ; Chu, SP; Schumacher, K; Shimazaki, CT; Vafeados, D; Kemper, A; Hawke, SD; Tallman, G; Tsien, RY; Harper, JF; Chory, J; Schroeder, JI			Alteration of stimulus-specific guard cell calcium oscillations and stomatal closing in Arabidopsis det3 mutant	SCIENCE			English	Article							CYTOSOLIC-FREE CALCIUM; ABSCISIC-ACID; CYTOPLASMIC CALCIUM; GENE-EXPRESSION; CLOSURE; DICTYOSTELIUM; SENSITIVITY; FREQUENCY; ELEVATION; STRESS	Cytosolic calcium oscillations control signaling in animal cells, whereas in plants their importance remains Largely unknown. In wild-type Arabidopsis guard cells abscisic acid, oxidative stress, cold, and external calcium elicited cytosolic calcium oscillations of differing amplitudes and frequencies and induced stomatal closure. In guard cells of the V-ATPase mutant det3, external calcium and oxidative stress elicited prolonged calcium increases, which did not oscillate, and stomatal closure was abolished. Conversely, cold and abscisic acid elicited calcium oscillations in det3, and stomatal closure occurred normally. Moreover, in det3 guard cells, experimentally imposing external calcium-induced oscillations rescued stomatal closure. These data provide genetic evidence that stimulus-specific calcium oscillations are necessary for stomatal closure.	Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Salk Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst, Plant Biol Lab, La Jolla, CA 92037 USA; Willamette Univ, Dept Biol, Salem, OR 97301 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Pharmacol & Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Cellular & Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute; Salk Institute; Willamette University; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Allen, GJ (corresponding author), Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA.		Schumacher, Karin/E-8500-2014	Schumacher, Karin/0000-0001-6484-8105; Schroeder, Julian/0000-0002-3283-5972	NIGMS NIH HHS [R01 GM60396-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Camello-Almaraz C, 2000, BIOCHEM BIOPH RES CO, V271, P311, DOI 10.1006/bbrc.2000.2633; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; Grabov A, 1998, P NATL ACAD SCI USA, V95, P4778, DOI 10.1073/pnas.95.8.4778; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; McAinsh MR, 1996, PLANT PHYSIOL, V111, P1031, DOI 10.1104/pp.111.4.1031; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; McAinsh MR, 1998, TRENDS PLANT SCI, V3, P32, DOI 10.1016/S1360-1385(97)01150-3; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; ROONEY EK, 1994, CELL CALCIUM, V16, P509, DOI 10.1016/0143-4160(94)90081-7; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; Xie YY, 1996, J CELL SCI, V109, P489	27	358	395	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2338	2342		10.1126/science.289.5488.2338	http://dx.doi.org/10.1126/science.289.5488.2338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009417				2022-12-28	WOS:000089593500049
J	Garcia-Tsao, G; Korzenik, JR; Young, L; Henderson, KJ; Jain, D; Byrd, B; Pollak, JS; White, RI				Garcia-Tsao, G; Korzenik, JR; Young, L; Henderson, KJ; Jain, D; Byrd, B; Pollak, JS; White, RI			Liver disease in patients with hereditary hemorrhagic telangiectasia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	49th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases	NOV 04-11, 1998	CHICAGO, IL	Amer Assoc Study Liver Dis			WEBER-RENDU DISEASE; HEPATIC ARTERIOVENOUS-MALFORMATIONS; TRANSCATHETER EMBOLIZATION; ARTERIAL EMBOLIZATION; DOPPLER SONOGRAPHY; FAILURE; TRANSPLANTATION; INVOLVEMENT; MANIFESTATIONS; TRANSFORMATION	Background: Hereditary hemorrhagic telangiectasia, or Rendu-Osler-Weber disease, is an autosomal dominant disorder characterized by angiodysplastic lesions (telangiectases and arteriovenous malformations) that affect many organs. Liver involvement in patients with this disease has not been fully characterized. Methods: We studied the clinical findings and results of hemodynamic, angiographic, and imaging studies in 19 patients with hereditary hemorrhagic telangiectasia and symptomatic liver involvement. Results: We evaluated 14 women and 5 men who ranged in age from 34 to 74 years. All but one of the patients had a hyperdynamic circulation (cardiac index, 4.2 to 7.3 liters per minute per square meter of body-surface area). In eight patients, the clinical findings were consistent with the presence of high-output heart failure. The cardiac index and pulmonary-capillary wedge pressure were elevated in the six patients in whom these measurements were performed. After a median period of 24 months, the condition of three of the eight patients had improved, four were in stable condition with medical therapy, and one had died. Six patients had manifestations of portal hypertension such as ascites or variceal bleeding. The hepatic sinusoidal pressure was elevated in the four patients in whom it was measured. After a median period of 19 months, the condition of two of the six patients had improved, and the other four had died. Five patients had manifestations of biliary disease, such as an elevated alkaline phosphatase level and abnormalities on bile duct imaging. After a median period of 30 months, the condition of two of the five had improved, the condition of one was unchanged, heart failure had developed in one, and one had died after an unsuccessful attempt at liver transplantation. Conclusions: In patients with hereditary hemorrhagic telangiectasia and symptomatic liver involvement, the typical clinical presentations include high-output heart failure, portal hypertension, and biliary disease. (N Engl J Med 2000;343:931-6.) (C)2000, Massachusetts Medical Society.	Yale Univ, Sch Med, Div Digest Dis, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Div Cardiol, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Garcia-Tsao, G (corresponding author), Yale Univ, Sch Med, Div Digest Dis, Dept Internal Med, 333 Cedar St,POB 3333, New Haven, CT 06520 USA.	guadalupe.garcia-tsao@yale.edu	Garcia-Tsao, Guadalupe/ABF-7374-2020					BALL NJ, 1990, ARCH PATHOL LAB MED, V114, P423; BAUER T, 1995, J HEPATOL, V22, P586, DOI 10.1016/0168-8278(95)80455-2; BERNARD G, 1993, GASTROENTEROLOGY, V105, P482, DOI 10.1016/0016-5085(93)90723-P; BJORO K, 1995, SCAND J GASTROENTERO, V30, P92, DOI 10.3109/00365529509093242; Boillot O, 1999, GASTROENTEROLOGY, V116, P187, DOI 10.1016/S0016-5085(99)70243-X; BOURGEOIS N, 1990, J CLIN GASTROENTEROL, V12, P236; BROHEE D, 1984, ARCH INTERN MED, V144, P1282, DOI 10.1001/archinte.144.6.1282; Buscarini E, 1997, J HEPATOL, V26, P111, DOI 10.1016/S0168-8278(97)80017-7; Caselitz M, 1998, GUT, V42, P123, DOI 10.1136/gut.42.1.123; CLOOGMAN HM, 1984, RADIOLOGY, V150, P521, DOI 10.1148/radiology.150.2.6691112; COHEN N, 1994, J CLIN GASTROENTEROL, V18, P172, DOI 10.1097/00004836-199403000-00026; COONEY T, 1977, J CLIN PATHOL, V30, P1134, DOI 10.1136/jcp.30.12.1134; DAGATA IDA, 1994, SEMIN LIVER DIS, V14, P215, DOI 10.1055/s-2007-1007313; DANCHIN N, 1983, AM HEART J, V105, P856, DOI 10.1016/0002-8703(83)90253-3; DERAUF BJ, 1987, CARDIOVASC INTER RAD, V10, P80, DOI 10.1007/BF02577971; FAGEL WJ, 1988, AM J MED, V85, P858; GOTHLIN JH, 1982, EUR J RADIOL, V2, P27; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; HENDERSON JM, 1981, J COMPUT ASSIST TOMO, V5, P773, DOI 10.1097/00004728-198110000-00037; Lee JY, 1998, J VASC INTERV RADIOL, V9, P994, DOI 10.1016/S1051-0443(98)70439-7; LIVNEH A, 1988, SOUTHERN MED J, V81, P1047, DOI 10.1097/00007611-198808000-00026; LUDWIG J, 1989, HEPATOLOGY, V9, P215, DOI 10.1002/hep.1840090209; MARTINI GA, 1978, GUT, V19, P531, DOI 10.1136/gut.19.6.531; McInroy B, 1998, AM J ROENTGENOL, V170, P413, DOI 10.2214/ajr.170.2.9456956; MENDOZA A, 1995, EUR J GASTROEN HEPAT, P999; Mukasa C, 1998, AM J GASTROENTEROL, V93, P471, DOI 10.1016/S0002-9270(98)80052-X; NAGANUMA H, 1995, AM J ROENTGENOL, V165, P1421, DOI 10.2214/ajr.165.6.7484577; Neumann UP, 1998, TRANSPL INT, V11, P323, DOI 10.1007/s001470050152; NIKOLOPOULOS N, 1988, HEPATO-GASTROENTEROL, V35, P167; Odorico JS, 1998, LIVER TRANSPLANT SUR, V4, P483, DOI 10.1002/lt.500040609; OUCHI K, 1994, AM J GASTROENTEROL, V89, P425; Peh WCG, 1996, BRIT J RADIOL, V69, P281, DOI 10.1259/0007-1285-69-819-281; PEPPER GM, 1981, NEW YORK STATE J MED, V81, P209; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; RADTKE WE, 1978, AM HEART J, V95, P235, DOI 10.1016/0002-8703(78)90468-4; RALLS PW, 1992, AM J ROENTGENOL, V159, P59, DOI 10.2214/ajr.159.1.1609722; REILLY PJ, 1984, AM J GASTROENTEROL, V79, P363; REWANE I, 1983, BRIT J RADIOL, V56, P207, DOI 10.1259/0007-1285-56-663-207; ROMAN CF, 1987, ANGIOLOGY, V38, P484, DOI 10.1177/000331978703800610; Saxena R, 1998, AM J SURG PATHOL, V22, P368, DOI 10.1097/00000478-199803000-00013; SCHWARTZ SI, 1961, SURGERY, V49, P611; Shimamatsu K, 1997, HEPATOLOGY, V26, P343, DOI 10.1002/hep.510260214; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; TRELL E, 1972, AM J MED, V53, P50, DOI 10.1016/0002-9343(72)90115-5; Trotter JF, 1998, AM J GASTROENTEROL, V93, P1569, DOI 10.1111/j.1572-0241.1998.00486.x; VILGRAIN V, 1991, AM J ROENTGENOL, V157, P413, DOI 10.2214/ajr.157.2.1853834; WANLESS IR, 1990, HEPATOLOGY, V11, P787, DOI 10.1002/hep.1840110512; WANLESS IR, 1986, ARCH PATHOL LAB MED, V110, P331; WHITING JH, 1992, J NUCL MED, V33, P260; ZAJKO AB, 1987, AM J ROENTGENOL, V149, P485, DOI 10.2214/ajr.149.3.485; ZENTLERMUNRO PL, 1989, GUT, V30, P1293, DOI 10.1136/gut.30.9.1293	51	243	259	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2000	343	13					931	936		10.1056/NEJM200009283431305	http://dx.doi.org/10.1056/NEJM200009283431305			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	357KT	11006369	Bronze			2022-12-28	WOS:000089501400005
J	Horton, R				Horton, R			Development aid: manna or myth?	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Horton, R (corresponding author), Lancet, London WC1X 8RR, England.							ANNAN K, 2000, COMMONWEALTH LE 0314; [Anonymous], 1999, DEV FREEDOM; ELLIOT L, 2000, GUARDIAN        0627, P13; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; Macilwain C, 1998, NATURE, V396, P711, DOI 10.1038/25409; PERLEZ J, 2000, NY TIMES        0507, P3; SHAWCROSS W, 2000, SUNDAY TIMES    0409, P9; Smith L.T., 1999, DECOLONIZING METHODO; TUCKER N, 1999, CRITICAL DEV THEORY, P1; United Nations Development Program, 2000, HUM DEV REP 2000; Yemaneberhan H, 1997, LANCET, V350, P85, DOI 10.1016/S0140-6736(97)01151-3; 2000, S AFRICAN MERCU 0711, P9	12	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2000	356	9235					1044	1045		10.1016/S0140-6736(00)02721-5	http://dx.doi.org/10.1016/S0140-6736(00)02721-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009134				2022-12-28	WOS:000089430500002
J	Allen, TM; O'Connor, DH; Jing, PC; Dzuris, JL; Mothe, BR; Vogel, TU; Dunphy, E; Liebl, ME; Emerson, C; Wilson, N; Kunstman, KJ; Wang, XC; Allison, DB; Hughes, AL; Desrosiers, RC; Altman, JD; Wolinsky, SM; Sette, A; Watkins, DI				Allen, TM; O'Connor, DH; Jing, PC; Dzuris, JL; Mothe, BR; Vogel, TU; Dunphy, E; Liebl, ME; Emerson, C; Wilson, N; Kunstman, KJ; Wang, XC; Allison, DB; Hughes, AL; Desrosiers, RC; Altman, JD; Wolinsky, SM; Sette, A; Watkins, DI			Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; PRIMARY INFECTION; GENETIC-VARIATION; NEF PROTEIN; EPITOPE; AIDS; CTL; MAMU-A-ASTERISK-01; RECOGNITION; PROGRESSION	Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections are characterized by early peaks of viraemia that decline as strong cellular immune responses develop(1,2). Although it has been shown that virus-specific CD8-positive cytotoxic T lymphocytes (CTLs) exert selective pressure during HIV and SIV infection(3-11), the data have been controversial(12,13). Here we show that Tat-specific CD8-positive T-lymphocyte responses select for new viral escape variants during the acute phase of infection. We sequenced the entire virus immediately after the acute phase, and found that amino-acid replacements accumulated primarily in Tat CTL epitopes. This implies that Tat-specific CTLs may be significantly involved in controlling wild-type virus replication, and suggests that responses against viral proteins that are expressed early during the viral life cycle might be attractive targets for HIV vaccine development.	Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53715 USA; Epimmune, San Diego, CA 92121 USA; Northwestern Univ, Sch Med, Chicago, IL 60611 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; New England Reg Primate Res Ctr, Southborough, MA 01772 USA; Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Emory University; Mount Sinai St. Luke's; Mount Sinai West; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Wisconsin System; University of Wisconsin Madison	Watkins, DI (corresponding author), Univ Wisconsin, Wisconsin Reg Primate Res Ctr, 1220 Capitol Court, Madison, WI 53715 USA.		Wolinsky, Steven/B-2893-2012; Allen, Todd/F-5473-2011; Sette, Alessandro/AFO-8916-2022	Allen, Todd/0000-0002-6609-1318; o'connor, david/0000-0003-2139-470X; Wolinsky, Steven/0000-0002-9625-6697; Dzuris, John/0000-0002-0046-8426; Allison, David/0000-0003-3566-9399				Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; Allen TM, 1998, J IMMUNOL, V160, P6062; ALLEN TM, IN PRESS J VIROL; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Balter M, 1998, SCIENCE, V280, P1860, DOI 10.1126/science.280.5371.1860; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COUILLIN I, 1994, J EXP MED, V180, P1129, DOI 10.1084/jem.180.3.1129; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Knapp LA, 1997, TISSUE ANTIGENS, V50, P657, DOI 10.1111/j.1399-0039.1997.tb02927.x; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; MEYERHANS A, 1991, EUR J IMMUNOL, V21, P2637, DOI 10.1002/eji.1830211051; Mortara L, 1998, J VIROL, V72, P1403, DOI 10.1128/JVI.72.2.1403-1410.1998; NEI M, 1986, MOL BIOL EVOL, V3, P418; Osterhaus ADME, 1999, VACCINE, V17, P2713, DOI 10.1016/S0264-410X(98)00498-8; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Price GE, 2000, J EXP MED, V191, P1853, DOI 10.1084/jem.191.11.1853; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993	28	612	625	0	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					386	390		10.1038/35030124	http://dx.doi.org/10.1038/35030124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014195	Bronze			2022-12-28	WOS:000089390700049
J	Liu, Z; Zhou, XY; Shapiro, SD; Shipley, JM; Twining, SS; Diaz, LA; Senior, RM; Werb, Z				Liu, Z; Zhou, XY; Shapiro, SD; Shipley, JM; Twining, SS; Diaz, LA; Senior, RM; Werb, Z			The serpin alpha 1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo	CELL			English	Article							BULLOUS PEMPHIGOID AUTOANTIGEN; RESPIRATORY-DISTRESS SYNDROME; HUMAN-LEUKOCYTE ELASTASE; BLISTER FLUIDS; MACROPHAGE ELASTASE; IV COLLAGENASE; SYNOVIAL-FLUID; HOST-DEFENSE; INACTIVATION; NEUTROPHILS	We have identified the key protein substrate of gelatinase B/MMP-9 (GB) that is cleaved in vivo during dermal-epidermal separation triggered by antibodies to the hemidesmosomal protein BP180 (collagen XVII, BPAG2). Mice deficient in either GB or neutrophil elastase (NE) are resistant to blister formation in response to these antibodies in a mouse model of the autoimmune disease bullous pemphigoid. Disease develops upon complementation of GB(-/-) mice with NE-/- neutrophils or NE-/- mice with GB(-/-) neutrophils. Only NE degrades BP180 and produces dermal-epidermal separation in vivo and in culture. Instead, GB acts upstream to regulates NE activity by inactivating alpha 1-proteinase inhibitor (alpha 1-PI). Excess NE produces lesions in GB(-/-) mice without cleaving alpha 1-PI. Excess alpha 1-PI phenocopies GB and NE deficiency in wild-type mice.	Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Medical College of Wisconsin; University of California System; University of California San Francisco	Liu, Z (corresponding author), Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA.	zhillu@med.unc.edu			NIAID NIH HHS [AI40768] Funding Source: Medline; NIAMS NIH HHS [AR32599, AR32081, R01 AR032081] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040768, R01AI040768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032599, R01AR032081, R37AR032081] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BANDA MJ, 1988, J EXP MED, V167, P1608, DOI 10.1084/jem.167.5.1608; BANDA MJ, 1980, J EXP MED, V152, P1563, DOI 10.1084/jem.152.6.1563; BANDA MJ, 1987, J CLIN INVEST, V79, P1314, DOI 10.1172/JCI112955; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Betsuyaku T, 1999, AM J RESP CELL MOL, V20, P1303, DOI 10.1165/ajrcmb.20.6.3558; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017; COCHRANE CG, 1983, J CLIN INVEST, V71, P754, DOI 10.1172/JCI110823; COLIGAN JE, 1994, CURR PROTOCOLS IMMUN, V3; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; DVORAK AM, 1982, J INVEST DERMATOL, V78, P91, DOI 10.1111/1523-1747.ep12505711; Gammon W R, 1989, Immunol Ser, V46, P509; GISSLER HM, 1992, BRIT J DERMATOL, V127, P272, DOI 10.1111/j.1365-2133.1992.tb00127.x; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; GRANDO SA, 1989, INT J TISSUE REACT, V11, P195; GRANDO SA, 1989, ARCH DERMATOL, V125, P925, DOI 10.1001/archderm.125.7.925; JANOFF A, 1983, AM REV RESPIR DIS, V127, P782; JORDON RE, 1985, J INVEST DERMATOL, V85, pS72, DOI 10.1111/1523-1747.ep12275497; KNAUPER V, 1990, FEBS LETT, V263, P355, DOI 10.1016/0014-5793(90)81412-H; KRAMER MD, 1993, J CLIN INVEST, V92, P978, DOI 10.1172/JCI116674; LIU Z, 1995, J IMMUNOL, V155, P5449; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; LIU Z, 1995, J CLIN INVEST, V95, P1539, DOI 10.1172/JCI117826; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Liu Z, 1998, J EXP MED, V188, P475, DOI 10.1084/jem.188.3.475; Liu Z, 2000, J CLIN INVEST, V105, P113, DOI 10.1172/JCI3693; MAST AE, 1991, J BIOL CHEM, V266, P15810; MORIHARA K, 1984, J BIOCHEM, V95, P795, DOI 10.1093/oxfordjournals.jbchem.a134671; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; OIKARINEN AI, 1983, J INVEST DERMATOL, V81, P261; OKADA Y, 1992, J BIOL CHEM, V267, P21712; OSSANNA PJ, 1986, J CLIN INVEST, V77, P1939, DOI 10.1172/JCI112523; PEI DQ, 1994, J BIOL CHEM, V269, P25849; POTEMPA J, 1986, J BIOL CHEM, V261, P14330; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; SAWAMURA D, 1991, J BIOL CHEM, V266, P17784; SCHAUMBURGLEVER G, 1972, ARCH DERMATOL, V106, P662, DOI 10.1001/archderm.106.5.662; STAHLEBACKDAHL M, 1994, J CLIN INVEST, V93, P2022, DOI 10.1172/JCI117196; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; TANAKA T, 1991, J BIOL CHEM, V266, P12555; Twining SS, 1996, INVEST OPHTH VIS SCI, V37, P511; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Vu TH, 1998, BIOL EXTRAC, P115; WEILAND JE, 1986, AM REV RESPIR DIS, V133, P218; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WELGUS HG, 1986, J INVEST DERMATOL, V87, P592, DOI 10.1111/1523-1747.ep12455837; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; WONG PS, 1980, BIOCHEM BIOPH RES CO, V96, P1449, DOI 10.1016/0006-291X(80)90113-8; Yu Q, 2000, GENE DEV, V14, P163; ZHANG Z, 1990, BIOCHEM SOC T, V18, P898, DOI 10.1042/bst0180898	51	293	302	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					647	655		10.1016/S0092-8674(00)00087-8	http://dx.doi.org/10.1016/S0092-8674(00)00087-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007483	Bronze			2022-12-28	WOS:000089105200013
J	Longacre, A; Storb, U				Longacre, A; Storb, U			A novel cytidine deaminase affects antibody diversity	CELL			English	Review							SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; ACTIVATION; TRANSCRIPTION; CELLS		Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago	Storb, U (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.							BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LIU YJ, 1991, EUR J IMMUNOL, V21, P1905, DOI 10.1002/eji.1830210819; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; MUTO T, 2000, IN PRESS GENOMICS; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Storb U, 1996, CURR OPIN IMMUNOL, V8, P206, DOI 10.1016/S0952-7915(96)80059-8; Storb U, 1998, IMMUNOL REV, V162, P153; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200	16	24	26	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					541	544		10.1016/S0092-8674(00)00075-1	http://dx.doi.org/10.1016/S0092-8674(00)00075-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007471	Bronze			2022-12-28	WOS:000089105200001
J	Hooton, TM; Scholes, D; Stapleton, AE; Roberts, PL; Winter, C; Gupta, K; Samadpour, M; Stamm, WE				Hooton, TM; Scholes, D; Stapleton, AE; Roberts, PL; Winter, C; Gupta, K; Samadpour, M; Stamm, WE			A prospective study of asymptomatic bacteriuria in sexually active young women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: Asymptomatic bacteriuria is common in young women, but little is known about its pathogenesis, natural history, risk factors, and temporal association with symptomatic urinary tract infection. Methods: We prospectively evaluated 796 sexually active, nonpregnant women from 18 through 40 years of age over a period of six months for the occurrence of asymptomatic bacteriuria (defined as at least 10(sup 5) colony-forming units of urinary tract pathogens per milliliter). The women were patients at either a university student health center or a health maintenance organization (HMO). Periodic urine cultures were taken, daily diaries were kept, and regularly scheduled interviews were performed. Escherichia coli strains were tested for hemolysin, the papG genotype, and the ribosomal RNA type. Results: The prevalence of asymptomatic bacteriuria (the proportion of urine cultures with bacteriuria in asymptomatic women) was 5 percent (95 percent confidence interval, 4 percent to 6 percent) among women in the university group and 6 percent (95 percent confidence interval, 5 percent to 8 percent) among women in the HMO group. Persistent asymptomatic bacteriuria with the same E. coli strain was rare. Symptomatic urinary tract infection developed within one week after 8 percent of occasions on which a culture showed asymptomatic bacteriuria, as compared with 1 percent of occasions when asymptomatic bacteriuria was not found (P<0.001). Asymptomatic bacteriuria was associated with the same risk factors as for symptomatic urinary tract infection, particularly the use of a diaphragm plus spermicide and sexual intercourse. Conclusions: Asymptomatic bacteriuria in young women is common but rarely persists. It is a strong predictor of subsequent symptomatic urinary tract infection. (N Engl J Med 2000;343:992-7.) (C) 2000, Massachusetts Medical Society.	Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Environm Hlth, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Hooton, TM (corresponding author), Univ Washington, Harborview Med Ctr, 325 9th Ave,Box 359930, Seattle, WA 98104 USA.		Stapleton, Ann E/N-2428-2015	Stapleton, Ann E/0000-0003-0130-8659	NIDDK NIH HHS [DK 40045, DK 47549] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047549, R01DK040045] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))			0	171	184	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					992	997		10.1056/NEJM200010053431402	http://dx.doi.org/10.1056/NEJM200010053431402			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018165				2022-12-28	WOS:000089619900002
J	Maghnie, M; Cosi, G; Genovese, E; Manca-Bitti, ML; Cohen, A; Zecca, S; Tinelli, C; Gallucci, M; Bernasconi, S; Boscherini, B; Severi, F; Arico, M				Maghnie, M; Cosi, G; Genovese, E; Manca-Bitti, ML; Cohen, A; Zecca, S; Tinelli, C; Gallucci, M; Bernasconi, S; Boscherini, B; Severi, F; Arico, M			Central diabetes insipidus in children and young adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LANGERHANS CELL HISTIOCYTOSIS; POSTERIOR PITUITARY-GLAND; MR; HYPOPITUITARISM; HYPOPHYSITIS; SIGNAL	Background: Central diabetes insipidus is rare in children and young adults, and up to 50 percent of cases are idiopathic. The clinical presentation and the long-term course of this disorder are largely undefined. Methods: We studied all 79 patients with central diabetes insipidus who were seen at four pediatric endocrinology units between 1970 and 1996. There were 37 male and 42 female patients whose median age at diagnosis was 7.0 years (range, 0.1 to 24.8). All patients underwent magnetic resonance imaging (MRI) and periodic studies of anterior pituitary function. The median duration of follow-up was 7.6 years (range, 1.6 to 26.2). Results: The causes of the central diabetes insipidus were Langerhans'-cell histiocytosis in 12 patients, an intracranial tumor in 18 patients, a skull fracture in 2 patients, and autoimmune polyendocrinopathy in 1 patient; 5 patients had familial disease. The cause was considered to be idiopathic in 41 patients (52 percent). In 74 patients (94 percent) the posterior pituitary was not hyperintense on the first MRI scan obtained, and 29 patients (37 percent) had thickening of the pituitary stalk. Eighteen patients had changes in the thickness of the pituitary stalk over time, ranging from normalization (six patients) or a decrease in thickness (one patient) to further thickening (seven patients) or thickening of a previously normal stalk (four patients). Anterior pituitary hormone deficiencies, primarily growth hormone deficiency, were documented in 48 patients (61 percent) a median of 0.6 year (range, 0.1 to 18.0) after the onset of central diabetes insipidus. Conclusions: Most children and young adults with acquired central diabetes insipidus have abnormal findings on MRI scans of the head, which may change over time, and at least half have anterior pituitary hormone deficiencies during follow-up. (N Engl J Med 2000;343:998-1007.) (C) 2000, Massachusetts Medical Society.	Univ Pavia, IRCCS Policlin S Matteo, Dept Pediat, I-27100 Pavia, Italy; Univ Pavia, Dept Radiol, I-27100 Pavia, Italy; Univ Pavia, Dept Biometry Sci Direct, I-27100 Pavia, Italy; Univ Roma Tor Vergata, Dept Pediat, Rome, Italy; Ist Giannina Gaslini, Ist Ricovero & Cura Carattere Sci, Genoa, Italy; Univ Aquila, Dept Radiol, I-67100 Laquila, Italy; Univ Modena, Dept Pediat, I-41100 Modena, Italy	IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; University of Pavia; University of Rome Tor Vergata; University of Genoa; IRCCS Istituto Giannina Gaslini; University of L'Aquila; Universita di Modena e Reggio Emilia	Maghnie, M (corresponding author), Univ Pavia, IRCCS Policlin S Matteo, Dept Pediat, I-27100 Pavia, Italy.		Arico, Maurizio/S-3039-2019; Bernasconi, Sergio/AAA-9419-2021	Arico, Maurizio/0000-0002-1908-6671; Tinelli, Carmine/0000-0002-8749-1978				AHMED SR, 1993, J CLIN ENDOCR METAB, V76, P1499, DOI 10.1210/jc.76.6.1499; BROOKS BS, 1989, AM J ROENTGENOL, V153, P1033, DOI 10.2214/ajr.153.5.1033; CZERNICHOW P, 1985, J PEDIATR-US, V106, P41, DOI 10.1016/S0022-3476(85)80461-3; FRASIER SD, 1967, AM J DIS CHILD, V114, P157, DOI 10.1001/archpedi.1967.02090230087009; FUJISAWA I, 1991, CANCER, V68, P1009, DOI 10.1002/1097-0142(19910901)68:5<1009::AID-CNCR2820680517>3.0.CO;2-R; Gagliardi PC, 1997, J CLIN ENDOCR METAB, V82, P3643, DOI 10.1210/jc.82.11.3643; LEGER J, 1999, J CLIN ENDOCR METAB, V84, P1974; Maghnie M, 1997, AM J NEURORADIOL, V18, P1749; MAGHNIE M, 1994, RADIOLOGY, V193, P493, DOI 10.1148/radiology.193.2.7972767; MAGHNIE M, 1993, AM J NEURORADIOL, V14, P1443; Maghnie M, 1998, J CLIN ENDOCR METAB, V83, P3089, DOI 10.1210/jc.83.9.3089; MENA W, 1993, J PEDIATR-US, V122, P911, DOI 10.1016/S0022-3476(09)90017-8; SKLAR CA, 1981, J CLIN ENDOCR METAB, V52, P9, DOI 10.1210/jcem-52-1-9; THODOU E, 1995, J CLIN ENDOCR METAB, V80, P2302, DOI 10.1210/jc.80.8.2302	14	267	279	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					998	1007		10.1056/NEJM200010053431403	http://dx.doi.org/10.1056/NEJM200010053431403			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018166				2022-12-28	WOS:000089619900003
J	Jencks, SF; Cuerdon, T; Burwen, DR; Fleming, B; Houck, PM; Kussmaul, AE; Nilasena, DS; Ordin, DL; Arday, DR				Jencks, SF; Cuerdon, T; Burwen, DR; Fleming, B; Houck, PM; Kussmaul, AE; Nilasena, DS; Ordin, DL; Arday, DR			Quality of medical care delivered to Medicare beneficiaries - A profile at state and national levels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COOPERATIVE CARDIOVASCULAR PROJECT; ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE	Context Despite condition-specific and managed care-specific reports, no systematic program has been developed for monitoring the quality of medical care provided to Medicare beneficiaries. Objective To create a monitoring system for a range of measures of clinical performance that supports quality improvement and provides repeated, reliable estimates at the national and state levels for fee-for-service (FFS) Medicare beneficiaries. Design, setting, and Participants National study of repeated, cross-sectional observational data collected in 1997-1999 on all Medicare FFS beneficiaries or on a representative sample of beneficiaries with a particular condition. Data were collected using medical record abstraction for inpatient care, analysis of Medicare claims for some ambulatory services, and surveys for immunization rates. Separate samples were drawn for each topic for each state. Main Outcome Measures Beneficiary patients' receipt of 24 process-of-care measures related to primary prevention, secondary prevention, or treatment of 6 medical conditions (acute myocardial infarction, breast cancer, diabetes mellitus, heart failure, pneumonia, and stroke) for which there is strong scientific evidence and professional consensus that the process of care either directly improves outcomes or is a necessary step in a chain of care that does so. Results Across all states for all measures, the percentage of patients receiving appropriate care in the median state ranged from a high of 95% (avoidance of sublingual nifedipine for patients with acute stroke) to a low of 11% (patients with pneumonia screened for pneumococcal immunization status before discharge). The median performance on an indicator is 69% (patients discharged with heart-failure diagnosis who received angiotensin-converting enzyme inhibitors; diabetic patients having an eye examination in the last 2 years). Some states (particularly less populous states and those in the Northeast) consistently ranked high in relative performance while others (particularly more populous states and those in the Southeast) consistently ranked low. Conclusions It is possible to assemble information on a diverse set of clinical performance measures that represent performance on the range of services in a health insurance program. These findings indicate substantial opportunities to improve the care delivered to Medicare beneficiaries and urgently invite a partnership among practitioners, hospitals, health plans, and purchasers to achieve that improvement.	US Hlth Care Financing Adm, Baltimore, MD 21244 USA		Jencks, SF (corresponding author), US Hlth Care Financing Adm, 53-02-01,7500 Secur Blvd, Baltimore, MD 21244 USA.							*CDCP, 1998, MMWR-MORBID MORTAL W, V47, P797; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; FLEMING B, 1999, QUALITY CARE NATL PR; *HLTH CAR FIN ADM, 2000, QUAL CAR PRO PRIOR N; *HLTH CAR FIN ADM, 2000, HLTH CAR COMP; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; *NAT COMM QUAL ASS, 1998, HEDIS 1999, V2; *NAT CTR CHRON DIS, CD ROM SERIES, P1; President's Advisory Commission on Consumer Protection and Quality in the Health Care Industry, 1998, QUAL 1 BETT HLTH CAR; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; SHEKETTE P, 2000, INTERVENTIONS INCREA; *US DHHS, 2000, HLTH PEOPL 2010	14	516	521	3	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1670	1676		10.1001/jama.284.13.1670	http://dx.doi.org/10.1001/jama.284.13.1670			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015797	Bronze			2022-12-28	WOS:000089501900027
J	LaCroix, AZ; Ott, SM; Ichikawa, L; Scholes, D; Barlow, WE				LaCroix, AZ; Ott, SM; Ichikawa, L; Scholes, D; Barlow, WE			Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults - A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							HIP FRACTURE; THIAZIDE DIURETICS; OSTEOPOROTIC FRACTURES; UNITED-STATES; RISK-FACTORS; ELDERLY MEN; DRUG-USE; WOMEN; CALCIUM; MASS	Background: Thiazide may have beneficial effects on bone mineral density and may reduce risk for hip fracture. However, the existence of a causal role remains uncertain because experimental evidence is limited. Objective: To determine the effect of hydrochlorothiazide on rates of bone loss in older adults. Design: Randomized, double-blind, placebo-controlled trial with 3-year follow-up. Setting: A large health maintenance organization in western Washington State. Participants: 320 healthy, normotensive adults (205 women, 115 men) 60 to 79 years of age. Intervention: Random assignment to one of three study groups: 12.5 mg of hydrochlorothiazide per day, 25 mg of hydrochlorothiazide per day, or placebo. Measurements: Bone mineral density using dual-energy x-ray absorptiometry at the total hip, posterior-anterior spine, and total body; blood and urine markers of bone metabolism; incident falls, clinical fractures, and radiographic vertebral fractures. Results: 309 of 320 participants completed the 36-month visit (97%). Adherence to study medication throughout follow-up was high in all participants (81.6% to 89.7%) except men in the high-dose hydrochlorothiazide group (60.5%). According to intention-to-treat analysis, the 36-month differences in percentage change in total hip bone mineral density were 0.79 percentage point (95% CI, -0.12 to 1.71) for the 12.5-mg hydrochlorothiazide group and 0.92 percentage point (CI, -0.001 to 1.85) for the 25-mg group compared with placebo (P = 0.03). Percentage change at the posterior-anterior spine was significantly greater for the 25-mg hydrochlorothiazide group at 6 months (intergroup difference, 1.04 percentage points [CI, 0.22 to 1.86]) compared with placebo (P = 0.005); at 36 months, this difference was 0.82 percentage point (CI, -0.36 to 2.01; P = 0.12). No significant differences were seen in total-body bone mineral density between the treatment groups. Treatment effects were stronger in women than in men. Conclusions: In healthy older adults, low-dose hydrochlorothiazide preserves bone mineral density at the hip and spine. The modest effects observed over 3 years, if accumulated over 10 to 20 years, may explain the one-third reduction in risk for hip fracture associated with thiazide in many epidemiologic studies.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Washington, Seattle, WA 98195 USA	Group Health Cooperative; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	LaCroix, AZ (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009825] Funding Source: NIH RePORTER; NIA NIH HHS [AG09825] Funding Source: Medline; NIDDK NIH HHS [P30 DK35816] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aubin R, 1996, KIDNEY INT, V50, P1476, DOI 10.1038/ki.1996.461; Barry ELR, 1997, AM J PHYSIOL-CELL PH, V272, pC109, DOI 10.1152/ajpcell.1997.272.1.C109; BAUER DC, 1993, ANN INTERN MED, V118, P657, DOI 10.7326/0003-4819-118-9-199305010-00001; BLACK DM, 1993, OSTEOPOROSIS INT, V3, pS29; CAULEY JA, 1993, ANN INTERN MED, V118, P666, DOI 10.7326/0003-4819-118-9-199305010-00002; CUMMING RG, 1993, MED J AUSTRALIA, V158, P414, DOI 10.5694/j.1326-5377.1993.tb121839.x; Cumming RG, 1998, DRUG AGING, V12, P43, DOI 10.2165/00002512-199812010-00005; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; DAWSONHUGHES B, 1993, BONE MINER, V21, P41, DOI 10.1016/S0169-6009(08)80119-5; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; FELSON DT, 1991, JAMA-J AM MED ASSOC, V265, P370, DOI 10.1001/jama.265.3.370; Feskanich D, 1997, OSTEOPOROSIS INT, V7, P79, DOI 10.1007/BF01623465; GLYNN NW, 1995, J BONE MINER RES, V10, P1769; Grisso JA, 1997, AM J EPIDEMIOL, V145, P786, DOI 10.1093/oxfordjournals.aje.a009171; HEIDRICH FE, 1991, ANN INTERN MED, V115, P1, DOI 10.7326/0003-4819-115-1-1; Herings RMC, 1996, J CLIN EPIDEMIOL, V49, P115, DOI 10.1016/0895-4356(95)00552-8; Heshmati HM, 1998, J CLIN ENDOCR METAB, V83, P1916, DOI 10.1210/jc.83.6.1916; JONES G, 1995, J BONE MINER RES, V10, P106; Kristal AR, 1997, AM J EPIDEMIOL, V146, P856, DOI 10.1093/oxfordjournals.aje.a009203; LACROIX A Z, 1991, Comprehensive Therapy, V17, P30; LACROIX AZ, 1993, AM J EPIDEMIOL, V137, P858, DOI 10.1093/oxfordjournals.aje.a116747; LACROIX AZ, 1990, NEW ENGL J MED, V322, P286, DOI 10.1056/NEJM199002013220502; MANOLIO TA, 1995, ARCH INTERN MED, V155, P829, DOI 10.1001/archinte.155.8.829; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; MORTON DJ, 1994, AM J EPIDEMIOL, V139, P1107, DOI 10.1093/oxfordjournals.aje.a116954; Nguyen TV, 1996, AM J EPIDEMIOL, V144, P255, DOI 10.1093/oxfordjournals.aje.a008920; ORWOLL ES, 1990, ANN INTERN MED, V112, P29, DOI 10.7326/0003-4819-112-1-29; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; RASHIQ S, 1986, BRIT MED J, V292, P861, DOI 10.1136/bmj.292.6524.861; RAY WA, 1989, LANCET, V1, P687; SAS, 1996, SAS STAT SOFTW CHANG; Siegel D, 1997, JAMA-J AM MED ASSOC, V278, P1745, DOI 10.1001/jama.278.21.1745; STEINICHE T, 1989, APMIS, V97, P302, DOI 10.1111/j.1699-0463.1989.tb00792.x; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; TAGGART HM, 1988, J AM GERIATR SOC, V36, P1006, DOI 10.1111/j.1532-5415.1988.tb04367.x; TRANSBOL I, 1982, METABOLISM, V31, P383, DOI 10.1016/0026-0495(82)90115-9; WASNICH R, 1990, BRIT MED J, V301, P1303, DOI 10.1136/bmj.301.6764.1303; WASNICH RD, 1995, OSTEOPOROSIS INT, V5, P247, DOI 10.1007/BF01774014; WASNICH RD, 1983, NEW ENGL J MED, V309, P344, DOI 10.1056/NEJM198308113090605	40	149	155	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					516	526		10.7326/0003-4819-133-7-200010030-00010	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015164				2022-12-28	WOS:000089678300003
J	Guttmacher, AE				Guttmacher, AE			Twenty lessons from the heart of medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1486	1487		10.1001/jama.284.12.1486	http://dx.doi.org/10.1001/jama.284.12.1486			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000619				2022-12-28	WOS:000089379700001
J	Bruning, JC; Gautam, D; Burks, DJ; Gillette, J; Schubert, M; Orban, PC; Klein, R; Krone, W; Muller-Wieland, D; Kahn, CR				Bruning, JC; Gautam, D; Burks, DJ; Gillette, J; Schubert, M; Orban, PC; Klein, R; Krone, W; Muller-Wieland, D; Kahn, CR			Role of brain insulin receptor in control of body weight and reproduction	SCIENCE			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; FOOD-INTAKE; GENE; RAT; RESISTANCE; KNOCKOUT; NEURONS; NIDDM	Insulin receptors (IRs) and insulin signaling proteins are widely distributed throughout the central nervous system (CNS). To study the physiological role of insulin signaling in the brain, we created mice with a neuron-specific disruption of the IR gene (NIRKO mice), Inactivation of the IR had no impact on brain development or neuronal survival. However, female NIRKO mice showed increased food intake, and both male and female mice developed diet-sensitive obesity with increases in body fat and plasma leptin levels, mild insulin resistance, elevated plasma insulin Levels, and hypertriglyceridemia. NIRKO mice also exhibited impaired spermatogenesis and ovarian follicle maturation because of hypothalamic dysregulation of luteinizing hormone. Thus, IR signaling in the CNS plays an important role in regulation of energy disposal, fuel metabolism, and reproduction.	Univ Cologne, Klin & Poliklin Innere Med 2, D-50931 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany	University of Cologne; University of Cologne; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; European Molecular Biology Laboratory (EMBL)	Bruning, JC (corresponding author), Univ Cologne, Klin & Poliklin Innere Med 2, Stelzmann Str 9, D-50931 Cologne, Germany.		Kahn, Ronald/AAY-2435-2021; Klein, Ruediger/C-6147-2008; Schubert, Markus/F-5150-2010	Kahn, Ronald/0000-0002-7583-9228; Klein, Ruediger/0000-0002-3109-0163; 	NIDDK NIH HHS [DK31036, DK55326-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031036, R01DK055326, R01DK031036] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; BURKS DJ, UNPUB; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; FIGLEWICZ DP, 1995, BEHAV NEUROSCI, V109, P567, DOI 10.1037/0735-7044.109.3.567; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; GAUTAM D, UNPUB; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; NAKAMURA F, 1989, ENDOCRINOL JAPON, V36, P349; OLSON BR, 1995, NEUROENDOCRINOLOGY, V62, P155, DOI 10.1159/000127000; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; ROBINSON LJ, 1994, ENDOCRINOLOGY, V135, P2568, DOI 10.1210/en.135.6.2568; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Svenningsen AF, 1996, GLIA, V18, P68, DOI 10.1002/(SICI)1098-1136(199609)18:1<68::AID-GLIA7>3.0.CO;2-#; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vento R, 1997, MOL CELL BIOCHEM, V170, P163, DOI 10.1023/A:1006813705101; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; WERTHER GA, 1987, ENDOCRINOLOGY, V121, P1562, DOI 10.1210/endo-121-4-1562; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Yura S, 2000, J CLIN INVEST, V105, P749, DOI 10.1172/JCI8353	28	1582	1640	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2122	2125		10.1126/science.289.5487.2122	http://dx.doi.org/10.1126/science.289.5487.2122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000114				2022-12-28	WOS:000089430900044
J	Bishop, AC; Ubersax, JA; Petsch, DT; Matheos, DP; Gray, NS; Blethrow, J; Shimizu, E; Tsien, JZ; Schultz, PG; Rose, MD; Wood, JL; Morgan, DO; Shokat, KM				Bishop, AC; Ubersax, JA; Petsch, DT; Matheos, DP; Gray, NS; Blethrow, J; Shimizu, E; Tsien, JZ; Schultz, PG; Rose, MD; Wood, JL; Morgan, DO; Shokat, KM			A chemical switch for inhibitor-sensitive alleles of any protein kinase	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; TYROSINE KINASE; BUDDING YEAST; CRYSTAL-STRUCTURE; COMPLEX; MITOSIS; GENES; CDC28; CDK2	Protein kinases have proved to be largely resistant to the design of highly specific inhibitors, even with the aid of combinatorial chemistry(1). The lack of these reagents has complicated efforts to assign specific signalling roles to individual kinases. Here we describe a chemical genetic strategy for sensitizing protein kinases to cell-permeable molecules that do not inhibit wildtype kinases(2). From two inhibitor scaffolds, we have identified potent and selective inhibitors for sensitized kinases from five distinct subfamilies. Tyrosine and serine/threonine kinases are equally amenable to this approach. We have analysed a budding yeast strain carrying an inhibitor-sensitive form of the cyclin-dependent kinase Cdc28 (CDK1) in place of the wild-type protein. Specific inhibition of Cdc28 in vivo caused a pre-mitotic cell-cycle arrest that is distinct from the G1 arrest typically observed in temperature-sensitive cdc28 mutants(3). The mutation that confers inhibitor-sensitivity is easily identifiable from primary sequence alignments. Thus, this approach can be used to systematically generate conditional alleles of protein kinases, allowing for rapid functional characterization of members of this important gene family.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; Princeton University; Novartis; Princeton University	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Shimizu, Eiji/K-4637-2017	Shimizu, Eiji/0000-0002-6741-9338; Rose, Mark/0000-0003-1112-4765; Morgan, David/0000-0001-8753-4416	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037739] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM037739] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; DOI S, 1977, ARCH MICROBIOL, V114, P287, DOI 10.1007/BF00446875; ESPINOZA FH, 1994, SCIENCE, V266, P1388, DOI 10.1126/science.7973730; Farrell A, 2000, MOL CELL BIOL, V20, P749, DOI 10.1128/MCB.20.3.749-754.2000; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; FUJIMURA HA, 1994, J CELL SCI, V107, P2617; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; KELLY PT, 1991, MOL NEUROBIOL, V5, P153, DOI 10.1007/BF02935544; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Laneuville P, 1995, Semin Immunol, V7, P255, DOI 10.1006/smim.1995.0030; Lawrie AM, 1997, NAT STRUCT BIOL, V4, P796, DOI 10.1038/nsb1097-796; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; REED SI, 1980, GENETICS, V95, P561; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sherman F., 1974, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stern B, 1996, TRENDS GENET, V12, P345; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wood JL, 1997, J AM CHEM SOC, V119, P9641, DOI 10.1021/ja9713035	30	832	848	2	99	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					395	401		10.1038/35030148	http://dx.doi.org/10.1038/35030148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014197				2022-12-28	WOS:000089390700051
J	Hanakahi, LA; Bartlet-Jones, M; Chappell, C; Pappin, D; West, SC				Hanakahi, LA; Bartlet-Jones, M; Chappell, C; Pappin, D; West, SC			Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair	CELL			English	Article							DEPENDENT PROTEIN-KINASE; V(D)J RECOMBINATION; LIGASE-IV; MYOINOSITOL HEXAPHOSPHATE; XRCC4 PROTEIN; GENE-PRODUCT; P-31 NMR; HEXAKISPHOSPHATE; INHIBITION; INTERACTS	In mammalian cells, double-strand breaks in DNA can be repaired by nonhomologous end-joining (NHEJ), a process dependent upon Ku70/80, DNA-PKcs, XRCC4, and DNA ligase IV. Starting with HeLa cell-free extracts, which promote NHEJ in a reaction dependent upon all of these proteins, we have purified a novel factor that stimulates DNA end-joining in vitro. Using a combination of phosphorus NMR, mass spectroscopy, and strong anion exchange chromatography, we identify this factor as inositol hexakisphosphate (IP6). Purified IP6 is bound by DNA-PK and specifically stimulates DNA-PK-dependent end-joining in vitro. The involvement of inositol phosphate in DNA-PK-dependent NHEJ is of particular interest since the catalytic domain of DNA-PKcs is similar to that found in the phosphatidylinositol 3 (PI 3)-kinase family.	Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Imperial Canc Res Fund, London WC2A 3PX, England	Cancer Research UK	West, SC (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	s.west@icrf.icnet.uk		West, Stephen/0000-0001-8848-9418; Pappin, Darryl/0000-0002-8981-8401; Elstob, Claire/0000-0003-4252-493X				Barrientos LG, 1996, CARBOHYD RES, V296, P39, DOI 10.1016/S0008-6215(96)00250-9; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; COSTELLO AJR, 1976, CARBOHYD RES, V46, P159, DOI 10.1016/S0008-6215(00)84287-1; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; DVIR A, 1993, J BIOL CHEM, V268, P10440; EMSLEY J, 1981, PHOSPHORUS SULFUR, V10, P401, DOI 10.1080/03086648108077394; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HAWKINS PT, 1993, BIOCHEM J, V294, P929, DOI 10.1042/bj2940929; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Larsson O, 1997, SCIENCE, V278, P471, DOI 10.1126/science.278.5337.471; Leber R, 1998, J BIOL CHEM, V273, P1794, DOI 10.1074/jbc.273.3.1794; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Modesti M, 1999, EMBO J, V18, P2008, DOI 10.1093/emboj/18.7.2008; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Rigden DJ, 1999, J MOL BIOL, V289, P691, DOI 10.1006/jmbi.1999.2848; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2000, FEBS LETT, V468, P28, DOI 10.1016/S0014-5793(00)01194-7; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; SZWERGOLD BS, 1987, BIOCHEM BIOPH RES CO, V149, P874, DOI 10.1016/0006-291X(87)90489-X; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; THEIBERT AB, 1992, J BIOL CHEM, V267, P9071; Weaver DT, 1996, CRIT REV EUKAR GENE, V6, P345, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.20; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	36	197	207	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					721	729		10.1016/S0092-8674(00)00061-1	http://dx.doi.org/10.1016/S0092-8674(00)00061-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030616	Bronze			2022-12-28	WOS:000089395200004
J	Ertem, IO; Leventhal, JM; Dobbs, S				Ertem, IO; Leventhal, JM; Dobbs, S			Intergenerational continuity of child physical abuse: how good is the evidence?	LANCET			English	Article							MALTREATMENT; TRANSMISSION; NEGLECT; ANTECEDENTS; PREDICTION; VIOLENCE; PARENTS; CYCLE; UNIT	Background There is widespread belief that individuals who were physically abused during childhood are more likely to abuse their own children than those who were not abused, but the empirical studies examining this belief have not been systematically reviewed. The aim of this study was to evaluate systematically, based on eight methodological standards derived from a hypothetical randomised controlled trial, the design of studies investigating the intergenerational transmission of child physical abuse. Methods We reviewed studies published between 1965 and 2000 in English that provided information about physical maltreatment in two generations and included a comparison group. Two investigators independently assessed whether each study met the methodological standards. Findings In the ten studies identified (four cohort, one cross-sectional, and five case-control), the relative risks of maltreatment in the children of parents who were abused during childhood were significantly increased in four studies (relative risks 4.75-37.8), but in three other studies the relative risks were less than 2. Most study reports provided a clear description of abuse of parents during childhood and abuse of their children. Five studies failed to avoid recall and detection bias; five did not ensure that controls were not themselves maltreated; eight did not provide adequate follow-up; and in six the report did not state whether the enrolled parent was responsible for the maltreatment. Most studies did not control for intervening factors, such as sociodemographic characteristics during the time of abuse of the parent generation and at the time their children were abused. Only one study met all eight criteria (relative risk of abuse transmission 12.6 [95% CI 1.82-87.2]) and one met six (1.05 [0.53-2.06]). Interpretation The one study that met ail eight methodological standards provided evidence for the intergenerational continuity of child physical abuse, but that which met six standards did not support the hypothesis. Use of our model and methodological standards should improve the scientific quality of studies examining the effects of risk factors for adverse outcomes that may continue across generations.	Ankara Univ, Sch Med, Dept Pediat, TR-06100 Ankara, Turkey; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Ankara University; Yale University	Ertem, IO (corresponding author), Ankara Univ, Sch Med, Dept Pediat, TR-06100 Ankara, Turkey.							ALTEMEIER WA, 1982, J PEDIATR-US, V100, P823; ALTEMEIER WA, 1986, CHILD ABUSE NEGLECT, V10, P319, DOI 10.1016/0145-2134(86)90007-4; ALTEMEIER WA, 1984, CHILD ABUSE NEGLECT, V8, P393, DOI 10.1016/0145-2134(84)90020-6; ALTEMEIER WA, 1979, J AM ACAD CHILD PSY, V18, P205, DOI 10.1016/S0002-7138(09)61037-2; BELSKY J, 1993, PSYCHOL BULL, V114, P413, DOI 10.1037/0033-2909.114.3.413; CICCHETTI D, 1980, HARVARD EDUC REV, V50, P244; Cicchetti D., 1981, NEW DIR CHILD ADOLES, V11, P31, DOI [10.1002/cd.23219811104, DOI 10.1002/CD.23219811104]; DUBOWITZ H, 1987, AM J ORTHOPSYCHIAT, V57, P525, DOI 10.1111/j.1939-0025.1987.tb03568.x; EGELAND B, 1988, CHILD DEV, V59, P1080, DOI 10.1111/j.1467-8624.1988.tb03260.x; Egeland B, 1983, Child Abuse Negl, V7, P459, DOI 10.1016/0145-2134(83)90053-4; Egeland B, 1987, CHILD ABUSE NEGLECT, P255; EGELAND B, 1979, CHILD ABUSE NEGLECT, V3, P269; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; Haapasalo J., 1999, CHILD ABUSE REV, V8, P231, DOI DOI 10.1002/(SICI)1099-0852(199907/08)8:4<LESS; HEALY K, 1991, BRIT J PSYCHIAT, V158, P234, DOI 10.1192/bjp.158.2.234; HUNTER RS, 1978, PEDIATRICS, V61, P629; HUNTER RS, 1979, AM J PSYCHIAT, V136, P1320; Kaufman J., 1989, CHILD MALTREATMENT T, P129, DOI [DOI 10.1017/CB09780511665707.006, 10.1017/CBO9780511665707.006, DOI 10.1017/CBO9780511665707.006]; Leventhal J M, 1982, Child Abuse Negl, V6, P113, DOI 10.1016/0145-2134(82)90003-5; MAIN M, 1984, CHILD ABUSE NEGLECT, V8, P203, DOI 10.1016/0145-2134(84)90009-7; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MULLER RT, 1995, CHILD ABUSE NEGLECT, V19, P1323, DOI 10.1016/0145-2134(95)00103-F; OLIVER JE, 1985, BRIT J PSYCHIAT, V147, P484, DOI 10.1192/bjp.147.5.484; OLIVER JE, 1993, AM J PSYCHIAT, V150, P1315; SMITH JAS, 1991, CHILD ABUSE NEGLECT, V15, P437, DOI 10.1016/0145-2134(91)90027-B; SMITH SM, 1975, BRIT J PSYCHIAT, V127, P513, DOI 10.1192/bjp.127.6.513; Straus M.A., 1979, CHILD ABUSE NEGLECT, V3, P213, DOI DOI 10.1016/0145-2134(79)90034-6; *US DHHS, 1999, CHILD MALTR 1997 REP; VIETZE P, 1980, INFANT MENT HEALTH J, V1, P248; WIDOM CS, 1989, PSYCHOL BULL, V106, P3, DOI 10.1037/0033-2909.115.2.287; WIDOM CS, 1989, AM J ORTHOPSYCHIAT, V59, P355, DOI 10.1111/j.1939-0025.1989.tb01671.x; ZEANAH CH, 1989, PSYCHIATRY, V52, P177, DOI 10.1080/00332747.1989.11024442	32	142	148	1	24	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					814	819		10.1016/S0140-6736(00)02656-8	http://dx.doi.org/10.1016/S0140-6736(00)02656-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	350LF	11022929				2022-12-28	WOS:000089101800012
J	Muramatsu, M; Kinoshita, K; Fagarasan, S; Yamada, S; Shinkai, Y; Honjo, T				Muramatsu, M; Kinoshita, K; Fagarasan, S; Yamada, S; Shinkai, Y; Honjo, T			Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme	CELL			English	Article							HEAVY-CHAIN LOCUS; X-LINKED IMMUNODEFICIENCY; HYPER-IGM SYNDROME; SOMATIC HYPERMUTATION; CD40 LIGAND; IMMUNOGLOBULIN GENES; CIRCULAR DNA; B-CELLS; SACCHAROMYCES-CEREVISIAE; REGION RECOMBINATION	Induced overexpression of AID in CH12F3-2 B lymphoma cells augmented class switching from IgM to IgA without cytokine stimulation. AID deficiency caused a complete defect in class switching and showed a hyper-IgM phenotype with enlarged germinal centers containing strongly activated B cells before or after immunization. AID(-/-) spleen cells stimulated in vitro with LPS and cytokines failed to undergo class switch recombination although they expressed germline transcripts. Immunization of AID(-/-) chimera with 4-hydroxy-3-nitrophenylacetyl (NP) chicken gamma-globulin induced neither accumulation of mutations in the NP-specific variable region gene nor class switching. These results suggest that AID may be involved in regulation or catalysis of the DNA modification step of both class switching and somatic hypermutation.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; Kyoto Univ, Inst Virus Res, Dept Cell Biol, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Shinkai, Yoichi/N-3909-2014; Fagarasan, Sidonia/A-5258-2016; Muramatsu, Masamichi/C-4339-2015; Honjo, Tasuku/N-4470-2016	Shinkai, Yoichi/0000-0002-6051-2484; Fagarasan, Sidonia/0000-0003-2086-6402; Muramatsu, Masamichi/0000-0002-0153-3533; 				ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Ballantyne J, 1998, J IMMUNOL, V161, P1336; BURSTEIN HJ, 1991, J IMMUNOL, V147, P2950; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369; Holbeck SL, 1997, GENETICS, V147, P1017; Horijo T, 1995, IMMUNOGLOBULIN GENES, P235; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KELLY BS, 1979, IMMUNOLOGY, V37, P45; Kinoshita K, 1999, COLD SPRING HARB SYM, V64, P217, DOI 10.1101/sqb.1999.64.217; Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2; Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9; LI SC, 1994, INT IMMUNOL, V6, P491, DOI 10.1093/intimm/6.4.491; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; MANTOVANI L, 1993, J IMMUNOL, V151, P473; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; MUTO T, 2000, IN PRESS GENOMICS; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9; NIKAIDO T, 1982, J BIOL CHEM, V257, P7322; Nishizawa M, 1998, ELECTROCHEM SOLID ST, V1, P10, DOI 10.1149/1.1390618; Oettinger MA, 1999, CURR OPIN CELL BIOL, V11, P325, DOI 10.1016/S0955-0674(99)80044-1; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 1999, IMMUNOL TODAY, V20, P522, DOI 10.1016/S0167-5699(99)01540-6; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0; Smith HC, 1996, TRENDS GENET, V12, P418, DOI 10.1016/0168-9525(96)10042-1; SOHN J, 1993, J EXP MED, V177, P493, DOI 10.1084/jem.177.2.493; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; Wabl M, 1999, CURR OPIN IMMUNOL, V11, P186, DOI 10.1016/S0952-7915(99)80031-4; Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441; Wilson P, 1998, IMMUNOL REV, V162, P143, DOI 10.1111/j.1600-065X.1998.tb01437.x; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x	62	2568	2625	5	315	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					553	563		10.1016/S0092-8674(00)00078-7	http://dx.doi.org/10.1016/S0092-8674(00)00078-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007474	Bronze			2022-12-28	WOS:000089105200004
J	Boyle, P; Langman, JS				Boyle, P; Langman, JS			ABC of colorectal cancer - Epidemiology	BRITISH MEDICAL JOURNAL			English	Review							COLON CANCER; WOMEN; RISK		European Inst, Div Epidemiol & Biostat, Milan, Italy; Univ Birmingham, Birmingham B15 2TT, W Midlands, England	European University Institute; University of Birmingham	Boyle, P (corresponding author), European Inst, Div Epidemiol & Biostat, Milan, Italy.		Boyle, Peter/A-4380-2014	Boyle, Peter/0000-0001-6251-0610				BERRINO F, 1999, SCI PUBLICATION INT, V151; BOYLE P, 1995, BRIT J CANCER, V72, P528, DOI 10.1038/bjc.1995.368; COLEMAN MP, 1971, CANC SURVIVAL TRENDS; Giovannucci E, 1996, CANCER CAUSE CONTROL, V7, P253, DOI 10.1007/BF00051301; MACLENNAN SC, 1995, MED J AUSTRALIA, V162, P491, DOI 10.5694/j.1326-5377.1995.tb140014.x; McLaren G, 1998, DEPRIVATION HLTH SCO; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; SHEPHARD RJ, 1993, SPORTS MED, V15, P258, DOI 10.2165/00007256-199315040-00004; WILLETT W, 1989, NATURE, V338, P389, DOI 10.1038/338389a0; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404	10	360	379	2	22	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					805	808		10.1136/bmj.321.7264.805	http://dx.doi.org/10.1136/bmj.321.7264.805			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009523	Green Published			2022-12-28	WOS:000089696600025
J	Poizot, P; Laruelle, S; Grugeon, S; Dupont, L; Tarascon, JM				Poizot, P; Laruelle, S; Grugeon, S; Dupont, L; Tarascon, JM			Nano-sized transition-metaloxides as negative-electrode materials for lithium-ion batteries	NATURE			English	Article							TIN; LI	Rechargeable solid-state batteries have long been considered an attractive power source for a wide variety of applications, and in particular, lithium-ion batteries are emerging as the technology of choice for portable electronics. One of the main challenges in the design of these batteries is to ensure that the electrodes maintain their integrity over many discharge-recharge cycles. Although promising electrode systems have recently been proposed(1-7), their lifespans are limited by Li-alloying agglomeration(8) or the growth of passivation layers(9), which prevent the fully reversible insertion of Li ions into the negative electrodes. Here we report that electrodes made of nanoparticles of transition-metal oxides (MO, where M is Co, Ni, Cu or Fe) demonstrate electrochemical capacities of 700 mAh g(-1), with 100% capacity retention for up to 100 cycles and high recharging rates. The mechanism of Li reactivity differs from the classical Li insertion/deinsertion or Li-alloying processes, and involves the formation and decomposition of Li2O, accompanying the reduction and oxidation of metal nanoparticles (in the range 1-5 nanometres) respectively. We expect that the use of transition-metal nanoparticles to enhance surface electrochemical reactivity will lead to further improvements in the performance of lithium-ion batteries.	Univ Picardie, Lab React & Chim Solides, CNRS UPRES A 6007, F-80039 Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Tarascon, JM (corresponding author), Univ Picardie, Lab React & Chim Solides, CNRS UPRES A 6007, 33 Rue St Leu, F-80039 Amiens, France.	Jean-Marie.Tarascon@u-picardie.fr	Smith, Victoria/G-8161-2014; Tarascon, Jean-Marie/B-5952-2016; POIZOT, Philippe/E-5722-2017; dupont, loic/B-6713-2013; Dee, Chang Fu/G-4842-2010	POIZOT, Philippe/0000-0003-1865-4902; dupont, loic/0000-0003-3810-6356; Dee, Chang Fu/0000-0003-1015-9181				Amatucci GG, 1996, J ELECTROCHEM SOC, V143, P1114, DOI 10.1149/1.1836594; BUFFAT P, 1976, PHYS REV A, V13, P2287, DOI 10.1103/PhysRevA.13.2287; Courtney IA, 1999, J ELECTROCHEM SOC, V146, P59, DOI 10.1149/1.1391565; Denis S, 1997, J ELECTROCHEM SOC, V144, P4099, DOI 10.1149/1.1838150; Figlarz M, 1985, French patent, Patent No. 8221483; Gozdz A.S., 1994, U.S. Patent, Patent No. [US5296318A, 5296318]; GUYOMARD D, 1993, J ELECTROCHEM SOC, V140, P3071, DOI 10.1149/1.2220987; Idota Y, 1997, SCIENCE, V276, P1395, DOI 10.1126/science.276.5317.1395; IDOTA Y, 1995, Patent No. 5478671; Kepler KD, 1999, ELECTROCHEM SOLID ST, V2, P307, DOI 10.1149/1.1390819; Mao O, 1999, J ELECTROCHEM SOC, V146, P405, DOI 10.1149/1.1391622; SHODAI T, 1996, SOLID STATE IONICS, V786, P86; SIGALA C, 1995, CR ACAD SCI II, V320, P523; Takeda Y, 2000, SOLID STATE IONICS, V130, P61, DOI 10.1016/S0167-2738(99)00293-3	14	7160	7425	107	5679	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					496	499		10.1038/35035045	http://dx.doi.org/10.1038/35035045			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028997				2022-12-28	WOS:000089727400045
J	Benedetti-Cecchi, L				Benedetti-Cecchi, L			Variance in ecological consumer-resource interactions	NATURE			English	Article							INTERACTION STRENGTH; FOOD-WEB; COMMUNITY ORGANIZATION; INTERTIDAL ZONE; SUCCESSION; PREDATION; SIZE; VARIABILITY; DYNAMICS; ALGAE	Food-web models use the effect size of trophic interactions to predict consumer-resource dynamics(1-3). These models anticipate that strong effects of consumers increase spatial and temporal variability in abundance of species, whereas weak effects dampen fluctuations(4-6). Empirical evidence indicates that opposite patterns may occur in natural assemblages(7). Here I show that spatial variance in the distribution of resource populations is sensitive to changes in the variance of the trophic interaction, in addition to the mean effect of consumers, relative to other causes of spatial variability. Simulations indicate that both strong and weak direct effects of consumers can promote spatial variability in abundance of resources, but only trophic interactions with a large mean effect size can reduce variation. Predictions of the model agree with the results of repeated field experiments and are consistent with data from published consumer-resource interactions, proving to be robust across widely varying environmental conditions and species' life histories. Thus, food-web models that embody variance in trophic interactions may have increased capacity to explain the wide range of effects of consumers documented in empirical studies.	Dipartimento Sci Uomo Ambiente, I-56126 Pisa, Italy		Benedetti-Cecchi, L (corresponding author), Dipartimento Sci Uomo Ambiente, Via A Volta 6, I-56126 Pisa, Italy.		Benedetti-Cecchi, Lisandro/J-8225-2019	Benedetti-Cecchi, Lisandro/0000-0001-5244-5202				Anderson MJ, 1997, OECOLOGIA, V109, P442, DOI 10.1007/s004420050104; Benedetti-Cecchi L, 2000, ECOL MONOGR, V70, P45, DOI 10.1890/0012-9615(2000)070[0045:PDAIID]2.0.CO;2; Berlow EL, 1997, J EXP MAR BIOL ECOL, V214, P195, DOI 10.1016/S0022-0981(97)00023-3; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; DETHIER MN, 1988, MAR ECOL PROG SER, V50, P97, DOI 10.3354/meps050097; Dungan M.L., 1987, P188; DUNGAN ML, 1986, AM NAT, V127, P292, DOI 10.1086/284486; FAIRWEATHER PG, 1988, OIKOS, V53, P87, DOI 10.2307/3565667; Lawton J.H., 1989, P43; LUBCHENCO J, 1978, ECOL MONOGR, V48, P67, DOI 10.2307/2937360; LUBCHENCO J, 1984, J EXP MAR BIOL ECOL, V78, P23, DOI 10.1016/0022-0981(84)90069-8; MARTIN TH, 1989, ECOLOGY, V70, P1935, DOI 10.2307/1938123; May R.M., 1973, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Menconi M, 1999, J EXP MAR BIOL ECOL, V233, P1, DOI 10.1016/S0022-0981(98)00123-3; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; MENGE BA, 1986, OECOLOGIA, V71, P75, DOI 10.1007/BF00377324; MORRISON D, 1988, ECOLOGY, V69, P1367, DOI 10.2307/1941634; Navarrete SA, 1996, ECOL MONOGR, V66, P301, DOI 10.2307/2963520; Osenberg CW, 1997, AM NAT, V150, P798, DOI 10.1086/286095; PAINE RT, 1980, J ANIM ECOL, V49, P667; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; SMITH SV, 1992, ANNU REV ECOL SYST, V23, P89, DOI 10.1146/annurev.es.23.110192.000513; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Underwood AJ, 1996, FRONTIERS OF POPULATION ECOLOGY, P369; WOOTTON JT, 1993, ECOLOGY, V74, P195, DOI 10.2307/1939514	30	57	58	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					370	374		10.1038/35030089	http://dx.doi.org/10.1038/35030089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014191				2022-12-28	WOS:000089390700045
J	Sekiyama, K; Miyauchi, S; Imaruoka, T; Egusa, H; Tashiro, T				Sekiyama, K; Miyauchi, S; Imaruoka, T; Egusa, H; Tashiro, T			Body image as a visuomotor transformation device revealed in adaptation to reversed vision	NATURE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; POSTERIOR PARIETAL CORTEX; MENTAL ROTATION; PREMOTOR CORTEX; WORKING-MEMORY; HUMAN BRAIN; MECHANISMS; NEURONS; OBJECTS; HANDS	People adapt with remarkable flexibility to reversal of the visual field caused by prism spectacles(1,2). With sufficient time, this adaptation restores visually guided behaviour and perceptual harmony between the visible and tactile worlds(1-3). Although it has been suggested that seeing one's own body is crucial for adaptation(1,2), the underlying mechanisms are unclear. Here we show that a new representation of visuomotor mapping with respect to the hands emerges in a month during adaptation to reversed vision. The subjects become bi-perceptual(3-5), or able to use both new and old representations. In a visual task designed to assess the new hand representation, subjects identified visually presented hands as left or right by matching the picture to the representation of their own hands. Functional magnetic resonance imaging showed brain activity in the left posterior frontal cortex (Broca's area) that was unique to the new hand representations of both hands, together with activation in the intraparietal sulcus and prefrontal cortex. The emergence of the new hand representation coincided with the adaptation of perceived location of visible objects in space. These results suggest that the hand representation operates as a visuomotor transformation device that provides an arm-centred frame of reference(6) for space perception.	Future Univ Hakodate, Div Cognit Psychol, Hakodate, Hokkaido 0418655, Japan; Kansai Adv Res Ctr, Commun Res Lab, Auditory & Visual Informat Sect, Kobe, Hyogo 6512492, Japan; Osaka Univ, Grad Sch Med, Suita, Osaka 5650781, Japan; Int Univ Hlth & Welf, Sch Hlth, Ohtawara 3248501, Japan; Osaka City Univ, Dept Psychol, Osaka 5588585, Japan	Future University Hakodate; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; International University of Health & Welfare; Osaka Metropolitan University	Sekiyama, K (corresponding author), Future Univ Hakodate, Div Cognit Psychol, Hakodate, Hokkaido 0418655, Japan.							Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; [Anonymous], 1993, BRAIN ACTIVATION; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Grafton ST, 1996, EXP BRAIN RES, V112, P103; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; HELD RICHARD, 1955, AMER JOUR PSYCHOL, V68, P526, DOI 10.2307/1418782; Iriki A, 1996, NEUROREPORT, V7, P2325; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Kohler I, 1964, PSYCHOL ISSUES, V3, P1; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; Kurata K, 1999, J NEUROPHYSIOL, V81, P1927, DOI 10.1152/jn.1999.81.4.1927; Miyauchi S, 1999, INVEST OPHTH VIS SCI, V40, pS820; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rushworth MFS, 1997, EXP BRAIN RES, V117, P292, DOI 10.1007/s002210050224; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; SEKIYAMA K, 1983, JPN PSYCHOL RES, V25, P95, DOI 10.4992/psycholres1954.25.95; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Stratton G.M., 1897, PSYCHOL REV, V4, P341, DOI [DOI 10.1037/H0075482, 10.1037/h0075482]; Sugita Y, 1996, NATURE, V380, P523, DOI 10.1038/380523a0; TAIRA M, 1990, EXP BRAIN RES, V83, P29; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740	29	73	73	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					374	377		10.1038/35030096	http://dx.doi.org/10.1038/35030096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	355NA	11014192				2022-12-28	WOS:000089390700046
J	Stott, LD; Berelson, W; Douglas, R; Gorsline, D				Stott, LD; Berelson, W; Douglas, R; Gorsline, D			Increased dissolved oxygen in Pacific intermediate waters due to lower rates of carbon oxidation in sediments	NATURE			English	Article							SANTA-BARBARA BASIN; NORTH PACIFIC; MONICA BASIN; SEA-FLOOR; CALIFORNIA; CLIMATE; OCEAN; DIAGENESIS; CENTURIES; RECORD	Concentrations of dissolved oxygen in the ocean seem to correlate well with climate instabilities over the past 100,000 years. For example, the concentration of dissolved oxygen in Pacific intermediate waters was considerably higher during Pleistocene glacial periods than it is today(1-4). This has been inferred from the presence of bioturbated sediments, implying that oxygen levels were sufficient for burrowing organisms to live. Today, basins in the northeastern Pacific Ocean are floored by laminated sediments implying lower oxygen levels, which may be explained by reduced ventilation(2-4). Here we report a recent return to bioturbated sediments in the northeastern Pacific Ocean since the late 1970s. From the carbon isotope composition of benthic foraminifers living in the sediment, we infer a twofold decrease in the carbon oxidation rate occurring within sediments, equivalent to an increase in dissolved oxygen concentration of 15-20 micromoles per litre. These changes, at the edges of the Santa Barbara, Santa Monica and Alfonso basins, are coincident with a change in North Pacific climate which has reduced upwelling by 20-30% and increased sea surface temperatures by 1.5-3 degrees C. This suggests that climate effects on surface productivity, reducing the supply organic matter to sediments, may have had a greater effect on benthic oxygen levels than changes in ocean circulation patterns.	Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	University of Southern California	Stott, LD (corresponding author), Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.							ALVAREZBORREGO S, 1991, MEMOIR AM ASS PETROL, V47, P555; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Berelson WM, 1996, J MAR RES, V54, P731, DOI 10.1357/0022240963213673; Biondi F, 1997, GEOPHYS RES LETT, V24, P193, DOI 10.1029/96GL03813; CHRISTENSEN CJ, 1994, MAR GEOL, V116, P399, DOI 10.1016/0025-3227(94)90054-X; DEDIEGO T, IN PRESS J FORAM RES; DOUGLAS R, 1998, ABSTR GEOL SOC AM, V30, pA55; Ebbesmeyer C. C., 1989, GEOPHYS MONOGR SER, V55, P399; GRAHAM NE, 1994, CLIM DYNAM, V10, P135, DOI 10.1007/BF00210626; JAHNKE RA, 1990, J MAR RES, V48, P413, DOI 10.1357/002224090784988773; Keigwin LD, 1990, PALEOCEANOGRAPHY, V5, P1009, DOI 10.1029/PA005i006p01009; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; LANGE CB, 1990, CLIMATIC CHANGE, V16, P319, DOI 10.1007/BF00144507; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; MCCORKLE DC, 1988, GEOCHIM COSMOCHIM AC, V52, P1169, DOI 10.1016/0016-7037(88)90270-0; NAMIAS J, 1978, MON WEATHER REV, V106, P279, DOI 10.1175/1520-0493(1978)106<0279:MCOTNA>2.0.CO;2; NAVASANCHEZ E, 1997, EOS F, V79; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; SOUTAR A, 1977, GEOL SOC AM BULL, V88, P1161, DOI 10.1130/0016-7606(1977)88<1161:SACPIT>2.0.CO;2; Stott LD, 2000, PALEOCEANOGRAPHY, V15, P161, DOI 10.1029/1999PA000375; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; VENRICK EL, 1987, SCIENCE, V238, P70, DOI 10.1126/science.238.4823.70	25	47	50	4	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					367	370		10.1038/35030084	http://dx.doi.org/10.1038/35030084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014190				2022-12-28	WOS:000089390700044
J	[Anonymous]				[Anonymous]			Bridging the Taiwan Strait	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					273	273						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014149				2022-12-28	WOS:000089390700001
J	Qian, H; Ricklefs, RE				Qian, H; Ricklefs, RE			Large-scale processes and the Asian bias in species diversity of temperate plants	NATURE			English	Article							NORTHERN HEMISPHERE; BIOGEOGRAPHY; RICHNESS; TERTIARY; AMERICA; ORIGIN	An important issue in the study of biodiversity is the extent to which global patterns of species richness reflect large-scale processes and historical contingencies(1,2). Ecological interactions in local assemblages may constrain the number of species that can coexist(3,4), but differences in diversity in similar habitats within different regions (diversity anomalies) suggest that this limit is not firm. Variation in rate of species production could influence regional and perhaps local diversity independently of the ecological capacity of an area to support coexisting species, thereby creating diversity anomalies(5,6). Temperate Zone genera of plants that are disjunct between similar environments in eastern Asia and eastern North America (EAS-ENA) have twice as many species in Asia as in North America(7). Because lineages of these genera in Asia and North America are mostly sister pairs(8), they share a common history of adaptation and ecological relationship before disjunction. Thus, the diversity anomaly in EAS-ENA genera is not an artefact of taxon or habitat sampling but reflects differences in the net diversification (speciation-extinction) of the lineages in each of the continents. Here we propose that the most probable cause of the EAS-ENA anomaly in diversity is the extreme physiographical heterogeneity of temperate eastern Asia, especially compared with eastern North America, which in conjunction with climate and sea-level change has provided abundant opportunities for evolutionary radiation through allopatric speciation.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada	University of Missouri System; University of Missouri Saint Louis; University of British Columbia	Ricklefs, RE (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.							BUSH MB, 1990, QUATERNARY RES, V34, P330, DOI 10.1016/0033-5894(90)90045-M; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Goldblatt P., 1985, MONOGRAPHS SYSTEMATI, V13; Goldblatt P, 1984, MONOGRAPHS SYSTEMATI, V8; Goldblatt P., 1981, MONOGRAPHS SYSTEMATI, V5; Graham, 2010, LATE CRETACEOUS CENO; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hill M.O., 1979, TWINSPAN FORTRAN PRO; Hong D.Y., 1993, CATHAYA, V5, P1; HOOGHIEMSTRA H, 1989, PALAEOGEOGR PALAEOCL, V72, P11, DOI 10.1016/0031-0182(89)90129-6; Kartesz J. T., 1994, SYNONYMIZED CHECKLIS; Kominz MA, 1998, GEOLOGY, V26, P311, DOI 10.1130/0091-7613(1998)026<0311:LTASTG>2.3.CO;2; Latham Roger Earl, 1993, P294; Li H. L., 1952, Transactions of the American Philosophical Society, Philadelphia, V42, P371, DOI 10.2307/1005654; LI S, 1997, SPECIES POOLS SEED P; MacArthur R.H., 1972, pvii; Mai DH., 1995, TERTI RE VEGETATIONS; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; MULLER MJ, 1982, SELECTED CLIMATE GLO; Qian H, 1999, AM NAT, V154, P160, DOI 10.1086/303230; Qian H, 1999, ANN BOT-LONDON, V83, P271, DOI 10.1006/anbo.1998.0816; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs Robert E., 1993, P215; Ricklefs Robert E., 1993, P350; Sauer J. D., 1988, PLANT MIGRATION DYNA; Schnabel A, 1998, AM J BOT, V85, P1753, DOI 10.2307/2446510; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; Wu Z. Y., 1996, FLORA CHINA, V15; Wu Z.Y., 1994, FLORA CHINA, V4; WU ZY, 1999, FLORA CHINA, V17; Xiang QY, 1998, EVOLUTION, V52, P988, DOI [10.2307/2411231, 10.1111/j.1558-5646.1998.tb01828.x]	34	483	521	10	165	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					180	182		10.1038/35025052	http://dx.doi.org/10.1038/35025052			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001054				2022-12-28	WOS:000089241000046
J	Nurse, P				Nurse, P			The incredible life and times of biological cells	SCIENCE			English	Article							DIVISION; CYCLE; YEAST		Imperial Canc Res Fund, Cell Cycle Lab, London WC2A 3PX, England	Cancer Research UK	Nurse, P (corresponding author), Imperial Canc Res Fund, Cell Cycle Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.							Alberts B., 1994, MOL BIOL CELL; Allen Garland E., 1978, LIFE SCI 20 CENTURY; Baker JR, 1988, CELL THEORY RESTATEM; Coleman W.L., 1977, BIOL 19 CENTURY PROB; DRESSLER D, 1991, DISCOVERING ENZYMES; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Harris H, 1999, BIRTH CELL; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; Howard A, 1953, HEREDITY           S, V6, P261; Kauffman S. A., 1993, ORIGINS ORDER; KORNBERG A, 1956, BIOCHIM BIOPHYS ACTA, V21, P197, DOI 10.1016/0006-3002(56)90127-5; Kornberg A., 1992, DNA REPLICATION; Lewin B., 1999, GENES; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MITCHISON JM, 1971, BIOL CELL CYCLE; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Murray A, 1993, CELL CYCLE INTRO; NOVAK B, 1995, J THEOR BIOL, V173, P283, DOI 10.1006/jtbi.1995.0063; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; SWIFT H, 1950, P NATL ACAD SCI USA, V36, P643, DOI 10.1073/pnas.36.11.643; Szathmary E, 1995, MAJOR TRANSITIONS EV; Varmus H., 1993, GENES BIOL CANC; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WILSON EB, 1987, CELL DEV HEREDITY	27	27	27	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1711	1716		10.1126/science.289.5485.1711	http://dx.doi.org/10.1126/science.289.5485.1711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	11001740				2022-12-28	WOS:000089195200037
J	Beaglehole, R; Bonita, R				Beaglehole, R; Bonita, R			Reinvigorating public health	LANCET			English	Editorial Material									Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Auckland 1, New Zealand; WHO, Noncummunicable Dis & Mental Hlth Cluster, CH-1211 Geneva, Switzerland	University of Auckland; World Health Organization	Beaglehole, R (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Auckland 1, New Zealand.							[Anonymous], 1998, INDEPENDENT INQUIRY; Beaglehole R, 1997, PUBLIC HLTH CROSSROA; Bettcher Douglas W., 1998, World Health Statistics Quarterly, V51, P44; DELEEUW E, 1995, LANCET, V345, P1158, DOI 10.1016/S0140-6736(95)90983-4; Gepkens A., 1996, European Journal of Public Health, V6, P218, DOI 10.1093/eurpub/6.3.218; Jamison DT, 1998, LANCET, V351, P514, DOI 10.1016/S0140-6736(97)11451-9; LEE K, 2000, GLOBALISATION HLTH P; Macfarlane S, 2000, LANCET, V356, P841, DOI 10.1016/S0140-6736(00)02664-7; McKee M, 2000, LANCET, V356, P665, DOI 10.1016/S0140-6736(00)02616-7; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; McMichael AJ, 2000, LANCET, V356, P495, DOI 10.1016/S0140-6736(00)02564-2; Pearce N, 1996, AM J PUBLIC HEALTH, V86, P678, DOI 10.2105/AJPH.86.5.678; RAEBURN J, 1997, PEOPLE CTR HLTH PROM; Sen K, 2000, LANCET, V356, P577, DOI 10.1016/S0140-6736(00)02590-3; Wolfensohn James D., 1998, OTHER CRISIS; World Health Organization, 1999, WORLD HLTH REPORT 19	16	13	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2000	356	9232					787	788		10.1016/S0140-6736(00)02651-9	http://dx.doi.org/10.1016/S0140-6736(00)02651-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022924				2022-12-28	WOS:000089101800007
J	McColl, A; Roland, M				McColl, A; Roland, M			Clinical governance in primary care - Knowledge and information for clinical governance	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH NEEDS ASSESSMENT; PERFORMANCE INDICATORS; GENERAL-PRACTICE; OUTCOMES; QUALITY; PATIENT		Woolpit Hlth Ctr, Bury St Edmunds IP30 9QU, Suffolk, England; Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England	University of Manchester	McColl, A (corresponding author), Woolpit Hlth Ctr, Bury St Edmunds IP30 9QU, Suffolk, England.	a.mccoll@ukgateway.net						[Anonymous], 1998, INDEPENDENT INQUIRY; Caldicott Committee Department of Health, 1997, REP REV PAT ID INF; *DAT STAND TEAM IM, 1997, DAT ADM GOOD PRACT G; *DEP HLTH, 1997, REV CONT PROF DEV GE; Giuffrida A, 1999, BRIT MED J, V319, P94, DOI 10.1136/bmj.319.7202.94; Gray JAM, 1999, BRIT MED J, V319, P1476, DOI 10.1136/bmj.319.7223.1476; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Huntington J, 2000, BRIT MED J, V321, P679, DOI 10.1136/bmj.321.7262.679; *IMPL CLIN GUID, 1994, EFFECTIVE HLTH CARE, V1; McColl A, 2000, QUAL HEALTH CARE, V9, P90, DOI 10.1136/qhc.9.2.90; McColl A, 1998, BMJ-BRIT MED J, V317, P1354, DOI 10.1136/bmj.317.7169.1354; McColl A, 1998, BRIT MED J, V316, P361, DOI 10.1136/bmj.316.7128.361; MURRAY SA, 1995, BRIT MED J, V310, P1443, DOI 10.1136/bmj.310.6992.1443; Newrick DC, 1996, BMJ-BRIT MED J, V312, P33, DOI 10.1136/bmj.312.7022.33; *NHS, 1999, GETT EV PRACT; *NHS EX, 2000, INF HLTH INF STRAT M; *NHS EX, 2000, BEAC SERV PART NHS L; *NHS EX, 2000, PAT PUBL INV NEW NHS; *NHS EX, 2000, CALD GUARD NHS; Pringle M, 2000, BRIT MED J, V321, P737, DOI 10.1136/bmj.321.7263.737; Pringle M, 1998, BMJ-BRIT MED J, V317, P1120; ROLAND M, 1998, QUALITY ASSESSMENT G; ROLAND M, 2000, CLIN GOVERNANCE PRAC; Sackett D. L., 1997, EVIDENCE BASED MED P; STEVENS A, 1997, HLTH CARE NEEDS ASSE; Wilkinson JR, 1998, BRIT MED J, V316, P1524, DOI 10.1136/bmj.316.7143.1524; 2000, COLLECTION HLTH DATA	27	20	21	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2000	321	7265					871	874		10.1136/bmj.321.7265.871	http://dx.doi.org/10.1136/bmj.321.7265.871			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021867	Bronze			2022-12-28	WOS:000089857500024
J	McDonagh, MS; Whiting, PF; Wilson, PM; Sutton, AJ; Chestnutt, I; Cooper, J; Misso, K; Bradley, M; Treasure, E; Kleijnen, J				McDonagh, MS; Whiting, PF; Wilson, PM; Sutton, AJ; Chestnutt, I; Cooper, J; Misso, K; Bradley, M; Treasure, E; Kleijnen, J			Systematic review of water fluoridation	BRITISH MEDICAL JOURNAL			English	Review								Objective To review the safety and efficacy of fluoridation of drinking water. Design Search of 25 electronic databases and world wide web. Relevant journals hand searched; further information requested from authors. Inclusion criteria were a predefined hierarchy of evidence and objectives. Study validity was assessed with checklists. Two reviewers independently screened sources, extracted data, and assessed validity. Main outcome measures Decayed, missing, and filled primary/permanent teeth. Proportion of children without caries. Measure of effect was the difference in change in prevalence of caries from baseline to final examination in fluoridated compared with control areas. For potential adverse effects, all outcomes reported were used. Results 214 studies were included. The quality of studies was low to moderate. Water fluoridation was associated with an increased proportion of children without caries and a reduction in the number of teeth affected by caries. The range (median) of mean differences in the proportion of children without caries was -5.0% to 64% (14.6%). The range (median) of mean change in decayed, missing, and filled primary/permanent teeth was 0.5 to 4.4 (2.25) teeth. A dose-dependent increase in dental fluorosis was found. At a fluoride level of 1 ppm an estimated 12.5% (95% confidence interval 7.0% to 21.5%) of exposed people would have fluorosis that they would find aesthetically concerning. Conclusions The evidence of a beneficial reduction in caries should be considered together with the increased prevalence of dental fluorosis. There was no clear evidence of other potential adverse effects.	Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Univ York, NHS Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; Univ Wales Coll Med, Sch Dent, Dent Publ Hlth Unit, Cardiff CF14 4XY, S Glam, Wales	University of Leicester; University of York - UK; Cardiff University	McDonagh, MS (corresponding author), Univ York, NHS Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.		Misso, Kate/D-2060-2016	Misso, Kate/0000-0002-4924-4327; Sutton, Alexander/0000-0002-8934-9940; Whiting, Penny/0000-0003-1138-5682				DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; *NHS CRD, 1996, 4 NHS CRD U YORK NH; *NHS CRD, 2000, 18 NHS CRD U YORK NH; *SECR STAT HLTH, 1999, SAV LIV OUR HLTH NAT; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V	6	345	365	1	172	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					855	859		10.1136/bmj.321.7265.855	http://dx.doi.org/10.1136/bmj.321.7265.855			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021861	Green Published, Bronze			2022-12-28	WOS:000089857500019
J	Lallemant, M; Jourdain, G; Le Coeur, S; Kim, S; Koetsawang, S; Comeau, AM; Phoolcharoen, W; Essex, M; McIntosh, K; Vithayasai, V				Lallemant, M; Jourdain, G; Le Coeur, S; Kim, S; Koetsawang, S; Comeau, AM; Phoolcharoen, W; Essex, M; McIntosh, K; Vithayasai, V		Perinatal HIV Prevention Trial Tha	A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; INFANT; HIV-1	Background: The optimal duration of zidovudine administration to prevent perinatal transmission of human immunodeficiency virus type 1 (HIV-1) should be determined to facilitate its use in areas where resources are limited. Methods: We conducted a randomized, double-blind equivalence trial of four regimens of zidovudine starting in the mother at 28 weeks' gestation, with 6 weeks of treatment in the infant (the long-long regimen), which is similar to protocol 076; zidovudine starting at 35 weeks' gestation, with 3 days of treatment in the infant (the short-short regimen); a long-short regimen; and a short-long regimen. The mothers received zidovudine orally during labor. The infants were fed formula and were tested for HIV DNA at 1, 45, 120, and 180 days. After the first interim analysis, the short-short regimen was stopped. Results: A total of 1437 women were enrolled. At the first interim analysis, the rates of HIV transmission were 4.1 percent for the long-long regimen and 10.5 percent for the short-short regimen (P=0.004); at this point the short-short regimen was stopped. For the entire study period, the transmission rates were 6.5 percent (95 percent confidence interval, 4.1 to 8.9 percent) for the long-long regimen, 4.7 percent (95 percent confidence interval, 2.4 to 7.0 percent) for the long-short regimen, and 8.6 percent (95 percent confidence interval, 5.6 to 11.6 percent) for the short-long regimen. The rate of in utero transmission was significantly higher with the two regimens with shorter maternal treatment (5.1 percent) than with the two with longer maternal treatment (1.6 percent). Conclusions: The short-short zidovudine regimen is inferior to the long-long regimen and leads to a higher rate of perinatal HIV transmission. The long-short, short-long, and long-long regimens had equivalent efficacy. However, the higher rate of in utero transmission with the short-long regimen suggests that longer treatment of the infant cannot substitute for longer treatment of the mother. (N Engl J Med 2000;343:982-91.) (C) 2000, Massachusetts Medical Society.	Inst Rech Dev, Epidemiol Clin, Paris, France; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Inst Natl Etud Demog, Paris, France; Mahidol Univ, Family Hlth Res Ctr, Bangkok 10700, Thailand; Univ Massachusetts, Sch Med, New England Newborn Screening Program, Boston, MA 02125 USA; Minist Publ Hlth, Bangkok, Thailand; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Chiang Mai Univ, Sch Med, Dept Microbiol, Chiang Mai 50000, Thailand	Institut de Recherche pour le Developpement (IRD); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Mahidol University; University of Massachusetts System; University of Massachusetts Boston; Ministry of Public Health - Thailand; Harvard University; Harvard Medical School; Chiang Mai University	Lallemant, M (corresponding author), PHPT, 57-2 Faham Rd,Soi 3, Muang Chiang Mai 50000, Thailand.		Jourdain, Gonzague/F-9117-2017	Jourdain, Gonzague/0000-0002-3365-7020	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033326] Funding Source: NIH RePORTER; NICHD NIH HHS [5 R01 HD 33326] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; International Conference on Harmonisation, 1997, FED REGISTER, V62, P25691; JOURDAIN G, 2000, 7 C RETR OPP INF SAN; Kalish LA, 1997, J INFECT DIS, V175, P712, DOI 10.1093/infdis/175.3.712; KHONGPHATTHANAY. M, 1999, 2 C GLOB STRAT PREV; LALLEMANT M, 1999, 2 C GLOB STRAT PREV; MAKUCH R, 1978, CANCER TREAT REP, V62, P1037; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Stiehm ER, 1999, J INFECT DIS, V179, P567, DOI 10.1086/314637; Thaineua Vallop, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P429; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001	16	268	283	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					982	991		10.1056/NEJM200010053431401	http://dx.doi.org/10.1056/NEJM200010053431401			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018164	Bronze			2022-12-28	WOS:000089619900001
J	Geiger, J; Hutchinson, R; Hohenkirk, L; McKenna, E; Chang, A; Mule, J				Geiger, J; Hutchinson, R; Hohenkirk, L; McKenna, E; Chang, A; Mule, J			Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells	LANCET			English	Article							IN-VITRO; T-CELLS; MATURE; BLOOD	Dendritic cells are potent stimulators of antigen-specific immune responses, including antitumour responses. We explored the use of tumour-lysate-pulsed dendritic cells in children with relapsed solid tumours. Dendritic cell treatment in children was feasible and apparently not toxic. The treatment was able to produce significant tumour regression in a child with metatstatic fibrosarcoma.	Univ Michigan, Sch Med, Dept Surg, Pediat Surg Sect, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Geiger, J (corresponding author), Univ Michigan, Sch Med, Dept Surg, Pediat Surg Sect, Ann Arbor, MI 48109 USA.	jgeiger@umich.edu			NCI NIH HHS [T32-CA-09672, 1-R29-CA-77471-01, 5PO1 CA 59327] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA077471, T32CA009672, P01CA059327] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen BG, 1998, BLOOD, V91, P4652, DOI 10.1182/blood.V91.12.4652.412a03_4652_4661; Fields RC, 1998, P NATL ACAD SCI USA, V95, P9482, DOI 10.1073/pnas.95.16.9482; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Schuler G, 1997, ADV EXP MED BIOL, V417, P7; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669	5	87	94	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2000	356	9236					1163	1165		10.1016/S0140-6736(00)02762-8	http://dx.doi.org/10.1016/S0140-6736(00)02762-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030299				2022-12-28	WOS:000089594300017
J	Josefson, D				Josefson, D			Mammography is no better than physical examination, study shows	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					785	785		10.1136/bmj.321.7264.785	http://dx.doi.org/10.1136/bmj.321.7264.785			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009507	Green Published			2022-12-28	WOS:000089696600012
J	O'Toole, T; Inglesby, TV				O'Toole, T; Inglesby, TV			Facing the biological weapons threat	LANCET			English	Editorial Material									Johns Hopkins Univ, Johns Hopkins Ctr Civilian Biodef Studies, Baltimore, MD 21202 USA	Johns Hopkins University	O'Toole, T (corresponding author), Johns Hopkins Univ, Johns Hopkins Ctr Civilian Biodef Studies, Baltimore, MD 21202 USA.							ERVIN FR, 1962, NEW ENGL J MED, V266, P1127, DOI 10.1056/NEJM196205312662204; Fenner F., 1988, SMALLPOX ITS ERADICA, P1460; *OFF TECHN ASS, 1993, OTAISC559, P53; TURNER S, 1999, CAGING GENIES WORKAB, P46; WHO Group of Consultants, 1970, HLTH ASP CHEM BIOL W, P98; WUDUNN S, 1998, NY TIMES        0526, P1; WUDUNN S, 1998, NY TIMES        0526, P6	7	7	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1128	1129		10.1016/S0140-6736(00)02751-3	http://dx.doi.org/10.1016/S0140-6736(00)02751-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030289				2022-12-28	WOS:000089594300006
J	Balsalobre, A; Brown, SA; Marcacci, L; Tronche, F; Kellendonk, C; Reichardt, HM; Schutz, G; Schibler, U				Balsalobre, A; Brown, SA; Marcacci, L; Tronche, F; Kellendonk, C; Reichardt, HM; Schutz, G; Schibler, U			Resetting of circadian time peripheral tissues by glucocorticoid signaling	SCIENCE			English	Article							DROSOPHILA CLOCK; GENE-EXPRESSION; CRYPTOCHROME; ONTOGENY; RECEPTOR; CULTURE; RHYTHMS; BRAIN	In mammals, circadian oscillators reside not only in the suprachiasmatic nucleus of the brain, which harbors the central pacemaker, but also in most peripheral tissues. Here, we show that the glucocorticoid hormone analog dexamethasone induces circadian gene expression in cultured rat-1 fibroblasts and transiently changes the phase of circadian gene expression in liver, kidney, and heart. However, dexamethasone does not affect cyclic gene expression in neurons of the suprachiasmatic nucleus. This enabled us to establish an apparent phase-shift response curve specifically for peripheral clocks in intact animals. In contrast to the central clock, circadian oscillators in peripheral tissues appear to remain responsive to phase resetting throughout the day.	Univ Geneva, Dept Biol Mol Sci 2, CH-1211 Geneva, Switzerland; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany	University of Geneva; Helmholtz Association; German Cancer Research Center (DKFZ)	Schibler, U (corresponding author), Univ Geneva, Dept Biol Mol Sci 2, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.		Kellendonk, Christoph/O-7229-2018; TRONCHE, François/F-3895-2011; Brown, Steven/E-4955-2013; Jansen, Heiko T./A-5770-2008; Reichardt, Holger/AAF-3048-2020	Kellendonk, Christoph/0000-0003-3302-2188; Jansen, Heiko T./0000-0003-0178-396X; Reichardt, Holger/0000-0003-4647-057X				Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Brown SA, 1999, CURR OPIN GENET DEV, V9, P588, DOI 10.1016/S0959-437X(99)00009-X; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery IF, 1997, P NATL ACAD SCI USA, V94, P4092, DOI 10.1073/pnas.94.8.4092; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; HASTINGS MH, 1997, CURR BIOL, V7, P670; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; LEMINH N, UNPUB; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; ROSENFELD P, 1988, DEV BRAIN RES, V42, P119, DOI 10.1016/0165-3806(88)90207-6; ROSENFELD P, 1993, CELL MOL NEUROBIOL, V13, P295, DOI 10.1007/BF00711575; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; White R, 1998, ENDOCR-RELAT CANCER, V5, P1, DOI 10.1677/erc.0.0050001; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	21	1292	1328	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2344	2347		10.1126/science.289.5488.2344	http://dx.doi.org/10.1126/science.289.5488.2344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009419				2022-12-28	WOS:000089593500051
J	Gomez, JL; Marscher, AP; Alberdi, A; Jorstad, SG; Garcia-Miro, C				Gomez, JL; Marscher, AP; Alberdi, A; Jorstad, SG; Garcia-Miro, C			Flashing superluminal components in the jet of the radio galaxy 3C120	SCIENCE			English	Article							MAGNETIC-FIELDS; SCALE STRUCTURE; BLACK-HOLE; 3C-120; M87	A 16-month sequence of radio images of the active galaxy 3C120 with the Very Long Baseline Array reveals a region in the relativistic jet where superluminal components flash on and off over time scales of months, while the polarization angle rotates. This can be explained by interaction between the jet and an interstellar cloud Located about 8 parsecs from the center of the galaxy. The cloud, which rotates the polarization direction and possibly eclipses a section of the jet, represents a "missing link" between the ultradense broad-emission-line clouds closer to the center and the Lower density narrow-emission-line clouds seen on kiloparsec scales.	CSIC, Inst Astrofis Andalucia, Granada 18080, Spain; Boston Univ, Inst Astrophys Res, Boston, MA 02215 USA; St Petersburg State Univ, Inst Astron, St Petersburg 198904, Russia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Boston University; Institute of Astronomy of the Russian Academy of Sciences; Saint Petersburg State University	Gomez, JL (corresponding author), CSIC, Inst Astrofis Andalucia, Apartado 3004, Granada 18080, Spain.	jlgomez@iaa.es	Jorstad, Svetlana G/H-6913-2013; Jorstad, Svetlana/AAM-3279-2021; Gómez, José L/C-4195-2008	Jorstad, Svetlana G/0000-0001-9522-5453; Jorstad, Svetlana/0000-0001-6158-1708; Gómez, José L/0000-0003-4190-7613				ALBERDI A, 1993, ASTROPHYS J, V402, P160, DOI 10.1086/172119; Aloy MA, 2000, ASTROPHYS J, V528, pL85, DOI 10.1086/312436; AXON DJ, 1989, NATURE, V341, P631, DOI 10.1038/341631a0; Bicknell GV, 1996, ASTROPHYS J, V467, P597, DOI 10.1086/177636; BURBIDGE EM, 1967, ASTROPHYS J, V149, pL51, DOI 10.1086/180054; GOMEZ JL, 1994, ASTRON ASTROPHYS, V292, P33; Gomez JL, 1999, ASTROPHYS J, V521, pL29, DOI 10.1086/312170; Gomez JL, 1998, ASTROPHYS J, V499, P221, DOI 10.1086/305644; Gomez JL, 1997, ASTROPHYS J, V482, pL33, DOI 10.1086/310671; HUA CT, 1988, ASTRON ASTROPHYS, V199, P105; ICKE V, 1991, BEAMS JETS ASTROPHYS, P238; Junor W, 1999, NATURE, V401, P891, DOI 10.1038/44780; Kellermann KI, 1998, ASTRON J, V115, P1295, DOI 10.1086/300308; Koide S, 1999, ASTROPHYS J, V522, P727, DOI 10.1086/307667; LEPPANEN KJ, 1995, ASTRON J, V110, P2479, DOI 10.1086/117706; MARSCHER AP, 1975, ASTROPHYS J, V200, P719, DOI 10.1086/153843; NETZER H, 1989, IAU SYMP, V134, P69; Ouyed R, 1997, NATURE, V385, P409, DOI 10.1038/385409a0; SEIELSTAD GA, 1979, ASTROPHYS J, V229, P53, DOI 10.1086/156929; Taylor GB, 1998, ASTROPHYS J, V506, P637, DOI 10.1086/306286; TERASRANTA H, COMMUNICATION; Tingay SJ, 1998, ASTRON J, V115, P960, DOI 10.1086/300257; Udomprasert PS, 1997, ASTROPHYS J, V483, pL9, DOI 10.1086/310725; WALKER RC, 1987, ASTROPHYS J, V316, P546, DOI 10.1086/165225	24	79	79	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2000	289	5488					2317	2320		10.1126/science.289.5488.2317	http://dx.doi.org/10.1126/science.289.5488.2317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009410				2022-12-28	WOS:000089593500042
J	Tamai, K; Semenov, M; Kato, Y; Spokony, R; Liu, CM; Katsuyama, Y; Hess, F; Saint-Jeannet, JP; He, X				Tamai, K; Semenov, M; Kato, Y; Spokony, R; Liu, CM; Katsuyama, Y; Hess, F; Saint-Jeannet, JP; He, X			LDL-receptor-related proteins in Wnt signal transduction	NATURE			English	Article							NEURAL CREST; MOLECULAR-CLONING; AXIS FORMATION; BETA-CATENIN; WINGLESS; FAMILY; PATHWAY; MEMBER; REQUIREMENTS; INDUCTION	The Wnt family of secreted signalling molecules are essential in embryo development and tumour formation(1). The Frizzled (Fz) family of serpentine receptors function as Wnt receptors(2-10), but how Fz proteins transduce signalling is not understood. In Drosophila, arrow phenocopies the wingless (DWnt-1) phenotype(11), and encodes a transmembrane protein(11) that is homologous to two members of the mammalian low-density lipoprotein receptor (LDLR)-related protein (LRP) family, LRP5 and LRP6 (refs 12-15). Here we report that LRP6 functions as a co-receptor for Wnt signal transduction. In Xenopus embryos, LRP6 activated Wnt-Fz signalling, and induced Wnt responsive genes, dorsal axis duplication and neural crest formation. An LRP6 mutant lacking the carboxyl intracellular domain blocked signalling by Wnt or Wnt-Fz, but not by Dishevelled or beta-catenin, and inhibited neural crest development. The extracellular domain of LRP6 bound Wnt-1 and associated with Fz in a Wnt-dependent manner. Our results indicate that LRP6 may be a component of the Wnt receptor complex.	Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol,Div Neurosci, Boston, MA 02115 USA; Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Merck Res Labs, Dept Human Genet, West Point, PA 19486 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Pennsylvania; Merck & Company	He, X (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol,Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	he_x@hub.tch.harvard.edu	Spokony, Rebecca/AAD-3014-2020					Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Brown SP, 1998, J AGING PHYS ACTIV, V6, P248, DOI 10.1123/japa.6.3.248; Chan TYK, 1998, PHARMACOEPIDEM DR S, V7, P129, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<129::AID-PDS326>3.0.CO;2-#; Chen CM, 1999, DEVELOPMENT, V126, P5441; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Kato Y, 1999, J NEUROSCI, V19, P9364; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Muller HAJ, 1999, DEVELOPMENT, V126, P577; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	30	1040	1111	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					530	535		10.1038/35035117	http://dx.doi.org/10.1038/35035117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029007				2022-12-28	WOS:000089727400055
J	Andersen, P; Munk, ME; Pollock, JM; Doherty, TM				Andersen, P; Munk, ME; Pollock, JM; Doherty, TM			Specific immune-based diagnosis of tuberculosis	LANCET			English	Review							MYCOBACTERIUM-BOVIS BCG; T-CELL RESPONSES; IMMUNODEFICIENCY-VIRUS INFECTION; DELAYED-TYPE HYPERSENSITIVITY; INTERFERON-GAMMA ASSAY; SKIN-TEST; AVIUM COMPLEX; GUINEA-PIG; MONOCLONAL-ANTIBODIES; COMPARATIVE GENOMICS	Current diagnostic tests for tuberculosis based on tuberculin have poor specificity, and both sos vaccination and exposure to non-tuberculosis mycobacteria produce a response similar to that induced by infection with Mycobacterium tuberculosis, The identification of regions of the M tuberculosis genome that are not present in BCG and non-tuberculous mycobacteria provides a unique opportunity to develop new highly specific diagnostic reagents. We describe the current status of attempts to exploit this information and summarise recent research that has used defined antigens for an accurate and rapid test for tuberculosis infection based on the detection of T cells sensitised to M tuberculosis either by blood tests in vitro or skin tests in vivo.	Statens Serum Inst, Dept TB Immunol, DK-2300 Copenhagen, Denmark; Dept Agr No Ireland, Vet Sci Div, Belfast BT9 5PX, Antrim, North Ireland	Statens Serum Institut; Agri-Food & Biosciences Institute	Andersen, P (corresponding author), Statens Serum Inst, Dept TB Immunol, DK-2300 Copenhagen, Denmark.	pa@ssi.dk		Andersen, Peter/0000-0002-5869-2551				ANDERSEN AB, 1986, J CLIN MICROBIOL, V23, P446, DOI 10.1128/JCM.23.3.446-451.1986; Andersen Ase Bengard, 1994, P307; ANDERSEN P, 1994, INFECT IMMUN, V62, P2536, DOI 10.1128/IAI.62.6.2536-2544.1994; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Arend SM, 2000, J INFECT DIS, V181, P1850, DOI 10.1086/315448; Baldwin SL, 1998, INFECT IMMUN, V66, P2951, DOI 10.1128/IAI.66.6.2951-2959.1998; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Bergmann JS, 1996, J CLIN MICROBIOL, V34, P1083, DOI 10.1128/JCM.34.5.1083-1085.1996; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Bosman MCJ, 1998, INT J TUBERC LUNG D, V2, P272; Brosch R, 1998, INFECT IMMUN, V66, P2221, DOI 10.1128/IAI.66.5.2221-2229.1998; Buddle BM, 1999, CLIN DIAGN LAB IMMUN, V6, P1; CARPENTIER E, 1995, J CLIN MICROBIOL, V33, P3106, DOI 10.1128/JCM.33.12.3106-3110.1995; CHAPARAS SD, 1970, AM REV RESPIR DIS, V101, P74; COATES ARM, 1981, LANCET, V2, P167; Converse PJ, 1997, J INFECT DIS, V176, P144, DOI 10.1086/514016; DABORN CJ, 1993, BRIT VET J, V149, P405, DOI 10.1016/S0007-1935(05)80107-1; DANIEL TM, 1996, TUBERCULOSIS, P223; EDWARDS LB, 1969, AM REV RESPIR DIS, V99, P1; Elhay MJ, 1998, INFECT IMMUN, V66, P3454, DOI 10.1128/IAI.66.7.3454-3456.1998; FELTEN MK, 1989, AM REV RESPIR DIS, V140, P1001, DOI 10.1164/ajrccm/140.4.1001; FINE PEM, 1994, LANCET, V344, P1245, DOI 10.1016/S0140-6736(94)90748-X; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; GREENBERG PD, 1991, AM REV RESPIR DIS, V143, P490, DOI 10.1164/ajrccm/143.3.490; HARBOE M, 1986, INFECT IMMUN, V52, P293, DOI 10.1128/IAI.52.1.293-302.1986; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; HASLOV K, 1995, INFECT IMMUN, V63, P804; HOROWITZ HW, 1995, AM J INFECT CONTROL, V23, P181, DOI 10.1016/0196-6553(95)90039-X; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Johnson PDR, 1999, CLIN DIAGN LAB IMMUN, V6, P934, DOI 10.1128/CDLI.6.6.934-937.1999; Krebs J., 1997, PB3423 HMSO; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Lein AD, 1999, CLIN DIAGN LAB IMMUN, V6, P606, DOI 10.1128/CDLI.6.4.606-609.1999; LI HY, 1993, INFECT IMMUN, V61, P1730, DOI 10.1128/IAI.61.5.1730-1734.1993; LIND A, 1991, TUBERCLE, V72, P29, DOI 10.1016/0041-3879(91)90021-J; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; Lyashchenko K, 1998, INFECT IMMUN, V66, P3606, DOI 10.1128/IAI.66.8.3606-3610.1998; MAGNUSSON M, 1986, EUR J RESPIR DIS, V69, P129; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Moda G, 1996, TUBERCLE LUNG DIS, V77, P103, DOI 10.1016/S0962-8479(96)90022-2; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; Mustafa AS, 1998, SCAND J IMMUNOL, V48, P535; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; Nakamura RM, 1998, INT J TUBERC LUNG D, V2, P541; NOORDHOEK GT, 1994, J CLIN MICROBIOL, V32, P277, DOI 10.1128/JCM.32.2.277-284.1994; Pollock JM, 1997, J INFECT DIS, V175, P1251, DOI 10.1086/593686; Pottumarthy S, 1999, J CLIN MICROBIOL, V37, P3229, DOI 10.1128/JCM.37.10.3229-3232.1999; Rajalahti I, 1998, J CLIN MICROBIOL, V36, P975, DOI 10.1128/JCM.36.4.975-978.1998; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; SALFINGER M, 1994, EUR J CLIN MICROBIOL, V13, P961, DOI 10.1007/BF02111498; Serwint JR, 1997, PEDIATRICS, V99, P529, DOI 10.1542/peds.99.4.529; SKJOT RLV, IN PRESS COMP EVALUA; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; SNIDER DE, 1982, AM REV RESPIR DIS, V125, P108; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Streeton JA, 1998, INT J TUBERC LUNG D, V2, P443; TUBOLY S, 1976, ACTA MICROBIOL HUNG, V23, P23; TURCOTTE R, 1975, CAN J MICROBIOL, V21, P774, DOI 10.1139/m75-115; Ulrichs T, 1998, EUR J IMMUNOL, V28, P3949, DOI 10.1002/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.0.CO;2-4; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000; von Reyn CF, 1998, J INFECT DIS, V177, P730, DOI 10.1086/514225; VONREYN CF, 1994, CLIN INFECT DIS, V19, P15, DOI 10.1093/clinids/19.1.15; Vordermeier HM, 1999, CLIN DIAGN LAB IMMUN, V6, P675, DOI 10.1128/CDLI.6.5.675-682.1999; *WHO, 1999, WORLD HLTH REP MAK D, P110; Wilcke JTR, 1996, TUBERCLE LUNG DIS, V77, P250, DOI 10.1016/S0962-8479(96)90009-X; WOOD PR, 1990, RES VET SCI, V49, P46, DOI 10.1016/S0034-5288(18)31044-0; WOOD PR, 1991, AUST VET J, V68, P286, DOI 10.1111/j.1751-0813.1991.tb03254.x; WORSAAE A, 1987, INFECT IMMUN, V55, P2922, DOI 10.1128/IAI.55.12.2922-2927.1987; WORSAAE A, 1988, J CLIN MICROBIOL, V26, P2608, DOI 10.1128/JCM.26.12.2608-2614.1988; [No title captured]	72	690	745	1	59	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2000	356	9235					1099	1104		10.1016/S0140-6736(00)02742-2	http://dx.doi.org/10.1016/S0140-6736(00)02742-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009160				2022-12-28	WOS:000089430500040
J	Torlesse, H; Hodges, M				Torlesse, H; Hodges, M			Anthelminthic treatment and haemoglobin concentrations during pregnancy	LANCET			English	Article								A longitudinal study was conducted in Sierra Leone to measure the impact of a single dose anthelminthic (400 mg albendazole) and daily iron-folate supplements (36 g iron and 5 mg folate) on haemoglobin (HG) concentration during pregnancy. After controlling for baseline Hb concentration and season, the mean benefit of anthelmintic treatment, relative to the control, on the change in haemoglobin concentration between baseline and the third trimester was 6.6 g/L Hb (p=0.0034). The corresponding value for iron-folate supplements was 13.7 g/L Hb (p<0.0001). These findings indicate that anthelminthic treatment should be included in strategies to control maternal anaemia in Sierra Leone.	St Andrews Clin Children, Freetown, Sierra Leone; Univ Glasgow, WHO Collaborating Ctr Soil Transmitted Helminthia, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Hodges, M (corresponding author), St Andrews Clin Children, Freetown, Sierra Leone.							de Silva NR, 1999, LANCET, V353, P1145, DOI 10.1016/S0140-6736(98)06308-9; FLEMING AF, 1989, T ROY SOC TROP MED H, V83, P441, DOI 10.1016/0035-9203(89)90241-1; Pawlowski ZS, 1991, HOOKWORM INFECT ANAE; Santiso R, 1997, INT J GYNECOL OBSTET, V58, P129, DOI 10.1016/S0020-7292(97)02865-8; *WHO, 1996, WHOCTDSIP961	5	44	46	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1083	1083		10.1016/S0140-6736(00)02738-0	http://dx.doi.org/10.1016/S0140-6736(00)02738-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009150				2022-12-28	WOS:000089430500019
J	Chen, GZ; Fray, DJ; Farthing, TW				Chen, GZ; Fray, DJ; Farthing, TW			Direct electrochemical reduction of titanium dioxide to titanium in molten calcium chloride	NATURE			English	Article							COST TITANIUM; POWDERS	Many reactive metals are difficult to prepare in pure form without complicated and expensive procedures(1-18). Although titanium has many desirable properties (it is light, strong and corrosion-resistant(1)), its use has been restricted because of its high processing cost. In the current pyrometallurgical process-the Kroll process(4,5)-the titanium minerals rutile and ilmenite are carbochlorinated to remove oxygen, iron and other impurities, producing a TiCl4 vapour. This is then reduced to titanium metal by magnesium metal; the by-product MgCl2 is removed by vacuum distillation. The prediction that this process would be replaced by an electrochemical route(6-10) has not been fulfilled; attempts involving the electro-deposition of titanium from ionic solutions have been hampered by difficulties in eliminating the redox cycling of multivalent titanium ions and in handling very reactive dendritic products(6-10). Here we report an electrochemical method for the direct reduction of solid TiO2, in which the oxygen is ionized, dissolved in a molten salt and discharged at the anode, leaving pure titanium at the cathode. The simplicity and rapidity of this process compared to conventional routes should result in reduced production costs and the approach should be applicable to a wide range of metal oxides.	Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge	Fray, DJ (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.	djf25@hermes.cam.ac.uk	Chen, George Zheng/A-4577-2009	Chen, George Zheng/0000-0002-5589-5767				BOGHOSIAN S, 1991, ACTA CHEM SCAND, V45, P145, DOI 10.3891/acta.chem.scand.45-0145; COBEL G, 1980, TITANIUM 80 SCI TECH; Elliott GRB, 1998, JOM-J MIN MET MAT S, V50, P48, DOI 10.1007/s11837-998-0415-2; Froes FH, 1998, JOM-J MIN MET MAT S, V50, P41, DOI 10.1007/s11837-998-0413-4; Froes FH, 1998, JOM-J MIN MET MAT S, V50, P15, DOI 10.1007/s11837-998-0407-2; GINETTA MV, 1983, Patent No. 4400247; GRUBER H, 1982, PHYS STATUS SOLIDI A, V69, P287, DOI 10.1002/pssa.2210690128; Habashi F., 1997, HDB EXTRACTIVE METAL, P1129; Hartman AD, 1998, JOM-J MIN MET MAT S, V50, P16, DOI 10.1007/s11837-998-0408-1; IKESHIMA T, 1985, TITANIUM SCI TECHNOL, P3; Kroll W., 1940, T ELECTROCHEM SOC, V78, P35, DOI [DOI 10.1149/1.3071290, 10.1149/1.3071290]; Larson HR, 1998, JOM-J MIN MET MAT S, V50, P56, DOI 10.1007/s11837-998-0418-z; MASSALSKI TB, 1990, BINARY ALLOY PHASE D, V3, P2924; MCKEE DW, 1982, CARBON, V20, P59, DOI 10.1016/0008-6223(82)90075-6; MCQUILLAN AD, 1956, TITANIUM, P402; Okabe T, 1998, JOM-J MIN MET MAT S, V50, P24, DOI 10.1007/s11837-998-0410-7; OKABE TH, 1992, METALL TRANS B, V23, P583, DOI 10.1007/BF02649718; OKABE TH, 1996, J ALLOY COMPD, V237, P841; OPIE WR, 1960, T AM I MIN MET ENG, V218, P646; SADOWAY DR, 1991, REFRACTORY METALS EX; Segall AE, 1998, JOM-J MIN MET MAT S, V50, P52, DOI 10.1007/s11837-998-0417-0; Sohn HY, 1998, JOM-J MIN MET MAT S, V50, P50, DOI 10.1007/s11837-998-0416-1; Suzuki K, 1998, JOM-J MIN MET MAT S, V50, P20, DOI 10.1007/s11837-998-0409-0; Tapphorn RM, 1998, JOM-J MIN MET MAT S, V50, P45, DOI 10.1007/s11837-998-0414-3	24	1174	1318	23	503	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					361	364		10.1038/35030069	http://dx.doi.org/10.1038/35030069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014188				2022-12-28	WOS:000089390700042
J	Abrieu, A; Kahana, JA; Wood, KW; Cleveland, DW				Abrieu, A; Kahana, JA; Wood, KW; Cleveland, DW			CENP-E as an essential component of the mitotic checkpoint in vitro	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; CYCLOSOME/ANAPHASE-PROMOTING COMPLEX; XENOPUS EGG EXTRACTS; SACCHAROMYCES-CEREVISIAE; UNATTACHED KINETOCHORES; PROTEIN MAD2; CHROMOSOME ALIGNMENT; ANAPHASE INITIATION; BUDDING YEAST; MAP KINASE	Accurate chromatid separation is monitored by a checkpoint mechanism that delays anaphase onset until all centromeres are correctly attached to the mitotic spindle. Using Xenopus egg extracts, the kinetochore-associated microtubule motor protein CENP-E is now found to be required for establishing and maintaining this checkpoint. When CENP-E function is disrupted by immunodepletion or antibody addition, extracts fail to arrest in response to spindle damage. Mitotic arrest can be restored by addition of high levels of soluble MAD2, demonstrating that the absence of CENP-E eliminates kinetochore-dependent signaling but not the downstream steps in checkpoint signal transduction. Because it directly binds both to spindle microtubules and to the kinetochore-associated checkpoint kinase BUBR1, CENP-E is a central component in the vertebrate checkpoint that modulates signaling activity in a microtubule-dependent manner.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Abrieu, Ariane/P-3307-2019	Cleveland, Don/0000-0002-1934-3682				Brown KD, 1996, J CELL SCI, V109, P961; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Chen RH, 1997, METHOD ENZYMOL, V283, P572; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; DAWSON IA, 1995, J CELL BIOL, V129, P725, DOI 10.1083/jcb.129.3.725; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Harlow ED., 1999, USING ANTIBODIES; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang XM, 1997, J CELL BIOL, V137, P433, DOI 10.1083/jcb.137.2.433; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; Yu HG, 1999, J CELL BIOL, V145, P425, DOI 10.1083/jcb.145.3.425; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	41	176	179	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					817	826		10.1016/S0092-8674(00)00070-2	http://dx.doi.org/10.1016/S0092-8674(00)00070-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030625	Bronze			2022-12-28	WOS:000089395200013
J	Eid, JE; Kung, AL; Scully, R; Livingston, DM				Eid, JE; Kung, AL; Scully, R; Livingston, DM			P300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion	CELL			English	Article							SYNOVIAL SARCOMA TRANSLOCATION; TRANSCRIPTION FACTORS; PROTEINS; INTEGRINS; DIFFERENTIATION; FAMILY; SSX; CBP; TRANSFORMATION; IDENTIFICATION	Complexes containing p300, but not CBP, and the nuclear proto-oncoprotein SYT were detected in confluent cultures of G1-arrested cells but not in sparse cells or during S or G2. SYT sequences constitute the N-terminal segment of a fusion oncogene product, SYT-SSX, routinely detected in synovial sarcoma, an aggressive human tumor. SYT/p300 complex formation promotes cell adhesion to a fibronectin matrix, as reflected by compromise of this process in cells expressing SYT dl mutants that retain p300 binding activity and in the primary fibroblasts of p300 but not CBP heterozygous null mice. The mechanism linking the action of SYT/p300 complexes to adhesion function is, at least in part, transcription activation-independent and results in proper activation of beta 1 integrin, a major adhesion receptor.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Livingston, DM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022; Scully, Ralph/F-5008-2013	Kung, Andrew L/0000-0002-9091-488X; 	NATIONAL CANCER INSTITUTE [K01CA079576] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAYLEY ST, 1994, INT J ONCOL, V5, P425; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Condorelli G, 1997, J CELL BIOCHEM, V67, P423, DOI 10.1002/(SICI)1097-4644(19971215)67:4<423::AID-JCB1>3.0.CO;2-U; Coppolino MG, 2000, INT J BIOCHEM CELL B, V32, P171, DOI 10.1016/S1357-2725(99)00043-6; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; dosSantos NR, 1997, HUM MOL GENET, V6, P1549, DOI 10.1093/hmg/6.9.1549; DULBECCO R, 1969, SCIENCE, V166, P962, DOI 10.1126/science.166.3908.962; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Harlow E., 1988, ANTIBODIES LAB MANUA; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Keely P, 1998, TRENDS CELL BIOL, V8, P101, DOI 10.1016/S0962-8924(97)01219-1; Kung AL, 2000, GENE DEV, V14, P272; LEE CA, 1995, HAEMOPHILIA, V1, P1, DOI 10.1111/j.1365-2516.1995.tb00031.x; Lee KY, 1999, MOL CELL BIOL, V19, P7724; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	36	76	79	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					839	848		10.1016/S0092-8674(00)00072-6	http://dx.doi.org/10.1016/S0092-8674(00)00072-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030627	Bronze			2022-12-28	WOS:000089395200015
J	Pestic-Dragovich, L; Stojiljkovic, L; Philimonenko, AA; Nowak, G; Ke, Y; Settlage, RE; Shabanowitz, J; Hunt, DF; Hozak, P; de Lanerolle, P				Pestic-Dragovich, L; Stojiljkovic, L; Philimonenko, AA; Nowak, G; Ke, Y; Settlage, RE; Shabanowitz, J; Hunt, DF; Hozak, P; de Lanerolle, P			A myosin I isoform in the nucleus	SCIENCE			English	Article							RNA-POLYMERASE-II; UNCONVENTIONAL MYOSINS; LARGEST SUBUNIT; PHOSPHORYLATION; TRANSCRIPTION; LOCALIZATION; CLONING; MUSCLE; ALPHA; CELL	A nuclear isoform of myosin I beta that contains a unique 16-amino acid aminoterminal extension has been identified. An affinity-purified antibody to the 16-amino acid peptide demonstrated nuclear staining. Confocal and electron microscopy revealed that nuclear myosin I beta colocalized with RNA polymerase II in an alpha-amanitin- and actinomycin D-sensitive manner. The antibody coimmunoprecipitated RNA polymerase II and blocked in vitro RNA synthesis. This isoform of myosin I beta appears to be in a complex with RNA polymerase II and may affect transcription.	Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; Acad Sci Czech Republ, Inst Expt Med, Dept Cell Ultrastruct & Mol Biol, Prague, Czech Republic; Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22901 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; University of Virginia; University of Virginia	de Lanerolle, P (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA.	primal@uic.edu	Hunt, Donald F/I-6936-2012; Hozak, Pavel/J-4182-2014; Hozak, Pavel/AAB-5359-2021	Hunt, Donald F/0000-0003-2815-6368; Hozak, Pavel/0000-0003-1901-1394; Hozak, Pavel/0000-0003-1901-1394	NIGMS NIH HHS [GM 37537, GM 56489] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537, R01GM056489] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Alberts B., 1994, MOL BIOL CELL; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Crozet F, 1997, GENOMICS, V40, P332, DOI 10.1006/geno.1996.4526; DELANEROLLE P, 1982, NATURE, V298, P871, DOI 10.1038/298871a0; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; Iborra FJ, 1996, J CELL SCI, V109, P1427; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lavoie SB, 1999, BIOCHEM CELL BIOL, V77, P367, DOI 10.1139/bcb-77-4-367; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Nowak G, 1997, J BIOL CHEM, V272, P17176, DOI 10.1074/jbc.272.27.17176; PHILIMONENKO AA, UNPUB; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; RUPPERT C, 1995, J CELL SCI, V108, P3775; Shabanowitz J, 2000, MASS SPECTROMETRY IN BIOLOGY & MEDICINE, P163; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653	24	202	213	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2000	290	5490					337	341		10.1126/science.290.5490.337	http://dx.doi.org/10.1126/science.290.5490.337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030652				2022-12-28	WOS:000089818100044
J	Keen, J; Wyatt, J				Keen, J; Wyatt, J			Back to basics on NHS networking	BRITISH MEDICAL JOURNAL			English	Article							SYSTEM		Kings Fund, London W1M 0AN, England; UCL, Sch Publ Policy, London WC1E 7HN, England; UCL, Knowledge Management Ctr, London WC1E 7HN, England	University of London; University College London; University of London; University College London	Keen, J (corresponding author), Kings Fund, 11-13 Cavendish Sq, London W1M 0AN, England.	j.keen@kehf.org.uk	Wyatt, Jeremy/F-8160-2010	Wyatt, Jeremy/0000-0001-7008-1473				Anderson R, 1996, BRIT MED J, V312, P109; *AUD COMM, 1998, GHOST MACH AN IT FRA; Barua A, 1997, INFORM SYST RES, V8, P398, DOI 10.1287/isre.8.4.398; Bingham CM, 1998, LANCET, V352, P441, DOI 10.1016/S0140-6736(97)11510-0; Borowitz SM, 1998, JAMA-J AM MED ASSOC, V280, P1321, DOI 10.1001/jama.280.15.1321; Cabinet Office, 1999, CM4310 CAB OFF; *COMM PUBL ACC, 2000, 1992 1998 INF MAN TE; DENHAM J, 1999, HANSARD         0430; *DEP HLTH, 1992, INF MAN TECHN STRAT; Department of Health, 1998, NEW NHS MOD DEP; KEEN J, 1998, BRIT MED J, V216, P1291; Lee MKO, 1998, COMPUT NETWORKS ISDN, V30, P1579, DOI 10.1016/S0169-7552(98)00208-6; MITCHELL P, 2000, HLTH SERV J      MAR, P16; *NAT AUD OFF, 1999, 1992 1998 INF MAN TE; *NHS EX, 1999, NHS COD CONN VERS 1; Roscoe TJ, 1999, BRIT MED J, V318, P377, DOI 10.1136/bmj.318.7180.377; Wood FB, 1998, J AM MED INFORM ASSN, V5, P528, DOI 10.1136/jamia.1998.0050528; [No title captured]	18	11	11	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					875	878		10.1136/bmj.321.7265.875	http://dx.doi.org/10.1136/bmj.321.7265.875			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021869	Bronze, Green Published			2022-12-28	WOS:000089857500025
J	Hong, L; Koelsch, G; Lin, XL; Wu, SL; Terzyan, S; Ghosh, AK; Zhang, XC; Tang, J				Hong, L; Koelsch, G; Lin, XL; Wu, SL; Terzyan, S; Ghosh, AK; Zhang, XC; Tang, J			Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEINASE; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; CANDIDA-ALBICANS; RESOLUTION; PEPSTATIN; SYSTEM; GENE	Memapsin 2 (beta-secretase) is a membrane-associated aspartic protease involved in the production of beta-amyloid peptide in Alzheimer's disease and is a major target for drug design. We determined the crystal structure of the protease domain of human memapsin 2 complexed to an eight-residue inhibitor at 1.9 angstrom resolution. The active site of memapsin 2 is more open and less hydrophobic than that of other human aspartic proteases. The subsite locations from S-4 to S-2' are well defined. A kink of the inhibitor chain at P-2' and the change of chain direction of P-3' and P-4' may be mimicked to provide inhibitor selectivity.	Oklahoma Med Res Fdn, Prot Studies Program, Oklahoma City, OK 73104 USA; Oklahoma Med Res Fdn, Crystallog Program, Oklahoma City, OK 73104 USA; Univ Illinois, Dept Chem, Chicago, IL 60607 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center	Tang, J (corresponding author), Oklahoma Med Res Fdn, Prot Studies Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	jordan-tang@omrf.ouhsc.edu						AbadZapatero C, 1996, PROTEIN SCI, V5, P640; BAILEY D, 1994, PROTEIN SCI, V3, P2129, DOI 10.1002/pro.5560031126; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUTFIELD SM, 1995, STRUCTURE, V3, P1261, DOI 10.1016/S0969-2126(01)00261-1; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; DEALWIS CG, 1994, J MOL BIOL, V236, P342, DOI 10.1006/jmbi.1994.1139; ERMOLIEFF J, IN PRESS BIOCHEMISTR; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fujinaga M, 2000, ACTA CRYSTALLOGR D, V56, P272, DOI 10.1107/S0907444999016376; FUJINAGA M, 1995, PROTEIN SCI, V4, P960; Ghosh AK, 2000, J AM CHEM SOC, V122, P3522, DOI 10.1021/ja000300g; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kearney BP, 1999, NEUROL CLIN, V17, P883, DOI 10.1016/S0733-8619(05)70171-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; LIN XL, 1994, METHOD ENZYMOL, V241, P195; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SIELECKI AR, 1990, J MOL BIOL, V214, P143, DOI 10.1016/0022-2836(90)90153-D; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Symersky J, 1997, BIOCHEMISTRY-US, V36, P12700, DOI 10.1021/bi970613x; TANG J, 1978, NATURE, V271, P618, DOI 10.1038/271618a0; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang J, 1999, ACTA CRYSTALLOGR D, V55, P625, DOI 10.1107/S0907444998013961	32	652	731	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					150	153		10.1126/science.290.5489.150	http://dx.doi.org/10.1126/science.290.5489.150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021803				2022-12-28	WOS:000089724800056
J	Bridges, CB; Thompson, WW; Meltzer, MI; Reeve, GR; Talamonti, WJ; Cox, NJ; Lilac, HA; Hall, H; Klimov, A; Fukuda, K				Bridges, CB; Thompson, WW; Meltzer, MI; Reeve, GR; Talamonti, WJ; Cox, NJ; Lilac, HA; Hall, H; Klimov, A; Fukuda, K			Effectiveness and cost-benefit of influenza vaccination of healthy working adults - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELDERLY PERSONS; EFFICACY; POPULATION; VIRUSES; ILLNESS; IMMUNIZATION; PNEUMONIA; EPIDEMICS; TECUMSEH; IMPACT	Context Although the cost-effectiveness and cost-benefit of influenza vaccination are well established for persons aged 65 years or older, the benefits for healthy adults younger than 65 years are less clear. Objective To evaluate the effectiveness and cost-benefit of influenza vaccine in preventing influenzalike illness (ILI) and reducing societal costs of ILI among healthy working adults. Design Double-blind, randomized, placebo-controlled trial conducted during 2 influenza seasons. Setting and Participants Healthy adults aged 18 to 64 years and employed full-time by a US manufacturing company (for 1997-1998 season, n=1184; for 1998-1999 season, n=1191). Interventions For each season, participants were randomly assigned to receive either trivalent inactivated influenza vaccine (n =595 in 1997-1998 and n = 587 in 1998-1999) or sterile saline injection (placebo; n = 589 in 1997-1998 and n = 604 in 1998-1999). Participants in 1997-1998 were rerandomized if they participated in 1998-1999. Main Outcome Measures Influenzalike illnesses and associated physician visits and work absenteeism reported in biweekly questionnaires by all participants, and serologically confirmed influenza illness among 23% of participants in each year (n = 275 in 1997-1998; n = 278 in 1998-1999); societal cost of ILI per vaccinated vs unvaccinated person. Results For 1997-1998 and 1998-1999, respectively, 95% (1130/1184) and 99% (1178/1191) of participants had complete follow-up, and 23% in each year had serologic testing. In 1997-1998, when the vaccine virus differed from the predominant circulating viruses, vaccine efficacy against serologically confirmed influenza illness was 50% (P=.33). In this season, vaccination did not reduce ILI, physician visits, or lost workdays; the net societal cost was $65.59 per person compared with no vaccination. In 1998-1999, the vaccine and predominant circulating viruses were well matched. Vaccine efficacy was 86% (P =.001), and vaccination reduced ILI, physician visits, and lost workdays by 34%, 42%, and 32%, respectively. However, vaccination resulted in a net societal cost of $11.17 per person compared with no vaccination. Conclusion Influenza vaccination of healthy working adults younger than 65 years can reduce the rates of ILI, lost workdays, and physician visits during years when the vaccine and circulating viruses are similar, but vaccination may not provide overall economic benefits in most years.	Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Off Director, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ford Motor Co, Dearborn, MI 48121 USA; Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ford Motor Company; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Bridges, CB (corresponding author), Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, MS A-32,1600 Clifton Rd, Atlanta, GA 30333 USA.	cbridges@cdc.gov	Meltzer, Martin/AAT-3235-2021	Meltzer, Martin/0000-0002-7250-0472; Fukuda, Keiji/0000-0002-9598-9565				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; *BUR LAB STAT, 1999, EMPL COSTS EMPL COMP; Campbell DS, 1997, J OCCUP ENVIRON MED, V39, P408, DOI 10.1097/00043764-199705000-00006; Carrat F, 1996, NEW ENGL J MED, V334, P403; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1039; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P280; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P374; Demicheli V, 2000, VACCINE, V18, P957, DOI 10.1016/S0264-410X(99)00332-1; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; Francisco P, 1996, PREVENTION EFFECTIVE; GLEZEN WP, 1982, EPIDEMIOL REV, V4, P25, DOI 10.1093/oxfordjournals.epirev.a036250; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Grotto I, 1998, CLIN INFECT DIS, V26, P913, DOI 10.1086/513934; HALL CE, 1973, AM J EPIDEMIOL, V98, P365, DOI 10.1093/oxfordjournals.aje.a121566; Keech M, 1998, OCCUP MED-OXFORD, V48, P85, DOI 10.1093/occmed/48.2.85; Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0; Kendal AP, 1982, CONCEPTS PROCEDURES; Kok T, 1997, PATHOLOGY, V29, P300, DOI 10.1080/00313029700169135; Kumpulainen V, 1997, SCAND J INFECT DIS, V29, P181, DOI 10.3109/00365549709035881; Leighton L, 1996, OCCUP MED-OXFORD, V46, P146, DOI 10.1093/occmed/46.2.146; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; MONTO AS, 1974, JAMA-J AM MED ASSOC, V227, P164, DOI 10.1001/jama.227.2.164; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; MONTO AS, 1999, 39 INT C ANT AG CHEM; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; *OFF TECHN ASS, 1981, COST EFF INFL VACC; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; PATRIARCA PA, 1995, NEW ENGL J MED, V333, P933, DOI 10.1056/NEJM199510053331410; Saxen H, 1999, PEDIATR INFECT DIS J, V18, P779, DOI 10.1097/00006454-199909000-00007; SMITH JWG, 1979, J HYG-CAMBRIDGE, V83, P157, DOI 10.1017/S0022172400025936; SULLIVAN KM, 1993, AM J PUBLIC HEALTH, V83, P1712, DOI 10.2105/AJPH.83.12.1712; WEINGARTEN S, 1988, J GEN INTERN MED, V3, P32, DOI 10.1007/BF02595754; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908	38	513	535	0	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1655	1663		10.1001/jama.284.13.1655	http://dx.doi.org/10.1001/jama.284.13.1655			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015795	Bronze			2022-12-28	WOS:000089501900025
J	Koenig, HG				Koenig, HG			Religion, spirituality, and medicine: Application to clinical practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEPRESSION		Duke Univ, Med Ctr, Durham, NC 27710 USA; Vet Affairs Med Ctr, GRECC, Durham, NC USA	Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Koenig, HG (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.		Koenig, Harold G/F-7379-2011					Hummer RA, 1999, DEMOGRAPHY, V36, P273, DOI 10.2307/2648114; Koenig HG, 1999, J GERONTOL A-BIOL, V54, pM370, DOI 10.1093/gerona/54.7.M370; Koenig HG, 1998, AM J PSYCHIAT, V155, P536, DOI 10.1176/ajp.155.4.536; KOENIG HG, 1992, AM J PSYCHIAT, V149, P1693; Koenig HG, 2000, HDB RELIG HLTH, P7; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; Post SG, 2000, ANN INTERN MED, V132, P578, DOI 10.7326/0003-4819-132-7-200004040-00010	7	120	123	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1708	1708		10.1001/jama.284.13.1708	http://dx.doi.org/10.1001/jama.284.13.1708			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015808	hybrid			2022-12-28	WOS:000089501900037
J	Koplan, JP; Fleming, DW				Koplan, JP; Fleming, DW			Current and future public health challenges	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Koplan, JP (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop D14, Atlanta, GA 30333 USA.							*AG HEALTHC RES QU, 2000, AHRQ PUB; *KAIS COMM MED UN, 2000, UN THEIR ACC HLTH CA; Krach CA, 1999, CURRENT POPULATION R; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; *MMWR, 2000, MMWR MORB MORTAL WEE, V49, P25; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; U. S. Census Bureau, 1993, WE AM ELD; *US DHHS, 1999, MENT HLTH REP SURG G; 2000, NY TIMES        0726, pA20	9	43	44	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1696	1698		10.1001/jama.284.13.1696	http://dx.doi.org/10.1001/jama.284.13.1696			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015801				2022-12-28	WOS:000089501900031
J	Helgason, S; Petursson, G; Gudmundsson, S; Sigurdsson, JA				Helgason, S; Petursson, G; Gudmundsson, S; Sigurdsson, JA			Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up	BRITISH MEDICAL JOURNAL			English	Article							ORAL ACYCLOVIR; CHRONIC PAIN; TRIALS; RISK	Objective To estimate the frequency, duration, and clinical importance of postherpetic neuralgia after a first episode of herpes tester. Design Prospective cohort study with long term follow up. Setting Primary health care in Iceland. Participants 421 patients with a first episode of herpes tester. Main outcome measures Age and sex distribution of patients with herpes tester, point prevalence or postherpetic neuralgia, and severity of pain at 1, 3, 6, and 12 months and up to 7.6 years after the outbreak of zoster. Results Among patients) younger than 60 years, the risk of postherpetic neuralgia three months after the start of the tester rash was 1.8% (95% confidence interval 0.59% to 4.18%) and pain was mild in all cases. In patients 60 years and older, the risk of postherpetic neuralgia increased but the pain was usually mild or moderate. After three months severe pain was recorded in two patients older than 60 years (1.7%, 2.14% to 6.15%). After 12 months no patient reported severe pain and 14 patients (3.3%) had mild or moderate pain. Seven of these became pain free within two to seven years, and five reported mild pain and one moderate pain after 7.6 years of follow up. Sex was not a predictor of postherpetic neuralgia. Possible immunomodulating comorbidity (such as malignancy, systemic steroid use, diabetes) was present in It patients. Conclusions The probability of longstanding pain of clinical importance after herpes tester is lo it in an unselected population of primary care patients essentially untreated with antiviral drugs.	Arbaer Hlth Care Ctr, IS-110 Reykjavik, Iceland; Univ Iceland, Dept Family Med, IS-105 Reykjavik, Iceland; Directorate Hlth, IS-150 Reykjavik, Iceland	University of Iceland	Helgason, S (corresponding author), Arbaer Hlth Care Ctr, IS-110 Reykjavik, Iceland.			Sigurdsson, Johann Agust/0000-0002-5646-6411	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEUTNER KR, 1995, ANTIMICROB AGENTS CH, V39, P1546, DOI 10.1128/AAC.39.7.1546; Bowsher D, 1999, EUR J PAIN-LONDON, V3, P335, DOI 10.1016/S1090-3801(99)90015-0; Christensen P, 1985, Ugeskr Laeger, V147, P3401; DWORKIN RH, 1992, J ABNORM PSYCHOL, V101, P200, DOI 10.1037/0021-843X.101.1.200; Dworkin RH, 1997, ANTIVIR RES, V33, P73, DOI 10.1016/S0166-3542(96)01007-8; Gardner M. J., 1989, STAT CONFIDENCE; GEBSKY V, 1992, SPIDA USERS MANUAL; HARDING SP, 1991, CURR EYE RES, V10, P177, DOI 10.3109/02713689109020376; HAYENS B, 1998, EVIDENCE BASED MED, V3, P130; HELGASON S, 1996, EUR J GEN PRACT, V2, P12; Hope-Simpson R E, 1975, J R Coll Gen Pract, V25, P571; Jackson JL, 1997, ARCH INTERN MED, V157, P909, DOI 10.1001/archinte.157.8.909; Johnson RW, 1997, ANTIVIR CHEM CHEMOTH, V8, P19, DOI 10.1177/09563202970080S606; Johnstone B, 1997, NEUROREHABILITATION, V8, P1, DOI 10.3233/NRE-1997-8101; KAY R, 1995, ANTIVIR CHEM CHEMOTH, V6, P28, DOI 10.1177/09563202950060S607; Knottnerus JA, 1997, BRIT MED J, V315, P1109; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; LANCASTER T, 1995, BRIT J GEN PRACT, V45, P39; LYDICK E, 1995, NEUROLOGY S8, V45, P52; MCKENDRICK MW, 1989, BRIT MED J, V298, P431, DOI 10.1136/bmj.298.6671.431; McQuay HJ, 1997, BRIT MED J, V314, P763, DOI 10.1136/bmj.314.7083.763; Petursson G, 1998, PEDIATR INFECT DIS J, V17, P905, DOI 10.1097/00006454-199810000-00011; RAGOZZINO MW, 1982, NEW ENGL J MED, V307, P393, DOI 10.1056/NEJM198208123070701; SACKETT DL, 1991, CLIN EPIDEMIOLOGY BA, P318; SANDERS HWA, 1968, THESIS U NIJMEGEN NI	25	164	173	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					794	796A		10.1136/bmj.321.7264.794	http://dx.doi.org/10.1136/bmj.321.7264.794			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009518	Bronze, Green Published			2022-12-28	WOS:000089696600022
J	Horton, R				Horton, R			Health and the UK Human Rights Act 1998	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Horton, R (corresponding author), Lancet, 84 Theobalds Rd, London WC1X 8RR, England.							BROWNLIE I, 1999, BASIC DOCUMENTS HUMA; Burke Edmund, 1999, REFLECTIONS REVOLUTI; *COMM PUBL ETH, 1999, COPE REP 1999; *DEP HLTH, 2000, NHS PLAN; Fallberg L H, 2000, Eur J Health Law, V7, P1; Gomien Donna, 1993, STRUCNA RUKOJET EVRO; HAWKES N, 2000, TIMES           0817, P6; KENNEDY D, 2000, TIMES           0905, P3; KINGSLAND, 2000, TIMES           0816, P17; MACARTHUR B, 2000, TIMES           0818, P23; Robertson Geoffrey, 2000, CRIMES HUMANITY; SEDLEY S, 2000, LONDON REV BOOK 0810, P13; Szmukler G, 2000, BRIT J PSYCHIAT, V177, P196, DOI 10.1192/bjp.177.3.196; Welsh J, 2000, LANCET, V356, P503, DOI 10.1016/S0140-6736(05)74170-2; Wollstonecraft Mary, 1994, POLITICAL WRITINGS	15	9	9	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1186	1188		10.1016/S0140-6736(00)02771-9	http://dx.doi.org/10.1016/S0140-6736(00)02771-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030313				2022-12-28	WOS:000089594300044
J	Steiner, M				Steiner, M			Recognition of premenstrual dysphoric disorder and its treatment	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; SERTRALINE TREATMENT; MENSTRUAL-CYCLE; FLUOXETINE; SEROTONIN; SYMPTOMS; PLACEBO; WOMEN		McMaster Univ, St Josephs Hosp, Dept Psychiat & Behav Neurosci & Obstet & Gynecol, Hamilton, ON L8N 4A6, Canada	McGill University; McMaster University	Steiner, M (corresponding author), McMaster Univ, St Josephs Hosp, Dept Psychiat & Behav Neurosci & Obstet & Gynecol, Hamilton, ON L8N 4A6, Canada.		Steiner, Meir/B-2121-2016					American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P715; Eriksson E, 1999, INT CLIN PSYCHOPHARM, V14, pS27; ERIKSSON E, 1995, NEUROPSYCHOPHARMACOL, V12, P167, DOI 10.1038/sj.npp.1380251; Freeman EW, 1999, ARCH GEN PSYCHIAT, V56, P932, DOI 10.1001/archpsyc.56.10.932; Jermain DM, 1999, ARCH FAM MED, V8, P328, DOI 10.1001/archfami.8.4.328; LEIBENLUFT E, 1994, ARCH GEN PSYCHIAT, V51, P761; Pearlstein TB, 2000, J CLIN PSYCHIAT, V61, P101, DOI 10.4088/JCP.v61n0205; Pearlstein TB, 1997, J CLIN PSYCHOPHARM, V17, P261, DOI 10.1097/00004714-199708000-00004; RAPKIN AJ, 1992, CLIN OBSTET GYNECOL, V35, P629, DOI 10.1097/00003081-199209000-00022; Roca CA, 1996, PSYCHIAT ANN, V26, P576, DOI 10.3928/0048-5713-19960901-10; STEINER M, 1980, ACTA PSYCHIAT SCAND, V62, P177, DOI 10.1111/j.1600-0447.1980.tb00605.x; Steiner M, 1999, J AFFECT DISORDERS, V53, P269, DOI 10.1016/S0165-0327(98)00121-9; Steiner M, 1997, Int J Psychiatry Clin Pract, V1, P241, DOI 10.3109/13651509709024735; Steiner M, 1997, PSYCHOPHARMACOL BULL, V33, P771; STEINER M, 1995, NEW ENGL J MED, V332, P1529, DOI 10.1056/NEJM199506083322301; STEINER M, 1998, DEPRESSION WOMEN; Thys-Jacobs S, 1998, AM J OBSTET GYNECOL, V179, P444, DOI 10.1016/S0002-9378(98)70377-1; Wikander I, 1998, J CLIN PSYCHOPHARM, V18, P390, DOI 10.1097/00004714-199810000-00007; Wyatt KM, 1999, BMJ-BRIT MED J, V318, P1375, DOI 10.1136/bmj.318.7195.1375; Yonkers KA, 1997, JAMA-J AM MED ASSOC, V278, P983, DOI 10.1001/jama.278.12.983	20	7	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2000	356	9236					1126	1127		10.1016/S0140-6736(00)02749-5	http://dx.doi.org/10.1016/S0140-6736(00)02749-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	359CQ	11030287				2022-12-28	WOS:000089594300004
J	Irmay, F; Merzouga, B; Vettorel, D				Irmay, F; Merzouga, B; Vettorel, D			The Krukenberg procedure: a surgical option for the treatment of double hand amputees in Sierra Leone	LANCET			English	Article								Background For the past 9 years, Sierra Leone has struggled with a cruel civil war in which the civilian population has been the principal target. The International Committee of the Red Cross established a surgical mission in Netland Hospital, Freetown, and during this surgical mission, we treated crippled individuals who had had one or both hands amputated. We assessed the benefit of the Krukenberg procedure to restore manual dexterity in this group.:ln this operation, radius and ulna are separated and a: pincer-like grasp is created. Methods From July 15, 1998, to Sept 9, 1998, we carried out the Krukenberg procedure on a group of double and single hand amputees. The main target group was double hand amputees, however, the procedure was initially done on three single hand amputees to assess the functional result. Between the original trauma and the operation, there had been an interval of 3 months or longer in all patients. Patients were followed up for 3 months after the procedure to assess gripping strength and self-sufficiency (feeding, personal hygiene, dressing, and manual dexterity). Findings 15 Kruhenberg procedures were done on 11 patients: eight men and three women (mean age 42 years). Three had single hand amputation and eight had double hand amputation. In only two patients had sufficient time passed for the stumps to heal. Of ten patients who were followed up at 3 months, all could eat and drink by themselves. The simple dressing test was passed by all patients and 75% of the patients had recovered some dexterity. Interpretation The Kruhenberg procedure is a surgical option to achieve some manual dexterity in double hand amputees, where resources for sophisticated hand prostheses are lacking.	Univ Hosp Geneva, Dept Surg, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Div Anaesthesiol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Irmay, F (corresponding author), Univ Hosp Geneva, Dept Surg, Rue Micheli du Crest 24, CH-1211 Geneva 14, Switzerland.							BAUMGARTNER R, 1994, Z ORTHOP GRENZGEB, V132, P180, DOI 10.1055/s-2008-1039960; CALANDRUCCIO JH, 1998, CAMPBELLS OPERATIVE, P3517; *CICR, 1977, PROT ADD CONV GEN 12, P136; *CICR, 1949, CONV GEN 12 AOUT 194, P256; Colp R, 1933, J BONE JOINT SURG, V15, P439; *COM INT CROIX ROU, 1999, ACT CICR SIERR LEON; GARST RJ, 1991, J BONE JOINT SURG BR, V73, P385, DOI 10.1302/0301-620X.73B3.1670433; GOSSET J, 1975, ANN CHIR, V29, P1073; Krukenberg H, 1931, ARCH KLIN CHIR, V165, P191; LESCOEUR JE, 1979, AMPUTES MEMBRES SUPE, P112; Lob A, 1970, Hefte Unfallheilkd, V105, P1; Loosli-Guignard R M, 1983, Ann Chir Main, V2, P154, DOI 10.1016/S0753-9053(83)80095-7; MATHUR BP, 1981, PROSTHET ORTHOT INT, V5, P135; RICHARDS P, 1996, FIGHTING RAIN FOREST, P182; SINAKI M, 1982, CLIN ORTHOP RELAT R, P163; SWANSON DB, 1980, CLIN ORTHOP RELAT R, V148, P55; TUBIANA R, 1981, ORTHOP CLIN N AM, V12, P819; United Nations, 1996, WORLD POP PROSP; 1998, UN CONS INT AG APP H, P62; 1998, AFRICA S SAHARA 1999, P928	20	17	17	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1072	1075		10.1016/S0140-6736(00)02731-8	http://dx.doi.org/10.1016/S0140-6736(00)02731-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009143				2022-12-28	WOS:000089430500012
J	Michael, WM; Ott, R; Fanning, E; Newport, J				Michael, WM; Ott, R; Fanning, E; Newport, J			Activation of the DNA replication checkpoint through RNA synthesis by primase	SCIENCE			English	Article							POLYMERASE-ALPHA; PROTEIN-KINASE; FISSION YEAST; S-PHASE; INITIATION; INHIBITOR; MITOSIS; DAMAGE; CDK	When DNA replication is inhibited during the synthesis (S) phase of the cell cycle, a signaling pathway (checkpoint) is activated that serves to prevent mitosis from initiating before completion of replication. This replication checkpoint acts by down-regulating the activity of the mitotic inducer cdc2-cyclin B. Here, we report the relation between chromatin structure and induction of the replication checkpoint. Chromatin was competent to initiate a checkpoint response only after the DNA was unwound and DNA polymerase or had been Loaded. Checkpoint induction did not require new DNA synthesis on the unwound template strand but did require RNA primer synthesis by primase. These findings Identify the RNA portion of the primer as an important component of the signal that activates the replication checkpoint.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Vanderbilt Univ, Dept Mol Biol, Nashville, TN 37235 USA	University of California System; University of California San Diego; Harvard University; Vanderbilt University	Michael, WM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.	matt@mcb.harvard.edu	McDermott, Michael Francis/GZM-5330-2022		NIGMS NIH HHS [R01GM33523-16] Funding Source: Medline; PHS HHS [52948] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033523] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhaumik D, 1998, MOL BIOL CELL, V9, P2107, DOI 10.1091/mbc.9.8.2107; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; DURSO G, 1995, J CELL SCI, V108, P3109; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; GROSSE F, 1985, J BIOL CHEM, V260, P1881; Kirk BW, 1999, BIOCHEMISTRY-US, V38, P7727, DOI 10.1021/bi990247c; KORNBERG A, 1992, DNA REPLICATION, P466; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MICHAEL WM, UNPUB; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; MURRAY GB, 1995, PSYCHOSOMATICS, V36, P581, DOI 10.1016/S0033-3182(95)71616-4; Rhind N, 1998, CURR OPIN CELL BIOL, V10, P749, DOI 10.1016/S0955-0674(98)80118-X; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; Schneider A, 1998, J BIOL CHEM, V273, P21608, DOI 10.1074/jbc.273.34.21608; SHEAFF R, 1991, BIOCHEMISTRY-US, V30, P8590, DOI 10.1021/bi00099a014; TANAKA S, 1982, J BIOL CHEM, V257, P8386; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1999, PRACT APPROACH SER, V199, P201; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wang TSF, 1995, METHOD ENZYMOL, V262, P77; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189	24	162	166	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2133	2137		10.1126/science.289.5487.2133	http://dx.doi.org/10.1126/science.289.5487.2133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000117				2022-12-28	WOS:000089430900047
J	Bodner, S; Paine, C				Bodner, S; Paine, C			When peer review fails - Problems with a giant laser project.	NATURE			English	Editorial Material									USN, Res Lab, Laser Fus Programme, Washington, DC 20375 USA; Nat Resources Def Council, Nucl Programme, Washington, DC 20005 USA	United States Department of Defense; United States Navy; Naval Research Laboratory								SACK S, 1997, SCIENCE, V277, P304; 2000, NATURE, V405, P110	2	3	3	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					129	130		10.1038/35025288	http://dx.doi.org/10.1038/35025288			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001033				2022-12-28	WOS:000089241000017
J	Tregenza, T; Butlin, RK; Wedell, N				Tregenza, T; Butlin, RK; Wedell, N			Evolutionary biology - Sexual conflict and speciation	NATURE			English	Article									Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Tregenza, T (corresponding author), Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England.		Butlin, Roger K/F-7709-2013	Butlin, Roger K/0000-0003-4736-0954; Tregenza, Thomas/0000-0003-4182-2222				ARNQVIST G, IN PRESS ANIM BEHAV; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208	4	10	10	0	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					149	150		10.1038/35025138	http://dx.doi.org/10.1038/35025138			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001043				2022-12-28	WOS:000089241000033
J	Pulverer, B				Pulverer, B			Signal transduction - An arresting tale	NATURE			English	Editorial Material																		Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					714	714		10.1038/35008179	http://dx.doi.org/10.1038/35008179			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	11012331	Bronze			2022-12-28	WOS:000086523600032
J	Ford, J; Cooke, L				Ford, J; Cooke, L			Priority setting in health care - Claims are not supported in research literature	BRITISH MEDICAL JOURNAL			English	Letter									Hlth Policy & Econ Res Unit, London WC1H 9JP, England		Ford, J (corresponding author), Hlth Policy & Econ Res Unit, BMA House, London WC1H 9JP, England.							*HLTH POL EC RES U, 2000, 1 HLTH POL EC RES UN; *NAT CONS COUNC, 1998, CONS 1998 CONS VIEW; Torgerson DJ, 2000, BRIT MED J, V320, P1679, DOI 10.1136/bmj.320.7250.1679	3	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					954	954						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030694				2022-12-28	WOS:000089975100033
J	Heeringa, M; Zweers, P; de Man, RA; de Groot, H				Heeringa, M; Zweers, P; de Man, RA; de Groot, H			Anaphylactic-like reaction associated with oral budesonide	BRITISH MEDICAL JOURNAL			English	Article							HYDROCORTISONE											COROMINAS N, 1992, PHARM WEEKBLAD, V14, P93, DOI 10.1007/BF01962693; DAJANI BM, 1981, J ALLERGY CLIN IMMUN, V68, P201, DOI 10.1016/0091-6749(81)90184-6; MENDELSON LM, 1974, J ALLERGY CLIN IMMUN, V54, P125, DOI 10.1016/0091-6749(74)90049-9	3	4	4	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					927	927		10.1136/bmj.321.7266.927	http://dx.doi.org/10.1136/bmj.321.7266.927			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030679	Bronze, Green Published			2022-12-28	WOS:000089975100021
J	Falkowski, P; Scholes, RJ; Boyle, E; Canadell, J; Canfield, D; Elser, J; Gruber, N; Hibbard, K; Hogberg, P; Linder, S; Mackenzie, FT; Moore, B; Pedersen, T; Rosenthal, Y; Seitzinger, S; Smetacek, V; Steffen, W				Falkowski, P; Scholes, RJ; Boyle, E; Canadell, J; Canfield, D; Elser, J; Gruber, N; Hibbard, K; Hogberg, P; Linder, S; Mackenzie, FT; Moore, B; Pedersen, T; Rosenthal, Y; Seitzinger, S; Smetacek, V; Steffen, W			The global carbon cycle: A test of our knowledge of earth as a system	SCIENCE			English	Review							ATMOSPHERIC CO2; OXIDE EMISSIONS; NITROGEN; OCEAN; CLIMATE; ECOSYSTEMS; DIOXIDE; SEQUESTRATION; FORESTS; MODEL	Motivated by the rapid increase in atmospheric CO2 due to human activities since the Industrial Revolution, several international scientific research programs have analyzed the role of individual components of the Earth system in the global carbon cycle. Our knowledge of the carbon cycle within the oceans, terrestrial ecosystems, and the atmosphere is sufficiently extensive to permit us to conclude that although natural processes can potentially slow the rate of increase in atmospheric CO2, there is no natural "savior" waiting to assimilate all the anthropogenically produced CO2 in the coming century. Our knowledge is insufficient to describe the interactions between the components of the Earth system and the relationship between the carbon cycle and other biogeochemical and climatological processes. Overcoming this limitation requires a systems approach.	Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; CSIR, Environm Div, ZA-0001 Pretoria, South Africa; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02142 USA; Commonwealth Sci & Ind Res Org Wildlife & Ecol, Global Change & Terr Ecosyst Int Project Off, Canberra, ACT 2601, Australia; Odense Univ, Inst Biol Sci, DK-5230 Odense, Denmark; Arizona State Univ, Dept Zool, Tempe, AZ 85287 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Atmospher Sci, Los Angeles, CA 90095 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; Swedish Univ Agr Sci, Dept Forest Ecol, S-90183 Umea, Sweden; Swedish Univ Agr Sci, Dept Prod Ecol, S-75007 Uppsala, Sweden; Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Royal Swedish Acad Sci, IGBP Secretariat, S-10405 Stockholm, Sweden	Rutgers State University New Brunswick; Council for Scientific & Industrial Research (CSIR) - South Africa; Massachusetts Institute of Technology (MIT); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Aarhus University; University of Southern Denmark; Arizona State University; Arizona State University-Tempe; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University System Of New Hampshire; University of New Hampshire; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; University of Hawaii System; University of Hawaii Manoa; University of British Columbia; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Royal Swedish Academy of Sciences	Falkowski, P (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	falko@imcs.rutgers.edu	Elser, James/A-7082-2008; Canfield, Don/C-1735-2012; Canadell, Pep/E-9419-2010; Steffen, Will/C-7651-2011; Gruber, Nicolas/B-7013-2009; Elser, James J/AAL-6199-2020; Högberg, Peter/B-2916-2012	Elser, James/0000-0002-1460-2155; Canfield, Don/0000-0001-7602-8366; Canadell, Pep/0000-0002-8788-3218; Gruber, Nicolas/0000-0002-2085-2310; Elser, James J/0000-0002-1460-2155; Högberg, Peter/0000-0002-2849-2719; Scholes, Robert/0000-0001-5537-6935				Arrhenius S, 1896, PHILOS MAG, V41, P237, DOI [DOI 10.1080/14786449608620846, 10.1080/14786449608620846]; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; BAZZAZ FA, 1990, ANNU REV ECOL SYST, V21, P167, DOI 10.1146/annurev.es.21.110190.001123; BROECKER WS, 1992, NATURE, V356, P587, DOI 10.1038/356587a0; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Budyko M. I., 1982, EARTHS CLIMATE PAST; Christensen JP, 1987, GLOBAL BIOGEOCHEM CY, V1, P97, DOI 10.1029/GB001i002p00097; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Crutzen P., 2000, IGBP GLOBAL CHANGE N, P17, DOI DOI 10.1007/3-540-26590-2_3; Dai A, 1997, J CLIMATE, V10, P2943, DOI 10.1175/1520-0442(1997)010<2943:SOGLPV>2.0.CO;2; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P281, DOI 10.1029/1999GB900059; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Hall SJ, 1999, NATURE, V400, P152, DOI 10.1038/22094; Hoffert MI, 1998, NATURE, V395, P881, DOI 10.1038/27638; HOUGHTON JT, 1996, CLIMATE CHANGE IPCC; Howarth R. W., 1996, NITROGEN CYCLING N A; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; Joos F, 1999, SCIENCE, V284, P464, DOI 10.1126/science.284.5413.464; KASTING JF, 1988, SCI AM, V258, P90, DOI 10.1038/scientificamerican0288-90; KEELING RF, 1992, NATURE, V358, P723, DOI 10.1038/358723a0; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Kroeze C, 1998, NUTR CYCL AGROECOSYS, V52, P195, DOI 10.1023/A:1009780608708; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; LAWS E, IN PRESS GLOBAL BIOG; LONG SP, 1992, CROP PHOTOSYNTHESIS, P69, DOI DOI 10.1016/B978-0-444-89608-7.50011-3; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; MITCHELL JFB, 1995, NATURE, V376, P501, DOI 10.1038/376501a0; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SAGE RF, 1995, GLOBAL CHANGE BIOL, V1, P93, DOI 10.1111/j.1365-2486.1995.tb00009.x; Sarmiento JL, 1996, SCIENCE, V274, P1346, DOI 10.1126/science.274.5291.1346; SARMIENTO JL, 1992, ENVIR SCI R, V43, P317; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; SARMIENTO JL, 1994, PHOTOSYNTH RES, V39, P209, DOI 10.1007/BF00014585; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Seitzinger SP, 1996, BIOGEOCHEMISTRY, V35, P235, DOI 10.1007/BF02179829; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; WALSH JJ, 1991, NATURE, V350, P53, DOI 10.1038/350053a0; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	52	1221	1404	81	1274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2000	290	5490					291	296		10.1126/science.290.5490.291	http://dx.doi.org/10.1126/science.290.5490.291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030643				2022-12-28	WOS:000089818100034
J	Strobl, J; Cave, E; Walley, T				Strobl, J; Cave, E; Walley, T			Data protection legislation: interpretation and barriers to research	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFORMED CONSENT		Univ Liverpool, Dept Pharmacol & Therapeut, Prescribing Res Grp, Liverpool L69 3GE, Merseyside, England; Univ Cent Lancashire, Ctr Profess Eth, Preston PR1 2HE, Lancs, England	University of Liverpool; University of Central Lancashire	Strobl, J (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, Prescribing Res Grp, Liverpool L69 3GE, Merseyside, England.	JudithStroblstrobl@liv.ac.uk	Cave, Emma/T-9890-2017	Cave, Emma/0000-0002-3988-9068				Caldicott Committee Department of Health, 1997, REP REV PAT ID INF; *DEP HLTH, 1998, RES DEV EV BAS HLTH; [Department of Health DoH], 1991, LOC RES ETH COMM; Doyal L, 1998, BRIT MED J, V316, P1000, DOI 10.1136/bmj.316.7136.1000; General Medical Council, 1999, SEEK PAT CONS ETH CO; Jones J, 2000, BRIT MED J, V320, P9; Lyons RA, 1999, BRIT MED J, V319, P372, DOI 10.1136/bmj.319.7206.372; *NHS EX, 1999, PROT US PAT INF MAN; *NHS EX, 1999, PROT US PAT INF; *NHS EX, 1999, CALD GUARD; Romano-Critchley G., 1999, CONFIDENTIALITY DISC; Royal Coll Phys, 1999, J ROY COLL PHYS LOND, V33, P241; *SECR HLTH HUM SER, 1999, CONF IND HLTH INF SE; Smith R, 1998, BMJ-BRIT MED J, V316, P949, DOI 10.1136/bmj.316.7136.949; Woodman R, 2000, BRIT MED J, V320, P77, DOI 10.1136/bmj.320.7227.77	15	61	61	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2000	321	7265					890	892		10.1136/bmj.321.7265.890	http://dx.doi.org/10.1136/bmj.321.7265.890			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021874	Green Published, Green Accepted			2022-12-28	WOS:000089857500029
J	Emanuel, EJ; Fairclough, D; Clarridge, BC; Blum, D; Bruera, E; Penley, WC; Schnipper, LE; Mayer, RJ				Emanuel, EJ; Fairclough, D; Clarridge, BC; Blum, D; Bruera, E; Penley, WC; Schnipper, LE; Mayer, RJ			Attitudes and practices of US oncologists regarding euthanasia and physician-assisted suicide	ANNALS OF INTERNAL MEDICINE			English	Article							WASHINGTON-STATE; REQUESTS; DEATH	Background: The practices of euthanasia and physician-assisted suicide remain controversial. Objective: To achieve better understanding of attitudes and practices regarding euthanasia and physician-assisted suicide in the context of end-of-life care. Design: Cohort study. Setting: United States. Participants: 3299 oncologists who are members of the American Society of Clinical Oncology. Measurements: Responses to survey questions on attitudes toward euthanasia and physician-assisted suicide for a terminally ill patient with prostate cancer who has unremitting pain, requests for and performance of euthanasia and physician-assisted suicide, and sociodemographic characteristics. Results: Of U.S. oncologists surveyed, 22.5% supported the use of physician-assisted suicide for a terminally ill patient with unremitting pain and 6.5% supported euthanasia Oncologists who were reluctant to increase the dose of intravenous morphine for terminally ill patients in excruciating pain (odds ratio [OR], 0.61 [95% CI, 0.48 to 0.77]) and had sufficient time to talk to dying patients about end-of-life care issues (OR, 0.79 [CI, 0.71 to 0.87]) were less likely to support euthanasia or physician-assisted suicide. During their career, 3.7% of surveyed oncologists had performed euthanasia and 10.8% had performed physician-assisted suicide. Oncologists who were reluctant to increase the morphine dose for patients in excruciating pain (OR, 0.58 [CI, 0.43 to 0.79]) and those who believed that they had received adequate training in end-of-life care (OR, 0.86 [CI, 0.79 to 0.95]) were less likely to have performed euthanasia or physician-assisted suicide. Oncologists who reported not being able to obtain all the care that a dying patient needed were more likely to have performed euthanasia (P = 0.001). Conclusions: Requests for euthanasia and physician-assisted suicide are likely to decrease as training in end-of-life care improves and the ability of physicians to provide this care to their patients is enhanced.	Dana Farber Canc Inst, Dept Med Adult Oncol, Boston, MA 02115 USA; NIH, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; AMC Canc Res Ctr, Denver, CO USA; Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Canc Care Inc, New York, NY USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Baptist Hosp, Nashville, TN USA	Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; AMC Cancer Research Center; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; UTMD Anderson Cancer Center; Saint Thomas Hospital	Mayer, RJ (corresponding author), Dana Farber Canc Inst, Dept Med Adult Oncol, 44 Binney St, Boston, MA 02115 USA.		Bruera, Eduardo/AAA-1550-2022					Bachman JG, 1996, NEW ENGL J MED, V334, P303, DOI 10.1056/NEJM199602013340506; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BROCK DW, 1992, HASTINGS CENT REP, V22, P10, DOI 10.2307/3562560; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; COHEN JS, 1994, NEW ENGL J MED, V331, P89, DOI 10.1056/NEJM199407143310206; DiMola G, 1996, ANN ONCOL, V7, P907, DOI 10.1093/oxfordjournals.annonc.a010792; DOUKAS DJ, 1995, J CLIN ONCOL, V13, P1055, DOI 10.1200/JCO.1995.13.5.1055; EMANUEL EJ, 1994, ARCH INTERN MED, V154, P1890, DOI 10.1001/archinte.154.17.1890; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; KINSELLA TD, 1993, CAN MED ASSOC J, V148, P1921; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2229; Portenoy RK, 1997, PSYCHOSOMATICS, V38, P277, DOI 10.1016/S0033-3182(97)71465-8; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; WARD BJ, 1994, BRIT MED J, V308, P1332, DOI 10.1136/bmj.308.6940.1332; Wolfe J, 1999, J CLIN ONCOL, V17, P1274, DOI 10.1200/JCO.1999.17.4.1274	17	115	115	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					527	532		10.7326/0003-4819-133-7-200010030-00011	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360QG	11015165				2022-12-28	WOS:000089678300004
J	Benatar, SR; Singer, PA				Benatar, SR; Singer, PA			A new look at international research ethics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEVELOPING-COUNTRIES; PROTECTIONS; HEALTH; TRIALS	The standard of care for subjects participating in clinical trials is not well defined Excessive reliance has been placed on international declarations to define what is ethical, but declarations, like constitutions, need to be interpreted International researchers must develop a deeper understanding of the context within which their research is being conducted An expanded concept for standard of care is offered that takes account of the context of the trial and is sensitive to the social, economic, and political milieu National and intel national bodies concerned with research ethics need to confront the greatest ethical challenge-the enormous inequities in global health.	Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; Univ Cape Town, Ctr Bioeth, ZA-7925 Cape Town, South Africa; Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G L4, Canada	University of Cape Town; University of Cape Town; University of Toronto	Benatar, SR (corresponding author), Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa.	solly.benatar@utoronto.ca						Angell M, 2000, NEW ENGL J MED, V342, P967, DOI 10.1056/NEJM200003303421309; Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; [Anonymous], 1997, LANCET, V350, P897; Beauchamp T. L., 1996, PHILOS REFLECTIONS B, P79; Benatar SR, 1998, J MED ETHICS, V24, P221, DOI 10.1136/jme.24.4.221; Benatar SR, 1998, AM J PUBLIC HEALTH, V88, P295, DOI 10.2105/AJPH.88.2.295; BENATAR SR, 2000, IN PRESS CAMBRIDGE Q; Bloom BR, 1999, NATURE, V402, pC63, DOI [10.1038/35011557, 10.1038/44959]; Clarke M, 1998, LANCET, V351, P286; *COMMHLTH RES DEV, 1990, HLTH RES ESS LINK EQ; Edejer TTT, 1999, BMJ-BRIT MED J, V319, P438, DOI 10.1136/bmj.319.7207.438; Ellis GB, 1999, JAMA-J AM MED ASSOC, V282, P1963, DOI 10.1001/jama.282.20.1963; Fairchild AL, 1999, SCIENCE, V284, P919, DOI 10.1126/science.284.5416.919; Falk R., 1999, PREDATORY GLOBALISAT; Hardy E, 1996, CLIN PHARMACOL THER, V60, P121, DOI 10.1016/S0009-9236(96)90126-5; *JF KENN SCH GOV C, DEB CLIN TRIALS AZT; Loue S, 1996, J LAW MED ETHICS, V24, P47, DOI 10.1111/j.1748-720X.1996.tb01832.x; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; MARSHALL PA, 1998, HDB IMMIGRANT HLTH, P206; Moreno J, 1998, JAMA-J AM MED ASSOC, V280, P1951, DOI 10.1001/jama.280.22.1951; NOWAK R, 1994, SCIENCE, V264, P1538, DOI 10.1126/science.8202708; Nuffield Council on Bioethics, 1999, ETH CLIN RES DEV COU; Silberner J, 2000, HASTINGS CENT REP, V30, P6; Singer PA, 2000, BRIT MED J, V321, P282, DOI 10.1136/bmj.321.7256.282; SPECE RG, 1997, CONFLICTS INTEREST C; Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411; Weijer C, 1999, NAT GENET, V23, P275, DOI 10.1038/15455; Woodward B, 1999, JAMA-J AM MED ASSOC, V282, P1947, DOI 10.1001/jama.282.20.1947; 1998, HUMAN RAD EXPT FINAL	29	158	158	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2000	321	7264					824	826		10.1136/bmj.321.7264.824	http://dx.doi.org/10.1136/bmj.321.7264.824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360ZE	11009528	Green Published, Green Submitted			2022-12-28	WOS:000089696600032
J	Costello, A; Zumla, A				Costello, A; Zumla, A			Moving to research partnerships in developing countries	BRITISH MEDICAL JOURNAL			English	Article								Much foreign-led research in developing countries remains semicolonial in nature and may have negative effects on partner countries "Annexed site" research led by expatriates should be phased out and replaced by a partnership model in which nationals lead research projects, with only technical support from outsiders Research funded through national academics and institutions improves the chances of findings being translated into national policy and practice The principles of an equal research partnership need monitoring by funding agencies.	UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England; UCL, Windeyer Inst Med Sci, Royal Free & Univ Coll Med Sch, Ctr Infect Dis & Int Hlth, London WC1N 6BD, England	University of London; University College London; University of London; University College London	Costello, A (corresponding author), UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England.	a.costello@ich.ucl.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANGELL M, 1997, NEW ENGL J MED, V337, P84797; COOVADIA HM, 1999, SEMINARS NEONATOLOGY, V4, P193; DAVIDOFF F, 1995, BRIT MED J, V310, P1122; Haines A, 1998, BMJ-BRIT MED J, V317, P72, DOI 10.1136/bmj.317.7150.72; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; PAYER L, 1990, MED CULTURE NOTIONS; PORTER AMW, 1980, LANCET, V1, P1071; Swiss Commission for Research Partnership with Developing Countries, 1998, GUID RES PARTN DEV C; World Health Organization, 2000, WORLD HLTH REP 2000	9	197	197	1	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					827	829		10.1136/bmj.321.7264.827	http://dx.doi.org/10.1136/bmj.321.7264.827			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009530	Green Published			2022-12-28	WOS:000089696600036
J	Nattinger, AB; Hoffmann, RG; Kneusel, RT; Schapira, MM				Nattinger, AB; Hoffmann, RG; Kneusel, RT; Schapira, MM			Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery	LANCET			English	Article							RANDOMIZED CLINICAL-TRIAL; CONSENSUS-DEVELOPMENT-CONFERENCE; AXILLARY DISSECTION; RADIATION-THERAPY; TOTAL MASTECTOMY; CANCER-PATIENTS; OLDER WOMEN; NODE; LUMPECTOMY; SURVIVAL	Background Breast-conserving surgery is a more complex treatment than mastectomy, because a separate incision is needed for axillary lymph-node dissection, and postoperative radiotherapy is necessary. We postulated that adoption of this therapy into clinical practice might have led to discrepancies between the care recommended and that received. Methods We used records of the US national Surveillance, Epidemiology, and End Results tumour registry to study 144:759 women aged 30 years and older who underwent surgery for early-stage breast cancer between 1983 and 1995. We calculated the proportion undergoing at least the minimum appropriate primary treatment (defined, in accordance with the recommendations of a National Institutes of Health Consensus Conference in 1990, as total mastectomy with axillary node dissection or breast-conserving surgery wit axillary node dissection and radiotherapy) during each 3-month period. Findings The proportion of women receiving appropriate primary therapy fell from 88% in 1983-89 to 78% by the end of 1995. This decline was observed in all subgroups of age, race, stage, and population density. Of all women in the cohort, the proportion undergoing an inappropriate form of mastectomy remained stable at about 2.7% throughout the study period. The proportion undergoing an inappropriate form of breast-conserving surgery (omission of radiotherapy, axillary node dissection, or both) increased from 10% in 1989 to 19% at the end of 1995. Interpretation Although most women undergo appropriate care, the appropriateness of care for early-stage breast cancer in the USA declined from 1990 to 1995. Because the proportion of all women who were treated by breast-conserving surgery increased, and because this approach was more likely than was mastectomy to be applied inappropriately, the proportion of all women having inappropriate care increased.	Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Biostat, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Nattinger, AB (corresponding author), Div Gen Internal Med, FEC Med Off Bldg,Suite 4200,9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.			Nattinger, Ann/0000-0002-8189-3300				ABE O, 1995, NEW ENGL J MED, V333, P1444; BallardBarbash R, 1996, JNCI-J NATL CANCER I, V88, P716, DOI 10.1093/jnci/88.11.716; *BUR HLTH PROF, 1992, AR RES FIL SYST INF; CABANES PA, 1992, LANCET, V339, P1245, DOI 10.1016/0140-6736(92)91591-U; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Clark RM, 1996, J NATL CANCER I, V88, P1659, DOI 10.1093/jnci/88.22.1659; DECKERS PJ, 1991, J SURG ONCOL, V48, P217, DOI 10.1002/jso.2930480402; Du XL, 1999, J CLIN EPIDEMIOL, V52, P463, DOI 10.1016/S0895-4356(99)00011-6; Du XL, 1999, J GERONTOL A-BIOL, V54, pM474, DOI 10.1093/gerona/54.9.M474; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; FISHER B, 1985, NEW ENGL J MED, V312, P674, DOI 10.1056/NEJM198503143121102; Goodwin JS, 1996, JNCI-J NATL CANCER I, V88, P1031, DOI 10.1093/jnci/88.15.1031; HARRIS JR, 1993, CANC PRINCIPLES PRAC, P1264; HOUGHTON J, 1980, LANCET, V2, P55; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; LAZOVICH D, 1991, JAMA-J AM MED ASSOC, V266, P3433, DOI 10.1001/jama.266.24.3433; Lazovich D, 1997, ARCH SURG-CHICAGO, V132, P418; Lazovich DA, 1999, CANCER-AM CANCER SOC, V86, P628, DOI 10.1002/(SICI)1097-0142(19990815)86:4<628::AID-CNCR11>3.0.CO;2-L; LEEFELDSTEIN A, 1994, JAMA-J AM MED ASSOC, V271, P1163, DOI 10.1001/jama.271.15.1163; LILJEGREN G, 1994, JNCI-J NATL CANCER I, V86, P717, DOI 10.1093/jnci/86.9.717; LIN PP, 1993, J CLIN ONCOL, V11, P1536, DOI 10.1200/JCO.1993.11.8.1536; MANN BA, 1988, JAMA-J AM MED ASSOC, V259, P3413; McMasters KM, 1998, NEW ENGL J MED, V339, P990, DOI 10.1056/NEJM199810013391410; *NAT CANC I DCPC S, 1998, SURV EP END RES PROG; Nattinger AB, 1996, NEW ENGL J MED, V335, P1035, DOI 10.1056/NEJM199610033351407; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; Nattinger AB, 1998, JAMA-J AM MED ASSOC, V279, P762; NATTINGER AB, 1992, NEW ENGL J MED, V326, P1102, DOI 10.1056/NEJM199204233261702; NATTINGER AB, 1996, MED CARE, V34, P749; Pastor R, 1998, AM J EPIDEMIOL, V148, P631, DOI 10.1093/aje/148.7.631; Riley GF, 1999, JAMA-J AM MED ASSOC, V281, P720, DOI 10.1001/jama.281.8.720; RUFFIN WK, 1995, J AM COLL SURGEONS, V180, P245; *TREATM EARL STAG, 1990, NIH CONS DEV C JUN 1, V8; White RE, 1996, J AM COLL SURGEONS, V183, P575; WINCHESTER DP, 1992, CA-CANCER J CLIN, V42, P134, DOI 10.3322/canjclin.42.3.134; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	36	142	143	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1148	1153		10.1016/S0140-6736(00)02757-4	http://dx.doi.org/10.1016/S0140-6736(00)02757-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030294				2022-12-28	WOS:000089594300012
J	Sarkar, S; Aziz, Q; Woolf, CJ; Hobson, AR; Thompson, DG				Sarkar, S; Aziz, Q; Woolf, CJ; Hobson, AR; Thompson, DG			Contribution of central sensitisation to the development of non-cardiac chest pain	LANCET			English	Article							SECONDARY HYPERALGESIA; VISCERAL PAIN; HUMANS; RAT; INFLAMMATION; CAPSAICIN; FIELDS; STATES	Background Non-cardiac chest pain mimics angina pectoris but generally originates from the oesophagus, Visceral hypersensitivity may contribute, but its neurophysiological basis, is unclear. We investigated whether central sensitisation, an activity-dependent amplification of sensory transfer in the central nervous system, underlies visceral pain hypersensitivity and non-cardiac chest pain. Methods We studied 19 healthy volunteers and seven patients with non-cardiac chest pain. Acid was infused into the lower oesophagus. Sensory responses to electrical stimulation were monitored within the acid-exposed lower oesophagus, the non-exposed upper oesophagus, and the cutaneous area of pain referral, before and after the infusion. Findings In healthy volunteers, acid infusion into the lower oesophagus lowered the pain threshold in the upper oesophagus (mean decrease 18.2% [95% CI 10.4 to 26.0]; p=0.01) and on the chest wall (24.5% [10.2 to 38.7]; p=0.01). Patients with non-cardiac chest pain had a lower resting oesophageal pain threshold than healthy controls (45 [30 to 58] vs 64 [49 to 81] mA; p=0.04). In response to acid infusion, their pain threshold in the upper oesophagus fell further and for longer (mean fall in area under threshold/time curve 26.7 [11.0 to 42.3] vs 5.8 [2.8 to 8.8] units; p=0.04). Interpretation The finding of secondary viscerovisceral and viscerosomatic pain hypersensitivity suggests that central sensitisation may contribute to visceral pain disorders. The prolonged visceral pain hypersensitivity in patients with noncardiac chest pain suggests a central enhancement of sensory transfer. New therapeutic opportunities are therefore possible.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Univ Manchester, Hope Hosp, Gastroenterol Sect, Salford M6 8HD, Lancs, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Manchester	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, 149 13th St,Room 4309, Charlestown, MA 02129 USA.		Woolf, Clifford/A-9784-2010; Aziz, Qasim/AAC-4730-2020	Aziz, Qasim/0000-0002-2718-2065				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Coutinho SV, 1996, BRAIN RES, V736, P7, DOI 10.1016/0006-8993(96)00661-0; GARRISON DW, 1992, PAIN, V49, P373, DOI 10.1016/0304-3959(92)90245-7; Gwee KA, 1999, GUT, V44, P400, DOI 10.1136/gut.44.3.400; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; HEFT MW, 1984, PAIN, V19, P153, DOI 10.1016/0304-3959(84)90835-2; Ilkjaer S, 1997, BRIT J ANAESTH, V79, P600, DOI 10.1093/bja/79.5.600; Ilkjaer S, 1996, BRIT J ANAESTH, V76, P829, DOI 10.1093/bja/76.6.829; KEMP HG, 1973, AM J MED, V54, P735, DOI 10.1016/0002-9343(73)90060-0; Lynn PA, 1999, J PHYSIOL-LONDON, V518, P271, DOI 10.1111/j.1469-7793.1999.0271r.x; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; MCMAHON SB, 1987, PAIN, V28, P109, DOI 10.1016/0304-3959(87)91065-7; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; NESS TJ, 1990, PAIN, V41, P167, DOI 10.1016/0304-3959(90)90021-5; Richter J E, 1988, Adv Intern Med, V33, P311; RICHTER JE, 1989, ANN INTERN MED, V110, P66, DOI 10.7326/0003-4819-110-1-66; RICHTER JE, 1986, GASTROENTEROLOGY, V91, P845, DOI 10.1016/0016-5085(86)90685-2; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SIMONE DA, 1989, PAIN, V38, P99, DOI 10.1016/0304-3959(89)90079-1; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; WOOLF CJ, 1991, PAIN, V44, P293, DOI 10.1016/0304-3959(91)90100-C; WOOLF CJ, IN PRESS P NATL ACAD	23	272	280	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1154	1159		10.1016/S0140-6736(00)02758-6	http://dx.doi.org/10.1016/S0140-6736(00)02758-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030295				2022-12-28	WOS:000089594300013
J	Edwards, JL; Lane, MA; Nielsen, ES				Edwards, JL; Lane, MA; Nielsen, ES			Interoperability of biodiversity databases: Biodiversity information on every desktop	SCIENCE			English	Editorial Material									Natl Sci Fdn, Directorate Biol Sci, Arlington, VA 22230 USA; Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; CSIRO Entomol, Australian Natl Insect Collect, Canberra, ACT 2601, Australia	National Science Foundation (NSF); NSF - Directorate for Biological Sciences (BIO); Drexel University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Edwards, JL (corresponding author), Natl Sci Fdn, Directorate Biol Sci, 4201 Wilson Blvd, Arlington, VA 22230 USA.							Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; Hammond P.M., 1995, GLOBAL BIODIVERSITY, P113; LANE MA, 1999, WEAVING WEB WEALTH B; Malakoff D, 2000, SCIENCE, V288, P1575, DOI 10.1126/science.288.5471.1575; Maurer SM, 2000, NATURE, V405, P117, DOI 10.1038/35012169; MAY RM, 1999, NATURE HUMAN SOC QUE, P30	6	158	169	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2312	2314		10.1126/science.289.5488.2312	http://dx.doi.org/10.1126/science.289.5488.2312			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009409				2022-12-28	WOS:000089593500041
J	Taylor, WR; He, SG; Levick, WR; Vaney, DI				Taylor, WR; He, SG; Levick, WR; Vaney, DI			Dendritic computation of direction selectivity by retinal ganglion cells	SCIENCE			English	Article							RABBIT RETINA; AMACRINE CELLS; MECHANISM	Direction-selective ganglion cells (DSGCs) in the retina respond strongly when stimulated by image motion in a preferred direction but are only weakly excited by image motion in the opposite null direction. Such coding represents an early manifestation of complex information processing in the visual system, but the cellular locus and the synaptic mechanisms have yet to be elucidated. We recorded the synaptic activity of DSGCs using strategies to observe the asymmetric inhibitory inputs that underlie the generation of direction selectivity. The critical nonlinear interactions between the excitatory and inhibitory inputs took place postsynaptically within the dendrites of the DSGCs.	Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; Australian Natl Univ, Ctr Visual Sci, Canberra, ACT 2601, Australia; Australian Natl Univ, Dept Psychol, Canberra, ACT 2601, Australia; Univ Queensland, Sch Biomed Sci, Vis Touch & Hearing Res Ctr, Brisbane, Qld 4072, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Australian National University; University of Queensland	Taylor, WR (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	Rowland.Taylor@anu.edu.au	LEVICK, WILLIAM R/A-9056-2008	LEVICK, WILLIAM R/0000-0002-8265-4424; Taylor, William/0000-0002-6806-3249				AMTHOR FR, 1993, J NEUROPHYSIOL, V69, P2174, DOI 10.1152/jn.1993.69.6.2174; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; He SG, 1999, J NEUROSCI, V19, P8049; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; MARCHIAFAVA PL, 1979, VISION RES, V19, P1203, DOI 10.1016/0042-6989(79)90185-8; OYSTER CW, 1993, VISION RES, V33, P579, DOI 10.1016/0042-6989(93)90181-U; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; VANEY DI, 1994, J NEUROSCI, V14, P6301; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857	16	130	134	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2347	2350		10.1126/science.289.5488.2347	http://dx.doi.org/10.1126/science.289.5488.2347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009420				2022-12-28	WOS:000089593500052
J	Simoncini, T; Hafezl-Moghadam, A; Brazil, DP; Ley, K; Chin, WW; Liao, JK				Simoncini, T; Hafezl-Moghadam, A; Brazil, DP; Ley, K; Chin, WW; Liao, JK			Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL GROWTH-FACTOR; HUMAN ESTROGEN-RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; PROTEIN; ACTIVATION; CELLS; AKT; INSULIN; PHOSPHORYLATION	Oestrogen produces diverse biological effects through binding to the oestrogen receptor (ER)(1). The ER is a steroid hormone nuclear receptor, which, when bound to oestrogen, modulates the transcriptional activity of target genes(2). Controversy exists, however, concerning whether ER has a role outside the nucleus(3), particularly in mediating the cardiovascular protective effects of oestrogen(4). Here we show that the ER isoform, ER alpha, binds in a ligand-dependent manner to the p85 alpha regulatory subunit of phosphatidylinositol-3-OH kinase (PI(3)K). Stimulation with oestrogen increases ER alpha-associated PI(3)K activity, leading to the activation of protein kinase B/Akt and endothelial nitric oxide synthase (eNOS). Recruitment and activation of PI(3)K by ligand-bound ERa are independent of gene transcription, do not involve phosphotyrosine adapter molecules or src-homology domains of p85 alpha, and extend to other steroid hormone receptors. Mice treated with oestrogen show increased eNOS activity and decreased vascular leukocyte accumulation after ischaemia and reperfusion injury. This vascular protective effect of oestrogen was abolished in the presence of PI(3)K or eNOS inhibitors. Our findings define a physiologically important non-nuclear oestrogen-signalling pathway involving the direct interaction of ERa with PI(3)K.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Virginia, Hlth Sci Ctr, Dept Biomed Engn, Charlottesville, VA 22908 USA; Joslin Diabet Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Virginia; Harvard University; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	Liao, JK (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 221 Longwood Ave, Boston, MA 02115 USA.		Simoncini, Tommaso/AAC-1879-2019	Simoncini, Tommaso/0000-0002-2971-0079; Brazil, Derek/0000-0003-1375-1076; Hafezi-Moghadam, Ali/0000-0002-5336-0697	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070274, P01HL048743, R01HL052233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062729] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070274-04, R01 HL052233-06, P01 HL048743-090008, R01 HL070274-02, R01 HL070274-03, R01 HL052233-05, R01 HL070274-01, R01 HL070274-05, R01 HL070274, P01 HL048743-080008, R01 HL052233, P01 HL048743, R01 HL052233-08, R01 HL052233-07] Funding Source: Medline; NIDDK NIH HHS [R01 DK062729-02, R01 DK062729-04, R01 DK062729, R01 DK062729-01A1, R01 DK062729-05, R01 DK062729-03] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; Gustafsson JA, 2000, J SOC GYNECOL INVEST, V7, pS8, DOI 10.1177/1071557600007001S04; Kanwar S, 1998, MICROCIRCULATION, V5, P281, DOI 10.1080/713773894; KAPELLER R, 1995, J BIOL CHEM, V270, P25985, DOI 10.1074/jbc.270.43.25985; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Stefano GB, 2000, CIRCULATION, V101, P1594, DOI 10.1161/01.CIR.101.13.1594; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871	30	1145	1176	0	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					538	541		10.1038/35035131	http://dx.doi.org/10.1038/35035131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029009	Green Accepted			2022-12-28	WOS:000089727400057
J	True, HL; Lindquist, SL				True, HL; Lindquist, SL			A yeast prion provides a mechanism for genetic variation and phenotypic diversity	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSLATION TERMINATION; OMNIPOTENT SUPPRESSORS; RELEASE FACTORS; PSI+ PRION; SUP35 GENE; EVOLUTION; DETERMINANT; MUTANTS; PROTEIN	A major enigma in evolutionary biology is that new forms or functions often require the concerted effects of several independent genetic changes. It is unclear how such changes might accumulate when they are likely to be deleterious individually and be lost by selective pressure. The Saccharomyces cerevisiae prion [PSI+] is an epigenetic modifier of the fidelity of translation termination, but its impact on yeast biology has been unclear. Here we show that [PSI+] provides the means to uncover hidden genetic variation and produce new heritable phenotypes. Moreover, in each of the seven genetic backgrounds tested, the constellation of phenotypes produced was unique. We propose that the epigenetic and metastable nature of [PSI+] inheritance allows yeast cells to exploit pre-existing genetic variation to thrive in fluctuating environments. Further, the capacity of [PSI+] to convert previously neutral genetic variation to a non-neutral state may facilitate the evolution of new traits.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Lindquist, SL (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 5841 S Maryland Ave, Chicago, IL 60637 USA.		True, Heather/D-2979-2012					Adams A, 1997, METHODS YEAST GENETI; BAILEY MJ, 1981, ENZYME MICROB TECH, V3, P153, DOI 10.1016/0141-0229(81)90076-4; Budavari S., 1989, MERCK INDEX; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1992, BIOCHIMIE, V74, P455, DOI 10.1016/0300-9084(92)90086-T; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Derkatch IL, 1997, GENETICS, V147, P507; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; EUSTICE DC, 1986, J MOL BIOL, V188, P207, DOI 10.1016/0022-2836(86)90305-0; FIROOZAN M, 1991, YEAST, V7, P173, DOI 10.1002/yea.320070211; GRANT CM, 1989, MOL MICROBIOL, V3, P215, DOI 10.1111/j.1365-2958.1989.tb01810.x; HALL BG, 1983, MOL BIOL EVOL, V1, P109; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; KIKUCHI Y, 1988, GENE EXPRESSION REGU, P257; KOCH AL, 1972, GENETICS, V72, P297; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; KUSHNIROV VV, 1990, YEAST, V6, P461, DOI 10.1002/yea.320060603; KUSHNIROV VV, 1988, GENE, V66, P45, DOI 10.1016/0378-1119(88)90223-5; LEVITT RC, 1991, GENOMICS, V11, P484, DOI 10.1016/0888-7543(91)90168-E; LIEBMAN SW, 1979, J BACTERIOL, V139, P1068, DOI 10.1128/JB.139.3.1068-1071.1979; Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Nadeau JH, 1997, GENETICS, V147, P1259; Ohno S., 1970, EVOLUTION GENE DUPLI; OHTA T, 1987, GENETICS, V115, P207; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Rieger KJ, 1997, YEAST, V13, P1547, DOI 10.1002/(SICI)1097-0061(199712)13:16<1547::AID-YEA230>3.3.CO;2-P; RONCERO C, 1988, J BACTERIOL, V170, P1950, DOI 10.1128/jb.170.4.1950-1954.1988; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Seoighe C, 1999, GENE, V238, P253, DOI 10.1016/S0378-1119(99)00319-4; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Tikhomirova VL, 1996, CURR GENET, V30, P44, DOI 10.1007/s002940050098; TUITE MF, 1981, GENETICS, V98, P691; WAKEM LP, 1990, GENETICS, V124, P515; WALSH JB, 1995, GENETICS, V139, P421; WILSON SP, 1988, SEC MESS PHOSPHOPROT, V12, P1; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	49	532	548	0	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					477	483		10.1038/35035005	http://dx.doi.org/10.1038/35035005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028992				2022-12-28	WOS:000089727400040
J	Ghez, AM; Morris, M; Becklin, EE; Tanner, A; Kremenek, T				Ghez, AM; Morris, M; Becklin, EE; Tanner, A; Kremenek, T			The accelerations of stars orbiting the Milky Way's central black hole	NATURE			English	Article							SAGITTARIUS-A-ASTERISK; GALACTIC-CENTER; PROPER-MOTION; GALAXY; TELESCOPE; DISTANCE; NUCLEI; RADIO	Recent measurements(1-4) of the velocities of stars near the centre of the Milky Way have provided the strongest evidence for the presence of a supermassive black hole in a galaxy(5), but the observational uncertainties poorly constrain many of the black hole's properties. Determining the accelerations of stars in their orbits around the centre provides much more precise information about the position and mass of the black hole. Here we report measurements of the accelerations of three stars located similar to 0.005 pc (projected on the sky) from the central radio source Sagittarius A(star) (Sgr A(star)); these accelerations are comparable to those experienced by the Earth as it orbits the Sun. These data increase the inferred minimum mass density in the central region of the Galaxy by an order of magnitude relative to previous results, and localize the dark mass to within 0.05 +/- 0.04 arcsec of the nominal position of Sgr A(star). In addition, the orbital period of one of the observed stars could be as short as 15 years, allowing us the opportunity in the near future to observe an entire period.	Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Ghez, AM (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.			Morris, Mark/0000-0002-6753-2066				Babu G.J., 1996, ASTROSTATISTICS; Backer DC, 1999, ASTROPHYS J, V524, P805, DOI 10.1086/307857; Eckart A, 1997, MON NOT R ASTRON SOC, V284, P576, DOI 10.1093/mnras/284.3.576; Genzel R, 1997, MON NOT R ASTRON SOC, V291, P219, DOI 10.1093/mnras/291.1.219; GENZEL R, IN PRESS MON NOT R A; GERHARD O, UNPUB ASTROPHYS J; Ghez AM, 1998, ASTROPHYS J, V509, P678, DOI 10.1086/306528; Gondolo P, 1999, PHYS REV LETT, V83, P1719, DOI 10.1103/PhysRevLett.83.1719; Lo KY, 1998, ASTROPHYS J, V508, pL61, DOI 10.1086/311726; Maoz E, 1998, ASTROPHYS J, V494, pL181, DOI 10.1086/311194; MATTHEWS K, 1994, ASTROPHYS SPACE SC L, V190, P239; Matthews K, 1996, PUBL ASTRON SOC PAC, V108, P615, DOI 10.1086/133773; Menten KM, 1997, ASTROPHYS J, V475, pL111, DOI 10.1086/310472; Morris M, 1999, ADV SPACE RES-SERIES, V23, P959, DOI 10.1016/S0273-1177(99)00219-7; Reid MJ, 1999, ASTROPHYS J, V524, P816, DOI 10.1086/307855; REID MJ, 1993, ANNU REV ASTRON ASTR, V31, P345; ROMANOWSKY A, IN PRESS ASP C SERIE; SALATI P, 1989, ASTROPHYS J, V338, P24, DOI 10.1086/167177; Salim S, 1999, ASTROPHYS J, V523, P633, DOI 10.1086/307756; SANDERS RH, 1992, NATURE, V359, P131, DOI 10.1038/359131a0; TORRES DF, IN PRESS ASTROPHYS J; Tsiklauri D, 1998, ASTROPHYS J, V500, P591, DOI 10.1086/305753	22	291	294	2	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					349	351		10.1038/35030032	http://dx.doi.org/10.1038/35030032			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014184	Green Submitted			2022-12-28	WOS:000089390700038
J	Huang, P; Feng, L; Oldham, EA; Keating, MJ; Plunkett, W				Huang, P; Feng, L; Oldham, EA; Keating, MJ; Plunkett, W			Superoxide dismutase as a target for the selective killing of cancer cells	NATURE			English	Article							ENDOGENOUS MAMMALIAN METABOLITE; INHIBITS TUBULIN POLYMERIZATION; DEPENDENT FORMATION; CYTOCHROME-C; 2-METHOXYESTRADIOL; APOPTOSIS; RADICALS; CYTOTOXICITY; OXIDASE; TISSUES	Superoxide dismutases (SOD) are essential enzymes that eliminate superoxide radical (O-2(-)) and thus protect cells from damage induced by free radicals(1-3). The active O-2(-) production and low SOD activity in cancer cells(3-7) may render the malignant cells highly dependent on SOD for survival and sensitive to inhibition of SOD. Here we report that certain oestrogen derivatives selectively kill human leukaemia cells but not normal lymphocytes. Using complementary DNA microarray and biochemical approaches, we identify SOD as a target of this drug action and show that chemical modifications at the 2-carbon (2-OH, 2-OCH3) of the derivatives are essential for SOD inhibition and for apoptosis induction. Inhibition of SOD causes accumulation of cellular O-2(-) and leads to free-radical-mediated damage to mitochondrial membranes, the release of cytochrome c from mitochondria and apoptosis of the cancer cells. Our results indicate that targeting SOD may be a promising approach to the selective killing of cancer cells, and that mechanism-based combinations of SOD inhibitors with free-radical-producing agents may have clinical applications.	Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Leukaemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Huang, P (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.			Hileman, Elizabeth/0000-0001-6822-9571				Bindokas VP, 1996, J NEUROSCI, V16, P1324; CASPARY WJ, 1979, MOL PHARMACOL, V16, P256; CUSHMAN M, 1995, J MED CHEM, V38, P2041, DOI 10.1021/jm00012a003; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P3964, DOI 10.1073/pnas.91.9.3964; DIONISI O, 1975, BIOCHIM BIOPHYS ACTA, V403, P292, DOI 10.1016/0005-2744(75)90059-5; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fujimura M, 1999, J NEUROSCI, V19, P3414; GAJEWSKI E, 1990, BIOCHEMISTRY-US, V29, P7876, DOI 10.1021/bi00486a014; GUTTERIDGE JMC, 1982, BIOCHEM J, V206, P605, DOI 10.1042/bj2060605; Halliwell B., 1985, FREE RADICALS BIOL M, DOI 10.1016/0748-5514(85)90140-0; HAMANA K, 1985, BIOCHEM INT, V10, P301; Heiden MGV, 1997, CELL, V91, P627; HUANG P, 1990, J BIOL CHEM, V265, P16617; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; MARKLUND SL, 1982, CANCER RES, V42, P1955; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Mohanty PS, 1997, SCI TECHNOL WELD JOI, V2, P133, DOI 10.1179/stw.1997.2.3.133; Mukhopadhyay T, 1998, ONCOGENE, V17, P241, DOI 10.1038/sj.onc.1201909; OBERLEY LW, 1979, CANCER RES, V39, P1141; Pervaiz S, 1999, FEBS LETT, V459, P343, DOI 10.1016/S0014-5793(99)01258-2; RIGO A, 1975, BIOCHEM BIOPH RES CO, V63, P1013, DOI 10.1016/0006-291X(75)90670-1; SHULYAKOVSKAYA T, 1993, BIOCHEM BIOPH RES CO, V195, P581, DOI 10.1006/bbrc.1993.2085; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Van Driel BEM, 1999, J HISTOCHEM CYTOCHEM, V47, P575, DOI 10.1177/002215549904700501; YOUNG RC, 1981, NEW ENGL J MED, V305, P139, DOI 10.1056/NEJM198107163050305; Zwacka RM, 1998, HUM GENE THER, V9, P1381, DOI 10.1089/hum.1998.9.9-1381	27	709	758	2	108	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					390	395		10.1038/35030140	http://dx.doi.org/10.1038/35030140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014196				2022-12-28	WOS:000089390700050
J	Kortner, G; Brigham, RM; Geiser, F				Kortner, G; Brigham, RM; Geiser, F			Metabolism - Winter torpor in a large bird	NATURE			English	Article							HIBERNATION		Univ New England, Sch Biol Sci, Armidale, NSW 2351, Australia; Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada	University of New England; University of Regina	Kortner, G (corresponding author), Univ New England, Sch Biol Sci, Armidale, NSW 2351, Australia.		Brigham, R Mark/E-6825-2010; Geiser, Fritz/O-4175-2018	Brigham, R Mark/0000-0001-6765-4250; Geiser, Fritz/0000-0001-7621-5049				BRIGHAM RM, 1992, PHYSIOL ZOOL, V65, P457, DOI 10.1086/physzool.65.2.30158263; Cossins AR, 1996, NATURE, V382, P582, DOI 10.1038/382582a0; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Kortner G, 1999, J ZOOL, V248, P501, DOI 10.1111/j.1469-7998.1999.tb01049.x; Kortner G, 2000, OECOLOGIA, V123, P350, DOI 10.1007/s004420051021; Lyman C.P., 1982, HIBERNATION TORPOR M; Reinertsen R.E., 1983, Polar Research, V1, P269, DOI 10.1111/j.1751-8369.1983.tb00743.x	7	60	63	1	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					318	318		10.1038/35030297	http://dx.doi.org/10.1038/35030297			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014178				2022-12-28	WOS:000089390700032
J	Schroder, A; Aeppli, G; Coldea, R; Adams, M; Stockert, O; von Lohneysen, H; Bucher, E; Ramazashvili, R; Coleman, P				Schroder, A; Aeppli, G; Coldea, R; Adams, M; Stockert, O; von Lohneysen, H; Bucher, E; Ramazashvili, R; Coleman, P			Onset of antiferromagnetism in heavy-fermion metals	NATURE			English	Article							QUANTUM-CRITICAL-POINT; MAGNETIC CORRELATIONS; LIQUID BEHAVIOR; KONDO LATTICE; CECU6-XAUX; SYSTEMS; FLUCTUATIONS; TEMPERATURE; INSTABILITY; RESISTIVITY	There are two main theoretical descriptions of antiferromagnets. The first arises from atomic physics, which predicts that atoms with unpaired electrons develop magnetic moments. In a solid, the coupling between moments on nearby ions then yields antiferromagnetic order at low temperatures(1). The second description, based on the physics of electron fluids or 'Fermi liquids', states that Coulomb interactions can drive the fluid to adopt a more stable configuration by developing a spin density wave(2,3). It is at present unknown which view is appropriate at a 'quantum critical point', where the antiferromagnetic transition temperature vanishes(4-7). Here we report neutron scattering and bulk magnetometry measurements of the metal CeCu6-xAux, which allow us to discriminate between the two models. We rnd evidence for an atomically local contribution to the magnetic correlations which develops at the critical gold concentration (x(c) = 0.1), corresponding to a magnetic ordering temperature of zero. This contribution implies that a Fermi-liquid-destroying spin-localizing transition, unanticipated from the spin density wave description, coincides with the antiferromagnetic quantum critical point.	Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, Piscataway, NJ 08854 USA; Univ Karlsruhe, Inst Phys, D-76128 Karlsruhe, Germany; NEC Corp Ltd, Princeton, NJ 08540 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Rutherford Appleton Lab, CCLRC, ISIS Facil, Didcot OX11 0QX, Oxon, England; Univ Constance, Dept Phys, D-78457 Constance, Germany; Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Rutgers State University New Brunswick; Helmholtz Association; Karlsruhe Institute of Technology; NEC Corporation; United States Department of Energy (DOE); Oak Ridge National Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Konstanz; Alcatel-Lucent; Lucent Technologies; AT&T; University of Illinois System; University of Illinois Urbana-Champaign	Coleman, P (corresponding author), Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, POB 849, Piscataway, NJ 08854 USA.	Coleman@physics.rutgers.edu	Loehneysen, Hilbert/W-2490-2019; Ramazashvili, Revaz/J-5090-2013	Ramazashvili, Revaz/0000-0001-5133-8253				AEPPLI G, 1994, HANDB PHYSI, V19, P123; ANDERSON PW, 1959, PHYS REV, V115, P2, DOI 10.1103/PhysRev.115.2; ARONSON MC, 1995, PHYS REV LETT, V75, P725, DOI 10.1103/PhysRevLett.75.725; CARLILE CJ, 1992, PHYSICA B, V182, P431, DOI 10.1016/0921-4526(92)90047-V; Castro Neto AH, 1998, PHYS REV LETT, V81, P3531, DOI 10.1103/PhysRevLett.81.3531; CHAKRAVARTY S, 1988, PHYS REV LETT, V60, P1057, DOI 10.1103/PhysRevLett.60.1057; DONIACH S, 1977, PHYSICA B & C, V91, P231, DOI 10.1016/0378-4363(77)90190-5; DONIACH S, 1987, P 5 INT C VAL FLUCT, P179; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; MORIYA T, 1995, J PHYS SOC JPN, V64, P960, DOI 10.1143/JPSJ.64.960; ONUKI Y, 1984, J PHYS SOC JPN, V53, P1210, DOI 10.1143/JPSJ.53.1210; OVERHAUSER AW, 1959, PHYS REV LETT, V3, P414, DOI 10.1103/PhysRevLett.3.414; Rosch A, 1999, PHYS REV LETT, V82, P4280, DOI 10.1103/PhysRevLett.82.4280; Rosch A, 1997, PHYS REV LETT, V79, P159, DOI 10.1103/PhysRevLett.79.159; RUCK M, 1993, ACTA CRYSTALLOGR B, V49, P936, DOI 10.1107/S0108768193005233; SACHDEV S, 1992, PHYS REV LETT, V69, P2411, DOI 10.1103/PhysRevLett.69.2411; SACHDEV S, 1994, Z PHYS B CON MAT, V94, P469, DOI 10.1007/BF01317409; SCHRODER A, 1994, PHYSICA B, V199, P47, DOI 10.1016/0921-4526(94)91733-7; Schroder A, 1998, PHYS REV LETT, V80, P5623, DOI 10.1103/PhysRevLett.80.5623; SCHRODER A, 1992, J MAGN MAGN MATER, V108, P47, DOI 10.1016/0304-8853(92)91342-Q; Si QM, 1999, INT J MOD PHYS B, V13, P2331, DOI 10.1142/S0217979299002435; STEWART GR, 1984, PHYS REV B, V30, P482, DOI 10.1103/PhysRevB.30.482; Stockert O, 1997, PHYSICA B, V230, P247, DOI 10.1016/S0921-4526(96)00667-9; Stockert O, 1998, PHYS REV LETT, V80, P5627, DOI 10.1103/PhysRevLett.80.5627; Stoner E C, 1936, P ROY SOC          A, VA154, P656; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; von Lohneysen H, 1998, EUR PHYS J B, V5, P447, DOI 10.1007/s100510050465; VONLOHNEYSEN H, 1994, PHYS REV LETT, V72, P3262, DOI 10.1103/PhysRevLett.72.3262	30	517	518	5	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					351	355		10.1038/35030039	http://dx.doi.org/10.1038/35030039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014185	Green Submitted			2022-12-28	WOS:000089390700039
J	Pelham, HRB; Rothman, JE				Pelham, HRB; Rothman, JE			The debate about transport in the Golgi - Two sides of the same coin?	CELL			English	Review							LUMINAL ER PROTEINS; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; CISTERNAL MATURATION; RETROGRADE TRANSPORT; SECRETORY PATHWAY; MEMBRANE-PROTEIN; COATED VESICLES; GTP HYDROLYSIS; COPI VESICLES		MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	MRC Laboratory Molecular Biology; Memorial Sloan Kettering Cancer Center	Pelham, HRB (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1984, CELL, V39, P525, DOI 10.1016/0092-8674(84)90459-8; Bannykh SI, 1997, J CELL BIOL, V138, P1, DOI 10.1083/jcb.138.1.1; Barlowe C, 2000, TRAFFIC, V1, P371, DOI 10.1034/j.1600-0854.2000.010501.x; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BEARNS HW, 1968, INT REV CYTOL, V23, P209; Becker B, 1996, MICROBIOL REV, V60, P697, DOI 10.1128/MMBR.60.4.697-721.1996; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Bonfanti L, 1999, MOL BIOL CELL, V10, p114A; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; BRUGGER B, 2000, IN PRESS J CELL BIOL; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; DEAN N, 1990, J CELL BIOL, V111, P369, DOI 10.1083/jcb.111.2.369; FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311; Glick BS, 1997, FEBS LETT, V414, P177, DOI 10.1016/S0014-5793(97)00984-8; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649; Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; KOOY J, 1992, J BIOL CHEM, V267, P20255; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; LEWIS MJ, 1990, CELL, V61, P1359, DOI 10.1016/0092-8674(90)90699-F; Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1; Lin CC, 1999, J CELL BIOL, V147, P1457, DOI 10.1083/jcb.147.7.1457; Linstedt AD, 1997, MOL BIOL CELL, V8, P1073, DOI 10.1091/mbc.8.6.1073; Love HD, 1998, J CELL BIOL, V140, P541, DOI 10.1083/jcb.140.3.541; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; MCNEW JA, 2000, IN PRESS NATURE; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Morin-Ganet MN, 2000, TRAFFIC, V1, P56, DOI 10.1034/j.1600-0854.2000.010109.x; Morin-Ganet MN, 1998, ANAT REC, V251, P256, DOI 10.1002/(SICI)1097-0185(199806)251:2<256::AID-AR15>3.0.CO;2-N; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; Orci L, 1998, P NATL ACAD SCI USA, V95, P2279, DOI 10.1073/pnas.95.5.2279; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; ORCI L, 2000, IN PRESS P NATL ACAD; ORCI L, 2000, IN PRESS J CELL BIOL; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; PELHAM HRB, 1994, CELL, V79, P1125, DOI 10.1016/0092-8674(94)90002-7; Pelham HRB, 1998, TRENDS CELL BIOL, V8, P45, DOI 10.1016/S0962-8924(97)01185-9; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; QUINN P, 1984, J CELL BIOL, V98, P2142, DOI 10.1083/jcb.98.6.2142; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Reinhard C, 1999, P NATL ACAD SCI USA, V96, P1224, DOI 10.1073/pnas.96.4.1224; ROTHMAN JE, 1981, SCIENCE, V213, P1212, DOI 10.1126/science.7268428; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Sonnichsen B, 1996, J CELL BIOL, V134, P1411, DOI 10.1083/jcb.134.6.1411; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Springer S, 2000, P NATL ACAD SCI USA, V97, P4034, DOI 10.1073/pnas.070044097; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; STINCHCOMBE JC, 1995, J CELL BIOL, V131, P1387, DOI 10.1083/jcb.131.6.1387; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200; Volchuk A, 2000, CELL, V102, P335, DOI 10.1016/S0092-8674(00)00039-8; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667	71	182	187	1	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					713	719		10.1016/S0092-8674(00)00060-X	http://dx.doi.org/10.1016/S0092-8674(00)00060-X			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030615	Bronze			2022-12-28	WOS:000089395200003
J	Takizawa, PA; DeRisi, JL; Wilhelm, JE; Vale, RD				Takizawa, PA; DeRisi, JL; Wilhelm, JE; Vale, RD			Plasma membrane compartmentalization in yeast by messenger RNA transport and a septin diffusion barrier	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MYOSIN MYO4P; LOCALIZATION; MORPHOGENESIS; PROTEINS; DEPENDS; GENE; DETERMINANT; EXPRESSION; ASH1P	Asymmetric Localization of proteins plays a key role in many cellular processes, including cell polarity and cell fate determination. Using DNA microarray analysis, we identified a plasma membrane protein-encoding mRNA (IST2) that is transported to the bud tip by an actomyosin-based process. mRNA localization created a higher concentration of IST2 protein in the bud compared with that of the mother cell, and this asymmetry was maintained by a septin-mediated membrane diffusion barrier at the mother-bud neck. These results indicate thar yeast creates distinct plasma membrane compartments, as has been described in neurons and epithelial cells.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.				PHS HHS [38496] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; DRUBIN DG, COMMUNICATION; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Munchow S, 1999, J CELL SCI, V112, P1511; NEHME CL, 1993, J CELL BIOL, V120, P687, DOI 10.1083/jcb.120.3.687; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Takizawa PA, 2000, P NATL ACAD SCI USA, V97, P5273, DOI 10.1073/pnas.080585897; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; TAKIZAWA PA, UNPUB; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	22	358	366	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					341	344		10.1126/science.290.5490.341	http://dx.doi.org/10.1126/science.290.5490.341			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030653				2022-12-28	WOS:000089818100045
J	Dodd, ME; Kellet, F; Davis, A; Simpson, JCG; Webb, AK; Haworth, CS; Niven, RM				Dodd, ME; Kellet, F; Davis, A; Simpson, JCG; Webb, AK; Haworth, CS; Niven, RM			Audit of oxygen prescribing before and after the introduction of a prescription chart	BRITISH MEDICAL JOURNAL			English	Article							NASAL		Manchester Univ Hosp NHS Trust, NW Lung Ctr, Manchester M23 9LT, Lancs, England; Stepping Hill Hosp, Stockport SK2 7JE, Lancs, England	University of Manchester	Dodd, ME (corresponding author), Manchester Univ Hosp NHS Trust, NW Lung Ctr, Manchester M23 9LT, Lancs, England.			Niven, Robert/0000-0003-2249-960X				Bateman NT, 1998, BRIT MED J, V317, P798, DOI 10.1136/bmj.317.7161.798; BAZUAYE EA, 1992, THORAX, V47, P609, DOI 10.1136/thx.47.8.609; DAVIES RJO, 1989, BRIT MED J, V299, P43, DOI 10.1136/bmj.299.6690.43; SMALL D, 1992, AM J MED, V92, P591, DOI 10.1016/0002-9343(92)90775-7; 1999, BRIT NATL FORMULARY, V37, P153	5	44	45	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					864	865		10.1136/bmj.321.7265.864	http://dx.doi.org/10.1136/bmj.321.7265.864			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021863	Green Published, Bronze			2022-12-28	WOS:000089857500021
J	Harris, E; Tanner, M				Harris, E; Tanner, M			Health technology transfer	BRITISH MEDICAL JOURNAL			English	Article							TANZANIAN CHILDREN; MALARIA; PARASITES; TRIAL; IDENTIFICATION; TRANSMISSION; CAPABILITY; VACCINE; INFANTS; INTENSE	More funding must be made available to scientists in developing countries and to organisations that support in-country training and research Genuine partnership and mutual trust is a prerequisite for the sustainable transfer of technology from developed to developing countries Building local scientific capacity and long term North-South and South-South partnerships are important in establishing effective health research programmes Research topics should have local relevance and priority, and technology transfer should be participatory equitable, and sustained Autonomous research centres attract funding and reduce administrative burdens.	Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA; Swiss Trop Inst, CH-4002 Basel, Switzerland	University of California System; University of California Berkeley; University of Basel; Swiss Tropical & Public Health Institute	Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA.							*AD HOC COMM HLTHR, 1996, INV HLTH RES DEV; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Aviles H, 1999, J PARASITOL, V85, P181, DOI 10.2307/3285616; Balmaseda A, 1999, AM J TROP MED HYG, V61, P893, DOI 10.4269/ajtmh.1999.61.893; Belli A, 1999, AM J TROP MED HYG, V61, P380, DOI 10.4269/ajtmh.1999.61.380; Belli A, 1998, AM J TROP MED HYG, V58, P102, DOI 10.4269/ajtmh.1998.58.102; Edoh D, 1997, T ROY SOC TROP MED H, V91, P361, DOI 10.1016/S0035-9203(97)90109-7; Edoh D, 1997, AM J TROP MED HYG, V57, P342, DOI 10.4269/ajtmh.1997.57.342; FREYVOGEL TA, 1997, 75 YEARS BALDEGG SIS, P138; Global Forum for Health Research, 2000, 10 90 REP HLTH RES 2; Gonzalez MA, 2000, B WORLD HEALTH ORGAN, V78, P97; Harris E, 1996, BIOCHEM EDUC, V24, P3, DOI 10.1016/0307-4412(95)00154-9; Harris E, 1996, NAT MED, V2, P737, DOI 10.1038/nm0796-737; Harris E, 1999, VIROLOGY, V253, P86, DOI 10.1006/viro.1998.9481; Harris E, 1998, J CLIN MICROBIOL, V36, P1989, DOI 10.1128/JCM.36.7.1989-1995.1998; Harris E., 1998, LOW COST APPROACH PC; Irion A, 1998, TROP MED INT HEALTH, V3, P490, DOI 10.1046/j.1365-3156.1998.00253.x; Kitua AY, 1999, PARASITE IMMUNOL, V21, P307, DOI 10.1046/j.1365-3024.1999.00230.x; LENGELER C, 1991, INT J EPIDEMIOL, V20, P796, DOI 10.1093/ije/20.3.796; MASELLI D, 1996, P INT C SCI RES PART; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; National Intelligence Council, 2000, GLOB INF DIS THREAT; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Swiss Commission for Research Partnership with Developing Countries, 1998, GUID RES PARTN DEV C; TANNER M, 1994, ACTA TROP, V57, P153, DOI 10.1016/0001-706X(94)90006-X; Tanner M, 1999, T ROY SOC TROP MED H, V93, pS1, DOI 10.1016/S0035-9203(99)90319-X; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ	27	31	31	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					817	820		10.1136/bmj.321.7264.817	http://dx.doi.org/10.1136/bmj.321.7264.817			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009526	Green Published			2022-12-28	WOS:000089696600030
J	Roberts, LJ; Handman, E; Foote, SJ				Roberts, LJ; Handman, E; Foote, SJ			Science, medicine, and future - Leishmaniasis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							T-CELL SUBSETS; MAJOR INFECTION; NATURAL-RESISTANCE; GENETIC-CONTROL; MICE; SUSCEPTIBILITY; IMMUNOGENETICS; CHROMOSOME-9; EXPRESSION; DISEASE		PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Genet & Bioinformat Div, Melbourne, Vic 3050, Australia; PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Leishmania Lab, Melbourne, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Foote, SJ (corresponding author), PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Genet & Bioinformat Div, Melbourne, Vic 3050, Australia.	foote@wehi.edu.au	Foote, Simon J/F-2802-2013	Foote, Simon/0000-0002-9142-2107				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Beebe AM, 1997, IMMUNITY, V6, P551, DOI 10.1016/S1074-7613(00)80343-X; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; BLACKWELL J, 1980, NATURE, V283, P72, DOI 10.1038/283072a0; Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; CELLIER M, 1994, J EXP MED, V180, P1741, DOI 10.1084/jem.180.5.1741; ElHassan AM, 1995, T ROY SOC TROP MED H, V89, P647, DOI 10.1016/0035-9203(95)90428-X; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hill AVS, 1996, CURR OPIN GENET DEV, V6, P348, DOI 10.1016/S0959-437X(96)80013-X; LARA ML, 1991, HUM IMMUNOL, V30, P129, DOI 10.1016/0198-8859(91)90081-J; Lopez-Velez R, 1998, AM J TROP MED HYG, V58, P436, DOI 10.4269/ajtmh.1998.58.436; MOCK B, 1993, EUR J IMMUNOGENET, V20, P335, DOI 10.1111/j.1744-313X.1993.tb00153.x; MOCK BA, 1985, CURR TOP MICROBIOL, V122, P115; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Roberts LJ, 1997, J EXP MED, V185, P1705, DOI 10.1084/jem.185.9.1705; Roberts LJ, 1999, EUR J IMMUNOL, V29, P3047, DOI 10.1002/(SICI)1521-4141(199909)29:09&lt;3047::AID-IMMU3047&gt;3.0.CO;2-L; Turk J L, 1971, Adv Immunol, V13, P209, DOI 10.1016/S0065-2776(08)60185-6; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Vieira LQ, 1996, J IMMUNOL, V157, P827; *WHO, 2000, DIV CONTR TROP DIS; Wilson ME, 1996, GASTROENTEROL CLIN N, V25, P535, DOI 10.1016/S0889-8553(05)70262-4	26	50	52	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2000	321	7264					801	804		10.1136/bmj.321.7264.801	http://dx.doi.org/10.1136/bmj.321.7264.801			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009521	Green Published			2022-12-28	WOS:000089696600024
J	Guttridge, DC; Mayo, MW; Madrid, LV; Wang, CY; Baldwin, AS				Guttridge, DC; Mayo, MW; Madrid, LV; Wang, CY; Baldwin, AS			NF-kappa B-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia	SCIENCE			English	Article							SKELETAL-MUSCLE; PROTEINS; DIFFERENTIATION; CANCER; MICE	MyoD regulates skeletal muscle differentiation (SMD) and is essential for repair of damaged tissue. The transcription factor nuclear factor kappa B (NF-kappa B) is activated by the cytokine tumor necrosis factor (TNF), a mediator of skeletal muscle wasting in cachexia, Here, the role of NF-kappa B in cytokine-induced muscle degeneration was explored. In differentiating C2C12 myocytes, TNF-induced activation of NF-kappa B inhibited SMD by suppressing MyoD mRNA at the post-transcriptional level. In contrast, in differentiated myotubes, TNF plus interferon-gamma (IFN-gamma) signaling was required for NF-kappa B-dependent down-regulation of MyoD and dysfunction of skeletal myofibers. MyoD mRNA was also down-regulated by TNF and IFN-gamma expression in mouse muscle in vivo. These data elucidate a possible mechanism that may underlie the skeletal muscle decay in cachexia.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Mason Farm Rd,Campus Box 7295, Chapel Hill, NC 27599 USA.			Guttridge, Denis/0000-0002-7276-6609	NATIONAL CANCER INSTITUTE [K01CA078595, R01CA072771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035098, R37AI035098] Funding Source: NIH RePORTER; NCI NIH HHS [CA72771, K01 CA78595] Funding Source: Medline; NIAID NIH HHS [AI35098] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Cooper RN, 1999, J CELL SCI, V112, P2895; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; GUTTRIDGE DC, UNPUB; Kawamura I, 1999, GENE THER, V6, P91, DOI 10.1038/sj.gt.3300819; KOISHI K, 1995, DEV DYNAM, V202, P244, DOI 10.1002/aja.1002020304; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; MOLDAWER LL, 1987, AM J PHYSIOL, V253, P766; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Szalay K, 1997, EUR J CELL BIOL, V74, P391; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; VANEYS J, 1985, ANNU REV NUTR, V5, P435, DOI 10.1146/annurev.nu.05.070185.002251	20	602	623	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2363	2366		10.1126/science.289.5488.2363	http://dx.doi.org/10.1126/science.289.5488.2363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009425	Green Submitted			2022-12-28	WOS:000089593500057
J	Li, S; Hill, CP; Sundquist, WI; Finch, JT				Li, S; Hill, CP; Sundquist, WI; Finch, JT			Image reconstructions of helical assemblies of the HIV-1CA protein	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CAPSID PROTEIN; IN-VITRO; CYCLOPHILIN-A; TYPE-1; CORE; DOMAIN; REPLICATION; TERMINUS; MODELS	The type 1 human immunodeficiency virus (HIV-1) contains a conical capsid comprising similar to 1,500 CA protein subunits, which organizes the viral RNA genome for uncoating and replication in a new host cell. In vitro, CA spontaneously assembles into helical tubes and cones that resemble authentic viral capsids(1-7). Here we describe electron cryo-microscopy and image reconstructions of CA tubes from six different helical families. In spite of their polymorphism, all tubes are composed of hexameric rings of CA arranged with approximate local p6 lattice symmetry. Crystal structures of the two CA domains were 'docked' into the reconstructed density, which showed that the amino-terminal domains form the hexameric rings and the carboxy-terminal dimerization domains connect each ring to six neighbours. We propose a molecular model for the HIV-1 capsid that follows the principles of a fullerene cone(6), in which the body of the cone is composed of curved hexagonal arrays of CA rings and the ends are closed by inclusion of 12 pentagonal 'defects'.	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; MRC, Mol Biol Lab, Div Struct Studies, Cambridge CB2 2QH, England	Utah System of Higher Education; University of Utah; MRC Laboratory Molecular Biology	Li, S (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA.			Li, Sam/0000-0002-0210-8192				Aberham C, 1996, J VIROL, V70, P3536, DOI 10.1128/JVI.70.6.3536-3544.1996; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CREMERS AFM, 1981, J MOL BIOL, V145, P545, DOI 10.1016/0022-2836(81)90544-1; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; FRANKE EK, 1995, ADV EXP MED BIOL, V374, P217; FUKUI T, 1993, MICROSC RES TECHNIQ, V25, P335, DOI 10.1002/jemt.1070250410; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Grattinger M, 1999, VIROLOGY, V257, P247, DOI 10.1006/viro.1999.9668; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATSURA I, 1978, J MOL BIOL, V121, P71, DOI 10.1016/0022-2836(78)90263-2; Kotov A, 1999, J VIROL, V73, P8824, DOI 10.1128/JVI.73.10.8824-8830.1999; MAMMANO F, 1994, J VIROL, V68, P4927, DOI 10.1128/JVI.68.8.4927-4936.1994; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; STEVEN AC, 1986, ELECTRON MICROS, V5, P1; TOYOSHIMA C, 1990, J CELL BIOL, V111, P2623, DOI 10.1083/jcb.111.6.2623; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Zhang H, 1996, P NATL ACAD SCI USA, V93, P12519, DOI 10.1073/pnas.93.22.12519	29	411	416	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					409	413		10.1038/35030177	http://dx.doi.org/10.1038/35030177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014200				2022-12-28	WOS:000089390700054
J	Smith, NA; Singh, SP; Wang, MB; Stoutjesdijk, PA; Green, AG; Waterhouse, PM				Smith, NA; Singh, SP; Wang, MB; Stoutjesdijk, PA; Green, AG; Waterhouse, PM			Gene expression - Total silencing by intron-spliced hairpin RNAs	NATURE			English	Article							VIRUS-RESISTANCE; PLANTS; SENSE		CSIRO, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Smith, NA (corresponding author), CSIRO, Canberra, ACT 2601, Australia.		, Neil/U-6272-2019; Green, Allan G/C-6572-2008; singh, surinder/C-9528-2009; Green, Allan/AAM-6856-2021	singh, surinder/0000-0003-4488-8147; Green, Allan/0000-0002-3248-2089; Waterhouse, Peter/0000-0002-2812-3753				Cartea ME, 1998, PLANT SCI, V136, P181, DOI 10.1016/S0168-9452(98)00089-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; JORGENSEN RA, 1995, SCIENCE, V268, P689; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Rosche E, 1995, PLANT MOL BIOL, V29, P663, DOI 10.1007/BF00041157; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; STALBERG K, 1993, PLANT MOL BIOL, V23, P671, DOI 10.1007/BF00021523; Wang M. B., 1997, Journal of Genetics and Breeding, V51, P325; Waterhouse PM, 1999, TRENDS PLANT SCI, V4, P452, DOI 10.1016/S1360-1385(99)01493-4; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959	12	709	1042	0	77	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					319	320		10.1038/35030305	http://dx.doi.org/10.1038/35030305			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014180				2022-12-28	WOS:000089390700034
J	Bryk, R; Griffin, P; Nathan, C				Bryk, R; Griffin, P; Nathan, C			Peroxynitrite reductase activity of bacterial peroxiredoxins	NATURE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; SALMONELLA-TYPHIMURIUM; NITRIC-OXIDE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; REDOX REGULATION; SULFENIC ACID; AHPC; ENZYME; DECOMPOSITION	Nitric oxide (NO) is present in soil and air, and is produced by bacteria, animals and plants. Superoxide (O-2(-)) arises in all organisms inhabiting aerobic environments. Thus, many organisms are likely to encounter peroxynitrite (OONO-), a product of NO and O-2(-) that forms at near diffusion-limited rates, and rapidly decomposes upon protonation through isomerization to nitrate (NO3-; ref. 1) while generating hydroxyl radical ((OH)-O-.) and nitrogen dioxide radical ((NO2)-N-.) (refs 2, 3), both more reactive than peroxynitrite's precursors. The oxidative, inflammatory, mutagenic and cytotoxic potential (ref. 4) of peroxynitrite contrasts with the antioxidant, anti-inflammatory and tissue-protective properties ascribed to NO itself(5). Thus, the ability of cells to cope with peroxynitrite is central in determining the biological consequences of NO production. We considered whether cells might be equipped with enzymes to detoxify peroxynitrite. Peroxiredoxins have been identified in most genomes sequenced, but their functions are only partly understood. Here we show that the peroxiredoxin alkylhydroperoxide reductase subunit C (AhpC) from Salmonella typhimurium catalytically detoxifies peroxynitrite to nitrite fast enough to forestall the oxidation of bystander molecules such as DNA. Results are similar with peroxiredoxins from Mycobacterium tuberculosis and Helicobacter pylori. Thus, peroxynitrite reductase activity may be widespread among bacterial genera.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Merck Res Labs, Basic Chem Analyt Support, Rahway, NJ 07065 USA	Cornell University; Merck & Company	Nathan, C (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.	cnathan@med.cornell.edu						Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Briviba K, 1998, CHEM RES TOXICOL, V11, P1398, DOI 10.1021/tx980086y; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Coddington JW, 1999, J AM CHEM SOC, V121, P2438, DOI 10.1021/ja982887t; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; Go YM, 1999, AM J PHYSIOL-HEART C, V277, pH1647, DOI 10.1152/ajpheart.1999.277.4.H1647; JIN DY, 2000, ANTIOXIDANT REDOX RE, P381; Kamisaki Y, 1998, P NATL ACAD SCI USA, V95, P11584, DOI 10.1073/pnas.95.20.11584; Koppenol WH, 1996, METHOD ENZYMOL, V269, P296; Merenyi G, 1998, CHEM RES TOXICOL, V11, P712, DOI 10.1021/tx980043h; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Niles JC, 1999, P NATL ACAD SCI USA, V96, P11729, DOI 10.1073/pnas.96.21.11729; OTOOLE PW, 1991, J BACTERIOL, V173, P505, DOI 10.1128/jb.173.2.505-513.1991; Pearce LL, 1999, J BIOL CHEM, V274, P35763, DOI 10.1074/jbc.274.50.35763; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; RADI R, 1991, J BIOL CHEM, V266, P4244; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; Uppu RM, 1996, METHOD ENZYMOL, V269, P322; Wilson T, 1998, MICROBIOL-UK, V144, P2687, DOI 10.1099/00221287-144-10-2687; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203	29	528	547	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					211	215		10.1038/35025109	http://dx.doi.org/10.1038/35025109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001062				2022-12-28	WOS:000089241000054
J	Aghazadeh, B; Lowry, WE; Huang, XY; Rosen, MK				Aghazadeh, B; Lowry, WE; Huang, XY; Rosen, MK			Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation	CELL			English	Article							NUCLEOTIDE EXCHANGE FACTOR; T-CELL RECEPTOR; PROTOONCOGENE PRODUCT; METHYL-GROUPS; SIGNAL-TRANSDUCTION; CHEMICAL-SHIFT; FAMILY KINASES; SRC FAMILY; B-CELLS; NMR	Rho-family GTPases transduce signals from receptors leading to changes in cell shape and motility, mitogenesis, and development. Proteins containing the Dbl homology (DH) domain are responsible for activating Rho GTPases by catalyzing the exchange of GDP for GTP, Receptor-initiated stimulation of Dbl protein Vav exchange activity involves tyrosine phosphorylation, We show through structure determination that the mVav1 DH domain is autoinhibited by an N-terminal extension, which lies in the GTPase interaction site. This extension contains the Tyr174 Src-family kinase recognition site, and phosphorylation or truncation of this peptide results in stimulation of GEF activity. NMR spectroscopy data show that the N-terminal peptide is released from the DH domain and becomes unstructured upon phosphorylation. Thus, tyrosine phosphorylation relieves autoinhibition by exposing the GTPase interaction surface of the DH domain, which is obligatory for Vav activation.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Physiol & Biophys, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Neurosci, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad program Biochem & Struct Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Rosen, MK (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA.	rosen@mmmr1.makcc.org						Abe R, 1999, J BIOL CHEM, V274, P30410, DOI 10.1074/jbc.274.43.30410; Aghazadeh B, 1998, NAT STRUCT BIOL, V5, P1098, DOI 10.1038/4209; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOUME HR, 1991, NATURE, V349, P117; BRUNATI AM, 1995, FEBS LETT, V367, P149, DOI 10.1016/0014-5793(95)00555-N; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bustelo XR, 1996, CRIT REV ONCOGENESIS, V7, P65, DOI 10.1615/CritRevOncog.v7.i1-2.50; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; BUSTELO XR, 1992, SCIENCE, V256, P1196, DOI 10.1126/science.256.5060.1196; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Chen YR, 2000, INT J ONCOL, V16, P651; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Downward J, 1996, CANCER SURV, V27, P87; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Gardner KH, 1996, J BIOMOL NMR, V8, P351, DOI 10.1007/BF00410333; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; KLYONO M, 2000, J BIOL CHEM, V275, P5441; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; Matsuo H, 1996, J MAGN RESON SER B, V111, P194, DOI 10.1006/jmrb.1996.0082; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Nomanbhoy TK, 1996, BIOCHEMISTRY-US, V35, P4602, DOI 10.1021/bi951743d; PASTERIS NG, 1994, CELL, V79, P669; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Szilak L, 1997, NAT STRUCT BIOL, V4, P112, DOI 10.1038/nsb0297-112; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wuthrich K, 1986, NMR PROTEINS NUCL AC; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHU K, 2000, IN PRESS J BIOL CHEM; Zwahlen C, 1998, J AM CHEM SOC, V120, P4825, DOI 10.1021/ja9742601	60	305	308	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					625	633		10.1016/S0092-8674(00)00085-4	http://dx.doi.org/10.1016/S0092-8674(00)00085-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007481	Bronze			2022-12-28	WOS:000089105200011
J	Shah, JL				Shah, JL			Lesson of the week - Postoperative pressure sores after epidural anaesthesia	BRITISH MEDICAL JOURNAL			English	Review							ANALGESIA; SURGERY		City Hosp, Dept Anaesthet, Birmingham B18 7QH, W Midlands, England	University of Birmingham	Shah, JL (corresponding author), Queen Elizabeth Hosp, Dept Anaesthet, Birmingham B15 2TH, W Midlands, England.							ABUOWN A, 1995, EUR J VASC ENDOVASC, V9, P327, DOI 10.1016/S1078-5884(05)80139-X; Bliss M, 1999, BMJ-BRIT MED J, V319, P863, DOI 10.1136/bmj.319.7214.863; BLISS MR, 1995, AGE AGEING, V24, P297, DOI 10.1093/ageing/24.4.297; Buggy DJ, 1999, BMJ-BRIT MED J, V319, P530, DOI 10.1136/bmj.319.7209.530; Gebhardt K S, 1996, J Wound Care, V5, P116; KOSIAK M, 1961, Arch Phys Med Rehabil, V42, P19; KROUSKOP TA, 1978, MED HYPOTHESES, V4, P37, DOI 10.1016/0306-9877(78)90025-7; PUNT CD, 1991, ANESTH ANALG, V73, P657; REULER JB, 1981, ANN INTERN MED, V94, P661, DOI 10.7326/0003-4819-94-5-661; Smet IGG, 1996, REGION ANESTH, V21, P338; Waltman N L, 1991, Oncol Nurs Forum, V18, P867	11	17	17	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					941	942		10.1136/bmj.321.7266.941	http://dx.doi.org/10.1136/bmj.321.7266.941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030688	Green Published			2022-12-28	WOS:000089975100027
J	Klimov, VI; Mikhailovsky, AA; Xu, S; Malko, A; Hollingsworth, JA; Leatherdale, CA; Eisler, HJ; Bawendi, MG				Klimov, VI; Mikhailovsky, AA; Xu, S; Malko, A; Hollingsworth, JA; Leatherdale, CA; Eisler, HJ; Bawendi, MG			Optical gain and stimulated emission in nanocrystal quantum dots	SCIENCE			English	Article							SEMICONDUCTOR NANOCRYSTALS; WELL LASER; DEPENDENCE; THRESHOLD; INTERBAND; DYNAMICS; EXCITON	The development of optical gain in chemically synthesized semiconductor nanoparticles (nanocrystal quantum dots) has been intensely studied as the first step toward nanocrystal quantum dot Lasers, We examined the competing dynamical processes involved in optical amplification and Lasing in nanocrystal quantum dots and found that, despite a highly efficient intrinsic nonradiative Auger recombination, Large optical gain can be developed at the wavelength of the emitting transition for close-packed solids of these dots. Narrowband stimulated emission with a pronounced gain threshold at wavelengths tunable with the size of the nanocrystal was observed, as expected from quantum confinement effects. These results unambiguously demonstrate the feasibility of nanocrystal quantum dot lasers.	Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Klimov, VI (corresponding author), Los Alamos Natl Lab, Div Chem, C-6,MS-J585, Los Alamos, NM 87545 USA.	klimov@lanl.gov; mgb@mit.edu	Han, Kyuhee/B-6201-2009; Klimov, Victor/Y-2823-2019	Klimov, Victor/0000-0003-1158-3179; Mikhailovsky, Alexander/0000-0002-6807-4810				ARAKAWA Y, 1982, APPL PHYS LETT, V40, P939, DOI 10.1063/1.92959; ASADA M, 1986, IEEE J QUANTUM ELECT, V22, P1915, DOI 10.1109/JQE.1986.1073149; BRUS LE, 1983, J CHEM PHYS, V79, P5566, DOI 10.1063/1.445676; BUTTY J, 1995, APPL PHYS LETT, V67, P2672, DOI 10.1063/1.114288; Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y; DNEPROVSKII VS, 1992, SOLID STATE COMMUN, V81, P227, DOI 10.1016/0038-1098(92)90504-3; EFROS AL, 1982, SOV PHYS SEMICOND+, V16, P772; Giessen H, 1999, PHASE TRANSIT, V68, P59, DOI 10.1080/01411599908224515; Grundmann M, 1999, PHYSICA E, V5, P167, DOI 10.1016/S1386-9477(99)00041-7; Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562; Hu YZ, 1996, PHYS REV B, V53, P4814, DOI 10.1103/PhysRevB.53.4814; KISTAEDTER N, 1994, ELECTRON LETT, V30, P1416; Klimov VI, 1999, PHYS REV B, V60, pR2177, DOI 10.1103/PhysRevB.60.R2177; Klimov VI, 2000, SCIENCE, V287, P1011, DOI 10.1126/science.287.5455.1011; Klimov VI, 1998, PHYS REV LETT, V80, P4028, DOI 10.1103/PhysRevLett.80.4028; Klimov VI, 2000, J PHYS CHEM B, V104, P6112, DOI 10.1021/jp9944132; LEBEDSON NN, 1994, SEMICONDUCTORS+, V28, P832; MEHUYS D, 1995, LASER FOCUS WORLD, V31, P117; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; NIRMAL M, 1995, PHYS REV LETT, V75, P3728, DOI 10.1103/PhysRevLett.75.3728; Norris DJ, 1996, PHYS REV B, V53, P16347, DOI 10.1103/PhysRevB.53.16347; STRASS A, 1994, LASER FOCUS WORLD, V30, P79	23	2455	2547	25	1007	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2000	290	5490					314	317		10.1126/science.290.5490.314	http://dx.doi.org/10.1126/science.290.5490.314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030645				2022-12-28	WOS:000089818100037
J	Stickgold, R; Malia, A; Maguire, D; Roddenberry, D; O'Connor, M				Stickgold, R; Malia, A; Maguire, D; Roddenberry, D; O'Connor, M			Replaying the game: Hypnagogic images in normals and amnesics	SCIENCE			English	Article							SLEEP ONSET; MEMORY	Participants playing the computer game Tetris reported intrusive, stereotypical, visual images of the game at sleep onset. Three amnesic patients with extensive bilateral medial temporal Lobe damage produced similar hypnagogic reports despite being unable to recall playing the game. suggesting that such imagery may arise without important contribution from the declarative memory system. In addition, control participants reported images from previously played versions of the game, demonstrating that remote memories can influence the images from recent waking experience.	Harvard Univ, Sch Med, Dept Psychiat, Neurophysiol Lab, Boston, MA 02115 USA; Boston Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Behav Neurol,Memory Disorders Res Ctr, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Boston University; Harvard University; Beth Israel Deaconess Medical Center	Stickgold, R (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Neurophysiol Lab, 74 Fenwood Rd, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH013923, R01MH013923, R01MH092638, R37MH013923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS026985] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-13,923, MH-48,832] Funding Source: Medline; NINDS NIH HHS [NS26985] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANTROBUS J, 1983, PSYCHOPHYSIOLOGY, V20, P562, DOI 10.1111/j.1469-8986.1983.tb03015.x; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; CATHALA H P, 1988, Neurophysiologie Clinique, V18, P173, DOI 10.1016/S0987-7053(88)80122-9; Domhoff GW, 1996, FINDING MEANING DREA, DOI DOI 10.1007/978-1-4899-0298-6; Foulkes D, 1985, DREAMING COGNITIVE P; FOULKES DAVID, 1965, J ABNORM PSYCHOL, V70, P231, DOI 10.1037/h0022217; FROST R, 1915, N BOSTON; GREENBERG R, 1968, ARCH GEN PSYCHIAT, V18, P203; GREENBERG R, 1974, PERSPECT BIOL MED, V17, P513; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; HEBB DO, 1968, PSYCHOL REV, V75, P466, DOI 10.1037/h0026771; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; HOBSON J A, 1987, Human Neurobiology, V6, P157; Hobson J. Allan, 1988, DREAMING BRAIN; Jouvet M, 1979, ANN PRATICIEN, V29, P27; MAACROMATIS A, 1987, HYPNAGOGIA UNIQUE ST; NIELSEN TA, 1989, PSYCHIAT J U OTTAWA, V14, P561; POWELL RA, 1995, PERCEPT MOTOR SKILL, V81, P95, DOI 10.2466/pms.1995.81.1.95; Rowley JT, 1998, CONSCIOUS COGN, V7, P67, DOI 10.1006/ccog.1998.0333; Schacter D. L., 1994, MEMORY SYSTEMS 1994; SCHACTER DL, 1976, PSYCHOL BULL, V83, P452, DOI 10.1037/0033-2909.83.3.452; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; SQUIRE LR, 1992, PSYCHOL REV, V99, P191; Stickgold R, 1999, J COGNITIVE NEUROSCI, V11, P182, DOI 10.1162/089892999563319; Stickgold R, 1998, TRENDS COGN SCI, V2, P484, DOI 10.1016/S1364-6613(98)01258-3; VERFAELLIE M, VARIETIES UNCONSCIOU; VERFAELLIE M, IN PRESS SEMIN NEURO; WINTER W, 1995, IMPLICIT EXPLICIT CO; WYATT JK, 1994, SLEEP, V17, P502, DOI 10.1093/sleep/17.6.502; Wyatt JK, 1997, SLEEP, V20, P512	30	143	146	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					350	353		10.1126/science.290.5490.350	http://dx.doi.org/10.1126/science.290.5490.350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	363CW	11030656				2022-12-28	WOS:000089818100048
J	Takemoto, SK; Terasaki, PI; Gjertson, DW; Cecka, JM				Takemoto, SK; Terasaki, PI; Gjertson, DW; Cecka, JM			Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-ALLOGRAFT SURVIVAL; IMPACT; DONORS	Background: In October 1987, the United Network for Organ Sharing (UNOS) established a national kidney-sharing program to increase the number of HLA-matched transplantations. Since then, over 7500 cadaveric kidneys have been shipped to centers in 48 states for transplantation to HLA-matched patients. We evaluated the efficacy of the program during its first 12 years of operation. Methods: We compared the rates of rejection and actuarial graft survival for 7614 HLA-matched and 81,364 HLA-mismatched cadaveric kidney transplantations reported to the UNOS Scientific Registry between October 1987 and September 1999. To assess the effects of the extended period of ischemia associated with shipping HLA-matched kidneys, we identified 3562 pairs of cadaveric kidneys in which one kidney went to an HLA-matched recipient and the other went to an HLA-mismatched recipient. Results: The estimated 10-year rate of graft survival was 52 percent for HLA-matched transplants, as compared with 37 percent for HLA-mismatched transplants. The estimated half-lives of the transplants were 12.5 years and 8.6 years, respectively, and the mean duration of cold ischemia was 23 hours and 22 hours, respectively. After adjustment for the effects of demographic characteristics, at 10 years the overall rates of graft survival and the rates of functional-graft survival (with data censored on patients who died with a functioning graft) were 10 percent and 11 percent higher, respectively, for HLA-matched transplants than for HLA-mismatched transplants. Among 3562 pairs of kidneys, HLA-matched transplants had higher rates of survival, a lower incidence of episodes of rejection, and a lower risk of loss as a result of rejection. Conclusions: A superior graft outcome with little increase in the duration of cold ischemia justifies national sharing of HLA-matched kidney transplants. (N Engl J Med 2000;343:1078-84.) (C) 2000, Massachusetts Medical Society.	Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA; United Network Organ Sharing Sci Renal Transplant, Los Angeles, CA USA	University of California System; University of California Los Angeles	Takemoto, SK (corresponding author), Univ Calif Los Angeles, Dept Pathol, 950 Vet Ave, Los Angeles, CA 90095 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054928] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54928-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEATTY PG, 1995, TRANSPLANTATION, V60, P778, DOI 10.1097/00007890-199510270-00003; Cosio FG, 1997, AM J KIDNEY DIS, V29, P419, DOI 10.1016/S0272-6386(97)90204-3; GJERTSON DW, 1997, CLIN TRANSPLANTS 199, P343; HARPER AM, 1999, CLIN TRANSPLANTS 199, P73; Hata Y, 1998, TRANSPLANTATION, V65, P208; HELD PJ, 1994, NEW ENGL J MED, V331, P765, DOI 10.1056/NEJM199409223311203; KAUFFMAN HM, 1997, TRANSPLANT REV, V11, P165; KERMAN RH, 1991, TRANSPLANT P, V23, P380; MICKEY MR, 1989, TRANSPLANTATION, V47, P401; Neylan JF, 1998, TRANSPL P, V30, P1355, DOI 10.1016/S0041-1345(98)00274-7; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; Schnitzler MA, 1999, NEW ENGL J MED, V341, P1440, DOI 10.1056/NEJM199911043411906; TAKEMOTO S, 1992, NEW ENGL J MED, V327, P834, DOI 10.1056/NEJM199209173271202; TAKIFF H, 1988, TRANSPLANTATION, V45, P410, DOI 10.1097/00007890-198802000-00033; Terasaki PI, 1996, TRANSPLANTATION, V62, P441, DOI 10.1097/00007890-199608270-00003; TERASAKI PI, 1978, AM J CLIN PATHOL, V69, P103; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601	17	184	193	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2000	343	15					1078	1084		10.1056/NEJM200010123431504	http://dx.doi.org/10.1056/NEJM200010123431504			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362FA	11027742				2022-12-28	WOS:000089766900004
J	Haverkate, I; Onwuteaka-Philipsen, BD; van der Heide, A; Kostense, PJ; van der Wal, G; van der Maas, PJ				Haverkate, I; Onwuteaka-Philipsen, BD; van der Heide, A; Kostense, PJ; van der Wal, G; van der Maas, PJ			Refused and granted requests for euthanasia and assisted suicide in the Netherlands: interview study with structured questionnaire	BRITISH MEDICAL JOURNAL			English	Article									Vrije Univ Amsterdam, Inst Res Extramural Med, Dept Social Med, NL-1081 BT Amsterdam, Netherlands; Erasmus Univ, Dept Publ Hlth, NL-3000 DK Rotterdam, Netherlands; Vrije Univ Amsterdam, Inst Res Extramural Med, Dept Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Vrije Universiteit Amsterdam	Haverkate, I (corresponding author), Vrije Univ Amsterdam, Inst Res Extramural Med, Dept Social Med, van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.							Breitbart W, 1996, AM J PSYCHIAT, V153, P238; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; VANDERWAL PJ, 1996, EUTHANASIA OTHER MED	4	54	54	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					865	866		10.1136/bmj.321.7265.865	http://dx.doi.org/10.1136/bmj.321.7265.865			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021864	Bronze, Green Published			2022-12-28	WOS:000089857500022
J	McLellan, AT; Lewis, DC; O'Brien, CP; Kleber, HD				McLellan, AT; Lewis, DC; O'Brien, CP; Kleber, HD			Drug dependence, a chronic medical illness - Implications for treatment, insurance, and outcomes evaluation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CEREBRAL BLOOD-FLOW; OUT-OF-TREATMENT; DSM-III-R; FOLLOW-UP; ALCOHOL DEPENDENCE; COCAINE ABUSERS; DIABETES-MELLITUS; FEMALE TWINS; BRAIN; CARE	The effects of drug dependence on social systems has helped shape the generally held view that drug dependence is primarily a social problem, not a health problem. In turn, medical approaches to prevention and treatment are lacking, We examined evidence that drug (including alcohol) dependence is a chronic medical illness. A literature review compared the diagnoses, heritability, etiology (genetic and environmental factors), pathophysiology, and response to treatments (adherence and relapse) of drug dependence vs type 2 diabetes mellitus, hypertension, and asthma, Genetic heritability, personal choice, and environmental factors are comparably involved in the etiology and course of all of these disorders. Drug dependence produces significant and lasting changes in brain chemistry and function. Effective medications are available for treating nicotine, alcohol, and opiate dependence but not stimulant or marijuana dependence, Medication adherence and relapse rates are similar across these illnesses. Drug dependence generally has been treated as if it were an acute illness, Review results suggest that long-term care strategies of medication management and continued monitoring produce lasting benefits. Drug dependence should be insured, treated, and evaluated like other chronic illnesses.	Treatment Res Inst, Philadelphia, PA 19106 USA; Vet Affairs Med Ctr, Penn VA Ctr Studies Addict, Philadelphia, PA USA; Univ Penn, Philadelphia, PA 19104 USA; Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA; Columbia Univ, Natl Ctr Addict & Subst Abuse, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Brown University; Columbia University	McLellan, AT (corresponding author), Treatment Res Inst, 150 S Independence Mall W,Suite 600, Philadelphia, PA 19106 USA.	tmclellan@tresearch.org						ALTERMAN AI, 1994, J NERV MENT DIS, V182, P157, DOI 10.1097/00005053-199403000-00005; *AM SOC ADD MED, 1998, PRINC ADD MED; [Anonymous], 1998, JAMA, V280, P1936; [Anonymous], 1995, NATURAL HIST ALCOHOL, DOI DOI 10.4159/9780674044562; BABOR TF, 1989, ADDICT BEHAV, V14, P139, DOI 10.1016/0306-4603(89)90043-9; Ball J.C., 2012, EFFECTIVENESS METHAD; Bickel WK, 1995, EXP CLIN PSYCHOPHARM, V3, P477, DOI 10.1037/1064-1297.3.4.477; Booth RE, 1996, DRUG ALCOHOL DEPEN, V42, P11, DOI 10.1016/0376-8716(96)01257-4; CARROLL KM, 1994, ARCH GEN PSYCHIAT, V51, P177; CARROLL KM, 1993, J NERV MENT DIS, V181, P71, DOI 10.1097/00005053-199302000-00001; CHAO YC, 1994, HEPATOLOGY, V19, P360, DOI 10.1002/hep.1840190214; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; CLARK LT, 1991, AM HEART J, V121, P664, DOI 10.1016/0002-8703(91)90443-L; CORNISH J, 1998, J SUBST ABUSE TREAT, V13, P477; DEKKER FW, 1993, EUR RESPIR J, V6, P886; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; FAGARD R, 1995, HYPERTENSION, V26, P919, DOI 10.1161/01.HYP.26.6.919; FINNEY JW, 1992, J STUD ALCOHOL, V53, P142, DOI 10.15288/jsa.1992.53.142; FLEMING MF, 1991, J STUD ALCOHOL, V52, P33, DOI 10.15288/jsa.1991.52.33; Fleming MF, 1999, J FAM PRACTICE, V48, P725; Fox BS, 1997, DRUG ALCOHOL DEPEN, V48, P153, DOI 10.1016/S0376-8716(97)00121-X; Frances A, 1994, DIAGN STAT MAN MENT, P175; FRENCH MT, 1998, BENEFITS Q, V6, P58; Fulco C.E., 1995, DEV MED TREATMENT OP; Gerstein D., 1990, TREATING DRUG PROBLE; GLASS RM, 1994, JAMA-J AM MED ASSOC, V272, P1065, DOI 10.1001/jama.272.13.1065; GOSSOP M, 1986, BRIT MED J, V293, P103, DOI 10.1136/bmj.293.6539.103; GRABER AL, 1992, DIABETES CARE, V15, P1477, DOI 10.2337/diacare.15.11.1477; HIGGINS ST, 1991, AM J PSYCHIAT, V148, P1218; HOLMAN BL, 1993, J NUCL MED, V34, P723; Hubbard RL, 1997, PSYCHOL ADDICT BEHAV, V11, P261, DOI 10.1037/0893-164X.11.4.261; *I MED, 1996, MAN MAN CAR QUAL IMP; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kendler KS, 1998, AM J PSYCHIAT, V155, P1016, DOI 10.1176/ajp.155.8.1016; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; Kurtz S M, 1990, Diabetes Educ, V16, P50, DOI 10.1177/014572179001600112; KYVIK KO, 1995, BRIT MED J, V311, P913; Lewis DC, 1997, MED CLIN N AM, V81, P831, DOI 10.1016/S0025-7125(05)70551-4; LING W, 1984, J CLIN PSYCHIAT, V45, P46; LONDON ED, 1990, ARCH GEN PSYCHIAT, V47, P567; LOWINSON J, 1992, SUBSTANCE ABUSE COMP, P56; Mattick RP, 1996, LANCET, V347, P97, DOI 10.1016/S0140-6736(96)90215-9; McLellan A. T., 1998, BRIDGING GAP FORGING; MCLELLAN AT, 1994, J CONSULT CLIN PSYCH, V62, P1141, DOI 10.1037/0022-006X.62.6.1141; MCLELLAN AT, 1995, P J MAC C MED ED NEW, P165; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Moos R, 1990, ALCOHOLISM TREATMENT; *NAT AC SCI, 1995, DISP MYTHS ADD; *NAT CTR ADD SUBST, 1998, BARS SUBST AB AM PRI; National Institute on Drug Abuse, 1999, NIH PUBL; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; NIEMINEN MM, 1991, CHEST, V100, P70, DOI 10.1378/chest.100.1.70; O'Connor PG, 1998, AM J MED, V105, P100, DOI 10.1016/S0002-9343(98)00194-6; OBRIEN CP, 1975, PHARMACOL REV, V27, P533; OBRIEN CP, 1975, AM J DRUG ALCOHOL AB, V2, P365, DOI 10.3109/00952997509005662; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; OCONNOR PG, 2000, ANN INTERN MED, V133, P234; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Ouimette PC, 1998, J STUD ALCOHOL, V59, P513, DOI 10.15288/jsa.1998.59.513; PEARLSON GD, 1993, AM J PSYCHIAT, V150, P495; RICE DP, 1991, PUBLIC HEALTH REP, V106, P280; Sass H, 1996, ARCH GEN PSYCHIAT, V53, P673; SCHAUB AF, 1993, CLIN EXP HYPERTENS, V15, P1121, DOI 10.3109/10641969309037099; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; SCHUCKIT MA, 1994, ADDICTION, V89, P1629, DOI 10.1111/j.1360-0443.1994.tb03764.x; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Self DW, 1998, DRUG ALCOHOL DEPEN, V51, P49, DOI 10.1016/S0376-8716(98)00065-9; SINNOCK P, 1985, DIABETES DATA NATL D; Svetkey LP, 1996, HYPERTENSION, V28, P854, DOI 10.1161/01.HYP.28.5.854; Svikis DS, 1997, DRUG ALCOHOL DEPEN, V45, P105, DOI 10.1016/S0376-8716(97)01352-5; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; True WR, 1999, ARCH GEN PSYCHIAT, V56, P655, DOI 10.1001/archpsyc.56.7.655; Tsuang MT, 1996, AM J MED GENET, V67, P473, DOI 10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.3.CO;2-D; *US DHHS, 1997, 10 US DEP HLTH HUM S; *US OFF PERS MAN, 1999, 1999027 FEHB US OFF; Vaillant GE, 1996, ARCH GEN PSYCHIAT, V53, P243; van den Bree MBM, 1998, DRUG ALCOHOL DEPEN, V52, P231, DOI 10.1016/S0376-8716(98)00101-X; VOLKOW ND, 1991, AM J PSYCHIAT, V148, P621; VOLKOW ND, 1992, SYNAPSE, V11, P184, DOI 10.1002/syn.890110303; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; WEISNER C, 1993, AM J PUBLIC HEALTH, V83, P824, DOI 10.2105/AJPH.83.6.824; WEISS F, 1996, I MED S NEUR RES ADV; WILLIAMS J, 1991, J COMMUNITY APPL SOC, V1, P23, DOI 10.1002/casp.2450010104; WISE RA, 1981, PROG NEURO-PSYCHOPHA, V5, P467, DOI 10.1016/0364-7722(81)90028-X; 1996, LANCET, V347, P373; 1996, LANCET, V347, P31; 1997, SCIENCE, V278, P1; 1996, LANCET, V347, P162; 1996, LANCET, V347, P301; 1996, LANCET, V347, P97; 1996, LANCET, V347, P237	93	1616	1642	8	233	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1689	1695		10.1001/jama.284.13.1689	http://dx.doi.org/10.1001/jama.284.13.1689			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357KY	11015800				2022-12-28	WOS:000089501900030
J	Goldstein, JA; Demetriou, D; Grines, CL; Pica, M; Shoukfeh, M; O'Neill, WW				Goldstein, JA; Demetriou, D; Grines, CL; Pica, M; Shoukfeh, M; O'Neill, WW			Multiple complex coronary plaques in patients with acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	72nd Annual Scientific Session of the American-Heart-Association	NOV 07-10, 1999	ATLANTA, GA	Amer Heart Assoc			UNSTABLE ANGINA-PECTORIS; ATHEROSCLEROTIC PLAQUES; ANGIOGRAPHIC MORPHOLOGY; SUDDEN-DEATH; RUPTURE; THROMBOSIS; DISEASE; PROGRESSION; STENOSES; EROSION	Background: Acute myocardial infarction is believed to be caused by rupture of an unstable coronary-artery plaque that appears as a single lesion on angiography. However, plaque instability might be caused by pathophysiologic processes, such as inflammation, that exert adverse effects throughout the coronary vasculature and that therefore result in multiple unstable lesions. Methods: To document the presence of multiple unstable plaques in patients with acute myocardial infarction and determine their influence on outcome, we analyzed angiograms from 253 patients for complex coronary plaques characterized by thrombus, ulceration, plaque irregularity, and impaired flow. Results: Single complex coronary plaques were identified in 153 patients (60.5 percent) and multiple complex plaques in the other 100 patients (39.5 percent). As compared with patients with single complex plaques, those with multiple complex plaques were less likely to undergo primary angioplasty (86.0 percent vs. 94.8 percent, P=0.03) and more commonly required urgent bypass surgery (27.0 percent vs. 5.2 percent, P less/equal 0.001). During the year after myocardial infarction, the presence of multiple complex plaques was associated with an increased incidence of recurrent acute coronary syndromes (19.0 percent vs. 2.6 percent, P less/equal 0.001); repeated angioplasty (32.0 percent vs. 12.4 percent, P less/equal 0.001), particularly of non-infarct-related lesions (17.0 percent vs. 4.6 percent, P less/equal 0.001); and coronary-artery bypass graft surgery (35.0 percent vs. 11.1 percent, P less/equal 0.001). Conclusions: Patients with acute myocardial infarction may harbor multiple complex coronary plaques that are associated with adverse clinical outcomes. Plaque instability may be due to a widespread process throughout the coronary vessels, which may have implications for the management of acute ischemic heart disease. (N Engl J Med 2000;343:915-22.) (C)2000, Massachusetts Medical Society.	William Beaumont Hosp, Div Cardiol, Royal Oak, MI 48073 USA	Beaumont Health	Goldstein, JA (corresponding author), William Beaumont Hosp, Div Cardiol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.	jgoldstein@beaumont.edu						AMBROSE JA, 1985, J AM COLL CARDIOL, V5, P609, DOI 10.1016/S0735-1097(85)80384-3; AMBROSE JA, 1991, J AM COLL CARDIOL, V18, P675, DOI 10.1016/0735-1097(91)90788-B; Boden W. E., 1997, European Heart Journal, V18, P123; CHAPMAN I, 1965, ARCH PATHOL, V80, P256; CHEN LJ, 1995, CIRCULATION, V91, P2319, DOI 10.1161/01.CIR.91.9.2319; Chen LJ, 1996, J AM COLL CARDIOL, V28, P597, DOI 10.1016/0735-1097(96)00203-3; Chester MR, 1996, J AM COLL CARDIOL, V28, P604, DOI 10.1016/0735-1097(96)00235-5; DAVIES MJ, 1990, CIRCULATION, V82, P38; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; DAVIES SW, 1991, J AM COLL CARDIOL, V18, P669, DOI 10.1016/0735-1097(91)90787-A; FALK E, 1983, BRIT HEART J, V50, P127; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; FALK E, 1985, CIRCULATION, V71, P699, DOI 10.1161/01.CIR.71.4.699; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; FREEMAN MR, 1989, CIRCULATION, V80, P17, DOI 10.1161/01.CIR.80.1.17; FRINK RJ, 1994, J INVASIVE CARDIOL, V6, P173; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Garcia-Moll X, 2000, J AM COLL CARDIOL, V35, P956, DOI 10.1016/S0735-1097(99)00640-3; GERTZ SD, 1990, AM J CARDIOL, V66, P1368, DOI 10.1016/0002-9149(90)91170-B; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Guazzi MD, 1997, CIRCULATION, V96, P1145, DOI 10.1161/01.CIR.96.4.1145; HAFT JI, 1991, AM HEART J, V121, P1050, DOI 10.1016/0002-8703(91)90662-2; KASKI JC, 1995, CIRCULATION, V92, P2058, DOI 10.1161/01.CIR.92.8.2058; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; LEVIN DC, 1982, CIRCULATION, V66, P316, DOI 10.1161/01.CIR.66.2.316; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; MOISE A, 1983, NEW ENGL J MED, V309, P685, DOI 10.1056/NEJM198309223091201; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; QIAO JH, 1991, J AM COLL CARDIOL, V17, P1138, DOI 10.1016/0735-1097(91)90844-Y; REHR R, 1989, J AM COLL CARDIOL, V14, P1429, DOI 10.1016/0735-1097(89)90376-8; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; ROBERTS WC, 1972, AM J MED, V52, P425, DOI 10.1016/0002-9343(72)90033-2; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; THEROUX P, 1995, CIRCULATION, V91, P2295, DOI 10.1161/01.CIR.91.9.2295; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; WARNES CA, 1984, AM J CARDIOL, V54, P65, DOI 10.1016/0002-9149(84)90305-9	41	754	779	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2000	343	13					915	922		10.1056/NEJM200009283431303	http://dx.doi.org/10.1056/NEJM200009283431303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	357KT	11006367	Bronze			2022-12-28	WOS:000089501400003
J	Whitworth, J; Morgen, D; Quigley, M; Smith, A; Mayanja, S; Eotu, H; Omoding, N; Okongo, M; Malamba, S; Ojwiya, A				Whitworth, J; Morgen, D; Quigley, M; Smith, A; Mayanja, S; Eotu, H; Omoding, N; Okongo, M; Malamba, S; Ojwiya, A			Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMODIUM-FALCIPARUM MALARIA; INFECTION; KINSHASA; CHILDREN; MALAWI; TYPE-1; ZAIRE; POPULATION; MORTALITY	Background An association between HIV-1 and malaria is expected in theory, but has not been convincingly shown in practice. We studied the effects of HIV-1 infection and advancing immunosuppression on falciparum parasitaemia and clinical malaria. Methods HIV-1-positive and HIV-1-negative adults selected from a population-based cohort in rural Uganda were invited to attend a clinic every 3 months (routine visits) and whenever they were sick (interim visits). At each visit, information was collected on recent fever, body temperature, and malaria parasites. Participants were assigned a clinical stage at each routine visit and had regular CD4-cell measurements. Findings 484 participants made 7220 routine clinic visits between 1990 and 1998. Parasitaemia was more common at visits by HIV-1-positive individuals (328 of 2788 [11.8%] vs 231 of 3688 [6.3%], p<0.0001). At HIV-1-positive visits, lower CD4-cell counts were associated with higher parasite densities, compared with HIV-1-negative visits (p=0.0076). Clinical malaria was significantly more common at HIV-1-positive visits (55 of 2788 12.0%] vs 26 of 3688 [0.7%], p=0.0003) and the odds of having clinical malaria increased with falling CD4-cell count (p=0.0002) and advancing clinical stage (p=0.0024). Participants made 3377 interim visits. The risk of clinical malaria was significantly higher at visits by HIV-1-positive individuals than HIV-1-negative individuals (4.0% vs 1.9%, p=0.009). The risk of clinical malaria Ended to increase with falling CD4-cell counts (p=0.052). Interpretation HIV-1 infection is associated with an increased frequency of clinical malaria and parasitaemia. This association tends to become more pronounced with advancing immunosuppression, and could have important public-health implications for sub-Saharan Africa.	Uganda Virus Res Inst, MRC, AIDS Program, Entebbe, Uganda; London Sch Hyg & Trop Med, London WC1, England	Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine	Whitworth, J (corresponding author), Uganda Virus Res Inst, MRC, AIDS Program, POB 49, Entebbe, Uganda.		Smith, Adrian D/A-6336-2009	Quigley, Maria/0000-0002-8058-6181; Smith, Adrian/0000-0003-0036-1490				ALLEN S, 1991, J INFECT DIS, V164, P67, DOI 10.1093/infdis/164.1.67; ATZORI C, 1993, ANN TROP MED PARASIT, V87, P585, DOI 10.1080/00034983.1993.11812814; BLOLAND PB, 1995, AIDS, V9, P721, DOI 10.1097/00002030-199507000-00009; *CDC, 1997, WKLY EPIDEMIOL REC, V72, P285; Chandramohan D, 1998, INT J EPIDEMIOL, V27, P296, DOI 10.1093/ije/27.2.296; COLEBUNDERS R, 1990, J INFECTION, V21, P167, DOI 10.1016/0163-4453(90)91701-E; GREENBERG AE, 1991, NEW ENGL J MED, V325, P105, DOI 10.1056/NEJM199107113250206; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; Huber P. H., 1981, ROBUST STAT; Kalyesubula I, 1997, PEDIATR INFECT DIS J, V16, P876, DOI 10.1097/00006454-199709000-00011; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; LEAVER RJ, 1990, T ROY SOC TROP MED H, V84, P201, DOI 10.1016/0035-9203(90)90253-B; Migot F, 1996, PARASITE IMMUNOL, V18, P333, DOI 10.1046/j.1365-3024.1996.d01-116.x; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; MULDER DW, 1994, LANCET, V343, P1021, DOI 10.1016/S0140-6736(94)90133-3; MULLER O, 1990, T ROY SOC TROP MED H, V84, P336, DOI 10.1016/0035-9203(90)90306-Y; NGUYENDINH P, 1987, B WORLD HEALTH ORGAN, V65, P607; NIYONGABO T, 1994, ACTA TROP, V56, P299, DOI 10.1016/0001-706X(94)90101-5; SIMOOYA OO, 1988, BRIT MED J, V297, P30, DOI 10.1136/bmj.297.6640.30; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Steketee RW, 1996, AM J TROP MED HYG, V55, P24, DOI 10.4269/ajtmh.1996.55.24; Steketee RW, 1996, AM J TROP MED HYG, V55, P17, DOI 10.4269/ajtmh.1996.55.17; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; *UANIDS, 1998, UNAIDS9835; WABWIREMANGEN F, 1989, AM J TROP MED HYG, V41, P504, DOI 10.4269/ajtmh.1989.41.504; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212	27	310	316	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1051	1056		10.1016/S0140-6736(00)02727-6	http://dx.doi.org/10.1016/S0140-6736(00)02727-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009139				2022-12-28	WOS:000089430500008
J	Oda, K; Arakawa, H; Tanaka, T; Matsuda, K; Tanikawa, C; Mori, T; Nishimori, H; Tamai, K; Tokino, T; Nakamura, Y; Taya, Y				Oda, K; Arakawa, H; Tanaka, T; Matsuda, K; Tanikawa, C; Mori, T; Nishimori, H; Tamai, K; Tokino, T; Nakamura, Y; Taya, Y			p53AlP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53	CELL			English	Article							HUMAN GENOMIC DNA; FUNCTIONAL DOMAIN; TARGET GENE; MUTANT P53; CELL-LINES; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; PROTEIN; CANCER	Through direct cloning of p53 binding sequences from human genomic DNA, we have isolated a novel gene, designated p53AIP1 (p89-regulated Apoptosis-Inducing Protein 1), whose expression is inducible by wildtype p53. Ectopically expressed p53AIP1, which is localized within mitochondria, leads to apoptotic cell death through dissipation of mitochondrial Delta psi m. We have found that upon severe DNA damage, Ser-46 on p53 is phosphorylated and apoptosis is induced. In addition, substitution of Ser-46 inhibits the ability of p53 to induce apoptosis and selectively blocks expression of p53AIP1. Our results suggest that p53AIP1 is likely to play an important role in mediating p53-dependent apoptosis, and phosphorylation of Ser-46 regulates the transcriptional activation of this apoptosis-inducing gene.	Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, Tokyo 1088639, Japan; Natl Canc Ctr, Res Inst, Div Biol, Tokyo 1040045, Japan; Cyclex Co Ltd, Nagano 3960002, Japan; Sapporo Med Coll, Canc Res Inst, Dept Mol Biol, Chuo Ku, Sapporo, Hokkaido 0608648, Japan	University of Tokyo; National Cancer Center - Japan; Sapporo Medical University	Taya, Y (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	yusuke@ims.u-tokyo.ac.jp; ytaya@gan2.ncc.go.jp	Arakawa, Hirofumi/L-3459-2013; Tamai, Katsuyuki/F-4743-2013; Tokino, Takashi/AAI-9887-2021; Matsuda, Koichi/D-4597-2011	Arakawa, Hirofumi/0000-0001-6077-0638; Tamai, Katsuyuki/0000-0003-4094-3911; Matsuda, Koichi/0000-0001-7292-2686; Tanikawa, Chizu/0000-0003-4759-4793				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chehab NH, 2000, GENE DEV, V14, P278; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Furuhata T, 1996, ONCOGENE, V13, P1965; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GomezManzano C, 1996, CANCER RES, V56, P694; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MIYASHITA T, 1995, CELL, V80, P293; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Ng CC, 1999, GENE CHROMOSOME CANC, V26, P329, DOI 10.1002/(SICI)1098-2264(199912)26:4<329::AID-GCC7>3.0.CO;2-C; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OREN M, 1994, SEMIN CANCER BIOL, V5, P221; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; RAMCHURREN N, 1995, INT J CANCER, V62, P237, DOI 10.1002/ijc.2910620302; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Takei Y, 1998, GENE CHROMOSOME CANC, V23, P1; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; Urano T, 1997, CANCER RES, V57, P3281; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; YEARGIN J, 1993, J CLIN INVEST, V91, P2111, DOI 10.1172/JCI116435; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	44	983	1024	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					849	862		10.1016/S0092-8674(00)00073-8	http://dx.doi.org/10.1016/S0092-8674(00)00073-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030628	Bronze			2022-12-28	WOS:000089395200016
J	Kolber, ZS; Van Dover, CL; Niederman, RA; Falkowski, PG				Kolber, ZS; Van Dover, CL; Niederman, RA; Falkowski, PG			Bacterial photosynthesis in surface waters of the open ocean	NATURE			English	Article							BACTERIOCHLOROPHYLL ALPHA; PACIFIC-OCEAN; PLUME WATERS; PHYTOPLANKTON; FLUORESCENCE; AUSTRALIA; COASTS	The oxidation of the global ocean by cyanobacterial oxygenic photosynthesis, about 2,100 Myr ago(1), is presumed to have limited anoxygenic bacterial photosynthesis to oceanic regions that are both anoxic and illuminated(2,3). The discovery of oxygen-requiring photosynthetic bacteria about 20 years ago(4) changed this notion, indicating that anoxygenic bacterial photosynthesis could persist under oxidizing conditions. However, the distribution of aerobic photosynthetic bacteria in the world oceans, their photosynthetic competence and their relationship to oxygenic photoautotrophs on global scales are unknown. Here we report the first biophysical evidence demonstrating that aerobic bacterial photosynthesis is widespread in tropical surface waters of the eastern Pacific Ocean and in temperate coastal waters of the northwestern Atlantic. Our results indicate that these organisms account for 2-5% of the photosynthetic electron transport in the upper ocean.	Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; William & Mary; Rutgers State University New Brunswick	Falkowski, PG (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA.							Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Binder B, 2000, J PHYCOL, V36, P120, DOI 10.1046/j.1529-8817.2000.99107.x; BLANKENSHIP RE, 1995, ANAXYGENIC PHOTOSYNT; DROOP MR, 1974, ALGAL PHYSL BIOCH, P531; Durnford DG, 1997, PHOTOSYNTH RES, V53, P229, DOI 10.1023/A:1005815725371; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Garcia D, 1998, PHOTOSYNTH RES, V55, P331, DOI 10.1023/A:1005941031263; Harashima H., 1987, AGR BIOL CHEM TOKYO, V42, P1627; Harashima K., 1989, AEROBIC PHOTOSYNTHET; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; NISBET EG, 1995, NATURE, V373, P479, DOI 10.1038/373479a0; NISHIMURA Y, 1994, J GEN APPL MICROBIOL, V40, P287, DOI 10.2323/jgam.40.287; NOGUCHI T, 1992, PHOTOSYNTH RES, V31, P21, DOI 10.1007/BF00049533; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Schwarze C, 2000, EUR J BIOCHEM, V267, P422, DOI 10.1046/j.1432-1327.2000.01018.x; SHIBA T, 1991, APPL ENVIRON MICROB, V57, P295, DOI 10.1128/AEM.57.1.295-300.1991; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; SHIBA T, 1984, J GEN APPL MICROBIOL, V30, P1313; Shimada K., 1995, ANOXYGENIC PHOTOSYNT, P105; VanDover CL, 1996, GEOPHYS RES LETT, V23, P2049, DOI 10.1029/96GL02151; Wiessner W., 1970, P95; WOESE CR, 1984, SYST APPL MICROBIOL, V5, P315, DOI 10.1016/S0723-2020(84)80034-X; Yurkov V, 1998, APPL ENVIRON MICROB, V64, P337; YURKOV V, 1994, INT J SYST BACTERIOL, V44, P427, DOI 10.1099/00207713-44-3-427; Yurkov VV, 1999, J BACTERIOL, V181, P4517, DOI 10.1128/JB.181.15.4517-4525.1999; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998	28	247	265	3	63	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					177	179		10.1038/35025044	http://dx.doi.org/10.1038/35025044			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001053				2022-12-28	WOS:000089241000045
J	Lacoste, V; Mauclere, P; Dubreuil, G; Lewis, J; Georges-Courbot, MC; Gessain, A				Lacoste, V; Mauclere, P; Dubreuil, G; Lewis, J; Georges-Courbot, MC; Gessain, A			Virology - KSHV-like herpesviruses in chimps and gorillas	NATURE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; IDENTIFICATION		Inst Pasteur, Dept SIDA & Retrovirus, Unite Oncol Virale, F-75724 Paris 15, France; Ctr Pasteur Cameroun, Yaounde, Cameroon; Ctr Int Rech Med, Franceville, Gabon; Int Zoo Vet Grp, Keighley BD21 1AG, W Yorkshire, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre Pasteur du Cameroun; International Zoo Veterinary Group (UK)	Lacoste, V (corresponding author), Inst Pasteur, Dept SIDA & Retrovirus, Unite Oncol Virale, 25-28 Rue Dr Roux, F-75724 Paris 15, France.		LACOSTE, Vincent/V-2321-2019	LACOSTE, Vincent/0000-0002-3173-4053				CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatlynne LG, 1998, BLOOD, V92, P53, DOI 10.1182/blood.V92.1.53.413k30_53_58; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Desrosiers RC, 1997, J VIROL, V71, P9764, DOI 10.1128/JVI.71.12.9764-9769.1997; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Greensill J, 2000, J VIROL, V74, P1572, DOI 10.1128/JVI.74.3.1572-1577.2000; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; Mahieux R, 1998, J VIROL, V72, P10316, DOI 10.1128/JVI.72.12.10316-10322.1998; ROIZMANN B, 1992, ARCH VIROL, V123, P425, DOI 10.1007/BF01317276; Rose TM, 1997, J VIROL, V71, P4138, DOI 10.1128/JVI.71.5.4138-4144.1997	11	67	70	1	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					151	152		10.1038/35025145	http://dx.doi.org/10.1038/35025145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001045				2022-12-28	WOS:000089241000036
J	Szilagyi, PG; Bordley, C; Vann, JC; Chelminski, A; Kraus, RM; Margolis, PA; Rodewald, LE				Szilagyi, PG; Bordley, C; Vann, JC; Chelminski, A; Kraus, RM; Margolis, PA; Rodewald, LE			Effect of patient reminder/recall interventions on immunization rates - A review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	32nd National Immunization Conference	JUL 21-24, 1998	ATLANTA, GA				COMPUTER-GENERATED REMINDERS; INFLUENZA VACCINATION RATES; RANDOMIZED CONTROLLED TRIAL; INNER-CITY; PRIMARY-CARE; CHILDHOOD IMMUNIZATION; SYSTEMATIC REVIEWS; POSTCARD REMINDERS; PUBLICATION BIAS; PREVENTIVE CARE	Context Immunization rates for children and adults remain below national goals. While experts recommend that health care professionals remind patients of needed immunizations, few practitioners actually use reminders. Little is known about the effectiveness of reminders in different settings or patient populations. Objectives To assess the effectiveness of patient reminder systems in improving immunization rates, and to compare the effectiveness of different types of reminders for a variety of patient populations. Data Sources A search was performed using MEDLINE, EMBASE, PsychINFO, Sociological Abstracts, and CAB Health Abstracts. Relevant articles, as well as published abstracts, conference proceedings, and tiles of study collaborators, were searched for relevant references. Study Selection and Data Extraction English-language studies involving patient reminder/recall interventions (using criteria established by the Cochrane Collaboration) were eligible for review if they involved randomized controlled trials, controlled before-after studies, or interrupted time series, and measured immunization rates. Of 109 studies identified, 41 met eligibility criteria. Studies were reviewed independently by 2 reviewers using a standardized checklist. Results of studies are expressed as absolute percentage-point changes in immunization rates and as odds ratios (ORs). Studies with similar characteristics of patients or interventions were pooled (random effects model). Data Synthesis Patient reminder systems were effective in improving immunization rates in 33 (80%) of the 41 studies, irrespective of baseline immunization rates, patient age, setting, or vaccination type. Increases in immunization rates due to reminders ranged from 5 to 20 percentage points. Reminders were effective for childhood Vaccinations (OR, 2.02; 95% confidence interval [CI], 1.49-2.72), childhood influenza vaccinations (OR, 4.25; 95% CI, 2.10-8.60), adult pneumococcus or tetanus vaccinations (OR, 5.14; 95% CI, 1.21-21.78), and adult influenza vaccinations (OR, 2.29; 95% CI, 1.69-3.10)? While reminders were most effective in academic settings (OR, 3.33; 95% CI, 1.98-5.58), they were also highly effective in private practice set tings (OR, 1.79; 95% CI, 1.45-2.22) and public health clinics (OR, 2.09; 95% CI, 1.42-3.07). All types of reminders were effective (postcards, letters, and telephone or autodialer calls), with telephone reminders being most effective but costliest. Conclusions Patient reminder systems in primary care settings are effective in improving immunization rates. Primary care physicians should use patient reminders to improve immunization delivery.	Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; Univ N Carolina, Dept Pediat, Childrens Primary Care Res Grp, Chapel Hill, NC USA; Univ N Carolina, Sch Publ Hlth, Publ Hlth Leadership Program, Chapel Hill, NC USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA USA	University of Rochester; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	Szilagyi, PG (corresponding author), Univ Rochester, Sch Med & Dent, Strong Mem Hosp, Box 632,601 Elmwood Ave, Rochester, NY 14642 USA.	peter_szilagyi@urmc.rochester.edu		Rodewald, Lance/0000-0003-2593-542X	PHS HHS [U66/CCU312166] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alemi F, 1996, MED CARE, V34, pOS45; Alto W A, 1994, J Am Board Fam Pract, V7, P472; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Baker AM, 1998, J GEN INTERN MED, V13, P469, DOI 10.1046/j.1525-1497.1998.00136.x; BARTON MB, 1990, AM J PUBLIC HEALTH, V80, P534, DOI 10.2105/AJPH.80.5.534; BECKER DM, 1989, AM J PREV MED, V5, P353, DOI 10.1016/S0749-3797(18)31056-0; BERNIER RH, 1993, JAMA-J AM MED ASSOC, V269, P1817, DOI 10.1001/jama.1993.03500140069038; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P1935, DOI 10.1001/jama.274.24.1935; BERO L, 1999, COCHRANE COLLABORATI; BRIMBERRY R, 1988, J FAM PRACTICE, V26, P397; BUCHNER DM, 1987, J AM GERIATR SOC, V35, P755, DOI 10.1111/j.1532-5415.1987.tb06354.x; BUFFINGTON J, 1991, J GEN INTERN MED, V6, P204, DOI 10.1007/BF02598961; CAMPBELL JR, 1994, CLIN PEDIATR, V33, P268, DOI 10.1177/000992289403300503; CARTER WB, 1986, ORGAN BEHAV HUM DEC, V38, P378, DOI 10.1016/0749-5978(86)90007-5; *CDCP, 1998, VACC COV LEV CHILDR; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P956; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P797; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P829; CHALMERS TC, 1990, JAMA-J AM MED ASSOC, V263, P1392, DOI 10.1001/jama.263.10.1392; CLARK M, 1999, REV MANAGER; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Fairbrother G, 1996, PEDIATRICS, V97, P785; FERSON MJ, 1995, PUBLIC HEALTH, V109, P25, DOI 10.1016/S0033-3506(95)80072-7; Frame P S, 1994, Arch Fam Med, V3, P581, DOI 10.1001/archfami.3.7.581; GOTTLIEB MS, 1982, AM J EPIDEMIOL, V116, P652; GYORKOS TW, 1994, CAN J PUBLIC HEALTH, V85, pS14; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; Hogg WE, 1998, CAN FAM PHYSICIAN, V44, P81; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; KEMPER KJ, 1993, AM J DIS CHILD, V147, P717; LARSON EB, 1979, J FAM PRACTICE, V8, P1207; LeBaron CW, 1998, ARCH PEDIAT ADOL MED, V152, P327; LEIRER VO, 1989, J AM GERIATR SOC, V37, P1147, DOI 10.1111/j.1532-5415.1989.tb06679.x; Lieu TA, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.4.e3; Lieu TA, 1997, PEDIATR INFECT DIS J, V16, P28, DOI 10.1097/00006454-199701000-00007; Linkins RW, 1998, PEDIATR ANN, V27, P349, DOI 10.3928/0090-4481-19980601-09; LINKINS RW, 1994, ARCH PEDIAT ADOL MED, V148, P908, DOI 10.1001/archpedi.1994.02170090022002; LUKASIK MH, 1987, CAN FAM PHYSICIAN, V33, P1997; MARGOLIS KL, 1992, J AM GERIATR SOC, V40, P1021, DOI 10.1111/j.1532-5415.1992.tb04480.x; Massoudi MS, 1999, PEDIATRICS, V103, P1218, DOI 10.1542/peds.103.6.1218; MCDOWELL I, 1986, CAN MED ASSOC J, V135, P991; MORAN WP, 1992, J GEN INTERN MED, V7, P535, DOI 10.1007/BF02599460; MULLOOLY JP, 1987, AM J PUBLIC HEALTH, V77, P626, DOI 10.2105/AJPH.77.5.626; Nexoe J, 1997, SCAND J PRIM HEALTH, V15, P109, DOI 10.3109/02813439709018497; OEFFINGER KC, 1992, J FAM PRACTICE, V35, P288; ORNSTEIN SM, 1991, J FAM PRACTICE, V32, P82; Poole C, 1999, AM J EPIDEMIOL, V150, P469, DOI 10.1093/oxfordjournals.aje.a010035; Puech M, 1998, AUST NZ J PUBL HEAL, V22, P254, DOI 10.1111/j.1467-842X.1998.tb01183.x; RODEWALD LE, 1995, ARCH PEDIAT ADOL MED, V149, P393, DOI 10.1001/archpedi.1995.02170160047007; Rodewald LE, 1999, PEDIATRICS, V103, P31, DOI 10.1542/peds.103.1.31; ROSSER WW, 1991, CAN MED ASSOC J, V145, P807; Satterthwaite P, 1997, NEW ZEAL MED J, V110, P58; Shea S, 1996, J AM MED INFORM ASSN, V3, P399, DOI 10.1136/jamia.1996.97084513; Shefer A, 1999, EPIDEMIOL REV, V21, P96, DOI 10.1093/oxfordjournals.epirev.a017992; SIEBERS MJ, 1985, J AM GERIATR SOC, V33, P175, DOI 10.1111/j.1532-5415.1985.tb04888.x; SOLJAK MA, 1987, NEW ZEAL MED J, V100, P244; SPAULDING SA, 1991, J FAM PRACTICE, V33, P495; STEHRGREEN PA, 1993, PUBLIC HEALTH REP, V108, P426; SZILAGYI PG, 1992, PEDIATRICS, V90, P871; SZILAGYI PG, 1994, PEDIATRICS, V94, P517; Szilagyi PG, 2000, AM J PREV MED, V18, P318, DOI 10.1016/S0749-3797(00)00120-3; SZILAGYI PG, 2000, COCHRANE LIB; THOMPSON SG, 1991, LANCET, V338, P1127, DOI 10.1016/0140-6736(91)91975-Z; TOLLESTRUP K, 1991, AM J PREV MED, V7, P24, DOI 10.1016/S0749-3797(18)30961-9; Udovic SL, 1998, PEDIATR ANN, V27, P355, DOI 10.3928/0090-4481-19980601-10; van Rooyen S, 1998, JAMA-J AM MED ASSOC, V280, P234, DOI 10.1001/jama.280.3.234; Wood D, 1998, JAMA-J AM MED ASSOC, V279, P29, DOI 10.1001/jama.279.1.29; YOUNG SA, 1980, AM J PUBLIC HEALTH, V70, P422, DOI 10.2105/AJPH.70.4.422	70	292	292	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1820	1827		10.1001/jama.284.14.1820	http://dx.doi.org/10.1001/jama.284.14.1820			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	359PW	11025835				2022-12-28	WOS:000089622100034
J	Tong, Q; Dalgin, G; Xu, HY; Ting, CN; Leiden, JM; Hotamisligil, GS				Tong, Q; Dalgin, G; Xu, HY; Ting, CN; Leiden, JM; Hotamisligil, GS			Function of GATA transcription factors in preadipocyte-adipocyte transition	SCIENCE			English	Article							FINGER PROTEIN; PPAR-GAMMA; ADIPOGENESIS; DIFFERENTIATION; EXPRESSION; CELLS; HEMATOPOIESIS; DROSOPHILA; ISOFORMS; OBESITY	Genes that control the early stages of adipogenesis remain largely unknown. Here, we show that murine GATA-2 and GATA-3 are specifically expressed in white adipocyte precursors and that their down-regulation sets the stage for terminal differentiation. Constitutive GATA-2 and GATA-3 expression suppressed adipocyte differentiation and trapped cells at the preadipocyte stage. This effect is mediated, at least in part, through the direct suppression of peroxisome proliferator-activated receptor gamma. GATA-3-deficient embryonic stem cells exhibit an enhanced capacity to differentiate into adipocytes, and defective GATA-2 and GATA-3 expression is associated with obesity. Thus, GATA-2 and GATA-3 regulate adipocyte differentiation through molecular control of the preadipocyte-adipocyte transition.	Harvard Univ, Sch Publ Hlth, Div Biol Sci, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Div Biol Sci, 665 Huntington Ave, Boston, MA 02115 USA.			Dalgin, Gokhan/0000-0002-9696-989X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056894, F32DK009940] Funding Source: NIH RePORTER; NIAID NIH HHS [R37AI29673] Funding Source: Medline; NIDDK NIH HHS [F32DK09940, DK56894] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABEL T, 1993, DEVELOPMENT, V119, P623; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Dani C, 1997, J CELL SCI, V110, P1279; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; TONG QY, UNPUB; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; YANG HY, 1992, MOL CELL BIOL, V12, P4562, DOI 10.1128/MCB.12.10.4562; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	22	373	392	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					134	138		10.1126/science.290.5489.134	http://dx.doi.org/10.1126/science.290.5489.134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021798				2022-12-28	WOS:000089724800051
J	Maurer, MS; Karmally, W; Rivadeneira, H; Parides, MK; Bloomfield, DM				Maurer, MS; Karmally, W; Rivadeneira, H; Parides, MK; Bloomfield, DM			Upright posture and postprandial hypotension in elderly persons	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE REDUCTION; MEAL INGESTION; RESPONSES	Background: Syncope and falls are common in elderly persons and often result from the interaction of multiple clinical abnormalities. Both orthostatic hypotension and postprandial hypotension Increase in prevalence with age. Objective: To determine whether meal ingestion enhances orthostatic hypotension in elderly persons. Design: Controlled paired comparison. Setting: Clinical research center. Patients: 50 functionally independent elderly persons recruited from local senior centers (n = 47) and from patients hospitalized with an unexplained fall or syncope (n = 3) (mean age, 78 years [range, 61 to 96 years]). Twenty-five participants (50%) were taking antihypertensive medication. Measurements: sequential head-up tilt-table testing at 60 degrees was performed before and 30 minutes after ingestion of a standardized warm liquid meal that was high in carbohydrates. Heart rate and blood pressure were continuously monitored. Results: Meal ingestion (P < 0.01) and time spent upright (P < 0.001) were significantly associated with systolic blood pressure, but no significant interaction was found between meal ingestion and time spent upright (P > 0.2). These findings suggest that the association between meal ingestion and head-up tilt-table testing were additive and not synergistic. However, the proportion of participants with symptomatic hypotension increased during head-up tilt-table testing after meal ingestion (12% during preprandial testing and 22% during postprandial testing). Symptomatic hypotension tended to occur more often and sooner after meal ingestion than before meal ingestion (P = 0.03). Conclusions: Meal ingestion and head-up tilt-table testing are associated with increasing occurrences of symptomatic hypotension. After meal ingestion and head-up tilt-table testing, 22% of functionally independent elderly persons had symptomatic hypotension.	Columbia Univ, Coll Phys & Surg, Div Circulatory Physiol, New York, NY 10032 USA	Columbia University	Maurer, MS (corresponding author), Columbia Univ, Coll Phys & Surg, Div Circulatory Physiol, 177 Ft Washington Ave,MHB5-435, New York, NY 10032 USA.	msm10@columbia.edu	Parides, Michael/GON-8474-2022		NCRR NIH HHS [MO1 RR-00645] Funding Source: Medline; NHLBI NIH HHS [HL-03466] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003466] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELLOMO G, 1988, GERONTOLOGY, V34, P311, DOI 10.1159/000212972; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Forman Daniel E., 1997, Cardiology Clinics, V15, P295; Imai C, 1998, AM J CARDIOL, V81, P1310, DOI 10.1016/S0002-9149(98)00163-5; JANSEN RW, 1986, J AM GERIATR SOC, V44, P383; JANSEN RWMM, 1995, ANN INTERN MED, V122, P286, DOI 10.7326/0003-4819-122-4-199502150-00009; JONSSON PV, 1990, ARCH INTERN MED, V150, P1518, DOI 10.1001/archinte.150.7.1518; KUIPERS HMM, 1991, J AM GERIATR SOC, V39, P181, DOI 10.1111/j.1532-5415.1991.tb01623.x; LIPSITZ LA, 1993, CIRCULATION, V87, P391, DOI 10.1161/01.CIR.87.2.391; LIPSITZ LA, 1983, NEW ENGL J MED, V309, P81, DOI 10.1056/NEJM198307143090205; LIPSITZ LA, 1986, J CHRON DIS, V39, P619, DOI 10.1016/0021-9681(86)90187-6; Ooi WL, 1997, JAMA-J AM MED ASSOC, V277, P1299, DOI 10.1001/jama.277.16.1299; VAITKEVICIUS PV, 1991, ANN INTERN MED, V115, P865, DOI 10.7326/0003-4819-115-11-865	13	36	40	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					533	536		10.7326/0003-4819-133-7-200010030-00012	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015166				2022-12-28	WOS:000089678300005
J	Ho, KKY				Ho, KKY			Diagnosis of adult GH deficiency	LANCET			English	Editorial Material							GROWTH-HORMONE DEFICIENCY		St Vincents Hosp, Garvan Inst Med Res, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney	Ho, KKY (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Sydney, NSW 2010, Australia.		Ho, Ken KY/E-5832-2011; Ho, Ken/AAA-7428-2019	Ho, Ken/0000-0002-2508-9588				Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; BOWERS CY, 1991, ENDOCRINOLOGY, V128, P2027, DOI 10.1210/endo-128-4-2027; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; HARTMAN ML, 2000, P 82 ANN M END SOC J; Hoffman D. M., 1996, GROWTH HORMONE ADULT, P168; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; LEALCERRO A, 1995, EUR J ENDOCRINOL, V132, P712, DOI 10.1530/eje.0.1320712; Mahajan T, 2000, J CLIN ENDOCR METAB, V85, P1473, DOI 10.1210/jc.85.4.1473; REITER EO, 1988, J CLIN ENDOCR METAB, V66, P68, DOI 10.1210/jcem-66-1-68; Smith RG, 1997, ENDOCR REV, V18, P621, DOI 10.1210/er.18.5.621; TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x	12	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1125	1126		10.1016/S0140-6736(00)02748-3	http://dx.doi.org/10.1016/S0140-6736(00)02748-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030286				2022-12-28	WOS:000089594300003
J	Ansari, A; Decesare, R				Ansari, A; Decesare, R			Mesenteric ischemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Fairview Southdale Hosp, Edina, MN 55435 USA		Ansari, A (corresponding author), Fairview Southdale Hosp, Edina, MN 55435 USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2000	343	13					937	937		10.1056/NEJM200009283431306	http://dx.doi.org/10.1056/NEJM200009283431306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KT	11006370				2022-12-28	WOS:000089501400006
J	Burkhart, SS				Burkhart, SS			A 26-year-old woman with shoulder pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							II SLAP LESIONS; GLENOID IMPINGEMENT; BANKART PROCEDURE; FOLLOW-UP; REPAIR; 2-YEAR; INJECTION		Baylor Coll Med, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio	Burkhart, SS (corresponding author), Care of Hartman EE, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,LY318, Boston, MA 02215 USA.							[Anonymous], 1934, SHOULDER RUPTURE SUP; Bacilla P, 1997, ARTHROSCOPY, V13, P51, DOI 10.1016/S0749-8063(97)90209-7; Bankart ASB, 1938, BRIT J SURG, V26, P23, DOI 10.1002/bjs.18002610104; Barber FA, 1998, ARTHROSCOPY, V14, P671, DOI 10.1016/S0749-8063(98)70092-1; Bigliani L, 1986, J ORTHOP TRANSL, V10; Bosworth BM, 1941, J AMER MED ASSOC, V116, P2477, DOI 10.1001/jama.1941.02820220019004; BRIDGMAN JF, 1972, ANN RHEUM DIS, V31, P69, DOI 10.1136/ard.31.1.69; BUCKLE P, 1987, J HAND SURG-AM, V12A, P885, DOI 10.1016/S0363-5023(87)80255-1; Burkhart SS, 2000, CLIN SPORT MED, V19, P125, DOI 10.1016/S0278-5919(05)70300-8; Burkhart SS, 2000, ARTHROSCOPY, V16, P82, DOI 10.1016/S0749-8063(00)90133-6; Burkhart SS, 1998, ARTHROSCOPY, V14, P637, DOI 10.1016/S0749-8063(98)70065-9; BURKHART SS, IN PRESS ARTHROSCOPY; CAHILL BR, 1982, J BONE JOINT SURG AM, V64, P1053, DOI 10.2106/00004623-198264070-00015; CAILLIETT R, 1981, SHOULDER PAIN, P15; Coumo F, 1999, DISORDERS SHOULDER D, P397; ELLMAN H, 1991, J BONE JOINT SURG BR, V73, P395, DOI 10.1302/0301-620X.73B3.1670435; ESCH C, 1988, ARTHROSCOPY, V4, P241; FORD LT, 1979, SOUTH MED J, V72, P827, DOI 10.1097/00007611-197907000-00019; GARTH WP, 1987, AM J SPORT MED, V15, P579, DOI 10.1177/036354658701500610; Gartsman GM, 1998, J BONE JOINT SURG AM, V80A, P832, DOI 10.2106/00004623-199806000-00007; Gartsman GM, 2000, J BONE JOINT SURG AM, V82A, P26, DOI 10.2106/00004623-200001000-00004; GREEN MR, 1995, AM J SPORT MED, V23, P276, DOI 10.1177/036354659502300304; HALL RH, 1959, J BONE JOINT SURG AM, V41, P489, DOI 10.2106/00004623-195941030-00013; HERBERTS P, 1984, CLIN ORTHOP RELAT R, P166; HERBERTS P, 1981, ACTA ORTHOP SCAND, V52, P299, DOI 10.3109/17453678109050107; Hill HA, 1940, RADIOLOGY, V35, P690; HOLLINGWORTH GR, 1983, BRIT MED J, V287, P1339, DOI 10.1136/bmj.287.6402.1339; HOVELIUS L, 1983, J BONE JOINT SURG AM, V65, P343, DOI 10.2106/00004623-198365030-00008; Hsu H C, 1994, J Shoulder Elbow Surg, V3, P159, DOI 10.1016/S1058-2746(09)80095-5; Inman VT, 1944, J BONE JOINT SURG, V26, P1; JACKSON RW, 2000, ORTHOP TODAY     JAN, P40; JOBE CM, 1995, ARTHROSCOPY, V11, P530, DOI 10.1016/0749-8063(95)90128-0; JOBE FW, 1991, AM J SPORT MED, V19, P428, DOI 10.1177/036354659101900502; Jobe FW, 1990, SHOULDER, P963; KELLEY MJ, 1999, DISORDERS SHOULDER D, P979; KNEELAND JB, 1999, DISORDERS SHOULDER D, P911; LEFFERT RD, 1990, SHOULDER, P750; Lehmann J F, 1970, Arch Phys Med Rehabil, V51, P481; Lundberg B J, 1969, Acta Orthop Scand Suppl, V119, P1; MADSEN B, 1963, BRIT J RADIOL, V36, P822, DOI 10.1259/0007-1285-36-431-822; MATSEN FA, 1990, SHOULDER, P633; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; Morgan CD, 1998, ARTHROSCOPY, V14, P553, DOI 10.1016/S0749-8063(98)70049-0; Morrison DS, 1997, J BONE JOINT SURG AM, V79A, P732, DOI 10.2106/00004623-199705000-00013; Moskal MJ, 1999, ARTHROSCOPY, V15, P408, DOI 10.1016/S0749-8063(99)70059-9; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; NEER CS, 1972, J BONE JOINT SURG AM, VA 54, P41, DOI 10.2106/00004623-197254010-00003; Nirschl R P, 1989, Instr Course Lect, V38, P439; PETTERSSON G., 1942, ACTA CHIR SCAND    S, V77, P1; POST M, 1987, CLIN ORTHOP RELAT R, P126; ROCKWOOD CA, 1990, SHOULDER, P178; ROWE CR, 1981, J BONE JOINT SURG AM, V63, P863, DOI 10.2106/00004623-198163060-00001; ROWE CR, 1978, J BONE JOINT SURG AM, V60, P1; ROY S, 1976, LANCET, V1, P1322; RUKOS JR, 1972, CLIN ORTHOPAEDICS, V82, P84; SCHENCK RC, 2000, ORTHOP TECHNOL REV, V2, P12; SENGAR DPS, 1987, TISSUE ANTIGENS, V29, P173; SOSLOWSKY LJ, 1996, ORTHOP T, V19, P1038; Speer K P, 1996, J Shoulder Elbow Surg, V5, P62, DOI 10.1016/S1058-2746(96)80032-2; Tauro JC, 1998, ARTHROSCOPY, V14, P45, DOI 10.1016/S0749-8063(98)70119-7; THOMAS SC, 1989, J BONE JOINT SURG AM, V71A, P506, DOI 10.2106/00004623-198971040-00005; TIMAN PF, 1994, RADIOLOGY, V190, P653; TIRMAN PFJ, 1994, RADIOLOGY, V193, P431, DOI 10.1148/radiology.193.2.7972758; UHTHOFF HK, 1976, CLIN ORTHOP RELAT R, P164; Uhthoff HK, 1990, SHOULDER, P774; UHTOFF H, 1986, P 3 INT C SURG SHOUL; Warner JJP, 1996, J BONE JOINT SURG AM, V78A, P1808, DOI 10.2106/00004623-199612000-00003; WEFLING J, 1965, REV RHUM, V32, P325; Wirth MA, 1996, J BONE JOINT SURG AM, V78A, P246, DOI 10.2106/00004623-199602000-00012; WORCESTER JN, 1968, CLIN ORTHOP RELAT R, P69; Yamanaka K, 1983, ORTHOP SURG TRAUMATO, V26, P713	71	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1559	1567		10.1001/jama.284.12.1559	http://dx.doi.org/10.1001/jama.284.12.1559			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000651				2022-12-28	WOS:000089379700033
J	Griffiths, PD				Griffiths, PD			Xenotransplantation: one trotter forward, one claw back	LANCET			English	Editorial Material							ENDOGENOUS RETROVIRUS; TRANSPLANTATION; RECEPTOR; TISSUE; ORGAN		UCL Royal Free & Univ Coll Med Sch, Dept Virol, London NW3 2PF, England	University of London; University College London; UCL Medical School	Griffiths, PD (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Virol, London NW3 2PF, England.							Desselberger U, 1998, REV MED VIROL, V8, P43; Fishman JA, 2000, XENOTRANSPLANTATION, V7, P93, DOI 10.1034/j.1399-3089.2000.00051.x; Fox JL, 2000, ASM NEWS, V66, P129; Murphy FA, 1996, SCIENCE, V273, P746, DOI 10.1126/science.273.5276.746; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Schmoeckel M, 1996, TRANSPLANTATION, V62, P729, DOI 10.1097/00007890-199609270-00005; Starzl TE, 1999, REV MED VIROL, V9, P3, DOI 10.1002/(SICI)1099-1654(199901/03)9:1<3::AID-RMV241>3.3.CO;2-4; van der Laan LJW, 2000, NATURE, V407, P90, DOI 10.1038/35024089; WARD T, 1994, EMBO J, V13, P5070, DOI 10.1002/j.1460-2075.1994.tb06836.x	12	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2000	356	9235					1049	1050		10.1016/S0140-6736(00)02725-2	http://dx.doi.org/10.1016/S0140-6736(00)02725-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009138				2022-12-28	WOS:000089430500006
J	Heyworth, MF				Heyworth, MF			Sky was not the limit for music-loving Herschel	NATURE			English	Letter									Vet Adm Med Ctr, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania	Heyworth, MF (corresponding author), Vet Adm Med Ctr, Univ & Woodland Ave, Philadelphia, PA 19104 USA.							CUDWORTH C, 1980, NEW GROVE DICT MUSIC, V8, P520; Jardine L, 2000, NATURE, V405, P397, DOI 10.1038/35013135; JEROME WD, 1998, MEMOIRS AM PHILOS SO, V225; LANDON HCR, 1976, HAYDN ENGLAND 1791 1, V3, P176	4	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					286	286		10.1038/35030202	http://dx.doi.org/10.1038/35030202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014165	Bronze			2022-12-28	WOS:000089390700018
J	Loder, N				Loder, N			Unfavourable economics put postdocs across Europe under strain	NATURE			English	Article																			0	0	0	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					427	429		10.1038/35030308	http://dx.doi.org/10.1038/35030308			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014202				2022-12-28	WOS:000089390700059
J	Paul, WE; Mage, RG				Paul, WE; Mage, RG			Elvin A. Kabat (1914-2000) - Obituary	NATURE			English	Biographical-Item									NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Paul, WE (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, ZIAAI000036, Z01AI000036, Z01AI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					316	316		10.1038/35030291	http://dx.doi.org/10.1038/35030291			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014176				2022-12-28	WOS:000089390700030
J	Allshire, R; Bickmore, W				Allshire, R; Bickmore, W			Pausing for thought on the boundaries of imprinting	CELL			English	Review							REPLICATION; MAINTENANCE; CHROMOSOME		MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Allshire, R (corresponding author), MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.		Bickmore, Wendy A/C-7314-2013	Bickmore, Wendy A/0000-0001-6660-7735; Allshire, Robin/0000-0002-8005-3625				Arcangioli B, 2000, EMBO J, V19, P1389, DOI 10.1093/emboj/19.6.1389; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BICKMORE WA, 1995, J CELL SCI, V108, P2801; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Dalgaard LZ, 1999, NATURE, V400, P181, DOI 10.1038/22139; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Partridge JF, 2000, GENE DEV, V14, P783; Pedone PV, 1999, FEBS LETT, V458, P45, DOI 10.1016/S0014-5793(99)01124-2; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9; Srivastava M, 2000, GENE DEV, V14, P1186; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Verreault A, 2000, GENE DEV, V14, P1430	18	16	17	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					705	708		10.1016/S0092-8674(00)00058-1	http://dx.doi.org/10.1016/S0092-8674(00)00058-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030613	Bronze			2022-12-28	WOS:000089395200001
J	Hobmayer, B; Rentzsch, F; Kuhn, K; Happel, CM; von Laue, CC; Snyder, P; Rothbacher, U; Holstein, TW				Hobmayer, B; Rentzsch, F; Kuhn, K; Happel, CM; von Laue, CC; Snyder, P; Rothbacher, U; Holstein, TW			WNT signalling molecules act in axis formation in the diploblastic metazoan Hydra	NATURE			English	Article							PATTERN-FORMATION; XENOPUS EMBRYOS; BETA-CATENIN; DROSOPHILA; REGENERATION; EVOLUTION; WINGLESS; HOMOLOG	Members of the Wnt/wingless family of secreted proteins act as short-range inducers and long-range organizers during axis formation, organogenesis and tumorigenesis in many developing tissues(1). Wnt signalling pathways are conserved in nematodes, insects and vertebrates(2). Despite its developmental significance, the evolutionary origin of Wnt signalling is unclear. Here we describe the molecular characterization of members of the Wnt signalling pathwayDWnt, Dishevelled, GSK3, beta-Catenin and Tcf/Lef-in Hydra, a member of the evolutionarily old metazoan phylum Cnidaria. Wnt and Tcf are expressed in the putative Hydra head organizer, the upper part of the hypostome. Wnt, beta-Catenin and Tcf are transcriptionally upregulated when head organizers are established early in bud formation and head regeneration. Wnt and Tcf expression domains also define head organizers created by de novo pattern formation in aggregates. Our results indicate that Wnt signalling may be involved in axis formation in Hydra and support the idea that it was central in the evolution of axial differentiation in early multicellular animals.	Tech Univ Darmstadt, Inst Zool, Dept Mol Cell Biol, D-64287 Darmstadt, Germany; IBDM, Lab Genet & Physiol Dev, F-13288 Marseille 9, France	Technical University of Darmstadt; UDICE-French Research Universities; Aix-Marseille Universite	Hobmayer, B (corresponding author), Tech Univ Darmstadt, Inst Zool, Dept Mol Cell Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	hobmayer@bio.tu-darmstadt.de; holstein@bio.tu-darmstadt.de	Rothbächer, Ute/AAB-6901-2022; Rothbächer, Ute/G-2688-2013	Rothbächer, Ute/0000-0002-9989-6139; Rothbächer, Ute/0000-0002-9989-6139; Holstein, Thomas/0000-0003-0480-4674				ACHERMANN J, 1985, DEV BIOL, V107, P13, DOI 10.1016/0012-1606(85)90371-9; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Bode HR, 1984, PATTERN FORMATION PR, V1, P213; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cox RT, 1998, CURR BIOL, V8, pR140, DOI 10.1016/S0960-9822(98)70081-8; Finnerty JR, 1998, CURR OPIN GENET DEV, V8, P681, DOI 10.1016/S0959-437X(98)80037-3; Frohman Michael A., 1995, P381; Gauchat D, 2000, P NATL ACAD SCI USA, V97, P4493, DOI 10.1073/pnas.97.9.4493; GIERER A, 1972, NATURE-NEW BIOL, V239, P98, DOI 10.1038/newbio239098a0; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Hobmayer E, 1996, GENE, V172, P155, DOI 10.1016/0378-1119(96)00162-X; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Kopp A, 1999, DEVELOPMENT, V126, P3495; Kuhn K, 1999, J EXP ZOOL, V285, P63, DOI 10.1002/(SICI)1097-010X(19990415)285:1<63::AID-JEZ8>3.0.CO;2-X; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Lessing D, 1998, DEVELOPMENT, V125, P1469; MACWILLIAMS HK, 1983, DEV BIOL, V96, P239, DOI 10.1016/0012-1606(83)90325-1; MEINHARDT H, 1993, DEV BIOL, V157, P321, DOI 10.1006/dbio.1993.1138; Minobe S, 2000, DEV GENES EVOL, V210, P258, DOI 10.1007/s004270050312; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morris SC, 1998, CURR OPIN GENET DEV, V8, P662, DOI 10.1016/S0959-437X(98)80034-8; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; OTTO JJ, 1977, J EXP ZOOL, V200, P417, DOI 10.1002/jez.1402000311; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Technau U, 1999, DEVELOPMENT, V126, P999; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Willmer P., 1990, INVERTEBRATE RELATIO; Wolpert L., 1998, PRINCIPLES DEV	30	405	424	0	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					186	189		10.1038/35025063	http://dx.doi.org/10.1038/35025063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001056				2022-12-28	WOS:000089241000048
J	London, SJ; Romieu, I				London, SJ; Romieu, I			Health costs due to outdoor air pollution by traffic	LANCET			English	Editorial Material							UNITED-STATES; MORTALITY		NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; Pan Amer Hlth Org, Mexico City, DF, Mexico	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Pan American Health Organization	London, SJ (corresponding author), NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.		London, Stephanie/C-3734-2019	London, Stephanie/0000-0003-4911-5290	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049018, Z01ES025045, ZIAES043012, Z01ES043012, ZIAES049019, ZIAES025045, Z01ES049019, Z01ES049017] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABBEY DE, 1995, ARCH ENVIRON HEALTH, V50, P139, DOI 10.1080/00039896.1995.9940891; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; *BUR TRANSP STUD, 1999, WHO MIN C ENV HLTH L; Burney P, 1999, LANCET, V353, P859, DOI 10.1016/S0140-6736(99)00002-1; Diaz-Sanchez D, 1999, J ALLERGY CLIN IMMUN, V104, P1183, DOI 10.1016/S0091-6749(99)70011-4; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dora C, 1999, BRIT MED J, V318, P1686, DOI 10.1136/bmj.318.7199.1686; Guo YLL, 1999, ENVIRON HEALTH PERSP, V107, P1001, DOI 10.1289/ehp.991071001; HOLGATE ST, 1999, AIR POLLUTION HUMAN; Ohtsuka Y, 2000, AM J RESP CELL MOL, V22, P574, DOI 10.1165/ajrcmb.22.5.3895; Ostro B, 1998, ENVIRON RES, V76, P94, DOI 10.1006/enrs.1997.3799; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669	12	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2000	356	9232					782	783		10.1016/S0140-6736(00)02646-5	http://dx.doi.org/10.1016/S0140-6736(00)02646-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022919				2022-12-28	WOS:000089101800002
J	Scotet, V; de Braekeleer, M; Roussey, M; Rault, G; Parent, P; Dagorne, M; Journel, H; Lemoigne, A; Codet, JP; Catheline, M; David, V; Chaventre, A; Dugueperoux, I; Verlingue, C; Quere, I; Mercier, B; Audrezet, MP; Ferec, C				Scotet, V; de Braekeleer, M; Roussey, M; Rault, G; Parent, P; Dagorne, M; Journel, H; Lemoigne, A; Codet, JP; Catheline, M; David, V; Chaventre, A; Dugueperoux, I; Verlingue, C; Quere, I; Mercier, B; Audrezet, MP; Ferec, C			Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis	LANCET			English	Article							IMMUNOREACTIVE TRYPSINOGEN; GENE; IDENTIFICATION; POPULATION; MUTATIONS; NEWBORNS; BABIES; BLOOD; DNA	Background Neonatal screening for cystic fibrosis has been a subject of debate over the past few years. This study assesses 10 years of neonatal screening in Brittany, France, and examines its impact on prenatal screening of subsequent pregnancies in couples with an affected child. Methods The study included all the neonates screened for cystic fibrosis in Brittany from Jan 1, 1989, to Dec 31, 1998. The screening consisted of an immunoreactive trypsinogen assay from dried blood spots, plus, from 1993, mutation analysis. Data were collected on incidence of cystic fibrosis, and genotypic and biochemical characteristics. The use of prenatal screening of subsequent pregnancies in affected families was also investigated. Findings Of the 343 756 neonates screened, 118 children with cystic fibrosis were identified, giving an incidence of one in 2913. All mutated alleles were characterised: 34 different mutations resulting in 36 genotypes were detected, The introduction of DNA analysis into the protocol greatly reduced the recall rate and increased the sensitivity of the test. The mean cost of the screening programme was US$2.32 per screened child. 39 (34%) of the families identified by neonatal screening opted for subsequent prenatal diagnosis at least once. 12 couples would have benefited from this procedure while their first child was still symptom-free. 42 healthy children were born, and 18 pregnancies were terminated (therapeutic abortion rate of 100%). Interpretation We have shown the feasibility of neonatal screening for cystic fibrosis in Brittany. Through the detection of a large range of mutations, neonatal screening provides the opportunity for more reliable prenatal diagnosis and cascade screening. The neonatal screening programme described here could provide a good model for other countries intending to initiate such a scheme.	EFS Bretagne, UBO, CHU Morvan, Lab Genet Mol & Histocompatibil, F-29275 Brest, France; Lab Anthropol & Demog Genet, Bordeaux, France; INED, Paris, France; CHRU Pontchaillou, Serv Pediat & Genet Med, Rennes, France; Ctr Hello Marin, Roscoff, France; CHU Morvan, Dept Pediat & Genet Med, Brest, France; CH Beauchee, Serv Pediat & Neonatal, St Brieuc, France; CH Chubert, Serv Pediat, Vannes, France; CH Bodelio, Serv Pediat & Neonatal, Lorient, France; CHU Morvan, Nucl Med Serv, Brest, France; CHRU Pontchaillou, Serv Biochim, Rennes, France; CHRU Pontchaillou, Genet Mol Lab, Rennes, France	CHU Brest; Universite de Bretagne Occidentale; CHU Rennes; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Rennes; CHU Rennes	Ferec, C (corresponding author), EFS Bretagne, UBO, CHU Morvan, Lab Genet Mol & Histocompatibil, BP 454, F-29275 Brest, France.	claude.ferec@univ-brest.fr	Ferec, Claude/ABG-9699-2020; Quere, Isabelle/AAB-8519-2020	Ferec, Claude/0000-0002-2325-0710; Quere, Isabelle/0000-0002-1492-9764; Scotet, Virginie/0000-0002-5447-4207				AUDREZET MP, 1993, MOL CELL PROBE, V7, P497, DOI 10.1006/mcpr.1993.1073; BALNAVES ME, 1995, J MED GENET, V32, P537, DOI 10.1136/jmg.32.7.537; BOIS E, 1978, CLIN GENET, V14, P73; Castellani C, 1997, J MED GENET, V34, P297, DOI 10.1136/jmg.34.4.297; CHATFIELD S, 1991, ARCH DIS CHILD-FETAL, V66, P29, DOI 10.1136/adc.66.1_Spec_No.29; DankertRoelse JE, 1997, NEW ENGL J MED, V337, P997, DOI 10.1056/NEJM199710023371409; DANKERTROELSE JE, 1995, THORAX, V50, P712, DOI 10.1136/thx.50.7.712; DEMENAIS F, 1979, REV EPIDEMIOL SANTE, V27, P5; Dodge JA, 1998, BRIT MED J, V317, P411; Farrell P M, 1992, Adv Pediatr, V39, P35; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; FARRELL PM, 1991, PEDIATR PULM, P11; FEREC C, 1995, HUM GENET, V96, P542, DOI 10.1007/BF00197409; FEREC C, 1992, NAT GENET, V1, P188, DOI 10.1038/ng0692-188; FEREC C, 1993, FETAL DIAGN THER, V8, P341, DOI 10.1159/000263850; GILTZELMANN R, 1981, HELV PAEDIATR ACTA, V36, P493; GREEN MR, 1993, ARCH DIS CHILD, V68, P464, DOI 10.1136/adc.68.4.464; GREGG RG, 1993, AM J HUM GENET, V52, P616; KAZAZIAN HH, 1994, HUM MUTAT, V4, P167; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lane B, 1998, BRIT MED J, V317, P411; MERELLE ME, 1999, COCHRANE LIB; MISHLER EH, 1989, WIS MED J, V88, P14; RANIERI E, 1994, BRIT MED J, V308, P1469, DOI 10.1136/bmj.308.6942.1469; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; TRAVERT G, 1983, ARCH FR PEDIATR, V40, P295; TRAVERT G, 1999, P INT C NEON SCREEN; Wald NJ, 1998, BRIT MED J, V316, P404, DOI 10.1136/bmj.316.7129.404; Waters DL, 1999, ARCH DIS CHILD-FETAL, V80, pF1, DOI 10.1136/fn.80.1.F1; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; WILCKEN B, 1985, LANCET, V2, P1319; WILCKEN B, 1995, J PEDIATR-US, V127, P965, DOI 10.1016/S0022-3476(95)70040-4; WILCKEN B, 1993, SCREENING, V2, P43	35	69	73	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2000	356	9232					789	794		10.1016/S0140-6736(00)02652-0	http://dx.doi.org/10.1016/S0140-6736(00)02652-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022925				2022-12-28	WOS:000089101800008
J	Robinson, D; Smith, AMJ; Johnston, GD				Robinson, D; Smith, AMJ; Johnston, GD			Severity of overdose after restriction of paracetamol availability: retrospective study	BRITISH MEDICAL JOURNAL			English	Article									Queens Univ Belfast, Dept Therapeut & Pharmacol, Belfast BT9 7BL, Antrim, North Ireland; Royal Victoria Hosp, Reg Med & Poisons Informat Unit, Belfast BT12 6BA, Antrim, North Ireland	Queens University Belfast	Johnston, GD (corresponding author), Queens Univ Belfast, Dept Therapeut & Pharmacol, Whitla Med Bldg, Belfast BT9 7BL, Antrim, North Ireland.							Fagan E, 1996, BRIT MED J, V313, P1417, DOI 10.1136/bmj.313.7070.1417; Prince MI, 2000, LANCET, V355, P2047, DOI 10.1016/S0140-6736(00)02354-0; Routledge P, 1998, BRIT MED J, V317, P1609; *SECR STAT HLTH, 1999, SAV LIV OUR HLTH NAT; Turvill JL, 2000, LANCET, V355, P2048, DOI 10.1016/S0140-6736(00)02355-2	5	33	34	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					926	927		10.1136/bmj.321.7266.926	http://dx.doi.org/10.1136/bmj.321.7266.926			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030678	Bronze, Green Published			2022-12-28	WOS:000089975100020
J	Baxter, T; Connor, G; Culver, J				Baxter, T; Connor, G; Culver, J			Paying for the NHS - What about health needs?	BRITISH MEDICAL JOURNAL			English	Letter									Barnsley Hlth Author, Barnsley S75 2PY, S Yorkshire, England		Baxter, T (corresponding author), Barnsley Hlth Author, Barnsley S75 2PY, S Yorkshire, England.							Dixon J, 1999, BRIT MED J, V318, P522, DOI 10.1136/bmj.318.7182.522; Mossialos E, 2000, BMJ-BRIT MED J, V320, P197, DOI 10.1136/bmj.320.7229.197	2	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					898	898						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021887				2022-12-28	WOS:000089857500046
J	Jeffcoate, W; Kong, MF				Jeffcoate, W; Kong, MF			Diabete des femmes a barbe: a classic paper reread	LANCET			English	Review							DISEASE		City Hosp, Dept Endocrinol & Diabet, Nottingham NG5 1PB, England	University of Nottingham	Jeffcoate, W (corresponding author), City Hosp, Dept Endocrinol & Diabet, Nottingham NG5 1PB, England.							Achard C., 1921, B ACAD NATL MED, V86, P51; BROWN RD, 1973, J CLIN ENDOCR METAB, V36, P445; Brown WH, 1928, LANCET, V2, P1022; JEFFCOATE WJ, 1978, CURRENT TOPICS EXPT, V3, P38; McKeigue P, 1996, BAILLIERE CLIN ENDOC, V10, P311, DOI 10.1016/S0950-351X(96)80155-8; Poretsky L, 1999, ENDOCR REV, V20, P535, DOI 10.1210/er.20.4.535; SPEISER PW, 1987, J CLIN ENDOCR METAB, V64, P86, DOI 10.1210/jcem-64-1-86; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6	8	4	6	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1183	1185		10.1016/S0140-6736(00)02770-7	http://dx.doi.org/10.1016/S0140-6736(00)02770-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030311				2022-12-28	WOS:000089594300042
J	Kenner, SJ; Segall, P				Kenner, SJ; Segall, P			A mechanical model for intraplate earthquakes: Application to the New Madrid Seismic Zone	SCIENCE			English	Article							NORTHERN MISSISSIPPI EMBAYMENT; TECTONISM; STRESS; FAULT	We present a time-dependent model for the generation of repeated intraplate earthquakes that incorporates a weak lower crustal zone within an elastic lithosphere. Relaxation of this weak zone after tectonic perturbations transfers stress to the overlying crust, generating a sequence of earthquakes that continues until the zone fully relaxes. Simulations predict Large (5 to 10 meters) slip events with recurrence intervals of 250 to 4000 years and cumulative offsets of about 100 meters, depending on material parameters and far-field stress magnitude. Most are consistent with earthquake magnitude, coseismic slip, recurrence intervals, cumulative offset, and surface deformation rates in the New Madrid Seismic Zone. Computed interseismic strain rates may not be detectable with available geodetic data, implying that low observed rates of strain accumulation cannot be used to rule out future damaging earthquakes.	Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	Stanford University	Kenner, SJ (corresponding author), CALTECH, Seismol Lab, Div Geol & Planetary Sci, Mail Code 252-21, Pasadena, CA 91125 USA.	kenner@gps.caltech.edu						BRAILE LW, 1986, TECTONOPHYSICS, V131, P1, DOI 10.1016/0040-1951(86)90265-9; CHI JM, 1992, SEISMOL RES LETT, V63, P375; COX RT, 1997, ENG GEOL, V46, P210; ELLIS WL, 1994, INVESTIGATIONS NEW M, P1; GINZBURG A, 1983, AAPG BULL, V67, P2031; GOMBERG J, 1994, J GEOPHYS RES-SOL EA, V99, P20299, DOI 10.1029/94JB00039; Grana JP, 1996, J GEOPHYS RES-SOL EA, V101, P5445, DOI 10.1029/95JB03255; GROLLIMUND B, UNPUB GEOLOGY; HAMILTON RM, 1985, INVESTIGATIONS NEW M, P55; HASEGAWA HS, 1989, NATO ADV SCI I C-MAT, V266, P483; HIBBIT, 1998, ABAQUS USERS MANUAL; HINZE WJ, 1988, REV GEOPHYS, V26, P699, DOI 10.1029/RG026i004p00699; HOUGH SE, IN PRESS J GEOPHYS R; HUGHES TJ, 1981, LAST GREAT ICE SHEET, P275; Johnston AC, 1996, GEOPHYS J INT, V126, P314, DOI 10.1111/j.1365-246X.1996.tb05294.x; JOHNSTON AC, 1989, NATO ADV SCI I C-MAT, V266, P581; Kane MF, 1977, STUDIES RELATED CHAR, V1028, P199; Kelson KI, 1996, J GEOPHYS RES-SOL EA, V101, P6151, DOI 10.1029/95JB01815; KERKELA S, 1998, EOS S, V79, P210; KUSZNIR NJ, 1977, TECTONOPHYSICS, V43, P247, DOI 10.1016/0040-1951(77)90119-6; Langbein J, 1997, J GEOPHYS RES-SOL EA, V102, P591, DOI 10.1029/96JB02945; Li Y., 1998, SEISMOL RES LETT, V69, P270, DOI [10.1785/gssrl.69.3.270, DOI 10.1785/GSSRL.69.3.270]; LIU LB, 1992, SCIENCE, V257, P1666, DOI 10.1126/science.257.5077.1666; Liu LB, 1997, TECTONICS, V16, P585, DOI 10.1029/97TC01467; Mayewski P. A., 1981, LAST GREAT ICE SHEET, P67; MCKEOWN FA, 1994, INVESTIGATIONS NEW M, P1; MOONEY WD, 1983, TECTONOPHYSICS, V94, P327, DOI 10.1016/0040-1951(83)90023-9; Murray M., COMMUNICATION; Newman A, 1999, SCIENCE, V284, P619, DOI 10.1126/science.284.5414.619; Pratt T. L., 1994, SEISMOL RES LETT, V65, P172, DOI [10.1785/gssrl.65.2.172, DOI 10.1785/GSSRL.65.2.172]; Saucier R. T., 1994, GEOMORPHOLOGY QUATER, V2; Saucier R.T., 1994, GEOMORPHOLOGY QUATER, V1; SAVAGE JC, 1973, J GEOPHYS RES, V78, P832, DOI 10.1029/JB078i005p00832; Segall P, 1997, J GEOPHYS RES-SOL EA, V102, P22391, DOI 10.1029/97JB01795; Shedlock K. M., 1995, INVESTIGATIONS NEW M, P1; Stuart WD, 1997, J GEOPHYS RES-SOL EA, V102, P27623, DOI 10.1029/97JB02716; SWANBERG CA, 1981, PHYSICAL PROPERTIES, V2, P540; SWANBERG CA, 1982, INVESTIGATIONS NEW M, P185; THATCHER W, 1990, SAN ANDREAS FAULT SY, P189; Townend J, 2000, GEOLOGY, V28, P399, DOI 10.1130/0091-7613(2000)28<399:HFKTCS>2.0.CO;2; Van Arsdale R, 2000, ENG GEOL, V55, P219, DOI 10.1016/S0013-7952(99)00093-9; Wu P, 2000, GEOPHYS RES LETT, V27, P1323, DOI 10.1029/1999GL011070; ZOBACK MD, 1980, SCIENCE, V209, P971, DOI 10.1126/science.209.4460.971	43	144	150	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2329	2332		10.1126/science.289.5488.2329	http://dx.doi.org/10.1126/science.289.5488.2329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009414				2022-12-28	WOS:000089593500046
J	Helbing, D; Farkas, I; Vicsek, T				Helbing, D; Farkas, I; Vicsek, T			Simulating dynamical features of escape panic	NATURE			English	Article								One of the most disastrous forms of collective human behaviour is the kind of crowd stampede induced by panic, often leading to fatalities as people are crushed or trampled. Sometimes this behaviour is triggered in life-threatening situations such as fires in crowded buildings(1,2); at other times, stampedes can arise during the rush for seats(3,4) or seemingly without cause. Although engineers are finding ways to alleviate the scale of such disasters, their frequency seems to be increasing with the number and size of mass events(2,5). But systematic studies of panic behaviour(6-9) and quantitative theories capable of predicting such crowd dynamics(5,10-12) are rare. Here we use a model of pedestrian behaviour to investigate the mechanisms of (and preconditions for) panic and jamming by uncoordinated motion in crowds. Our simulations suggest practical ways to prevent dangerous crowd pressures. Moreover, we rnd an optimal strategy for escape from a smoke-filled room, involving a mixture of individualistic behaviour and collective `herding' instinct.	Collegium Budapest, Inst Adv Study, H-1014 Budapest, Hungary; Tech Univ Dresden, Inst Econ & Traff, D-01062 Dresden, Germany; Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary	Technische Universitat Dresden; Eotvos Lorand University	Helbing, D (corresponding author), Collegium Budapest, Inst Adv Study, Szentharomsag 2, H-1014 Budapest, Hungary.	helbing@trafficforum.de	Helbing, Dirk/C-6114-2008; Vicsek, Tamas/A-3305-2009; Farkas, Illes/C-1504-2008	Farkas, Illes/0000-0001-5341-5582				Brown R., 1965, SOC PSYCHOL-GERMANY; DRAGER KH, 1992, PROCEEDINGS OF THE 1992 INTERNATIONAL EMERGENCY MANAGEMENT AND ENGINEERING CONFERENCE : MANAGING RISK WITH COMPUTER SIMULATION, P101; Ebihara M., 1992, Microcomputers in Civil Engineering, V7, P63; Elliott D, 1993, IND ENV CRISIS Q, V7, P205; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2000, PHYS REV LETT, V84, P1240, DOI 10.1103/PhysRevLett.84.1240; Jacobs BD, 1992, HAZARD MANAGEMENT EM; JOHNSON NR, 1987, SOC PROBL, V34, P362, DOI 10.1525/sp.1987.34.4.03a00040; KEATING JP, 1982, FIRE J, V57, P147; Kelley H. H., 1969, HDB SOCIAL PSYCHOL, V4; KELLEY HH, 1965, J EXP SOC PSYCHOL, V1, P20, DOI 10.1016/0022-1031(65)90035-1; MINTZ A, 1951, J ABNORM SOC PSYCH, V46, P150, DOI 10.1037/h0063293; Predtetschenski W.M., 1971, PERSONENSTROME GEBAU; QUARANTELLI E, 1957, SOCIOL SOC RES, V41, P187; RISTOW GH, 1994, PHYS REV E, V50, pR5, DOI 10.1103/PhysRevE.50.R5; SMITH RA, 1993, ENG CROWD SAFETY, P45502; STILL GK, 1993, FIRE, V84, P40; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Weidmann U., 1993, TRANSPORTTECHNIK FUS; WOLF D, 1997, FRICTION ARCHING CON	20	2893	3196	67	888	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					487	490		10.1038/35035023	http://dx.doi.org/10.1038/35035023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028994	Green Submitted			2022-12-28	WOS:000089727400042
J	Pinson, KI; Brennan, J; Monkley, S; Avery, BJ; Skarnes, WC				Pinson, KI; Brennan, J; Monkley, S; Avery, BJ; Skarnes, WC			An LDL-receptor-related protein mediates Wnt signalling in mice	NATURE			English	Article							INT-1 PROTOONCOGENE; MOUSE; DISRUPTION; FAMILY; EMBRYO	Wnt genes comprise a large family of secreted polypeptides that are expressed in spatially and tissue-restricted patterns during vertebrate embryonic development(1). Mutational analysis in mice has shown the importance of Wnts in controlling diverse developmental processes such as patterning of the body axis, central nervous system and limbs, and the regulation of inductive events during organogenesis(2). Although many components of the Wnt signalling pathway have been identified, little is known about how Wnts and their cognate Frizzled receptors signal to downstream effector molecules. Here we present evidence that a new member of the low-density lipoprotein (LDL)-receptor-related protein family, LRP6 (ref. 3), is critical for Wnt signalling in mice. Embryos homozygous for an insertion mutation in the LRP6 gene exhibit developmental defects that are a striking composite of those caused by mutations in individual Wnt genes. Furthermore, we show a genetic enhancement of a Wnt mutant phenotype in mice lacking one functional copy of LRP6. Together, our results support a broad role for LRP6 in the transduction of several Wnt signals in mammals.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Skarnes, WC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	skarnes@socrates.berkeley.edu		Brennan, Jane/0000-0003-3222-5485; Monkley, Susan/0000-0001-9174-6278				BALLYCUIF L, 1995, MECH DEVELOP, V53, P23, DOI 10.1016/0925-4773(95)00421-1; Brennan J, 1999, METH MOL B, V97, P123, DOI 10.1385/1-59259-270-8:123; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Brown SP, 1998, J AGING PHYS ACTIV, V6, P248, DOI 10.1123/japa.6.3.248; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; HOGAN B, 1994, MANIPULATING MOUSE E, P260; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Uusitalo M, 1999, EXP CELL RES, V253, P336, DOI 10.1006/excr.1999.4710; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Willnow TE, 1999, J MOL MED-JMM, V77, P306, DOI 10.1007/s001090050356; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; YANG Y, CELL, V80, P939; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	24	857	909	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					535	538		10.1038/35035124	http://dx.doi.org/10.1038/35035124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029008				2022-12-28	WOS:000089727400056
J	Ben-Ami, H; Behar, DM; Fischer, D; Edoute, Y				Ben-Ami, H; Behar, DM; Fischer, D; Edoute, Y			Talking to the patient	LANCET			English	Article							BRUCELLOSIS		Rambam Med Ctr, Dept Internal Med C, IL-31096 Haifa, Israel; Rambam Med Ctr, Dept Diagnost Radiol, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Ben-Ami, H (corresponding author), Rambam Med Ctr, Dept Internal Med C, POB 9602, IL-31096 Haifa, Israel.							ARIZA J, 1992, ANN INTERN MED, V117, P25, DOI 10.7326/0003-4819-117-1-25; COLMENERO JD, 1991, ANN RHEUM DIS, V50, P23, DOI 10.1136/ard.50.1.23; Colmenero JD, 1992, INFECTION, V20, P38, DOI 10.1007/BF01704893; MADKOUR MM, 1999, HARRISONS PRINCIPLES, V1, P969; SADATALI M, 1991, TROP GEOGR MED, V43, P148	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1076	1076		10.1016/S0140-6736(00)02732-X	http://dx.doi.org/10.1016/S0140-6736(00)02732-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009144				2022-12-28	WOS:000089430500013
J	Taylor, TE; Hoffman, IF				Taylor, TE; Hoffman, IF			Can HIV-1 infections in Africa provide insights into acquired immunity to malaria?	LANCET			English	Editorial Material									Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA; Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA	Michigan State University; Michigan State University College of Osteopathic Medicine; University of North Carolina; University of North Carolina Chapel Hill	Taylor, TE (corresponding author), Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA.							Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Plebanski M, 2000, CURR OPIN IMMUNOL, V12, P437, DOI 10.1016/S0952-7915(00)00117-5	3	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1046	1046		10.1016/S0140-6736(00)02722-7	http://dx.doi.org/10.1016/S0140-6736(00)02722-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009135				2022-12-28	WOS:000089430500003
J	Grosberg, RK; Hart, MW				Grosberg, RK; Hart, MW			Mate selection and the evolution of highly polymorphic self/nonself recognition genes	SCIENCE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; ASCIDIAN BOTRYLLUS-SCHLOSSERI; HYDRACTINIA-SYMBIOLONGICARPUS; CLONAL INVERTEBRATES; MATING PREFERENCES; NO EVIDENCE; ALLORECOGNITION; SYSTEM; GERM; HLA	Multicellular organisms use the products of highly polymorphic genes to distinguish self from conspecific nonself cells or tissues. These allorecognition polymorphisms may regulate somatic interactions between hosts and pathogens or between competitors (to avoid various forms of parasitism), as well as reproductive interactions between mates or between gametes (to avoid inbreeding). In both cases, rare alleles may be advantageous, but it remains unclear which mechanism maintains the genetic polymorphism for specificity in self/nonself recognition. Contrary to earlier reports, we show that mate selection cannot be a strong force maintaining allorecognition polymorphism in two colonial marine invertebrates. Instead, the regulation of intraspecific competitive interactions appears to promote the evolution of polymorphisms in these species.	Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	University of California System; University of California Davis; University of California System; University of California Davis; Dalhousie University	Grosberg, RK (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Dr, Davis, CA 95616 USA.	rkgrosberg@ucdavis.edu						Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; BROWN JL, 1994, AM NAT, V143, P435, DOI 10.1086/285612; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; BUSS LW, 1984, BIOL BULL, V167, P139, DOI 10.2307/1541343; BUSS LW, 1985, DEV COMP IMMUNOL, V9, P191, DOI 10.1016/0145-305X(85)90110-7; BUSS LW, 1990, TRENDS ECOL EVOL, V5, P352, DOI 10.1016/0169-5347(90)90093-S; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI DOI 10.1515/9781400858712; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cohen CS, 1998, EVOLUTION, V52, P746, DOI 10.1111/j.1558-5646.1998.tb03699.x; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; GRAFEN A, 1990, ANIM BEHAV, V39, P42, DOI 10.1016/S0003-3472(05)80724-9; Grosberg RK, 1996, EVOLUTION, V50, P2221, DOI 10.1111/j.1558-5646.1996.tb03612.x; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; GROSBERG RK, 1991, EVOLUTION, V45, P130, DOI 10.1111/j.1558-5646.1991.tb05272.x; GROSBERG RK, 1987, INVERTEBRATE HISTORE, P157; Hedrick PW, 1997, AM J HUM GENET, V61, P505, DOI 10.1086/515519; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; MATTON DP, 1994, P NATL ACAD SCI USA, V91, P1992, DOI 10.1073/pnas.91.6.1992; Mokady O, 1996, GENETICS, V143, P823; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Oka H., 1957, Proceedings of the Japan Academy, V33, P657; Oka H., 1970, PROFILES JAPANESE SC, P195; Palumbi SR, 1998, ENDLESS FORMS, P271; Paterson S, 1997, P ROY SOC B-BIOL SCI, V264, P1813, DOI 10.1098/rspb.1997.0250; Penn D, 1998, P ROY SOC B-BIOL SCI, V265, P1299, DOI 10.1098/rspb.1998.0433; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; RINKEVICH B, 1995, P ROY SOC B-BIOL SCI, V259, P319, DOI 10.1098/rspb.1995.0047; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; SABBADIN A, 1989, Acta Embryologiae et Morphologiae Experimentalis New Series, V10, P205; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Szathmary E, 1995, MAJOR TRANSITIONS EV; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087	36	100	101	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2111	2114		10.1126/science.289.5487.2111	http://dx.doi.org/10.1126/science.289.5487.2111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000110				2022-12-28	WOS:000089430900040
J	Falci, G; Fazio, R; Palma, GM; Siewert, J; Vedral, V				Falci, G; Fazio, R; Palma, GM; Siewert, J; Vedral, V			Detection of geometric phases in superconducting nanocircuits	NATURE			English	Article							QUANTUM COMPUTATION; JOSEPHSON-JUNCTIONS; COOPER PAIRS	When a quantum-mechanical system undergoes an adiabatic cyclic evolution, it acquires a geometrical phase factor(1) in addition to the dynamical one; this effect has been demonstrated in a variety of microscopic systems(2). Advances in nanotechnology should enable the laws of quantum dynamics to be tested at the macroscopic level(3), by providing controllable artificial two-level systems (for example, in quantum dots(4) and superconducting devices(5,6)). Here we propose an experimental method to detect geometric phases in a superconducting device. The setup is a Josephson junction nanocircuit consisting of a superconducting electron box. We discuss how interferometry based on geometrical phases may be realized, and show how the effect may be applied to the design of gates for quantum computation.	Univ Catania, Dipartimento Metodol Fis & Chim, I-95125 Catania, Italy; Univ Palermo, Dipartimento Sci Fis & Astron, I-90123 Palermo, Italy; Univ Oxford, Clarendon Lab, Ctr Quantum Computat, Oxford OX1 3PU, England; Ist Nazl Fis Mat, Unita Catania & Palermo, Catania, Italy	University of Catania; University of Palermo; University of Oxford; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR)	Falci, G (corresponding author), Univ Catania, Dipartimento Metodol Fis & Chim, Viale A Doria 6, I-95125 Catania, Italy.		Palma, G.Massimo/AAN-4406-2020; Siewert, Jens/AAC-3404-2021; Siewert, Jens/AAE-1265-2020; vedral, vlatko/P-1712-2014; Falci, Giuseppe/J-4556-2012; Fazio, Rosario/M-1742-2013; Vedral, Vlatko/L-3270-2016; Palma, G.Massimo/A-8286-2010	Palma, G.Massimo/0000-0001-7009-4573; Siewert, Jens/0000-0002-9410-5043; Falci, Giuseppe/0000-0001-5842-2677; Fazio, Rosario/0000-0002-7793-179X; Vedral, Vlatko/0000-0002-8588-2940; Palma, G.Massimo/0000-0001-7009-4573				Averin DV, 1998, SOLID STATE COMMUN, V105, P659, DOI 10.1016/S0038-1098(97)10001-1; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; CALDEIRA AO, 1981, PHYS REV LETT, V46, P211, DOI 10.1103/PhysRevLett.46.211; DEUTSCH D, 1995, P R SOC-MATH PHYS SC, V449, P669, DOI 10.1098/rspa.1995.0065; Ekert A, 1996, REV MOD PHYS, V68, P733, DOI 10.1103/RevModPhys.68.733; Ekert A., 1998, COMPLEXITY, V4, P33; Fazio R, 1999, PHYS REV LETT, V83, P5385, DOI 10.1103/PhysRevLett.83.5385; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; GRADSHTEYN IS, 1999, TABLES INTEGRALS SER; Ioffe LB, 1999, NATURE, V398, P679, DOI 10.1038/19464; Jones JA, 2000, NATURE, V403, P869, DOI 10.1038/35002528; Makhlin Y, 1999, NATURE, V398, P305, DOI 10.1038/18613; MATTERS M, 1995, PHYS REV LETT, V75, P721, DOI 10.1103/PhysRevLett.75.721; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Oosterkamp TH, 1998, NATURE, V395, P873, DOI 10.1038/27617; Pekola JP, 1999, PHYS REV B, V60, pR9931, DOI 10.1103/PhysRevB.60.R9931; Shapere A., 1989, GEOMETRIC PHASES PHY; Shnirman A, 1997, PHYS REV LETT, V79, P2371, DOI 10.1103/PhysRevLett.79.2371; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Zanardi P, 1999, PHYS LETT A, V264, P94, DOI 10.1016/S0375-9601(99)00803-8	22	357	366	1	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					355	358		10.1038/35030052	http://dx.doi.org/10.1038/35030052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014186	Green Submitted			2022-12-28	WOS:000089390700040
J	Swinbanks, D; Cyranoski, D				Swinbanks, D; Cyranoski, D			Taiwan backs experience in quest for biotech success	NATURE			English	Article																			0	4	4	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					417	426		10.1038/35030326	http://dx.doi.org/10.1038/35030326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014201				2022-12-28	WOS:000089390700058
J	Sinal, CJ; Tohkin, M; Miyata, M; Ward, JM; Lambert, G; Gonzalez, FJ				Sinal, CJ; Tohkin, M; Miyata, M; Ward, JM; Lambert, G; Gonzalez, FJ			Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis	CELL			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; MICROSOMAL EPOXIDE HYDROLASE; BINDING PROTEIN GENE; RETINOID-X RECEPTOR; SALT EXPORT PUMP; CHOLESTEROL 7-ALPHA-HYDROXYLASE; FUNCTIONAL EXPRESSION; ESTROGEN-RECEPTOR; RESPONSE PATHWAY; HORMONE-RECEPTOR	Mice lacking the nuclear bile acid receptor FXR/BAR developed normally and were outwardly identical to wild-type littermates. RXR/BAR null mice were distinguished from wild-type mice by elevated serum bile acid, cholesterol, and triglycerides, increased hepatic cholesterol and triglycerides, and a proatherogenic serum lipoprotein profile. FXR/BAR null mice also had reduced bile acid pools and reduced fecal bile acid excretion due to decreased expression of the major hepatic canalicular bile acid transport protein. Bile acid repression and induction of cholesterol 7 alpha-hydroxylase and the ileal bile acid binding protein, respectively, did not occur in FXR/BAR null mice, establishing the regulatory role of FXR/BAR for the expression of these genes in vivo. These data demonstrate that FXR/BAR is critical for bile acid and lipid homeostasis by virtue of its role as an intracellular bile acid sensor.	NIH, Lab Metab, Div Basic Sci, Bethesda, MD 20892 USA; NCI, Vet & Tumor Pathol Sect, Off Lab Anim Sci, NIH, Frederick, MD 21702 USA; NHLBI, Metab Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gonzalez, FJ (corresponding author), NIH, Lab Metab, Div Basic Sci, Bldg 10, Bethesda, MD 20892 USA.			Lambert, Gilles/0000-0001-5632-0685; Sinal, Christopher/0000-0001-8301-3349	NATIONAL CANCER INSTITUTE [ZIABC005708, Z01BC005708] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberti S, 2000, GENE, V243, P93, DOI 10.1016/S0378-1119(99)00555-7; Aldini R, 1996, GASTROENTEROLOGY, V110, P459, DOI 10.1053/gast.1996.v110.pm8566593; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bahar RJ, 1999, GASTROENTEROL CLIN N, V28, P27, DOI 10.1016/S0889-8553(05)70042-X; Balistreri WF, 1999, GASTROENTEROL CLIN N, V28, P145, DOI 10.1016/S0889-8553(05)70048-0; Berard AM, 1997, NAT MED, V3, P744, DOI 10.1038/nm0797-744; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Cattori V, 1999, BBA-GENE STRUCT EXPR, V1445, P154, DOI 10.1016/S0167-4781(99)00029-9; COLEMAN R, 1987, BIOCHEM J, V244, P249, DOI 10.1042/bj2440249; CROSSMAN MW, 1994, J CELL BIOL, V126, P1547, DOI 10.1083/jcb.126.6.1547; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gafvels M, 1999, GENOMICS, V56, P184, DOI 10.1006/geno.1998.5606; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; GOODWIN B, 2000, IN PRESS MOL CELL; Green RM, 2000, GENE, V241, P117, DOI 10.1016/S0378-1119(99)00460-6; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; GROS P, 1988, MOL CELL BIOL, V8, P2770, DOI 10.1128/MCB.8.7.2770; GUO YD, 1993, P NATL ACAD SCI USA, V90, P8668, DOI 10.1073/pnas.90.18.8668; Hagenbuch B, 2000, BIOCHEM J, V345, P115, DOI 10.1042/0264-6021:3450115; HARDIKAR W, 1995, J BIOL CHEM, V270, P20841, DOI 10.1074/jbc.270.35.20841; Hylemon P B, 1994, Prog Liver Dis, V12, P99; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jansen PLM, 1999, GASTROENTEROLOGY, V117, P1370, DOI 10.1016/S0016-5085(99)70287-8; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Johansson L, 1999, J BIOL CHEM, V274, P345, DOI 10.1074/jbc.274.1.345; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lambert G, 2000, J LIPID RES, V41, P667; Lambert G, 1999, J LIPID RES, V40, P1294; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; LU TT, 2000, IN PRESS MOL CELL; LUND E, 1993, BIOCHIM BIOPHYS ACTA, V1166, P177, DOI 10.1016/0005-2760(93)90094-P; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Miyata M, 1999, J BIOL CHEM, V274, P23963, DOI 10.1074/jbc.274.34.23963; NATHANSON MH, 1991, HEPATOLOGY, V14, P551, DOI 10.1002/hep.1840140324; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Osuga J, 1998, J CLIN INVEST, V102, P386, DOI 10.1172/JCI1124; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Rao YP, 1999, J STEROID BIOCHEM, V70, P1, DOI 10.1016/S0960-0760(99)00099-0; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Roberts LR, 1997, GASTROENTEROLOGY, V113, P1714, DOI 10.1053/gast.1997.v113.pm9352877; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Saeki T, 1999, J BIOCHEM-TOKYO, V125, P846, DOI 10.1093/oxfordjournals.jbchem.a022358; Schroeder F, 1998, CHEM PHYS LIPIDS, V92, P1, DOI 10.1016/S0009-3084(98)00003-6; Schwarz M, 1997, J BIOL CHEM, V272, P23995, DOI 10.1074/jbc.272.38.23995; Seel WG, 1998, MOL ENDOCRINOL, V12, P1551, DOI 10.1210/mend.12.10.0184; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Seol W, 1997, MOL CELL BIOL, V17, P7126, DOI 10.1128/MCB.17.12.7126; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; SHAYIQ RM, 1992, J BIOL CHEM, V267, P2421; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; STAPLETON G, 1995, J BIOL CHEM, V270, P29739, DOI 10.1074/jbc.270.50.29739; Strautnieks SS, 1997, AM J HUM GENET, V61, P630, DOI 10.1086/515501; TZUNG KW, 1994, GENOMICS, V21, P244, DOI 10.1006/geno.1994.1250; Vlahcevic ZR, 1999, GASTROENTEROL CLIN N, V28, P1, DOI 10.1016/S0889-8553(05)70041-8; vonDippe P, 1996, J BIOL CHEM, V271, P18176, DOI 10.1074/jbc.271.30.18176; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Yang YZ, 1996, J BIOL CHEM, V271, P28235, DOI 10.1074/jbc.271.45.28235; Zavacki AM, 1997, P NATL ACAD SCI USA, V94, P7909, DOI 10.1073/pnas.94.15.7909; ZHANG XK, 1994, MOL CELL BIOL, V14, P4311, DOI 10.1128/MCB.14.6.4311	74	1332	1398	11	131	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					731	744		10.1016/S0092-8674(00)00062-3	http://dx.doi.org/10.1016/S0092-8674(00)00062-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030617	Bronze			2022-12-28	WOS:000089395200005
J	Bains, S; Norris, RD; Corfield, RM; Faul, KL				Bains, S; Norris, RD; Corfield, RM; Faul, KL			Termination of global warmth at the Palaeocene/Eocene boundary through productivity feedback	NATURE			English	Article							PALEOCENE-EOCENE BOUNDARY; CENTRAL EQUATORIAL PACIFIC; OCEANIC METHANE HYDRATE; LATEST PALEOCENE; MARINE BARITE; EVOLUTIONARY CONSEQUENCES; THERMAL MAXIMUM; CLIMATE; END; DISSOCIATION	The onset of the Palaeocene/Eocene thermal maximum (about 55 Myr ago) was marked by global surface temperatures warming by 5-7 degrees C over approximately 30,000 yr (ref. 1), probably because of enhanced mantle outgassing(2,3) and the pulsed release of similar to 1,500 gigatonnes of methane carbon from decomposing gas-hydrate reservoirs(4-7). The aftermath of this rapid, intense and global warming event may be the best example in the geological record of the response of the Earth to high atmospheric carbon dioxide concentrations and high temperatures. This response has been suggested to include an intensified flux of organic carbon from the ocean surface to the deep ocean and its subsequent burial through biogeochemical feedback mechanisms(8). Here we present firm evidence for this view from two ocean drilling cores, which record the largest accumulation rates of biogenic barium-indicative of export palaeoproductivity-at times of maximum global temperatures and peak excursion values of delta(13)C. The unusually rapid return of delta(13)C to values similar to those before the methane release(7) and the apparent coupling of the accumulation rates of biogenic barium to temperature, suggests that the enhanced deposition of organic matter to the deep sea may have efficiently cooled this greenhouse climate by the rapid removal of excess carbon dioxide from the atmosphere.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02540 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	University of Oxford; Woods Hole Oceanographic Institution; University of California System; University of California Santa Cruz	Bains, S (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	santo.bains@earth.ox.ac.uk						Bains S, 1999, SCIENCE, V285, P724, DOI 10.1126/science.285.5428.724; Beerling DJ, 2000, GFF, V122, P23, DOI 10.1080/11035890001221023; Bernstein RE, 1998, DEEP-SEA RES PT I, V45, P491, DOI 10.1016/S0967-0637(97)00095-2; Bertram MA, 1997, J MAR RES, V55, P577, DOI 10.1357/0022240973224292; BISHOP JKB, 1988, NATURE, V332, P341, DOI 10.1038/332341a0; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; Budyko M, 1999, GLOBAL PLANET CHANGE, V20, P281, DOI 10.1016/S0921-8181(98)00062-9; CORFIELD RM, 1994, EARTH-SCI REV, V37, P225, DOI 10.1016/0012-8252(94)90030-2; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; DICKENS GR, IN PRESS W N ATLANTI; Dymond J, 1992, PALEOCEANOGRAPHY, V7, P163, DOI 10.1029/92PA00181; ELDHOLM O, 1993, EARTH PLANET SC LETT, V117, P319, DOI 10.1016/0012-821X(93)90087-P; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Kelly DC, 1998, PALAEOGEOGR PALAEOCL, V141, P139, DOI 10.1016/S0031-0182(98)00017-0; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Kvenvolden KA, 1998, GEOL SOC SPEC PUBL, V137, P9, DOI 10.1144/GSL.SP.1998.137.01.02; Legeleux F, 1996, DEEP-SEA RES PT I, V43, P1857, DOI 10.1016/S0967-0637(96)00086-6; McManus J, 1998, GEOCHIM COSMOCHIM AC, V62, P3453, DOI 10.1016/S0016-7037(98)00248-8; MURRAY RW, 1993, PALEOCEANOGRAPHY, V8, P651, DOI 10.1029/93PA02195; Norris RD, 1999, NATURE, V401, P775, DOI 10.1038/44545; Pak DK, 1992, PALEOCEANOGRAPHY, V7, P405, DOI 10.1029/92PA01234; Paytan A, 1996, EARTH PLANET SC LETT, V142, P439, DOI 10.1016/0012-821X(96)00120-3; PAYTAN A, 1993, NATURE, V366, P445, DOI 10.1038/366445a0; Paytan A, 1996, SCIENCE, V274, P1355, DOI 10.1126/science.274.5291.1355; REA DK, 1990, PALAEOGEOGR PALAEOCL, V79, P117, DOI 10.1016/0031-0182(90)90108-J; ROBERT C, 1994, GEOLOGY, V22, P211, DOI 10.1130/0091-7613(1994)022<0211:ASHEAT>2.3.CO;2; Schmitz B, 1997, TERRA NOVA, V9, P95, DOI 10.1111/j.1365-3121.1997.tb00011.x; Thomas DJ, 1999, PALEOCEANOGRAPHY, V14, P561, DOI 10.1029/1999PA900031; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Zachos JC, 2000, GFF, V122, P188, DOI 10.1080/11035890001221188	32	180	190	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					171	174		10.1038/35025035	http://dx.doi.org/10.1038/35025035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001051				2022-12-28	WOS:000089241000043
J	Wang, XJ; Moylan, B; Leopold, DA; Kim, J; Rubenstein, RC; Togias, A; Proud, D; Zeitlin, PL; Cutting, GR				Wang, XJ; Moylan, B; Leopold, DA; Kim, J; Rubenstein, RC; Togias, A; Proud, D; Zeitlin, PL; Cutting, GR			Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NASAL POLYPS; CFTR GENE; DISEASE	Context Chronic rhinosinusitis (CRS) is a common condition in the US general population, yet little is known about its underlying molecular cause. Chronic rhinosinusitis is a consistent feature of the autosomal recessive disorder cystic fibrosis (CF). Objective To determine whether mutations in the cystic fibrosis transmembrane regulator (CFTR) gene, which is responsible for CF, predispose to CRS. Design Case-control study conducted from 1996 to 1999 in which the DNA of CRS patients and controls was typed for 16 mutations that account for 85% of CF alleles in the general population. Chronic rhinosinusitis patients with 1 CF mutation were evaluated for a CF diagnosis by sweat chloride testing, nasal potential difference measurement, and DNA analysis for additional mutations. Setting Otolaryngology-head and neck clinic of a US teaching hospital. Participants One hundred forty-seven consecutive adult white patients who met stringent diagnostic criteria for CRS and 123 CRS-free white control volunteers of similar age range, geographic region, and socioeconomic status. Main Outcome Measures Presence of CF mutations by DNA analysis among CRS patients vs controls. Results Eleven CRS patients were found to have a CF mutation (Delta F508, n = 9; G542X, n = 1; and N1303K, n = 1). Diagnostic testing excluded CF in 10 of these patients and led to CF diagnosis in 1. Excluding this patient from the analyses, the proportion of CRS patients who were found to have a CF mutation (7%) was significantly higher than in the control group (n = 2 [2%]; P = .04, both having Delta F508 mutations). Furthermore, 9 of the 10 CF carriers had the polymorphism M470V, and M470V homozygotes were overrepresented in the remaining 136 CRS patients (P = .03). Conclusion These data indicate that mutations in the gene responsible for CF may be associated with the development of CRS in the general population.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cutting, GR (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, CMSC 1004, Baltimore, MD 21287 USA.			Rubenstein, Ronald/0000-0002-3138-4006; Zeitlin, Pamela/0000-0002-2719-1834	NCRR NIH HHS [RR00052] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BURGER J, 1991, LANCET, V337, P974, DOI 10.1016/0140-6736(91)91603-R; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Collins J G, 1993, Vital Health Stat 10, P1; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; CUPPENS H, 1994, HUM MOL GENET, V3, P607, DOI 10.1093/hmg/3.4.607; Cutting GR., 1997, EMERY RIMOINS PRINCI, P2685; CUTTING GR, 2000, DIS SINUSES DIAGNOST; GIBSON LE, 1959, PEDIATRICS, V23, P545; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; Hamosh A, 1998, J PEDIATR-US, V132, P255, DOI 10.1016/S0022-3476(98)70441-X; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; *INT RHIN ADV BOAR, 1997, EAR NOSE THROAT J S, V76, P1; Irving RM, 1997, CLIN OTOLARYNGOL, V22, P519, DOI 10.1046/j.1365-2273.1997.00058.x; Kaliner MA, 1997, J ALLERGY CLIN IMMUN, V99, pS829, DOI 10.1016/S0091-6749(97)70041-1; KAWASAKI E, 1993, METHOD ENZYMOL, V218, P369; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; Lazaro C, 1999, HUM MUTAT, V14, P510, DOI 10.1002/(SICI)1098-1004(199912)14:6<510::AID-HUMU10>3.0.CO;2-O; LEDESMAMEDINA J, 1980, PEDIATR RADIOL, V9, P61, DOI 10.1007/BF00977665; LeGrys V. A., 1994, SWEAT TESTING SAMPLE; Macek M, 1997, HUM MUTAT, V9, P136, DOI 10.1002/(SICI)1098-1004(1997)9:2<136::AID-HUMU6>3.3.CO;2-M; Mak V, 1999, JAMA-J AM MED ASSOC, V281, P2217, DOI 10.1001/jama.281.23.2217; RAMSEY B, 1992, J ALLERGY CLIN IMMUN, V90, P547, DOI 10.1016/0091-6749(92)90183-3; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; STRONG TV, 1991, NEW ENGL J MED, V325, P1630, DOI 10.1056/NEJM199112053252307; VARON R, 1995, HUM MOL GENET, V4, P1463, DOI 10.1093/hmg/4.8.1463; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799	31	181	191	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1814	1819		10.1001/jama.284.14.1814	http://dx.doi.org/10.1001/jama.284.14.1814			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025834				2022-12-28	WOS:000089622100033
J	Johnson, KR; Braden, CR; Cairns, KL; Field, KW; Colombel, AC; Yang, ZH; Woodley, CL; Morlock, GP; Weber, AM; Boudreau, AY; Bell, TA; Onorato, IM; Valway, SE; Stehr-Green, PA				Johnson, KR; Braden, CR; Cairns, KL; Field, KW; Colombel, AC; Yang, ZH; Woodley, CL; Morlock, GP; Weber, AM; Boudreau, AY; Bell, TA; Onorato, IM; Valway, SE; Stehr-Green, PA			Transmission of Mycobacterium tuberculosis from medical waste	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	48th Annual Conference of the Epidemic-Intelligence-Service	APR 19-23, 1999	ATLANTA, GEORGIA	Ctr Dis Control & Prevent, Epidem Intelligence Serv			NOSOCOMIAL TRANSMISSION; IDENTIFICATION; BRONCHOSCOPE; RISK	Context Washington State has a relatively low incidence rate of tuberculosis (TB) infection. However, from May to September 1997, 3 cases of pulmonary TB were reported among medical waste treatment workers at 1 facility in Washington. There is no previous documentation of Mycobacterium tuberculosis transmission as a result of processing medical waste. Objective To identify the source(s) of these 3 TB infections. Design, Setting, and Participants Interviews of the 3 infected patient-workers and their contacts, review of patient-worker medical records and the state TB registry, and collection of all multidrug-resistant TB (MDR-TB) isolates identified after January 1, 1995, from the facility's catchment area; DNA fingerprinting of all isolates; polymerase chain reaction and automated DNA sequencing to determine genetic mutations associated with drug resistance; and occupational safety and environmental evaluations of the facility. Main Outcome Measures Previous exposures of patient-workers to TB; verification of patient-worker tuberculin skin test histories; identification of other cases of TB in the community and at the facility; drug susceptibility of patient-worker isolates; and potential for worker exposure to live M tuberculosis cultures. Results All 3 patient-workers were younger than 55 years, were born in the United States, and reported no known exposures to TB. We did not identify other TB cases. The 3 patient-workers' isolates had different DNA fingerprints. One of 10 MDR-TB catchment-area isolates matched an MDR-TB patient-worker isolate by DNA fingerprint pattern, DNA sequencing demonstrated the same rare mutation in these isolates. There was no evidence of personal contact between these 2 individuals. The laboratory that initially processed the matching isolate sent contaminated waste to the treatment facility. The facility accepted contaminated medical waste where it was shredded, blown, compacted, and finally deactivated. Equipment failures, insufficient employee training, and respiratory protective equipment inadequacies were identified at the facility. Conclusion Processing contaminated medical waste resulted in transmission of M tuberculosis to at least 1 medical waste treatment facility worker.	Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Washington State Dept Hlth, Olympia, WA USA; Washington State Dept Hlth, Seattle, WA USA; Cent Arkansas Vet Hlth Care Syst, Little Rock, AR USA; NIOSH, Hazard Evaluat & Tech Assistance Branch, Div Surveillance Hazard Evaluat & Field Studies, Atlanta, GA USA; NIOSH, Hazard Evaluat & Tech Assistance Branch, Div Surveillance Hazard Evaluat & Field Studies, Denver, CO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Johnson, KR (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, 1600 Clifton Rd NE,MS E-23, Atlanta, GA 30333 USA.		Salah, Mohamed/AAN-9962-2020					Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073; BASS JB, 1990, AM REV RESPIR DIS, V142, P725; Braden CR, 1997, CLIN INFECT DIS, V24, P35, DOI 10.1093/clinids/24.1.35; CAIRNS KL, 1999, P N AM REG INT UN TB; *CDCP, 1993, DHHS PUBL; *CDCP, 1998, 9800272709 NIOSH CTR; *CDCP, 1995, MMWR-MORBID MORTAL W, V44, P19; *CDCP, 1998, REP TUB US 1997, P9; DEAN A, 1995, EPI INFO VERSION 6 W; EMERY R, 1992, AM IND HYG ASSOC J, V53, P339, DOI 10.1202/0002-8894(1992)053<0339:ROBADI>2.0.CO;2; Gershon RRM, 1998, J OCCUP ENVIRON MED, V40, P497, DOI 10.1097/00043764-199805000-00014; HUTTON MD, 1990, J INFECT DIS, V161, P286, DOI 10.1093/infdis/161.2.286; KAPUR V, 1994, J INFECT DIS, V170, P1348, DOI 10.1093/infdis/170.5.1348; Matlow AG, 2000, INFECT CONT HOSP EP, V21, P222, DOI 10.1086/501749; McKenna MT, 1996, AM J RESP CRIT CARE, V154, P587, DOI 10.1164/ajrccm.154.3.8810591; Michele TM, 1997, JAMA-J AM MED ASSOC, V278, P1093, DOI 10.1001/jama.278.13.1093; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Sterling TR, 2000, NEW ENGL J MED, V342, P246, DOI 10.1056/NEJM200001273420404; TEMPLETON GL, 1995, ANN INTERN MED, V122, P922, DOI 10.7326/0003-4819-122-12-199506150-00005; TURNBURG WL, 1996, BIOHAZARDOUS WASTE R, P269; USSERY XT, 1995, INFECT CONT HOSP EP, V16, P160; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; *WA STAT DEP HLTH, 1996, INFECT DIS REPROD HL, V11, P23; *WA STAT DEP LAB I, 1997, 115232399 WISHA WA S	24	38	43	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1683	1688		10.1001/jama.284.13.1683	http://dx.doi.org/10.1001/jama.284.13.1683			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015799				2022-12-28	WOS:000089501900029
J	Currier, JS; Williams, PL; Koletar, SL; Cohn, SE; Murphy, RL; Heald, AE; Hafner, R; Bassily, EL; Lederman, HM; Knirsch, C; Benson, CA; Valdez, H; Aberg, JA; McCutchan, JA				Currier, JS; Williams, PL; Koletar, SL; Cohn, SE; Murphy, RL; Heald, AE; Hafner, R; Bassily, EL; Lederman, HM; Knirsch, C; Benson, CA; Valdez, H; Aberg, JA; McCutchan, JA		AIDS Clin Trials Grp 362 Study Tea	Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count - A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							PNEUMOCYSTIS-CARINII PNEUMONIA; IMMUNODEFICIENCY-VIRUS INFECTION; CYTOMEGALOVIRUS RETINITIS; MAINTENANCE THERAPY; DISEASE PROGRESSION; HIV-INFECTION; AIDS PATIENTS; LYMPHADENITIS; AZITHROMYCIN; INITIATION	Background: Patients infected with HIV who experience increases in CD4(+) cell counts are at reduced risk for opportunistic infections. However, the safety of discontinuing prophylaxis against Mycobacterium avium complex has been uncertain. Objective: To compare the rate of M. avium complex infection in patients with increased CD4(+) cell counts who receive azithromycin and those receiving placebo. Design: Randomized, double-blind, placebo-controlled trial. Setting: 29 university-based clinical centers in the United States. Participants: 643 HIV-1-infected patients with a previous CD4(+) cell count less than 0.05 x 10(9) cells/L and a sustained increase to greater than 0.10 x 10(9) cells/L during antiretroviral therapy. Intervention: Azithromycin, 1200 mg once weekly (n = 321), or matching placebo (n = 322). Measurements: Mycobacterium avium complex cultures, CD4+ cell counts, and clinical evaluations for AIDS-defining illnesses and bacterial infections were done every 8 weeks. Plasma HIV-1 RNA levels were measured at 16-week intervals. Results: During follow-up (median, 16 months), 2 cases of M. avium complex infection were reported among the 321 patients assigned to placebo (incidence rate, 0.5 event per 100 person-years [95% CI, 0.06 to 1.83 events per 100 person-years]) compared with no cases among the 322 patients assigned to azithromycin (CI, 0 to 0.92 events per 100 person-years), resulting in a treatment difference of 0.5 event per 100 person-years (CI, -0.20 to 1.21 events per 100 person-years) for placebo versus azithromycin. Both cases were atypical in that M. avium complex was localized to the vertebral spine. Patients receiving azithromycin were more likely than those receiving placebo to discontinue treatment with the study drug permanently because of adverse events (8% vs. 2%; hazard ratio, 0.24 [CI, 0.10 to 0.57]). Conclusions: Prophylaxis against Mycobacterium avium complex can safely be withdrawn or withheld in adults with HIV infection who experience increases in CD4(+) cell count while receiving antiretroviral therapy.	Univ Calif Los Angeles, Los Angeles, CA 90095 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Ohio State Univ, Columbus, OH 43210 USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Northwestern Univ, Sch Med, Evanston, IL 60208 USA; Duke Univ, Med Ctr, Durham, NC USA; NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Baltimore, MD USA; Pfizer Inc, New York, NY USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; University System of Ohio; Ohio State University; University of Rochester; Northwestern University; Duke University; National Institutes of Health (NIH) - USA; Johns Hopkins University; Pfizer; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Case Western Reserve University; University of California System; University of California San Francisco; University of California System; University of California San Diego	Currier, JS (corresponding author), Univ Calif Los Angeles, 10833 LeConte Ave,Room BH-412, Los Angeles, CA 90095 USA.	jscurrier@mednet.ucla.edu	Cohn, Susan E/ABB-3629-2020	Murphy, Robert/0000-0003-3936-2052				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Benson CA, 2000, J INFECT DIS, V181, P1289, DOI 10.1086/315380; Cabie A, 1998, EUR J CLIN MICROBIOL, V17, P812, DOI 10.1007/s100960050196; Dionisio D, 1998, J CLIN PATHOL, V51, P138, DOI 10.1136/jcp.51.2.138; Dunne MW, 1999, LANCET, V354, P891, DOI 10.1016/S0140-6736(98)10328-8; DWORKIN M, 1999, P 6 C RETR OPP INF C, P198; Dworkin MS, 1998, ARCH INTERN MED, V158, P1828, DOI 10.1001/archinte.158.16.1828; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; El-Sadr WM, 2000, NEW ENGL J MED, V342, P1085, DOI 10.1056/NEJM200004133421503; ELSADR W, 1996, INT C ANT AG CHEM WA, P191; Furrer H, 1999, NEW ENGL J MED, V340, P1301, DOI 10.1056/NEJM199904293401701; Hafner R, 1999, J INFECT DIS, V180, P438, DOI 10.1086/314865; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Havlir DV, 1996, NEW ENGL J MED, V335, P392, DOI 10.1056/NEJM199608083350604; HUGHES AJ, 1997, ANN C AUSTR SOC HIV, P136; Jones RE, 1999, B RHEUM DIS, V48, P1; JOUAN M, 1998, 38 INT C ANT AG CHEM, P205; Kirk O, 1999, AIDS, V13, P1647, DOI 10.1097/00002030-199909100-00007; KOLETAR SL, 2000, P 7 C RETR OPP INF S, P122; Kovacs JA, 2000, NEW ENGL J MED, V342, P1416, DOI 10.1056/NEJM200005113421907; LEDERGERBER B, 2000, P 7 C RETR OPP INF S, P235; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LOPEZ JC, 1999, 39 INT C ANT AG CHEM; Macdonald JC, 2000, OPHTHALMOLOGY, V107, P877, DOI 10.1016/S0161-6420(00)00023-3; Macdonald JC, 1998, J INFECT DIS, V177, P1182, DOI 10.1086/515281; MELNICK SL, 1994, JAMA-J AM MED ASSOC, V272, P1915, DOI 10.1001/jama.272.24.1915; Miller V, 1999, ANN INTERN MED, V130, P570, DOI 10.7326/0003-4819-130-7-199904060-00005; Miller V, 1999, LANCET, V353, P463, DOI 10.1016/S0140-6736(98)04954-X; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Phillips P, 1999, J ACQ IMMUN DEF SYND, V20, P122, DOI 10.1097/00042560-199902010-00003; Pierce M, 1996, NEW ENGL J MED, V335, P384, DOI 10.1056/NEJM199608083350603; Race EM, 1998, LANCET, V351, P252, DOI 10.1016/S0140-6736(97)04352-3; RUBINSTEIN LV, 1981, J CHRON DIS, V34, P469, DOI 10.1016/0021-9681(81)90007-2; Schneider MME, 1999, LANCET, V353, P201, DOI 10.1016/S0140-6736(98)07204-3; Tural C, 1998, J INFECT DIS, V177, P1080, DOI 10.1086/517399; [U.S. Public Health Service (USPHS) Infectious Diseases Society of America (IDSA)], 1999, MMWR-MORBID MORTAL W, V48, p[1, 61]; Vrabec TR, 1998, OPHTHALMOLOGY, V105, P1259, DOI 10.1016/S0161-6420(98)97031-2; Weverling GJ, 1999, LANCET, V353, P1293, DOI 10.1016/S0140-6736(99)03287-0; Whitcup SM, 2000, JAMA-J AM MED ASSOC, V283, P653, DOI 10.1001/jama.283.5.653; Whitcup SM, 1999, JAMA-J AM MED ASSOC, V282, P1633, DOI 10.1001/jama.282.17.1633; Yangco BG, 2000, ANN INTERN MED, V132, P201, DOI 10.7326/0003-4819-132-3-200002010-00005	42	90	92	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					493	503		10.7326/0003-4819-133-7-200010030-00008	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015162				2022-12-28	WOS:000089678300001
J	Bisby, FA				Bisby, FA			The quiet revolution: Biodiversity informatics and the internet	SCIENCE			English	Editorial Material									Univ Reading, Sch Plant Sci, Ctr Plant Divers & Systemat, Reading RG6 6AS, Berks, England	University of Reading	Bisby, FA (corresponding author), Univ Reading, Sch Plant Sci, Ctr Plant Divers & Systemat, Reading RG6 6AS, Berks, England.	f.a.bisby@reading.ac.uk						BEACH JH, 1993, ADVANCES IN COMPUTER METHODS FOR SYSTEMATIC BIOLOGY, P241; BERENDSOHN WG, 1995, TAXON, V44, P207, DOI 10.2307/1222443; Bisby FA, 1996, SPECIES 2000 PROJECT; Bisby FA, 1993, DESIGNS GLOBAL PLANT, P145; Edwards JL, 2000, SCIENCE, V289, P2312, DOI 10.1126/science.289.5488.2312; JONES AC, 2000, P 12 INT C SCI STAT, P3; Leow R, 2000, 12TH INTERNATIONAL CONFERENCE ON SCIENTIFIC AND STATISTICAL DATABASE MANAGEMENT, PROCEEDINGS, P25, DOI 10.1109/SSDM.2000.869776; Pullan MR, 2000, TAXON, V49, P55, DOI 10.2307/1223932; YAKOVLEV GP, 1998, LEGUMES NO EURASIA; Zhong Y, 1996, TAXON, V45, P223, DOI 10.2307/1224663	10	151	160	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2000	289	5488					2309	2312		10.1126/science.289.5488.2309	http://dx.doi.org/10.1126/science.289.5488.2309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009408				2022-12-28	WOS:000089593500040
J	Moorcock, M; Richardson, M				Moorcock, M; Richardson, M			Through the shaving mirror ... or, a tight night at the surrealist sporting club.	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					455	455		10.1038/35035170	http://dx.doi.org/10.1038/35035170			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028980	Bronze			2022-12-28	WOS:000089727400024
J	Noseworthy, JH; Lucchinetti, C; Rodriguez, M; Weinshenker, BG				Noseworthy, JH; Lucchinetti, C; Rodriguez, M; Weinshenker, BG			Medical progress: Multiple sclerosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PLACEBO-CONTROLLED TRIAL; CENTRAL-NERVOUS-SYSTEM; CLINICAL THERAPEUTIC TRIALS; DOUBLE-BLIND; NATURAL-HISTORY; OPTIC NEURITIS; WHITE-MATTER; HUMAN HERPESVIRUS-6; INTERFERON BETA-1B; OLMSTED COUNTY		Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic	Noseworthy, JH (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol, 200 1St St SW, Rochester, MN 55905 USA.		Badve, Monica/W-2187-2017; Weinshenker, Brian G/ABH-6146-2020	Badve, Monica/0000-0002-1115-6719; Weinshenker, Brian G/0000-0001-5806-6203; Rodriguez, Moses/0000-0001-6328-6497	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031506, R01NS032129] Funding Source: NIH RePORTER; NEI NIH HHS [U10 EY1093-01] Funding Source: Medline; NINDS NIH HHS [NS 32129, NS 31506] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN IV, 1979, J NEUROL SCI, V41, P81, DOI 10.1016/0022-510X(79)90142-4; ALTER M, 1966, ARCH NEUROL-CHICAGO, V15, P234, DOI 10.1001/archneur.1966.00470150012002; ANDERSON DW, 1992, ANN NEUROL, V31, P333, DOI 10.1002/ana.410310317; [Anonymous], 1999, Neurology, V53, P457; Archer DR, 1997, NAT MED, V3, P54, DOI 10.1038/nm0197-54; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; BECK RW, 1995, ARCH OPHTHALMOL-CHIC, V113, P136, DOI 10.1001/archopht.1995.01100020014004; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Boman J, 2000, NEUROLOGY, V54, P265, DOI 10.1212/WNL.54.1.265; BUFILL E, 1995, J NEUROL NEUROSUR PS, V58, P577, DOI 10.1136/jnnp.58.5.577; Carrigan DR, 1996, NEUROLOGY, V47, P145, DOI 10.1212/WNL.47.1.145; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Chataway J, 1998, BRAIN, V121, P1869, DOI 10.1093/brain/121.10.1869; Cole SR, 1998, NEUROLOGY, V51, P885, DOI 10.1212/WNL.51.3.885; Comi G, 2000, NEUROLOGY, V54, pA85; Compston A, 1997, MULT SCLER J, V3, P51, DOI 10.1177/135245859700300201; COMPSTON A, 1990, J NEUROL NEUROSUR PS, V53, P821, DOI 10.1136/jnnp.53.10.821; COMPSTON A, 1998, MCALPINE MULTIPLE SC; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; COOK SD, 1985, NEUROLOGY, V35, P545, DOI 10.1212/WNL.35.4.545; Cottrell DA, 1999, BRAIN, V122, P641, DOI 10.1093/brain/122.4.641; DEAN G, 1967, BRIT MED J, V2, P724, DOI 10.1136/bmj.2.5554.724; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers G, 1999, NEUROLOGY, V53, P679; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Ebers GC, 1999, LANCET, V353, P678; ELIAN M, 1990, J NEUROL NEUROSUR PS, V53, P906, DOI 10.1136/jnnp.53.10.906; Evangelou N, 1999, J NEUROL NEUROSUR PS, V67, P203, DOI 10.1136/jnnp.67.2.203; Fazekas F, 1997, LANCET, V349, P589, DOI 10.1016/S0140-6736(96)09377-4; Filippi M, 1998, ANN NEUROL, V43, P809, DOI 10.1002/ana.410430616; Forbes RB, 1999, BMJ-BRIT MED J, V319, P1529, DOI 10.1136/bmj.319.7224.1529; Freedman MS, 2000, NEUROLOGY, V54, P2351; Goodkin DE, 2000, NEUROLOGY, V54, P2352; Goodkin DE, 1998, NEUROLOGY, V51, P1689, DOI 10.1212/WNL.51.6.1689; Gronseth GS, 2000, NEUROLOGY, V54, P1720, DOI 10.1212/WNL.54.9.1720; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hohlfeld R, 1997, BRAIN, V120, P865, DOI 10.1093/brain/120.5.865; Hughes RAC, 2000, NEUROLOGY, V54, pA233; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V40, P480; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JERSILD C, 1973, LANCET, V2, P1221; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Krapf H, 1999, NEUROLOGY, V52, pA495; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; KURTZKE JF, 1991, NEUROEPIDEMIOLOGY, V10, P1, DOI 10.1159/000110240; KURTZKE JF, 1987, ACTA NEUROL SCAND, V76, P317, DOI 10.1111/j.1600-0404.1987.tb03590.x; Lassmann H, 1998, J NEUROIMMUNOL, V86, P213, DOI 10.1016/S0165-5728(98)00031-9; LININGTON C, 1988, AM J PATHOL, V130, P443; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Lucchinetti CF, 1998, SEMIN NEUROL, V18, P337, DOI 10.1055/s-2008-1040885; Marrosu MG, 1998, HUM MOL GENET, V7, P1235, DOI 10.1093/hmg/7.8.1235; MIDGARD R, 1991, NEUROLOGY, V41, P887, DOI 10.1212/WNL.41.6.887; Miller AE, 1997, NEUROLOGY, V48, P312, DOI 10.1212/WNL.48.2.312; Miller DH, 1999, ANN NEUROL, V46, P850, DOI 10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q; Miller DH, 1998, BRAIN, V121, P3, DOI 10.1093/brain/121.1.3; Myhr KM, 1999, NEUROLOGY, V52, P1771, DOI 10.1212/WNL.52.9.1771; Noseworthy JH, 1998, NEUROLOGY, V51, P1342, DOI 10.1212/WNL.51.5.1342; Noseworthy JH, 1999, NATURE, V399, pA40, DOI 10.1038/399a040; Noseworthy JH, 1999, CURR OPIN NEUROL, V12, P279, DOI 10.1097/00019052-199906000-00007; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; PATY D, 1999, 9 ANN M EUR NEUR SOC; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; PIDDLESDEN SJ, 1993, AM J PATHOL, V143, P555; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Raine CS, 1999, ANN NEUROL, V46, P144, DOI 10.1002/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K; Rivera-Quinones C, 1998, NAT MED, V4, P187, DOI 10.1038/nm0298-187; Robertson NP, 1999, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, P51; RODRIGUEZ M, 1994, NEUROLOGY, V44, P28, DOI 10.1212/WNL.44.1.28; Rosati G, 1996, NEUROEPIDEMIOLOGY, V15, P10, DOI 10.1159/000109884; Rudge P, 1999, LANCET, V353, P1033, DOI 10.1016/S0140-6736(98)00407-3; Rudick RA, 1997, NEUROLOGY, V49, P358, DOI 10.1212/WNL.49.2.358; SADOVNICK AD, 1991, NEUROLOGY, V41, P1193, DOI 10.1212/WNL.41.8.1193; SADOVNICK AD, 1988, AM J MED GENET, V29, P533, DOI 10.1002/ajmg.1320290310; SADOVNICK AD, 1993, ANN NEUROL, V33, P281, DOI 10.1002/ana.410330309; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Schmidt S, 1997, BRAIN, V120, P1437, DOI 10.1093/brain/120.8.1437; Schrijver HM, 1999, NEUROLOGY, V52, P595, DOI 10.1212/WNL.52.3.595; SIBLEY WA, 1985, LANCET, V1, P1313; Simon JH, 1998, ANN NEUROL, V43, P79, DOI 10.1002/ana.410430114; Sriram S, 1999, ANN NEUROL, V46, P6, DOI 10.1002/1531-8249(199907)46:1<6::AID-ANA4>3.3.CO;2-D; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Storch MK, 1998, ANN NEUROL, V43, P465, DOI 10.1002/ana.410430409; SVENNINGSSON A, 1990, ACTA NEUROL SCAND, V82, P161, DOI 10.1111/j.1600-0404.1990.tb04483.x; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tubridy N, 1999, NEUROLOGY, V53, P466, DOI 10.1212/WNL.53.3.466; Van den Noort S, 1998, NATL MULTIPLE SCLERO; Van der Meulen MA, 1997, GENET EPIDEMIOL, V14, P915, DOI 10.1002/(SICI)1098-2272(1997)14:6<915::AID-GEPI59>3.0.CO;2-P; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Waxman SG, 1998, NEW ENGL J MED, V338, P323, DOI 10.1056/NEJM199801293380510; WEINSHENKER BG, 1991, BRAIN, V114, P1057, DOI 10.1093/brain/114.2.1057; Weinshenker BG, 1998, NEUROLOGY, V51, P742, DOI 10.1212/WNL.51.3.742; Weinshenker BG, 1999, ANN NEUROL, V46, P878, DOI 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; WEINSHENKER BG, 1994, NEUROL DIS, V29, P533; Wolswijk G, 1998, J NEUROSCI, V18, P601; WYNN DR, 1990, NEUROLOGY, V40, P780, DOI 10.1212/WNL.40.5.780	106	2650	2791	3	341	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2000	343	13					938	952		10.1056/NEJM200009283431307	http://dx.doi.org/10.1056/NEJM200009283431307			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KT	11006371				2022-12-28	WOS:000089501400007
J	Weijer, C; Shapiro, SH; Glass, KC; Enkin, MW				Weijer, C; Shapiro, SH; Glass, KC; Enkin, MW			For and against - Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The ethical basis for entering patients in randomised controlled trials is under debate, Some doctors espouse the uncertainty principle whereby randomisation to treatment is acceptable when an individual doctor is genuinely unsure which treatment is best for a patient. Others believe that clinical equipoise, reflecting collective professional uncertainty over treatment, is the soundest ethical criterion. Here doctors from two Canadian centres discuss their positions.	Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 4H7, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Human Genet, Biomed Eth Unit, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Pediat, Biomed Eth Unit, Montreal, PQ H3A 1A2, Canada	Dalhousie University; McGill University; McGill University; McGill University	Weijer, C (corresponding author), Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 4H7, Canada.	charles.weijer@dal.ca		Weijer, Charles/0000-0002-5510-1074				COLLINS R, 1992, INTRO NEW TREATMENTS; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Fuks A, 1998, J CLIN EPIDEMIOL, V51, P69, DOI 10.1016/S0895-4356(97)00240-0; HELLMAN S, 1991, NEW ENGL J MED, V324, P1585, DOI 10.1056/NEJM199105303242208; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; TAYLOR KM, 1984, NEW ENGL J MED, V310, P1363, DOI 10.1056/NEJM198405243102106; Weijer C, 1999, SCHIZOPHR RES, V35, P211, DOI 10.1016/S0920-9964(98)00127-3; Weijer C, 1999, J CLIN ETHIC, V10, P100; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	11	115	117	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2000	321	7263					756	758		10.1136/bmj.321.7263.756	http://dx.doi.org/10.1136/bmj.321.7263.756			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999914	Green Published			2022-12-28	WOS:000089546600034
J	Brendza, RP; Serbus, LR; Duffy, JB; Saxton, WM				Brendza, RP; Serbus, LR; Duffy, JB; Saxton, WM			A function for kinesin I in the posterior transport of oskar mRNA and Staufen protein	SCIENCE			English	Article							DROSOPHILA OOGENESIS; ANTERIOR-POSTERIOR; MESSENGER-RNA; EGF RECEPTOR; LOCALIZATION; OOCYTES; ORB; POLARIZATION; MICROTUBULES; COMPONENT	The asymmetric localization of messenger RNA (mRNA) and protein determinants plays an important role in the establishment of complex body plans. In Drosophila oocytes, the anterior localization of bicoid mRNA and the posterior Localization of oskar mRNA are key events in establishing the anterior-posterior axis. Although the mechanisms that drive bicoid and oskar Localization have been elusive, oocyte microtubules are known to be essential. Here we report that the plus end-directed microtubule motor kinesin 1 is required for the posterior Localization of oskar mRNA and an associated protein, Staufen, but not for the anterior-posterior localization of other asymmetric factors. Thus, a complex containing oskar mRNA and Staufen may be transported along microtubules to the posterior pole by kinesin I.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Saxton, WM (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046295] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046295, R01GM46295, R01 GM046295-09] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brendza RP, 2000, MOL BIOL CELL, V11, P1329, DOI 10.1091/mbc.11.4.1329; BRENDZA RP, 1999, THESIS INDIANA U; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; CHOU TB, 1993, DEVELOPMENT, V119, P1359; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KOCH EA, 1983, CELL TISSUE RES, V228, P21; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Lasko P, 1999, FASEB J, V13, P421, DOI 10.1096/fasebj.13.3.421; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Martin MAE, 1999, CELL MOL LIFE SCI, V56, P200, DOI 10.1007/s000180050422; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4	26	283	291	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2120	2122		10.1126/science.289.5487.2120	http://dx.doi.org/10.1126/science.289.5487.2120			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000113	Green Accepted			2022-12-28	WOS:000089430900043
J	Zuber, MT; Smith, DE; Cheng, AF; Garvin, JB; Aharonson, O; Cole, TD; Dunn, PJ; Guo, YP; Lemoine, FG; Neumann, GA; Rowlands, DD; Torrence, MH				Zuber, MT; Smith, DE; Cheng, AF; Garvin, JB; Aharonson, O; Cole, TD; Dunn, PJ; Guo, YP; Lemoine, FG; Neumann, GA; Rowlands, DD; Torrence, MH			The shape of 433 Eros from the NEAR-Shoemaker Laser Rangefinder	SCIENCE			English	Article							ASTEROIDS; IMPACT; SATELLITES; GRAVITY; PHOBOS	Measurements from the Near Earth Asteroid Rendezvous (NEAR)-Shoemaker Laser Rangefinder (NLR) indicate that asteroid 433 Eros is a consolidated body with a complex shape dominated by collisions. The offset between the asreroid's center of mass and center of figure indicates a small deviation from a homogeneous internal structure that is most simply explained by variations in mechanical structure. Regional-scale relief and slope distributions show evidence for control of topography by a competent substrate. impact crater morphology is influenced by both gravity and structural control. Small-scale topography reveals ridges and grooves that may be generated by impact-related fracturing.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; NASA, Earth Sci Directorate, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Raytheon Informat Technol & Sci Serv, Greenbelt, MD 20771 USA	Massachusetts Institute of Technology (MIT); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.		Rowlands, David/D-2751-2012; Neumann, Gregory A/I-5591-2013; Lemoine, Frank/D-1215-2013	Neumann, Gregory A/0000-0003-0644-9944; Guo, Yanping/0000-0001-6813-4468; Aharonson, Oded/0000-0001-9930-2495; Garvin, James/0000-0003-1606-5645; Lemoine, Frank G./0000-0002-3051-1456				AHARONSON O, UNPUB; ASPHAUG E, 1993, ICARUS, V101, P144, DOI 10.1006/icar.1993.1012; Asphaug E, 1998, NATURE, V393, P437, DOI 10.1038/30911; Bell J.F., 1989, ASTEROIDS, P921; CATULLO V, 1984, ASTRON ASTROPHYS, V138, P464; Cheng AF, 1997, J GEOPHYS RES-PLANET, V102, P23695, DOI 10.1029/96JE03364; CHENG AF, IN PRESS ICARUS; Cole TD, 1997, SPACE SCI REV, V82, P217, DOI 10.1023/A:1005056828065; Consolmagno GJ, 1998, METEORIT PLANET SCI, V33, P1231, DOI 10.1111/j.1945-5100.1998.tb01308.x; COOPER MR, 1974, REV GEOPHYS, V12, P291, DOI 10.1029/RG012i003p00291; Davis D.R., 1979, ASTER 528; FUJIWARA A, 1991, ICARUS, V89, P384, DOI 10.1016/0019-1035(91)90185-V; FUJIWARA A, 1991, ICARUS, V83, P156; Fujiwara A., 1989, ASTEROIDS, VII, P240; HOUSEN KR, 1990, ICARUS, V84, P226, DOI 10.1016/0019-1035(90)90168-9; Love SG, 1996, ICARUS, V124, P141, DOI 10.1006/icar.1996.0195; MCCARTHY JJ, 1994, GEODYN SYSTEMS DESCR; Nolan MC, 1996, ICARUS, V124, P359, DOI 10.1006/icar.1996.0214; OSTRO SJ, 1990, ICARUS, V84, P334, DOI 10.1016/0019-1035(90)90042-8; Ostro SJ, 2000, SCIENCE, V288, P836, DOI 10.1126/science.288.5467.836; OSTRO SJ, 1990, SCIENCE, V248, P1523, DOI 10.1126/science.248.4962.1523; ROWLANDS DD, 1993, GEODYN, V2; RYAN EV, 1991, ICARUS, V94, P283, DOI 10.1016/0019-1035(91)90228-L; THOMAS PC, 1989, ICARUS, V77, P248, DOI 10.1016/0019-1035(89)90089-4; Trombka JI, 2000, SCIENCE, V289, P2101, DOI 10.1126/science.289.5487.2101; Veverka J, 2000, SCIENCE, V289, P2088, DOI 10.1126/science.289.5487.2088; Yeomans DK, 2000, SCIENCE, V289, P2085, DOI 10.1126/science.289.5487.2085; Zuber MT, 1997, J GEOPHYS RES-PLANET, V102, P23761, DOI 10.1029/97JE00890	29	140	146	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2097	2101		10.1126/science.289.5487.2097	http://dx.doi.org/10.1126/science.289.5487.2097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000106				2022-12-28	WOS:000089430900036
J	Abbott, A				Abbott, A			Hunt for Higgs particle wins time for CERN collider	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					276	276		10.1038/35030370	http://dx.doi.org/10.1038/35030370			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014154	Bronze			2022-12-28	WOS:000089390700005
J	Grom, GF; Lockwood, DJ; McCaffrey, JP; Labbe, HJ; Fauchet, PM; White, B; Diener, J; Kovalev, D; Koch, F; Tsybeskov, L				Grom, GF; Lockwood, DJ; McCaffrey, JP; Labbe, HJ; Fauchet, PM; White, B; Diener, J; Kovalev, D; Koch, F; Tsybeskov, L			Ordering and self-organization in nanocrystalline silicon	NATURE			English	Article							STRAINED-LAYER SUPERLATTICES; SI NANOCRYSTALS; POROUS SILICON; RECRYSTALLIZATION; MICROSTRUCTURE; ORIENTATION; MECHANISM; PHONONS	The spontaneous formation of organized nanocrystals in semiconductors has been observed(1-5) during heteroepitaxial growth and chemical synthesis. The ability to fabricate size-controlled silicon nanocrystals encapsulated by insulating SiO2 would be of significant interest to the microelectronics industry. But reproducible manufacture of such crystals is hampered by the amorphous nature of SiO2 and the differing thermal expansion coefficients of the two materials. Previous attempts(6-10) to fabricate Si nanocrystals failed to achieve control over their shape and crystallographic orientation, the latter property being important in systems such as Si quantum dots. Here we report the self-organization of Si nanocrystals larger than 80 Angstrom into brick-shaped crystallites oriented along the [111] crystallographic direction. The nanocrystals are formed by the solid-phase crystallization of nanometre-thick layers of amorphous Si confined between SiO2 layers. The shape and orientation of the crystallites results in relatively narrow photoluminescence, whereas isotropic particles produce qualitatively different, broad light emission. Our results should aid the development of maskless, reproducible Si nanofabrication techniques.	Univ Rochester, Dept Elect & Comp Engn, Nanoscale Silicon Res Initiat, Rochester, NY 14618 USA; Natl Res Council Canada, Inst Microstruct Sci, Ottawa, ON K1A 0R6, Canada; Motorola DigitalDNA Labs, Austin, TX USA; Tech Univ Munich, Phys Dept E16, D-85747 Garching, Germany	University of Rochester; National Research Council Canada; Technical University of Munich	Tsybeskov, L (corresponding author), Univ Rochester, Dept Elect & Comp Engn, Nanoscale Silicon Res Initiat, Rochester, NY 14618 USA.		Lockwood, David J./Q-7117-2019					Baron T, 2000, J CRYST GROWTH, V209, P1004, DOI 10.1016/S0022-0248(99)00742-3; Budai JD, 1997, NATURE, V390, P384, DOI 10.1038/37079; CALCOTT PDJ, 1993, J LUMIN, V57, P257, DOI 10.1016/0022-2313(93)90144-C; Cullis AG, 1997, J APPL PHYS, V82, P909, DOI 10.1063/1.366536; CULLIS AG, 1991, NATURE, V353, P335, DOI 10.1038/353335a0; Empedocles SA, 1999, NATURE, V399, P126, DOI 10.1038/20138; GHANBARI RA, 1990, PHYS REV B, V42, P7033, DOI 10.1103/PhysRevB.42.7033; HAJI L, 1994, J APPL PHYS, V75, P3944, DOI 10.1063/1.356014; Han WQ, 1997, SCIENCE, V277, P1287, DOI 10.1126/science.277.5330.1287; Ivchenko E., 1995, SUPERLATTICES OTHER, V110; LEVI D, 1987, PHYS REV B, V36, P8032, DOI 10.1103/PhysRevB.36.8032; LITTAU KA, 1993, J PHYS CHEM-US, V97, P1224, DOI 10.1021/j100108a019; LOCKWOOD DJ, 1987, PHYS REV B, V35, P2243, DOI 10.1103/PhysRevB.35.2243; MIZOGUCHI K, 1989, J APPL PHYS, V65, P2583, DOI 10.1063/1.342787; Nakajima A, 1996, J APPL PHYS, V80, P4006, DOI 10.1063/1.363359; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Shimizu-Iwayama T, 1999, J PHYS-CONDENS MAT, V11, P6595, DOI 10.1088/0953-8984/11/34/312; Tsybeskov L, 1998, APPL PHYS LETT, V72, P43, DOI 10.1063/1.120640; WILSON WL, 1993, SCIENCE, V262, P1242, DOI 10.1126/science.262.5137.1242; Yip S, 1998, NATURE, V391, P532, DOI 10.1038/35254	20	218	228	1	68	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					358	361		10.1038/35030062	http://dx.doi.org/10.1038/35030062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014187				2022-12-28	WOS:000089390700041
J	Zhou, ZL; Luo, M; Straesser, K; Katahira, J; Hurt, E; Reed, R				Zhou, ZL; Luo, M; Straesser, K; Katahira, J; Hurt, E; Reed, R			The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans	NATURE			English	Article							CONSTITUTIVE TRANSPORT ELEMENT; BINDING-PROTEINS; SPLICEOSOME; RIBONUCLEOPROTEINS; AUTOANTIBODIES; HOMOLOG; INVITRO; PATHWAY; MEX67P; EF-2	In metazoans, most pre-messenger RNAs contain introns that are removed by splicing. The spliced mRNAs are then exported to the cytoplasm. Recent studies showed that splicing promotes efficient mRNA export(1), but the mechanism for coupling these two processes is not known. Here we show that Aly, the metazoan homologue of the yeast mRNA export factor Yra1p (ref. 2), is recruited to messenger ribonucleoprotein (mRNP) complexes generated by splicing. In contrast, Aly does not associate with mRNPs assembled on identical mRNAs that already have no introns or with heterogenous nuclear RNP (hnRNP) complexes. Aly is recruited during spliceosome assembly, and then becomes tightly associated with the spliced mRNP. Aly shuttles between the nucleus and cytoplasm, and excess recombinant Aly increases both the rate and efficiency of mRNA export in vivo. Consistent with its splicing-dependent recruitment, Aly co-localizes with splicing factors in the nucleus. We conclude that splicing is required for efficient mRNA export as a result of coupling between the splicing and the mRNA export machineries.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Heidelberg, BZH, D-69120 Heidelberg, Germany	Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Katahira, Jun/0000-0001-5188-0368; Strasser, Katja/0000-0003-3533-5516				Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; BENNETT M, 1992, MOL CELL BIOL, V12, P3165, DOI 10.1128/MCB.12.7.3165; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; FU XD, 1995, RNA, V1, P663; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; HABETS WJ, 1989, J IMMUNOL, V143, P2560; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Le Hir H, 2000, GENE DEV, V14, P1098; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; NAIELNY S, 1999, CELL, V99, P677; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; PINOLROMA S, 1988, GENE DEV, V2, P490; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; PORTENOY RK, 1997, T PALLIAT CARE, V1, P3; REED R, 1990, P NATL ACAD SCI USA, V87, P8031, DOI 10.1073/pnas.87.20.8031; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Wichmann I, 1999, HUM IMMUNOL, V60, P57, DOI 10.1016/S0198-8859(98)00085-8	31	390	397	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					401	405		10.1038/35030160	http://dx.doi.org/10.1038/35030160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014198				2022-12-28	WOS:000089390700052
J	Gibbs, HL; Sorenson, MD; Marchetti, K; Brooke, MD; Davies, NB; Nakamura, H				Gibbs, HL; Sorenson, MD; Marchetti, K; Brooke, MD; Davies, NB; Nakamura, H			Genetic evidence for female host-specific races of the common cuckoo	NATURE			English	Article							CUCULUS-CANORUS; EGG MIMICRY; DIFFERENTIATION; DISCRIMINATION; MITOCHONDRIAL	The common cuckoo Cuculus canorus is divided into host-specific races (gentes)(1). Females of each race lay a distinctive egg type that tends to match the host's eggs, for instance, brown and spotted for meadow pipit hosts or plain blue for redstart hosts(2-4). The puzzle is how these gentes remain distinct. Here, we provide genetic evidence that gentes are restricted to female lineages, with cross mating by males maintaining the common cuckoo genetically as one species. We show that there is differentiation between gentes in maternally inherited mitochondrial DNA, but not in microsatellite loci of nuclear DNA. This supports recent behavioural evidence that female, but not male, common cuckoos specialize on a particular host(5), and is consistent with the possibility that genes affecting cuckoo egg type are located on the female-specific W sex chromosome(6). Our results also support the ideas that common cuckoos often switched hosts during evolution(7,8), and that some gentes may have multiple, independent origins, due to colonization by separate ancestral lineages.	McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; Boston Univ, Dept Biol, Boston, MA 02215 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Shinshu Univ, Fac Educ, Nagano 380, Japan	McMaster University; Boston University; University of Cambridge; Shinshu University	Gibbs, HL (corresponding author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	gibbs@mcmaster.ca	Sorenson, Michael/D-8065-2011	Sorenson, Michael/0000-0001-5375-2917				Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Baker ECS, 1942, CUCKOO PROBLEMS; BROOKE MD, 1991, ETHOLOGY, V89, P154; BROOKE MD, 1988, NATURE, V335, P630; COLLIAS EC, 1993, AUK, V110, P683, DOI 10.2307/4088624; Davies N. B, 2000, COWBIRDS OTHER CHEAT; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; DAWKINS R, 1998, UNWEAVING RAINBOW; EXCOFFIER L, 1992, GENETICS, V131, P479; Gibbs HL, 1996, P ROY SOC B-BIOL SCI, V263, P89, DOI 10.1098/rspb.1996.0015; Gibbs HL, 1998, MOL ECOL, V7, P1437; GOODNIGHT K, 1997, VER 1 2; HUDSON RR, 1992, GENETICS, V132, P583; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Marchetti K, 1998, SCIENCE, V282, P471, DOI 10.1126/science.282.5388.471; MOKSNES A, 1995, J ZOOL, V236, P625, DOI 10.1111/j.1469-7998.1995.tb02736.x; Nakamura H, 1998, OX ORN SER, V9, P94; Nakamura Hiroshi, 1997, Japanese Journal of Ornithology, V46, P23, DOI 10.3838/jjo.46.23; Newton A., 1893, DICT BIRDS; Punnett RC, 1933, NATURE, V132, P892, DOI 10.1038/132892b0; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, 10.1111/j.1558-5646.1989.tb04226.x]; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Roldan ERS, 1999, TRENDS ECOL EVOL, V14, P58, DOI 10.1016/S0169-5347(98)01567-5; Schneider S., 1997, ARLEQUIN VER 1 1 SOF; SCHOFFNER RN, 1982, POULTRY SCI, V61, P817; SLATKIN M, 1995, GENETICS, V139, P457; Steel MA, 1996, SYST BIOL, V45, P127, DOI 10.2307/2413610; SWOFFORD D, 1999, PAUP VER 4 0; Teuschl Y, 1998, ANIM BEHAV, V56, P1425, DOI 10.1006/anbe.1998.0931	30	186	194	3	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					183	186		10.1038/35025058	http://dx.doi.org/10.1038/35025058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001055				2022-12-28	WOS:000089241000047
J	Grant, PM				Grant, PM			Currents without borders	NATURE			English	Editorial Material							GRAIN-BOUNDARIES		Elect Power Res Inst, Palo Alto, CA 94303 USA	Electric Power Research Institute (EPRI)	Grant, PM (corresponding author), Elect Power Res Inst, 3412 Hillview Ave, Palo Alto, CA 94303 USA.							BABCOCK S, 1994, PHYSICA C, V277, P183; DANIELS GA, IN PRESS APPL PHYS L; DIMOS D, 1988, PHYS REV LETT, V61, P218; GRANT PM, 1995, NATURE, V375, P107, DOI 10.1038/375107a0; Gurevich A, 1998, PHYS REV B, V57, P13878, DOI 10.1103/PhysRevB.57.13878; Hammerl G, 2000, NATURE, V407, P162, DOI 10.1038/35025014; Kirtley JR, 1996, PHYS REV LETT, V76, P1336, DOI 10.1103/PhysRevLett.76.1336; Schmehl A, 1999, EUROPHYS LETT, V47, P110, DOI 10.1209/epl/i1999-00359-2; Stolbov SV, 1999, SUPERCOND SCI TECH, V12, P1071, DOI 10.1088/0953-2048/12/12/308; STOLBOV SV, IN PRESS PHYS REV B; Vase P, 2000, SUPERCOND SCI TECH, V13, pR71, DOI 10.1088/0953-2048/13/7/201	11	6	6	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					139	141		10.1038/35025162	http://dx.doi.org/10.1038/35025162			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001036				2022-12-28	WOS:000089241000025
J	Burstein, HJ; Winer, EP				Burstein, HJ; Winer, EP			Primary care - Primary care for survivors of breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ESTROGEN REPLACEMENT THERAPY; QUALITY-OF-LIFE; SURGICAL-ADJUVANT-BREAST; BONE-MINERAL DENSITY; LYMPH-NODE DISSECTION; BOWEL-PROJECT P-1; FOLLOW-UP CARE; RADIATION-THERAPY; ENDOMETRIAL CANCER; CONTRALATERAL BREAST		Dana Farber Canc Inst, Breast Oncol Ctr, Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Burstein, HJ (corresponding author), Dana Farber Canc Inst, Breast Oncol Ctr, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.							Armstrong K, 2000, NEW ENGL J MED, V342, P564, DOI 10.1056/NEJM200002243420807; Barakat RR, 1999, J CLIN ONCOL, V17, P1967, DOI 10.1200/JCO.1999.17.7.1967; Barton DL, 1998, J CLIN ONCOL, V16, P495, DOI 10.1200/JCO.1998.16.2.495; Bast RC, 1996, J CLIN ONCOL, V14, P2843; BERNSTEIN JL, 1992, AM J EPIDEMIOL, V136, P937, DOI 10.1093/oxfordjournals.aje.a116566; Bernstein L, 1999, J NATL CANCER I, V91, P1654, DOI 10.1093/jnci/91.19.1654; BERTELLI G, 1991, ANN ONCOL, V2, P575, DOI 10.1093/oxfordjournals.annonc.a058023; Bines J, 1996, J CLIN ONCOL, V14, P1718, DOI 10.1200/JCO.1996.14.5.1718; BOICE JD, 1992, NEW ENGL J MED, V326, P781, DOI 10.1056/NEJM199203193261201; BRYCE CJ, 1998, BREAST CANC RES TREA, V50, P284; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Burstein HJ, 1999, NEW ENGL J MED, V340, P1733, DOI 10.1056/NEJM199906033402206; BYRNE J, 1992, AM J OBSTET GYNECOL, V166, P788, DOI 10.1016/0002-9378(92)91335-8; CAMORIANO JK, 1990, J CLIN ONCOL, V8, P1327, DOI 10.1200/JCO.1990.8.8.1327; CARPENTER JS, 1997, CANCER, V82, P1682; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Chang J, 1998, BREAST CANCER RES TR, V48, P81, DOI 10.1023/A:1005999008736; Chlebowski RT, 1999, J CLIN ONCOL, V17, P130, DOI 10.1200/JCO.1999.17.1.130; COBLEIGH MA, 1994, JAMA-J AM MED ASSOC, V272, P540, DOI 10.1001/jama.272.7.540; COBLEIGH MA, 1995, JAMA-J AM MED ASSOC, V273, P378; Col NF, 1997, JAMA-J AM MED ASSOC, V277, P1140, DOI 10.1001/jama.277.14.1140; Collichio FA, 1998, ONCOLOGY-NY, V12, P759; COLLICHIO FA, 1998, ONCOLOGY HUNTINGT, V12, P769; COUZI RJ, 1995, J CLIN ONCOL, V13, P2737, DOI 10.1200/JCO.1995.13.11.2737; Cummings SR, 1999, JAMA-J AM MED ASSOC, V282, P2124; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Dawson LA, 1998, EUR J CANCER, V34, P2000, DOI 10.1016/S0959-8049(98)00208-1; Day R, 1999, J CLIN ONCOL, V17, P2659, DOI 10.1200/JCO.1999.17.9.2659; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; DELTURCO MR, 1994, JAMA-J AM MED ASSOC, V271, P1593, DOI 10.1001/jama.1994.03510440053032; DEMARKWAHNEFRIED W, 1993, J CLIN ONCOL, V11, P1418, DOI 10.1200/JCO.1993.11.7.1418; DHODAPKAR MV, 1995, CANCER-AM CANCER SOC, V75, P43, DOI 10.1002/1097-0142(19950101)75:1<43::AID-CNCR2820750109>3.0.CO;2-#; Diamandidou E, 1996, J CLIN ONCOL, V14, P2722, DOI 10.1200/JCO.1996.14.10.2722; Dorval M, 1998, J CLIN ONCOL, V16, P487, DOI 10.1200/JCO.1998.16.2.487; Duckitt K, 1998, CURR OPIN OBSTET GYN, V10, P199, DOI 10.1097/00001703-199806000-00004; Eastell R, 1998, NEW ENGL J MED, V338, P736, DOI 10.1056/NEJM199803123381107; EVANS GRD, 1995, PLAST RECONSTR SURG, V96, P1111, DOI 10.1097/00006534-199510000-00016; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; Ganz PA, 1996, BREAST CANCER RES TR, V38, P183, DOI 10.1007/BF01806673; Ganz PA, 1998, J CLIN ONCOL, V16, P501, DOI 10.1200/JCO.1998.16.2.501; GHEZZI P, 1994, JAMA-J AM MED ASSOC, V271, P1587, DOI 10.1001/jama.1994.03510440047031; Goodwin PJ, 1999, J CLIN ONCOL, V17, P120, DOI 10.1200/JCO.1999.17.1.120; Goodwin PJ, 1999, J CLIN ONCOL, V17, P2365, DOI 10.1200/JCO.1999.17.8.2365; Grosse A, 1997, INT J RADIAT ONCOL, V38, P761, DOI 10.1016/S0360-3016(97)00062-X; Hack TF, 1999, J CLIN ONCOL, V17, P143, DOI 10.1200/JCO.1999.17.1.143; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Hewitt M, 1999, J NATL CANCER I, V91, P1480, DOI 10.1093/jnci/91.17.1480; HIGGINS S, 1994, CANCER-AM CANCER SOC, V73, P2175, DOI 10.1002/1097-0142(19940415)73:8<2175::AID-CNCR2820730823>3.0.CO;2-#; Hojris I, 1999, LANCET, V354, P1425, DOI 10.1016/S0140-6736(99)02245-X; Holmes MD, 1999, CANCER, V86, P826, DOI 10.1002/(SICI)1097-0142(19990901)86:5&lt;826::AID-CNCR19&gt;3.0.CO;2-0; Holmes MD, 1999, CANCER, V86, P2707; HORTOBAGYI G N, 1986, NCI (National Cancer Institute) Monographs, P105; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; JOHNSON CH, 1989, ARCH SURG-CHICAGO, V124, P819; Kavanagh AM, 2000, LANCET, V355, P270, DOI 10.1016/S0140-6736(99)07319-5; Kroman N, 1997, LANCET, V350, P319, DOI 10.1016/S0140-6736(97)03052-3; LARSON D, 1986, INT J RADIAT ONCOL, V12, P1575, DOI 10.1016/0360-3016(86)90280-4; Laya MB, 1996, J NATL CANCER I, V88, P643, DOI 10.1093/jnci/88.10.643; LINGOS TI, 1991, INT J RADIAT ONCOL, V21, P355, DOI 10.1016/0360-3016(91)90782-Y; Loprinzi C. L., 1999, Breast Cancer Research and Treatment, V57, P34; Loprinzi CL, 1997, J CLIN ONCOL, V15, P969, DOI 10.1200/JCO.1997.15.3.969; LOPRINZI CL, 1994, NEW ENGL J MED, V331, P347, DOI 10.1056/NEJM199408113310602; LOPRINZI CL, 2000, P AN M AM SOC CLIN, V19, pA2; LOVE RR, 1991, ARCH INTERN MED, V151, P1842, DOI 10.1001/archinte.151.9.1842; MAUNSELL E, 1992, CANCER-AM CANCER SOC, V70, P120, DOI 10.1002/1097-0142(19920701)70:1<120::AID-CNCR2820700120>3.0.CO;2-U; MELLINK WAM, 1991, CANCER-AM CANCER SOC, V67, P1844, DOI 10.1002/1097-0142(19910401)67:7<1844::AID-CNCR2820670705>3.0.CO;2-W; Mortimer JE, 1999, J CLIN ONCOL, V17, P1488, DOI 10.1200/JCO.1999.17.5.1488; MULVIHILL JJ, 1987, CANCER, V60, P1143, DOI 10.1002/1097-0142(19870901)60:5<1143::AID-CNCR2820600537>3.0.CO;2-E; MUSS HB, 1991, AM J CLIN ONCOL-CANC, V14, P55, DOI 10.1097/00000421-199102000-00013; Nixon AJ, 1998, J CLIN ONCOL, V16, P1374, DOI 10.1200/JCO.1998.16.4.1374; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; PANDYA KJ, 1985, CANCER, V55, P202, DOI 10.1002/1097-0142(19850101)55:1<202::AID-CNCR2820550132>3.0.CO;2-X; Paszat, 1999, J CLIN ONCOL, V17, P740; Paszat LF, 1998, J CLIN ONCOL, V16, P2625, DOI 10.1200/JCO.1998.16.8.2625; PETREK JA, 2000, DIS BREAST, P1033; PEZNER RD, 1986, INT J RADIAT ONCOL, V12, P2079, DOI 10.1016/0360-3016(86)90005-2; PIERCE SM, 1992, INT J RADIAT ONCOL, V23, P915, DOI 10.1016/0360-3016(92)90895-O; POWLES TJ, 1993, LANCET, V342, P60, DOI 10.1016/0140-6736(93)91931-B; Powles TJ, 1998, J NATL CANCER I, V90, P704, DOI 10.1093/jnci/90.9.704; Pritchard KI, 1996, J CLIN ONCOL, V14, P2731, DOI 10.1200/JCO.1996.14.10.2731; Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068; Ragaz J, 1998, J CLIN ONCOL, V16, P2018, DOI 10.1200/JCO.1998.16.6.2018; RIES L, 1996, NIH PUBL; Rockson SG, 1998, CANCER, V83, P2814; Saarto T, 1997, J CLIN ONCOL, V15, P1341, DOI 10.1200/JCO.1997.15.4.1341; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; SCHAG CAC, 1993, J CLIN ONCOL, V11, P783, DOI 10.1200/JCO.1993.11.4.783; SCHAPIRA DV, 1991, JAMA-J AM MED ASSOC, V265, P380, DOI 10.1001/jama.265.3.380; Schrag D, 2000, JAMA-J AM MED ASSOC, V283, P617, DOI 10.1001/jama.283.5.617; SCHUSTER RH, 1992, PLAST RECONSTR SURG, V90, P445, DOI 10.1097/00006534-199209000-00013; Segar M L, 1998, Oncol Nurs Forum, V25, P107; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Shapiro CL, 1998, J CLIN ONCOL, V16, P3493, DOI 10.1200/JCO.1998.16.11.3493; SLAVIN SA, 1994, PLAST RECONSTR SURG, V93, P1191, DOI 10.1097/00006534-199405000-00013; SMITH P, 1993, MATURITAS, V16, P145, DOI 10.1016/0378-5122(93)90059-Q; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Somerfield MR, 1997, J CLIN ONCOL, V15, P2149; STEARNS V, 1998, BREAST CANC RES TREA, V50, P308; STIERER M, 1989, CANCER, V64, P1128, DOI 10.1002/1097-0142(19890901)64:5<1128::AID-CNCR2820640527>3.0.CO;2-H; Suh-Burgmann EJ, 1999, ANN INTERN MED, V131, P127, DOI 10.7326/0003-4819-131-2-199907200-00009; Surbone A, 1997, CANCER, V79, P1271, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1271::AID-CNCR1>3.0.CO;2-K; SUTTON R, 1990, CANCER, V65, P847, DOI 10.1002/1097-0142(19900215)65:4<847::AID-CNCR2820650402>3.0.CO;2-A; Swain S, 1999, ONCOLOGY-NY, V13, P397; Swain S, 1999, ONCOLOGY-NY, V13, P551; Swain S, 1999, ONCOLOGY-NY, V13, P859; SWAIN S, 1999, ONCOLOGY, V13, P727; SWAIN S, 1999, ONCOLOGY, V13, P109; SWAIN S, 1999, ONCOLOGY, V13, P245; Thune I, 1997, NEW ENGL J MED, V336, P1269, DOI 10.1056/NEJM199705013361801; TRALINS AH, 1995, AM J CLIN ONCOL-CANC, V18, P40, DOI 10.1097/00000421-199502000-00008; VALAGUSSA P, 1994, ANN ONCOL, V5, P209, DOI 10.1093/oxfordjournals.annonc.a058795; VALAGUSSA P, 1994, ANN ONCOL, V5, P803, DOI 10.1093/oxfordjournals.annonc.a059008; Vassilopoulou-Sellin R, 1999, J CLIN ONCOL, V17, P1482, DOI 10.1200/JCO.1999.17.5.1482; VASSILOPOULOUSE.R, 1996, CANCER, V79, P867; VassilopoulouSellin R, 1996, CANCER-AM CANCER SOC, V78, P1043, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1043::AID-CNCR14>3.0.CO;2-2; Velentgas P, 1999, CANCER, V85, P2424, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2424::AID-CNCR17>3.0.CO;2-4; Venn A, 1999, LANCET, V354, P1586, DOI 10.1016/S0140-6736(99)05203-4; Warmuth MA, 1998, CANCER, V83, P1362, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1362::AID-CNCR13>3.0.CO;2-2; Weber B, 1998, EUR J CANCER, V34, pS42, DOI 10.1016/S0959-8049(98)80161-5; WINCHESTER DP, 1979, CANCER, V43, P956, DOI 10.1002/1097-0142(197903)43:3<956::AID-CNCR2820430326>3.0.CO;2-L; WOLF DM, 1992, GYNECOL ONCOL, V45, P118, DOI 10.1016/0090-8258(92)90273-L; Zhang YQ, 1997, NEW ENGL J MED, V336, P611, DOI 10.1056/NEJM199702273360903	124	158	159	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2000	343	15					1086	1094		10.1056/NEJM200010123431506	http://dx.doi.org/10.1056/NEJM200010123431506			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362FA	11027744				2022-12-28	WOS:000089766900006
J	Kaplan, BS; Meyers, K				Kaplan, BS; Meyers, K			Schistosoma haematobium	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia	Kaplan, BS (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2000	343	15					1085	1085		10.1056/NEJM200010123431505	http://dx.doi.org/10.1056/NEJM200010123431505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362FA	11027743				2022-12-28	WOS:000089766900005
J	Popovic, V; Leal, A; Micic, D; Koppeschaar, HPF; Torres, E; Paramo, C; Obradovic, S; Dieguez, C; Casanueva, FF				Popovic, V; Leal, A; Micic, D; Koppeschaar, HPF; Torres, E; Paramo, C; Obradovic, S; Dieguez, C; Casanueva, FF			GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults	LANCET			English	Article							INSULIN TOLERANCE-TEST; GROWTH; SECRETION; REPRODUCIBILITY; ARGININE; OBESITY; GHRP-6	Background The diagnosis of growth hormone (GH) deficiency in adults is based on provocative testing of GH secretion. The insulin tolerance test (ITT), currently the favoured test for this diagnosis, has been criticised for poor reproducibility and inconvenience. Since the combined administration of GH-releasing hormone (GHRH) plus GH-releasing peptide-6 (GHRP-6) is the most potent stimulus of GH secretion, we did a multicentre study comparing GH peaks elicited by ITT with those elicited by the GHRH/GHRP-6 rest in healthy controls and GH-deficient individuals (cases), Methods 125 adult patients with organic pituitary disease and 125 healthy individuals were studied. All cases and controls were given GHRH 1 mu g per kg bodyweight intravenously plus GHRP-6 1 E-g per hg intravenously at 0 min and blood samples were obtained during a subsequent 120 min period. 27 controls and all cases had an ITT. Inclusion criteria were severe GH deficiency-ie, a GH peak after ITT of less than or equal to 3 mu g/L Results of the GHRH/GHRP-6 test were analysed by receiver-operating characteristic curve methodology. Findings GH peaks seen after the GHRH/GHRP-6 test did not result in any side-effects and were not affected by age, sex, amount of adipose tissue, or by the GH assay system used. The GH mean peak after the GHRH/GHRP-6 test was 59.2 mu g/L (SD 2.2) for controls and 4.1 mu g/L (0.3) for cases, whereas after ITT the mean peak was 14.3 mu g/L (1.7) and 0.5 mu g/L (0.06), respectively. The differential peak responses of controls and cases was greater (p<0.001), for GHRH/GHRP-6 test than for ITT, When individually analysed GH peaks were a continuum, from 139.0 mu g/L to 0.01 mu g/L, with a cut-off point of 15.0 mu g/L. The GHRH/GHRP-6 test performed well under the ROC curve analysis. For clinical utility, it is then proposed that values greater than or equal to 20.00 mu g/L be considered normal and less than or equal to 10.00 mu g/L as GH deficient Interpretation The GHRH/GHRP-6 test is a convenient, safe and reliable test for adult GH deficiency and is not confounded by clinical factors known to alter GH secretory patterns. An evoked GH concentration of greater than or equal to 15.0 mu g/L accurately distinguishes between healthy and GH-deficient adults.	Univ Clin Ctr, Inst Endocrinol, Belgrade, Yugoslavia; Acad Ziekenhuis Utrecht, Dept Endocrinol, Utrecht, Netherlands; Hosp Xeral Vigo, Div Endocrinol, Vigo, Spain; Hosp Virgen del Rocio Sevilla, Div Endocrinol, Seville, Spain; Hosp Clin Granada, Div Endocrinol, Granada, Spain; Univ Santiago de Compostela, Sch Med & Complejo Hosp Univ Santiago, Dept Physiol, Santiago De Compostela, Spain; Univ Santiago de Compostela, Sch Med & Complejo Hosp Univ Santiago, Dept Med, Santiago De Compostela, Spain	Utrecht University; Utrecht University Medical Center; Complexo Hospitalario Universitario de Vigo; Virgen del Rocio University Hospital; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Casanueva, FF (corresponding author), Dept Med, Endocrine Unit, San Francisco St S-N,POB 563, E-15780 Santiago De Compostela, Spain.	melage@usc.es		dieguez, carlos/0000-0002-0919-4337				Andersen M., 1996, ENDOCRINOLOGY METABO, V3, P197; ANDERSSON AM, 1995, EUR J ENDOCRINOL, V132, P340, DOI 10.1530/eje.0.1320340; Casanueva FF, 1999, TRENDS ENDOCRIN MET, V10, P30, DOI 10.1016/S1043-2760(98)00116-7; Casanueva FF, 1996, EUR J ENDOCRINOL, V135, P168, DOI 10.1530/eje.0.1350168; CORDIDO F, 1993, J CLIN ENDOCR METAB, V76, P819, DOI 10.1210/jc.76.4.819; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DIEGUEZ C, 1995, TRENDS ENDOCRIN MET, V6, P55, DOI 10.1016/1043-2760(94)00206-J; Fisker S, 1998, CLIN ENDOCRINOL, V48, P109; FRANTZ AG, 1965, J CLIN ENDOCR METAB, V25, P1470, DOI 10.1210/jcem-25-11-1470; *GROWTH HORM RES S, 1999, J CLIN ENDOCR METAB, V83, P379; HALL GH, 1967, LANCET, V2, P555; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOECK HC, 1995, EUR J ENDOCRINOL, V133, P305, DOI 10.1530/eje.0.1330305; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; JONES SL, 1994, CLIN ENDOCRINOL, V41, P123, DOI 10.1111/j.1365-2265.1994.tb03793.x; JORGENSEN JOL, 1989, LANCET, V1, P1221; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Micic D, 1998, J CLIN ENDOCR METAB, V83, P2569, DOI 10.1210/jc.83.7.2569; POPOVIC V, 1995, J CLIN ENDOCR METAB, V80, P942, DOI 10.1210/jc.80.3.942; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; SHAH A, 1992, BRIT MED J, V304, P173, DOI 10.1136/bmj.304.6820.173; Shalet SM, 1998, ENDOCR REV, V19, P203, DOI 10.1210/er.19.2.203; TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x; Valetto MR, 1996, EUR J ENDOCRINOL, V135, P568, DOI 10.1530/eje.0.1350568; WEISSBERGER AJ, 1994, LANCET, V344, P483	27	133	139	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2000	356	9236					1137	1142		10.1016/S0140-6736(00)02755-0	http://dx.doi.org/10.1016/S0140-6736(00)02755-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030292				2022-12-28	WOS:000089594300010
J	Denver, DR; Morris, K; Lynch, M; Vassilieva, LL; Thomas, WK				Denver, DR; Morris, K; Lynch, M; Vassilieva, LL; Thomas, WK			High direct estimate of the mutation rate in the mitochondrial genome of Caenorhabditis elegans	SCIENCE			English	Article							HOT-SPOTS; DNA; INSTABILITY; SEQUENCES; EVOLUTION; BIAS	Mutations in the mitochondrial genome have been implicated in numerous human genetic disorders and offer important data for phylogenetic, forensic. and population genetic studies. Using a long-term series of Caenorhabditis elegans mutation accumulation lines, we performed a wide-scale screen for mutations in the mitochondrial genome that revealed a mutation rate that is two orders of magnitude higher than previous indirect estimates, a highly biased mutational spectrum, multiple mutations affecting coding function, as welt as mutational hotspots at homopolymeric nucleotide stretches.	Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; Univ Oregon, Dept Biol, Eugene, OR 97403 USA	University of Missouri System; University of Missouri Kansas City; University of Oregon	Thomas, WK (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.				NIGMS NIH HHS [R01-GM36827] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASAKAWA S, 1991, J MOL EVOL, V32, P511, DOI 10.1007/BF02102653; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; CABOT E, 1997, EYEBALL SEQUENCE EDI; Drake JW, 1998, GENETICS, V148, P1667; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Habano W, 1998, ONCOGENE, V17, P1931, DOI 10.1038/sj.onc.1202112; Hodgkin J, 1997, GENETICS, V146, P149; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 1996, AM J HUM GENET, V59, P501; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; OKIMOTO R, 1992, GENETICS, V130, P471; Paabo S, 1996, AM J HUM GENET, V59, P493; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PREPARATA G, 1987, J MOL EVOL, V26, P7, DOI 10.1007/BF02111277; THOMAS WK, 1991, GENETICS, V128, P269; Vassilieva LL, 1999, GENETICS, V151, P119; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WALLACE DC, 1999, NEUROMUSCULAR DISORD, V9, P9; Xia XH, 1996, J MOL EVOL, V43, P32, DOI 10.1007/BF02352297; Yokobori S, 1999, GENETICS, V153, P1851	24	228	229	6	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2342	2344		10.1126/science.289.5488.2342	http://dx.doi.org/10.1126/science.289.5488.2342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009418				2022-12-28	WOS:000089593500050
J	Nakagaki, T; Yamada, H; Toth, A				Nakagaki, T; Yamada, H; Toth, A			Maze-solving by an amoeboid organism	NATURE			English	Article							PHYSARUM PLASMODIUM; PATTERN-FORMATION; POLYCEPHALUM; WAVES		RIKEN, Biomimet Control Res Ctr, Nagoya, Aichi 4630003, Japan; RIKEN, Local Spatiotemporal Funct Lab, Wako, Saitama 3510198, Japan; Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan; Univ Szeged, Dept Phys Chem, H-6701 Szeged, Hungary	RIKEN; RIKEN; Hokkaido University; Szeged University	Nakagaki, T (corresponding author), RIKEN, Biomimet Control Res Ctr, Nagoya, Aichi 4630003, Japan.		Nakagaki, Toshiyuki/L-3049-2013; Toth, Agota/I-4466-2015	Nakagaki, Toshiyuki/0000-0002-3446-4888; Toth, Agota/0000-0001-8254-6354				DURHAM ACH, 1976, J CELL BIOL, V69, P218, DOI 10.1083/jcb.69.1.218; EPULCHRE JA, 1991, P INT C ART NEUR NET, P1265; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; MATSUMOTO K, 1986, J THEOR BIOL, V122, P339, DOI 10.1016/S0022-5193(86)80125-4; MIYAKE Y, 1994, CELL STRUCT FUNCT, V19, P363, DOI 10.1247/csf.19.363; Nakagaki T, 1999, J THEOR BIOL, V197, P497, DOI 10.1006/jtbi.1998.0890; Nakagaki T, 2000, BIOPHYS CHEM, V84, P195, DOI 10.1016/S0301-4622(00)00108-3; SEPULCHRE JA, 1993, PHYS REV E, V48, P187, DOI 10.1103/PhysRevE.48.187; STEINBOCK O, 1995, SCIENCE, V267, P868, DOI 10.1126/science.267.5199.868; Yamada H, 1999, PHYS REV E, V59, P1009, DOI 10.1103/PhysRevE.59.1009	10	609	624	10	240	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					470	470		10.1038/35035159	http://dx.doi.org/10.1038/35035159			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028990	Bronze			2022-12-28	WOS:000089727400038
J	[Anonymous]				[Anonymous]			Reviews for reviews' sake	NATURE			English	Editorial Material																			0	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					273	273						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014150				2022-12-28	WOS:000089390700002
J	Abbott, A				Abbott, A			Physicists haunted by hints of Higgs boson	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					118	118		10.1038/35025291	http://dx.doi.org/10.1038/35025291			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001022	Bronze			2022-12-28	WOS:000089241000004
J	Wang, SX; Sun, NX; Yamaguchi, M; Yabukami, S				Wang, SX; Sun, NX; Yamaguchi, M; Yabukami, S			Sandwich films - Properties of a new soft magnetic material	NATURE			English	Article									Stanford Univ, Dept Mat Sci & Engn, Adv Mat Lab, Stanford, CA 94305 USA; Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 9808577, Japan	Stanford University; Tohoku University	Wang, SX (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Adv Mat Lab, Stanford, CA 94305 USA.		Sun, Nian-xiang/G-8330-2011					Charap SH, 1997, IEEE T MAGN, V33, P978, DOI 10.1109/20.560142; CLOW H, 1962, NATURE, V194, P1035, DOI 10.1038/1941035a0; Hayakawa Y, 1997, J APPL PHYS, V81, P3747, DOI 10.1063/1.365498; Jin S, 1997, APPL PHYS LETT, V70, P3161, DOI 10.1063/1.119120; Osaka T, 1998, NATURE, V392, P796, DOI 10.1038/33888; SUN NX, IN PRESS IEEE T MAGN; Wang S. X., 1999, MAGNETIC INFORMATION; Yabukami S, 1999, J APPL PHYS, V85, P5148, DOI 10.1063/1.369106; Yamaguchi M, 1999, J APPL PHYS, V85, P7919, DOI 10.1063/1.370608	9	226	242	5	82	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					150	151		10.1038/35025142	http://dx.doi.org/10.1038/35025142			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001044				2022-12-28	WOS:000089241000035
J	Des Marais, DJ				Des Marais, DJ			Evolution - When did photosynthesis emerge on earth?	SCIENCE			English	Editorial Material							BIOGEOCHEMICAL CARBON-CYCLE; WESTERN-AUSTRALIA; OXYGENIC PHOTOSYNTHESIS; STROMATOLITES; GA		NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Des Marais, DJ (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.							Beukes N.J., 1992, PROTEROZOIC BIOSPHER, P147; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; BUICK R, 1990, Palaios, V5, P441, DOI 10.2307/3514837; Buick R, 1998, AAPG BULL, V82, P50; CHICARELLI MI, 1987, ACS SYM SER, V344, P40; Des Marais DJ, 1997, ORG GEOCHEM, V27, P185, DOI 10.1016/S0146-6380(97)00061-2; DesMarais DJ, 1997, REV MINERAL, V35, P429; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; Grotzinger J.P., 1989, SOC EC PALEONTOLOGIS, V44, P79, DOI DOI 10.2110/PEC; HAYES JM, 1994, EARLY LIFE EARTH, P220; Hofmann HJ, 1999, GEOL SOC AM BULL, V111, P1256, DOI 10.1130/0016-7606(1999)111<1256:OOGCSI>2.3.CO;2; Holland HD., 1984, CHEM EVOLUTION ATMOS; Kadko D., 1995, GEOPHYS MONOGRAPH AM, V91, P446, DOI DOI 10.1029/GM091; Knoll A.H., 1996, PALYNOLOGY PRINCIPLE, V1, P51; KNOLL AH, 1988, PRECAMBRIAN RES, V38, P257, DOI 10.1016/0301-9268(88)90005-8; LOWE DR, 1983, PRECAMBRIAN RES, V19, P239, DOI 10.1016/0301-9268(83)90016-5; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Olson J.S., 1985, ATMOSPHERIC CARBON D, P175; Schidlowski M., 1983, P149; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P25; SCHOPF J.W., 1992, PROTEROZOIC BIOSPHER; SUMMONS RE, 1986, NATURE, V319, P763, DOI 10.1038/319763a0; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; TURCOTTE DL, 1980, EARTH PLANET SC LETT, V48, P53, DOI 10.1016/0012-821X(80)90169-7; Walter M. R., 1976, STROMATOLITES; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724	29	227	237	7	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1703	1705						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	11001737				2022-12-28	WOS:000089195200034
J	Heller, RF; Dobson, AJ				Heller, RF; Dobson, AJ			Disease impact number and population impact number: population perspectives to measures of risk and benefit	BRITISH MEDICAL JOURNAL			English	Article							TREAT		Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia; Univ Queensland, Dept Social & Prevent Med, Brisbane, Qld 4006, Australia	University of Newcastle; University of Queensland	Heller, RF (corresponding author), Royal Newcastle Hosp, Ctr Clin Epidemiol & Biostat, David Maddison Clin Sci Bldg, Newcastle, NSW 2308, Australia.		Dobson, Annette J/B-5273-2008	Heller, Richard/0000-0003-3161-5967				APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; HELLER R, IN PRESS B WHO; Jorgensen HS, 1999, BRIT MED J, V319, P288, DOI 10.1136/bmj.319.7205.288; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LAUPACIS A, 1992, ANN INTERN MED    S3, V116, pA12; MATHESON NK, 1985, POLYSACCHARIDES, V3, P1; Miller DB, 1997, ARCH INTERN MED, V157, P2045, DOI 10.1001/archinte.157.18.2045; Rembold CM, 1998, BMJ-BRIT MED J, V317, P307, DOI 10.1136/bmj.317.7154.307; Smeeth L, 1999, BMJ-BRIT MED J, V318, P1548, DOI 10.1136/bmj.318.7197.1548; 1999, ACP J CLUB, V131, P1; 1999, ACP J CLUB, V131, pA21	14	47	49	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					950	952		10.1136/bmj.321.7266.950	http://dx.doi.org/10.1136/bmj.321.7266.950			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030691	Green Published			2022-12-28	WOS:000089975100030
J	Joossens, L; Raw, M				Joossens, L; Raw, M			How can cigarette smuggling be reduced?	BRITISH MEDICAL JOURNAL			English	Article							EUROPE		Int Union Against Canc, EU Liaison Off, B-1040 Brussels, Belgium; Univ London, Guys Kings & St Thomass Sch Med, Dept Publ Hlth Sci, London, England	University of London; King's College London	Joossens, L (corresponding author), Int Union Against Canc, EU Liaison Off, Rue Pascale 33, B-1040 Brussels, Belgium.							*ATT GEN CAN, 1999, COMPL DAM INJ DECL R; *BATCO, 1994, GLOB 5 YEAR PLAN; CLARKE K, 2000, GUARDIAN        0203, P19; *COMM EUR COMM, 1999, PROT COMM FIN INT FI; *HLTH CAN, 1994, SURV SMOK CAN CYCL 1; *HM TREAS HM CUST, 2000, TOB SMUGGL TOLD YOUR; *HOUS COMM SEL COM, 2000, 2 HOUS COMM SEL COMM; JOOSSENS L, 1995, BRIT MED J, V310, P1393, DOI 10.1136/bmj.310.6991.1393; Joossens L, 1998, TOB CONTROL, V7, P66, DOI 10.1136/tc.7.1.66; JOOSSENS L, 2000, TOBACCO CONTROL DEV, P393; *MARK TRACK INT, 1998, WORLD TOB FIL 1998; MARSDEN W, 1999, GAZETTE         1218, P1; *REUT, 2000, EU WILL SUE AM TOB C; SWEANOR DT, 1997, SMUGGLING TOBACCO PR; 2000, GUARDIAN        0402, P21	15	68	69	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					947	950		10.1136/bmj.321.7266.947	http://dx.doi.org/10.1136/bmj.321.7266.947			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030690	Green Published			2022-12-28	WOS:000089975100029
J	Gogotsi, Y; Libera, JA; Kalashnikov, N; Yoshimura, M				Gogotsi, Y; Libera, JA; Kalashnikov, N; Yoshimura, M			Graphite polyhedral crystals	SCIENCE			English	Article							CARBON NANOTUBES; RAMAN	Polyhedral nano- and microstructures with shapes of faceted needles, rods, rings, barrels, and double-tipped pyramids, which we call graphite polyhedral crystals (GPCs), have been discovered. They were found in pores of glassy carbon. They have nanotube cores and graphite faces, and they can exhibit unusual sevenfold, ninefold, or more complex axial symmetry. Although some are giant radially extended nanotubes, Raman spectroscopy and transmission electron microscopy suggest GPCs have a degree of perfection higher than in multiwall nanotubes of similar size. The crystals are up to 1 micrometer in cross section and 5 micrometers in Length, and they can probably be grown in much Larger sires. Preliminary results suggest a high electrical conductivity, strength, and chemical stability of GPC.	Univ Illinois, Dept Mech Engn, Chicago, IL 60607 USA; Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 226, Japan	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tokyo Institute of Technology	Gogotsi, Y (corresponding author), Drexel Univ, Dept Mat Engn, Philadelphia, PA 19104 USA.		Yoshimura, Masahiro/H-5938-2011; Gogotsi, Yury/B-2167-2008	Yoshimura, Masahiro/0000-0003-1810-0301; Gogotsi, Yury/0000-0001-9423-4032				Ajayan P.M., 1997, CARBON NANOTUBES PRE, P111; BACON R, 1960, J APPL PHYS, V31, P283, DOI 10.1063/1.1735559; BRABEC CJ, 1995, CHEM PHYS LETT, V236, P150, DOI 10.1016/0009-2614(95)00194-9; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Dresselhaus M.S., 1999, ANAL APPL RAMAN SPEC, P367; Ebbesen TW, 1996, PHYS TODAY, V49, P26, DOI 10.1063/1.881603; ENDO M, 1997, CARBON NANOTUBES PRE, P35; GOGOTSI YG, 1992, J MATER SCI LETT, V11, P308, DOI 10.1007/BF00729423; HEIDENRE.RD, 1968, J APPL CRYSTALLOGR, V1, P1, DOI 10.1107/S0021889868004930; HIURA H, 1993, CHEM PHYS LETT, V202, P509, DOI 10.1016/0009-2614(93)90040-8; IHARA S, 1996, CARBON NANOTUBES, P77; IIJIMA S, 1994, MRS BULL, V19, P43, DOI 10.1557/S0883769400048405; IIJIMA S, 1992, PHYS REV LETT, V69, P3100, DOI 10.1103/PhysRevLett.69.3100; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Liu KF, 1994, MATH RES LETT, V1, P53; MURAYAMA H, 1990, NATURE, V345, P791, DOI 10.1038/345791a0; OSAWA E, 1994, MRS BULL, V19, P33, DOI 10.1557/S0883769400048387; Rao AM, 1997, SCIENCE, V275, P187, DOI 10.1126/science.275.5297.187; Ray K, 1997, ANAL CHEM, V69, P4680, DOI 10.1021/ac9705531; Tanaka K., 1999, SCI TECHNOLOGY CARBO, P143; Ugarte D., 1996, CARBON NANOTUBES, P163, DOI [10.1016/B978-0-08-042682-2.50024-2, DOI 10.1016/B978-0-08-042682-2.50024-2]; Ugarte D., 1999, SCI TECHNOLOGY CARBO, P128; WITTAKER EJW, 1966, ACTA CRYSTALLOGR, V21, P461; [No title captured]	24	174	178	5	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					317	320		10.1126/science.290.5490.317	http://dx.doi.org/10.1126/science.290.5490.317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030646				2022-12-28	WOS:000089818100038
J	Ogata, H; Audic, S; Barbe, V; Artiguenave, F; Fournier, PE; Raoult, D; Claverie, JM				Ogata, H; Audic, S; Barbe, V; Artiguenave, F; Fournier, PE; Raoult, D; Claverie, JM			Selfish DNA in protein-coding genes of Rickettsia	SCIENCE			English	Article							GENOME; SEQUENCE	Rickettsia conorii, the aetiological agent of Mediterranean spotted fever, is an intracellular bacterium transmitted by ticks. Preliminary analyses of the nearly complete genome sequence of R. conorii have revealed 44 occurrences of a previously undescribed palindromic repeat (150 base pairs Long) throughout the genome. Unexpectedly, this repeat was found inserted in-frame within 19 different R. conorii open reading frames likely to encode functional proteins. We found the same repeat in proteins of other Rickettsia species. The finding of a mobile element inserted in many unrelated genes suggests the potential role of selfish DNA in the creation of new protein sequences.	CNRS AVENTIS UMR 1889, F-13402 Marseille, France; Ctr Natl Sequencage, F-91000 Evry, France; Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS UPRES A 6020, F-13385 Marseille, France	Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite	Claverie, JM (corresponding author), CNRS AVENTIS UMR 1889, 31 Chemin Joseph Aiguier, F-13402 Marseille, France.		Claverie, Jean-Michel/AAG-4889-2019; RAOULT, Didier/A-8434-2008; Claverie, Jean Michel/Z-2183-2019; Fournier, Pierre-Edouard/AAC-6155-2021	Claverie, Jean-Michel/0000-0003-1424-0315; RAOULT, Didier/0000-0002-0633-5974; Fournier, Pierre-Edouard/0000-0001-8463-8885; Audic, Stephane/0000-0001-6193-4374				Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Audic S, 1998, P NATL ACAD SCI USA, V95, P10026, DOI 10.1073/pnas.95.17.10026; Bachellier S, 1999, RES MICROBIOL, V150, P627, DOI 10.1016/S0923-2508(99)00128-X; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Kato S, 1998, CURR GENET, V34, P303, DOI 10.1007/s002940050400; MONCHOIS V, COMMUNICATION; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Perler FB, 1999, NUCLEIC ACIDS RES, V27, P346, DOI 10.1093/nar/27.1.346; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; SHARPLES GJ, 1990, NUCLEIC ACIDS RES, V18, P6503, DOI 10.1093/nar/18.22.6503; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443	18	88	106	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					347	350		10.1126/science.290.5490.347	http://dx.doi.org/10.1126/science.290.5490.347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030655				2022-12-28	WOS:000089818100047
J	Lee, EG; Boone, DL; Chai, S; Libby, SL; Chien, M; Lodolce, JP; Ma, A				Lee, EG; Boone, DL; Chai, S; Libby, SL; Chien, M; Lodolce, JP; Ma, A			Failure to regulate TNF-induced NF-kappa B and cell death responses in A20-deficient mice	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; ZINC-FINGER PROTEIN; A20; ACTIVATION; ALPHA; EXPRESSION; APOPTOSIS; INHIBITOR; SIGNAL	A20 is a cytoplasmic zinc finger protein that inhibits nuclear factor kappa B (NF-kappa B) activity and tumor necrosis factor (TNF)-mediated programmed cell death (PCD). TNF dramatically increases A20 messenger RNA expression in all tissues. Mice deficient far A20 develop severe inflammation and cachexia, are hypersensitive to both Lipopolysaccharide and TNF, and die prematurely. A20-deficient cells fail to terminate TNF-induced NF-kappa B responses. These cells are also more susceptible than control cells to undergo TNF-mediated PCD. Thus, AZO is critical for limiting inflammation by terminating TNF-induced NF-kappa B responses in vivo.	Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Ma, A (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 6084, Chicago, IL 60637 USA.				NIAID NIH HHS [R01 AI045860] Funding Source: Medline; NIDDK NIH HHS [R01 DK052751] Funding Source: Medline; NIGMS NIH HHS [T32 GM007839, 5T32GM07183, T32GM07839, T32 GM007183] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183, T32GM007839] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; GIROIR BP, 1992, P NATL ACAD SCI USA, V89, P4864, DOI 10.1073/pnas.89.11.4864; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; TEWARI M, 1995, J IMMUNOL, V154, P1699; VAN AD, 1996, SCIENCE, V274, P787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WONG GHW, 1994, J IMMUNOL, V152, P1751; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	16	1148	1221	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2350	2354		10.1126/science.289.5488.2350	http://dx.doi.org/10.1126/science.289.5488.2350			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009421	Green Accepted			2022-12-28	WOS:000089593500053
J	Miller, JS; Venable, DL				Miller, JS; Venable, DL			Polyploidy and the evolution of gender dimorphism in plants	SCIENCE			English	Article							INBREEDING DEPRESSION; SELF-INCOMPATIBILITY; FLOWERING PLANTS; SEED PLANTS; DIOECY; INHERITANCE; ANGIOSPERMS; GYNODIOECY	Gender dimorphism and polyploidy are important evolutionary transitions that have evolved repeatedly in many plant families. We show that gender dimorphism in North American Lycium (Solanaceae) has evolved in polyploid, self-compatible taxa whose closest relatives are cosexual, self-incompatible diploids. This has occurred independently in South African Lycium. We present additional evidence for this pathway to gender dimorphism from 12 genera involving at Least 20 independent evolutionary events. We propose that polyploidy is a trigger of unrecognized importance for the evolution of gender dimorphism, which operates by disrupting self-incompatibility and leading to inbreeding depression. Subsequently, male sterile mutants invade and increase because they are unable to inbreed.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Miller, JS (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.							BAKER HG, 1984, AM NAT, V124, P149, DOI 10.1086/284260; BAKER HG, 1959, COLD SPRING HARB SYM, V24, P177, DOI 10.1101/SQB.1959.024.01.019; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth D., 1985, EVOLUTION ESSAYS HON, P237; CHARNOV EL, 1976, NATURE, V263, P125, DOI 10.1038/263125a0; Chawla B, 1997, THEOR APPL GENET, V95, P992, DOI 10.1007/s001220050652; Chiang-Cabrera F., 1981, THESIS U TEXAS AUSTI; DENETTANCOURT D, 1977, IMCOMPATIBILITY ANGI; DEWEY DR, 1969, CROP SCI, V9, P592, DOI 10.2135/cropsci1969.0011183X000900050023x; Geber MA, 1999, GENDER SEXUAL DIMORP; Husband BC, 1997, EVOLUTION, V51, P737, DOI [10.2307/2411150, 10.1111/j.1558-5646.1997.tb03657.x]; JOHNSTON MO, 1994, EVOLUTION, V48, P1735, DOI 10.1111/j.1558-5646.1994.tb02209.x; KOHN JR, 1988, NATURE, V335, P431, DOI 10.1038/335431a0; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LLOYD DG, 1975, GENETICA, V45, P325, DOI 10.1007/BF01508307; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MCCOMB JA, 1968, AUST J BOT, V16, P525, DOI 10.1071/BT9680525; MILLER JA, UNPUB; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Richards A.J, 1997, PLANT BREEDING SYSTE; Richman AD, 1996, SCIENCE, V273, P1212, DOI 10.1126/science.273.5279.1212; Richman AD, 2000, PLANT MOL BIOL, V42, P169, DOI 10.1023/A:1006336206637; Ronfort J, 1999, GENET RES, V74, P31, DOI 10.1017/S0016672399003845; Stout AB, 1941, SCIENCE, V94, P118, DOI 10.1126/science.94.2431.118; SWOFFORD DL, 2000, PHYTOGENETIC ANAL US; THOMSON JD, 1990, TRENDS ECOL EVOL, V5, P11, DOI 10.1016/0169-5347(90)90006-Y; VENTER AM, 1999, 16 INT BOT C ST LOUI; Webb C.J., 1999, GENDER SEXUAL DIMORP, P61, DOI DOI 10.1007/978-3-662-03908-3_3; Wen J, 1996, MOL PHYLOGENET EVOL, V6, P167, DOI 10.1006/mpev.1996.0069	30	154	162	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2335	2338		10.1126/science.289.5488.2335	http://dx.doi.org/10.1126/science.289.5488.2335			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009416				2022-12-28	WOS:000089593500048
J	Hingson, RW; Heeren, T; Jamanka, A; Howland, J				Hingson, RW; Heeren, T; Jamanka, A; Howland, J			Age of drinking onset and unintentional injury involvement after drinking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALCOHOL-USE; ACCIDENTAL FALLS; RISK; INTERVENTIONS; BEHAVIORS; ADULTS; DEATH	Context In 1997, unintentional injury was the leading cause of death for persons aged 1 to 34 years. Approximately one third of deaths due to unintentional injury in the United States are estimated to be alcohol related. Onset of drinking at an early age has been found to be associated with alcohol dependence, but whether early-onset drinking increases risk for unintentional injury while drinking is unknown. Objective To explore whether persons who started drinking at an early age are more likely to have experienced unintentional injuries while under the influence of alcohol. Design and Setting The National Longitudinal Alcohol Epidemiology Survey, a cross-sectional survey conducted in 1992 of a representative sample of the US population. Participants A total of 42 862 randomly selected adults (response rate, 90%; mean age, 44 years). Main Outcome Measures Unintentional injury involvement while under the influence of alcohol by age of drinking onset (categorized as <14 years, each age from 14-20 years, or greater than or equal to 21 years). Results Relative to respondents who began drinking at age 21 years or older, those who started before age 14 years as well as those who started at each intervening age up to 21 years were significantly more likely to have been injured while under the influence of alcohol, even after controlling for history of alcohol dependence, heavy drinking frequency during the period that they drank most, family history of alcoholism, and other characteristics associated with earlier onset of drinking. After adjusting for these variables, odds ratios for having been injured while under the influence of alcohol were as follows: for younger than 14 years, 2.98 (95% confidence interval [CI], 2.29-3.89); age 14 years, 2.96 (95% CI, 2.26-3.88); age 15 years, 3.14 (95% CI, 2.48-3.97); age 16 years, 2.38 (95% CI, 1.90-2.98); age 17 years, 2.12 (95% CI, 1.66-2.71); age 18 years, 1.33 (95% CI, 1.08-1.64); age 19 years, 1.42 (95% CI, 1.07-1.89); and age 20 years, 1.39 (95% CI, 1.01-1.91). Conclusion Drinking onset at ages younger than 21 years is associated with;having experienced alcohol-related injuries.	Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Hingson, RW (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, 715 Albany St,T 2W, Boston, MA 02118 USA.	rhingson@bu.edu		Howland, Jonathan/0000-0001-8079-1188; Heeren, Timothy/0000-0001-5643-3559				*CDC NAT CTR HLTH, 1999, OFF STAT PROGR DAT; CLAPPER RL, 1995, INT J ADDICT, V30, P507, DOI 10.3109/10826089509048741; Dinh-Zarr T, 1999, ALCOHOL ALCOHOLISM, V34, P609, DOI 10.1093/alcalc/34.4.609; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; *GEN ACC OFF, 1987, DRINK AG LAWS EV SYN; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Grant BF, 1998, ALCOHOL HEALTH RES W, V22, P144; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P37, DOI 10.1016/0376-8716(95)01134-K; HINGSON R, 1993, ADDICTION, V88, P877, DOI 10.1111/j.1360-0443.1993.tb02105.x; HINGSON R, 1987, J STUD ALCOHOL, V48, P212, DOI 10.15288/jsa.1987.48.212; Hingson R., 1990, J TRAFFIC MED, V3, P123; HONKANEN R, 1983, J STUD ALCOHOL, V44, P231, DOI 10.15288/jsa.1983.44.231; HOWLAND J, 1988, ACCIDENT ANAL PREV, V20, P19, DOI 10.1016/0001-4575(88)90011-5; JONES NE, 1992, AM J PUBLIC HEALTH, V82, P112, DOI 10.2105/AJPH.82.1.112; MASSEY JT, 1985, VITAL HLTH STAT REPO, V2; *NAT HIGHW TRAFF S, 1996, US DEP TRANSP PUBL; *NAT HIGHW TRAFF S, 1998, TRAFF SAF FACTS 1997; *NAT HIGHW TRAFF S, 1998, TRAFF SAF FACTS ALC; O'Malley PM, 1999, AM J PUBLIC HEALTH, V89, P678, DOI 10.2105/AJPH.89.5.678; OMALLEY PM, 1991, J STUD ALCOHOL, V52, P478, DOI 10.15288/jsa.1991.52.478; Prescott CA, 1999, ALCOHOL CLIN EXP RES, V23, P101, DOI 10.1097/00000374-199901000-00014; Robins L. N., 1993, MENTAL DISORDER CRIM, P173; Schuckit MA, 1999, JAMA-J AM MED ASSOC, V281, P1875, DOI 10.1001/jama.281.20.1875; Shah BV, 1996, SUDAAN USERS MANUAL; Smith GS, 1999, ANN EMERG MED, V33, P659, DOI 10.1016/S0196-0644(99)70195-2; Zador PL, 2000, J STUD ALCOHOL, V61, P387, DOI 10.15288/jsa.2000.61.387; ZADOR PL, 1991, J STUD ALCOHOL, V52, P302, DOI 10.15288/jsa.1991.52.302	27	219	219	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1527	1533		10.1001/jama.284.12.1527	http://dx.doi.org/10.1001/jama.284.12.1527			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355HF	11000646	Green Submitted, Bronze			2022-12-28	WOS:000089379700028
J	Simpson, JL; Ljungqvist, A; Ferguson-Smifh, MA; de la Chapelle, A; Elsas, LJ; Ehrhardt, AA; Genel, M; Ferris, EA; Carlson, A				Simpson, JL; Ljungqvist, A; Ferguson-Smifh, MA; de la Chapelle, A; Elsas, LJ; Ehrhardt, AA; Genel, M; Ferris, EA; Carlson, A			Gender verification in the Olympics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SEX; SPORTS		Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Int Amateur Athlet Fdn, Monaco, Monaco; Univ Cambridge, Dept Clin Vet Med, Cambridge CB3 0ES, England; Ohio State Univ, Columbus, OH 43210 USA; Emory Univ, Sch Med, Atlanta, GA USA; New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA; Yale Univ, New Haven, CT USA; Univ London Kings Coll, London WC2R 2LS, England; Womens Sports Fdn, E Meadow, NY USA	Baylor College of Medicine; Baylor College of Medicine; University of Cambridge; Ohio State University; Emory University; New York State Psychiatry Institute; Yale University; University of London; King's College London	Simpson, JL (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, 6550 Fannin,Suite 901A, Houston, TX 77030 USA.							CARLSON A, 1991, WOMENS SPORT FIT MAR, P24; DELACHAPELLE A, 1987, LANCET, V2, P1265; DELACHAPELLE A, 1986, JAMA-J AM MED ASSOC, V256, P1920, DOI 10.1001/jama.256.14.1920; DELACHAPELLE A, 1983, PRINCIPLES PRACTICE, P193; DELACHAPELLE A, 1986, NEW STUD ATHLETICS, V2, P49; DINGEON B, 1993, JAMA-J AM MED ASSOC, V269, P357, DOI 10.1001/jama.269.3.357; Elsas L J, 1997, J Med Assoc Ga, V86, P50; Ferguson-Smith M A, 1991, Br J Sports Med, V25, P17; FERGUSONSMITH MA, 1992, NATURE, V355, P10, DOI 10.1038/355010a0; FERGUSONSMITH MA, 1989, OXFORD TXB SPORTS ME, P355; FERRIS EAE, 1992, BRIT MED BULL, V48, P683, DOI 10.1093/oxfordjournals.bmb.a072571; HAY E, 1972, J AMER MED ASSOC, V221, P998; LJUNGQVIST A, 1992, JAMA-J AM MED ASSOC, V267, P850, DOI 10.1001/jama.267.6.850; Ljungqvist Arne, 2000, OLYMPIC ENCYCLOPEDIA, V8, p[183, 183]; MASCAGNI K, 1996, OLYMPIC REV, V26, P23; SERRAT A, 1993, LANCET, V341, P1593, DOI 10.1016/0140-6736(93)90728-Y; Simpson J. P., 2000, PEDIAT ADOLESCENT GY, P1; SIMPSON JL, 1986, JAMA-J AM MED ASSOC, V256, P1938; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V269, P357; SIMPSON JL, 1993, SPORTS MED, V16, P305, DOI 10.2165/00007256-199316050-00002; Stephenson J, 1996, JAMA-J AM MED ASSOC, V276, P177, DOI 10.1001/jama.276.3.177	21	43	43	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1568	1569		10.1001/jama.284.12.1568	http://dx.doi.org/10.1001/jama.284.12.1568			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000653				2022-12-28	WOS:000089379700035
J	Arnold, JJ; Sarks, SH				Arnold, JJ; Sarks, SH			Extracts from "Clinical evidence" - Age related macular degeneration	BRITISH MEDICAL JOURNAL			English	Review							SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; RETINAL-PIGMENT EPITHELIUM; LASER PHOTOCOAGULATION; GEOGRAPHIC ATROPHY; RADIATION-THERAPY; RANDOMIZED TRIAL; MACULOPATHY; PREVALENCE; EYE		Aberdeen Royal Hosp NHS Trust, Aberdeen, Scotland; Prince Wales Med Res Inst, Randwick, NSW, Australia	Prince Wales Medical Research Institute	Arnold, JJ (corresponding author), Aberdeen Royal Hosp NHS Trust, Aberdeen, Scotland.							Arnold J, 1997, GRAEF ARCH CLIN EXP, V235, P208, DOI 10.1007/BF00941761; BARONDES MJ, 1992, BRIT J OPHTHALMOL, V76, P5, DOI 10.1136/bjo.76.1.5; Bergink GJ, 1998, GRAEF ARCH CLIN EXP, V236, P321, DOI 10.1007/s004170050085; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bressler NM, 1996, ARCH OPHTHALMOL-CHIC, V114, P1456, DOI 10.1001/archopht.1996.01100140654002; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; BRESSLER SB, 1994, ARCH OPHTHALMOL-CHIC, V112, P1176; Char DH, 1999, AM J OPHTHALMOL, V127, P574, DOI 10.1016/S0002-9394(99)00038-0; Ciulla TA, 1998, SURV OPHTHALMOL, V43, P134, DOI 10.1016/S0039-6257(98)00014-9; COSCAS G, 1991, ARCH OPHTHALMOL-CHIC, V109, P1258, DOI 10.1001/archopht.1991.01080090082028; Finger PT, 1996, OPHTHALMOLOGY, V103, P878, DOI 10.1016/S0161-6420(96)30592-7; Guyer DR, 1997, ARCH OPHTHALMOL-CHIC, V115, P865; Hart PM, 1996, BRIT J OPHTHALMOL, V80, P1046, DOI 10.1136/bjo.80.12.1046; HAWKINS BS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1200; HAWKINS BS, 1991, ARCH OPHTHALMOL-CHIC, V109, P1109; HAWKINS BS, 1986, ARCH OPHTHALMOL-CHIC, V104, P694; Holz FG, 1999, OPHTHALMOLOGY, V106, P2239; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Lewis H, 1997, OPHTHALMOLOGY, V104, P1847, DOI 10.1016/S0161-6420(97)30018-9; Maguire MG, 1997, ARCH OPHTHALMOL-CHIC, V115, P741; MAGUIRE MG, 1994, ARCH OPHTHALMOL-CHIC, V112, P489; MAGUIRE MG, 1994, ARCH OPHTHALMOL-CHIC, V112, P480; MAGUIRE P, 1986, AM J OPHTHALMOL, V102, P621, DOI 10.1016/0002-9394(86)90535-0; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Pieramici D J, 1998, Curr Opin Ophthalmol, V9, P38, DOI 10.1097/00055735-199806000-00007; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; SCHACHAT AP, 1994, ARCH OPHTHALMOL-CHIC, V112, P500; Spaide RF, 1999, OPHTHALMOLOGY, V106, P2254, DOI 10.1016/S0161-6420(99)90524-9; STERNBERG P, 1991, ARCH OPHTHALMOL-CHIC, V109, P1242; Sternberg P, 1996, ARCH OPHTHALMOL-CHIC, V114, P400; THOMAS MA, 1994, OPHTHALMOLOGY, V101, P1384; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Willan AR, 1996, CAN J OPHTHALMOL, V31, P11	34	19	24	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					741	744		10.1136/bmj.321.7263.741	http://dx.doi.org/10.1136/bmj.321.7263.741			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999909	Green Published			2022-12-28	WOS:000089546600029
J	Lin, SJ; Defossez, PA; Guarente, L				Lin, SJ; Defossez, PA; Guarente, L			Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae	SCIENCE			English	Article							GENE-EXPRESSION; YEAST; PATHWAY; RAS; MECHANISMS; COMPLEX; MUTANTS; STRESS	Calorie restriction extends Life-span in a wide variety of organisms. Although it has been suggested that calorie restriction may work by reducing the levels of reactive oxygen species produced during respiration. the mechanism by which this regimen slows aging is uncertain. Here, we mimicked calorie restriction in yeast by physiological or genetic means and showed a substantial extension in Life-span. This extension was not observed in strains mutant for SIR2 (which encodes the silencing protein Sir2p) or NPT1 (a gene in a pathway in the synthesis of NAD, the oxidized form of nicotinamide adenine dinucleotide), These findings suggest that the increased longevity induced by calorie restriction requires the activation of Sir2p by NAD.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Defossez, Pierre-Antoine/0000-0002-6463-9263	NATIONAL INSTITUTE ON AGING [F32AG005857] Funding Source: NIH RePORTER; NIA NIH HHS [5-F32-AG05857-02] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BROACH JR, 1991, TRENDS GENET, V7, P28, DOI 10.1016/0168-9525(91)90018-L; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Grubmeyer CT, 1999, METHOD ENZYMOL, V308, P28; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lin S.-T., UNPUB; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Rajavel M, 1998, BIOCHEMISTRY-US, V37, P4181, DOI 10.1021/bi9720134; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; WALSH RB, 1983, J BACTERIOL, V154, P1002, DOI 10.1128/JB.154.2.1002-1004.1983; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; YU BP, 1994, MODULATION AGING PRO	24	1383	1443	4	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2126	2128		10.1126/science.289.5487.2126	http://dx.doi.org/10.1126/science.289.5487.2126			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000115				2022-12-28	WOS:000089430900045
J	Turner, GC; Varshavsky, A				Turner, GC; Varshavsky, A			Detecting and measuring cotranslational protein degradation in vivo	SCIENCE			English	Article							N-END RULE; SACCHAROMYCES-CEREVISIAE; IN-VITRO; UBIQUITIN; PROTEASOME	Nascent polypeptides emerging from the ribosome and not yet folded may at Least transiently present degradation signals similar to those recognized by the ubiquitin system in misfolded proteins. The ubiquitin sandwich technique was used to detect and measure cotranslational protein degradation in living cells. More than 50 percent of nascent protein molecules bearing an amino-terminal degradation signal can be degraded cotranslationally, never reaching their mature size before their destruction by processive proteolysis. Thus, the folding of nascent proteins, including abnormal ones, may be in kinetic competition with pathways that target these proteins for degradation cotranslationally.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.			Turner, Glenn/0000-0002-5341-2784				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Liao W, 1998, J BIOL CHEM, V273, P27225, DOI 10.1074/jbc.273.42.27225; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Spirin A, 1986, RIBOSOME STRUCTURE P; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5	19	201	205	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2117	2120		10.1126/science.289.5487.2117	http://dx.doi.org/10.1126/science.289.5487.2117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000112				2022-12-28	WOS:000089430900042
J	Lerner, LS				Lerner, LS			Good and bad science in US schools - One-third of US states have unsatisfactory standards for teaching evolution.	NATURE			English	Editorial Material									Calif State Univ Long Beach, Long Beach, CA 90840 USA	California State University System; California State University Long Beach	Lerner, LS (corresponding author), Calif State Univ Long Beach, Long Beach, CA 90840 USA.								0	26	27	1	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					287	290		10.1038/35030204	http://dx.doi.org/10.1038/35030204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014166				2022-12-28	WOS:000089390700019
J	Loder, N				Loder, N			UK advised to step up asteroid hunt	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					275	275		10.1038/35030368	http://dx.doi.org/10.1038/35030368			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014152	Bronze			2022-12-28	WOS:000089390700004
J	Gazzaniga, MS				Gazzaniga, MS			Neuroscience - Regional differences in cortical organization	SCIENCE			English	Editorial Material									Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College	Gazzaniga, MS (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA.							ALLMAN JM, 1999, EVOLVING BRAINS, V68; BLOOM FE, 1997, HDB CHEM NEUROANAT 1, V13; BLOOM FE, 1999, HDB CHEM NEUROANAT 3, V15; BLOOM FE, 1998, HDB CHEM NEUROANAT 2, V14; BRODMANN K, 1960, SOME PAPERS CEREBRAL; BROWN VR, COMMUNICATION; GALLISTEL R, 2000, NEW COGNITIVE NEUROS; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; HAYES TL, 1995, BRAIN LANG, V49, P289, DOI 10.1006/brln.1995.1035; Hutsler JJ, 1996, CEREB CORTEX, V6, P260, DOI 10.1093/cercor/6.2.260; PIACENTINI JC, 1988, CLIN PSYCHOL REV, V8, P595, DOI 10.1016/0272-7358(88)90083-9; SINGER W, 1991, PATTERN RECOGNITION	12	12	14	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1887	1888		10.1126/science.289.5486.1887	http://dx.doi.org/10.1126/science.289.5486.1887			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	11012363				2022-12-28	WOS:000089355800029
J	Gigant, B; Curmi, PA; Martin-Barbey, C; Charbaut, E; Lachkar, S; Lebeau, L; Siavoshian, S; Sobel, A; Knossow, M				Gigant, B; Curmi, PA; Martin-Barbey, C; Charbaut, E; Lachkar, S; Lebeau, L; Siavoshian, S; Sobel, A; Knossow, M			The 4 angstrom X-ray structure of a tubulin : stathmin-like domain complex	CELL			English	Article							MICROTUBULE-DESTABILIZING ACTIVITY; NEURON-ENRICHED PHOSPHOPROTEIN; MOLECULAR REPLACEMENT; PROTEIN SCG10; DOUBLE RINGS; IN-VITRO; PHOSPHORYLATION; DYNAMICS; ONCOPROTEIN-18; GROWTH	Phosphoproteins of the stathmin family interact with the alpha beta tubulin heterodimer (tubulin) and hence interfere with microtubule dynamics. The structure of the complex of GDP-tubulin with the stathmin-like domain of the neural protein RB3 reveals a head-to-tail assembly of two tubulins with a 91-residue RB3 alpha helix in which each copy of an internal duplicated sequence interacts with a different tubulin. As a result of the relative orientations adopted by tubulins and by their alpha and beta subunits, the tubulin:RB3 complex forms a curved structure. The RB3 helix thus most likely prevents incorporation of tubulin into microtubules by holding it in an assembly with a curvature very similar to that of the depolymerization products of microtubules.	Lab Enzymol & Biochim Struct, CNRS, UPR 9063, F-91198 Gif Sur Yvette, France; Inst Fer Moulin, INSERM, U440, F-75005 Paris, France; Fac Pharm, CNRS, UMR 7514, F-67401 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Knossow, M (corresponding author), Lab Enzymol & Biochim Struct, CNRS, UPR 9063, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	knossow@lebs.cnrs-gif.fr	CURMI, Patrick/G-4036-2013; Lebeau, Luc/M-9964-2019	CURMI, Patrick A./0000-0001-5045-8501; Gigant, Benoit/0000-0002-5946-6759; Lebeau, Luc/0000-0002-3276-6727				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; CURMI PA, 1994, BIOCHEM J, V300, P331, DOI 10.1042/bj3000331; DIAZ JF, 1994, J MOL BIOL, V238, P214, DOI 10.1006/jmbi.1994.1282; DiPaolo G, 1997, FEBS LETT, V416, P149, DOI 10.1016/S0014-5793(97)01188-5; DOYE V, 1989, J BIOL CHEM, V264, P12134; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gavet O, 1998, J CELL SCI, V111, P3333; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; HAILAT N, 1990, ONCOGENE, V5, P1615; Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Larsson NL, 1999, MOL CELL BIOL, V19, P2242; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MAUCUER A, 1990, FEBS LETT, V264, P275, DOI 10.1016/0014-5793(90)80266-L; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; MELKI R, 1989, BIOCHEMISTRY-US, V28, P9143, DOI 10.1021/bi00449a028; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; NAVAZA J, 1995, ACTA CRYSTALLOGR A, V51, P445, DOI 10.1107/S0108767394011335; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Redeker V, 2000, J BIOL CHEM, V275, P6841, DOI 10.1074/jbc.275.10.6841; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; SOBEL A, 1989, J BIOL CHEM, V264, P3765; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; Wallon G, 2000, EMBO J, V19, P213, DOI 10.1093/emboj/19.2.213	43	211	217	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					809	816		10.1016/S0092-8674(00)00069-6	http://dx.doi.org/10.1016/S0092-8674(00)00069-6			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030624	Bronze			2022-12-28	WOS:000089395200012
J	Johnson, AE; Haigh, NG				Johnson, AE; Haigh, NG			The ER translocon and retrotranslocation: Is the shift into reverse manual or automatic?	CELL			English	Review							ENDOPLASMIC-RETICULUM; PROTEIN-DEGRADATION; PROTEASOME; MEMBRANE		Texas A&M Univ, Dept Med Biochem & Genet, College Stn, TX 77843 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Univ, Dept Med Biochem & Genet, College Stn, TX 77843 USA.		Johnson, Arthur E/G-3457-2012					Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Johnson CH, 1999, YEAST, V15, P799, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;799::AID-YEA419&gt;3.0.CO;2-N; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Romisch K, 1999, J CELL SCI, V112, P4185; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilson CM, 2000, J BIOL CHEM, V275, P21224, DOI 10.1074/jbc.M000567200; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	17	68	70	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					709	712		10.1016/S0092-8674(00)00059-3	http://dx.doi.org/10.1016/S0092-8674(00)00059-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030614	Bronze			2022-12-28	WOS:000089395200002
J	Davies, KG				Davies, KG			Creative tension - What links Aristotle, William Blake, Darwin and GM crops?	NATURE			English	Editorial Material									IACR Rothamsted, Dept Entomol & Nematol, Harpenden AL5 2JQ, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Davies, KG (corresponding author), IACR Rothamsted, Dept Entomol & Nematol, Harpenden AL5 2JQ, Herts, England.			Davies, Keith/0000-0001-6060-2394					0	8	8	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					135	135		10.1038/35025156	http://dx.doi.org/10.1038/35025156			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001034	Bronze			2022-12-28	WOS:000089241000023
J	Glotzer, JB; Saltik, M; Chiocca, S; Michou, AI; Moseley, P; Cotten, M				Glotzer, JB; Saltik, M; Chiocca, S; Michou, AI; Moseley, P; Cotten, M			Activation of heat-shock response by an adenovirus is essential for virus replication	NATURE			English	Article							SIMIAN-VIRUS-40 LARGE-T; VIRAL-DNA REPLICATION; ESCHERICHIA-COLI; HUMAN HSP70; J-DOMAIN; TRANSCRIPTIONAL ACTIVATION; HUMAN CYTOMEGALOVIRUS; PROTEIN HSP70; CELL-LINE; GENE	Successful viral infection requires viruses to redirect host biochemistry to replicate the viral genome, and produce and assemble progeny virions. Cellular heat-shock responses, which are characterized as elevation and relocalization of heat-shock proteins, occur during replication of many viruses(1-7). Such responses might be host reactions to the synthesis of foreign protein, or might be irrelevant consequences of the viral need to activate transcription. Alternatively, as heat-shock proteins can facilitate protein folding(8,9), activating a heat-shock response might be a specific virus function ensuring proper synthesis of viral proteins and virions. It is not possible to determine whether heat-shock response is essential for virus replication, because the implicated viral genes (such as Ad5 E1A, ref. 10) also control other essential replication steps. Here we report that expression of Gam1, a protein encoded by the avian virus CELO (ref. 11), elevates and relocalizes hsp70 and hsp40. Gam1-negative CELO is replication-defective; however, Gam1 function can be partially replaced by either heat shock or forced hsp40 expression. Thus, an essential function of Gam1 during virus replication is to activate host heat-shock responses with hsp40 as a primary target.	Inst Mol Pathol, A-1030 Vienna, Austria; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); IRCCS European Institute of Oncology (IEO); University of New Mexico	Cotten, M (corresponding author), Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Chiocca, Susanna/AAC-8863-2019; Chiocca, Susanna/K-5233-2016	Chiocca, Susanna/0000-0002-9721-0850; Cotten, Matthew/0000-0002-3361-3351; Moseley, Pope/0000-0002-3723-9950				Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chiocca S, 1997, J VIROL, V71, P3168, DOI 10.1128/JVI.71.4.3168-3177.1997; Chiocca S, 1996, J VIROL, V70, P2939, DOI 10.1128/JVI.70.5.2939-2949.1996; COLLINS PL, 1982, J VIROL, V44, P703, DOI 10.1128/JVI.44.2.703-707.1982; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HATTORI H, 1992, CELL STRUCT FUNCT, V17, P77, DOI 10.1247/csf.17.77; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; KAO HT, 1983, MOL CELL BIOL, V3, P2058, DOI 10.1128/MCB.3.11.2058; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; KOBAYASHI K, 1994, MICROBIOL IMMUNOL, V38, P321, DOI 10.1111/j.1348-0421.1994.tb01785.x; Liu JS, 1998, J BIOL CHEM, V273, P30704, DOI 10.1074/jbc.273.46.30704; Mayer MP, 1998, BIOL CHEM, V379, P261; Michou AI, 1999, J VIROL, V73, P1399, DOI 10.1128/JVI.73.2.1399-1410.1999; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; NEVINS JR, 1982, CELL, V29, P913, DOI 10.1016/0092-8674(82)90453-6; Ohgitani E, 1999, J GEN VIROL, V80, P63, DOI 10.1099/0022-1317-80-1-63; OHTSUKA K, 1993, BIOCHEM BIOPH RES CO, V197, P235, DOI 10.1006/bbrc.1993.2466; PHILLIPS B, 1991, J VIROL, V65, P5680, DOI 10.1128/JVI.65.11.5680-5692.1991; POLISSI A, 1995, FEMS MICROBIOL REV, V17, P159; SANTOMENNA LD, 1990, J VIROL, V64, P2033, DOI 10.1128/JVI.64.5.2033-2040.1990; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; Stubdal H, 1997, MOL CELL BIOL, V17, P4979, DOI 10.1128/MCB.17.9.4979; WELCH WJ, 1984, J BIOL CHEM, V259, P4501	30	145	152	2	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					207	211		10.1038/35025102	http://dx.doi.org/10.1038/35025102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001061				2022-12-28	WOS:000089241000053
J	Rubin, EM; Tall, A				Rubin, EM; Tall, A			Perspectives for vascular genomics	NATURE			English	Article							BINDING CASSETTE TRANSPORTER-1; TANGIER-DISEASE; CARDIOVASCULAR DEVELOPMENT; HEMATOPOIETIC LINEAGES; INSULIN-RESISTANCE; APOLIPOPROTEIN-E; DEFICIENT MICE; GENE-PRODUCT; ATHEROSCLEROSIS; ZEBRAFISH	Diseases of the vascular system result from a complex mixture of genetic and environmental factors. Data sets, technologies and strategies emanating from the human genome programme have been applied to the analysis of both rare single-gene and common multigenic vascular disorders. Genomic approaches including inter- and intraspecies sequence comparisons, genotyping with dense marker sets spanning the genome, large-scale mutagenesis screens of model organisms, and genome-wide expression profiling have all begun to contribute to the identification of new genes and mechanisms that are central to cardiovascular disease processes.	Univ Calif Berkeley, Lawrence Berkeley Lab, Genome Sci Dept, Berkeley, CA 94720 USA; Columbia Univ Coll Phys & Surg, Dept Med, Div Mol Med, New York, NY 10032 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Columbia University	Rubin, EM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genome Sci Dept, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	emrubin@lbl.gov	Tall, Alan/AAT-8528-2021					Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Friddle CJ, 2000, P NATL ACAD SCI USA, V97, P6745, DOI 10.1073/pnas.100127897; Gelfand MS, 2000, NUCLEIC ACIDS RES, V28, P695, DOI 10.1093/nar/28.3.695; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hayden MR, 2000, CURR OPIN LIPIDOL, V11, P117, DOI 10.1097/00041433-200004000-00003; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; Koonin EV, 1997, CURR OPIN GENET DEV, V7, P757, DOI 10.1016/S0959-437X(97)80037-8; KREUTZ R, 1995, P NATL ACAD SCI USA, V92, P8778, DOI 10.1073/pnas.92.19.8778; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; LEE RKK, 1994, DEVELOPMENT, V120, P3361; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MAYOR C, IN PRESS BIOINFORMAT; Mu JL, 1999, J LIPID RES, V40, P1328; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Rust S, 1998, NAT GENET, V20, P312, DOI 10.1038/3134; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STAINIER DYR, 1993, DEVELOPMENT, V119, P31; Stanton LW, 2000, CIRC RES, V86, P939, DOI 10.1161/01.RES.86.9.939; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; 1999, NATURE GENET S, V21, P1	43	35	36	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					265	269		10.1038/35025236	http://dx.doi.org/10.1038/35025236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001070				2022-12-28	WOS:000089241000063
J	Baron, R				Baron, R			Capsaicin and nociception: from basic mechanisms to novel drugs	LANCET			English	Editorial Material							INDUCED SECONDARY HYPERALGESIA; POSTHERPETIC NEURALGIA; TOPICAL CAPSAICIN; EVOKED PAIN; ALLODYNIA; RECEPTOR; TRIAL		Univ Kiel, Neurol Klin, D-24105 Kiel, Germany	University of Kiel	Baron, R (corresponding author), Univ Kiel, Neurol Klin, D-24105 Kiel, Germany.		Baron, Ralf/E-4298-2010					Baron R, 2000, BRAIN RES, V871, P75, DOI 10.1016/S0006-8993(00)02444-6; Baron R, 1999, NEUROLOGY, V53, P548, DOI 10.1212/WNL.53.3.548; BARON R, 1993, BRAIN, V116, P1477, DOI 10.1093/brain/116.6.1477; Baron R, 1999, NEUROLOGY, V52, P923, DOI 10.1212/WNL.52.5.923; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DONOFRIO P, 1991, ARCH INTERN MED, V151, P2225; Fields HL, 1998, NEUROBIOL DIS, V5, P209, DOI 10.1006/nbdi.1998.0204; Iadarola MJ, 1998, BRAIN, V121, P931, DOI 10.1093/brain/121.5.931; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; PARK KM, 1995, PAIN, V63, P163, DOI 10.1016/0304-3959(95)00029-R; Robbins WR, 1998, ANESTH ANALG, V86, P579, DOI 10.1097/00000539-199803000-00027; Sterner O, 1999, TRENDS PHARMACOL SCI, V20, P459, DOI 10.1016/S0165-6147(99)01393-0; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; WATSON CPN, 1993, CLIN THER, V15, P510; WATSON CPN, 1992, PAIN, V51, P375, DOI 10.1016/0304-3959(92)90223-X	18	37	38	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2000	356	9232					785	787		10.1016/S0140-6736(00)02649-0	http://dx.doi.org/10.1016/S0140-6736(00)02649-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022922				2022-12-28	WOS:000089101800005
J	Ma, YC; Huang, JY; All, S; Lowry, W; Huang, XY				Ma, YC; Huang, JY; All, S; Lowry, W; Huang, XY			Src tyrosine kinase is a novel direct effector of G proteins	CELL			English	Article							BETA-GAMMA-SUBUNITS; ADENYLYL-CYCLASE; CRYSTAL-STRUCTURE; MAP KINASE; C-SRC; COUPLED RECEPTORS; ALPHA-SUBUNITS; FAMILY KINASES; FIBROBLAST TRANSFORMATION; REGULATORY INTERACTIONS	Heterotrimeric G proteins transduce signals from cell surface receptors to modulate the activity of cellular effecters. Src, the product of the first characterized proto-oncogene and the first identified protein tyrosine kinase, plays a critical role in the signal transduction of G protein-coupled receptors. However, the mechanism of biochemical regulation of Src by G proteins is not known. Here we demonstrate that G alpha s and G alpha i, but neither G alpha q, G alpha 12 nor G beta gamma, directly stimulate the kinase activity of downregulated c-Src. G alpha s and G alpha i similarly modulate Hck, another member of Src-family tyrosine kinases. G alpha s and G alpha i bind to the catalytic domain and change the conformation of Src, leading to increased accessibility of the active site to substrates. These data demonstrate that the Src family tyrosine kinases are direct effecters of G proteins.	Cornell Univ, Coll Med, Dept Physiol, New York, NY 10021 USA	Cornell University	Huang, XY (corresponding author), Cornell Univ, Coll Med, Dept Physiol, New York, NY 10021 USA.			Ma, Yongchao/0000-0002-2469-4356	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014563] Funding Source: NIH RePORTER; NIA NIH HHS [AG14563] Funding Source: Medline; NIGMS NIH HHS [GM56904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIHO H, 1993, ARCH BIOCHEM BIOPHYS, V304, P235, DOI 10.1006/abbi.1993.1344; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; Boerner RJ, 1996, BIOCHEMISTRY-US, V35, P9519, DOI 10.1021/bi960248u; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; BUSHMAN WA, 1990, P NATL ACAD SCI USA, V87, P7462, DOI 10.1073/pnas.87.19.7462; CHEN YH, 1994, J BIOL CHEM, V269, P27372; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Grishina G, 1997, J BIOL CHEM, V272, P20619, DOI 10.1074/jbc.272.33.20619; Gu CH, 2000, J BIOL CHEM, V275, P20726, DOI 10.1074/jbc.M000152200; GUPTA SK, 1992, MOL CELL BIOL, V12, P190, DOI 10.1128/MCB.12.1.190; GUPTA SK, 1992, J BIOL CHEM, V267, P7987; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HAUSDORFF WP, 1992, P NATL ACAD SCI USA, V89, P5720, DOI 10.1073/pnas.89.13.5720; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Kleuss C, 1997, P NATL ACAD SCI USA, V94, P6116, DOI 10.1073/pnas.94.12.6116; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LANGHANSRAJASEKARAN SA, 1995, P NATL ACAD SCI USA, V92, P8601, DOI 10.1073/pnas.92.19.8601; LEE E, 1994, METHOD ENZYMOL, V237, P146; LINDER ME, 1991, J BIOL CHEM, V266, P4654; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Ma YC, 1998, P NATL ACAD SCI USA, V95, P12197, DOI 10.1073/pnas.95.21.12197; MAGUIRE ME, 1980, J BIOL CHEM, V255, P1030; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; MOYERS JS, 1995, BIOCHEM J, V305, P411, DOI 10.1042/bj3050411; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; NEER EJ, 1985, P NATL ACAD SCI USA, V82, P6025, DOI 10.1073/pnas.82.18.6025; PACE AM, 1991, P NATL ACAD SCI USA, V88, P7031, DOI 10.1073/pnas.88.16.7031; PACE AM, 1995, MOL BIOL CELL, V6, P1685, DOI 10.1091/mbc.6.12.1685; Postma FR, 1998, J CELL BIOL, V140, P1199, DOI 10.1083/jcb.140.5.1199; PTASZNIK A, 1995, J BIOL CHEM, V270, P19969, DOI 10.1074/jbc.270.34.19969; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; Schieffer B, 1996, J BIOL CHEM, V271, P10329, DOI 10.1074/jbc.271.17.10329; Schieffer B, 1997, AM J PHYSIOL-CELL PH, V272, pC2019, DOI 10.1152/ajpcell.1997.272.6.C2019; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Simonson MS, 1996, J BIOL CHEM, V271, P77, DOI 10.1074/jbc.271.1.77; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Sondhi D, 1998, BIOCHEMISTRY-US, V37, P165, DOI 10.1021/bi9722960; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Sun GQ, 1998, ONCOGENE, V17, P1587, DOI 10.1038/sj.onc.1202076; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TORTI M, 1992, BIOCHEM BIOPH RES CO, V186, P440, DOI 10.1016/S0006-291X(05)80827-7; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Wan Y, 1997, J BIOL CHEM, V272, P17209, DOI 10.1074/jbc.272.27.17209; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wolfgang WJ, 1996, P NATL ACAD SCI USA, V93, P14542, DOI 10.1073/pnas.93.25.14542; WONG TW, 1984, J BIOL CHEM, V259, P3127; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0	74	360	362	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					635	646		10.1016/S0092-8674(00)00086-6	http://dx.doi.org/10.1016/S0092-8674(00)00086-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007482	Bronze			2022-12-28	WOS:000089105200012
J	Lara-Tejero, M; Galan, JE				Lara-Tejero, M; Galan, JE			A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein	SCIENCE			English	Article							CYTOLETHAL DISTENDING TOXIN; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; SALMONELLA-TYPHIMURIUM; CAMPYLOBACTER-JEJUNI; HAEMOPHILUS-DUCREYI; CLONING; GENES; CDT	Many bacterial pathogens encode a multisubunit toxin, termed cytolethal distending toxin (CDT), that induces cell cycle arrest, cytoplasm distention, and, eventually, chromatin fragmentation and cell death. In one such pathogen, Campylobacter jejuni, one of the subunits of this toxin, CdtB, was shown to exhibit features of type I deoxyribonucleases. Transient expression of this subunit in cultured cells caused marked chromatin disruption. Microinjection of Low amounts of CdtB induced cytoplasmic distention and cell cycle arrest. CdtB mutants with substitutions in residues equivalent to those required for catalysis or magnesium binding in type I deoxyribonucleases did not cause chromatin disruption. CDT holotoxin containing these mutant forms of CdtB did not induce morphological changes or cell cycle arrest.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yate.edu						Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Cope LD, 1997, P NATL ACAD SCI USA, V94, P4056, DOI 10.1073/pnas.94.8.4056; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Evans SJ, 1999, BIOCHEMISTRY-US, V38, P3902, DOI 10.1021/bi9824893; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P115, DOI 10.1016/0882-4010(88)90053-8; Jones SJ, 1996, J MOL BIOL, V264, P1154, DOI 10.1006/jmbi.1996.0703; Liu QY, 1999, ANN NY ACAD SCI, V887, P60, DOI 10.1111/j.1749-6632.1999.tb07922.x; Mayer MPA, 1999, INFECT IMMUN, V67, P1227, DOI 10.1128/IAI.67.3.1227-1237.1999; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; OKUDA J, 1995, MICROB PATHOGENESIS, V18, P167, DOI 10.1016/S0882-4010(95)90022-5; Peres SY, 1997, MOL MICROBIOL, V24, P1095, DOI 10.1046/j.1365-2958.1997.4181785.x; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; PICKETT CL, 1994, INFECT IMMUN, V62, P1046, DOI 10.1128/IAI.62.3.1046-1051.1994; Pickett CL, 1996, INFECT IMMUN, V64, P2070, DOI 10.1128/IAI.64.6.2070-2078.1996; SCOTT DA, 1994, INFECT IMMUN, V62, P244, DOI 10.1128/IAI.62.1.244-251.1994; Sert V, 1999, ONCOGENE, V18, P6296, DOI 10.1038/sj.onc.1203007; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Young VB, 2000, INFECT IMMUN, V68, P184, DOI 10.1128/IAI.68.1.184-191.2000; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	27	398	411	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2000	290	5490					354	357		10.1126/science.290.5490.354	http://dx.doi.org/10.1126/science.290.5490.354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030657				2022-12-28	WOS:000089818100049
J	Hayday, A; Viney, JL				Hayday, A; Viney, JL			The ins and outs of body surface immunology	SCIENCE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; T-CELL ACTIVATION; DENDRITIC CELLS; PEYERS-PATCHES; ORAL TOLERANCE; INDUCTION; IMMUNITY; RECEPTOR; ANTIGEN; VIVO	Rather than being confined to the secondary Lymphoid tissue of the spleen and Lymph nodes, Large numbers of Lymphocytes are intrinsically associated with the epithelial surfaces of the body. The best studied is gut-associated Lymphoid tissue, but distinct epithelium-associated Lymphoid tissue also exists in the reproductive tract, the Lung, and the skin. The multiple cell types and functions composing these Lymphoid tissues are increasingly seen as the key to how antigens delivered to body surfaces can elicit either immunogenic or tolerogenic responses. In some instances, these responses occur purely within the local body surface tissue, yet in other cases both Local and systemic responses are elicited.	Univ London, Guys Hosp, Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England; Immunex Res & Dev Corp, Dept Immunobiol, Seattle, WA 98101 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Hayday, A (corresponding author), Univ London, Guys Hosp, Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793				Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Boismenu R, 1996, J IMMUNOL, V157, P985; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cosman D, 2000, FASEB J, V14, pA1018; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; Gordon J, 2000, IMMUNOLOGY, V100, P269, DOI 10.1046/j.1365-2567.2000.00074.x; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groux H, 1999, IMMUNOL TODAY, V20, P442, DOI 10.1016/S0167-5699(99)01510-8; Gutgemann I, 1998, IMMUNITY, V8, P667, DOI 10.1016/S1074-7613(00)80571-3; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; Hoyne GF, 2000, IMMUNOLOGY, V100, P281, DOI 10.1046/j.1365-2567.2000.00073.x; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Lee HO, 2000, GASTROENTEROLOGY, V119, P129, DOI 10.1053/gast.2000.8542; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Lin TS, 1999, J CLIN INVEST, V104, P1297, DOI 10.1172/JCI7437; Liu LM, 1998, J IMMUNOL, V161, P1146; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; Mellor AL, 2000, ANNU REV IMMUNOL, V18, P367, DOI 10.1146/annurev.immunol.18.1.367; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Muller S, 2000, J IMMUNOL, V164, P1986, DOI 10.4049/jimmunol.164.4.1986; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Opal SM, 1998, CLIN INFECT DIS, V27, P1497, DOI 10.1086/515032; Poussier P, 2000, GASTROENTEROLOGY, V118, P880, DOI 10.1016/S0016-5085(00)70174-0; RAMSBURG E, UNPUB; REYNAUD CA, 1991, CELL, V64, P995, DOI 10.1016/0092-8674(91)90323-Q; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Ruedl C, 1996, EUR J IMMUNOL, V26, P1801, DOI 10.1002/eji.1830260821; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Shiohara T, 1996, J EXP MED, V183, P1483, DOI 10.1084/jem.183.4.1483; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Steele CR, 2000, CURR BIOL, V10, pR282, DOI 10.1016/S0960-9822(00)00408-5; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Sun JR, 1999, J IMMUNOL, V162, P5868; Viney JL, 1998, J IMMUNOL, V160, P5815; Williamson E, 1999, IMMUNOLOGY, V97, P565; Williamson E, 1999, J IMMUNOL, V163, P3668	49	37	51	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					97	100		10.1126/science.290.5489.97	http://dx.doi.org/10.1126/science.290.5489.97			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021807				2022-12-28	WOS:000089724800040
J	Hurwitz, ES; Haber, M; Chang, A; Shope, T; Teo, S; Ginsberg, M; Waecker, N; Cox, NJ				Hurwitz, ES; Haber, M; Chang, A; Shope, T; Teo, S; Ginsberg, M; Waecker, N; Cox, NJ			Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY ILLNESS; OTITIS-MEDIA; INFECTIONS; ATTENDANCE	Context A growing proportion of young children in the United States participate in day care, and these children are considered to be at high risk for influenza infection. Whether vaccinating day care children reduces household transmission of influenza is not known. Objective To evaluate the effect of vaccinating day care children on reducing influenza-related morbidity among their household contacts. Design Single-blind, randomized controlled trial conducted during the 1996-1997 influenza season. Setting Ten day care centers for children of US Navy personnel in San Diego, Calif. Participants A total of 149 day care attendees (aged 24-60 months) and their families were randomized; 127 children and their 328 household contacts received 2 vaccine doses and were included in the analysis. Interventions Inactivated influenza vaccine was administered to 60 children with 162 household contacts, and hepatitis A vaccine as a control was administered to 67 age-matched children with 166 household contacts. Main Outcome Measures Information regarding febrile respiratory illnesses and related morbidity for household contacts of influenza-vaccinated vs control children (subgrouped by influenza-vaccinated and unvaccinated contacts), obtained by telephone interviews with parents every 2 weeks from November 1996 through April 1997, Results Influenza-unvaccinated household contacts (n=120) of influenza-vaccinated day care children had 42% fewer febrile respiratory illnesses (P=.04) compared with unvaccinated household contacts of control children. Among school-aged household contacts (aged 5-17 years), there was an 80% reduction among contacts of vaccinated children (n=28) vs contacts of unvaccinated children (n=31) in febrile respiratory illnesses (P=.01), as well as reductions of more than 70% in school days missed (P=.02), reported earaches (P=.02), physician visits (P=.007), physician-prescribed antibiotics (P=.02), and adults who missed work to take care of ill children (P=.04), Conclusions These results indicate that vaccinating day care children against influenza helps reduce influenza-related morbidity among their household contacts, particularly among school-aged contacts. Future studies should be conducted in civilian populations to assess the full effect of vaccinating day care children against influenza.	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA; San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; USN, Dept Pediat, Med Ctr, San Diego, CA 92152 USA; San Diego Cty Hlth Dept, San Diego, CA USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; California State University System; San Diego State University; United States Department of Defense; United States Navy	Hurwitz, ES (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd NE,MS A-39, Atlanta, GA 30333 USA.			Shope, Timothy/0000-0002-0974-2639				BELL DM, 1989, AM J PUBLIC HEALTH, V79, P479, DOI 10.2105/AJPH.79.4.479; CLEMENTS DA, 1995, ARCH PEDIAT ADOL MED, V149, P1113, DOI 10.1001/archpedi.1995.02170230067009; DAWSON DA, 1990, CHILD CARE ARRANGEME; DOYLE A, 1976, PEDIATRICS, V59, P607; FLEMING DW, 1987, PEDIATRICS, V79, P55; HEIKKINEN T, 1991, AM J DIS CHILD, V145, P445, DOI 10.1001/archpedi.1991.02160040103017; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Hurwitz ES, 2000, J INFECT DIS, V182, P1218, DOI 10.1086/315820; HURWITZ ES, 1991, PEDIATRICS, V87, P62; HURWITZ ES, 1996, INT C ANT AG CHEM SE; HURWITZ ES, 1998, INT C ANT AG CHEM SE; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Monto Arnold S., 1997, Journal of Infectious Diseases, V176, pS32, DOI 10.1086/514172; STRANGERT K, 1976, PEDIATRICS, V57, P191; WALD ER, 1988, J PEDIATR-US, V112, P540, DOI 10.1016/S0022-3476(88)80164-1; *WORKSH 6, 1997, J INFECT DIS S1, V176, pS85	16	225	234	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1677	1682		10.1001/jama.284.13.1677	http://dx.doi.org/10.1001/jama.284.13.1677			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015798				2022-12-28	WOS:000089501900028
J	Sobel, DS				Sobel, DS			Mind matters, money matters: The cost-effectiveness of mind/body medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MANAGEMENT		Kaiser Permanente No Calif, Oakland, CA 94612 USA	Kaiser Permanente	Sobel, DS (corresponding author), Kaiser Permanente No Calif, Oakland, CA 94612 USA.							Blumenthal JA, 1997, ARCH INTERN MED, V157, P2213, DOI 10.1001/archinte.157.19.2213; DREHER H, 1998, ADV MIND BODY MED, V14, P207; FRIEDMAN R, 1995, HEALTH PSYCHOL, V14, P509, DOI 10.1037/0278-6133.14.6.509; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; SCAFIDI FA, 1990, INFANT BEHAV DEV, V13, P167, DOI 10.1016/0163-6383(90)90029-8; Sobel DS, 2000, PROG BRAIN RES, V122, P393; WILLIAMSON P, 1981, J FAM PRACTICE, V13, P999	7	31	32	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1705	1705		10.1001/jama.284.13.1705	http://dx.doi.org/10.1001/jama.284.13.1705			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357KY	11015806	hybrid			2022-12-28	WOS:000089501900035
J	Cervero, F				Cervero, F			Visceral hyperalgesia revisited	LANCET			English	Editorial Material							PAIN		Univ Alcala de Henares, Dept Fisiol, Edificio Med, Madrid 28871, Spain	Universidad de Alcala	Cervero, F (corresponding author), Univ Alcala de Henares, Dept Fisiol, Edificio Med, Madrid 28871, Spain.							ACCARINO AM, 1995, GASTROENTEROLOGY, V108, P636, DOI 10.1016/0016-5085(95)90434-4; Cervero F, 1999, LANCET, V353, P2145, DOI 10.1016/S0140-6736(99)01306-9; Coutinho SV, 1996, BRAIN RES, V736, P7, DOI 10.1016/0006-8993(96)00661-0; GARRISON DW, 1992, PAIN, V49, P373, DOI 10.1016/0304-3959(92)90245-7; Giamberardino MA, 1999, EUR J PAIN, V3, P77, DOI 10.1053/eujp.1999.0117; Giamberardino MA, 2000, PROG PAIN RES MANAG, V16, P523; Head H, 1893, BRAIN, V16, P1, DOI DOI 10.1093/BRAIN/16.1-2.1; Hummel T, 1997, AM J PHYSIOL-REG I, V273, pR1147, DOI 10.1152/ajpregu.1997.273.3.R1147; Laird JMA, 2000, NEUROSCIENCE, V98, P345, DOI 10.1016/S0306-4522(00)00148-2; MACKENZIE J, 1909, SYMPTOMS THEIR INTER, P1; MAYER EA, 1994, GASTROENTEROLOGY, V107, P271, DOI 10.1016/0016-5085(94)90086-8; Olivar T, 1999, PAIN, V79, P67, DOI 10.1016/S0304-3959(98)00152-3; Roza C, 1998, J NEUROPHYSIOL, V79, P1603, DOI 10.1152/jn.1998.79.4.1603; Serra J, 1998, J PHYSIOL-LONDON, V506, P579, DOI 10.1111/j.1469-7793.1998.579bw.x	14	23	25	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2000	356	9236					1127	1128		10.1016/S0140-6736(00)02750-1	http://dx.doi.org/10.1016/S0140-6736(00)02750-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030288				2022-12-28	WOS:000089594300005
J	Sainsbury, R				Sainsbury, R			Towards appropriate local surgery for patients with breast cancer	LANCET			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; POSTOPERATIVE RADIOTHERAPY; IRRADIATION; LUMPECTOMY		Huddersfield Royal Infirm, Huddersfield HD3 3EA, W Yorkshire, England		Sainsbury, R (corresponding author), Huddersfield Royal Infirm, Huddersfield HD3 3EA, W Yorkshire, England.							Clark RM, 1996, J NATL CANCER I, V88, P1659, DOI 10.1093/jnci/88.22.1659; *EARL STAG BREAST, 1990, NIH CONS DEV C JUN 1, V8; Expert Advisory Group on Cancer, 1995, POL FRAM COMM CANC S; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; Fortin A, 1999, J CLIN ONCOL, V17, P101, DOI 10.1200/JCO.1999.17.1.101; Kroman N, 2000, BRIT MED J, V320, P474, DOI 10.1136/bmj.320.7233.474; Liljegren G, 1999, J CLIN ONCOL, V17, P2326, DOI 10.1200/JCO.1999.17.8.2326; *NHS BREAST SCREEN, 2000, BASO BREAST GROUP M; SAINSBURY R, 1995, BRIT J CANCER, V71, P1275, DOI 10.1038/bjc.1995.246	9	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1124	1125		10.1016/S0140-6736(00)02747-1	http://dx.doi.org/10.1016/S0140-6736(00)02747-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030285				2022-12-28	WOS:000089594300002
J	Parker, RA; Hartman, EE				Parker, RA; Hartman, EE			A 55-year-old woman with rheumatoid arthritis, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		Goldring SR, 2000, JAMA-J AM MED ASSOC, V283, P524, DOI 10.1001/jama.283.4.524	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1567	1567		10.1001/jama.284.12.1567	http://dx.doi.org/10.1001/jama.284.12.1567			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000652				2022-12-28	WOS:000089379700034
J	Trombka, JI; Squyres, SW; Bruckner, J; Boynton, WV; Reedy, RC; McCoy, TJ; Gorenstein, P; Evans, LG; Arnold, JR; Starr, RD; Nittler, LR; Murphy, ME; Mikheeva, I; McNutt, RL; McClanahan, TP; McCartney, E; Goldsten, JO; Gold, RE; Floyd, SR; Clark, PE; Burbine, TH; Bhangoo, JS; Bailey, SH; Petaev, M				Trombka, JI; Squyres, SW; Bruckner, J; Boynton, WV; Reedy, RC; McCoy, TJ; Gorenstein, P; Evans, LG; Arnold, JR; Starr, RD; Nittler, LR; Murphy, ME; Mikheeva, I; McNutt, RL; McClanahan, TP; McCartney, E; Goldsten, JO; Gold, RE; Floyd, SR; Clark, PE; Burbine, TH; Bhangoo, JS; Bailey, SH; Petaev, M			The elemental composition of asteroid 433 Eros: Results of the NEAR-Shoemaker x-ray spectrometer	SCIENCE			English	Article							RENDEZVOUS MISSION; INFRARED SPECTROMETER; MULTISPECTRAL IMAGER; TEMPERATURE; RADIATION; SPECTRUM; PLASMA	We report major element composition ratios for regions of the asteroid 433 Eros imaged during two solar flares and quiet sun conditions during the period of May to July 2000, Low aluminum abundances for all regions argue against global differentiation of Eros. Magnesium/silicon, aluminum/silicon, calcium/silicon, and iron/silicon ratios are best interpreted as a relatively primitive, chondritic composition. Marked depletions in sulfur and possible aluminum and calcium depletions, relative to ordinary chondrites, may represent signatures of Limited partial melting or impact volatilization.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Cornell Univ, Ithaca, NY 14853 USA; Max Planck Inst Chem, D-55020 Mainz, Germany; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA; Smithsonian Astrophys Observ, Cambridge, MA 02138 USA; Comp Sci Corp, Syst Sci Div, Laurel, MD 20707 USA; Univ Calif San Diego, La Jolla, CA 92093 USA; Catholic Univ Amer, Dept Phys, Washington, DC 20064 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Cornell University; Max Planck Society; University of Arizona; United States Department of Energy (DOE); Los Alamos National Laboratory; Smithsonian Institution; Smithsonian National Museum of Natural History; Harvard University; Smithsonian Institution; University of California System; University of California San Diego; Catholic University of America; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Trombka, JI (corresponding author), NASA, Goddard Space Flight Ctr, Code 691, Greenbelt, MD 20771 USA.		McNutt, Ralph L/E-8006-2010	McNutt, Ralph L/0000-0002-4722-9166; Reedy, Robert/0000-0002-2189-1303				ADLER I, 1972, ANAL CHEM, V44, pA28; Clark PE, 1997, J GEOPHYS RES-PLANET, V102, P16361, DOI 10.1029/97JE01086; CLARK PE, 1997, NASA C PUBL, P31; CLARK PE, 1979, THESIS U MARYLAND CO; Compton AH, 1935, XRAYS THEORY EXPT; FICHTEL C, 1997, NASA REF PUBL, V1386, P1; GARCIA HA, 1994, SOL PHYS, V154, P275, DOI 10.1007/BF00681100; Goldsten JO, 1997, SPACE SCI REV, V82, P169, DOI 10.1023/A:1005052720796; GORENSTEIN P, 1968, ASTROPHYS J, V153, P885, DOI 10.1086/149713; Hawkins SE, 1997, SPACE SCI REV, V82, P31, DOI 10.1023/A:1005099211710; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; KREPLIN RW, 1977, SOLAR OUTPUT ITS VAR, P287; KULLERUD G, 1963, ANN REP GEOPHYS RES, V67, P4055; McClanahan TP, 1999, NUCL INSTRUM METH A, V422, P582, DOI 10.1016/S0168-9002(98)00942-5; MCCOY TJ, IN PRESS ICARUS; MEWE R, 1972, SOL PHYS, V22, P459, DOI 10.1007/BF00148711; Mittlefehldt DW, 1998, REV MINERAL, V36, pD1; NITTLER LR, 2000, LUN PLAN SCI C, V31; NITTLER LR, 1999, ASTEROIDS COMETS MET; RAYMOND JC, 1977, ASTROPHYS J SUPPL S, V35, P419, DOI 10.1086/190486; Rubin AE, 2000, METEORIT PLANET SCI, V35, pA138; THOMAS RJ, 1985, SOL PHYS, V95, P323, DOI 10.1007/BF00152409; Trombka JI, 1997, J GEOPHYS RES-PLANET, V102, P23729, DOI 10.1029/97JE00270; TROMBKA JI, 1979, COMPUTERS ACTIVATION, P26; TROMBKA JI, 1977, NASA SPEC PUBL, P153; TUCKER WH, 1971, ASTROPHYS J, V168, P283, DOI 10.1086/151083; UREY HC, 1953, GEOCHIM COSMOCHIM AC, V4, P36, DOI 10.1016/0016-7037(53)90064-7; Veverka J, 1997, J GEOPHYS RES-PLANET, V102, P23709, DOI 10.1029/97JE01742; Warren JW, 1997, SPACE SCI REV, V82, P101, DOI 10.1023/A:1005015719887; [No title captured]	30	106	108	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2101	2105		10.1126/science.289.5487.2101	http://dx.doi.org/10.1126/science.289.5487.2101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000107				2022-12-28	WOS:000089430900037
J	Dalgaard, JZ; Klar, AJS				Dalgaard, JZ; Klar, AJS			swi1 and swi3 perform imprinting, pausing, and termination of DNA replication in S-pombe	CELL			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; SWITCHING GENES; PROTEIN; CELLS; VIABILITY; MECHANISM; ASYMMETRY; BINDING	The developmental program of cell-type switching of S. pombe requires a strand-specific imprinting event at the mating-type locus (mat1). Imprinting occurs only when mat1 is replicated in a specific direction and requires several trans-acting factors. This work shows (1) that the factors swi1p and swi3p act by pausing the replication fork at the imprinting site; and (2) that swi1p and swi3p are involved in termination at the mat1-proximal polar-terminator of replication (RTS1). A genetic screen to identify termination factors identified an allele that separated pausing/imprinting and termination functions of swi1p. These results suggest that swi1p and swi3p promote imprinting in novel ways both by pausing replication at mat1 and by terminating replication at RTS1.	NCI, DHHS, Div Basic Sci,Gene Regulat & Chromosome Biol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Klar, AJS (corresponding author), NCI, DHHS, Div Basic Sci,Gene Regulat & Chromosome Biol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA.	klar@mail.ncifcfr.gov		Dalgaard, Jacob/0000-0001-9545-7254				Arcangioli B, 1998, EMBO J, V17, P4503, DOI 10.1093/emboj/17.15.4503; ARCANGIOLI B, 1994, MOL CELL BIOL, V14, P2058, DOI 10.1128/MCB.14.3.2058; ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; BEACH DH, 1983, NATURE, V305, P682, DOI 10.1038/305682a0; BEACH DH, 1984, EMBO J, V3, P603, DOI 10.1002/j.1460-2075.1984.tb01855.x; Bussiere DE, 1999, MOL MICROBIOL, V31, P1611, DOI 10.1046/j.1365-2958.1999.01287.x; Dalgaard LZ, 1999, NATURE, V400, P181, DOI 10.1038/22139; Duggin IG, 1999, J MOL BIOL, V286, P1325, DOI 10.1006/jmbi.1999.2553; EGEL R, 1984, P NATL ACAD SCI-BIOL, V81, P3481, DOI 10.1073/pnas.81.11.3481; EGEL R, 1987, CURR GENET, V12, P429, DOI 10.1007/BF00434820; Egel R., 1989, MOL BIOL FISSION YEA, P31; GUTZ H, 1985, CURR GENET, V9, P325, DOI 10.1007/BF00421601; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; KLAR AJS, 1990, EMBO J, V9, P1407, DOI 10.1002/j.1460-2075.1990.tb08256.x; KLAR AJS, 1987, NATURE, V326, P466, DOI 10.1038/326466a0; KLAR AJS, 1993, COLD SPRING HARB SYM, V58, P457, DOI 10.1101/SQB.1993.058.01.052; Klar AJS, 1998, CIBA F SYMP, V214, P87; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Lakin-Thomas PL, 2000, TRENDS GENET, V16, P135, DOI 10.1016/S0168-9525(99)01945-9; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; MEADE JH, 1975, GENETICS, V80, P711; MIYATA H, 1981, J GEN APPL MICROBIOL, V27, P365, DOI 10.2323/jgam.27.365; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORHAM SG, 1992, J BIOL CHEM, V267, P15984; NIELSEN O, 1989, EMBO J, V8, P269, DOI 10.1002/j.1460-2075.1989.tb03373.x; Park H, 1999, YEAST, V15, P35, DOI 10.1002/(SICI)1097-0061(19990115)15:1<35::AID-YEA340>3.0.CO;2-R; SCHMIDT H, 1987, MOL GEN GENET, V210, P485, DOI 10.1007/BF00327201; SCHMIDT H, 1987, CURR GENET, V11, P303, DOI 10.1007/BF00355404; SINGH J, 1993, NATURE, V361, P271, DOI 10.1038/361271a0; STYRKARSDOTTIR U, 1993, CURR GENET, V23, P184, DOI 10.1007/BF00352020; UEMURA T, 1987, NUCLEIC ACIDS RES, V15, P9727, DOI 10.1093/nar/15.23.9727	32	122	126	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					745	751		10.1016/S0092-8674(00)00063-5	http://dx.doi.org/10.1016/S0092-8674(00)00063-5			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030618	Bronze			2022-12-28	WOS:000089395200006
J	Rowen, L; Wong, GKS; Lane, RP; Hood, L				Rowen, L; Wong, GKS; Lane, RP; Hood, L			Intellectual property - Publication rights in the era of open data release policies	SCIENCE			English	Editorial Material									Inst Syst Biol, Seattle, WA 98105 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rowen, L (corresponding author), Inst Syst Biol, Seattle, WA 98105 USA.		WONG, Gane Ka-Shu/G-5784-2013	WONG, Gane Ka-Shu/0000-0001-6108-5560				Allcock RJN, 2000, IMMUNOL TODAY, V21, P328, DOI 10.1016/S0167-5699(00)01654-6; Gottlieb M, 2000, NATURE, V406, P121, DOI 10.1038/35018270; Macilwain C, 2000, NATURE, V405, P601, DOI 10.1038/35015216; Yu CY, 2000, IMMUNOL TODAY, V21, P320, DOI 10.1016/S0167-5699(00)01664-9; 2000, NATURE, V405, P719	5	14	16	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1881	1881		10.1126/science.289.5486.1881	http://dx.doi.org/10.1126/science.289.5486.1881			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	11012360				2022-12-28	WOS:000089355800024
J	Lusis, AJ				Lusis, AJ			Atherosclerosis	NATURE			English	Review							LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY DISEASE; DEFICIENT MICE; HEART-DISEASE; IN-VIVO; MYOCARDIAL-INFARCTION; PHOSPHOLIPASE A(2); LIPID-ACCUMULATION; HYPERTENSIVE RATS; APOLIPOPROTEIN-E	Atherosclerosis, a disease of the large arteries, is the primary cause of heart disease and stroke. In westernized societies, it is the underlying cause of about 50% of all deaths. Epidemiological studies have revealed several important environmental and genetic risk factors associated with atherosclerosis. Progress in defining the cellular and molecular interactions involved, however, has been hindered by the disease's aetiological complexity. Over the past decade, the availability of new investigative tools, including genetically modified mouse models of disease, has resulted in a clearer understanding of the molecular mechanisms that connect altered cholesterol metabolism and other risk factors to the development of atherosclerotic plaque. It is now clear that atherosclerosis is not simply an inevitable degenerative consequence of ageing, but rather a chronic inflammatory condition that can be converted into an acute clinical event by plaque rupture and thrombosis.	Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lusis, AJ (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.				NHLBI NIH HHS [P01 HL028481, P01 HL030568, P01 HL030568-160009, P01 HL028481-140008, R01 HL094322] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, R01HL094322, P01HL030568] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Assmann G, 1999, ARTERIOSCL THROM VAS, V19, P1819, DOI 10.1161/01.ATV.19.8.1819; Boren J, 1998, J CLIN INVEST, V101, P2658, DOI 10.1172/JCI2265; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; COHEN JC, 1994, J CLIN INVEST, V94, P2377, DOI 10.1172/JCI117603; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Desurmont C, 2000, ARTERIOSCL THROM VAS, V20, P435, DOI 10.1161/01.ATV.20.2.435; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Franco RF, 2000, HAEMATOLOGICA, V85, P67; FYFE AI, 1994, J CLIN INVEST, V94, P2516, DOI 10.1172/JCI117622; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; Gerhard GT, 1999, CURR OPIN LIPIDOL, V10, P417, DOI 10.1097/00041433-199910000-00006; Gimbrone MA, 1999, AM J PATHOL, V155, P1, DOI 10.1016/S0002-9440(10)65090-0; Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.4; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hegele RA, 1999, ANN MED, V31, P217, DOI 10.3109/07853899909115981; Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hu H, 1999, J CLIN INVEST, V103, P747, DOI 10.1172/JCI4582; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; Kronenberg F, 1999, CIRCULATION, V100, P1154, DOI 10.1161/01.CIR.100.11.1154; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Luft FC, 1998, J HYPERTENS, V16, P1871, DOI 10.1097/00004872-199816121-00004; Lusis AJ, 1998, TXB CARDIOVASCULAR M, P2389; Marathe S, 1999, ARTERIOSCL THROM VAS, V19, P2648, DOI 10.1161/01.ATV.19.11.2648; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; Moultan KS, 1999, MOL BASIS CARDIOVASC, P393; Nathan L, 1997, ANNU REV PHARMACOL, V37, P477, DOI 10.1146/annurev.pharmtox.37.1.477; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; NEGORO N, 1995, J CLIN INVEST, V95, P1140, DOI 10.1172/JCI117762; NIEVELSTEIN PFEM, 1991, ARTERIOSCLER THROMB, V11, P1795, DOI 10.1161/01.ATV.11.6.1795; NIEVELSTEINPOST P, 1994, ARTERIOSCLER THROMB, V14, P1151, DOI 10.1161/01.ATV.14.7.1151; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Samani NJ, 1996, CIRCULATION, V94, P708, DOI 10.1161/01.CIR.94.4.708; Schonbeck U, 2000, AM J PATHOL, V156, P7, DOI 10.1016/S0002-9440(10)64699-8; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Schwartz SM, 1998, ANNU REV MED, V49, P437; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Shi WB, 2000, CIRCULATION, V102, P75, DOI 10.1161/01.CIR.102.1.75; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Shih PT, 1999, CIRC RES, V84, P345, DOI 10.1161/01.RES.84.3.345; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; SMITHIES O, 1995, P NATL ACAD SCI USA, V92, P5266, DOI 10.1073/pnas.92.12.5266; Steinberg D., 1999, MOL BASIS CARDIOVASC, P458; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tamminen M, 1999, ARTERIOSCL THROM VAS, V19, P847, DOI 10.1161/01.ATV.19.4.847; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tuomainen TP, 1999, CIRCULATION, V100, P1274, DOI 10.1161/01.CIR.100.12.1274; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205; Wittrup HH, 1999, CIRCULATION, V99, P2901, DOI 10.1161/01.CIR.99.22.2901; Young SG, 1999, NAT GENET, V22, P316, DOI 10.1038/11878	71	4310	4614	25	940	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					233	241		10.1038/35025203	http://dx.doi.org/10.1038/35025203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001066	Green Accepted			2022-12-28	WOS:000089241000059
J	Simmons, D				Simmons, D			Madame Bovary, c'est moi - Once upon a time, fiction required the suspension of disbelief.	NATURE			English	Editorial Material																			0	1	1	1	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					137	137		10.1038/35025159	http://dx.doi.org/10.1038/35025159			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001035	Bronze			2022-12-28	WOS:000089241000024
J	Smith, O				Smith, O			Biomedicine - Sleep, eat, and be merry	SCIENCE			English	Editorial Material							NARCOLEPSY											Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; THANNICKAL T, IN PRESS NEURON	4	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1706	1706		10.1126/science.289.5485.1706	http://dx.doi.org/10.1126/science.289.5485.1706			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	11001739				2022-12-28	WOS:000089195200036
J	Kunzli, N; Kaiser, R; Medina, S; Studnicka, M; Chanel, O; Filliger, P; Herry, M; Horak, F; Puybonnieux-Texier, V; Quenel, P; Schneider, J; Seethaler, R; Vergnaud, JC; Sommer, H				Kunzli, N; Kaiser, R; Medina, S; Studnicka, M; Chanel, O; Filliger, P; Herry, M; Horak, F; Puybonnieux-Texier, V; Quenel, P; Schneider, J; Seethaler, R; Vergnaud, JC; Sommer, H			Public-health impact of outdoor and traffic-related air pollution: a European assessment	LANCET			English	Article							TERM AMBIENT CONCENTRATIONS; RESPIRATORY HEALTH; TIME-SERIES; PARTICULATE MATTER; NONSMOKING POPULATION; INHALABLE PARTICLES; HOSPITAL ADMISSIONS; ASTHMATIC-CHILDREN; SULFUR-DIOXIDE; UNITED-STATES	Background Air pollution contributes to mortality and morbidity. We estimated the impact of outdoor (total) and traffic-related air pollution on public health in Austria, France, and Switzerland. Attributable cases of morbidity and mortality were estimated. Methods Epidemiology-based exposure-response functions for a 10 mu g/m(3) increase in particulate matter (PM10) were used to quantify the effects of air pollution. Cases attributable to air pollution were estimated for mortality (adults greater than or equal to 30 years), respiratory and cardiovascular hospital admissions tall ages), incidence of chronic bronchitis (adults greater than or equal to 25 years), bronchitis episodes in children (<15 years), restricted activity days (adults greater than or equal to 20 years), and asthma attacks in adults and children. Population exposure (PM10) was modelled for each km(2). The traffic-related fraction was estimated based on PM10 emission inventories. Findings Air pollution caused 6% of total mortality or more than 40 000 attributable cases per year. About half of all mortality caused by air pollution was attributed to motorised traffic, accounting also for: more than 25 000 new cases of chronic bronchitis (adults); more than 290 000 episodes of bronchitis (children); more than 0.5 million asthma attacks; and more than 16 million person-days of restricted activities. Interpretation This assessment estimates the public-health impacts of current patterns of air pollution. Although individual health risks of air pollution are relatively small, the public-health consequences are considerable. Traffic-related air pollution remains a key target for public-health action in Europe. Our results, which have also been used for economic valuation, should guide decisions on the assessment of environmental health-policy options.	Univ Basel, Inst Sozial & Pravent Med, CH-4051 Basel, Switzerland; Natl Inst Publ Hlth Surveillance, Dept Environm Hlth, St Maurice, France; Ctr Pulm Dis, Vienna, Austria; GREQAM, Dept Econ, French Natl Ctr Sci Res, Marseille, France; BUWAL, Swiss Agcy Environm Forest & Landscape, Bern, Switzerland; Consultancy Dr Max Henry, Vienna, Austria; Univ Childrens Hosp, Vienna, Austria; Univ Paris 07, LED, Paris, France; Fed Environm Agcy, Dept Air Qual Control, Vienna, Austria; Univ Sydney, Inst Transport Studies, Sydney, NSW 2006, Australia; EUREQUA, Dept Econ, Franch Natl Ctr Sci Res, Paris, France; ECOPLAN, Econ & Environm Studies, Bern, Switzerland; ECOPLAN, Econ & Environm Studies, Altdorf, Switzerland	University of Basel; Institute of Public Health Surveillance; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite; University of Sydney	Kunzli, N (corresponding author), Univ Basel, Inst Sozial & Pravent Med, Steinengraben 49, CH-4051 Basel, Switzerland.	Nino.Kuenzli@unibas.ch	Kuenzli, Nino/F-7195-2014; QUENEL, PHILIPPE/J-4351-2015; Chanel, Olivier/H-6500-2013	Kuenzli, Nino/0000-0001-8360-080X; QUENEL, PHILIPPE/0000-0003-3361-3623; Chanel, Olivier/0000-0002-8221-7558; Vergnaud, Jean-Christophe/0000-0001-6604-4186				ABBEY DE, 1993, ARCH ENVIRON HEALTH, V48, P33, DOI 10.1080/00039896.1993.9938391; ABBEY DE, 1995, ARCH ENVIRON HEALTH, V50, P139, DOI 10.1080/00039896.1995.9940891; Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; *AM LUNG ASS, 1998, DOLL CENTS EC HLTH B; Baldi I, 1999, EUR RESPIR J, V24, pS392; BATES DV, 1992, ENVIRON RES, V59, P336, DOI 10.1016/S0013-9351(05)80040-4; Bates DV, 2000, ENVIRON HEALTH PERSP, V108, P91, DOI 10.2307/3454504; BraunFahrlander C, 1997, AM J RESP CRIT CARE, V155, P1042, DOI 10.1164/ajrccm.155.3.9116984; Brunekreef B, 1999, EPIDEMIOLOGY, V10, P661, DOI 10.1097/00001648-199911000-00001; *DEP HLTH AD HOC G, 1999, EC APPR HLTH EFF AIR; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DOCKERY DW, 1989, AM REV RESPIR DIS, V139, P587, DOI 10.1164/ajrccm/139.3.587; Dockery DW, 1996, ENVIRON HEALTH PERSP, V104, P500, DOI 10.2307/3432990; Dora C, 1999, BRIT MED J, V318, P1686, DOI 10.1136/bmj.318.7199.1686; DUSSELDORP A, 1995, AM J RESP CRIT CARE, V152, P1932, DOI 10.1164/ajrccm.152.6.8520758; Eder W, 1998, WIEN KLIN WOCHENSCHR, V110, P669; FILLIGER P, 1999, POPULATION EXPOSURE; Gielen MH, 1997, AM J RESP CRIT CARE, V155, P2105, DOI 10.1164/ajrccm.155.6.9196122; HAIDINGER W, 1998, SCHLUSSBERICHT ISAAC; Hiltermann TJN, 1998, EUR RESPIR J, V11, P686; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; Kunzli N, 1997, ENVIRON HEALTH PERSP, V105, P1078, DOI 10.2307/3433849; Kunzli N, 1999, HLTH COSTS DUE ROAD; Lai DJ, 1999, INT J EPIDEMIOL, V28, P894, DOI 10.1093/ije/28.5.894; McMichael AJ, 1998, INT J EPIDEMIOL, V27, P450, DOI 10.1093/ije/27.3.450; Medina S, 1997, EVALUATION RISQUES P; *NAT RES DEF COUNC, 1996, BREATH TAK PREM MORT; National Research Council, 1999, RES PRIOR AIRB PART; Neukirch F, 1998, ARCH ENVIRON HEALTH, V53, P320, DOI 10.1080/00039899809605716; OBERFELD G, 1996, 1 SALZBURGER KINDERG; Ostro B, 1996, J EXPO ANAL ENV EPID, V6, P97; Ostro B, 1998, ENVIRON RES, V76, P94, DOI 10.1006/enrs.1997.3799; OSTRO BD, 1990, RISK ANAL, V10, P421, DOI 10.1111/j.1539-6924.1990.tb00525.x; Poloniecki JD, 1997, OCCUP ENVIRON MED, V54, P535, DOI 10.1136/oem.54.8.535; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Prescott GJ, 1998, OCCUP ENVIRON MED, V55, P697, DOI 10.1136/oem.55.10.697; ROEMER W, 1993, AM REV RESPIR DIS, V147, P118, DOI 10.1164/ajrccm/147.1.118; Samet J., 1999, AIR POLLUTION HLTH; Samet JM, 1998, AM J EPIDEMIOL, V148, P929; Segala C, 1998, EUR RESPIR J, V11, P677; Smith KR, 1999, EPIDEMIOLOGY, V10, P573, DOI 10.1097/00001648-199909000-00027; SOMMER H, HLTH COSTS DUE ROAD; Sommer H, 1999, 3 WHO MIN C ENV HLTH; Studnicka M, 1997, EUR RESPIR J, V10, P2275, DOI 10.1183/09031936.97.10102275; Wilson R., 1996, PARTICLES OUR AIR CO; Wordley J, 1997, OCCUP ENVIRON MED, V54, P108, DOI 10.1136/oem.54.2.108; Zemp E, 1999, AM J RESP CRIT CARE, V159, P1257, DOI 10.1164/ajrccm.159.4.9807052; Zmirou D, 1998, EPIDEMIOLOGY, V9, P495, DOI 10.1097/00001648-199809000-00005; 1998, ANN STAT REP SWITZ S	49	1145	1208	4	378	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2000	356	9232					795	801		10.1016/S0140-6736(00)02653-2	http://dx.doi.org/10.1016/S0140-6736(00)02653-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022926				2022-12-28	WOS:000089101800009
J	Krebs, JE; Fry, CJ; Samuels, ML; Peterson, CL				Krebs, JE; Fry, CJ; Samuels, ML; Peterson, CL			Global role for chromatin remodeling enzymes in mitotic gene expression	CELL			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; YEAST SACCHAROMYCES-CEREVISIAE; POLYMERASE-II HOLOENZYME; SWI-SNF COMPLEX; SWI/SNF COMPLEX; IN-VIVO; TRANSCRIPTION FACTOR; ACTIVATOR-BINDING; PHO5 PROMOTER; HO GENE	Regulation of eukaryotic gene expression requires ATP-dependent chromatin remodeling enzymes, such as SWI/SNF, and histone acetyltransferases, such as Gcn5p. Here we show that SWI/SNF remodeling controls recruitment of Gcn5p HAT activity to many genes in late mitosis and that these chromatin remodeling enzymes play a role in regulating mitotic exit. In contrast, interphase expression of GAL1, HIS3, PHO5, and PHO8 is accompanied by SWI/SNF-independent recruitment of Gcn5p HAT activity. Surprisingly, prearresting cells in late mitosis imposes a requirement for SWI/SNF in recruiting Gcn5p HAT activity to the GAL1 promoter, and GAL1 expression also becomes dependent on both chromatin remodeling enzymes. We propose that SWI/SNF and Gcn5p are globally required for mitotic gene expression due to the condensed state of mitotic chromatin.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.				NIGMS NIH HHS [GM49650, R01 GM049650, R37 GM049650] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049650, R37GM049650] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aerne BL, 1998, MOL BIOL CELL, V9, P945, DOI 10.1091/mbc.9.4.945; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Burns LG, 1997, MOL CELL BIOL, V17, P4811, DOI 10.1128/MCB.17.8.4811; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Drysdale CM, 1998, MOL CELL BIOL, V18, P1711, DOI 10.1128/MCB.18.3.1711; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Filetici P, 1998, BIOCHEM BIOPH RES CO, V242, P84, DOI 10.1006/bbrc.1997.7918; Fry CJ, 1999, J BIOL CHEM, V274, P15883, DOI 10.1074/jbc.274.22.15883; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kuo CH, 1996, IEEE SIGNAL PROC LET, V3, P269, DOI 10.1109/97.536598; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Massari ME, 1999, MOL CELL, V4, P63, DOI 10.1016/S1097-2765(00)80188-4; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; Roberts SM, 1997, GENETICS, V147, P451; SAWA H, 2000, IN PRESS MOL CELL; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Sirri V, 2000, J CELL BIOL, V148, P259, DOI 10.1083/jcb.148.2.259; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; TOONE WM, 1995, EMBO J, V14, P5824, DOI 10.1002/j.1460-2075.1995.tb00270.x; Toyn JH, 1997, GENETICS, V145, P85; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	53	189	195	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					587	598		10.1016/S0092-8674(00)00081-7	http://dx.doi.org/10.1016/S0092-8674(00)00081-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007477	Bronze			2022-12-28	WOS:000089105200007
J	Cole, TRP; Sleightholme, HV				Cole, TRP; Sleightholme, HV			ABC of colorectal cancer - The role of clinical genetics in management	BRITISH MEDICAL JOURNAL			English	Review							NONPOLYPOSIS		Birmingham Womens Hosp, Dept Clin Genet, Birmingham, W Midlands, England	Birmingham Women's Hospital	Cole, TRP (corresponding author), Birmingham Womens Hosp, Dept Clin Genet, Birmingham, W Midlands, England.							Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; Foulkes WD, 1995, QJM-MON J ASSOC PHYS, V88, P853; Hodgson SV., 1999, PRACTICAL GUIDE HUMA; HOULSTON RS, 1990, BRIT MED J, V301, P366, DOI 10.1136/bmj.301.6748.366; Vasen HFA, 1998, CANCER, V82, P1632, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1632::AID-CNCR6>3.3.CO;2-X	5	8	9	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					943	946		10.1136/bmj.321.7266.943	http://dx.doi.org/10.1136/bmj.321.7266.943			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030689	Green Published			2022-12-28	WOS:000089975100028
J	Keightley, PD; Eyre-Walker, A				Keightley, PD; Eyre-Walker, A			Deleterious nutations and the evolution of sex	SCIENCE			English	Article							MOLECULAR CLOCK; MUTATION-RATES; DROSOPHILA; SELECTION; PATTERNS; RECOMBINATION; DIVERGENCE; ADVANTAGE; ISLANDS; NUMBER	It has been suggested that sexual reproduction is maintained because it reduces the load imposed by recurrent deleterious mutations. If rates of deleterious mutation per diploid genome per generation (U) exceed 1, and mutations interact synergistically, then sexuals can overcome their inherent twofold disadvantage. We have tested this hypothesis by estimating genomic point mutation rates for protein-coding genes in a range of animal taxa. We find a positive Linear relationship between U and generation time. In species with short generation times. U is predicted to be far below 1, suggesting that sex is not maintained by its capacity to purge the genome of deleterious mutations.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England	University of Edinburgh; University of Sussex; University of Sussex	Keightley, PD (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	p.keightley@ed.ac.uk; a.c.eyre-walker@sussex.ac.uk	Eyre-Walker, Adam/G-6216-2011	Eyre-Walker, Adam/0000-0001-5527-8729				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AKASHI H, 1995, GENETICS, V139, P1067; ALLAN JD, 1976, AM NAT, V110, P165, DOI 10.1086/283056; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Bell G., 1982, MASTERPIECE NATURE; BLACKBURN TM, 1991, J ANIM ECOL, V60, P151, DOI 10.2307/5451; BULMER M, 1991, P NATL ACAD SCI USA, V88, P5974, DOI 10.1073/pnas.88.14.5974; Carroll RL, 1988, VERTEBRATE PALEONTOL; CHAO L, 1993, EVOLUTION, V47, P688, DOI 10.1111/j.1558-5646.1993.tb02124.x; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; CHITWOOD WG, 1974, INTRO NEMATOLOGY; DENNO RF, 1989, ECOL ENTOMOL, V14, P31, DOI 10.1111/j.1365-2311.1989.tb00751.x; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; HOWARD RS, 1994, THEOR POPUL BIOL, V45, P313, DOI 10.1006/tpbi.1994.1015; JAEGER JJ, 1986, CR ACAD SCI II, V302, P917; Keightley PD, 1999, GENETICS, V153, P515; KIMURA M, 1966, GENETICS, V54, P1337; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Maside X, 2000, GENET RES, V75, P275, DOI 10.1017/S0016672399004474; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; NUZHDIN SV, 1995, MOL BIOL EVOL, V12, P180, DOI 10.1093/oxfordjournals.molbev.a040188; Ohta T, 1972, J Mol Evol, V1, P150, DOI 10.1007/BF01659161; Ophir R, 1997, GENE, V205, P191, DOI 10.1016/S0378-1119(97)00398-3; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; POWELL JR, 1995, EVOL BIOL, V28, P87; Shabalina SA, 1999, GENET RES, V74, P23, DOI 10.1017/S0016672399003821; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; STEIPER M, COMMUNICATION; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Varley G.C., 1973, INSECT POPULATION EC; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389	40	181	183	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2000	290	5490					331	333		10.1126/science.290.5490.331	http://dx.doi.org/10.1126/science.290.5490.331			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030650				2022-12-28	WOS:000089818100042
J	Xie, T; Spradling, AC				Xie, T; Spradling, AC			A niche maintaining germ line stem cells in the Drosophila ovary	SCIENCE			English	Article							OOCYTE SPECIFICATION; SIGNALING PATHWAY; MAINTENANCE; OOGENESIS; SCHNURRI; ENCODES; FATE	Stromal cells are thought to generate specific regulatory microenviroments or "niches" that control stem cell behavior. Characterizing stem cell niches in vivo remains an important goal that has been difficult to achieve. The individual ovarioles of the Drosophila ovary each contain about two germ line stem cells that maintain oocyte production. Here we show that anterior ovariolar somatic cells comprising three cell types act as a germ line stem cell niche. Germ line stem cells Lost by normal or induced differentiation are efficiently replaced, and the ability to repopulate the niche increases the functional lifetime of ovarioles in vivo. Our studies implicate one of the somatic cell types, the cap cells, as a key niche component.	Carnegie Inst Washington, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD 21210 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Xie, T (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.				Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Cox DN, 2000, DEVELOPMENT, V127, P503; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FIELDING CJ, 1967, J EMBRYOL EXP MORPH, V17, P375; Forbes AJ, 1996, DEVELOPMENT, V122, P3283; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Fuller Margaret T., 1993, P71; GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5; Jones PH, 1997, BIOESSAYS, V19, P683, DOI 10.1002/bies.950190808; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; King FJ, 1999, DEVELOPMENT, V126, P1833; Lin HF, 1998, CURR OPIN CELL BIOL, V10, P687, DOI 10.1016/S0955-0674(98)80108-7; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Spradling AC, 1997, COLD SPRING HARB SYM, V62, P25; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xie T., UNPUB	27	568	598	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					328	330		10.1126/science.290.5490.328	http://dx.doi.org/10.1126/science.290.5490.328			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030649				2022-12-28	WOS:000089818100041
J	Balabin, IA; Onuchic, JN				Balabin, IA; Onuchic, JN			Dynamically controlled protein tunneling paths in photosynthetic reaction centers	SCIENCE			English	Article							ELECTRON-TRANSFER; PATHWAYS; REDUCTION; MODELS; TUBES	Marcus theory has explained how thermal nuclear motions modulate the energy gap between donor and acceptor sites in protein electron transfer reactions, Thermal motions, however, may also modulate electron tunneling between these reactions. Here we identify a new mechanism of nuclear dynamics amplification that plays a central role when interference among the dominant tunneling pathway tubes is destructive. In these cases, tunneling takes place in protein conformations far from equilibrium that minimize destructive interference. As an example, we demonstrate how this dynamical amplification mechanism affects certain reaction rates in the photosynthetic reaction center and therefore may be critical for biological function.	Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Onuchic, JN (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	jonuchic@ucsd.edu	Balabin, Ilya/P-2421-2019; Balabin, Ilya/B-3967-2013	Balabin, Ilya/0000-0001-6245-3855; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048043] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48043] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; Aquino AJA, 1997, CHEM PHYS LETT, V275, P181, DOI 10.1016/S0009-2614(97)00742-2; Balabin IA, 1998, J PHYS CHEM B, V102, P7497, DOI 10.1021/jp9819442; Balabin IA, 1996, J PHYS CHEM-US, V100, P11573, DOI 10.1021/jp953568g; BENDALL DS, 1996, PROTEIN ELECTRON TRA; Bertini I., 1994, BIOINORGANIC CHEM; BETTS JN, 1992, J AM CHEM SOC, V114, P4043, DOI 10.1021/ja00037a004; Bixon M, 1997, J CHEM PHYS, V107, P5154, DOI 10.1063/1.474878; CURRY WB, 1995, J BIOENERG BIOMEMBR, V27, P285, DOI 10.1007/BF02110098; Daizadeh I, 1997, P NATL ACAD SCI USA, V94, P3703, DOI 10.1073/pnas.94.8.3703; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Graige MS, 1998, P NATL ACAD SCI USA, V95, P11679, DOI 10.1073/pnas.95.20.11679; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Hyslop AG, 1998, INORG CHIM ACTA, V276, P427; KUKI A, 1987, SCIENCE, V236, P1647, DOI 10.1126/science.3603005; Kuznetsov AM, 1998, SPECTROCHIM ACTA A, V54, P1201, DOI 10.1016/S1386-1425(98)00070-5; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; McMahon BH, 1998, BIOPHYS J, V74, P2567, DOI 10.1016/S0006-3495(98)77964-0; Okamura MY, 2000, BBA-BIOENERGETICS, V1458, P148, DOI 10.1016/S0005-2728(00)00065-7; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PLATO M, 1989, FEBS LETT, V249, P70, DOI 10.1016/0014-5793(89)80018-3; Priyadarshy S, 1998, J BIOL INORG CHEM, V3, P196, DOI 10.1007/s007750050221; Priyadarshy S, 1996, J CHEM PHYS, V104, P9473, DOI 10.1063/1.471690; Regan JJ, 1999, ADV CHEM PHYS, V107, P497; SIGEL H, 1991, ELECTRON TRANSFER RE; Skourtis SS, 1997, J PHYS CHEM B, V101, P1215, DOI 10.1021/jp9619245; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; Wolfgang J, 1997, J PHYS CHEM B, V101, P2986, DOI 10.1021/jp963771r	28	242	247	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					114	117		10.1126/science.290.5489.114	http://dx.doi.org/10.1126/science.290.5489.114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021791				2022-12-28	WOS:000089724800044
J	Martinelli, I; Taioli, E; Cetin, I; Marinoni, A; Gerosa, S; Villa, MV; Bozzo, M; Mannucci, PM				Martinelli, I; Taioli, E; Cetin, I; Marinoni, A; Gerosa, S; Villa, MV; Bozzo, M; Mannucci, PM			Mutations in coagulation factors in women with unexplained late fetal loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR-V-LEIDEN; ANTIPHOSPHOLIPID ANTIBODIES; RECURRENT MISCARRIAGE; PREGNANCY LOSS; RISK FACTOR; PROTEIN-C; THROMBOPHILIA; THROMBOSIS; STILLBIRTH; FREQUENCY	Background: The Factor V Leiden and prothrombin-gene mutations are independent risk factors for venous thrombosis; it is debated whether a mutation in the gene encoding methylenetetrahydrofolate reductase, an enzyme involved in homocysteine metabolism, also increases the risk of venous thrombosis. Whether any of these mutations is associated with an increased risk of late fetal death is not known. Methods: We studied 67 women with a first episode of unexplained late fetal loss (fetal death after 20 weeks or more of gestation) and 232 women who had had one or more normal pregnancies and no late fetal losses. All the women were tested for the presence of three gene mutations. Women with other thrombophilic conditions were excluded from the study. Results: Eleven of the 67 women with late fetal loss (16 percent) and 13 of the 232 control women (6 percent) had either the factor V or the prothrombin mutation. The relative risks of late fetal loss in carriers of the factor V and prothrombin mutations were 3.2 (95 percent confidence interval, 1.0 to 10.9) and 3.3 (95 percent confidence interval, 1.1 to 10.3), respectively. Thirteen percent of the women whose fetuses died and 20 percent of the control women were homozygous for the mutation in the methylenetetrahydrofolate reductase gene (relative risk, 0.8; 95 percent confidence interval, 0.5 to 1.2). Conclusions: Both the factor V and the prothrombin mutations are associated with an approximate tripling of the risk of late fetal loss. (N Engl J Med 2000;343:1015-8.) (C) 2000, Massachusetts Medical Society.	Univ Milan, IRCCS Maggiore Hosp, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy; Univ Milan, IRCCS Maggiore Hosp, Epidemiol Unit, I-20122 Milan, Italy; Univ Milan, San Paolo Hosp, Dept Obstet & Gynecol, I-20122 Milan, Italy; Univ Milan, Ist Clin Perfezionamento, Dept Obstet & Gynecol, I-20122 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; San Paolo-Polo Universitaria Hospital; University of Milan; University of Milan	Martinelli, I (corresponding author), Univ Milan, IRCCS Maggiore Hosp, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy.		Martinelli, ida/J-2287-2015; cetin, irene/K-6112-2016; Marinoni, Angela/AAK-9587-2021	Martinelli, ida/0000-0001-9218-3622; cetin, irene/0000-0002-9217-3034; Marinoni, Angela/0000-0002-6580-7126				BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Breart G, 1997, EUR J OBSTET GYN R B, V75, P71, DOI 10.1016/S0301-2115(97)00190-5; Brenner B, 1997, BLOOD REV, V11, P72, DOI 10.1016/S0268-960X(97)90013-8; Cattaneo M, 1999, THROMB HAEMOSTASIS, V81, P165; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; DAVIES BR, 1985, AM J OBSTET GYNECOL, V152, P17, DOI 10.1016/S0002-9378(85)80168-X; DizonTomson DS, 1997, AM J OBSTET GYNECOL, V177, P402, DOI 10.1016/S0002-9378(97)70205-9; Festin Mario R., 1997, Kobe Journal of Medical Sciences, V43, P143; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Grandone E, 1997, THROMB HAEMOSTASIS, V77, P822; Gris JC, 1999, THROMB HAEMOSTASIS, V81, P891; Kupferminc MJ, 1999, NEW ENGL J MED, V341, P384; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; Martinelli I, 1998, BLOOD, V92, P2353, DOI 10.1182/blood.V92.7.2353.2353_2353_2358; Meinardi JR, 1999, ANN INTERN MED, V130, P736, DOI 10.7326/0003-4819-130-9-199905040-00013; OBRIEN WF, 1990, OBSTET GYNECOL, V75, P445; Ogunyemi D, 1998, ACTA OBSTET GYN SCAN, V77, P722, DOI 10.1034/j.1600-0412.1998.770705.x; Oshiro BT, 1996, OBSTET GYNECOL, V87, P489, DOI 10.1016/0029-7844(95)00498-X; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Preston FE, 1996, LANCET, V348, P913, DOI 10.1016/S0140-6736(96)04125-6; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253; Rai RS, 1995, HUM REPROD, V10, P3301, DOI 10.1093/oxfordjournals.humrep.a135907; Rand JH, 1997, NEW ENGL J MED, V337, P1327; Rand JH, 1997, NEW ENGL J MED, V337, P154, DOI 10.1056/NEJM199707173370303; Rees DC, 1996, BRIT J HAEMATOL, V95, P579, DOI 10.1046/j.1365-2141.1996.d01-1954.x; Ridker PM, 1998, ANN INTERN MED, V128, P1000, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00007; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; Rosendaal FR, 1998, THROMB HAEMOSTASIS, V79, P706; SAMUELOFF A, 1993, J REPROD MED, V38, P883; Sanson BJ, 1996, THROMB HAEMOSTASIS, V75, P387; Sanson BJ, 1999, THROMB HAEMOSTASIS, V81, P668, DOI 10.1055/s-0037-1614550; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Tormene D, 1999, THROMB HAEMOSTASIS, V82, P1237	35	254	264	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					1015	1018		10.1056/NEJM200010053431405	http://dx.doi.org/10.1056/NEJM200010053431405			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018168	Bronze			2022-12-28	WOS:000089619900005
J	Hosler, BA; Siddique, T; Sapp, PC; Sailor, W; Huang, MC; Hossain, A; Daube, JR; Nance, M; Fan, CH; Kaplan, J; Hung, WY; McKenna-Yasek, D; Haines, JL; Pericak-Vance, MA; Horvitz, HR; Brown, RH				Hosler, BA; Siddique, T; Sapp, PC; Sailor, W; Huang, MC; Hossain, A; Daube, JR; Nance, M; Fan, CH; Kaplan, J; Hung, WY; McKenna-Yasek, D; Haines, JL; Pericak-Vance, MA; Horvitz, HR; Brown, RH			Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MOTOR-NEURON DISEASE; ALZHEIMERS-DISEASE; PRESENILE-DEMENTIA; HUMAN GENOME; SUPEROXIDE-DISMUTASE; MISSENSE MUTATIONS; CANDIDATE GENE; PARKINSONISM; MAP; LOCUS	Context Occasionally, 2 or more major neurodegenerative diseases arise simultaneously, An understanding of the genetic bases of combined disorders, such as amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD), will likely provide insight into mechanisms of these and related neurodegenerative diseases, Objective To identify loci that contain genes whose defects cause ALS. Design A genome-wide linkage analysis of 2 data sets from an ongoing study begun in the mid-1980s at 4 university research centers, Subjects An initial subset of 16 families (549 people) potentially informative for genetic analysis, in which 2 or more individuals were diagnosed as having ALS, identified from a Boston data set of 400 families and 4 families potentially informative (244 people) subsequently identified from a Chicago data set of more than 300 families to test a hypothesis based on findings from the Boston families, Main Outcome Measures Linkage calculations assuming autosomal dominant inheritance with age-dependent penetrance (a parametric logarithm-of-odds [lod] score of 1.0 or greater required for further study of a potential locus); crossover analysis involving the ALS-FTD locus, Results In a set of families in which persons develop both ALS and FTD or either ALS or FTD alone, a genetic locus that is linked to ALS with FTD located between markers D9S301 and D9S167 was identified on human chromosome 9q21-q22, Families with ALS alone did not show linkage to this locus. Crossover analysis indicates this region covers approximately 77 cM, Conclusion These data suggest that a defective gene located in the chromosome 9q21-q22 region may be linked to ALS with FTD.	Massachusetts Gen Hosp E, Cecil B Day Lab Neuromuscular Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Cell Mol & Struct Biol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Inst Neurosci, Chicago, IL USA; MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Nashville, TN USA; Mayo Clin, Dept Neurol, Rochester, MN USA; Univ Minnesota, Dept Neurol, Struthers Parkinsons Ctr, Minneapolis, MN 55455 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA	Harvard University; Harvard Medical School; Northwestern University; Northwestern University; Northwestern University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Vanderbilt University; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Duke University; Duke University	Brown, RH (corresponding author), Massachusetts Gen Hosp E, Cecil B Day Lab Neuromuscular Res, Bldg 149,13th St, Charlestown, MA 02129 USA.	brown@helix.mgh.harvard.edu	Haines, Jonathan/C-3374-2012; Siddique, Teepu/AAT-8166-2021; Huang, MC/G-3349-2010	Haines, Jonathan/0000-0002-4351-4728; Siddique, Teepu/0000-0001-7293-9146	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031248, P01NS021442, R01NS037912] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS37912, P01NS21442, 1PO1NS31248-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; BROWN J, 1995, HUM MOL GENET, V4, P1625, DOI 10.1093/hmg/4.9.1625; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; FINLAYSON MH, 1973, ACTA NEUROPATHOL, V26, P237, DOI 10.1007/BF00684433; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GUNNARSSON LG, 1991, ACTA NEUROL SCAND, V84, P429, DOI 10.1111/j.1600-0404.1991.tb04983.x; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; HUDSON AJ, 1981, BRAIN, V104, P217, DOI 10.1093/brain/104.2.217; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEVY ML, 1998, BLUE BOOK PRACT NEUR, V19, P45; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LYNCH T, 1994, NEUROLOGY, V44, P1878, DOI 10.1212/WNL.44.10.1878; MAJOORKRAKAUER D, 1994, NEUROLOGY, V44, P1872, DOI 10.1212/WNL.44.10.1872; MITSUYAMA Y, 1984, J NEUROL NEUROSUR PS, V47, P953, DOI 10.1136/jnnp.47.9.953; MITSUYAMA Y, 1979, ARCH NEUROL-CHICAGO, V36, P592, DOI 10.1001/archneur.1979.00500450086021; MORITA K, 1987, ARCH GERONTOL GERIAT, V6, P263, DOI 10.1016/0167-4943(87)90026-4; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; NEARY D, 1990, J NEUROL NEUROSUR PS, V53, P23, DOI 10.1136/jnnp.53.1.23; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rubio A, 1996, ACTA NEUROPATHOL, V92, P421, DOI 10.1007/s004010050539; SCHMITT HP, 1984, ANN NEUROL, V16, P642, DOI 10.1002/ana.410160604; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; SIDDIQUE T, 1998, AM J HUM GENET, V63, pA308; SLAUGENHAUPT SA, 1995, GENOMICS, V25, P730, DOI 10.1016/0888-7543(95)80019-I; Sobel E, 1996, AM J HUM GENET, V58, P1323; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Wilhelmsen KC, 1997, J NEURAL TRANSM-SUPP, P269; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159	47	248	256	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1664	1669		10.1001/jama.284.13.1664	http://dx.doi.org/10.1001/jama.284.13.1664			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015796	Bronze			2022-12-28	WOS:000089501900026
J	van Dis, J				van Dis, J			Against the grain: Living with the human immunodeficiency virus in rural South Dakota	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							URBAN		Univ S Dakota, Vermillion, SD 57069 USA	University of South Dakota	van Dis, J (corresponding author), Univ S Dakota, Vermillion, SD 57069 USA.							*CDCP, 1993, HIV AIDS SURV; COLE SW, 1997, CRIT REV NEUROBIOL, V11, P298; Heckman TG, 1998, J RURAL HEALTH, V14, P138, DOI 10.1111/j.1748-0361.1998.tb00615.x; Lansky A, 2000, J RURAL HEALTH, V16, P20, DOI 10.1111/j.1748-0361.2000.tb00433.x; Mainous AG, 1996, ARCH FAM MED, V5, P469, DOI 10.1001/archfami.5.8.469; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P167, DOI 10.1001/jama.284.2.167	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1706	1707		10.1001/jama.284.13.1706	http://dx.doi.org/10.1001/jama.284.13.1706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015807	hybrid			2022-12-28	WOS:000089501900036
J	Quill, TE; Lee, BC; Nunn, S				Quill, TE; Lee, BC; Nunn, S			Palliative treatment of last resort and assisted suicide - Response	ANNALS OF INTERNAL MEDICINE			English	Letter							VOLUNTARY		Genesee Hosp, Rochester, NY 14607 USA; Compass Dying Federat, Portland, OR 97201 USA; Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania	Quill, TE (corresponding author), Genesee Hosp, Rochester, NY 14607 USA.							BERNAT JL, 1993, ARCH INTERN MED, V153, P2723, DOI 10.1001/archinte.153.24.2723; Miller FG, 1998, ANN INTERN MED, V128, P559, DOI 10.7326/0003-4819-128-7-199804010-00007; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Ventafridda V, 1990, J Palliat Care, V6, P7	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					563	563		10.7326/0003-4819-133-7-200010030-00024	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00024			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015178				2022-12-28	WOS:000089678300015
J	Jensenius, M; Lovstad, RZ; Dhaenens, G; Rorvik, LM				Jensenius, M; Lovstad, RZ; Dhaenens, G; Rorvik, LM			A heroin user with a wobbly head	LANCET			English	Article									Aker Univ Hosp, Dept Internal Med, Div Infect Dis, N-0514 Oslo, Norway; Aker Univ Hosp, Dept Anaesthesiol, Oslo, Norway; Norwegian Sch Vet Sci, Dept Pharmacol Microbiol & Food Hyg, Oslo, Norway; Ulleval Univ Hosp, Clin Neurophysiol Lab, Oslo, Norway	University of Oslo; University of Oslo; Norwegian University of Life Sciences; University of Oslo	Jensenius, M (corresponding author), Aker Univ Hosp, Dept Internal Med, Div Infect Dis, N-0514 Oslo, Norway.							BURNENS AP, 2000, EUROSURVEILLANCE WEE, V4, P203; KHAN M, 2000, EUROSURVEILLANCE WEE, V4, P622; Kuusi M, 1999, Euro Surveill, V4, P11; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Therre Helene, 1999, Euro Surveill, V4, P2	5	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1160	1160		10.1016/S0140-6736(00)02759-8	http://dx.doi.org/10.1016/S0140-6736(00)02759-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030296				2022-12-28	WOS:000089594300014
J	Bao, HM; Campbell, DA; Bockheim, JG; Thiemens, MH				Bao, HM; Campbell, DA; Bockheim, JG; Thiemens, MH			Origins of sulphate in Antarctic dry-valley soils as deduced from anomalous O-17 compositions	NATURE			English	Article							SULFATE; AEROSOL; SULFUR; ICE; AGE	The dry valleys of Antarctica are some of the oldest terrestrial surfaces on the Earth. Despite much study of soil weathering and development, ecosystem dynamics and the occurrence of life in these extreme environments(1-3), the reasons behind the exceptionally high salt content of the dry-valley soils(4-6) have remained uncertain. In particular, the origins of sulphate are still controversial; proposed sources include wind-blown sea salt(5,7), chemical weathering(8), marine incursion(9), hydrothermal processes(10) and oxidation of biogenic sulphur in the atmosphere(1). Here we report measurements of delta(18)O and delta(17)O values of sulphates from a range of dry-valley soils. These sulphates all have a large positive anomaly(11) of O-17, of up to 3.4 parts per thousand. This suggests that Antarctic sulphate comes not just from sea salt (which has no anomaly of O-17) but also from the atmospheric oxidation of reduced gaseous sulphur compounds, the only known process that can generate the observed O-17 anomaly. This source is more prominent in high inland soils, suggesting that the distributions of sulphate are largely explained by differences in particle size and transport mode which exist between sea-salt aerosols and aerosols formed from biogenic sulphur emission.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA	University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison	Bao, HM (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Mail Code 0356,9500 Gilman Dr, La Jolla, CA 92093 USA.	hbao@chem.ucsd.edu	Bao, Huiming/C-1069-2012					[Anonymous], 1987, ANTARCTICA SOILS WEA; BAO H, IN PRESS GEOCHIM COS; Bao HM, 2000, ANAL CHEM, V72, P4029, DOI 10.1021/ac000086e; Bao HM, 2000, NATURE, V406, P176, DOI 10.1038/35018052; BOCKHEIM JG, 1979, SOIL SCI, V128, P142, DOI 10.1097/00010694-197909000-00003; Bockheim JG, 1997, SOIL SCI SOC AM J, V61, P224, DOI 10.2136/sssaj1997.03615995006100010031x; Claridge GG, 1997, ECOSYSTEM PROCESSES IN ANTARCTIC ICE-FREE LANDSCAPES, P137; CLARIDGE GGC, 1977, SOIL SCI, V123, P377, DOI 10.1097/00010694-197706000-00006; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; CUNNINGHAM J, 1993, ATMOS ENVIRON A-GEN, V27, P2943, DOI 10.1016/0960-1686(93)90327-U; Farquhar J, 2000, NATURE, V404, P50, DOI 10.1038/35003517; GIBSON EK, 1983, J GEOPHYS RES A, V88, P912; Graham IJ, 1997, NUCL INSTRUM METH B, V123, P307, DOI 10.1016/S0168-583X(96)00737-9; KEY JR, 1981, GEOCHIM COSMOCHIM AC, V45, P2299; LEE CC, UNPUB J GEOPHYS RES; Legrand M, 1995, NATO ASI SER SER I, V30, P91; LINKLETTER GO, 1972, ANTARCT GEOL GEOPHYS, V1, P441; Minikin A, 1998, J GEOPHYS RES-ATMOS, V103, P10975, DOI 10.1029/98JD00249; NAKAI N, 1975, MEM NATL I POLAR RES, V4, P30; PETIT JR, 1981, NATURE, V293, P391, DOI 10.1038/293391a0; Priscu JC, 1998, ECOSYSTEM DYNAMICS P; PROSPERO JM, 1991, NATURE, V350, P221, DOI 10.1038/350221a0; SAVARINO J, IN PRESS J GEOPHYS R; Schafer JM, 1999, EARTH PLANET SC LETT, V167, P215, DOI 10.1016/S0012-821X(99)00029-1; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; TAKAMATSU N, 1993, PROC INT ASSOC THEOR, V25, P954; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; TORII T, 1979, MEM NATL I POLAR RES, V13, P22; Wagenbach D, 1998, J GEOPHYS RES-ATMOS, V103, P11007, DOI 10.1029/97JD03364; WELCH KA, 1993, GEOPHYS RES LETT, V20, P443, DOI 10.1029/93GL00499	30	78	82	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					499	502		10.1038/35035054	http://dx.doi.org/10.1038/35035054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028998				2022-12-28	WOS:000089727400046
J	Guthrie, B; Wyke, S				Guthrie, B; Wyke, S			Controversy in primary care - Does continuity in general practice really matter?	BRITISH MEDICAL JOURNAL			English	Article							PATIENT SATISFACTION; RANDOMIZED TRIAL; PRACTITIONERS; CONSULTATIONS	Continuity is an official core value of general practice in the United Kingdom,(1) but there are at least two potentially conflicting definitions of it Both definitions are powerfully expressed in a recent report from the BMA, entitled Shaping Tomorrow.(2) For general practitioners, continuity of care has traditionally meant that a patient visits the same doctor(3 4) What matters is personal continuity, in which an ongoing doctor-patient relationship ensures that care takes account of the patient's personal and social context By contrast, recent statements from the NHS Executive emphasise the importance of consistency and coordination of care.(5) From this perspective, continuity can be enhanced by appropriate organisation, guidelines, and electronic medical records, irrespective of which doctor is seen.	Univ Edinburgh, Dept Community Hlth Sci, Div Gen Practice, Edinburgh EH8 9DX, Midlothian, Scotland; Royal Coll Gen Practitioners, Scottish Sch Primary Care, Edinburgh EH2 1JX, Midlothian, Scotland	University of Edinburgh	Guthrie, B (corresponding author), Univ Edinburgh, Dept Community Hlth Sci, Div Gen Practice, Edinburgh EH8 9DX, Midlothian, Scotland.		Guthrie, Bruce/HHM-9696-2022	Guthrie, Bruce/0000-0003-4191-4880				BAKER R, 1995, BRIT J GEN PRACT, V45, P654; Baker R, 1996, BRIT J GEN PRACT, V46, P601; BECKER MH, 1974, AM J PUBLIC HEALTH, V64, P1062, DOI 10.2105/AJPH.64.11.1062; *BMA GEN PRACT COM, 2000, PRIM CAR TRUSTS IMPL; *BMA GEN PRACT COM, 2000, SHAP TOM ISS FAC GEN; ETTLINGER PRA, 1981, BRIT MED J, V282, P1192, DOI 10.1136/bmj.282.6271.1192; Flint C, 1989, Midwifery, V5, P11, DOI 10.1016/S0266-6138(89)80059-2; FREEMAN G, 1985, J ROY COLL GEN PRACT, V35, P423; Freeman G, 1997, BRIT MED J, V314, P1870, DOI 10.1136/bmj.314.7098.1870; FREEMAN GK, 1994, BRIT J GEN PRACT, V44, P395; GORDIS L, 1971, PEDIATRICS, V48, P766; HJORTDAHL P, 1992, BRIT MED J, V304, P1287, DOI 10.1136/bmj.304.6837.1287; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; NAZARETH I, 1993, BRIT MED J, V306, P1103, DOI 10.1136/bmj.306.6885.1103; *NHS EX, 2000, PRIM COMM CAR; ROWLEY MJ, 1995, MED J AUSTRALIA, V163, P289, DOI 10.5694/j.1326-5377.1995.tb124592.x; Royal College of General Practitioners, 1972, FUT GEN PRACT; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413	18	44	47	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					734	735		10.1136/bmj.321.7263.734	http://dx.doi.org/10.1136/bmj.321.7263.734			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999906	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000089546600025
J	Small, PM; Perkins, MD				Small, PM; Perkins, MD			More rigour needed in trials of new diagnostic agents for tuberculosis	LANCET			English	Editorial Material							TESTS		Stanford Univ, Med Ctr, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; WHO, CH-1211 Geneva, Switzerland	Stanford University; World Health Organization	Small, PM (corresponding author), Stanford Univ, Med Ctr, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.							Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; *GLOB TUB CONTR, 2000, WHO REP 2000; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Somi GR, 1999, INT J TUBERC LUNG D, V3, P231; Tsubura E, 1997, Kekkaku, V72, P611; *US FOOD DRUG ADM, 2000, REV CRIT ASS IN VITR; VANDERSCHOUW YT, 1995, INVEST RADIOL, V30, P334, DOI 10.1097/00004424-199506000-00002; *WHO, 2000, WHO WORKSH TUB DIAB	9	49	46	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1048	1049		10.1016/S0140-6736(00)02724-0	http://dx.doi.org/10.1016/S0140-6736(00)02724-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009137				2022-12-28	WOS:000089430500005
J	Victora, CG; Vaughan, JP; Barros, FC; Silva, AC; Tomasi, E				Victora, CG; Vaughan, JP; Barros, FC; Silva, AC; Tomasi, E			Explaining trends in inequities: evidence from Brazilian child health studies	LANCET			English	Article							SOCIAL INEQUALITIES; CESAREAN-SECTIONS; MORTALITY	There is considerable international concern that child-health inequities seem to be getting worse between and within richer and poorer countries. The "inverse equity hypothesis" is proposed to explain how such health inequities may get worse, remain the same, or improve over time. We postulate that as new public-health interventions and programmes initially reach those of higher socioeconomic status and only later affect the poor, there are early increases in inequity ratios for coverage, morbidity, and mortality Indicators. Inequities only improve later when the rich have achieved new minimum achievable levels for morbidity and mortality and the poor gain greater access to the interventions. The hypothesis was examined using three epidemiological data sets for time trends in child-health inequities within Brazil. Time trends for inequity ratios for morbidity and mortality, which were consistent with the hypothesis, showed both improvements and deterioration over time, despite the indicators showing absolute improvements in health status between rich and poor.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; Fed Univ Pelotas, Postgrad Programme Epidemiol, Pelotas, Brazil; Latin amer Ctr Perinatol, Montevideo, Uruguay; Hosp Albert Sabin, Fortaleza, Ceara, Brazil	University of London; London School of Hygiene & Tropical Medicine; Universidade Federal de Pelotas	Vaughan, JP (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.		Barros, Fernando C/D-4857-2013; Victora, Cesar Gomes/Y-2455-2019; Tomasi, Elaine/AAH-2226-2021; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180				Araujo G, 1983, Bull Pan Am Health Organ, V17, P233; BARROS FC, 1991, LANCET, V338, P167, DOI 10.1016/0140-6736(91)90149-J; Barros FC, 1996, LANCET, V347, P839, DOI 10.1016/S0140-6736(96)90922-8; BARROS FC, 1990, PAEDIATR PERINAT EP, V4, P267; Black D, 1999, BMJ-BRIT MED J, V318, P724, DOI 10.1136/bmj.318.7185.724; CASAS JA, IN PRESS EQUITY HLTH; GRAHAM H, 1998, HLTH VARIATIONS, V3, P2; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Jozan P, 1999, BRIT MED J, V318, P914, DOI 10.1136/bmj.318.7188.914; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; MONTEIRO CA, 1997, MOLHORIA INDICADORES; *PAN AM HLTH ORG, 1998, 287 PAHO; *PAN AM HLTH ORG, 1998, PAHO SCI PUBL, V569; SILVA AMC, 1998, THESIS U FEDERAL CEA; TOMASI E, 1996, CADERNOS SAUDE PUB S, V12, pS15; United Nations Children's Fund World Health Organization World Bank Group, 2021, LEVELS TRENDS CHILD; Victora CG, 1996, REV SAUDE PUBL, V30, P34, DOI 10.1590/S0034-89101996000100005; VICTORA CG, 1991, REV SAUDE PUBL, V25, P218, DOI 10.1590/S0034-89101991000300009; Whitehead M, 1999, BRIT MED J, V318, P908, DOI 10.1136/bmj.318.7188.908; WHO. World Health Organization, 1995, TECHNICAL REPORT SER, V854; Williams RB, 1998, JAMA-J AM MED ASSOC, V279, P1745, DOI 10.1001/jama.279.21.1745; World Bank, 1999, WORLD DEV REP 1998 9; 1997, LANCET, V349, P1185	23	460	481	1	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1093	1098		10.1016/S0140-6736(00)02741-0	http://dx.doi.org/10.1016/S0140-6736(00)02741-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009159				2022-12-28	WOS:000089430500039
J	Wakayama, T; Shinkai, Y; Tamashiro, KLK; Niida, H; Blanchard, DC; Blanchard, RJ; Ogura, A; Tanemura, K; Tachibana, M; Perry, ACF; Colgan, DF; Mombaerts, P; Yanagimachi, R				Wakayama, T; Shinkai, Y; Tamashiro, KLK; Niida, H; Blanchard, DC; Blanchard, RJ; Ogura, A; Tanemura, K; Tachibana, M; Perry, ACF; Colgan, DF; Mombaerts, P; Yanagimachi, R			Ageing - Cloning of mice to six generations	NATURE			English	Article									Rockefeller Univ, New York, NY 10021 USA; Univ Hawaii, John A Burns Sch Med, Dept Anat & Reprod Biol, Honolulu, HI 96822 USA; Kyoto Univ, Inst Virus Res, Dept Cell Biol, Sakyo Ku, Kyoto 6068507, Japan; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Hawaii, Bekesy Lab Neurobiol, Honolulu, HI 96822 USA; Natl Inst Infect Dis, Dept Vet Sci, Tokyo 1628640, Japan	Rockefeller University; University of Hawaii System; Kyoto University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Hawaii System; National Institute of Infectious Diseases (NIID)	Wakayama, T (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Shinkai, Yoichi/N-3909-2014; Ogura, Atsuo/J-3916-2014	Shinkai, Yoichi/0000-0002-6051-2484; Ogura, Atsuo/0000-0003-0447-1988; Tamashiro, Kellie/0000-0002-9398-8796; Perry, Tony/0000-0003-3136-5355				Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Tamashiro KLK, 2000, BIOL REPROD, V63, P328, DOI 10.1095/biolreprod63.1.328; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Wilmut I, 2000, NAT BIOTECHNOL, V18, P599, DOI 10.1038/76430; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	8	165	181	1	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					318	319		10.1038/35030301	http://dx.doi.org/10.1038/35030301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014179				2022-12-28	WOS:000089390700033
J	Srivastava, D; Olson, EN				Srivastava, D; Olson, EN			A genetic blueprint for cardiac development	NATURE			English	Article							CONGENITAL HEART-DISEASE; HOLT-ORAM-SYNDROME; BHLH TRANSCRIPTION FACTOR; NEURAL-CREST; VENTRAL MORPHOGENESIS; MICE DEFICIENT; TUBE FORMATION; FACTOR NKX2-5; NF-ATC; MUTATIONS	Congenital heart disease is the leading non-infectious cause of death in children. It is becoming increasingly clear that many cardiac abnormalities once thought to have multifactorial aetiologies are attributable to mutations in developmental control genes. The consequences of these mutations can be manifest at birth as life-threatening cardiac malformations or later as more subtle cardiac abnormalities. Understanding the genetic underpinnings of cardiac development has important implications not only for understanding congenital heart disease, but also for the possibility of cardiac repair through genetic reprogramming of non-cardiac cells to a cardiogenic fate.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Srivastava, D (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 600 Harry Hines Blvd, Dallas, TX 75390 USA.	dsriva@mednet.swmed.edu; eolson@hamon.swmed.edu						Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Bruneau BG, 2000, DEV BIOL, V217, P266, DOI 10.1006/dbio.1999.9548; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Clouthier DE, 1998, DEVELOPMENT, V125, P813; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; DYSON E, 1995, P NATL ACAD SCI USA, V92, P7386, DOI 10.1073/pnas.92.16.7386; EMANUEL BS, 1998, HEART DEV, P463; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Fu YC, 1998, DEVELOPMENT, V125, P4439; Gajewski K, 1997, EMBO J, V16, P515, DOI 10.1093/emboj/16.3.515; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Grow MW, 1998, DEV BIOL, V204, P187, DOI 10.1006/dbio.1998.9080; Gruber PJ, 1996, J CLIN INVEST, V98, P1332, DOI 10.1172/JCI118920; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hyer J, 1999, P NATL ACAD SCI USA, V96, P13214, DOI 10.1073/pnas.96.23.13214; Iida K, 1997, DEVELOPMENT, V124, P4627; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; Krantz ID, 1999, AM J MED GENET, V84, P56; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Li J, 1999, DEVELOPMENT, V126, P2495; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Li QY, 1997, NAT GENET, V15, P21; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thomas T, 1998, DEVELOPMENT, V125, P3005; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Yamagishi H, 1999, SCIENCE, V283, P1158, DOI 10.1126/science.283.5405.1158; Yelon D, 2000, DEVELOPMENT, V127, P2573; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	53	472	503	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					221	226		10.1038/35025190	http://dx.doi.org/10.1038/35025190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001064				2022-12-28	WOS:000089241000057
J	Lin, YY; Lisitza, N; Ahn, SD; Warren, WS				Lin, YY; Lisitza, N; Ahn, SD; Warren, WS			Resurrection of crushed magnetization and chaotic dynamics in solution NMR spectroscopy	SCIENCE			English	Article							MULTIPLE-QUANTUM COHERENCES; DIPOLAR FIELD; RESONANCE; SUPPRESSION; LIQUIDS; ECHOES; WATER	We show experimentally and theoretically that two readily observed effects in solution nuclear magnetic resonance (NMR)-radiation damping and the dipolar field-combine to generate bizarre spin dynamics (including chaotic evolution) even with extraordinarily simple sequences. For example, seemingly insignificant residual magnetization after a crusher gradient triggers exponential regrowth of the magnetization, followed by aperiodic turbulent spin motion. The estimated Lyapunov exponent suggests the onset of spatial-temporal chaos and the existence of chaotic attractors. This effect Leads to highly irreproducible experimental decays that amplify minor nonuniformities such as temperature gradients. Imaging applications and consequences for other NMR studies are discussed.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University	Warren, WS (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.		Ahn, Sangdoo/A-4615-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035253] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alekseev K. N., 1992, Soviet Physics - Uspekhi, V35, P572, DOI 10.1070/PU1992v035n07ABEH002248; BADII R, 1994, REV MOD PHYS, V66, P1389, DOI 10.1103/RevModPhys.66.1389; BAX A, 1987, J AM CHEM SOC, V109, P6511, DOI 10.1021/ja00255a047; BLOEMBERGEN N, 1954, PHYS REV, V95, P8, DOI 10.1103/PhysRev.95.8; BOWTELL R, 1990, J MAGN RESON, V88, P643, DOI 10.1016/0022-2364(90)90297-M; BROEKAERT P, 1995, J MAGN RESON SER A, V113, P60, DOI 10.1006/jmra.1995.1056; DEVILLE G, 1979, PHYS REV B, V19, P5666, DOI 10.1103/PhysRevB.19.5666; EDZES HT, 1990, J MAGN RESON, V86, P293, DOI 10.1016/0022-2364(90)90261-7; Enss T, 1999, CHEM PHYS LETT, V305, P101, DOI 10.1016/S0009-2614(99)00366-8; Garrett-Roe S, 2000, J MAGN RESON, V146, P1, DOI 10.1006/jmre.2000.2096; GUERON M, 1991, PROG NUCL MAG RES SP, V23, P135, DOI 10.1016/0079-6565(91)80007-O; HE QH, 1993, J CHEM PHYS, V98, P6779, DOI 10.1063/1.464770; Jeener J, 1999, PHYS REV LETT, V82, P1772, DOI 10.1103/PhysRevLett.82.1772; JEENER J, 1995, J CHEM PHYS, V103, P1309, DOI 10.1063/1.469808; Lee S, 1996, J CHEM PHYS, V105, P874, DOI 10.1063/1.471968; RICHTER W, 1995, SCIENCE, V267, P654, DOI 10.1126/science.7839140; Vathyam S, 1996, SCIENCE, V272, P92, DOI 10.1126/science.272.5258.92; Warren WS, 1995, CHEM PHYS LETT, V247, P207, DOI 10.1016/0009-2614(95)01184-5; Warren WS, 1998, SCIENCE, V281, P247, DOI 10.1126/science.281.5374.247; WARREN WS, 1993, SCIENCE, V262, P2005, DOI 10.1126/science.8266096	20	101	104	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					118	121		10.1126/science.290.5489.118	http://dx.doi.org/10.1126/science.290.5489.118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021793				2022-12-28	WOS:000089724800046
J	Assaf, C; Goerdt, S; Seibold, M; Orfanos, C				Assaf, C; Goerdt, S; Seibold, M; Orfanos, C			Cutaneous hyalohyphomycosis	LANCET			English	Article									Free Univ Berlin, Univ Med Ctr Benjamin Franklin, Dept Dermatol, D-1000 Berlin, Germany; Robert Koch Inst, D-1000 Berlin, Germany; Univ Heidelberg, Dept Dermatol Venereol & Allergol, D-6800 Mannheim, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Ruprecht Karls University Heidelberg	Assaf, C (corresponding author), Free Univ Berlin, Univ Med Ctr Benjamin Franklin, Dept Dermatol, D-1000 Berlin, Germany.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1185	1185		10.1016/S0140-6736(00)02774-4	http://dx.doi.org/10.1016/S0140-6736(00)02774-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030312				2022-12-28	WOS:000089594300043
J	Liu, SM; Manson, JE; Stampfer, MJ; Rexrode, KM; Hu, FB; Rimm, EB; Willett, WC				Liu, SM; Manson, JE; Stampfer, MJ; Rexrode, KM; Hu, FB; Rimm, EB; Willett, WC			Whole grain consumption and risk of ischemic stroke in women - A prospective study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; FOOD-FREQUENCY QUESTIONNAIRE; DIETARY PATTERNS; POPULATION; FRUIT; MEN; REPRODUCIBILITY; POTASSIUM; MORTALITY; VALIDITY	Context Although increased intake of grain products has been recommended to prevent cardiovascular disease (CVD), prospective data examining the relation of whole grain intake to risk of ischemic stroke are sparse, especially among women. Objective To examine the hypothesis that higher whole grain intake reduces the risk of ischemic stroke in women. Design, Setting, and Participants A prospective cohort of 75521 US women aged 38 to 63 years without previous diagnosis of diabetes mellitus, coronary heart disease, stroke, or other CVDs in 1984, who completed detailed food frequency questionnaires (FFQs) in 1984, 1986, 1990, and 1994, and were followed up for 12 years as part of the Nurses' Health Study. Main Outcome Measure Incidence of ischemic stroke, confirmed by medical records, by quintile of whole grain intake according to FFQ responses. Results During 861 900 person-years of follow-up, 352 confirmed incident cases of ischemic stroke occurred. We observed an inverse association between whole grain intake and ischemic stroke risk. The age-adjusted relative risks (RRs) from the lowest to highest quintiles of whole grain intake were 1.00 (referent), 0.68 (95% confidence interval [CII, 0.49-0.94), 0.69 (95% CI, 0.51-0.95), 0.49 (95% CI, 0.35-0.69), and 0.57 (95% CI, 0.42-0.78; P=.003 for trend). Adjustment for smoking modestly attenuated this association (RR comparing extreme quintiles, 0.64; 95% CI, 0.47-0.89). This inverse association remained essentially unchanged with further adjustment for known CVD risk factors, including saturated fat and transfatty acid intake (multivariate-adjusted RR comparing extreme quintiles, 0.69; 95% Cf, 0.50-0.98). The inverse relation between whole grain intake and risk of ischemic stroke was also consistently observed among subgroups of women who never smoked, did not drink alcohol, did not exercise regularly, or who did not use postmenopausal hormones. No significant association was observed between total grain intake and risk of ischemic stroke. Conclusions tn this cohort, higher intake of whole grain foods was associated with a lower risk of ischemic stroke among women, independent of known CVD risk factors. These prospective data support the notion that higher intake of whole grains may reduce the risk of ischemic stroke.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Liu, SM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.		Liu, Simin/I-3689-2014; Liu, Simin/GSN-4159-2022; Rexrode, Kathryn M/I-1177-2018	Liu, Simin/0000-0003-2098-3844; Rexrode, Kathryn/0000-0003-3387-8429	NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NCI NIH HHS [CA40356] Funding Source: Medline; NHLBI NIH HHS [HL34594, HL24704] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERTSON AM, 1995, J AM DIET ASSOC, V95, P703, DOI 10.1016/S0002-8223(95)00194-8; *AM HEART ASS, 2000, 200 HEART STROK STAT; ANDERSON GH, 1994, CRIT REV FOOD SCI, V34, P435, DOI 10.1080/10408399409527673; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; BRONNER LL, 1995, NEW ENGL J MED, V333, P1392, DOI 10.1056/NEJM199511233332106; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; GRUNDY SM, 1990, J LIPID RES, V31, P1149; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Knekt P, 1996, BRIT MED J, V312, P478, DOI 10.1136/bmj.312.7029.478; LIU S, IN PRESS AM J CLIN N; Liu SM, 1999, AM J CLIN NUTR, V70, P412; *MMWR, 1999, MMWR-MORBID MORTAL W, V48, P649; Ness AR, 1999, J CARDIOVASC RISK, V6, P229; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Selhub J, 1996, J NUTR, V126, pS1258, DOI 10.1093/jn/126.suppl_4.1258S; Slavin J, 1997, NUTR CANCER, V27, P14, DOI 10.1080/01635589709514495; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; *USDA, 2000, NUTR YOUR HLTH DIET; Weinfeld, 1981, STROKE S1, V12, pI13; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WILLETT WC, 1998, MODERN EPIDEMIOLOGY, P623; WOLK AM, IN PRESS BMJ	31	216	226	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1534	1540		10.1001/jama.284.12.1534	http://dx.doi.org/10.1001/jama.284.12.1534			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000647				2022-12-28	WOS:000089379700029
J	Godfrey-Faussett, P; Sonnenberg, P; Shearer, SC; Bruce, MC; Mee, C; Morris, L; Murray, J				Godfrey-Faussett, P; Sonnenberg, P; Shearer, SC; Bruce, MC; Mee, C; Morris, L; Murray, J			Tuberculosis control and molecular epidemiology in a South African gold-mining community	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FALSE-POSITIVE CULTURES; NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; STRAIN DIFFERENTIATION; RECENT TRANSMISSION; DIAGNOSIS	Background Gold miners have very high rates of tuberculosis. The :contribution of infections imported into mining communities versus transmission within them is not known and has implications for control strategies, Methods We did a prospective, population-based molecular and,conventional epidemiological study of pulmonary tuberculosis in a group of goldminers. Clusters were defined as groups of patients with Mycobacterium tuberculosis isolates with identical IS6110 DNA fingerprints. We compared the frequency of possible risk factors in the clustered and nonclustered patients whose isolates had fingerprints with more than four bands, and re-interviewed members of 45 clusters. Findings Of 448 patients, ten were excluded because they had false-positive cultures. Fingerprints were made in 419 of 438, of which 371 had more than four bands. 248 of 371 were categorised into 62 clusters. At least 50% of tuberculosis cases were due to transmission within the community. Patients who had failed treatment at entry to the study were more likely to be: in clusters (adjusted odds ratio 3.41 [95% CI 1.25-9.27]). Patients with multidrug-resistant isolates were more likely to have failed treatment but were less likely to be clustered than those with a sensitive strain(0.27 [0.09-0.83]). HIV infection was common (177 of 370 tested) but not associated with clustering. Interpretation Despite a control programme that cures 86% of new cases, most tuberculosis in this mining community is due to ongoing transmission. Persistently infectious individuals who have:previously failed treatment may be responsible for one third of tuberculosis cases. WHO targets for cure rates are not sufficient to interrupt transmission of tuberculosis in this setting. Indicators that are more closely linked to the rate of ongoing transmission are needed.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Teaching Hosp, Dept Med, ZAMBART Project, Lusaka, Zambia; Epidemiol Res Unit, Johannesburg, South Africa; Univ Witwatersrand, Dept Community Hlth, Parktown, South Africa; Gold Fields S Africa, Johannesburg, South Africa; Univ Witwatersrand, Dept Virol, Johannesburg, South Africa; Univ Witwatersrand, Natl Inst Virol, MRC, AIDS Virus Res Unit, Johannesburg, South Africa; Natl Ctr Occupat Hlth, Dept Hlth, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Zambia; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Godfrey-Faussett, P (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	peter.godfrey-faussett@lshtm.ac.uk	Morris, Lynn/V-3941-2018	Morris, Lynn/0000-0003-3961-7828; Sonnenberg, Pam/0000-0002-1067-1583				ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Barnes PF, 1997, JAMA-J AM MED ASSOC, V278, P1159, DOI 10.1001/jama.278.14.1159; Behr MA, 1998, AM J RESP CRIT CARE, V158, P465, DOI 10.1164/ajrccm.158.2.9801062; Borgdorff MW, 1998, AM J EPIDEMIOL, V147, P187; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P321, DOI 10.1164/ajrccm.155.1.9001331; Churchyard CJ, 1999, INT J TUBERC LUNG D, V3, P791; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; DIPERRI G, 1989, LANCET, V2, P1502; Frieden TR, 1996, TUBERCLE LUNG DIS, V77, P407, DOI 10.1016/S0962-8479(96)90112-4; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; Godfrey-Faussett P, 1999, LANCET, V353, P427, DOI 10.1016/S0140-6736(98)00352-3; Harries AD, 1997, T ROY SOC TROP MED H, V91, P15, DOI 10.1016/S0035-9203(97)90376-X; International Union Against Tuberculosis and Lung Disease, 1996, TUB GUID LOW INC COU; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M; LEGER JP, 1992, S AFR MED J, V81, P197; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; ROSS BC, 1992, J CLIN MICROBIOL, V30, P942, DOI 10.1128/JCM.30.4.942-946.1992; SMALL PM, 1993, J CLIN MICROBIOL, V31, P1677, DOI 10.1128/JCM.31.7.1677-1682.1993; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sonnenberg P, 1998, INT J TUBERC LUNG D, V2, P168; Sutherland I., 1968, TUBERCULOSIS SURVEIL; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; Warren R, 1996, S AFR MED J, V86, P45; *WHO, 1997, WHOTUBERCULOSIS97220; Wilkinson D, 1997, TROP MED INT HEALTH, V2, P747, DOI 10.1046/j.1365-3156.1997.d01-386.x	28	120	129	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2000	356	9235					1066	1071		10.1016/S0140-6736(00)02730-6	http://dx.doi.org/10.1016/S0140-6736(00)02730-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009142				2022-12-28	WOS:000089430500011
J	Torgerson, DJ; Campbell, MK				Torgerson, DJ; Campbell, MK			Economic notes - Use of unequal randomisation to aid the economic efficiency of clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland	University of York - UK; University of Aberdeen	Torgerson, DJ (corresponding author), Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England.		Torgerson, David/L-4566-2019; Campbell, Marion/ABB-7063-2020	Torgerson, David/0000-0002-1667-4275; 				CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Moser C.A., 2017, SURVEY METHODS SOCIA; PEDERSEN TR, 1994, LANCET, V344, P1383; Pocock S, 1983, CLIN TRIALS; Torgerson D, 1997, J Health Serv Res Policy, V2, P81; Torgerson DJ, 2000, BRIT MED J, V321, P697, DOI 10.1136/bmj.321.7262.697	6	21	21	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2000	321	7263					759	759		10.1136/bmj.321.7263.759	http://dx.doi.org/10.1136/bmj.321.7263.759			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999916	Green Published			2022-12-28	WOS:000089546600035
J	Carter, AP; Clemons, WM; Brodersen, DE; Morgan-Warren, RJ; Wimberly, BT; Ramakrishnan, V				Carter, AP; Clemons, WM; Brodersen, DE; Morgan-Warren, RJ; Wimberly, BT; Ramakrishnan, V			Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics	NATURE			English	Article							ESCHERICHIA-COLI RIBOSOME; AMINOACYL-TRANSFER-RNA; PEPTIDYL-TRANSFER-RNA; A-SITE; P-SITE; CONFORMATIONAL SWITCH; CROSS-LINKING; STREPTOMYCIN; BINDING; MUTATIONS	The 30S ribosomal subunit has two primary functions in protein synthesis. It discriminates against aminoacyl transfer RNAs that do not match the codon of messenger RNA, thereby ensuring accuracy in translation of the genetic message in a process called decoding. Also, it works with the 50S subunit to move the tRNAs and associated mRNA by precisely one codon, in a process called translocation. Here we describe the functional implications of the high-resolution 30S crystal structure presented in the accompanying paper, and infer details of the interactions between the 30S subunit and its tRNA and mRNA ligands. We also describe the crystal structure of the 30S subunit complexed with the antibiotics paromomycin, streptomycin and spectinomycin, which interfere with decoding and translocation. This work reveals the structural basis for the action of these antibiotics, and leads to a model for the role of the universally conserved 16S RNA residues A1492 and A1493 in the decoding process.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA	MRC Laboratory Molecular Biology; Utah System of Higher Education; University of Utah	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	brianw@mrc-lmb.cam.ac.uk; ramak@mrc-lmb.cam.ac.uk	Clemons, William M/D-1026-2009; Brodersen, Ditlev E./AAQ-5241-2020	Clemons, William M/0000-0002-0021-889X; Brodersen, Ditlev/0000-0002-5413-4667; Ramakrishnan, V/0000-0002-4699-2194; Carter, Andrew/0000-0001-7292-5430	NIGMS NIH HHS [F31 GM019384] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM019384] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; ALLEN PN, 1989, J MOL BIOL, V208, P457, DOI 10.1016/0022-2836(89)90509-3; BILGIN N, 1994, J MOL BIOL, V235, P813, DOI 10.1006/jmbi.1994.1041; BILGIN N, 1990, EMBO J, V9, P735, DOI 10.1002/j.1460-2075.1990.tb08167.x; BOCK A, 1979, FEBS LETT, V104, P317, DOI 10.1016/0014-5793(79)80842-X; BRINK MF, 1994, NUCLEIC ACIDS RES, V22, P325, DOI 10.1093/nar/22.3.325; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; Garrett R. A., 2000, RIBOSOME STRUCTURE F; GRAVEL M, 1987, BIOCHEMISTRY-US, V26, P6227, DOI 10.1021/bi00393a041; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Karimi R, 1996, EMBO J, V15, P1149, DOI 10.1002/j.1460-2075.1996.tb00453.x; KARIMI R, 1994, EUR J BIOCHEM, V226, P355, DOI 10.1111/j.1432-1033.1994.tb20059.x; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; KURLAND CG, 1996, LIMITATIONS TRANSLAT, P979; LECLERC D, 1991, NUCLEIC ACIDS RES, V19, P3973, DOI 10.1093/nar/19.14.3973; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; MELANCON P, 1984, BIOCHEMISTRY-US, V23, P6697, DOI 10.1021/bi00321a064; MELANCON P, 1988, NUCLEIC ACIDS RES, V16, P9631, DOI 10.1093/nar/16.20.9631; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MONTANDON PE, 1985, NUCLEIC ACIDS RES, V13, P4299, DOI 10.1093/nar/13.12.4299; MONTROSE L, 1986, ENGL LITERARY RENAIS, V16, P5, DOI 10.1111/j.1475-6757.1986.tb00895.x; Mueller F, 1997, J MOL BIOL, V271, P566, DOI 10.1006/jmbi.1997.1212; Mueller F, 1997, J MOL BIOL, V271, P524, DOI 10.1006/jmbi.1997.1210; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Pape T, 2000, NAT STRUCT BIOL, V7, P104; PINARD R, 1993, FASEB J, V7, P173, DOI 10.1096/fasebj.7.1.7678560; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; PRINCE JB, 1982, P NATL ACAD SCI-BIOL, V79, P5450, DOI 10.1073/pnas.79.18.5450; RUUSALA T, 1984, MOL GEN GENET, V198, P100, DOI 10.1007/BF00328707; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; VanLoock MS, 1999, J MOL BIOL, V285, P2069, DOI 10.1006/jmbi.1998.2442; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WITTMANNLIEBOLD B, 1978, FEBS LETT, V95, P91, DOI 10.1016/0014-5793(78)80059-3; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722	46	1215	1281	7	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					340	348		10.1038/35030019	http://dx.doi.org/10.1038/35030019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014183				2022-12-28	WOS:000089390700037
J	Riebesell, U; Zondervan, I; Rost, B; Tortell, PD; Zeebe, RE; Morel, FMM				Riebesell, U; Zondervan, I; Rost, B; Tortell, PD; Zeebe, RE; Morel, FMM			Reduced calcification of marine plankton in response to increased atmospheric CO2	NATURE			English	Article							TOTAL CARBON-DIOXIDE; EMILIANIA-HUXLEYI; CALCIUM-CARBONATE; COCCOLITHOPHORE; SEAWATER; SYSTEM; GROWTH; OCEAN	The formation of calcareous skeletons by marine planktonic organisms and their subsequent sinking to depth generates a continuous rain of calcium carbonate to the deep ocean and underlying sediments(1). This is important in regulating marine carbon cycling and ocean-atmosphere CO2 exchange(2). The present rise in atmospheric CO2 levels(3) causes significant changes in surface ocean pH and carbonate chemistry(4). Such changes have been shown to slow down calcification in corals and coralline macroalgae(5,6), but the majority of marine calcification occurs in planktonic organisms. Here we report reduced calcite production at increased CO2 concentrations in monospecific cultures of two dominant marine calcifying phytoplankton species, the coccolithophorids Emiliania huxleyi and Gephyrocapsa oceanica. This was accompanied by an increased proportion of malformed coccoliths and incomplete coccospheres. Diminished calcification led to a reduction in the ratio of calcite precipitation to organic matter production. Similar results were obtained in incubations of natural plankton assemblages from the north Pacific ocean when exposed to experimentally elevated CO2 levels. We suggest that the progressive increase in atmospheric CO2 concentrations may therefore slow down the production of calcium carbonate in the surface ocean. As the process of calcification releases CO2 to the atmosphere, the response observed here could potentially act as a negative feedback on atmospheric CO2 levels.	Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Princeton University; Princeton University; Columbia University	Riebesell, U (corresponding author), Alfred Wegener Inst Polar & Marine Res, POB 120161, D-27515 Bremerhaven, Germany.		Morel, Francois M M/A-8107-2008; Rost, Bjoern/B-4447-2015; Riebesell, Ulf/AAC-9717-2020	Rost, Bjoern/0000-0001-5452-5505; Riebesell, Ulf/0000-0002-9442-452X; Tortell, Philippe/0000-0003-0212-2151				BOOTH BC, 1993, PROG OCEANOGR, V32, P57, DOI 10.1016/0079-6611(93)90009-3; BRADSHAW AL, 1981, EARTH PLANET SC LETT, V55, P99, DOI 10.1016/0012-821X(81)90090-X; FRANKIGNOULLE M, 1994, LIMNOL OCEANOGR, V39, P458, DOI 10.4319/lo.1994.39.2.0458; Fritz JJ, 1996, J EXP MAR BIOL ECOL, V207, P127, DOI 10.1016/S0022-0981(96)02633-0; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; GOYET C, 1989, DEEP-SEA RES, V36, P1635, DOI 10.1016/0198-0149(89)90064-2; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HARRIS RP, 1994, MAR BIOL, V119, P431, DOI 10.1007/BF00347540; Holligan PM, 1996, GLOB CHANGE BIOL, V2, P85, DOI 10.1111/j.1365-2486.1996.tb00053.x; HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731; Houghton JT., 1995, CLIMATE CHANGE 1994; JOHNSON KM, 1993, MAR CHEM, V44, P167, DOI 10.1016/0304-4203(93)90201-X; KHESHGI HS, 1991, J GEOPHYS RES-OCEANS, V96, P4957, DOI 10.1029/90JC02336; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Lewis E., 1998, ORNLCDIAC105 US DEP; McConnaughey TA, 1997, EARTH-SCI REV, V42, P95, DOI 10.1016/S0012-8252(96)00036-0; McConnaughey Ted A., 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P137; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Morse J.W., 1990, DEV SEDIMENTOLOGY, V48; Nielsen MV, 1997, J PHYCOL, V33, P818, DOI 10.1111/j.0022-3646.1997.00818.x; PURDIE DA, 1994, SARSIA, V79, P379, DOI 10.1080/00364827.1994.10413569; WESTBROEK P, 1993, GLOBAL PLANET CHANGE, V8, P27, DOI 10.1016/0921-8181(93)90061-R; WESTBROEK P, 1989, J PROTOZOOL, V36, P368, DOI 10.1111/j.1550-7408.1989.tb05528.x; Westbroek P., 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P37; Winter Amos, 1994, P161; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Young Jeremy R., 1994, P63; YOUNG JR, 1994, SARSIA, V79, P417, DOI 10.1080/00364827.1994.10413573	28	996	1050	22	510	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					364	367		10.1038/35030078	http://dx.doi.org/10.1038/35030078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014189	Green Published			2022-12-28	WOS:000089390700043
J	Coughlin, SR				Coughlin, SR			Thrombin signalling and protease-activated receptors	NATURE			English	Article							ENDOTHELIAL BARRIER FUNCTION; G-PROTEINS; PLATELET ACTIVATION; P-SELECTIN; MOLECULAR-CLONING; PLASMA-MEMBRANE; TISSUE FACTOR; P115 RHOGEF; CELLS; COAGULATION	How does the coagulation protease thrombin regulate cellular behaviour? The protease-activated receptors (PARs) provide one answer. In concert with the coagulation cascade, these receptors provide an elegant mechanism linking mechanical information in the form of tissue injury or vascular leakage to cellular responses. Roles for PARs are beginning to emerge in haemostasis and thrombosis, inflammation, and perhaps even blood vessel development.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, HSE-1300,505 Parnassus Ave, San Francisco, CA 94143 USA.							Andrews RK, 1999, THROMB HAEMOSTASIS, V82, P357, DOI 10.1055/s-0037-1615854; Barr AJ, 1997, J BIOL CHEM, V272, P2223; Bernatowicz MS, 1996, J MED CHEM, V39, P4879, DOI 10.1021/jm960455s; BEVILACQUA MP, 1987, SEMIN THROMB HEMOST, V13, P425, DOI 10.1055/s-2007-1003519; BRASS LF, 1992, J BIOL CHEM, V267, P13795; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; CHEN J, 1994, J BIOL CHEM, V269, P16041; Cirino G, 1996, J EXP MED, V183, P821, DOI 10.1084/jem.183.3.821; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; COLMAN RW, 1994, HEMOSTASIS THROMBOSI, P3; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; CONNOLLY TM, 1994, THROMB HAEMOSTASIS, V72, P627; Coughlin SR, 1998, ARTERIOSCL THROM VAS, V18, P514, DOI 10.1161/01.ATV.18.4.514; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; DERIAN CK, 1995, THROMB RES, V78, P505, DOI 10.1016/0049-3848(95)00084-5; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; Esmon CT, 1999, HAEMATOLOGICA, V84, P254; Esmon CT, 2000, BLOOD, V95, P1113, DOI 10.1182/blood.V95.4.1113.004k54_1113_1116; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HATTORI R, 1989, J BIOL CHEM, V264, P7768; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; HUNG DT, 1992, J BIOL CHEM, V267, P20831; HUNG DT, 1992, J CLIN INVEST, V89, P1350, DOI 10.1172/JCI115721; Inbal A, 1997, THROMB HAEMOSTASIS, V77, P1086; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; ISHII K, 1993, J BIOL CHEM, V268, P9780; Johnson K, 1998, J IMMUNOL, V160, P5130; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; LUM H, 1994, AM J PHYSIOL, V267, pL223, DOI 10.1152/ajplung.1994.267.3.L223; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; OKAMURA T, 1978, J BIOL CHEM, V253, P3435; Osterud B, 1998, BLOOD COAGUL FIBRIN, V9, pS9; PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; SELAK MA, 1988, BIOCHEM J, V251, P293, DOI 10.1042/bj2510293; SHAPIRO MJ, IN PRESS J BIOL CHEM; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Subramaniam M, 1996, BLOOD, V87, P1238, DOI 10.1182/blood.V87.4.1238.bloodjournal8741238; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zimmerman GA, 1996, ADV EXP MED BIOL, V416, P297	64	1981	2072	3	174	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					258	264		10.1038/35025229	http://dx.doi.org/10.1038/35025229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001069				2022-12-28	WOS:000089241000062
J	McNew, JA; Parlati, F; Fukuda, R; Johnston, RJ; Paz, K; Paumet, F; Sollner, TH; Rothman, JE				McNew, JA; Parlati, F; Fukuda, R; Johnston, RJ; Paz, K; Paumet, F; Sollner, TH; Rothman, JE			Compartmental specificity of cellular membrane fusion encoded in SNARE proteins	NATURE			English	Article							T-SNARE; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; V-SNARE; ENDOPLASMIC-RETICULUM; TRANSPORT PATHWAYS; VESICLE TRANSPORT; COMPLEX-FORMATION; GOLGI TRANSPORT; YEAST	Membrane-enveloped vesicles travel among the compartments of the cytoplasm of eukaryotic cells, delivering their specific cargo to programmed locations by membrane fusion. The pairing of vesicle v-SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) with target membrane t-SNAREs has a central role in intracellular membrane fusion. We have tested all of the potential v-SNAREs encoded in the yeast genome for their capacity to trigger fusion by partnering with t-SNAREs that mark the Golgi, the vacuole and the plasma membrane. Here we rnd that, to a marked degree, the pattern of membrane flow in the cell is encoded and recapitulated by its isolated SNARE proteins, as predicted by the SNARE hypothesis.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Rothman, JE (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.		McNew, James/AAV-4911-2020; Zdilla, Michael J/B-4145-2011; Wunder, Stephanie L/B-5066-2012; McNew, James/ABD-8081-2020	McNew, James/0000-0001-8459-3664; Paumet, Fabienne/0000-0003-4466-6966				AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Abeliovich H, 1998, J BIOL CHEM, V273, P11719, DOI 10.1074/jbc.273.19.11719; BANFIELD DK, 1995, NATURE, V375, P806, DOI 10.1038/375806a0; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Gerst JE, 1997, J BIOL CHEM, V272, P16591, DOI 10.1074/jbc.272.26.16591; GERST JE, 1992, P NATL ACAD SCI USA, V89, P4338, DOI 10.1073/pnas.89.10.4338; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Katz L, 1998, EMBO J, V17, P6200, DOI 10.1093/emboj/17.21.6200; Lupashin VV, 1997, MOL BIOL CELL, V8, P2659, DOI 10.1091/mbc.8.12.2659; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; NEWMAN AP, 1990, MOL CELL BIOL, V10, P3405, DOI 10.1128/MCB.10.7.3405; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Nichols BJ, 1998, BBA-MOL CELL RES, V1404, P9, DOI 10.1016/S0167-4889(98)00044-5; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	50	517	531	4	64	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					153	159		10.1038/35025000	http://dx.doi.org/10.1038/35025000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001046				2022-12-28	WOS:000089241000038
J	Jones, RL; Young, LS; Adams, DH				Jones, RL; Young, LS; Adams, DH			Immunotherapy in hepatocellular carcinoma	LANCET			English	Editorial Material							TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; PEPTIDE		Univ Birmingham, Inst Clin Sci, Liver Res Labs, Birmingham B15 2TH, W Midlands, England; Univ Birmingham, Inst Clin Sci, CRC Inst Canc Studies, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham	Adams, DH (corresponding author), Univ Birmingham, Inst Clin Sci, Liver Res Labs, Birmingham B15 2TH, W Midlands, England.		Young, Lawrence S/B-7213-2009; Adams, David H/C-9092-2009	Young, Lawrence S/0000-0003-3919-4298; Adams, David H/0000-0001-6776-0336				BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Brinckerhoff LH, 2000, CURR OPIN ONCOL, V12, P163, DOI 10.1097/00001622-200003000-00012; Butterfield LH, 1999, CANCER RES, V59, P3134; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; LAFRENIERE R, 1986, J IMMUNOL METHODS, V94, P37, DOI 10.1016/0022-1759(86)90213-9; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; Yoong KF, 1998, J IMMUNOL, V160, P3978	10	5	6	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					784	785		10.1016/S0140-6736(00)02648-9	http://dx.doi.org/10.1016/S0140-6736(00)02648-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022921				2022-12-28	WOS:000089101800004
J	Ollier, WER				Ollier, WER			Role of interferon-gamma gene in rheumatoid arthritis?	LANCET			English	Editorial Material							LINKAGE; LOCUS		Univ Manchester, Sch Med, ARC Epidemiol Unit, Manchester M13 9PT, Lancs, England	University of Manchester	Ollier, WER (corresponding author), Univ Manchester, Sch Med, ARC Epidemiol Unit, Manchester M13 9PT, Lancs, England.							Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Cox A, 1999, HUM MOL GENET, V8, P1707, DOI 10.1093/hmg/8.9.1707; FIFE M, IN PRESS ARTHRITIS R; John S, 1999, ARTHRITIS RHEUM, V42, P1617, DOI 10.1002/1529-0131(199908)42:8<1617::AID-ANR8>3.0.CO;2-N; John S, 1998, ANN RHEUM DIS, V57, P361, DOI 10.1136/ard.57.6.361; Ollier W, 1997, BRIT J RHEUMATOL, V36, P931; OLLIER WER, 1995, BRIT MED BULL, V51, P267, DOI 10.1093/oxfordjournals.bmb.a072960; OLLIER WER, 1997, CONTROVERSIES RHEUMA, P1; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602	9	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					783	784		10.1016/S0140-6736(00)02647-7	http://dx.doi.org/10.1016/S0140-6736(00)02647-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022920				2022-12-28	WOS:000089101800003
J	Chang, WH; Kornberg, RD				Chang, WH; Kornberg, RD			Electron crystal structure of the transcription factor and DNA repair complex, core TFIIH	CELL			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; LIPID-LAYER CRYSTALLIZATION; TWO-DIMENSIONAL CRYSTALS; START SITE SELECTION; SACCHAROMYCES-CEREVISIAE; XERODERMA-PIGMENTOSUM; RAD3 GENE; FACTOR-B; YEAST	Core TFIIH from yeast, made up of five subunits required both for RNA polymerase II transcription and nucleotide excision DNA repair, formed 2D crystals on charged lipid layers. Diffraction from electron micrographs of the crystals in negative stain extended to about 13 Angstrom resolution, and 3D reconstruction revealed several discrete densities whose volumes corresponded well with those of individual TFIIH subunits. The structure is based on a ring of three subunits, Tfb1, Tfb2, and Tfb3, to which are appended several functional moieties: Rad3, bridged to Tfb1 by SsI1; SsI2, known to interact with Tfb2; and Kin28, known to interact with Tfb3.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.		Chang, Wei-Hau/F-1965-2015	Chang, Wei-Hau/0000-0002-2612-850X	NIAID NIH HHS [AI21144] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen G, 1997, EMBO J, V16, P958, DOI 10.1093/emboj/16.5.958; Asturias FJ, 1998, ULTRAMICROSCOPY, V70, P133, DOI 10.1016/S0304-3991(97)00108-3; Asturias FJ, 1997, J MOL BIOL, V272, P536, DOI 10.1006/jmbi.1997.1273; ASTURIAS FJ, 1995, J STRUCT BIOL, V114, P60, DOI 10.1006/jsbi.1995.1005; BARDWELL AJ, 1994, MOL CELL BIOL, V14, P3569, DOI 10.1128/MCB.14.6.3569; BARDWELL L, 1994, P NATL ACAD SCI USA, V91, P3926, DOI 10.1073/pnas.91.9.3926; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; FEAVER WJ, 1991, J BIOL CHEM, V266, P19000; Feaver WJ, 2000, J BIOL CHEM, V275, P5941, DOI 10.1074/jbc.275.8.5941; Feaver WJ, 1997, J BIOL CHEM, V272, P19319, DOI 10.1074/jbc.272.31.19319; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; FRIEDBERG EC, 1992, CELL, V71, P887, DOI 10.1016/0092-8674(92)90384-O; Friedberg EC, 1996, ANNU REV BIOCHEM, V65, P15; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; Jensen P, 1998, LIT HIST-THIRD SER, V7, P1; Kornberg RD, 1991, CURR OPIN STRUC BIOL, V1, P642, DOI 10.1016/S0959-440X(05)80090-9; Leuther KK, 1996, CELL, V85, P773, DOI 10.1016/S0092-8674(00)81242-8; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; LUDWIG DS, 1986, P NATL ACAD SCI USA, V83, P8585, DOI 10.1073/pnas.83.22.8585; MATSUI P, 1995, NUCLEIC ACIDS RES, V23, P767, DOI 10.1093/nar/23.5.767; NAUMOVSKI L, 1987, MOL GEN GENET, V209, P458, DOI 10.1007/BF00331150; NAUMOVSKI L, 1986, MOL CELL BIOL, V6, P1218, DOI 10.1128/MCB.6.4.1218; Poglitsch CL, 1999, CELL, V98, P791, DOI 10.1016/S0092-8674(00)81513-5; RIBI HO, 1987, BIOCHEMISTRY-US, V26, P7974, DOI 10.1021/bi00398a064; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; SUNG P, 1987, P NATL ACAD SCI USA, V84, P6045, DOI 10.1073/pnas.84.17.6045; Sung P, 1996, J BIOL CHEM, V271, P10821, DOI 10.1074/jbc.271.18.10821; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6; Sweder KS, 1996, NUCLEIC ACIDS RES, V24, P1540, DOI 10.1093/nar/24.8.1540; UNGER VM, 1995, BIOPHYS J, V68, P1776, DOI 10.1016/S0006-3495(95)80354-1; UZGIRIS EE, 1983, NATURE, V301, P125, DOI 10.1038/301125a0; WANG ZG, 1995, MOL CELL BIOL, V15, P2288	49	79	80	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					609	613		10.1016/S0092-8674(00)00083-0	http://dx.doi.org/10.1016/S0092-8674(00)00083-0			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007479	Bronze			2022-12-28	WOS:000089105200009
J	Revy, P; Muto, T; Levy, Y; Geissmann, F; Plebani, A; Sanal, O; Catalan, N; Forveille, M; Dufourcq-Lagelouse, R; Gennery, A; Tezcan, I; Ersoy, F; Kayserili, H; Ugazio, AG; Brousse, N; Muramatsu, M; Notarangelo, LD; Kinoshita, K; Honjo, T; Fischer, A; Durandy, A				Revy, P; Muto, T; Levy, Y; Geissmann, F; Plebani, A; Sanal, O; Catalan, N; Forveille, M; Dufourcq-Lagelouse, R; Gennery, A; Tezcan, I; Ersoy, F; Kayserili, H; Ugazio, AG; Brousse, N; Muramatsu, M; Notarangelo, LD; Kinoshita, K; Honjo, T; Fischer, A; Durandy, A			Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2)	CELL			English	Article							CLASS SWITCH RECOMBINATION; X-LINKED IMMUNODEFICIENCY; FACTOR-KAPPA-B; CD40 LIGAND; SOMATIC HYPERMUTATION; GERMINAL-CENTERS; DEFECTIVE EXPRESSION; IMMUNOGLOBULIN GENES; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR	The activation-induced cytidine deaminase (AID) gene, specifically expressed in germinal center B cells in mice, is a member of the cytidine deaminase family. We herein report mutations in the human counterpart of AID in patients with the autosomal recessive form of hyper-IgM syndrome (HIGM2). Three major abnormalities characterize AID deficiency: (1) the absence of immunoglobulin class switch recombination, (2) the lack of immunoglobulin somatic hypermutations, and (3) lymph node hyperplasia caused by the presence of giant germinal centers. The phenotype observed in HIGM2 patients (and in AID(-/-) mice) demonstrates the absolute requirement for AID in several crucial steps of B cell terminal differentiation necessary for efficient antibody responses.	Hop Necker Enfants Malad, INSERM, U429, Paris, France; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan; Hop Cochin, INSERM, U474, F-75674 Paris, France; Hop Necker Enfants Malad, Serv Anatomopathol, Paris, France; Univ Brescia, Pediat Clin, Brescia, Italy; Univ Brescia, Ist Med Mol Angelo Novicelli, Brescia, Italy; Hacettepe Univ, Div Immunol, Ihsan Dogramaci Childrens Hosp, Ankara, Turkey; Istanbul Univ, Inst Child Hlth, Istanbul, Turkey; Hop Necker Enfants Malad, Unite Immunol Hematol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Kyoto University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Brescia; University of Brescia; Hacettepe University; Istanbul University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Durandy, A (corresponding author), Hop Necker Enfants Malad, INSERM, U429, Paris, France.	durandy@necker.fr	Notarangelo, Luigi D/F-9718-2016; Revy, Patrick/H-8137-2017; Plebani, Alessandro/C-8593-2011; Ugazio, Alberto/AAA-6092-2020; Kayserili, Hülya/AAA-5593-2021; Muramatsu, Masamichi/C-4339-2015; Honjo, Tasuku/N-4470-2016; Durandy, Anne/H-7475-2017	Notarangelo, Luigi D/0000-0002-8335-0262; Kayserili, Hülya/0000-0003-0376-499X; Muramatsu, Masamichi/0000-0002-0153-3533; geissmann, frederic/0000-0001-5029-2468; Revy, Patrick/0000-0003-0758-8022; Durandy, Anne/0000-0001-7706-8466	Telethon [E.0668] Funding Source: Medline	Telethon(Fondazione Telethon)		ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BERBERICH I, 1994, J IMMUNOL, V153, P4357; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; CALLARD RE, 1994, J IMMUNOL, V153, P3295; Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; CONLEY ME, 1994, J CLIN INVEST, V94, P1404, DOI 10.1172/JCI117476; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; DURANDY A, 1993, EUR J IMMUNOL, V23, P2294, DOI 10.1002/eji.1830230936; Durandy A, 1997, J IMMUNOL, V158, P2576; DURANDY A, 1990, J IMMUNOL, V144, P60; FACCHETTI F, 1995, J IMMUNOL, V154, P6624; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369; HU HM, 1994, J BIOL CHEM, V269, P30069; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; KRAUTER K, 1995, NATURE, V377, P321; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Lagresle C, 1996, J EXP MED, V183, P1377, DOI 10.1084/jem.183.4.1377; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; Lebecque S, 1997, J EXP MED, V185, P563, DOI 10.1084/jem.185.3.563; LEDERMAN S, 1992, J IMMUNOL, V149, P3817; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; Levy Y, 1998, P NATL ACAD SCI USA, V95, P13135, DOI 10.1073/pnas.95.22.13135; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; MUTO T, 2000, IN PRESS GENOMICS; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; Revy P, 1998, EUR J IMMUNOL, V28, P3648, DOI 10.1002/(SICI)1521-4141(199811)28:11<3648::AID-IMMU3648>3.3.CO;2-L; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; ROUSSET F, 1991, J EXP MED, V173, P705, DOI 10.1084/jem.173.3.705; SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q; SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0; SIMPSON L, 1995, CELL, V81, P837, DOI 10.1016/0092-8674(95)90003-9; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; STEWART AK, 1993, J EXP MED, V177, P409, DOI 10.1084/jem.177.2.409; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tracy RB, 2000, SCIENCE, V288, P1058, DOI 10.1126/science.288.5468.1058; Wiesendanger M, 1998, CELL, V94, P415, DOI 10.1016/S0092-8674(00)81581-0; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; Zan H, 1999, J IMMUNOL, V162, P3437; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x	76	1216	1247	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					565	575		10.1016/S0092-8674(00)00079-9	http://dx.doi.org/10.1016/S0092-8674(00)00079-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007475	Bronze, Green Published			2022-12-28	WOS:000089105200005
J	Olkkonen, VM; Ikonen, E				Olkkonen, VM; Ikonen, E			Mechanisms of disease - Genetic defects of intracellular-membrane transport	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHEDIAK-HIGASHI-SYNDROME; RAB GERANYLGERANYL TRANSFERASE; SYNDROME TYPE 1B; PICK C1 PROTEIN; MYOSIN-VIIA; CHOLESTEROL TRANSPORT; LOWE-SYNDROME; PLASMA-MEMBRANE; GOLGI NETWORK; CHOROIDEREMIA		Natl Publ Hlth Inst, Dept Biochem, Helsinki, Finland	Finland National Institute for Health & Welfare	Olkkonen, VM (corresponding author), Natl Publ Hlth Inst, Dept Biochem, Mannerheimintie 166, Helsinki, Finland.			Olkkonen, Vesa/0000-0001-5553-7997				Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BAETZ K, 1995, J IMMUNOL, V154, P6122; Barbosa MDFS, 1997, NATURE, V385, P97, DOI 10.1038/385097a0; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Brodsky FM, 1999, IMMUNOL REV, V168, P199, DOI 10.1111/j.1600-065X.1999.tb01294.x; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; D'Adamo P, 1998, NAT GENET, V19, P303, DOI 10.1038/1001; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Erickson RP, 1997, P NATL ACAD SCI USA, V94, P8924, DOI 10.1073/pnas.94.17.8924; Faigle W, 1998, J CELL BIOL, V141, P1121, DOI 10.1083/jcb.141.5.1121; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; Jolley CD, 1998, J LIPID RES, V39, P2143; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; KLEIN C, 1994, J PEDIATR-US, V125, P886, DOI 10.1016/S0022-3476(05)82003-7; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Kuehn MJ, 1997, CURR OPIN CELL BIOL, V9, P477, DOI 10.1016/S0955-0674(97)80022-1; Kuznetsov G, 1998, NEW ENGL J MED, V339, P1688, DOI 10.1056/NEJM199812033392307; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Le Borgne R, 1998, CURR OPIN CELL BIOL, V10, P499; Lippincott-Schwartz J, 1998, CURR OPIN CELL BIOL, V10, P52, DOI 10.1016/S0955-0674(98)80086-0; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MERCER JA, 1991, NATURE, V352, P547, DOI 10.1038/352547b0; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; MERRY DE, 1992, P NATL ACAD SCI USA, V89, P2135, DOI 10.1073/pnas.89.6.2135; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; Pastural E, 1999, NAT GENET, V23, P373, DOI 10.1038/15565; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Perou CM, 1997, J BIOL CHEM, V272, P29790, DOI 10.1074/jbc.272.47.29790; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Richardson GP, 1997, J NEUROSCI, V17, P9506; Roth MG, 1999, TRENDS CELL BIOL, V9, P174, DOI 10.1016/S0962-8924(99)01535-4; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Shields D, 1999, CURR OPIN CELL BIOL, V11, P489, DOI 10.1016/S0955-0674(99)80070-2; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spritz RA, 1998, J CLIN IMMUNOL, V18, P97, DOI 10.1023/A:1023247215374; SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; vandenHurk JAJM, 1997, HUM MOL GENET, V6, P851, DOI 10.1093/hmg/6.6.851; von Figura K, 1991, Curr Opin Cell Biol, V3, P642, DOI 10.1016/0955-0674(91)90035-W; Watari H, 1999, P NATL ACAD SCI USA, V96, P805, DOI 10.1073/pnas.96.3.805; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Young SG, 1999, NAT GENET, V22, P316, DOI 10.1038/11878; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	76	48	49	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2000	343	15					1095	1104		10.1056/NEJM200010123431507	http://dx.doi.org/10.1056/NEJM200010123431507			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362FA	11027745				2022-12-28	WOS:000089766900007
J	Kreng, VM				Kreng, VM			Hands that held other hands	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1757	1758		10.1001/jama.284.14.1757	http://dx.doi.org/10.1001/jama.284.14.1757			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025804				2022-12-28	WOS:000089622100001
J	Madhok, R; Kerr, H; Capell, HA				Madhok, R; Kerr, H; Capell, HA			Recent advances - Rheumatology	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED TRIAL; ANTIRHEUMATIC DRUGS; KNEE OSTEOARTHRITIS; DOUBLE-BLIND; ARTHRITIS; PLACEBO; METHOTREXATE; SULFASALAZINE; OSTEOPOROSIS; DISABILITY		Glasgow Royal Infirm, Ctr Rheumat Dis, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow	Capell, HA (corresponding author), Glasgow Royal Infirm, Ctr Rheumat Dis, Glasgow G4 0SF, Lanark, Scotland.	gcll0l@clinmed.gla.ac.uk						Berman BM, 1999, RHEUMATOLOGY, V38, P346, DOI 10.1093/rheumatology/38.4.346; Birrell F, 1999, ANN RHEUM DIS, V58, P569, DOI 10.1136/ard.58.9.569; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; CUMMINGS SR, 1998, JAMA-J AM MED ASSOC, V280, P2977; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Eastell R, 1998, J INTERN MED, V244, P271, DOI 10.1046/j.1365-2796.1998.00408.x; EGSMOSE C, 1995, J RHEUMATOL, V22, P2208; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; FRIES JF, 1996, ARTHRITIS RHEUM, V39, P606; Gotzsche PC, 1996, SCAND J RHEUMATOL, V25, P194, DOI 10.3109/03009749609069987; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; HENCH PS, 1949, P STAFF M MAYO CLIN, V24, P181; Hurley MV, 1998, BRIT J RHEUMATOL, V37, P1181; Jordan VC, 1999, BRIT MED J, V319, P331, DOI 10.1136/bmj.319.7206.331; KIRWAN JR, 1995, NEW ENGL J MED, V333, P142, DOI 10.1056/NEJM199507203330302; Lane N. E., 1997, Arthritis and Rheumatism, V40, pS238; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Mazzuca SA, 1997, ARTHRITIS RHEUM-US, V40, P1466, DOI 10.1002/art.1780400815; McAlindon T, 1997, ANN RHEUM DIS, V56, P397, DOI 10.1136/ard.56.7.397; McAlindon TE, 1996, ANN INTERN MED, V125, P353, DOI 10.7326/0003-4819-125-5-199609010-00001; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; McAlindon TE, 1999, AM J MED, V106, P151, DOI 10.1016/S0002-9343(98)00413-6; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Munro R, 1998, ANN RHEUM DIS, V57, P88, DOI 10.1136/ard.57.2.88; O'Reilly SC, 1999, ANN RHEUM DIS, V58, P15, DOI 10.1136/ard.58.1.15; Reginster JY, 1999, ARTHRITIS RHEUM, V42, pS400; SAAG K, 1998, ARTHRITIS RHEUM S9, V41, P583; Simon LS, 1999, JAMA-J AM MED ASSOC, V282, P1921, DOI 10.1001/jama.282.20.1921; Smolen JS, 1999, LANCET, V353, P259, DOI 10.1016/S0140-6736(98)09403-3; tenWolde S, 1996, LANCET, V347, P347, DOI 10.1016/S0140-6736(96)90535-8; Toda Y, 1998, J RHEUMATOL, V25, P2181; Torgerson DJ, 1998, ANN RHEUM DIS, V57, P378, DOI 10.1136/ard.57.6.378; Tsakonas E, 2000, J RHEUMATOL, V27, P623; vanderHeide A, 1996, ANN INTERN MED, V124, P699, DOI 10.7326/0003-4819-124-8-199604150-00001; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401	37	12	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2000	321	7265					882	885		10.1136/bmj.321.7265.882	http://dx.doi.org/10.1136/bmj.321.7265.882			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021871	Green Accepted, Green Published			2022-12-28	WOS:000089857500027
J	Orphanides, G; Reinberg, D				Orphanides, G; Reinberg, D			RNA polymerase II elongation through chromatin	NATURE			English	Review							TRANSCRIPTION ELONGATION; HISTONE OCTAMER; IN-VIVO; SACCHAROMYCES-CEREVISIAE; TRANSCRIBING POLYMERASE; NUCLEOSOMAL TEMPLATES; GENE-REGULATION; ACTIVATION; HOLOENZYME; YEAST	The machinery that transcribes protein-coding genes in eukaryotic cells must contend with repressive chromatin structures in order to find its target DNA sequences. Diverse arrays of proteins modify the structure of chromatin at gene promoters to help transcriptional regulatory proteins access their DNA recognition sites. The way in which disruption of chromatin structure at a promoter is transmitted through a whole gene has not been defined. Recent breakthroughs suggest that the passage of an RNA polymerase through a gene is coupled to mechanisms that propagate the breakdown of chromatin.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucleic Acids Enzymol,Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Zeneca Cent Toxicol Lab, Macclesfield SK10 4TJ, Cheshire, England	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucleic Acids Enzymol,Howard Hughes Med Inst, Piscataway, NJ 08854 USA.			Reinberg, Danny/0000-0003-4288-2016				Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BAER BW, 1983, NATURE, V301, P482, DOI 10.1038/301482a0; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; CLARK DJ, 1992, CELL, V71, P11, DOI 10.1016/0092-8674(92)90262-B; DING HF, 1994, SCIENCE, V265, P796, DOI 10.1126/science.8047885; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; Fraser P, 1998, CURR OPIN CELL BIOL, V10, P361, DOI 10.1016/S0955-0674(98)80012-4; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KOLESKE AJ, 1995, TRENDS BIOCHEM SCI, V20, P113, DOI 10.1016/S0968-0004(00)88977-X; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Lee D, 1998, NATURE, V393, P389, DOI 10.1038/30770; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; McNeil JB, 1998, GENE DEV, V12, P2510, DOI 10.1101/gad.12.16.2510; NACHEVA GA, 1989, CELL, V58, P27, DOI 10.1016/0092-8674(89)90399-1; Neugebauer KM, 1997, GENE DEV, V11, P3279, DOI 10.1101/gad.11.24.3279; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Owen-Hughes Thomas, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P403; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; Travers A, 1999, P NATL ACAD SCI USA, V96, P13634, DOI 10.1073/pnas.96.24.13634; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; van Holde KE., 1989, SPRINGER SERIES MOL; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Walia H, 1998, J BIOL CHEM, V273, P14516, DOI 10.1074/jbc.273.23.14516; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	52	211	217	1	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					471	475		10.1038/35035000	http://dx.doi.org/10.1038/35035000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028991				2022-12-28	WOS:000089727400039
J	Abbott, A				Abbott, A			European space panel picks new priorities	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					277	277		10.1038/35030376	http://dx.doi.org/10.1038/35030376			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014155	Bronze			2022-12-28	WOS:000089390700007
J	Azzam, NA; Hallenbeck, JM; Kachar, B				Azzam, NA; Hallenbeck, JM; Kachar, B			Membrane changes during hibernation - Organelle lipids undergo rapidly reversible rearrangement as body temperature drops.	NATURE			English	Article							PHASE-TRANSITIONS		NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, Sect Struct Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Azzam, NA (corresponding author), NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	kacharb@nidcd.nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002856, ZIANS002856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000002, ZIADC000002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALOIA RC, 1980, FED PROC, V39, P2974; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Crowe JH, 1999, CRYOBIOLOGY, V38, P180, DOI 10.1006/cryo.1998.2137; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Geiser F, 1997, J COMP PHYSIOL B, V167, P416, DOI 10.1007/s003600050091; Lyman C.P., 1982, HIBERNATION TORPOR M; WADA H, 1990, NATURE, V347, P200, DOI 10.1038/347200a0; WILLIAMS WP, 1990, PHILOS T ROY SOC B, V326, P555, DOI 10.1098/rstb.1990.0031	9	31	35	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					317	318		10.1038/35030294	http://dx.doi.org/10.1038/35030294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014177				2022-12-28	WOS:000089390700031
J	Zhang, JR; Mostov, KE; Lamm, ME; Nanno, M; Shimida, S; Ohwaki, M; Tuomanen, E				Zhang, JR; Mostov, KE; Lamm, ME; Nanno, M; Shimida, S; Ohwaki, M; Tuomanen, E			The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells	CELL			English	Article							CANINE KIDNEY-CELLS; STREPTOCOCCUS-PNEUMONIAE; SECRETORY COMPONENT; IG RECEPTOR; LISTERIA-MONOCYTOGENES; CYTOKINE RESPONSES; DEFENSE-MECHANISMS; SURFACE PROTEIN; BINDING-PROTEIN; HOST-DEFENSE	The polymeric immunoglobulin receptor (plgR) plays a crucial role in mucosal immunity against microbial infection by transporting polymeric immunoglobulins (plg) across the mucosal epithelium. We report here that the human plgR (hplgR) can bind to a major pneumococcal adhesin, CbpA. Expression of hplgR in human nasopharyngeal cells and MDCK cells greatly enhanced pneumococcal adherence and invasion. The hplgR-mediated bacterial adherence and invasion were abolished by either insertional knockout of cbpA or antibodies against either hplgR or CbpA. In contrast, rabbit plgR (rplgR) did not bind to CbpA and its expression in MDCK cells did not enhance pneumococcal adherence and invasion. These results suggest that pneumococci are a novel example of a pathogen co-opting the pig transcytosis machinery to promote translocation across a mucosal barrier.	St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Yakult Cent Inst Microbiol Res, Tokyo, Japan	St Jude Children's Research Hospital; University of California System; University of California San Francisco; Case Western Reserve University; Yakult Honsha Company, Limited	Tuomanen, E (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	elaine.tuomanen@stjude.org	Tuomanen, Elaine I/N-3081-2018	Tuomanen, Elaine I/0000-0003-0349-8716; mostov, keith/0000-0002-8123-6247	NHLBI NIH HHS [HL55980] Funding Source: Medline; NIAID NIH HHS [AI39482, AI27913] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039482, R01AI027913, R01AI039482] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AROETI B, 1993, J CELL BIOL, V123, P1149, DOI 10.1083/jcb.123.5.1149; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Blanch VJ, 1999, J IMMUNOL, V162, P1232; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; DANIELE RP, 1990, ANNU REV PHYSIOL, V52, P177; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P331, DOI 10.1016/S0928-8244(98)00153-9; Estcourt MJ, 1998, CURR OPIN MICROBIOL, V1, P411, DOI 10.1016/S1369-5274(98)80058-1; FUBARA ES, 1973, J IMMUNOL, V111, P395; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; HOEPRICH PD, 1994, INFECT DIS, P421; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; KILIAN M, 1988, MICROBIOL REV, V52, P296, DOI 10.1128/MMBR.52.2.296-303.1988; KOBAYASHI K, 1971, IMMUNOCHEMISTRY, V8, P785, DOI 10.1016/0019-2791(71)90446-0; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; Maples CJ, 1997, J BIOL CHEM, V272, P6741, DOI 10.1074/jbc.272.10.6741; MCNABB PC, 1981, ANNU REV MICROBIOL, V35, P477, DOI 10.1146/annurev.mi.35.100181.002401; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; MIZOGUCHI A, 1982, J BIOL CHEM, V257, P9612; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; MOSTOV K, 1999, MUCOSAL IMMUNOLOGY, P181; MOSTOV KE, 1982, J BIOL CHEM, V257, P1816; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; MOSTOV KE, 1995, BIOESSAYS, V17, P129, DOI 10.1002/bies.950170208; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; OVERTURF GD, 1994, INFECT DIS, P1107; PHILLIPS JO, 1990, J IMMUNOL, V145, P1740; PISKURICH JF, 1993, MOL IMMUNOL, V30, P413, DOI 10.1016/0161-5890(93)90071-I; Prasadarao NV, 1999, INFECT IMMUN, V67, P1131, DOI 10.1128/IAI.67.3.1131-1138.1999; PURKAYASTHA S, 1979, J BIOL CHEM, V254, P6583; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shimada S, 1999, J IMMUNOL, V163, P5367; Singer KL, 1998, MOL BIOL CELL, V9, P901, DOI 10.1091/mbc.9.4.901; SOLLID LM, 1987, J IMMUNOL, V138, P4303; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Talbot UM, 1996, INFECT IMMUN, V64, P3772, DOI 10.1128/IAI.64.9.3772-3777.1996; TAMER CM, 1995, J IMMUNOL, V155, P707; TIRABY JG, 1973, P NATL ACAD SCI USA, V70, P3541, DOI 10.1073/pnas.70.12.3541; TOMANA M, 1978, ANAL BIOCHEM, V89, P110, DOI 10.1016/0003-2697(78)90731-5; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0; YOTHER J, 1994, J BACTERIOL, V176, P2976, DOI 10.1128/JB.176.10.2976-2985.1994; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8	51	292	312	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2000	102	6					827	837		10.1016/S0092-8674(00)00071-4	http://dx.doi.org/10.1016/S0092-8674(00)00071-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030626	Bronze			2022-12-28	WOS:000089395200014
J	Baumann, CA; Ribon, V; Kanzaki, M; Thurmond, DC; Mora, S; Shigematsu, S; Bickel, PE; Pessin, JE; Saltiel, AR				Baumann, CA; Ribon, V; Kanzaki, M; Thurmond, DC; Mora, S; Shigematsu, S; Bickel, PE; Pessin, JE; Saltiel, AR			CAP defines a second signalling pathway required for insulin-stimulated glucose transport	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; GLUT4 TRANSLOCATION; TYROSINE PHOSPHORYLATION; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOSE-CELLS; C-CBL; CAVEOLAE; RECEPTOR	Insulin stimulates the transport of glucose into fat and muscle cells. Although the precise molecular mechanisms involved in this process remain uncertain, insulin initiates its actions by binding to its tyrosine kinase receptor, leading to the phosphorylation of intracellular substrates. One such substrate is the Cbl protooncogene product(1). Cbl is recruited to the insulin receptor by interaction with the adapter protein CAP, through one of three adjacent SH3 domains in the carboxy terminus of CAP(2). Upon phosphorylation of Cbl, the CAP-Cbl complex dissociates from the insulin receptor and moves to a caveolin-enriched, triton-insoluble membrane fraction(3). Here, to identify a molecular mechanism underlying this subcellular redistribution, we screened a yeast two-hybrid library using the amino-terminal region of CAP and identified the caveolar protein flotillin. Flotillin forms a ternary complex with CAP and Cbl, directing the localization of the CAP-Cbl complex to a lipid raft subdomain of the plasma membrane. Expression of the N-terminal domain of CAP in 3T3-L1 adipocytes blocks the stimulation of glucose transport by insulin, without affecting signalling events that depend on phosphatidylinositol-3-OH kinase. Thus, localization of the Cbl-CAP complex to lipid rafts generates a pathway that is crucial in the regulation of glucose uptake.	Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA; Warner Lambert Co, Parke Davis Pharmaceut Res Div, Ann Arbor, MI 48105 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; Pfizer; University of Iowa; Washington University (WUSTL); Washington University (WUSTL)	Saltiel, AR (corresponding author), Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA.		Kanzaki, Makoto/H-6680-2017; Bickel, Perry/Q-9185-2019; Saltiel, Alan/L-3632-2019; Mora, Silvia/Y-3131-2019	Kanzaki, Makoto/0000-0002-6884-2955; Mora, Silvia/0000-0002-8473-1497; Saltiel, Alan/0000-0002-9726-9828				Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; Gustavsson J, 1996, MOL MED, V2, P367, DOI 10.1007/BF03401634; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; ISAKOFF SJ, 1995, P NATL ACAD SCI USA, V92, P10247, DOI 10.1073/pnas.92.22.10247; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; KANDROR KV, 1995, J CELL BIOL, V129, P999, DOI 10.1083/jcb.129.4.999; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; KELLER SR, 1995, J BIOL CHEM, V270, P30236; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Malide D, 1997, J CELL SCI, V110, P2795; Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; OKA Y, 1984, P NATL ACAD SCI-BIOL, V81, P4028, DOI 10.1073/pnas.81.13.4028; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Ribon V, 1997, BIOCHEM J, V324, P839, DOI 10.1042/bj3240839; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; Ribon V, 1998, P NATL ACAD SCI USA, V95, P14751, DOI 10.1073/pnas.95.25.14751; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; WARDZALA LJ, 1984, J BIOL CHEM, V259, P8378; WIESE RJ, 1995, J BIOL CHEM, V270, P3442, DOI 10.1074/jbc.270.7.3442	30	525	562	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					202	207		10.1038/35025089	http://dx.doi.org/10.1038/35025089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001060	Green Published			2022-12-28	WOS:000089241000052
J	Takamori, S; Rhee, JS; Rosenmund, C; Jahn, R				Takamori, S; Rhee, JS; Rosenmund, C; Jahn, R			Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons	NATURE			English	Article							INORGANIC-PHOSPHATE COTRANSPORTER; BRAIN SYNAPTIC VESICLES; CAENORHABDITIS-ELEGANS; FUNCTIONAL RECONSTITUTION; ENERGY-DEPENDENCE; NEUROTRANSMISSION; EXPRESSION; LOCALIZATION; PROTEINS; CLONING	Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system. Synaptic vesicles are loaded with neurotransmitter by means of specific vesicular transporters. Here we show that expression of BNPI, a vesicle-bound transporter associated with sodium-dependent phosphate transport(1-3), results in glutamate uptake by intracellular vesicles. Substrate specificity and energy dependence are very similar to glutamate uptake by synaptic vesicles. Stimulation of exocytosis-fusion of the vesicles with the cell membrane and release of their contents-resulted in quantal release of glutamate from BNPI-expressing cells. Furthermore, we expressed BNPI in neurons containing GABA (gamma-aminobutyric acid) and maintained them as cultures of single, isolated neurons that form synapses to themselves. After stimulation of these neurons, a component of the postsynaptic current is mediated by glutamate as it is blocked by a combination of the glutamate receptor antagonists, but is insensitive to a GABA(A) receptor antagonist. We conclude that BNPI functions as vesicular glutamate transporter and that expression of BNPI suffices to define a glutamatergic phenotype in neurons.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444; Jahn, Reinhard/0000-0003-1542-3498				Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Hartinger J, 1996, ANAL BIOCHEM, V240, P126, DOI 10.1006/abio.1996.0339; HELL JW, 1990, J BIOL CHEM, V265, P2111; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; HELL JW, 1994, CELL BIOL LAB HDB, P567; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; LOMBARDPLATET G, 1993, BIOTECHNIQUES, V15, P668; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; NAITO S, 1983, J BIOL CHEM, V258, P696; Ni BH, 1996, J NEUROCHEM, V66, P2227; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; PAREKH D, 1994, PANCREAS, V9, P83, DOI 10.1097/00006676-199401000-00013; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Reimer RJ, 1998, CURR OPIN NEUROBIOL, V8, P405, DOI 10.1016/S0959-4388(98)80068-8; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Takamori S, 2000, J NEUROSCI, V20, P4904	23	669	696	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					189	194		10.1038/35025070	http://dx.doi.org/10.1038/35025070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001057	Green Published			2022-12-28	WOS:000089241000049
J	Brown, PG; Hildebrand, AR; Zolensky, ME; Grady, M; Clayton, RN; Mayeda, TK; Tagliaferri, E; Spalding, R; MacRae, ND; Hoffman, EL; Mittlefehldt, DW; Wacker, JF; Bird, JA; Campbell, MD; Carpenter, R; Gingerich, H; Glatiotis, M; Greiner, E; Mazur, MJ; McCausland, PJA; Plotkin, H; Mazur, TR				Brown, PG; Hildebrand, AR; Zolensky, ME; Grady, M; Clayton, RN; Mayeda, TK; Tagliaferri, E; Spalding, R; MacRae, ND; Hoffman, EL; Mittlefehldt, DW; Wacker, JF; Bird, JA; Campbell, MD; Carpenter, R; Gingerich, H; Glatiotis, M; Greiner, E; Mazur, MJ; McCausland, PJA; Plotkin, H; Mazur, TR			The fall, recovery, orbit, and composition of the Tagish Lake meteorite: A new type of carbonaceous chondrite	SCIENCE			English	Article							OXYGEN-ISOTOPE; ABUNDANCES; MINERALOGY; ELEMENTS; SAMPLES	The preatmospheric mass of the Tagish Lake meteoroid was about 200,000 kilograms. Its calculated orbit indicates affinity to the Apollo asteroids with a semimajor axis in the middle of the asteroid belt, consistent with a linkage to low-albedo C, D, and P type asteroids. The mineralogy, oxygen isotope, and bulk chemical composition of recovered samples of the Tagish Lake meteorite are intermediate between CM and Cl meteorites. These data suggest that the Tagish Lake meteorite may be one of the most primitive solar system materials yet studied.	Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; Univ Western Ontario, Dept Philosophy, London, ON N6A 3K7, Canada; Univ Calgary, Dept Geol & Geophys, Calgary, AB T2N 1N4, Canada; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Nat Hist Museum, Dept Mineral, London SW7 5BD, England; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; ET Space Syst, Camarillo, CA 93012 USA; Sandia Natl Labs, Org 5909, Albuquerque, NM 87185 USA; Univ Western Ontario, Dept Earth Sci, London, ON N6A 5B7, Canada; Activat Labs Ltd, Ancaster, ON L9G 4V5, Canada; Lockheed Martin SO, Houston, TX 77058 USA; Pacific NW Natl Lab, Richland, WA 99352 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Calgary; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Natural History Museum London; University of Chicago; University of Chicago; University of Chicago; United States Department of Energy (DOE); Sandia National Laboratories; Western University (University of Western Ontario); Lockheed Martin; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Brown, PG (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada.		Brown, Peter/C-8763-2018	Grady, Monica/0000-0002-4055-533X; Zolensky, Michael/0000-0002-3181-1303; Brown, Peter/0000-0001-6130-7039				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Baker L., 1998, LUNAR PLANET SCI, VXXIX, P1740; BHANDARI N, 1993, GEOCHIM COSMOCHIM AC, V57, P23611; BROWN P, 1994, NATURE, V367, P624, DOI 10.1038/367624a0; Brown P, 1996, METORIT PLANET SCI, V31, P502, DOI 10.1111/j.1945-5100.1996.tb02092.x; Ceplecha Z, 1998, SPACE SCI REV, V84, P327, DOI 10.1023/A:1005069928850; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; CLAYTON RN, 1984, EARTH PLANET SC LETT, V67, P151, DOI 10.1016/0012-821X(84)90110-9; CRESSY PJ, 1972, J GEOPHYS RES, V76, P4905; CRONIN JR, 1993, NATO ADV SCI INST SE, V416, P209; EVANS JC, 1982, J GEOPHYS RES, V87, P5577, DOI 10.1029/JB087iB07p05577; GRADIE J, 1989, ASTEROIDS, V2, P316; GRADY MM, 1988, GEOCHIM COSMOCHIM AC, V52, P2855, DOI 10.1016/0016-7037(88)90152-4; Hiroi T, 1996, METORIT PLANET SCI, V31, P321, DOI 10.1111/j.1945-5100.1996.tb02068.x; HOFFMAN EL, 1978, ANAL CHIM ACTA, V102, P157, DOI 10.1016/S0003-2670(01)93469-5; LEYA I, 2000, METEORIT PLANET SCI, V259, P35; LIPSCHUTZ ME, 1989, ASTEROIDS, V2, P740; LIPSCHUTZ ME, 1999, ANTARCT METEORITE RE, V12, P57; LODDERS K, 1998, PLANETARY SCI COMPAN, P314; MCSWEEN HY, 1979, REV GEOPHYS, V17, P1059, DOI 10.1029/RG017i005p01059; PROSSER SJ, 1990, CHEM GEOL, V83, P71, DOI 10.1016/0009-2541(90)90141-S; SPERGEL MS, 1986, LUNAR PLANET SCI, V16, P756; Tomeoka K, 1989, P NIPR S ANT MET, V2, P36; YATES PD, 1992, CHEM GEOL, V101, P81, DOI 10.1016/0009-2541(92)90205-J; ZOLENSKY M, 1993, GEOCHIM COSMOCHIM AC, V57, P3123, DOI 10.1016/0016-7037(93)90298-B; Zolensky ME, 1996, METEORIT PLANET SCI, V31, P518, DOI 10.1111/j.1945-5100.1996.tb02093.x; Zolensky ME, 1999, SCIENCE, V285, P1377, DOI 10.1126/science.285.5432.1377; Zolensky ME, 1997, GEOCHIM COSMOCHIM AC, V61, P5099, DOI 10.1016/S0016-7037(97)00357-8	30	246	248	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					320	325		10.1126/science.290.5490.320	http://dx.doi.org/10.1126/science.290.5490.320			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030647				2022-12-28	WOS:000089818100039
J	Funnell, MM; Anderson, RM				Funnell, MM; Anderson, RM			The problem with compliance in diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT EMPOWERMENT		Univ Michigan, Michigan Diabet Res & Training Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Funnell, MM (corresponding author), Univ Michigan, Michigan Diabet Res & Training Ctr, Ann Arbor, MI 48109 USA.							Anderson RM, 2000, DIABETES EDUCATOR, V26, P597, DOI 10.1177/014572170002600405; Anderson RM, 1999, DIABETES EDUCATOR, V25, P43, DOI 10.1177/014572179902500622; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; ANDERSON RM, 1995, DIABETES CARE, V18, P412, DOI 10.2337/diacare.18.3.412; ANDERSON RM, 2000, ART EMPOWERMENT STOR; Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108; FUNNELL MM, 2000, DIABETES SPECTRUM, V13, P69; Glasgow RE, 1999, DIABETES CARE, V22, P2090, DOI 10.2337/diacare.22.12.2090	8	112	118	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1709	1709		10.1001/jama.284.13.1709	http://dx.doi.org/10.1001/jama.284.13.1709			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015809	hybrid			2022-12-28	WOS:000089501900038
J	Jones, AH				Jones, AH			Medicine and the movies: Lorenzo's Oil at century's end	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							X-LINKED ADRENOLEUKODYSTROPHY; THERAPY; HOPE		Univ Texas, Med Branch, Inst Med Humanities, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Jones, AH (corresponding author), Univ Texas, Med Branch, Inst Med Humanities, 2-210 Ashbel Smith Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	ahjones@utmb.edu						BANKS JT, 1998, LIT MED, V17, P1; Crawford TH, 1998, LIT MED, V17, P24, DOI 10.1353/lm.1998.0002; DANS PE, 2000, DOCTORS MOVIES BOIL; DUTKA E, 1992, LOS ANGELES TIM 1230, pF1; EBERT R, 1993, CHICAGO SUN TIM 0115; Gabbard Glen O., 1999, PSYCHIAT CINEMA; JONES AH, 1989, HDB AM POPULAR CULTU, P721; KEMPLEY R, 1993, WASHINGTON POST 0115, pB1; KOLATA G, 1993, NY TIMES        0209, P6; Kolata G., 1993, NY TIMES        1116, p[C1, C3]; KOLATA G, 2000, NY TIMES        0306; MARBELLA J, 1993, BALTIMORE SUN   0126, P3; MARBELLA J, 1993, BALTIMORE SUN   0126, pD1; Moser H W, 1994, Control Clin Trials, V15, P161, DOI 10.1016/0197-2456(94)90053-1; Moser H W, 1993, Lancet, V341, P544, DOI 10.1016/0140-6736(93)90295-R; Moser HW, 1999, J NEUROL NEUROSUR PS, V67, P279, DOI 10.1136/jnnp.67.3.279; MOSER HW, 1993, ANN NEUROL, V34, P121, DOI 10.1002/ana.410340202; NOWAK R, 1993, J NIH RES, V5, P34; ODONE A, 1994, NEW ENGL J MED, V330, P1904; ODONE A, 1992, MYELIN PROJECT PROGR; ODONE A, 1997, MYELIN PROJECT PROGR; POLLACK R, 1999, MISSING MOMENT UNCON, P1; Pollack R., 1994, SIGNS LIFE LANGUAGE; RIZZO WB, 1990, INT CONGR SER, V898, P149; RIZZO WB, 1993, NEW ENGL J MED, V329, P801, DOI 10.1056/NEJM199309093291110; RIZZO WB, 1989, NEUROLOGY, V39, P1415, DOI 10.1212/WNL.39.11.1415; ROSEN FS, 1993, NATURE, V361, P695; STOLBERG SG, 2000, NY TIMES        0127; TURAN K, 1992, LOS ANGELES TIM 1230, pF1; van Geel BM, 1999, J NEUROL NEUROSUR PS, V67, P290, DOI 10.1136/jnnp.67.3.290	30	8	9	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					567	571		10.7326/0003-4819-133-7-200010030-00030	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00030			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	360QG	11015184				2022-12-28	WOS:000089678300021
J	Brackley, KJ; Kilby, MD; Wright, JG; Brawn, WJ; Sethia, B; Stumper, O; Holder, R; Wyldes, MP; Whittle, MJ				Brackley, KJ; Kilby, MD; Wright, JG; Brawn, WJ; Sethia, B; Stumper, O; Holder, R; Wyldes, MP; Whittle, MJ			Outcome after prenatal diagnosis of hypoplastic left-heart syndrome: a case series	LANCET			English	Article							MODIFIED NORWOOD-PROCEDURE; FETAL ECHOCARDIOGRAPHY; DISEASE; INFANTS; OBSTRUCTION; PREVALENCE; ANOMALIES; SURGERY	Background Traditionally, after prenatal diagnosis of hypoplastic left-heart syndrome (HLHS) couples have been offered termination of pregnancy or comfort care. Success of postnatal surgical options such as the Norwood procedure have been associated with survival of up to 60%. Whether survival is affected by the congenital anomaly being identified prenatally or postnatally remains uncertain. Methods We reviewed all cases of prenatally diagnosed HLHS referred to the Fetal Medicine Unit at Birmingham Women's Hospital over 6 years between 1994 and 1999. Findings 87 cases of HLHS were referred at a median gestational age (95% CI) of 23 (19-37) weeks. Of these, 53 (61%) chose prenatal karyotyping. The overall frequency of abnormal karyotype was found in seven of 59 cases (12%) and associated structural anomalies in 18 of 87 (21%). After counselling, 38 of 87 couples (44%) chose termination of pregnancy. Of the remaining 49 fetuses, 11 (23%) were not considered for postnatal surgery because of parental choice and they died after compassionate care. Of the 36 babies who had surgery postnatally, 12 survived (33%). We recorded a survival rate of 38% for the stage-1 Norwood procedure in the prenatally diagnosed HLHS in our centre. These data suggest that at the point of prenatal detection, the overall survival rate for fetuses with HLHS is 25% (if terminated pregnancies are excluded). Interpretation Fetal echocardiography allows early diagnosis of HLHS and gives clinicians the opportunity to triage this group dependent on prenatal findings, including karyotyping and the exclusion of other structural anomalies. These prospective data provide up-to-date information on the basis of which parents can make decisions.	Univ Birmingham, Birmingham Womens Hosp, Div Reprod & Child Hlth, Birmingham B15 2TG, W Midlands, England; Univ Birmingham, Childrens Hosp, Birmingham B15 2TG, W Midlands, England; Princess Diana Childrens Hosp, Div Paediat Cardiol & Cardiothorac Surg, Birmingham, W Midlands, England; St Chads Court, W Midlands Reg Congenital Anomaly Registry, Birmingham B16 9RG, W Midlands, England; Univ Birmingham, Sch Math & Stat, Birmingham B15 2TT, W Midlands, England	Birmingham Women's Hospital; University of Birmingham; University of Birmingham; University of Birmingham	Kilby, MD (corresponding author), Univ Birmingham, Birmingham Womens Hosp, Div Reprod & Child Hlth, Birmingham B15 2TG, W Midlands, England.		FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223				Allan LD, 1998, HEART, V79, P371, DOI 10.1136/hrt.79.4.371; ALLAN LD, 1991, LANCET, V337, P959, DOI 10.1016/0140-6736(91)91582-F; ALLAN LD, 1989, INT J CARDIOL, V25, P341, DOI 10.1016/0167-5273(89)90226-X; ALLAN LD, 1994, J AM COLL CARDIOL, V23, P1452, DOI 10.1016/0735-1097(94)90391-3; Bartram U, 1997, ANN THORAC SURG, V64, P1795, DOI 10.1016/S0003-4975(97)01041-2; Brace V, 2000, PRENATAL DIAG, V20, P51, DOI 10.1002/(SICI)1097-0223(200001)20:1<51::AID-PD755>3.3.CO;2-F; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; BULOCK FA, 1995, BRIT HEART J, V73, P456; CHANG AC, 1991, J THORAC CARDIOV SUR, V102, P841, DOI 10.1016/S0022-5223(19)33933-9; FYLER DC, 1980, PEDIATRICS S, V65, P377; GREENWOOD RD, 1975, PEDIATRICS, V55, P485; Howe DT, 1996, PRENATAL DIAG, V16, P1003, DOI 10.1002/(SICI)1097-0223(199611)16:11<1003::AID-PD995>3.0.CO;2-D; Ishino K, 1999, J THORAC CARDIOV SUR, V117, P920, DOI 10.1016/S0022-5223(99)70373-9; Kern JH, 1997, AM J CARDIOL, V80, P170, DOI 10.1016/S0002-9149(97)00313-5; Kumar RK, 1999, AM J CARDIOL, V83, P1649, DOI 10.1016/S0002-9149(99)00172-1; Montana E, 1996, J AM COLL CARDIOL, V28, P1805, DOI 10.1016/S0735-1097(96)00381-6; Munn M B, 1999, J Matern Fetal Med, V8, P147; NATOWICZ M, 1988, PEDIATRICS, V82, P698; NOONAN J A, 1958, Pediatr Clin North Am, V5, P1029; NORWOOD WI, 1980, AM J CARDIOL, V45, P87, DOI 10.1016/0002-9149(80)90224-6; OKelly SW, 1997, BRIT MED J, V314, P87, DOI 10.1136/bmj.314.7074.87; Reis PM, 1998, AM J OBSTET GYNECOL, V179, P1150, DOI 10.1016/S0002-9378(98)70123-1; VANEGMOND H, 1988, BRIT HEART J, V60, P69; WALLGREN EI, 1978, EUR J CARDIOL, V7, P15; WHITTLE MJW, 2000, P ROYAL COLL OBST GY	25	67	72	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 30	2000	356	9236					1143	1147		10.1016/S0140-6736(00)02756-2	http://dx.doi.org/10.1016/S0140-6736(00)02756-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359CQ	11030293				2022-12-28	WOS:000089594300011
J	Wilmoth, JR; Deegan, LJ; Lundstrom, H; Horiuchi, S				Wilmoth, JR; Deegan, LJ; Lundstrom, H; Horiuchi, S			Increase of maximum life-span in Sweden, 1861-1999	SCIENCE			English	Article							MORTALITY; LONGEVITY; VARIABILITY; COUNTRIES; AGE	A fundamental question in aging research is whether humans and other species possess an immutable life-span limit. We examined the maximum age at death in Sweden, which rose from about 101 years during the 1860s to about 108 years during the 1990s. The pace of increase was 0.44 years per decade before 1969 but accelerated to 1.11 years per decade after that date. More than 70 percent of the rise in the maximum age at death from 1861 to 1999 is attributable to reductions in death rates above age 70. The rest are due to increased numbers of survivors to old age (both larger birth cohorts and increased survivorship from infancy to age 70). The more rapid rise in the maximum age since 1969 is due to the faster pace of old-age mortality decline during recent decades.	Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA; Stat Sweden, S-10451 Stockholm, Sweden; Rockefeller Univ, Lab Populat, New York, NY 10021 USA	University of California System; University of California Berkeley; Statistics Sweden; Rockefeller University	Wilmoth, JR (corresponding author), Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA.	jrw@demog.berkeley.edu			NIA NIH HHS [R01-AG14698, K02-AG00778, R01-AG11552] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K02AG000778, R01AG014698, R01AG011552] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1958, STAT EXTREMES, DOI DOI 10.7312/GUMB92958; BRILLINGER DR, 1986, BIOMETRICS, V42, P693, DOI 10.2307/2530689; Finch CE, 1996, J GERONTOL A-BIOL, V51, pB183, DOI 10.1093/gerona/51A.3.B183; Gavrilov L.A., 1991, BIOL LIFE SPAN QUANT; Gumbel E.J., 1937, DUREE EXTREME VIE HU; HAYFLICK L, 1996, HOW WHY WE AGE, P66; Hill ME, 2000, DEMOGRAPHY, V37, P175, DOI 10.2307/2648119; Horiuchi S, 1991, Popul Bull UN, P38; HORIUCHI S, UNPUB; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; Manton KG, 1996, J GERONTOL A-BIOL, V51, pB362, DOI 10.1093/gerona/51A.5.B362; Robine JM, 1999, MGR POPULATION AGING, V6, P145; Thatcher A. R., 1998, FORCE MORTALITY AGES; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Vaupel JW, 1995, EXCEPTIONAL LONGEVIT, V2; Wilmoth JR, 1999, DEMOGRAPHY, V36, P475, DOI 10.2307/2648085; Wilmoth JR, 1996, EUR J POPUL, V12, P63, DOI 10.1007/BF01797166; Wilmoth JR, 1998, SCIENCE, V280, P395, DOI 10.1126/science.280.5362.395; YASHIN AI, 1994, MECH AGEING DEV, V74, P1, DOI 10.1016/0047-6374(94)90094-9	19	162	167	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2000	289	5488					2366	2368		10.1126/science.289.5488.2366	http://dx.doi.org/10.1126/science.289.5488.2366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	359CG	11009426				2022-12-28	WOS:000089593500058
J	Hughes, AP; Jackson, JM; Callen, JP				Hughes, AP; Jackson, JM; Callen, JP			Clinical features and treatment of peristomal pyoderma grangrenosum	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLAMMATORY BOWEL-DISEASE; GANGRENOSUM	Context Peristomal pyoderma gangrenosum (PPG), an unusual Variant of pyoderma gangrenosum, has been reported almost exclusively in patients with inflammatory bowel disease (IBD) and-is frequently misdiagnosed. Objective To better characterize the clinical manifestations, diagnosis, and management of PPG. Design, Setting, and Patients Retrospective analysis of 7 patients with PPG observed in a university-affiliated community setting between 1988 and December 1999. Main Outcome Measures Clinical and histopathologic features, associated disorders, and microbiologic findings. Results Two patients had Crohn disease, 2 had ulcerative colitis, and 3 had abdominal cancer. Five patients had at least 1 relapse of PPC after initial healing. Although 3 of 4 patients with IBD had active bowel disease, a parallel course with PPG occurred in only 1 patient. Both patients whose stoma was relocated developed an ulcer at the new site. Effective therapies included topical superpotent corticosteroids; intralesional injection of triamcinolone acetonide at the ulcer margin; topical cromolyn sodium; oral dapsone, prednisone, cyclosporine, mycophenolate mofetil; and intravenous infliximab. Conclusion Our experiences demonstrate that although PPG has been most often reported in patients with IBD, it may occur in the absence of IBD. Biopsy of the skin lesion is not diagnostic but excludes other causes. Relocation of the stoma may be associated with a new ulceration and should be avoided. Trauma to the skin of a predisposed patient may elicit the pustules or ulcerations associated with pathergy.	Univ Louisville, Sch Med, Dept Med, Div Dermatol, Louisville, KY 40292 USA	University of Louisville	Callen, JP (corresponding author), 310 E Broadway, Louisville, KY 40202 USA.							Bennett ML, 2000, MEDICINE, V79, P37, DOI 10.1097/00005792-200001000-00004; Brunsting LA, 1930, ARCH DERMATOL SYPH, V22, P655, DOI 10.1001/archderm.1930.01440160053009; CAIRNS BA, 1994, ARCH SURG-CHICAGO, V129, P769; Callen JP, 1998, LANCET, V351, P581, DOI 10.1016/S0140-6736(97)10187-8; Cuttino C, 1987, J Enterostomal Ther, V14, P216; DEHIJAS CM, 1993, J AM ACAD DERMATOL, V29, P1034, DOI 10.1016/S0190-9622(08)82037-3; KELTZ M, 1992, J AM ACAD DERMATOL, V27, P360, DOI 10.1016/0190-9622(92)70200-Y; LEBWOHL MG, 1995, ATLAS SKIN SYSTEMIC, P65; Lyon CC, 2000, J AM ACAD DERMATOL, V42, P992, DOI 10.1016/S0190-9622(00)90292-5; Powell FC, 1996, J AM ACAD DERMATOL, V34, P395, DOI 10.1016/S0190-9622(96)90428-4; POWELL FC, 1985, Q J MED, V55, P173; TJANDRA JJ, 1994, DIS COLON RECTUM, V37, P938, DOI 10.1007/BF02052602; Von den Driesch P, 1997, BRIT J DERMATOL, V137, P1000, DOI 10.1046/j.1365-2133.1997.20022083.x; WILLE R, 1984, INT CLASSIF, V11, P77; WOLFSEN HC, 1990, J CLIN GASTROENTEROL, V12, P651, DOI 10.1097/00004836-199012000-00011	15	120	122	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1546	1548		10.1001/jama.284.12.1546	http://dx.doi.org/10.1001/jama.284.12.1546			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000649	Bronze			2022-12-28	WOS:000089379700031
J	White, N				White, N			X-ray astronomy - Imaging black holes	NATURE			English	Editorial Material							ACCRETION DISK		NASA, Goddard Space Flight Ctr, High Energy Astrophys Lab, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	White, N (corresponding author), NASA, Goddard Space Flight Ctr, High Energy Astrophys Lab, Greenbelt, MD 20771 USA.		White, Nicholas/B-6428-2012	White, Nicholas/0000-0003-3853-3462				Bromley BC, 1998, NATURE, V391, P54, DOI 10.1038/34130; Cash W, 2000, NATURE, V407, P160, DOI 10.1038/35025009; TANAKA Y, 1995, NATURE, V375, P659, DOI 10.1038/375659a0	3	39	41	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					146	147		10.1038/35025179	http://dx.doi.org/10.1038/35025179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001040				2022-12-28	WOS:000089241000030
J	Khani-Hanjani, A; Lacaille, D; Hoar, D; Chalmers, A; Horsman, D; Anderson, M; Balshaw, R; Keown, PA				Khani-Hanjani, A; Lacaille, D; Hoar, D; Chalmers, A; Horsman, D; Anderson, M; Balshaw, R; Keown, PA			Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis	LANCET			English	Article							TUMOR-NECROSIS-FACTOR; DEPENDENT DIABETES-MELLITUS; IFN-GAMMA; FACTOR-ALPHA; POLYMORPHISM; RECEPTOR; SECRETION; INTERLEUKIN-1-BETA; METHOTREXATE; EXPRESSION	Background Rheumatoid arthritis ranges from a mild, non-deforming arthropathy with little long-term disability to severe, incapacitating, deforming arthritis which may be refractory to conventional disease-modifying agents. Epidemiological studies show an important genetic influence in rheumatoid arthritis, and MHC region genes and cytokine genes within and outside this region have been considered as candidates. We did a case-control study to test whether polymorphisms in the interferon-gamma gene are associated with severity of rheumatoid arthritis. Methods Interferon gamma dinucleotide repeat polymorphisms were examined with quantitative genescan technology, and HLA-DR alleles were identified by PCR and restriction-fragment-length polymorphism analysis. We studied 60 patients with severe rheumatoid arthritis, 39 with mild disease, and 65 normal controls. Findings Susceptibility to, and severity of, rheumatoid arthritis were related to a microsatellite polymorphism within the first intron of the interferon-gamma gene. A 126 bp allele was seen in 44 (73%) of 60 patients with severe rheumatoid arthritis, compared with eight (21%) of 39 with mild disease (odds ratio 10.66 [95% CI 4.1-24.9]), and with eight (12%) of 65 normal controls (19.59 [7.7-49.9]). Conversely, a 122 bp allele at the same locus was found in four (7%) patients with severe disease compared with 25 (64%) of those with mild disease (0.04 [0.01-0.1]) and with 52 (80%) of controls (0.018 [0.005-0.06]). Interpretation This association may be valuable for understanding the mechanism of disease progression, for predicting the course of the disease, and for guiding therapy.	Vancouver Gen Hosp, Dept Med, Immunol Lab, Vancouver, BC V5Z 1M9, Canada; Vancouver Gen Hosp, Dept Lab Med & Pathol, Vancouver, BC V5Z 1M9, Canada; Mary Pack Arthrit Ctr, Vancouver, BC, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; BC Canc Agcy, Dept Lab Med & Pathol, Vancouver, BC, Canada; Simon Fraser Univ, Dept Math & Stat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; Simon Fraser University	Keown, PA (corresponding author), Vancouver Gen Hosp, Dept Med, Immunol Lab, Vancouver, BC V5Z 1M9, Canada.			Balshaw, Robert/0000-0002-2455-8792				Abbas AK, 1994, CELLULAR MOL IMMUNOL; ADAMS RB, 1993, J IMMUNOL, V150, P2356; ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; ALVAROGRACIA JM, 1993, J CLIN IMMUNOL, V13, P212, DOI 10.1007/BF00919974; AWATA T, 1994, DIABETOLOGIA, V37, P1159, DOI 10.1007/BF00418381; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Cantagrel A, 1999, ARTHRITIS RHEUM, V42, P1093, DOI 10.1002/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO;2-P; CASSATELLA MA, 1989, J CLIN INVEST, V83, P1570, DOI 10.1172/JCI114054; COMBE B, 1995, BRIT J RHEUMATOL, V34, P529; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; DANIS VA, 1995, DIS MARKERS, V12, P127, DOI 10.1155/1994/756247; Ebnet K, 1996, ANNU REV IMMUNOL, V14, P155, DOI 10.1146/annurev.immunol.14.1.155; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; HORNE C, 1993, TISSUE ANTIGENS, V41, P243, DOI 10.1111/j.1399-0039.1993.tb02013.x; John S, 1998, ANN RHEUM DIS, V57, P361, DOI 10.1136/ard.57.6.361; MACHOLD KP, 1992, ANN RHEUM DIS, V51, P1039, DOI 10.1136/ard.51.9.1039; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mu H, 1999, ARTHRITIS RHEUM, V42, P438, DOI 10.1002/1529-0131(199904)42:3<438::AID-ANR7>3.0.CO;2-F; Nepom GT, 1996, J RHEUMATOL, V23, P5; POCIOT F, 1991, SCAND J IMMUNOL, V33, P37, DOI 10.1111/j.1365-3083.1991.tb02490.x; Pociot F, 1997, J INTERF CYTOK RES, V17, P87, DOI 10.1089/jir.1997.17.87; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Pravica V, 1999, EUR J IMMUNOGENET, V26, P1, DOI 10.1046/j.1365-2370.1999.00122.x; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; REVEL M, 1986, TRENDS BIOCHEM SCI, V11, P166, DOI 10.1016/0968-0004(86)90134-9; RUIZLINARES A, 1993, HUM MOL GENET, V2, P1508; Schiff Michael, 1997, American Journal of Medicine, V102, p11S, DOI 10.1016/S0002-9343(97)00411-7; Siegmund T, 1998, THYROID, V8, P1013, DOI 10.1089/thy.1998.8.1013; Vandenbroeck K, 1998, ANN NEUROL, V44, P841, DOI 10.1002/ana.410440525; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weyand CM, 1997, J MOL MED-JMM, V75, P772, DOI 10.1007/s001090050167; Weyand Cornelia M., 1995, Current Opinion in Rheumatology, V7, P206, DOI 10.1097/00002281-199505000-00009; Wolfe F, 1997, AM J MED, V103, P12	35	90	93	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					820	825		10.1016/S0140-6736(00)02657-X	http://dx.doi.org/10.1016/S0140-6736(00)02657-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022930				2022-12-28	WOS:000089101800013
J	Schultz, P; Fribourg, S; Poterszman, A; Mallouh, V; Moras, D; Egly, JM				Schultz, P; Fribourg, S; Poterszman, A; Mallouh, V; Moras, D; Egly, JM			Molecular structure of human TFIIH	CELL			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION FACTOR TFIIH; CDK-ACTIVATING KINASE; RING FINGER PROTEIN; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; XERODERMA-PIGMENTOSUM; COCKAYNE-SYNDROME; CTD KINASE	TFIIH is a multiprotein complex required for both transcription and DNA repair. Single particles of human TFIIH were revealed by electron microscopy and image processing at a resolution of 3.8 nm. TFIIH is 16 x 12.5 x 7.5 nm in size and is organized into a ring-like structure from which a large protein domain protrudes out. A subcomplex assembled from five recombinant core subunits also forms a circular architecture that can be superimposed on the ring found in human TFIIH. Immunolabeling experiments localize several subunits: p44, within the ring structure, forms the base of the protruding protein density which includes the cdk7 kinase, cyclin H, and MAT1. Within the ring structure, p44 was flanked on either side by the XPB and XPD helicases. These observations provide us with a quartenary organizational model of TFIIH.	Univ Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schultz, P (corresponding author), Univ Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries,BP 163, F-67404 Illkirch Graffenstaden, France.	pat@moorea.u-strasbg.fr	Fribourg, Sebastien/M-7418-2014	Fribourg, Sebastien/0000-0003-4112-7510; POTERSZMAN, Arnaud/0000-0002-6702-5777; schultz, patrick/0000-0002-7310-6186				AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Andersen G, 1997, EMBO J, V16, P958, DOI 10.1093/emboj/16.5.958; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL AJ, 1994, MOL CELL BIOL, V14, P3569, DOI 10.1128/MCB.14.6.3569; Busso D, 2000, J BIOL CHEM, V275, P22815, DOI 10.1074/jbc.M002578200; Chang WH, 2000, CELL, V102, P609, DOI 10.1016/S0092-8674(00)00083-0; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DEVAULT A, 1995, EMBO J, V14, P5027, DOI 10.1002/j.1460-2075.1995.tb00185.x; DICAPUA E, 1982, J MOL BIOL, V157, P87, DOI 10.1016/0022-2836(82)90514-9; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Faye G, 1997, MOL GEN GENET, V255, P460, DOI 10.1007/s004380050518; Feaver WJ, 2000, J BIOL CHEM, V275, P5941, DOI 10.1074/jbc.275.8.5941; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; FRIBOURG S, 2000, IN PRESS J BIOL CHEM; GERARD M, 1991, J BIOL CHEM, V266, P20940; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; HUMBERT S, 1994, EMBO J, V13, P2393, DOI 10.1002/j.1460-2075.1994.tb06523.x; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; MAKELA TP, 1995, P NATL ACAD SCI USA, V92, P5174, DOI 10.1073/pnas.92.11.5174; Marinoni JC, 1997, METHODS, V12, P235, DOI 10.1006/meth.1997.0476; MATSUI P, 1995, NUCLEIC ACIDS RES, V23, P767, DOI 10.1093/nar/23.5.767; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; OSSIPOW V, 1995, CELL, V83, P137, DOI 10.1016/0092-8674(95)90242-2; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; Passy SI, 1999, P NATL ACAD SCI USA, V96, P4279, DOI 10.1073/pnas.96.8.4279; QIU HF, 1993, GENE DEV, V7, P2161, DOI 10.1101/gad.7.11.2161; RADERMACHER M, 1986, J MICROSC-OXFORD, V141, pRP1, DOI 10.1111/j.1365-2818.1986.tb02693.x; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Rossignol M, 1999, J BIOL CHEM, V274, P22387, DOI 10.1074/jbc.274.32.22387; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; SanMartin MC, 1997, J MOL BIOL, V268, P15, DOI 10.1006/jmbi.1997.0952; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SEROZ T, 1995, CURR OPIN GENET DEV, V5, P217, DOI 10.1016/0959-437X(95)80011-5; SEROZ T, 2000, IN PRESS J BIOL CHEM; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; Svejstrup JQ, 1996, J BIOL CHEM, V271, P643, DOI 10.1074/jbc.271.2.643; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VERMEULEN W, 1994, COLD SPRING HARBOR S; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U	54	154	161	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					599	607		10.1016/S0092-8674(00)00082-9	http://dx.doi.org/10.1016/S0092-8674(00)00082-9			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007478	Bronze			2022-12-28	WOS:000089105200008
J	Shih, WM; Gryczynski, Z; Lakowicz, JR; Spudich, JA				Shih, WM; Gryczynski, Z; Lakowicz, JR; Spudich, JA			A FRET-based sensor reveals large ATP hydrolysis-induced conformational changes and three distinct states of the molecular motor myosin	CELL			English	Article							FLUORESCENCE ENERGY-TRANSFER; REGULATORY LIGHT-CHAIN; SMOOTH-MUSCLE MYOSIN; DICTYOSTELIUM-DISCOIDEUM; STRUCTURAL DYNAMICS; ATOMIC-STRUCTURE; BINDING DOMAIN; ADP RELEASE; LEVER ARM; ACTIN	The molecular motor myosin is proposed to bind to actin and swing its light-chain binding region through a large angle to produce an similar to 10 nm step in motion coupled to changes in the nucleotide state at the active site. To date, however, direct dynamic measurements have largely failed to show changes of that magnitude. Here, we use a cysteine engineering approach to create a high resolution, FRET-based sensor that reports a large, similar to 70 degree nucleotide-dependent angle change of the light-chain binding region. The combination of steady-state and time-resolved fluorescence resonance energy transfer measurements unexpectedly reveals two distinct prestroke states. The measurements also show that bound Mg.ADP.P-i, and not bound Mg.ATP, induces the myosin to adopt the prestroke states.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA	Stanford University; University System of Maryland; University of Maryland Baltimore	Spudich, JA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	jspudich@cmgm.stanford.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [S06RR008110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035154] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-08110] Funding Source: Medline; NIAMS NIH HHS [AR42895] Funding Source: Medline; NIGMS NIH HHS [GM-35154] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brust-Mascher I, 1999, BIOCHEMISTRY-US, V38, P12607, DOI 10.1021/bi9905967; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; Dayhoff MO, 1978, ATLAS PROTEIN SEQUEN, V5; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; EISENBERG E, 1980, ANNU REV PHYSIOL, V42, P293, DOI 10.1146/annurev.ph.42.030180.001453; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Getz EB, 1998, BIOPHYS J, V74, P2451, DOI 10.1016/S0006-3495(98)77953-6; Giese KC, 1997, BIOCHEMISTRY-US, V36, P8465, DOI 10.1021/bi963141f; Goldman YE, 1998, CELL, V93, P1, DOI 10.1016/S0092-8674(00)81137-X; HEIDECKER M, 1995, BIOCHEMISTRY-US, V34, P11017, DOI 10.1021/bi00035a007; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 1997, CURR BIOL, V7, pR112, DOI 10.1016/S0960-9822(06)00051-0; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Huxley AF, 1998, NATURE, V396, P317, DOI 10.1038/24503; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; LACZKO G, 1990, REV SCI INSTRUM, V61, P2331, DOI 10.1063/1.1141360; LAKOWICZ JR, 1987, BIOPHYS CHEM, V28, P35, DOI 10.1016/0301-4622(87)80073-X; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MANSTEIN DJ, 1989, SCIENCE, V246, P656, DOI 10.1126/science.2530629; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Palm T, 1999, BIOCHEMISTRY-US, V38, P13026, DOI 10.1021/bi991164z; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rayment I, 1996, J BIOL CHEM, V271, P15850, DOI 10.1074/jbc.271.27.15850; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; Roopnarine O, 1998, BIOCHEMISTRY-US, V37, P14428, DOI 10.1021/bi9808363; ROSENFELD SS, 2000, IN PRESS J BIOL CHEM; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sasaki N, 1998, J BIOL CHEM, V273, P20334, DOI 10.1074/jbc.273.32.20334; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; SELLERS JR, 1995, MYOSIN, V2; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Smyczynski C, 1997, BIOCHEMISTRY-US, V36, P13201, DOI 10.1021/bi970746i; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; STIRVING M, 1995, NATURE, V375, P688; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Suzuki Y, 1998, NATURE, V396, P380, DOI 10.1038/24640; Taylor KA, 1999, CELL, V99, P421, DOI 10.1016/S0092-8674(00)81528-7; WERBER MM, 1992, BIOCHEMISTRY-US, V31, P7190, DOI 10.1021/bi00146a023; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; WOODWARD SK, 1995, BIOCHEMISTRY-US, V90, P8619; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Xiao M, 1998, P NATL ACAD SCI USA, V95, P15309, DOI 10.1073/pnas.95.26.15309	54	110	112	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					683	694		10.1016/S0092-8674(00)00090-8	http://dx.doi.org/10.1016/S0092-8674(00)00090-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007486	Bronze			2022-12-28	WOS:000089105200016
J	Sack, RL; Brandes, RW; Kendall, AR; Lewy, AJ				Sack, RL; Brandes, RW; Kendall, AR; Lewy, AJ			Entrainment of free-running circadian rhythms by melatonin in blind people	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-RESPONSE CURVE; SLEEP-WAKE CYCLE; WINTER DEPRESSION; CORTISOL; LIGHT; TEMPERATURE	Background: Most totally blind people have circadian rhythms that are "free-running'' (i.e., that are not synchronized to environmental time cues and that oscillate on a cycle slightly longer than 24 hours). This condition causes recurrent insomnia and daytime sleepiness when the rhythms drift out of phase with the normal 24-hour cycle. We investigated whether a daily dose of melatonin could entrain their circadian rhythms to a normal 24-hour cycle. Methods: We performed a crossover study involving seven totally blind subjects who had free-running circadian rhythms. The subjects were given 10 mg of melatonin or placebo daily, one hour before their preferred bedtime, for three to nine weeks. They were then given the other treatment. The timing of the production of endogenous melatonin was measured as a marker of the circadian time (phase), and sleep was monitored by polysomnography. Results: At base line, the subjects had free-running circadian rhythms with distinct and predictable cycles averaging 24.5 hours (range, 24.2 to 24.9). These rhythms were unaffected by the administration of placebo. In six of the seven subjects the rhythm was entrained to a 24.0-hour cycle during melatonin treatment (P<0.001). After entrainment, the subjects spent less time awake after the initial onset of sleep (P=0.05) and the efficiency of sleep was higher (P=0.06). Three subjects subsequently participated in a trial in which a 10-mg dose of melatonin was given daily until entrainment was achieved. The dose was then reduced to 0.5 mg per day over a period of three months; the entrainment persisted, even at the lowest dose. Conclusions: Administration of melatonin can entrain circadian rhythms in most blind people who have free-running rhythms. (N Engl J Med 2000;343:1070-7.) (C) 2000, Massachusetts Medical Society.	Oregon Hlth & Sci Univ, Sch Med, Dept Psychiat, Sleep & Mood Disorders Lab, Portland, OR 97201 USA	Oregon Health & Science University	Sack, RL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Psychiat, Sleep & Mood Disorders Lab, Mail Code L-469, Portland, OR 97201 USA.	sackr@ohsu.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056874, R01MH055703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015140] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG15140] Funding Source: Medline; NIMH NIH HHS [R01 MH 56874, R01 MH55703] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Czeisler CA, 1997, J BIOL RHYTHM, V12, P618, DOI 10.1177/074873049701200617; FOLKARD S, 1990, NEUROSCI LETT, V113, P193, DOI 10.1016/0304-3940(90)90302-P; KENNAWAY DJ, 1977, ENDOCRINOLOGY, V101, P119, DOI 10.1210/endo-101-1-119; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KLEIN T, 1993, SLEEP, V16, P333, DOI 10.1093/sleep/16.4.333; LAPIERRE O, 1995, BIOL PSYCHIAT, V38, P119, DOI 10.1016/0006-3223(95)00072-O; Lewy AJ, 1998, PSYCHIAT RES, V77, P57, DOI 10.1016/S0165-1781(97)00128-5; LEWY AJ, 1992, CHRONOBIOL INT, V9, P380, DOI 10.3109/07420529209064550; Lewy AJ, 1998, CHRONOBIOL INT, V15, P71, DOI 10.3109/07420529808998671; Lewy AJ, 1998, ARCH GEN PSYCHIAT, V55, P890, DOI 10.1001/archpsyc.55.10.890; LEWY AJ, 1983, J CLIN ENDOCR METAB, V56, P1103, DOI 10.1210/jcem-56-6-1103; LEWY AJ, 1997, SLEEP RES, V26, P73; Lockley SW, 2000, J ENDOCRINOL, V164, pR1, DOI 10.1677/joe.0.164R001; Lockley SW, 1998, INT CONGR SER, V1152, P247; MILES LEM, 1977, SCIENCE, V198, P421, DOI 10.1126/science.910139; MOOREEDE M, 1982, CLOCKS TIME PHYSL CI; NAKAGAWA H, 1992, SLEEP, V15, P330, DOI 10.1093/sleep/15.4.330; *NIH, 1998, NIH PUBL, V98, P4288; ORTH DN, 1979, CLIN ENDOCRINOL, V10, P603, DOI 10.1111/j.1365-2265.1979.tb02120.x; PALM L, 1991, ANN NEUROL, V29, P336, DOI 10.1002/ana.410290318; Pen S, 1999, SLEEP, V22, pS138; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; SACK R, 1999, SLEEP RES ONLINE S, V2, pS624; Sack RL, 1997, SLEEP, V20, P908, DOI 10.1093/sleep/20.10.908; SACK RL, 1991, J BIOL RHYTHM, V6, P249, DOI 10.1177/074873049100600305; SACK RL, 1992, J CLIN ENDOCR METAB, V75, P127, DOI 10.1210/jcem.75.1.1619000; Sack RL, 1997, J BIOL RHYTHM, V12, P595, DOI 10.1177/074873049701200615; Sack RL, 1987, TEMPORAL DISORDER HU, P219; Sack RL, 1990, SLEEP RES, V19, P404; SACK RL, 1999, SLEEP S1, V22, pS140; SKENE D, 1999, SLEEP RES ONLINE S, V2, pS725; ZAIDAN R, 1994, NEUROENDOCRINOLOGY, V60, P105, DOI 10.1159/000126726	32	306	324	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2000	343	15					1070	1077		10.1056/NEJM200010123431503	http://dx.doi.org/10.1056/NEJM200010123431503			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	362FA	11027741				2022-12-28	WOS:000089766900003
J	Futran, ND; Alsarraf, R				Futran, ND; Alsarraf, R			Microvascular free-flap reconstruction in the head and neck	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANDIBLE RECONSTRUCTION; DEFECTS; EXPERIENCE; MIDFACE; BONE		Univ Washington, Sch Med, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Futran, ND (corresponding author), Univ Washington, Sch Med, Dept Otolaryngol Head & Neck Surg, Box 356515, Seattle, WA 98195 USA.	nfutran@u.washington.edu						ALLISON GR, 1987, AM J SURG, V154, P419, DOI 10.1016/0002-9610(89)90016-0; BAEK SM, 1983, PLAST RECONSTR SURG, V71, P354, DOI 10.1097/00006534-198303000-00012; BAKER SR, 1986, ARCH OTOLARYNGOL, V112, P733; BAKER SR, 1988, ARCH OTOLARYNGOL, V114, P267; BROWN KE, 1968, J PROSTHET DENT, V20, P176, DOI 10.1016/0022-3913(68)90143-1; COLEMAN JJ, 1994, CLIN PLAST SURG, V21, P113; Cordeiro PG, 1998, PLAST RECONSTR SURG, V102, P1874, DOI 10.1097/00006534-199811000-00011; Duffy FJ, 1998, J RECONSTR MICROSURG, V14, P89, DOI 10.1055/s-2007-1000149; FISHER SR, 1990, HEAD NECK-J SCI SPEC, V12, P126, DOI 10.1002/hed.2880120206; FUTRAN ND, 1994, CURRENT THERAPY OTOL, P327; HIDALGO DA, 1989, PLAST RECONSTR SURG, V84, P71, DOI 10.1097/00006534-198907000-00014; HOFFMAN HT, 1991, ARCH OTOLARYNGOL, V117, P917; KATSAROS J, 1991, PLAST RECONSTR SURG, V87, P902, DOI 10.1097/00006534-199105000-00015; KLOTCH DW, 1990, AM J SURG, V160, P396, DOI 10.1016/S0002-9610(05)80551-3; KURILOFF DB, 1993, HEAD NECK SURG OTOLA, P1949; MATIN H, 1992, ARCH SURG-CHICAGO, V44, P599; MCLEAN DH, 1972, PLAST RECONSTR SURG, V49, P268, DOI 10.1097/00006534-197203000-00005; MELAND NB, 1989, PLAST RECONSTR SURG, V83, P481, DOI 10.1097/00006534-198903000-00014; SHESTAK K C, 1988, Microsurgery, V9, P128, DOI 10.1002/micr.1920090214; Triana R J Jr, 2000, Arch Facial Plast Surg, V2, P91, DOI 10.1001/archfaci.2.2.91; URKEN ML, 1993, ARCH OTOLARYNGOL, V119, P1318; URKEN ML, 1991, LARYNGOSCOPE, V101, P257; URKEN ML, 1990, LARYNGOSCOPE, V100, P161; Urken ML, 1995, ATLAS REGIONAL FREE	24	16	17	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1761	1763		10.1001/jama.284.14.1761	http://dx.doi.org/10.1001/jama.284.14.1761			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025806				2022-12-28	WOS:000089622100002
J	Lanzavecchia, A; Sallusto, F				Lanzavecchia, A; Sallusto, F			Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells	SCIENCE			English	Review							MHC CLASS-II; CHEMOKINE RECEPTOR EXPRESSION; CYTOKINE GENE-EXPRESSION; HUMAN DENDRITIC CELLS; IN-VIVO; DOWN-REGULATION; DEVELOPMENTAL REGULATION; EFFICIENT PRESENTATION; IMMUNOLOGICAL MEMORY; UP-REGULATION	The immune response is initiated in organized Lymphoid tissues where antigen-loaded dendritic cells (DCs) encounter antigen-specific T cells. DCs function as packets of information that must be decoded by the T cell before an appropriate immune response can be mounted. We discuss how the dynamics of DC-T cell encounter and the mechanism of T cell differentiation make the decoding of this information stochastic rather than determinate. This results in the generation of both terminally differentiated effector cells and intermediates that play distinctive roles in,protection, immunoregulation, and immunological memory.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	lanzavecchia@irb.unisi.ch; federica.sallusto@irb.unisi.ch						Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Braun MC, 1999, J EXP MED, V189, P541, DOI 10.1084/jem.189.3.541; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Busch DH, 2000, J IMMUNOL, V164, P4063, DOI 10.4049/jimmunol.164.8.4063; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cai ZL, 1997, J EXP MED, V185, P641, DOI 10.1084/jem.185.4.641; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; Coffman RL, 1999, SCIENCE, V284, P1283, DOI 10.1126/science.284.5418.1283; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; CROFT M, 1994, J IMMUNOL, V152, P2675; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DeBenedette MA, 1999, J IMMUNOL, V163, P4833; DEMEURE CE, 1995, EUR J IMMUNOL, V25, P2722, DOI 10.1002/eji.1830250950; DeSmedt T, 1997, EUR J IMMUNOL, V27, P1229, DOI 10.1002/eji.1830270526; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Groux H, 1999, IMMUNOL TODAY, V20, P442, DOI 10.1016/S0167-5699(99)01510-8; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; HORGAN KJ, 1990, EUR J IMMUNOL, V20, P1111, DOI 10.1002/eji.1830200525; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; IEZZI G, UNPUB; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; KALINSKI P, 1995, J IMMUNOL, V154, P3753; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; LANGENKAMP A, IN PRESS NATURE IMMU; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Li JF, 1999, J IMMUNOL, V163, P6386; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Manjunath N, 1999, P NATL ACAD SCI USA, V96, P13932, DOI 10.1073/pnas.96.24.13932; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Pannetier C, 1999, COLD SPRING HARB SYM, V64, P599, DOI 10.1101/sqb.1999.64.599; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Robert C, 1999, J EXP MED, V189, P627, DOI 10.1084/jem.189.4.627; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; RON Y, 1987, J IMMUNOL, V138, P2848; SAD S, 1994, J IMMUNOL, V153, P3514; SAGERSTROM CG, 1993, P NATL ACAD SCI USA, V90, P8987, DOI 10.1073/pnas.90.19.8987; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SALLUSTO F, UNPUB; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Sprent J, 1997, IMMUNOL REV, V156, P79, DOI 10.1111/j.1600-065X.1997.tb00960.x; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Vendetti S, 2000, J IMMUNOL, V165, P1175, DOI 10.4049/jimmunol.165.3.1175; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Walker LSK, 2000, IMMUNOL TODAY, V21, P333, DOI 10.1016/S0167-5699(00)01636-4; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	126	618	651	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					92	97		10.1126/science.290.5489.92	http://dx.doi.org/10.1126/science.290.5489.92			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021806				2022-12-28	WOS:000089724800039
J	Simon, AR; Vikis, HG; Stewart, S; Fanburg, BL; Cochran, BH; Guan, KL				Simon, AR; Vikis, HG; Stewart, S; Fanburg, BL; Cochran, BH; Guan, KL			Regulation of STAT3 by direct binding to the Rac1 GTPase	SCIENCE			English	Article							EPIDERMAL GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; CYTOKINE RECEPTORS; ACTIVATION; KINASE; PROTEINS; GENE; IDENTIFICATION; PATHWAY; JAKS	The signal transducers and activators of transcription (STAT) transcription factors become phosphorylated on tyrosine and translocate to the nucleus after stimulation of cells with growth factors or cytokines. We show that the Rad guanosine triphosphatase can bind to and regulate STAT3 activity. Dominant negative Rad inhibited STAT3 activation by growth factors, whereas activated Rad stimulated STAT3 phosphorylation on both tyrosine and serine residues. Moreover, activated Rad formed a complex with STAT3 in mammalian cells, Yeast two-hybrid analysis indicated that STAT3 binds directly to active but not inactive Rad and that the interaction occurs via the effector domain. Rad may serve as an alternate mechanism for targeting STAT3 to tyrosine kinase signaling complexes.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Tupper Res Inst, Div Pulm & Crit Care, Boston, MA 02111 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Tufts University; Tufts Medical Center; University of Michigan System; University of Michigan	Cochran, BH (corresponding author), Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA.	cochran@opal.tufts.edu	Guan, Kun-Liang/ADK-7088-2022	Cochran, Brent/0000-0002-7598-5604	NHLBI NIH HHS [K08-HL-03547] Funding Source: Medline; NIDDK NIH HHS [P30-DK34928] Funding Source: Medline; NIGMS NIH HHS [GM-54304] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054304] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; HELM MH, 1995, SCIENCE, V267, P1347; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Leaman DW, 1996, MOL CELL BIOL, V16, P369; NAKAMURA K, 1993, ONCOGENE, V8, P3133; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SIMON A, UNPUB; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Vignais ML, 1996, MOL CELL BIOL, V16, P1759; Vignais ML, 1999, MOL CELL BIOL, V19, P3727; VIKIS H, UNPUB; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Wang YZ, 2000, ONCOGENE, V19, P2075, DOI 10.1038/sj.onc.1203548; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	29	186	191	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					144	147		10.1126/science.290.5489.144	http://dx.doi.org/10.1126/science.290.5489.144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021801				2022-12-28	WOS:000089724800054
J	Vdovin, EE; Levin, A; Patane, A; Eaves, L; Main, PC; Khanin, YN; Dubrovskii, YV; Henini, M; Hill, G				Vdovin, EE; Levin, A; Patane, A; Eaves, L; Main, PC; Khanin, YN; Dubrovskii, YV; Henini, M; Hill, G			Imaging the electron wave function in self-assembled quantum dots	SCIENCE			English	Article							MAGNETOTUNNELING SPECTROSCOPY; ORGANIZED GROWTH; STATES; GAAS	Magnetotunneling spectroscopy is used as a noninvasive and nondestructive probe to produce two-dimensional spatial images of the probability density of an electron confined in a self-assembled semiconductor quantum dot, The technique exploits the effect of the classical Lorentz force on the motion of a tunneling electron and can be regarded as the momentum (k) space analog of scanning tunneling microscopy imaging. The images reveal the elliptical symmetry of the ground state and the characteristic Lobes of the higher energy states.	Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; Russian Acad Sci, Inst Microelect Technol, Chernogolovka 142432, Russia; Univ Sheffield, Dept Elect & Elect Engn, Sheffield S1 3JD, S Yorkshire, England	University of Nottingham; Russian Academy of Sciences; University of Sheffield	Eaves, L (corresponding author), Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England.		Levin, Alexander D/L-4920-2013; Khanin, Yurii N/L-1601-2018; Henini, Mohamed/O-3341-2019; Vdovin, Evgenii E/R-9911-2016	Henini, Mohamed/0000-0001-9414-8492; Levine, Alexandre/0000-0001-8371-3580; patane, amalia/0000-0003-3015-9496; Eaves, Laurence/0000-0002-5334-0987				Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Austing DG, 1999, APPL PHYS LETT, V75, P671, DOI 10.1063/1.124477; BETON PH, 1995, PHYS REV LETT, V75, P196; BIMBERG, 1999, QUANTUM DOT HETEROST; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Empedocles SA, 1997, SCIENCE, V278, P2114, DOI 10.1126/science.278.5346.2114; GEIM AK, 1994, PHYS REV LETT, V72, P2061, DOI 10.1103/PhysRevLett.72.2061; Hapke-Wurst I, 1999, SEMICOND SCI TECH, V14, pL41, DOI 10.1088/0268-1242/14/11/104; HAYDEN RK, 1991, PHYS REV LETT, V66, P1749, DOI 10.1103/PhysRevLett.66.1749; Itskevich IE, 1996, PHYS REV B, V54, P16401, DOI 10.1103/PhysRevB.54.16401; Landin L, 1998, SCIENCE, V280, P262, DOI 10.1126/science.280.5361.262; Main PC, 2000, PHYS REV LETT, V84, P729, DOI 10.1103/PhysRevLett.84.729; MARZIN JY, 1994, PHYS REV LETT, V73, P716, DOI 10.1103/PhysRevLett.73.716; Narihiro M, 1997, APPL PHYS LETT, V70, P105, DOI 10.1063/1.119276; NOTZEL R, 1994, NATURE, V369, P131, DOI 10.1038/369131a0; Pan SH, 2000, NATURE, V403, P746, DOI 10.1038/35001534; PATANE A, IN PRESS PHYS REV B; Pryor C, 1998, PHYS REV B, V57, P7190, DOI 10.1103/PhysRevB.57.7190; SAKAI JW, 1993, PHYS REV B, V48, P5664, DOI 10.1103/PhysRevB.48.5664; Stier O, 1999, PHYS REV B, V59, P5688, DOI 10.1103/PhysRevB.59.5688; Suzuki T, 1997, JPN J APPL PHYS 1, V36, P1917, DOI 10.1143/JJAP.36.1917; Wang LW, 1999, PHYS REV B, V59, P5678, DOI 10.1103/PhysRevB.59.5678; Yang WD, 2000, PHYS REV B, V61, P2784, DOI 10.1103/PhysRevB.61.2784; Zhitenev NB, 2000, NATURE, V404, P473, DOI 10.1038/35006591	24	164	164	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					122	124		10.1126/science.290.5489.122	http://dx.doi.org/10.1126/science.290.5489.122			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021794				2022-12-28	WOS:000089724800047
J	Jacob, G; Costa, F; Shannon, JR; Robertson, RM; Wathen, M; Stein, M; Biaggioni, I; Ertl, A; Black, B; Robertson, D				Jacob, G; Costa, F; Shannon, JR; Robertson, RM; Wathen, M; Stein, M; Biaggioni, I; Ertl, A; Black, B; Robertson, D			The neuropathic postural tachycardia syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITRAL-VALVE PROLAPSE; IDIOPATHIC ORTHOSTATIC INTOLERANCE; PURE AUTONOMIC FAILURE; BLOOD-PRESSURE; PLASMA NOREPINEPHRINE; HYPOTENSION; TYRAMINE; HUMANS; HYPOVOLEMIA; RESISTANCE	Background: The postural tachycardia syndrome is a common disorder that is characterized by chronic orthostatic symptoms and a dramatic increase in heart rate on standing, but that does not involve orthostatic hypotension. Several lines of evidence indicate that this disorder may result from sympathetic denervation of the legs. Methods: We measured norepinephrine spillover (the rate of entry of norepinephrine into the venous circulation) in the arms and legs both before and in response to exposure to three stimuli (the cold pressor test, sodium nitroprusside infusion, and tyramine infusion) in 10 patients with the postural tachycardia syndrome and in 8 age- and sex-matched normal subjects. Results: At base line, the mean (+/-SD) plasma norepinephrine concentration in the femoral vein was lower in the patients with the postural tachycardia syndrome than in the normal subjects (135+/-30 vs. 215+/-55 pg per milliliter [0.80+/-0.18 vs. 1.27+/-0.32 nmol per liter], P=0.001). Norepinephrine spillover in the arms increased to a similar extent in the two groups in response to each of the three stimuli, but the increases in the legs were smaller in the patients with the postural tachycardia syndrome than in the normal subjects (0.001+/-0.09 vs. 0.12+/-0.12 ng per minute per deciliter of tissue [0.006+/-0.53 vs. 0.71+/-0.71 nmol per minute per deciliter] with the cold pressor test, P=0.02; 0.02+/-0.07 vs. 0.23+/-0.17 ng per minute per deciliter [0.12+/-0.41 vs. 1.36+/-1.00 nmol per minute per deciliter] with nitroprusside infusion, P=0.01; and 0.008+/-0.09 vs. 0.19+/-0.25 ng per minute per deciliter [0.05+/-0.53 vs. 1.12+/-1.47 nmol per minute per deciliter] with tyramine infusion, P=0.04). Conclusions: The neuropathic postural tachycardia syndrome results from partial sympathetic denervation, especially in the legs. (N Engl J Med 2000;343:1008-14.) (C) 2000, Massachusetts Medical Society.	Vanderbilt Univ, Autonom Dysfunct Ctr, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Rambam Med Ctr, Jacob Recanati Autonom Dysfunct Ctr, Haifa, Israel; Rambam Med Ctr, Dept Internal Med C, Haifa, Israel	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology	Robertson, D (corresponding author), Vanderbilt Univ, Autonom Dysfunct Ctr, AA3228 MCN, Nashville, TN 37232 USA.				NCRR NIH HHS [RR-00095] Funding Source: Medline; NHLBI NIH HHS [HL-56693] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056693] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aneman A, 1996, J CLIN INVEST, V97, P1640, DOI 10.1172/JCI118590; BOUDOULAS H, 1980, CIRCULATION, V61, P1200, DOI 10.1161/01.CIR.61.6.1200; Bradbury S, 1927, AM HEART J, V3, P105, DOI 10.1016/S0002-8703(27)90177-X; CAMPBELL TJ, 1958, J LAB CLIN MED, V52, P768; CONVERTINO VA, 1980, J APPL PHYSIOL, V48, P665, DOI 10.1152/jappl.1980.48.4.665; COUSINEAU D, 1986, J APPL PHYSIOL, V60, P147, DOI 10.1152/jappl.1986.60.1.147; ESLER M, 1990, PHYSIOL REV, V70, P963, DOI 10.1152/physrev.1990.70.4.963; FOUAD FM, 1986, ANN INTERN MED, V104, P298, DOI 10.7326/0003-4819-104-3-298; FOUADTARAZI FM, 1995, AM J MED, V99, P604, DOI 10.1016/S0002-9343(99)80246-0; FROHLICH ED, 1969, ARCH INTERN MED, V123, P1, DOI 10.1001/archinte.123.1.1; FROHLICH ED, 1966, ARCH INTERN MED, V117, P614; GOLDSTEIN DS, 1988, J CLIN INVEST, V81, P213, DOI 10.1172/JCI113298; GROSSMAN E, 1991, AM J PHYSIOL, V260, pR946, DOI 10.1152/ajpregu.1991.260.5.R946; GRUCHALLA RS, 1995, AM J MED SCI, V309, P328, DOI 10.1097/00000441-199506000-00007; Hague K, 1997, ACTA NEUROPATHOL, V94, P192, DOI 10.1007/s004010050693; HICKLER RB, 1959, NEW ENGL J MED, V261, P788, DOI 10.1056/NEJM195910152611604; HOELDTKE RD, 1989, NEUROLOGY, V39, P34, DOI 10.1212/WNL.39.1.34; HOELDTKE RD, 1991, J CLIN ENDOCR METAB, V73, P132, DOI 10.1210/jcem-73-1-132; Jacob G, 1997, AM J MED, V103, P128, DOI 10.1016/S0002-9343(97)00133-2; Jacob G, 1997, CIRCULATION, V96, P575; Jacob G, 1999, CIRCULATION, V99, P1706, DOI 10.1161/01.CIR.99.13.1706; Jacob G, 1996, CIRCULATION S1, V94, P627; Jordan J, 1998, HYPERTENSION, V32, P699, DOI 10.1161/01.HYP.32.4.699; Jordan J, 1998, AM J MED, V105, P116, DOI 10.1016/S0002-9343(98)00193-4; Kanda T, 1998, ANN NEUROL, V43, P267, DOI 10.1002/ana.410430220; LOW PA, 1995, NEUROLOGY, V45, pS19; LOW PA, 1983, ANN NEUROL, V14, P573, DOI 10.1002/ana.410140513; Mosqueda-Garcia R, 1995, DISORDERS AUTONOMIC, P25; Narkiewicz K, 1998, CIRCULATION, V98, P2105, DOI 10.1161/01.CIR.98.20.2105; ONROT J, 1986, AM J MED, V80, P454, DOI 10.1016/0002-9343(86)90720-5; PASTERNAC A, 1982, AM J MED, V73, P783, DOI 10.1016/0002-9343(82)90758-6; RAPOPORT RM, 1981, PHARMACOLOGY, V23, P235; REA RF, 1990, AM J PHYSIOL, V258, pR982, DOI 10.1152/ajpregu.1990.258.4.R982; Schafers RF, 1997, N-S ARCH PHARMACOL, V355, P239, DOI 10.1007/PL00004938; SCHONDORF R, 1993, NEUROLOGY, V43, P132, DOI 10.1212/WNL.43.1_Part_1.132; SCRIVEN AJI, 1983, CLIN PHARMACOL THER, V33, P710, DOI 10.1038/clpt.1983.97; SCRIVEN AJI, 1984, J CARDIOVASC PHARM, V6, P954, DOI 10.1097/00005344-198409000-00033; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Shannon JR, 1998, CIRCULATION, V98, P336; Siggaard-Andersen J, 1970, DANISH MED B      S1, V17, P1; STREETEN DHP, 1988, J LAB CLIN MED, V111, P326; STREETEN DHP, 1990, J CLIN INVEST, V86, P1582, DOI 10.1172/JCI114878; VISSING SF, 1989, CIRC RES, V65, P1710, DOI 10.1161/01.RES.65.6.1710; WOOLEY CF, 1976, CIRCULATION, V53, P749, DOI 10.1161/01.CIR.53.5.749	44	245	253	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2000	343	14					1008	1014		10.1056/NEJM200010053431404	http://dx.doi.org/10.1056/NEJM200010053431404			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PU	11018167	Bronze			2022-12-28	WOS:000089619900004
J	Feudtner, C				Feudtner, C			Dare we go gently	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material													Feudtner, Chris/AAI-1126-2019	Feudtner, Chris/0000-0002-5879-0434					0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1621	1622		10.1001/jama.284.13.1621	http://dx.doi.org/10.1001/jama.284.13.1621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015775				2022-12-28	WOS:000089501900001
J	Wehrli, M; Dougan, ST; Caldwell, K; O'Keefe, L; Schwartz, S; Vaizel-Ohayon, D; Schejter, E; Tomlinson, A; DiNardo, S				Wehrli, M; Dougan, ST; Caldwell, K; O'Keefe, L; Schwartz, S; Vaizel-Ohayon, D; Schejter, E; Tomlinson, A; DiNardo, S			Arrow encodes an LDL-receptor-related protein essential for Wingless signalling	NATURE			English	Article							LONG-RANGE ACTION; SIGNALING PATHWAYS; MORPHOGEN GRADIENT; MOLECULAR-CLONING; DROSOPHILA LEG; POLARITY; FAMILY; EXPRESSION; PATTERN; MEMBER	The Wnt family of secreted molecules functions in cell-fate determination and morphogenesis during development in both vertebrates and invertebrates (reviewed in ref. 1). Drosophila Wingless is a founding member of this family, and many components of its signal transduction cascade have been identified, including the Frizzled class of receptor. But the mechanism by which the Wingless signal is received and transduced across the membrane is not completely understood. Here we describe a gene that is necessary for all Wingless signalling events in Drosophila. We show that arrow gene function is essential in cells receiving Wingless input and that it acts upstream of Dishevelled. arrow encodes a single-pass transmembrane protein, indicating that it may be part of a receptor complex with Frizzled class proteins. Arrow is a low-density lipoprotein (LDL)receptor-related protein (LRP), strikingly homologous to murine and human LRP5 and LRP6. Thus, our data suggests a new and conserved function for this LRP subfamily in Wingless/Wnt signal reception.	Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Columbia Univ, New York, NY 10032 USA; Rockefeller Univ, New York, NY 10021 USA; Weizmann Inst Sci, IL-76100 Rehovot, Israel	University of Pennsylvania; Columbia University; Rockefeller University; Weizmann Institute of Science	DiNardo, S (corresponding author), Univ Penn, Sch Med, BRB 2 Room 1223,421 Curie Blvd, Philadelphia, PA 19104 USA.		Dougan, Scott/B-8416-2008; O'Keefe, Louise V/B-9856-2008	Dougan, Scott/0000-0003-0214-4772; Caldwell, Kim/0000-0003-1580-6122; DiNardo, Stephen/0000-0003-4131-5511	NIGMS NIH HHS [R01 GM045747] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045747] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chen D, 1999, GENOMICS, V55, P314, DOI 10.1006/geno.1998.5688; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; DOUGAN S, 1992, NATURE, V360, P347, DOI 10.1038/360347a0; Heslip TR, 1997, DEVELOPMENT, V124, P1069; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Muller HAJ, 1999, DEVELOPMENT, V126, P577; Neumann CJ, 1997, DEVELOPMENT, V124, P871; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Penton A, 1996, NATURE, V382, P162, DOI 10.1038/382162a0; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Wehrli M, 1998, DEVELOPMENT, V125, P1421; WEHRLI M, 1995, DEVELOPMENT, V121, P2451; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	30	685	718	0	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					527	530		10.1038/35035110	http://dx.doi.org/10.1038/35035110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029006				2022-12-28	WOS:000089727400054
J	Kondo, M; Scherer, DC; Miyamoto, T; King, AG; Akashi, K; Sugamura, K; Weissman, IL				Kondo, M; Scherer, DC; Miyamoto, T; King, AG; Akashi, K; Sugamura, K; Weissman, IL			Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines	NATURE			English	Article							RECEPTOR-GAMMA-CHAIN; MOUSE BONE-MARROW; IL-2 RECEPTOR; SIGNAL-TRANSDUCTION; BETA-CHAIN; STEM-CELLS; ERYTHROPOIETIN RECEPTOR; INTERLEUKIN-2 RECEPTOR; MYELOGENOUS LEUKEMIA; GENE REARRANGEMENT	The primary role of cytokines in haemato-lymphopoiesis is thought to be the regulation of cell growth and survival(1-3). But the instructive action of cytokines in haematopoiesis has not been well addressed(4). Here we show that a clonogenic common lymphoid progenitor(5), a bone marrow-resident cell that gives rise exclusively to lymphocytes (T, B and natural killer cells), can be redirected to the myeloid lineage by stimulation through exogenously expressed interleukin (IL)-2 and GM-CSF (granulocyte/ macrophage colony-stimulating factor) receptors. Analysis of mutants of the beta-chain of the IL-2 receptor revealed that the granulocyte- and monocyte-differentiation signals are triggered by different cytoplasmic domains, showing that the signalling pathway(s) responsible for these unique developmental outcomes are separable. Finally, we show that the endogenous myelomonocytic cytokine receptors for GM-CSF and macrophage colony-stimulating factor (M-CSF) are expressed at low to moderate levels on the more primitive haematopoietic stem cells, are absent on common lymphoid progenitors, and are upregulated after myeloid lineage induction by IL-2. We conclude that cytokine signalling can regulate cell-fate decisions and propose that a critical step in lymphoid commitment is downregulation of cytokine receptors that drive myeloid cell development.	Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; Tohoku Univ, Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 9808575, Japan	Stanford University; Stanford University; Tohoku University	Kondo, M (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	motonari.kondo@stanford.edu		Fleischman, Angela/0000-0002-3701-6079				ASANO M, 1994, J IMMUNOL, V153, P5373; CHENG GY, 1986, J EXP MED, V163, P414, DOI 10.1084/jem.163.2.414; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; Ghaffari S, 1999, P NATL ACAD SCI USA, V96, P13186, DOI 10.1073/pnas.96.23.13186; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GODFREY DI, 1994, J IMMUNOL, V152, P4783; HA K, 1984, CANCER RES, V44, P4658; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HENRY C, 1981, SELECTED METHODS CEL, P138; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Metcalf D, 1999, ANN NY ACAD SCI, V872, P289, DOI 10.1111/j.1749-6632.1999.tb08473.x; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; NEMOTO T, 1995, EUR J IMMUNOL, V25, P3001, DOI 10.1002/eji.1830251102; Ogasawara K, 1998, NATURE, V392, P843, DOI 10.1038/33977; OGAWA M, 1993, BLOOD, V81, P2844; PALUMBO A, 1984, BLOOD, V64, P1059; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; WATANABE S, 1993, MOL CELL BIOL, V13, P1440, DOI 10.1128/MCB.13.3.1440; Watowich SS, 1996, ANNU REV CELL DEV BI, V12, P91, DOI 10.1146/annurev.cellbio.12.1.91	28	300	316	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2000	407	6802					383	386		10.1038/35030112	http://dx.doi.org/10.1038/35030112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014194				2022-12-28	WOS:000089390700048
J	Wilson, RC				Wilson, RC			The Great Goodbye - The emotional cost of the post-evolutionary divide.	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					303	303						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014168				2022-12-28	WOS:000089390700022
J	Johnson, HP; Hutnak, M; Dziak, RP; Fox, CG; Urcuyo, I; Cowen, JP; Nabelek, J; Fisher, C				Johnson, HP; Hutnak, M; Dziak, RP; Fox, CG; Urcuyo, I; Cowen, JP; Nabelek, J; Fisher, C			Earthquake-induced changes in a hydrothermal system on the Juan de Fuca mid-ocean ridge	NATURE			English	Article								Hydrothermal vents on mid-ocean ridges of the northeast Pacific Ocean are known to respond to seismic disturbances, with observed changes in vent temperature(1-4). But these disturbances resulted from submarine volcanic activity; until now, there have been no observations of the response of a vent system to nonmagmatic, tectonic events. Here we report measurements of hydrothermal vent temperature from several vents on the Juan de Fuca ridge in June 1999, before, during and after an earthquake swarm of apparent tectonic origin. Vent fluid temperatures began to rise 4-11 days after the first earthquake. Following this initial increase, the vent temperatures oscillated for about a month before settling down to higher values. We also observed a tenfold increase in fluid output from the hydrothermal system over a period of at least 80 days, extending along the entire ridge segment. Such a large, segment-wide thermal response to relatively modest tectonic activity is surprising, and raises questions about the sources of excess heat and fluid, and the possible effect on vent biological communities.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Oregon State Univ, Newport, OR 97365 USA; NOAA, PMEL, Newport, OR 97365 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Oregon State Univ, COAS, Corvallis, OR 97331 USA	University of Washington; University of Washington Seattle; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Hawaii System; Oregon State University	Johnson, HP (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.		Fisher, Charles/H-7912-2012; Dziak, Robert/AAC-6107-2020					DELANEY JR, 1992, J GEOPHYS RES-SOL EA, V97, P19663, DOI 10.1029/92JB00174; DELANEY JR, 1997, RIDGE EVENTS, V8, P11; Dziak RP, 1999, GEOPHYS RES LETT, V26, P3429, DOI 10.1029/1999GL002332; Fox CG, 1998, DEEP-SEA RES PT II, V45, P2513, DOI 10.1016/S0967-0645(98)00081-2; FOX CG, 1995, GEOPHYS RES LETT, V22, P131, DOI 10.1029/94GL02059; FOX CG, 1993, MAR TECHNOL SOC J, V27, P22; Holden JF, 1998, FEMS MICROBIOL ECOL, V25, P33, DOI 10.1111/j.1574-6941.1998.tb00458.x; JOHNSON HP, 1993, GEOPHYS RES LETT, V20, P1875, DOI 10.1029/93GL00734; NABELEK J, 1995, GEOPHYS RES LETT, V22, P13, DOI 10.1029/94GL02760; Sohn RA, 1999, J GEOPHYS RES-SOL EA, V104, P25367, DOI 10.1029/1999JB900263; Taylor CD, 1997, SCIENCE, V277, P1483, DOI 10.1126/science.277.5331.1483	11	121	122	1	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					174	177		10.1038/35025040	http://dx.doi.org/10.1038/35025040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001052				2022-12-28	WOS:000089241000044
J	Tapscott, SJ				Tapscott, SJ			Biomedicine - Deconstructing myotonic dystrophy	SCIENCE			English	Editorial Material							TRINUCLEOTIDE REPEAT; REDUCES EXPRESSION; CTG REPEAT; EXPANSION; PROTEIN; MYOPATHY; RNA; ADJACENT; LOCUS; DMAHP		Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Tapscott, SJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.			Tapscott, Stephen/0000-0002-0319-0968				Alwazzan M, 1999, HUM MOL GENET, V8, P1491, DOI 10.1093/hmg/8.8.1491; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Day JW, 1999, NEUROMUSCULAR DISORD, V9, P19, DOI 10.1016/S0960-8966(98)00094-7; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klesert TR, 2000, NAT GENET, V25, P105, DOI 10.1038/75490; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 1998, NAT GENET, V19, P196, DOI 10.1038/570; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Ricker K, 1999, NEUROLOGY, V52, P170, DOI 10.1212/WNL.52.1.170; Sarkar PS, 2000, NAT GENET, V25, P110, DOI 10.1038/75500; Steinbach P, 1998, AM J HUM GENET, V62, P278, DOI 10.1086/301711; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Timchenko LT, 1999, AM J HUM GENET, V64, P360, DOI 10.1086/302268; Tiscornia G, 2000, MOL CELL, V5, P959, DOI 10.1016/S1097-2765(00)80261-0; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599	20	43	47	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1701	1702		10.1126/science.289.5485.1701	http://dx.doi.org/10.1126/science.289.5485.1701			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	11001736				2022-12-28	WOS:000089195200032
J	Takayama, T; Sekine, T; Makuuchi, M; Yamasaki, S; Kosuge, T; Yamamoto, J; Shimada, K; Sakamoto, M; Hirohashi, S; Ohashi, Y; Kakizoe, T				Takayama, T; Sekine, T; Makuuchi, M; Yamasaki, S; Kosuge, T; Yamamoto, J; Shimada, K; Sakamoto, M; Hirohashi, S; Ohashi, Y; Kakizoe, T			Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial	LANCET			English	Article							ACTIVATED KILLER CELLS; T-CELLS; RECOMBINANT INTERLEUKIN-2; CANCER; LIVER; RESECTION; LYMPHOCYTES; ANTIGENS; PROGRESS; SURGERY	Background Postsurgical recurrence of hepatocellular carcinoma (HCC) is frequent and fatal. Adoptive immunotherapy is active against HCC. We assessed whether postoperative immunotherapy could lower the frequency of recurrence. Methods Between 1992 and 1995, we did a randomised trial in which 150 patients who had undergone curative resection for HCC were assigned adoptive immunotherapy (n=76) or no adjuvant treatment (n=74). Autologous lymphocytes activated vitro with recombinant interleukin-2 and antibody to CD3 were infused five times during the first 6 months. Primary endpoints were time to first recurrence and recurrence-free survival and analyses were by intention to treat. Findings 76 patients received 370 (97%) of 380 scheduled lymphocyte infusions (mean cell number per patient 7.1x10(10) [SD 2.1]; CD3 and HLA-DR ceils 78% [16]), and none had grade 3 or 4 adverse events. After a median follow-up of 4.4 years (range 0.2-6.7), adoptive immunotherapy decreased the frequency of recurrence by 18% compared with controls (45% [59] vs 57% [77]) and reduced the risk of recurrence by 41% (95% CI 12-60, p=0.01). Time to first recurrence in the immunotherapy group was significantly longer than that in the control group (48% [37-59] vs 33% [22-43] at 3 years, 38% [22-54] vs 22% [11-34] at 5 years; p=0.008). The immunotherapy group had significantly longer recurrence-free survival (p=0.01) and disease-specific survival (p=0.04) than the control group. Overall survival did not differ significantly between groups (p=0.09). Interpretation Adoptive immunotherapy is a safe, feasible treatment that can lower recurrence and improve recurrence-free outcomes after surgery for HCC.	Univ Tokyo, Fac Med,Dept Surg, Div Hepatobiliary Pancreat & Transplantat Surg, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Natl Canc Ctr Hosp, Tokyo 1130033, Japan; Univ Tokyo, Div Expt Med, Tokyo 1130033, Japan; Univ Tokyo, Div Pathol, Tokyo 1130033, Japan; Univ Tokyo, Natl Canc Ctr, Res Inst, Tokyo 1130033, Japan; Univ Tokyo, Sch Hlth Sci & Nursing, Dept Biostat, Tokyo 1130033, Japan	University of Tokyo; National Cancer Center - Japan; University of Tokyo; University of Tokyo; University of Tokyo; National Cancer Center - Japan; University of Tokyo; University of Tokyo	Takayama, T (corresponding author), Univ Tokyo, Fac Med,Dept Surg, Div Hepatobiliary Pancreat & Transplantat Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Sakamoto, Michiie/N-2917-2015; 幕内, 雅敏 m/A-2140-2012					ARUGA A, 1991, INT J CANCER, V49, P19, DOI 10.1002/ijc.2910490105; BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; BISMUTH H, 1993, ANN SURG, V218, P145, DOI 10.1097/00000658-199308000-00005; Bruix J, 1997, HEPATOLOGY, V25, P259; Chang AE, 1996, CRIT REV ONCOL HEMAT, V22, P213, DOI 10.1016/1040-8428(96)00194-1; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; Funaki NO, 1997, HEPATOLOGY, V25, P564, DOI 10.1002/hep.510250312; KONOMI Y, 1995, JPN J CANCER RES, V86, P854, DOI 10.1111/j.1349-7006.1995.tb03096.x; LAFRENIERE R, 1985, CANCER RES, V45, P3735; LAI ECS, 1995, ANN SURG, V221, P291, DOI 10.1097/00000658-199503000-00012; Lau WY, 1999, LANCET, V353, P797, DOI 10.1016/S0140-6736(98)06475-7; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; OKUDA K, 1992, HEPATOLOGY, V15, P948, DOI 10.1002/hep.1840150532; ONISHI S, 1989, HEPATOLOGY, V10, P349, DOI 10.1002/hep.1840100318; OSBAND ME, 1990, LANCET, V335, P994, DOI 10.1016/0140-6736(90)91064-H; ROSENBERG SA, 1987, NEW ENGL J MED, V316, P889, DOI 10.1056/NEJM198704093161501; SAWCZUK IS, 1997, P AN M AM SOC CLIN, V16, pA326; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Scott Andrew M., 1997, Lancet (North American Edition), V349, P19; SEKINE T, 1993, BIOMED PHARMACOTHER, V47, P73, DOI 10.1016/0753-3322(93)90294-U; SUNG CH, 1989, J CLIN INVEST, V83, P421, DOI 10.1172/JCI113900; Takayama T, 1998, HEPATOLOGY, V28, P1241, DOI 10.1002/hep.510280511; TAKAYAMA T, 1991, CANCER, V68, P2391, DOI 10.1002/1097-0142(19911201)68:11<2391::AID-CNCR2820681110>3.0.CO;2-7; Takayama T, 1998, HEPATOLOGY, V28, P1436, DOI 10.1002/hep.510280539; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; Yamamoto J, 1996, BRIT J SURG, V83, P1219	28	697	768	1	44	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 2	2000	356	9232					802	807		10.1016/S0140-6736(00)02654-4	http://dx.doi.org/10.1016/S0140-6736(00)02654-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350LF	11022927				2022-12-28	WOS:000089101800010
J	Szefler, S; Weiss, S; Tonascia, A; Adkinson, NF; Bender, B; Cherniack, R; Donithan, M; Kelly, HW; Reisman, J; Shapiro, GG; Sternberg, AL; Strunk, R; Taggart, V; Van Natta, M; Wise, R; Wu, M; Zeiger, R				Szefler, S; Weiss, S; Tonascia, A; Adkinson, NF; Bender, B; Cherniack, R; Donithan, M; Kelly, HW; Reisman, J; Shapiro, GG; Sternberg, AL; Strunk, R; Taggart, V; Van Natta, M; Wise, R; Wu, M; Zeiger, R		Childhood Asthma Management Progr	Long-term effects of budesonide or nedocromil in children with asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHALED CORTICOSTEROIDS; CHILDHOOD ASTHMA; BECLOMETHASONE DIPROPIONATE; MANAGEMENT PROGRAM; PULMONARY-FUNCTION; LUNG-FUNCTION; MILD ASTHMA; ADULT LIFE; GROWTH; DURATION	Background: Antiinflammatory therapies, such as inhaled corticosteroids or nedocromil, are recommended for children with asthma, although there is limited information on their long-term use. Methods: We randomly assigned 1041 children from 5 through 12 years of age with mild-to-moderate asthma to receive 200 microg of budesonide (311 children), 8 mg of nedocromil (312 children), or placebo (418 children) twice daily. We treated the participants for four to six years. All children used albuterol for asthma symptoms. Results: There was no significant difference between either treatment and placebo in the primary outcome, the degree of change in the forced expiratory volume in one second (FEV(sub 1), expressed as a percentage of the predicted value) after the administration of a bronchodilator. As compared with the children assigned to placebo, the children assigned to receive budesonide had a significantly smaller decline in the ratio of FEV(sub 1) to forced vital capacity (FVC, expressed as a percentage) before the administration of a bronchodilator (decline in FEV(sub 1):FVC, 0.2 percent vs. 1.8 percent). The children given budesonide also had lower airway responsiveness to methacholine, fewer hospitalizations (2.5 vs. 4.4 per 100 person-years), fewer urgent visits to a caregiver (12 vs. 22 per 100 person-years), greater reduction in the need for albuterol for symptoms, fewer courses of prednisone, and a smaller percentage of days on which additional asthma medications were needed. As compared with placebo, nedocromil significantly reduced urgent care visits (16 vs. 22 per 100 person-years) and courses of prednisone. The mean increase in height in the budesonide group was 1.1 cm less than in the placebo group (22.7 vs. 23.8 cm, P=0.005); this difference was evident mostly within the first year. The height increase was similar in the nedocromil and placebo groups. Conclusions: In children with mild-to-moderate asthma, neither budesonide nor nedocromil is better than placebo in terms of lung function, but inhaled budesonide improves airway responsiveness and provides better control of asthma than placebo or nedocromil. The side effects of budesonide are limited to a small, transient reduction in growth velocity. (N Engl J Med 2000;343:1054-63.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Univ, Childhood Asthma Management Program, Coordinating Ctr, Baltimore, MD 21205 USA; Asthma Inc, Seattle, WA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; Natl Jewish Med & Res Ctr, Chairs Off, Denver, CO USA; Univ Calif San Diego, San Diego, CA 92103 USA; Kaiser Permanente, San Diego, CA USA; Univ New Mexico, Albuquerque, NM 87131 USA; Washington Univ, Bone Age Reading Ctr, St Louis, MO USA; Johns Hopkins Asthma & Allergy Ctr, Dermatol Allergy & Clin Immunol Reference Lab, Baltimore, MD USA; McKesson Bioserv Corp, Drug Distribut Ctr, Rockville, MD USA; Univ Wisconsin, Fundus Photog Reading Ctr, Madison, WI USA; Natl Jewish Med & Res Ctr, Patient Educ Ctr, Denver, CO USA; PDS Instrumentat, Louisville, CO USA; NHLBI, Project Off, Bethesda, MD 20892 USA; Natl Jewish Med & Res Ctr, Immunol & Complement Lab, Denver, CO USA; Univ Iowa, Coll Pharm, Div Pharmaceut Serv, Iowa City, IA 52242 USA	Johns Hopkins University; Harvard University; Brigham & Women's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University; Johns Hopkins Medicine; National Jewish Health; University of California System; University of California San Diego; Kaiser Permanente; University of New Mexico; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Medicine; McKesson Corporation; University of Wisconsin System; University of Wisconsin Madison; National Jewish Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Jewish Health; University of Iowa	Tonascia, A (corresponding author), Johns Hopkins Univ, Childhood Asthma Management Program, Coordinating Ctr, 615 N Wolfe St,Rm 5010, Baltimore, MD 21205 USA.			Zeiger, Robert/0000-0001-5788-5063; Williams, Paul/0000-0003-3300-1328; Wise, Robert/0000-0002-8353-2349	DIVISION OF LUNG DISEASES [N01HR016045, N01HR016046, N01HR016044] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HR-16045, N01-HR-16046, N01-HR-16044] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; ALLEN DB, 1994, J ALLERGY CLIN IMMUN, V93, P967, DOI 10.1016/S0091-6749(94)70043-5; BROGDEN RN, 1992, DRUGS, V44, P375, DOI 10.2165/00003495-199244030-00007; BROGDEN RN, 1992, DRUGS, V44, P1012, DOI 10.1007/BF03259142; BROGDEN RN, 1993, DRUGS, V45, P130, DOI 10.1007/BF03259101; CALLAGHAN B, 1992, CHEST, V101, P787, DOI 10.1378/chest.101.3.787; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Childhood Asthma Management Program Res Grp, 1999, J ASTHMA, V36, P217; COULTAS DB, 1988, AM REV RESPIR DIS, V138, P1386, DOI 10.1164/ajrccm/138.6.1386; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; DOULL IJM, 1995, AM J RESP CRIT CARE, V151, P1715, DOI 10.1164/ajrccm.151.6.7767512; Doull IJM, 1998, ARCH DIS CHILD, V78, P172, DOI 10.1136/adc.78.2.172; Garbe E, 1998, JAMA-J AM MED ASSOC, V280, P539, DOI 10.1001/jama.280.6.539; Garbe E, 1998, JAMA-J AM MED ASSOC, V280, P1830; Greulich WW., 1959, CALIF MED, V91, P53; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; Hosmer D. W., 1999, APPL SURVIVAL ANAL; KLEIN BEK, 1990, PB90138306; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; KOVACS M, 1981, ACTA PAEDOPSYCHIATR, V46, P305; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; LESOUEF PN, 1995, AM J RESP CRIT CARE, V152, P576, DOI 10.1164/ajrccm.152.2.7633710; Maier WC, 1998, J CLIN EPIDEMIOL, V51, P557, DOI 10.1016/S0895-4356(98)00027-4; MARTIN AJ, 1980, BRIT MED J, V280, P1397, DOI 10.1136/bmj.280.6229.1397; MARTIN AJ, 1980, AM REV RESPIR DIS, V122, P609; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MEAD J, 1980, AM REV RESPIR DIS, V121, P339; MEINERT CL, 1986, MONOGRAPHS EPIDEMIOL, V8; MERKUS PJFM, 1993, PEDIATRICS, V91, P1121; *NAT ASTHM ED PREV, 1997, NIH PUBL; Nelson HS, 1999, J ALLERGY CLIN IMMUN, V104, P775, DOI 10.1016/S0091-6749(99)70287-3; [NHLBI WHO Workshop Report], 1995, NIH PUBL; NYHOLM E, 1984, EUR J RESPIR DIS, V65, P339; Oswald H, 1997, PEDIATR PULM, V23, P14, DOI 10.1002/(SICI)1099-0496(199701)23:1<14::AID-PPUL2>3.0.CO;2-P; Overbeek SE, 1996, CHEST, V110, P35, DOI 10.1378/chest.110.1.35; Peat JK, 1998, J ASTHMA, V35, P235, DOI 10.3109/02770909809068213; Rachelefsky GS, 1998, J ALLERGY CLIN IMMUN, V101, pS236; SCHWARTZ HJ, 1993, J ALLERGY CLIN IMMUN, V92, P204, DOI 10.1016/0091-6749(93)90110-2; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; SELROOS O, 1995, CHEST, V108, P1228, DOI 10.1378/chest.108.5.1228; Silverstein MD, 1997, J ALLERGY CLIN IMMUN, V99, P466, DOI 10.1016/S0091-6749(97)70072-1; Simons FER, 1997, NEW ENGL J MED, V337, P1659, DOI 10.1056/NEJM199712043372304; Szefler SJ, 1998, ANN ALLERG ASTHMA IM, V81, P571; Tanner JM., 1983, ASSESSMENT SKELETAL; Thurlbeck W M, 1975, Pathobiol Annu, V5, P1; TINKELMAN DG, 1993, PEDIATRICS, V92, P64; Verberne AAPH, 1997, AM J RESP CRIT CARE, V156, P688, DOI 10.1164/ajrccm.156.3.9611067; Warner JO, 1998, PEDIATR PULM, V25, P1; WEISS ST, 1995, EUR RESPIR REV, V5, P303; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888; Zeiger RS, 1999, J ALLERGY CLIN IMMUN, V103, P376, DOI 10.1016/S0091-6749(99)70460-4	51	634	669	2	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2000	343	15					1054	1063						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362FA	11027739				2022-12-28	WOS:000089766900001
J	Nikiforova, MN; Stringer, JR; Blough, R; Medvedovic, M; Fagin, JA; Nikiforov, YE				Nikiforova, MN; Stringer, JR; Blough, R; Medvedovic, M; Fagin, JA; Nikiforov, YE			Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells	SCIENCE			English	Article							THYROID PAPILLARY CARCINOMAS; RET PROTOONCOGENE; RET/PTC1 ONCOGENE; HIGH PREVALENCE; TUMORS; CHILDREN; EXPRESSION; ACCIDENT; MODEL	Rearrangements involving the RET gene are common in radiation-associated papillary thyroid cancer (PTC). The RET/PTC1 type of rearrangement is an inversion of chromosome 10 mediated by illegitimate recombination between the RET and the H4 genes, which are 30 megabases apart. Here we ask whether despite the great linear distance between them, RET;and H4 recombination might be promoted by their proximity in the nucleus. We used two-color fluorescence in situ hybridization and three-dimensional microscopy to map the positions of the RET and H4 loci within interphase nuclei. At least one pair of RET and H4 was juxtaposed in 35% of normal human thyroid cells and in 21% of peripheral blood lymphocytes, but only in 6% of normal mammary epithelial cells. Spatial contiguity of RFT and H4 may provide a structural basis for generation of RET/PTC1 rearrangement by allowing, a single radiation track to produce a double-strand break in each gene at the same site in the nucleus.	Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Div Endocrinol & Metab, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Mol Genet, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Ctr Biostat Serv, Cincinnati, OH 45267 USA; Childrens Hosp, Med Ctr, Div Human Genet, Cytogenet Lab, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Nikiforov, YE (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.				NCI NIH HHS [CA 72597] Funding Source: Medline; NIEHS NIH HHS [P01 ES 05652-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005652] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arscott PL, 1997, ENDOCRINOLOGY, V138, P5019, DOI 10.1210/en.138.11.5019; Bounacer A, 1997, ONCOGENE, V15, P1263, DOI 10.1038/sj.onc.1200206; CANNIZZARO LA, 1997, BASIC CELL CULTURE P, V75, pCH26; FUGAZZOLA L, 1995, CANCER RES, V55, P5617; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; ITO T, 1993, CANCER RES, V53, P2940; Jhiang SM, 1996, ENDOCRINOLOGY, V137, P375, DOI 10.1210/en.137.1.375; Jossart GH, 1996, CYTOGENET CELL GENET, V75, P254, DOI 10.1159/000134495; Klugbauer S, 1995, ONCOGENE, V11, P2459; Kozubek S, 1997, BLOOD, V89, P4537, DOI 10.1182/blood.V89.12.4537; Mizuno T, 1997, ONCOGENE, V15, P1455, DOI 10.1038/sj.onc.1201313; Nikiforov YE, 1999, ONCOGENE, V18, P6330, DOI 10.1038/sj.onc.1203019; Nikiforov YE, 1997, CANCER RES, V57, P1690; NIKIFOROVA MN, UNPUB; Portella G, 1996, ONCOGENE, V13, P2021; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; SANTORO M, 1993, BRIT J CANCER, V68, P460, DOI 10.1038/bjc.1993.370; SANTORO M, 1994, ONCOGENE, V9, P509; Savage JRK, 1996, MUTAT RES-REV GENET, V366, P81, DOI 10.1016/S0165-1110(96)90030-5; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; Weir B.S., 1996, GENETIC DATA ANAL; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239	22	338	353	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					138	141		10.1126/science.290.5489.138	http://dx.doi.org/10.1126/science.290.5489.138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021799				2022-12-28	WOS:000089724800052
J	Osorio, MRZ; Bejar, VJS; Martin, EL; Rebolo, R; Navascues, DBY; Bailer-Jones, CAL; Mundt, R				Osorio, MRZ; Bejar, VJS; Martin, EL; Rebolo, R; Navascues, DBY; Bailer-Jones, CAL; Mundt, R			Discovery of young, isolated planetary mass objects in the sigma Orionis star cluster	SCIENCE			English	Article							EXTRASOLAR GIANT PLANETS; BROWN DWARFS; MAIN-SEQUENCE; EVOLUTIONARY MODELS; MOLECULAR CLOUDS; COMPANION; FRAGMENTATION; DENSITY	We present the discovery by optical and near-infrared imaging of an extremely red, Low-Luminosity population of isolated objects in the young, nearby stellar cluster around the multiple, massive star a Orionis. The proximity (352 parsecs), youth (1 million to 5 million years), and low internal extinction make this cluster an ideal site to explore the substellar domain from the hydrogen mass limit down to a few Jupiter masses. Optical and near-infrared Low-resolution spectroscopy of three of these objects confirms the very cool spectral energy distribution (atmospheric effective temperatures of 1700 to 2200 kelvin) expected for cluster members with masses in the range 5 to 15 times that of Jupiter. Like the planets of the solar system, these objects are unable to sustain stable nuclear burning in their interiors, but in contrast they; are not bound to stars. This new kind of isolated giant planet, which apparently forms on time scales of less than a few million years, offers a challenge to our understanding. of the formation processes of planetary mass objects.	Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; CSIC, Madrid, Spain; Max Planck Inst Astron, D-69117 Heidelberg, Germany; Univ Autonoma Madrid, E-28049 Madrid, Spain	Instituto de Astrofisica de Canarias; California Institute of Technology; University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); Max Planck Society; Autonomous University of Madrid	Osorio, MRZ (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	mosorio@lLiac.es	Béjar, Victor J. Sánchez/AAA-2094-2019; Navascues, David Barrado/C-1439-2017; Rebolo, Rafael/S-1563-2019; Zapatero Osorio, Maria Rosa/C-2744-2017	Béjar, Victor J. Sánchez/0000-0002-5086-4232; Navascues, David Barrado/0000-0002-5971-9242; Zapatero Osorio, Maria Rosa/0000-0001-5664-2852; Rebolo, Rafael/0000-0003-3767-7085				Adams FC, 1996, ASTROPHYS J, V464, P256, DOI 10.1086/177318; Baraffe I, 1998, ASTRON ASTROPHYS, V337, P403; Basri G, 1999, ASTRON J, V118, P2460, DOI 10.1086/301079; Basri G, 2000, ASTROPHYS J, V538, P363, DOI 10.1086/309095; Basri G, 1997, AIP CONF PROC, P228, DOI 10.1063/1.52787; Bejar VJS, 1999, ASTROPHYS J, V521, P671, DOI 10.1086/307583; Bodenheimer P, 1998, ASTR SOC P, V134, P115; Boss AP, 1997, SCIENCE, V276, P1836, DOI 10.1126/science.276.5320.1836; BROWN AGA, 1994, ASTRON ASTROPHYS, V289, P101; Burkert A, 1997, MON NOT R ASTRON SOC, V289, P497, DOI 10.1093/mnras/289.3.497; Burrows A, 1997, ASTROPHYS J, V491, P856, DOI 10.1086/305002; CHABRIER G, IN PRESS ASTROPHYS J; Cochran WD, 1997, ASTROPHYS J, V483, P457, DOI 10.1086/304245; DANTONA F, 1994, ASTROPHYS J SUPPL S, V90, P467, DOI 10.1086/191867; Delfosse X, 1999, ASTRON ASTROPHYS SUP, V135, P41, DOI 10.1051/aas:1999158; FERGUSON HC, IN PRESS ANN REV AST; Hillenbrand LA, 2000, ASTROPHYS J, V540, P236, DOI 10.1086/309309; Kirkpatrick JD, 2000, ASTRON J, V120, P447, DOI 10.1086/301427; KIRKPATRICK JD, 1994, ASTROPHYS J SUPPL S, V94, P749, DOI 10.1086/192089; Kirkpatrick JD, 1999, ASTROPHYS J, V519, P802, DOI 10.1086/307414; LANDOLT AU, 1992, ASTRON J, V104, P340, DOI 10.1086/116242; LEE TA, 1968, ASTROPHYS J, V152, P913, DOI 10.1086/149607; Lucas PW, 2000, MON NOT R ASTRON SOC, V314, P858, DOI 10.1046/j.1365-8711.2000.03515.x; Luhman KL, 1999, ASTROPHYS J, V525, P466, DOI 10.1086/307902; Marcy GW, 2000, PUBL ASTRON SOC PAC, V112, P137, DOI 10.1086/316516; Martin EL, 1999, ASTRON J, V118, P2466, DOI 10.1086/301107; NAJITA JR, IN PRESS ASTROPHYS J; Osorio MRZ, 1999, ASTROPHYS J, V524, pL115, DOI 10.1086/312317; OSORIO MRZ, IN PRESS VERY LOW MA; Padoan P, 1997, MON NOT R ASTRON SOC, V288, P145, DOI 10.1093/mnras/288.1.145; Pavlenko Y, 2000, ASTRON ASTROPHYS, V355, P245; Saumon D, 1996, ASTROPHYS J, V460, P993, DOI 10.1086/177027; SILK J, 1977, ASTROPHYS J, V214, P718, DOI 10.1086/155301; Tamura M, 1998, SCIENCE, V282, P1095, DOI 10.1126/science.282.5391.1095; Thompson D, 1999, ASTROPHYS J, V523, P100, DOI 10.1086/307708; WARREN WH, 1978, ASTROPHYS J SUPPL S, V36, P497, DOI 10.1086/190510; White RJ, 1999, ASTROPHYS J, V520, P811, DOI 10.1086/307494; Wolk S. J., 1996, THESIS STATE U NEW Y; [No title captured]	40	285	285	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					103	107		10.1126/science.290.5489.103	http://dx.doi.org/10.1126/science.290.5489.103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021788				2022-12-28	WOS:000089724800041
J	Snyder, L				Snyder, L			Palliative treatment of last resort and assisted suicide - Response	ANNALS OF INTERNAL MEDICINE			English	Letter									Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania	Snyder, L (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					564	564		10.7326/0003-4819-133-7-200010030-00026	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015180				2022-12-28	WOS:000089678300017
J	Snyder, L				Snyder, L			Publication of papers on assisted suicide and terminal sedation - Response	ANNALS OF INTERNAL MEDICINE			English	Letter									Univ Penn, Ctr Bioeth, Amer Coll Phys, Amer Soc Internal Med, Philadelphia, PA 19106 USA	American College of Physicians; University of Pennsylvania	Snyder, L (corresponding author), Univ Penn, Ctr Bioeth, Amer Coll Phys, Amer Soc Internal Med, Philadelphia, PA 19106 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					565	566		10.7326/0003-4819-133-7-200010030-00028	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00028			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015182				2022-12-28	WOS:000089678300019
J	Uda, T; Jacob, KT; Hirasawa, M				Uda, T; Jacob, KT; Hirasawa, M			Technique for enhanced rare earth separation	SCIENCE			English	Article							CHEMICAL-VAPOR TRANSPORT; GAS-PHASE COMPLEXES; ELEMENTS; THERMODYNAMICS; CHEMISTRY; CHLORIDES; SYSTEM; DY	A process is demonstrated for the efficient separation of rare earth elements, using a combination of selective reduction and vacuum distillation of halides. Tho large differences in the redox chemistry of the rare earth elements and in the vapor pressures of rare earth di- and trihalides are exploited for separation. Experimental proof of concept is provided for the binary systems praseodymium-neodymium and neodymium-samarium. This process enhances the separation factor for the isolation of samarium and neodymium from their mixture by more than an order of magnitude.	Tohoku Univ, Inst Adv Mat Proc, Res Ctr Met Proc Engn, Sendai, Miyagi 9808577, Japan; Indian Inst Sci, Dept Met, Bangalore 560012, Karnataka, India	Tohoku University; Indian Institute of Science (IISC) - Bangalore	Uda, T (corresponding author), Tohoku Univ, Inst Adv Mat Proc, Res Ctr Met Proc Engn, Sendai, Miyagi 9808577, Japan.		/I-3315-2015	/0000-0002-4498-2742; Uda, Tetsuya/0000-0002-2484-4297				ADACHI G, 1991, J LESS-COMMON MET, V169, pL1, DOI 10.1016/0022-5088(91)90225-S; ADACHI G, 1999, SCI RARE EARTHS, P188; Barin I., 1995, THERMODYNAMICAL DATA; BERGMANN H, 1978, GMELIN HDB INORGA C6; Choppin G.R., 1994, HDB PHYS CHEM RARE E, V18, P197, DOI DOI 10.1016/S0168-1273(05)80044-3; CZACK G, 1982, GMELIN HDB INORGANIC, V4; GUPTA CK, 1992, INT MATER REV, V37, P197, DOI 10.1179/imr.1992.37.1.197; HARIHARAN AV, 1972, HIGH TEMP SCI, V4, P91; JOHNSON DA, 1969, J CHEM SOC A, V20, P2578; JOHNSON DA, 1977, ADV INORG CHEM, V20, P1; KACZMARK J, 1981, IND APPL RARE EARTH, P135; Kudin LS, 1997, ELEC SOC S, V97, P704; MEYER G, 1988, CHEM REV, V88, P93, DOI 10.1021/cr00083a005; MORSS LR, 1992, Z ANORG ALLG CHEM, V616, P162, DOI 10.1002/zaac.19926161025; MURASE K, 1992, B CHEM SOC JPN, V65, P2724, DOI 10.1246/bcsj.65.2724; MURASE K, 1993, J ALLOY COMPD, V198, P31, DOI 10.1016/0925-8388(93)90139-E; NOVIKOV GI, 1964, RUSS CHEM REV, V33, P343; Shibata J, 1999, MATER SCI FORUM, V315-3, P268, DOI 10.4028/www.scientific.net/MSF.315-317.268; Uda T, 1998, J JPN I MET, V62, P796, DOI 10.2320/jinstmet1952.62.9_796; Uda T, 1999, J ALLOY COMPD, V284, P282, DOI 10.1016/S0925-8388(98)00944-X	20	119	121	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2326	2329		10.1126/science.289.5488.2326	http://dx.doi.org/10.1126/science.289.5488.2326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009413	Green Accepted			2022-12-28	WOS:000089593500045
J	Rosenberg, ES; Altfeld, M; Poon, SH; Phillips, MN; Wilkes, BM; Eldridge, RL; Robbins, GK; D'Aquila, RT; Goulder, PJR; Walker, BD				Rosenberg, ES; Altfeld, M; Poon, SH; Phillips, MN; Wilkes, BM; Eldridge, RL; Robbins, GK; D'Aquila, RT; Goulder, PJR; Walker, BD			Immune control of HIV-1 after early treatment of acute infection	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTE; ACTIVE ANTIRETROVIRAL THERAPY; CELL RESPONSES; DISCONTINUATION; RESISTANCE; EFFECTOR; VIREMIA; MICE	Virus-specific T-helper cells are considered critical for the control of chronic viral infections(1,2). Successful treatment of acute HIV-1 infection leads to augmentation of these responses(3-5), but whether this enhances immune control has not been determined. We administered one or two supervised treatment interruptions to eight subjects with treated acute infection, with the plan to restart therapy if viral load exceeded 5,000 copies of HIV-1 RNA per millilitre of plasma (the level at which therapy has been typically recommended) for three consecutive weeks, or 50,000 RNA copies per ml at one time. Here we show that, despite rebound in viraemia, all subjects were able to achieve at least a transient steady state off therapy with viral load below 5,000 RNA copies per ml. At present, five out of eight subjects remain off therapy with viral loads of less than 500 RNA copies per ml plasma after a median 6.5 months (range 5-8.7 months). We observed increased virus-specific cytotoxic T lymphocytes and maintained T-helper-cell responses in all. Our data indicate that functional immune responses can be augmented in a chronic viral infection, and provide rationale for immunotherapy in HIV-1 infection.	Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Walker, BD (corresponding author), Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA.	bwalker@helix.mgh.harvard.edu	Robbins, Gregory/F-7988-2011; Altfeld, Marcus/AAE-7306-2019	Altfeld, Marcus/0000-0001-5972-2997; Robbins, Gregory/0000-0001-7545-5817				Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; BRANDER C, 1997, MOL IMMUNOLOGY DATA, P50; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Goulder PJR, 2000, J VIROL, V74, P5679, DOI 10.1128/JVI.74.12.5679-5690.2000; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; Lori F, 1999, J INFECT DIS, V180, P1827, DOI 10.1086/315113; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; Martinez-Picado J, 1999, J CLIN MICROBIOL, V37, P2943, DOI 10.1128/JCM.37.9.2943-2951.1999; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Ortiz GM, 1999, J CLIN INVEST, V104, pR13, DOI 10.1172/JCI7371; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; WALKER BD, 1989, P NATL ACAD SCI USA, V86, P9514, DOI 10.1073/pnas.86.23.9514; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	29	796	822	1	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					523	526		10.1038/35035103	http://dx.doi.org/10.1038/35035103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029005				2022-12-28	WOS:000089727400053
J	Bhatt, DL; Topol, EJ				Bhatt, DL; Topol, EJ			Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WAVE MYOCARDIAL-INFARCTION; REFRACTORY UNSTABLE ANGINA; PARTIAL THROMBOPLASTIN TIME; ISCHEMIC-HEART-DISEASE; RANDOMIZED TRIAL; CLINICAL RESTENOSIS; C7E3 FAB; ABCIXIMAB; INTERVENTION; ANGIOPLASTY	Context The central role of platelet-rich thrombus in the pathogenesis of acute coronary syndromes (ACSs) is well-known. Glycoprotein IIb/IIIa (Gp IIb/IIIa) receptor antagonists are potent inhibitors of platelet function that may be expected to affect favorably the natural history of ACSs, Objective To define the optimal role of Gp IIb/IIIa inhibitors in treatment strategies for ACSs, Data Sources A MEDLINE search was performed to identify all English-language articles regarding use of Cp IIb/IIIa inhibitors in ACSs published between 1966 and June 2000, In addition, relevant abstracts from the annual meetings of the American Heart Association, American College of Cardiology, and the European Society of Cardiology were reviewed. Study Selection Only studies of 500 or more patients were included. Of 15 studies identified, 10 randomized, placebo-controlled, double-blind trials of Gp IIb/IIIa inhibitors in ACSs were selected for review. Data Extraction Data quality was determined by publication in the peer-reviewed literature or presentation at an official cardiology society-sponsored meeting, as well as by verification with the primary author. Data Synthesis Three members of this class of drugs are available for intravenous use. Abciximab, eptifibatide, and tirofiban hydrochloride, each have data demonstrating their value in improving the outcomes of patients presenting with ACSs, Current evidence supports use of these drugs in both conservative and invasive treatment strategies. Glycoprotein IIb/IIIa-blocking therapy is safe, and with proper precautions, bleeding risks can be minimized. Biological differences exist among these agents, but as of yet, no head-to-head comparisons have been made of their clinical efficacy. Unlike intravenous Cp IIb/IIIa inhibitors, available data regarding any role of oral Cp IIb/IIIa inhibitors are not favorable. Conclusion Current data indicate that intravenous Gp IIb/IIIa inhibitor therapy merits a prominent role in the initial management of patients with ACSs.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Topol, EJ (corresponding author), Cleveland Clin Fdn, Dept Cardiol, F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	topole@ccf.org		Topol, Eric/0000-0002-1478-4729				Alexander JH, 1999, AM J CARDIOL, V83, P1147, DOI 10.1016/S0002-9149(99)00049-1; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; Ault KA, 1999, J AM COLL CARDIOL, V33, P634, DOI 10.1016/S0735-1097(98)00635-4; Barr E, 1998, CIRCULATION, V98, P504; Bazzino O, 1998, NEW ENGL J MED, V338, P1498; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Becker RC, 1996, AM HEART J, V131, P421, DOI 10.1016/S0002-8703(96)90519-0; Bhatt DL, 2000, J AM COLL CARDIOL, V35, P922, DOI 10.1016/S0735-1097(99)00650-6; Bhatt DL, 2000, AM J CARDIOL, V85, P1060, DOI 10.1016/S0002-9149(00)00696-2; Bhatt DL, 1998, AM J CARDIOL, V82, P1105, DOI 10.1016/S0002-9149(98)00565-7; Bhatt DL, 1998, CIRCULATION, V98, P560; BHATT DL, IN PRESS ACUTE CORON; BOEHRER JD, 1994, AM J CARDIOL, V74, P1166, DOI 10.1016/0002-9149(94)90474-X; Boersma E, 1999, CIRCULATION, V100, P2045, DOI 10.1161/01.CIR.100.20.2045; Braunwald E, 1998, AM HEART J, V135, pS56, DOI 10.1016/S0002-8703(98)70298-4; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; Cannon CP, 2000, CIRCULATION, V102, P149, DOI 10.1161/01.CIR.102.2.149; CHEW DP, IN PRESS CIRCULATION; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; Cohen M., 1999, European Heart Journal, V20, P376; Cura FA, 2000, CIRCULATION, V102, P28, DOI 10.1161/01.CIR.102.1.28; Dangas G, 1998, ARTERIOSCL THROM VAS, V18, P1342, DOI 10.1161/01.ATV.18.8.1342; Ellis SG, 1998, J AM COLL CARDIOL, V32, P1619, DOI 10.1016/S0735-1097(98)00403-3; Gibler WB, 1998, ANN EMERG MED, V32, P712, DOI 10.1016/S0196-0644(98)70072-1; Granger CB, 1996, CIRCULATION, V93, P870, DOI 10.1161/01.CIR.93.5.870; Greenbaum AB, 1998, CIRCULATION, V98, P561; Haase KK, 1999, AM HEART J, V137, P234, DOI 10.1053/hj.1999.v137.93038; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Hanrath P, 1997, CIRCULATION, V96, P1445; Harrington RA, 1998, CIRCULATION, V98, P359; Heeschen C, 1999, CIRCULATION, V100, P1509, DOI 10.1161/01.CIR.100.14.1509; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; Holmes MB, 1999, AM J CARDIOL, V84, P203, DOI 10.1016/S0002-9149(99)00235-0; Juergens CP, 1997, AM J CARDIOL, V80, P74, DOI 10.1016/S0002-9149(97)00286-5; Kereiakes DJ, 1999, AM J CARDIOL, V84, P391, DOI 10.1016/S0002-9149(99)00321-5; Kereiakes DJ, 2000, J INVASIVE CARDIOL, V12, p1A; Kleiman NS, 2000, J AM COLL CARDIOL, V36, P310, DOI 10.1016/S0735-1097(00)00805-6; Kleiman NS, 1999, CIRCULATION, V100, P328; Klootwijk P, 1998, CIRCULATION, V98, P1358, DOI 10.1161/01.CIR.98.14.1358; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; Kong DF, 1999, CIRCULATION, V100, P2049, DOI 10.1161/01.CIR.100.20.2049; Lancaster GI, 1999, CIRCULATION, V100, P620; Lauer MA, 1998, CIRCULATION, V98, P767; LEFKOVITS J, 1995, NEW ENGL J MED, V332, P1553, DOI 10.1056/NEJM199506083322306; Lincoff AM, 1997, J AM COLL CARDIOL, V30, P149, DOI 10.1016/S0735-1097(97)00110-1; Lincoff AM, 1999, CIRCULATION, V99, P1951, DOI 10.1161/01.CIR.99.15.1951; Lincoff AM, 1999, CONTEMP CARDIOL, V2, P169; Lincoff AM, 1999, NEW ENGL J MED, V341, P319, DOI 10.1056/NEJM199907293410503; Mahaffey KW, 1999, CIRCULATION, V99, P2371, DOI 10.1161/01.CIR.99.18.2371; Mark DB, 2000, CIRCULATION, V101, P366, DOI 10.1161/01.CIR.101.4.366; MARSO SP, IN PRESS CIRCULATION; Muhlestein JB, 1997, J AM COLL CARDIOL, V30, P1729, DOI 10.1016/S0735-1097(97)00395-1; MUKHERJEE D, IN PRESS ACUTE CORON; Newby LK, 1998, CIRCULATION, V98, P1853, DOI 10.1161/01.CIR.98.18.1853; O'Neill WW, 2000, NEW ENGL J MED, V342, P1316, DOI 10.1056/NEJM200005043421803; Peterson JG, 1998, CIRCULATION, V98, P360; Poggio Emilio D., 1999, Journal of the American College of Cardiology, V33, p254A; Ramanathan AV, 1999, CIRCULATION, V100, P709; Raymond R. E., 1998, European Heart Journal, V19, P238; Reverter JC, 1996, J CLIN INVEST, V98, P863, DOI 10.1172/JCI118859; Roe MT, 1999, CIRCULATION, V100, P187; ROE MT, IN PRESS CIRCULATION; Santopinto J, 1999, CIRCULATION, V100, P620; Schulman SP, 1996, CIRCULATION, V94, P2083, DOI 10.1161/01.CIR.94.9.2083; Schwaab B, 1999, J AM COLL CARDIOL, V33, P317, DOI 10.1016/S0735-1097(98)00562-2; Simoons ML, 1997, LANCET, V349, P1429; Smith JW, 1999, CIRCULATION, V99, P620, DOI 10.1161/01.CIR.99.5.620; Steinhubl SR, 1999, CIRCULATION, V100, P1977, DOI 10.1161/01.CIR.100.19.1977; Steinhubl SR, 2000, J THROMB THROMBOLYS, V9, P199, DOI 10.1023/A:1018754309025; Tardiff BE, 1999, J AM COLL CARDIOL, V33, P88, DOI 10.1016/S0735-1097(98)00551-8; Tcheng JE, 1997, LANCET, V349, P1422; Theroux P, 1998, CIRCULATION, V98, P359; Topol CE, 2000, LANCET, V355, P337; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol E, 1998, CIRCULATION, V97, P2386; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3; Topol EJ, 1999, LANCET, V354, P2019, DOI 10.1016/S0140-6736(99)10018-7; Topol EJ, 1997, JAMA-J AM MED ASSOC, V278, P479, DOI 10.1001/jama.278.6.479; TOPOL EJ, 1994, LANCET, V343, P881, DOI 10.1016/S0140-6736(94)90007-8; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Topol EJ, 2000, CIRCULATION, V101, P570, DOI 10.1161/01.CIR.101.5.570; Tramuta D A, 2000, J Invasive Cardiol, V12 Suppl C, p3C; Van Belle E, 1998, CIRCULATION, V97, P26, DOI 10.1161/01.CIR.97.1.26; van den Brand M, 1999, EUR HEART J, V20, P1572, DOI 10.1053/euhj.1999.1662; van Hout BA, 1998, EUR HEART J, V19, pD59; Vorchheimer DA, 1999, JAMA-J AM MED ASSOC, V281, P1407, DOI 10.1001/jama.281.15.1407; Wallentin L, 1999, LANCET, V354, P701; Yeghiazarians Y, 2000, NEW ENGL J MED, V342, P101, DOI 10.1056/NEJM200001133420207; Yusuf S, 1999, LANCET, V353, P429	91	183	193	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1549	1558		10.1001/jama.284.12.1549	http://dx.doi.org/10.1001/jama.284.12.1549			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000650	Bronze			2022-12-28	WOS:000089379700032
J	Daniels, NA; Ray, B; Easton, A; Marano, N; Kahn, E; McShan, AL; Del Rosario, L; Baldwin, T; Kingsley, MA; Puhr, ND; Wells, JG; Angulo, FJ				Daniels, NA; Ray, B; Easton, A; Marano, N; Kahn, E; McShan, AL; Del Rosario, L; Baldwin, T; Kingsley, MA; Puhr, ND; Wells, JG; Angulo, FJ			Emergence of a new Vibrio parahaemolyticus serotype in raw oysters - A prevention quandary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTROENTERITIS; SHELLFISH; INFECTIONS; OUTBREAK; CHOLERAE	Context In May and June 1998, reported Vibrio parahaemolyticus infections increased sharply in Texas. Objective To determine factors that contributed to the increase in V parahaemolyticus infections. Design, Setting, and Participants Cross-sectional survey of persons reporting gas troenteritis after eating seafood in Texas; survey of environmental conditions in Galveston Bay. Main Outcome Measures Traceback of oysters, water quality measures in harvest areas, presence of V parahaemolyticus in stool cultures; comparison of median values for environmental conditions before and during the outbreak compared with during the previous 5 years. Results Between May 31 and July 10, 1998, 416 persons in 13 states reported having gastroenteritis after eating oysters harvested from Galveston Bay. All 28 available stool specimens from affected persons yielded V parahaemolyticus serotype O3:K6 isolates. Oyster beds met current bacteriologic standards during harvest and fecal coliform counts in water samples were within acceptable limits. Median water temperature and salinity during May and June 1998 were 30.0 degrees C and 29.6 parts per thousand (ppt) compared with 28.9 degrees C and 15.6 ppt for the previous 5 years (P<.001). Conclusions This is the first reported outbreak of V parahaemolyticus serotype O3:K6 infection in the United States. The emergence of a virulent serotype and elevated seawater temperatures and salinity levels may have contributed to this large multistate outbreak of V parahaemolyticus. Bacteriologic monitoring at harvest sites did not prevent this outbreak, suggesting that current policy and regulations regarding the safety of raw oysters require reevaluation. Consumers and physicians should understand that raw or undercooked oysters can cause illness even if harvested from monitored beds. In patients who develop acute gastroenteritis within 4 days of consuming raw or undercooked oysters, a stool specimen should be tested for Vibrio species using specific media.	Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94115 USA; Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidemiol Branch, Off Smoking & Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Texas Dept Hlth, Austin, TX 78756 USA; Meharry Med Coll, Nashville, TN 37208 USA	University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Texas Department of State Health Services; Meharry Medical College	Daniels, NA (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, 1701 Divisadero,Suite 500, San Francisco, CA 94115 USA.	ndaniels@medicine.ucsf.edu		Kahn, Emily/0000-0001-7812-7958				Arakawa E, 1999, JPN J INFECT DIS, V52, P246; BARTH SS, 1999, 99 GEN M AM SOC MICR; Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; CDC (Centers for Disease Control and Prevention), 2008, MMWR-MORBID MORTAL W, V47, P457; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P48; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; DOWELL SF, 1995, J INFECT DIS, V171, P1497, DOI 10.1093/infdis/171.6.1497; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; LEVINE WC, 1993, J INFECT DIS, V167, P479, DOI 10.1093/infdis/167.2.479; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; MCCARTHY SA, 1994, APPL ENVIRON MICROB, V60, P2597, DOI 10.1128/AEM.60.7.2597-2601.1994; McLaughlin James C., 1995, P465; MORRIS JG, 1985, NEW ENGL J MED, V312, P343, DOI 10.1056/NEJM198502073120604; NOLAN CM, 1984, DIAGN MICR INFEC DIS, V2, P119, DOI 10.1016/0732-8893(84)90007-5; Okuda N, 1997, J CLIN MICROBIOL, V35, P3150, DOI 10.1128/JCM.35.12.3150-3155.1997; PORTNOY BL, 1975, JAMA-J AM MED ASSOC, V233, P1065, DOI 10.1001/jama.233.10.1065; Shapiro RL, 1998, J INFECT DIS, V178, P752, DOI 10.1086/515367; THOMPSON CA, 1976, J FOOD SCI, V41, P204, DOI 10.1111/j.1365-2621.1976.tb01138.x; *USDA, 1997, GUID CONTR MOLL SHEL; WILSON R, 1981, AM J EPIDEMIOL, V114, P293, DOI 10.1093/oxfordjournals.aje.a113194; Wong HC, 1996, J CLIN MICROBIOL, V34, P1535, DOI 10.1128/JCM.34.6.1535-1539.1996; ZENYOJI H, 1970, HEALTH LAB SCI, V7, P100	24	123	133	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1541	1545		10.1001/jama.284.12.1541	http://dx.doi.org/10.1001/jama.284.12.1541			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000648	Bronze			2022-12-28	WOS:000089379700030
J	Williams, JW; Barrett, J; Oxman, T; Frank, E; Katon, W; Sullivan, M; Cornell, J; Sengupta, A				Williams, JW; Barrett, J; Oxman, T; Frank, E; Katon, W; Sullivan, M; Cornell, J; Sengupta, A			Treatment of dysthymia and minor depression in primary care - A randomized controlled trial in older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROBLEM-SOLVING TREATMENT; COLLABORATIVE MANAGEMENT; TREATMENT GUIDELINES; MENTAL-DISORDERS; PLACEBO; DISABILITY; IDENTIFICATION; AMITRIPTYLINE; OUTCOMES; SEVERITY	Context Insufficient evidence exists for recommendation of specific effective treatments for older primary care patients with minor depression or dysthymia, Objective To compare the effectiveness of pharmacotherapy and psychotherapy in primary care settings among older persons with minor depression or dysthymia. Design Randomized, placebo-controlled trial (November 1995-August 1998). Setting Four geographically and clinically diverse primary care practices. Participants A total of 415 primary care patients (mean age, 71 years) with minor depression (n=204) or dysthymia(n=211) and a Hamilton Depression Rating Scale (HDRS) score of at least 10 were randomized; 311 (74.9%) completed all study visits. Interventions Patients were randomly assigned to receive paroxetine (n=137) or placebo (n=140), starting at 10 mg/d and titrated to a maximum of 40 mg/d, or problem-solving treatment-primary care (PST-PC; n=138). For the paroxetine and placebo groups, the 6 visits over 11 weeks included general support and symptom and adverse effects monitoring; for the PST-PC group, visits were for psychotherapy. Main Outcome Measures Depressive symptoms, by the 20-item Hopkins Symptom Checklist Depression Scale (HSCL-D-20) and the HDRS; and functional status, by the Medical Outcomes Study Short-Form 36 (SF-36) physical and mental components. Results Paroxetine patients showed greater (difference in mean [SE] Ii-week change in HSCL-D-20 scores, 0.21 [0.07]; P=.004) symptom resolution than placebo patients. Patients treated with PST-PC did not show more improvement than placebo (difference in mean [SE] change in HSCL-D-20 scores, 0.11 [0.13]; P=.13), but their symptoms improved more rapidly than those of placebo patients during the latter treatment weeks (P=.01). For dysthymia, paroxetine improved mental health functioning vs placebo among patients whose baseline functioning was high (difference in mean [SE] change in SF-36 mental component scores, 5.8 [2.02]; P=.01) or intermediate (difference in mean [SE] change in SF-36 mental component scores, 4.4 [1.74]; P=.03). Mental health functioning in dysthymia patients was not significantly improved by PST-PC corn pared with placebo (P greater than or equal to.12 for low-, intermediate; and high-functioning groups). For minor depression, both paroxetine and PST-PC improved mental health functioning in patients in the lowest tertile of baseline functioning (difference vs placebo in mean [SE] change in SF-36 mental component scores, 4.7 [2.03] for those taking paroxetine; 4.7 [1.96] for the PST-PC treatment; P=.02 vs placebo). Conclusions Paroxetine showed moderate benefit for depressive symptoms and mental health function in elderly patients with dysthymia and more severely impaired elderly patients with minor depression. The benefits of PST-PC were smaller, had slower onset, and were more subject to site differences than those of paroxetine.	Univ Texas, Hlth Sci Ctr, S Texas Vet Affairs Htlh Care Syst, Audie Murphy Div, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, Div Gen Internal Med, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, Div Geriatr, San Antonio, TX USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH 03756 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Psychiat, Hanover, NH 03756 USA; Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Dartmouth College; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University of Washington; University of Washington Seattle	Williams, JW (corresponding author), Ambulatory Care 11C6, 74 Merton Minter Blvd, San Antonio, TX 78284 USA.		Williams, John W/A-3696-2008; Williams, John/AAM-4572-2020	Williams, John W/0000-0002-5267-5558; Williams, John/0000-0002-5267-5558				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Barrett JE, 1999, GEN HOSP PSYCHIAT, V21, P260, DOI 10.1016/S0163-8343(99)00023-7; Beusterien KM, 1996, J GERIATR PSYCH NEUR, V9, P13, DOI 10.1177/089198879600900103; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; *COCHR CONTR TRIAL, 1999, UPD SOFTW; CooperPatrick L, 1997, J GEN INTERN MED, V12, P431, DOI 10.1046/j.1525-1497.1997.00075.x; Coulehan JL, 1997, ARCH INTERN MED, V157, P1113, DOI 10.1001/archinte.157.10.1113; Dunner D L, 1996, Depression, V4, P34, DOI 10.1002/(SICI)1522-7162(1996)4:1<34::AID-DEPR4>3.0.CO;2-F; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Katon W, 1997, J CLIN PSYCHIAT, V58, P20; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; LANGE N, 1992, J AM STAT ASSOC, V87, P615, DOI 10.2307/2290194; LIMA MS, 1999, UPD SOFTW; LIPMAN RS, 1979, J AFFECT DISORDERS, V1, P9, DOI 10.1016/0165-0327(79)90021-1; Lynch DJ, 1997, J FAM PRACTICE, V44, P293; MARKOWITZ JC, 1994, AM J PSYCHIAT, V151, P1114; MIRANDA J, 1994, PSYCHOSOM MED, V56, P136, DOI 10.1097/00006842-199403000-00009; Mulrow CD, 2000, AM J MED, V108, P54, DOI 10.1016/S0002-9343(99)00316-2; Mulrow CD, 1998, PSYCHOPHARMACOL BULL, V34, P409; MULROW CD, 1999, 7 US DEP HLTH HUM SE; MynorsWallis L, 1996, INT J PSYCHIAT MED, V26, P249, DOI 10.2190/0HVY-CD2F-0KC7-FVTB; MynorsWallis L, 1997, BRIT J PSYCHIAT, V170, P113, DOI 10.1192/bjp.170.2.113; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; PARKERSON GR, 1993, J CLIN EPIDEMIOL, V46, P379, DOI 10.1016/0895-4356(93)90153-R; PARNETTI L, 1993, DRUG INVEST, V6, P181, DOI 10.1007/BF03259242; PAYKEL ES, 1988, J AFFECT DISORDERS, V14, P83, DOI 10.1016/0165-0327(88)90075-4; Penninx BWJH, 1999, AM J PUBLIC HEALTH, V89, P1346, DOI 10.2105/AJPH.89.9.1346; Pincus HA, 1999, BRIT J PSYCHIAT, V174, P288, DOI 10.1192/bjp.174.4.288; Rost K, 2000, GEN HOSP PSYCHIAT, V22, P66, DOI 10.1016/S0163-8343(00)00059-1; SAS Institute, 1996, SAS STAT SOFTW CHANG; Schulberg HC, 1996, ARCH GEN PSYCHIAT, V53, P913; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; STEWART JW, 1983, ARCH GEN PSYCHIAT, V40, P202; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Thase ME, 1996, ARCH GEN PSYCHIAT, V53, P777; *US DHHS, 1993, AHCPR PUBL; Ware JE, 1993, SF36 HLTH SURVEY MAN; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; WERNICKE JF, 1987, PSYCHOPHARMACOL BULL, V23, P164; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; WILLIAMS JW, 1995, J GEN INTERN MED, V10, P7, DOI 10.1007/BF02599568; Williams JW, 1999, ARCH FAM MED, V8, P58, DOI 10.1001/archfami.8.1.58; World Health Organization, 1977, INT CLASS DIS; [No title captured]	48	327	329	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1519	1526		10.1001/jama.284.12.1519	http://dx.doi.org/10.1001/jama.284.12.1519			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355HF	11000645				2022-12-28	WOS:000089379700027
J	Versluis, M; Schmitz, B; von der Heydt, A; Lohse, D				Versluis, M; Schmitz, B; von der Heydt, A; Lohse, D			How snapping shrimp snap: Through cavitating bubbles	SCIENCE			English	Article							ALPHEUS-HETEROCHAELIS; DYNAMICS; ACOUSTICS	The snapping shrimp (Alpheus heterochaelis) produces a loud snapping sound by an extremely rapid closure of its snapper claw. One of the effects of the snapping is to stun or kill prey animals. During the rapid snapper claw closure, a high-velocity water jet is emitted from the claw with a speed exceeding cavitation conditions. Hydrophone measurements in conjunction with time-controlled high-speed imaging of the claw closure demonstrate that the sound is emitted at the cavitation bubble collapse and not on claw closure. A model for the bubble dynamics based on a Rayleigh-Plesset-type equation quantitatively accounts for the time dependence of the bubble radius and for the emitted sound.	Univ Twente, Dept Appl Phys, NL-7500 AE Enschede, Netherlands; Univ Twente, JM Burgers Res Ctr Fluid Dynam, NL-7500 AE Enschede, Netherlands; Tech Univ Munich, Dept Zool, D-85747 Garching, Germany; Univ Marburg, Dept Phys, D-35032 Marburg, Germany	University of Twente; University of Twente; Technical University of Munich; Philipps University Marburg	Lohse, D (corresponding author), Univ Twente, Dept Appl Phys, POB 217, NL-7500 AE Enschede, Netherlands.		Versluis, Michel/F-3541-2011; Lohse, Detlef/B-4915-2013; von der Heydt, Anna S/B-9250-2008	Versluis, Michel/0000-0002-2296-1860; Lohse, Detlef/0000-0003-4138-2255; von der Heydt, Anna S/0000-0002-5557-3282				Au WWL, 1998, J ACOUST SOC AM, V103, P41, DOI 10.1121/1.423234; Blake JR, 1998, APPL SCI RES, V58, P77, DOI 10.1023/A:1000711113941; Brennen C.E., 1995, CAVITATION BUBBLE DY; Brooks WK, 1891, MEM NAT AKAD SCI WAS, V5, P319; CATO DH, 1992, MRLTR9123 DEF SCI TE; CECCIO SL, 1991, J FLUID MECH, V233, P633, DOI 10.1017/S0022112091000630; Epifanio CL, 1999, J ACOUST SOC AM, V106, P3211, DOI 10.1121/1.428175; EVEREST FA, 1948, J ACOUST SOC AM, V20, P137, DOI 10.1121/1.1906355; Hao Y, 1999, PHYS FLUIDS, V11, P2008, DOI 10.1063/1.870064; Herberholz J, 1998, BIOL BULL, V195, P156, DOI 10.2307/1542823; Herberholz J, 1999, J COMP PHYSIOL A, V185, P41, DOI 10.1007/s003590050364; Hilgenfeldt S, 1998, EUR PHYS J B, V4, P247, DOI 10.1007/s100510050375; Hilgenfeldt S, 1996, PHYS FLUIDS, V8, P2808, DOI 10.1063/1.869131; JOHNSON MW, 1947, BIOL BULL, V93, P122, DOI 10.2307/1538284; Landau L.D., 1987, PHYS TODAY, V6; MacGinitie G.E., 1949, NATURAL HIST MARINE, P276; PLESSET MS, 1977, ANNU REV FLUID MECH, V9, P145, DOI 10.1146/annurev.fl.09.010177.001045; PROSPERETTI A, 1977, Q APPL MATH, V34, P339, DOI 10.1090/qam/99652; PROSPERETTI A, 1986, J FLUID MECH, V168, P457, DOI 10.1017/S0022112086000460; RITZMANN RE, 1974, J COMP PHYSIOL, V95, P217, DOI 10.1007/BF00625445; SCHEIN H, 1975, Marine Behaviour and Physiology, V3, P83; SCHMITZ B, IN PRESS CRUSTACEAN; SCHMITZ B, 1998, NEW NEUROETHOLOGY MO, V2, P241; Schultz S., 1998, ZOOL-ANAL COMPLEX SY, V101, P85; Storey BD, 2000, P ROY SOC A-MATH PHY, V456, P1685, DOI 10.1098/rspa.2000.0582; TOGEL R, IN PRESS PHYS REV LE; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; VERSLUIS M, UNPUB; VOLZ P., 1938, ZEITSCHR MORPH U OKOL TIERE, V34, P272, DOI 10.1007/BF00408760	29	289	300	11	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2114	2117		10.1126/science.289.5487.2114	http://dx.doi.org/10.1126/science.289.5487.2114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000111				2022-12-28	WOS:000089430900041
J	Veverka, J; Robinson, M; Thomas, P; Murchie, S; Bell, JF; Izenberg, N; Chapman, C; Harch, A; Bell, M; Carcich, B; Cheng, A; Clark, B; Domingue, D; Dunham, D; Farquhar, R; Gaffey, MJ; Hawkins, E; Joseph, J; Kirk, R; Li, H; Lucey, P; Malin, M; Martin, P; McFadden, L; Merline, WJ; Miller, JK; Owen, WM; Peterson, C; Prockter, L; Warren, J; Wellnitz, D; Williams, BG; Yeomans, DK				Veverka, J; Robinson, M; Thomas, P; Murchie, S; Bell, JF; Izenberg, N; Chapman, C; Harch, A; Bell, M; Carcich, B; Cheng, A; Clark, B; Domingue, D; Dunham, D; Farquhar, R; Gaffey, MJ; Hawkins, E; Joseph, J; Kirk, R; Li, H; Lucey, P; Malin, M; Martin, P; McFadden, L; Merline, WJ; Miller, JK; Owen, WM; Peterson, C; Prockter, L; Warren, J; Wellnitz, D; Williams, BG; Yeomans, DK			NEAR at Eros: Imaging and spectral results	SCIENCE			English	Article							ASTEROID RENDEZVOUS MISSION; NEAR-INFRARED SPECTROMETER; MULTISPECTRAL IMAGER; EJECTA BLOCKS; 433-EROS; IDA; DISCOVERY; 243-IDA; GASPRA; FLYBY	Eros is a very elongated (34 kilometers by 11 kilometers by 11 kilometers) asteroid, most of the surface of which is saturated with craters smaller than 1 kilometer in diameter. The Largest crater is 5.5 kilometers across, but there is a 10-kilometer saddle-like depression with attributes of a large degraded crater. Surface Lineations, both grooves and ridges, are prominent on Eros; some probably exploit planes of weakness produced by collisions on Ems and/or its parent body. Ejecta blocks (30 to 100 meters across) are abundant but not uniformly distributed over the surface. Albedo variations are restricted to the inner walls of certain craters and may be related to downslope movement of regolith. On scales of 200 meters to 1 kilometer, Eros is more bland in terms of color variations than Gaspra or Ida. Spectra (800 to 2500 nanometers) are consistent with an ordinary chondrite composition for which the measured mean density of 2.67 +/- 0.1 grams per cubic centimeter implies internal porosities ranging from about 10 to 30 percent.	Cornell Univ, Ithaca, NY 14853 USA; Northwestern Univ, Dept Geol Sci, Evanston, IL 60208 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; SW Res Inst, Boulder, CO 80302 USA; Rensselaer Polytech Inst, Ctr Sci, Dept Earth & Environm Sci, Troy, NY 12180 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Malin Space Sci Syst, San Diego, CA 92191 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Cornell University; Northwestern University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Rensselaer Polytechnic Institute; United States Department of the Interior; United States Geological Survey; University of Hawaii System; University System of Maryland; University of Maryland College Park; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Veverka, J (corresponding author), Cornell Univ, Space Sci Bldg, Ithaca, NY 14853 USA.		Wellnitz, Dennis/B-4080-2012; Izenberg, Noam R/F-3952-2015; Murchie, Scott L/E-8030-2015; Dunham, David W/A-5214-2014; McFadden, Lucy-Ann/I-4902-2013	Izenberg, Noam R/0000-0003-1629-6478; Murchie, Scott L/0000-0002-1616-8751; Dunham, David W/0000-0001-7527-4207; McFadden, Lucy-Ann/0000-0002-0537-9975				ADAMS JB, 1967, J GEOPHYS RES, V72, P5705, DOI 10.1029/JZ072i022p05705; Asphaug E, 1996, ICARUS, V120, P158, DOI 10.1006/icar.1996.0043; Belton MJS, 1996, ICARUS, V120, P185, DOI 10.1006/icar.1996.0044; Black GJ, 1999, ICARUS, V140, P239, DOI 10.1006/icar.1999.6126; CARR MH, 1994, ICARUS, V107, P61, DOI 10.1006/icar.1994.1006; CHAPMAN CR, 1975, ICARUS, V25, P104, DOI 10.1016/0019-1035(75)90191-8; Chapman CR, 1999, ICARUS, V140, P28, DOI 10.1006/icar.1999.6119; CHAPMAN CR, 1976, ICARUS, V28, P91, DOI 10.1016/0019-1035(76)90090-7; Chapman CR, 1996, ICARUS, V120, P231, DOI 10.1006/icar.1996.0048; Chapman CR, 1996, ICARUS, V120, P77, DOI 10.1006/icar.1996.0038; Consolmagno GJ, 1998, METEORIT PLANET SCI, V33, P1231, DOI 10.1111/j.1945-5100.1998.tb01308.x; Consolmagno GJ, 1998, METEORIT PLANET SCI, V33, P1221, DOI 10.1111/j.1945-5100.1998.tb01307.x; EGAN WG, 1973, ICARUS, V19, P358, DOI 10.1016/0019-1035(73)90114-0; FARQUHAR RW, 1999, J ASTRONAUT SCI, V43, P560; Flynn GJ, 1999, ICARUS, V142, P97, DOI 10.1006/icar.1999.6210; Gaffey M.J., 1989, ASTEROIDS, P98; GAFFEY MJ, 1993, ICARUS, V106, P573, DOI 10.1006/icar.1993.1194; GEHRELS T, 1970, ASTRON J, V75, P186, DOI 10.1086/110962; Geissler P, 1996, ICARUS, V120, P140, DOI 10.1006/icar.1996.0042; GRADIE J, 1981, P LUNAR PLANET SCI, V13, P1769; HAPKE B, 1963, J GEOPHYS RES, V15, P4545; Hawkins SE, 1997, SPACE SCI REV, V82, P31, DOI 10.1023/A:1005099211710; HELFENSTEIN P, 1994, ICARUS, V107, P37, DOI 10.1006/icar.1994.1005; Hicks MD, 1999, ICARUS, V141, P411, DOI 10.1006/icar.1999.6178; HOWEVER AH, 1999, ICARUS, V142, P173; LARSON HP, 1976, ICARUS, V28, P95, DOI 10.1016/0019-1035(76)90091-9; Lee P, 1996, ICARUS, V120, P87, DOI 10.1006/icar.1996.0039; LEE SW, 1986, ICARUS, V68, P77, DOI 10.1016/0019-1035(86)90075-8; Merline WJ, 1999, NATURE, V401, P565, DOI 10.1038/44089; Michel P, 1998, ASTRON J, V116, P2023, DOI 10.1086/300562; Murchie SL, 1996, J GEOPHYS RES-PLANET, V101, P2201, DOI 10.1029/95JE03438; NEUKUM G, 1975, MOON PLANETS, V12, P201, DOI 10.1007/BF00577878; Opik E.J., 1951, P R IRISH ACAD A, V54, P165; PIETERS C, 1976, ICARUS, V28, P105, DOI 10.1016/0019-1035(76)90092-0; PIETERS CM, 1983, J GEOPHYS RES, V88, P9534, DOI 10.1029/JB088iB11p09534; PIETERS CM, 1993, J GEOPHYS RES-PLANET, V98, P20817, DOI 10.1029/93JE02467; Pike RJ., 1977, IMPACT EXPLOSION CRA, P489; Shoemaker E. M., 1979, ASTEROIDS, P253; Sullivan R, 1996, ICARUS, V120, P119, DOI 10.1006/icar.1996.0041; Thomas PC, 1996, ICARUS, V120, P20, DOI 10.1006/icar.1996.0033; Thomas PC, 1999, ICARUS, V142, P89, DOI 10.1006/icar.1999.6211; Thomas PC, 1998, ICARUS, V131, P78, DOI 10.1006/icar.1997.5858; Trombka JI, 1997, J GEOPHYS RES-PLANET, V102, P23729, DOI 10.1029/97JE00270; VANDENBOS WH, 1931, ASTRON NACH, V241, P23; Veverka J, 1999, ICARUS, V140, P3, DOI 10.1006/icar.1999.6120; VEVERKA J, 1994, ICARUS, V107, P72, DOI 10.1006/icar.1994.1007; Veverka J, 1997, J GEOPHYS RES-PLANET, V102, P23709, DOI 10.1029/97JE01742; Veverka J, 1999, SCIENCE, V285, P562, DOI 10.1126/science.285.5427.562; Veverka J, 1997, SCIENCE, V278, P2109, DOI 10.1126/science.278.5346.2109; Veverka J, 1996, ICARUS, V120, P66, DOI 10.1006/icar.1996.0037; VEVERKA J, 1994, ICARUS, V107, P2, DOI 10.1006/icar.1994.1002; VEVERKA J, 1971, NASA SPEC PUBL, V91, P91; VILAS F, 1992, ICARUS, V100, P85, DOI 10.1016/0019-1035(92)90020-8; Warren JW, 1997, SPACE SCI REV, V82, P101, DOI 10.1023/A:1005015719887; WILKINSON SL, IN PRESS METEORIT PL; WISNIEWSKI WZ, 1976, ICARUS, V28, P87, DOI 10.1016/0019-1035(76)90089-0; Yeomans DK, 2000, SCIENCE, V289, P2085, DOI 10.1126/science.289.5487.2085; Yeomans DK, 1999, SCIENCE, V285, P560, DOI 10.1126/science.285.5427.560; Yeomans DK, 1995, J ASTRONAUT SCI, V43, P417; ZELLNER B, 1976, ICARUS, V28, P149, DOI 10.1016/0019-1035(76)90097-X; Zuber MT, 2000, SCIENCE, V289, P2097, DOI 10.1126/science.289.5487.2097	61	201	208	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2088	2097		10.1126/science.289.5487.2088	http://dx.doi.org/10.1126/science.289.5487.2088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000105				2022-12-28	WOS:000089430900035
J	Ciau-Uitz, A; Walmsley, M; Patient, R				Ciau-Uitz, A; Walmsley, M; Patient, R			Distinct origins of adult and embryonic blood in Xenopus	CELL			English	Article							HEMATOPOIETIC STEM-CELL; DEFINITIVE HEMATOPOIESIS; PARAAORTIC SPLANCHNOPLEURA; MOUSE EMBRYOS; FATE MAP; YOLK-SAC; IN-VIVO; LAEVIS; AORTA; LIVER	Whether embryonic and adult blood derive from a single (yolk sac) or dual (yolk sac plus intraembryonic) origin is controversial. Here, we show, in Xenopus, that the yolk sac (VBI) and intraembryonic (DLP) blood compartments derive from distinct blastomeres in the 32-cell embryo. The first adult hematopoietic stem cells (HSCs) are thought to form in association with the floor of the dorsal aorta, and we have detected such aortic clusters in Xenopus using hematopoietic markers. Lineage tracing shows that the aortic clusters derive from the blastomere that gives rise to the DLP. These observations indicate that the first adult HSCs arise independently of the embryonic lineage.	Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England	University of Nottingham	Patient, R (corresponding author), Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England.		Ciau-Uitz, Aldo/AAE-8989-2020	Ciau-Uitz, Aldo/0000-0002-0505-6607				BECHTOLD TE, 1992, J IMMUNOL, V148, P2975; Bertwistle D, 1996, MECH DEVELOP, V57, P199, DOI 10.1016/0925-4773(96)00547-3; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Cleaver O, 1997, DEV DYNAM, V210, P66, DOI 10.1002/(SICI)1097-0177(199709)210:1<66::AID-AJA7>3.3.CO;2-S; CORMIER F, 1986, DEV BIOL, V118, P167, DOI 10.1016/0012-1606(86)90084-9; CORMIER F, 1988, DEVELOPMENT, V102, P279; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; DALE L, 1987, DEVELOPMENT, V99, P527; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4; FLAJNIK MF, 1984, DEV BIOL, V104, P247, DOI 10.1016/0012-1606(84)90052-6; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; KAU CL, 1983, J IMMUNOL, V131, P2262; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Lane MC, 1999, DEVELOPMENT, V126, P423; MAENO M, 1985, DEV BIOL, V110, P503, DOI 10.1016/0012-1606(85)90108-3; MAENO M, 1985, DEV GROWTH DIFFER, V27, P137; Manaia A, 2000, DEVELOPMENT, V127, P643; Mead PE, 1998, DEVELOPMENT, V125, P2611; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Medvinsky A, 1999, BLOOD, V94, P3613; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; METCALF D, 1971, HAEMATOPOIETIC CELLS, V24; Meyer D, 1995, INT J DEV BIOL, V39, P909; Mills KR, 1999, DEV BIOL, V209, P352, DOI 10.1006/dbio.1999.9245; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; MOODY SA, 1987, DEV BIOL, V122, P300, DOI 10.1016/0012-1606(87)90296-X; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; NAKAMURA O, 1971, P JPN ACAD, V47, P407, DOI 10.2183/pjab1945.47.407; Newman CS, 1997, MECH DEVELOP, V66, P83, DOI 10.1016/S0925-4773(97)00092-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; North T, 1999, DEVELOPMENT, V126, P2563; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Tavian M, 1999, DEVELOPMENT, V126, P793; TOMPKINS R, 1980, DEV DIFFERENTIATION, P25; Tracey WD, 1998, DEVELOPMENT, V125, P1371; TURPEN JB, 1982, DEV BIOL, V89, P138, DOI 10.1016/0012-1606(82)90302-5; Turpen JB, 1997, IMMUNITY, V7, P325, DOI 10.1016/S1074-7613(00)80354-4; VOLPE EP, 1981, ASPECTS DEV COMP IMM, P192; WALMSLEY ME, 1994, DEVELOPMENT, V120, P2519; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wood HB, 1997, BLOOD, V90, P2300; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776	50	185	187	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					787	796		10.1016/S0092-8674(00)00067-2	http://dx.doi.org/10.1016/S0092-8674(00)00067-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030622	Bronze			2022-12-28	WOS:000089395200010
J	Chien, KR				Chien, KR			Genomic circuits and the integrative biology of cardiac diseases	NATURE			English	Article							CONGENITAL HEART-DISEASE; NEURAL CREST DEFECTS; TRANSCRIPTION FACTOR; DILATED CARDIOMYOPATHY; TARGETED DISRUPTION; MUSCULAR-DYSTROPHY; SIGNALING PATHWAY; DEFICIENT MICE; GENE LEADS; MOUSE	Human cardiac disease is the result of complex interactions between genetic susceptibility and environmental stress. The challenge is to identify modifiers of disease, and to design new therapeutic strategies to interrupt the underlying disease pathways. The availability of genomic databases for many species is uncovering networks of conserved cardiac-specific genes within given physiological pathways. A new classification of human cardiac diseases can be envisaged based on the disruption of integrated genomic circuits that control heart morphogenesis, myocyte survival, biomechanical stress responses, cardiac contractility and electrical conduction.	Univ Calif San Diego, Salk Program Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Chien, KR (corresponding author), Univ Calif San Diego, Salk Program Mol Med, La Jolla, CA 92093 USA.	kchien@ucsd.edu						Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Chen J, 1999, J CLIN INVEST, V103, P1483, DOI 10.1172/JCI7297; Chen J, 1998, DEVELOPMENT, V125, P1943; Chien KR, 1996, J CLIN INVEST, V97, P901, DOI 10.1172/JCI118512; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; CURRAN ME, 1999, MOL BASIS CARDIOVASC, P302; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; DINOVIACCARUGO K, 1999, CELL, V98, P537; Donovan MJ, 1996, NAT GENET, V14, P210, DOI 10.1038/ng1096-210; EMANUEL BS, 1999, HEART DEV, P463; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; FRANZ T, 1989, ANAT EMBRYOL, V180, P457, DOI 10.1007/BF00305120; Galili N, 1997, GENOME RES, V7, P17, DOI 10.1101/gr.7.1.17; Gourdie RG, 1999, TRENDS CARDIOVAS MED, V9, P18, DOI 10.1016/S1050-1738(98)00035-8; Grossfeld P, 1999, MOL BASIS CARDIOVASC, P135; Gruber PJ, 1996, J CLIN INVEST, V98, P1332, DOI 10.1172/JCI118920; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Iida K, 1997, DEVELOPMENT, V124, P4627; KRELDBERG JA, 1993, CELL, V4, P679; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Mark M, 1999, P NUTR SOC, V58, P609, DOI 10.1017/S0029665199000798; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Nguyen-Tran VTB, 2000, CELL, V102, P671, DOI 10.1016/S0092-8674(00)00089-1; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sheng ZL, 1996, DEVELOPMENT, V122, P419; SLAMON D, 1998, P AN M AM SOC CLIN, V17, pA98; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Tada M, 1998, TRENDS CARDIOVAS MED, V8, P330, DOI 10.1016/S1050-1738(98)00032-2; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Waldo K, 1999, J CLIN INVEST, V103, P1499, DOI 10.1172/JCI6501; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Yamagishi H, 1999, SCIENCE, V283, P1158, DOI 10.1126/science.283.5405.1158; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261; ZHU H, 1993, MOL CELL BIOL, V13, P4432, DOI 10.1128/MCB.13.7.4432	54	149	153	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					227	232		10.1038/35025196	http://dx.doi.org/10.1038/35025196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001065				2022-12-28	WOS:000089241000058
J	Hammerl, G; Schmehl, A; Schulz, RR; Goetz, B; Bielefeldt, H; Schneider, CW; Hilgenkamp, H; Mannhart, J				Hammerl, G; Schmehl, A; Schulz, RR; Goetz, B; Bielefeldt, H; Schneider, CW; Hilgenkamp, H; Mannhart, J			Enhanced supercurrent density in polycrystalline YBa2Cu3O7-delta at 77 K from calcium doping of grain boundaries	NATURE			English	Article							THIN-FILMS; BICRYSTALS; TRANSPORT; JUNCTIONS	With the discovery of high-temperature superconductivity(1), it seemed that the vision of superconducting power cables operating at the boiling point of liquid nitrogen (77 K) was close to realization. But it was soon found that the critical current density J(c) of the supercurrents that can pass through these polycrystalline materials without destroying superconductivity is remarkably small(1,2). In many materials, J(c) is suppressed at grain boundaries(2-4), by phenomena such as interface charging and bending of the electronic band structure(5-9). Partial replacement (`doping') of the yttrium in YBa2Cu3O7-delta with calcium has been used to increase grain-boundary J(c) values substantially, but only at temperatures much lower than 77 K (ref. 9). Here we show that preferentially overdoping the grain boundaries, relative to the grains themselves, yields values of J(c) at 77 K that far exceed previously published values. Our results indicate that grain-boundary doping is a viable approach for producing a practical, cost-effective superconducting power cable operating at liquid-nitrogen temperatures.	Univ Augsburg, Inst Phys, Ctr Elect Correlat & Magnetism, D-86135 Augsburg, Germany; Univ Twente, Low Temp Div, NL-7500 AE Enschede, Netherlands; Univ Twente, MESA Inst, NL-7500 AE Enschede, Netherlands	University of Augsburg; University of Twente; University of Twente	Mannhart, J (corresponding author), Univ Augsburg, Inst Phys, Ctr Elect Correlat & Magnetism, D-86135 Augsburg, Germany.		Schneider, Christof W/I-5857-2014; Hammerl, German/E-9358-2017; Schneider, Christof/AAC-9106-2020	Schneider, Christof W/0000-0002-4292-8574; Schneider, Christof/0000-0002-4292-8574; Mannhart, Jochen/0000-0001-6331-2640; Hammerl, German/0000-0002-2010-5163				BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; DIMOS D, 1990, PHYS REV B, V41, P4038, DOI 10.1103/PhysRevB.41.4038; Gurevich A, 1998, PHYS REV B, V57, P13878, DOI 10.1103/PhysRevB.57.13878; Heinig NF, 1999, PHYS REV B, V60, P1409, DOI 10.1103/PhysRevB.60.1409; Hilgenkamp H, 1998, APPL PHYS LETT, V73, P265, DOI 10.1063/1.121775; IIJIMA Y, 1992, APPL PHYS LETT, V60, P769, DOI 10.1063/1.106514; IVANOV ZG, 1994, PHYSICA B, V194, P2187, DOI 10.1016/0921-4526(94)91593-8; IVANOV ZG, 1991, APPL PHYS LETT, V59, P3030, DOI 10.1063/1.105783; Mannhart J, 1998, MAT SCI ENG B-SOLID, V56, P77, DOI 10.1016/S0921-5107(98)00217-7; Mannhart J, 1997, SUPERCOND SCI TECH, V10, P880, DOI 10.1088/0953-2048/10/12/004; Norton DP, 1996, SCIENCE, V274, P755, DOI 10.1126/science.274.5288.755; READE RP, 1992, APPL PHYS LETT, V61, P2231, DOI 10.1063/1.108277; Schmehl A, 1999, EUROPHYS LETT, V47, P110, DOI 10.1209/epl/i1999-00359-2; WU XD, 1995, APPL PHYS LETT, V67, P2397, DOI 10.1063/1.114559	14	220	222	1	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					162	164		10.1038/35025014	http://dx.doi.org/10.1038/35025014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001048	Green Submitted			2022-12-28	WOS:000089241000040
J	Macfarlane, S; Racelis, M; Muli-Musiime, F				Macfarlane, S; Racelis, M; Muli-Musiime, F			Public health in developing countries	LANCET			English	Article								Poverty not only excludes people from the benefits of healthcare systems but also restricts them from participating in decisions that affect their health. The resulting health inequalities are well documented, and the search for greater equity attracts many concerned players and initiatives. Fundamental to the success of these efforts, however, is the need for people to be able to negotiate their own inclusion into health systems and demand adequate health care. This calls for a restatement of the centrality of people in public health and its practice. New forms of communication and cooperation are required at all levels of society, nationally, and internationally, to ensure equitable exchange of views and knowledge to formulate appropriate action to redress Inequalities and improve people's health and wellbeing.	Rockefeller Fdn, New York, NY 10018 USA; Atenes Manila Univ, Inst Philippine Culture, Quezon City, Philippines; Rockefeller Fdn, Nairobi, Kenya	Ateneo de Manila University	Macfarlane, S (corresponding author), Rockefeller Fdn, 420 5th Ave, New York, NY 10018 USA.							Acheson D., 1998, INDEPENDENT INQUIRY; Adams O. B., 1998, World Health Statistics Quarterly, V51, P28; Atkinson S, 2000, SOC SCI MED, V51, P619, DOI 10.1016/S0277-9536(00)00005-8; Banerji D, 1999, INT J HEALTH SERV, V29, P227, DOI 10.2190/RAB4-D873-99AM-ACJR; Beaglehole R, 2000, LANCET, V356, P787, DOI 10.1016/S0140-6736(00)02651-9; BINKA FN, 1995, STUD FAMILY PLANN, V26, P121, DOI 10.2307/2137832; Boussinesq M, 1998, Med Trop (Mars), V58, P285; CANAVEANUNG L, 1999, 3 GEN ASS PHIL COMM; Cassels A, 1995, J Int Dev, V7, P329, DOI 10.1002/jid.3380070303; CHAMBERS R, 1995, PEOPLE IMPOVERISHMEN, P1; CHOLIL A, 1998, LIFE SAVER MOTHER FR, P104; CORNWALL A, 2000, IDS B ACCOUNTABILITY; DUBE L, 1996, NUTR DISCRIMINATION, P137; GALLIARD J, 1996, SCI OCC 20 SIECL 7 P, P220; *GOV REP PHIL UN C, 1997, SIT CHILDR WOM PHIL, P21; HEAVER R, 1988, WORLD BNAK WORKING P, V81; HILDERBRAND ME, 1996, BUILDING SUSTAINABLE, P27; HOLLNSTEINER R, 1979, PHILLIPPINE STUDIES, V27, P387; Johnston T, 1999, INVESTING HLTH DEV E; Kickbusch I, 2000, SOC SCI MED, V51, P979, DOI 10.1016/S0277-9536(00)00076-9; KNOWLES JC, 1999, 60 AS DEV BANK, P48; LAFOND A, 1995, SUSTAINING PRIMARY H, P24; LAFOND A, 1995, SUSTAINING PRIMARY H, P101; Martinez J, 1998, HEALTH POLICY PLANN, V13, P345, DOI 10.1093/heapol/13.4.345; McKee M, 2000, LANCET, V356, P665, DOI 10.1016/S0140-6736(00)02616-7; McMichael AJ, 2000, LANCET, V356, P495, DOI 10.1016/S0140-6736(00)02564-2; Narayan D., 2000, VOICES POOR CAN ANYO, DOI DOI 10.1002/JID.793; NARAYAN D, 1999, CRUMBLING FDN CONFLI; NYERERE JK, 1967, POKICY SELF RELIANCE; OKELLO D, 1998, ROLE DONORS UGANDA H; ONDUU DO, 1999, INT FOR URB POV IFUP; OXAAL Z, 1995, HLTH POVERTY GENDER, P1; *PEOPL HLTH ASS, 2000, PEOPL HLTH ASS 200; RACELIS M, IN PRESS FUNDING VIR; RANSOMEKUTI O, 1998, WHO CARES HLTH AFRIC; SACHS J, 1999, ECONOMIST       0814, P17; SAND R, 1952, ADV SOCIAL MED, P443; Sen K, 2000, LANCET, V356, P577, DOI 10.1016/S0140-6736(00)02590-3; Sidel V. W., 1975, Health by the people, P1; Silliman G. S., 1998, ORG DEMOCRACY NGOS C, P280; Sittirak S., 1998, DAUGHTERS DEV WOMEN; *UN DEV PROGR, 1998, HUM DEV REP 1998, P20; *UN POP FUND, 1998, 1997 COUNTR BRIEF; *UNICEF, 1988, NOT CSDR UCI PHC PRE; United Nations Development Programme, 1999, HUM DEV REP 1999; VENERACION C, 1994, COMMUNITY HLTH DEV E, P102; WEE V, 1995, FEMINIZATION POVERTY, P35; White KL., 1991, HEALING SCHISM EPIDE; *WHO, 1999, ROLL BACK MAL PROJ R; *WHO WORLD BANK, 1996, GLOB BURD DIS COMPR; WHO (World Health Organization), 1978, PRIM HLTH CAR REP IN; Wolffers I, 1998, LANCET, V351, P1652, DOI 10.1016/S0140-6736(97)10237-9; *WORLD BANK, 1999, BETT HLTH AFR EXP LE; World Bank, 2000, WORLD DEV REP 1999 2; *WORLD BANK, 1999, CONS POOR NAT SYNTH; World Health Organisation (WHO), 1999, WHO REP INF DIS REM; World Health Organization, 2000, WORLD HLTH REP 2000; Yach D, 1998, AM J PUBLIC HEALTH, V88, P738, DOI 10.2105/AJPH.88.5.738; [No title captured]; 1999, NAT MED, V5, P963	60	77	78	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2000	356	9232					841	846		10.1016/S0140-6736(00)02664-7	http://dx.doi.org/10.1016/S0140-6736(00)02664-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	350LF	11022943	Green Published			2022-12-28	WOS:000089101800036
J	Whittet, S; Trail, P; de Ruiter, A; O'Sullivan, D; Jones, R				Whittet, S; Trail, P; de Ruiter, A; O'Sullivan, D; Jones, R			General practitioners' attitudes and beliefs on antenatal testing for HIV: postal questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article									The Surg, London SW4 6TB, England; Lambeth Southwark & Lewisham Hlth Author, London SE1 7NT, England; Guys & St Thomass Hosp Trust, Dept Genitourinary Med, London SE1 7EH, England; Guys Kings & St Thomass Sch Med, Dept Gen Practice & Primary Care, London SE11 5SP, England	University of London; King's College London	Whittet, S (corresponding author), The Surg, London SW4 6TB, England.							Department of Health, 1999, 1999183 HSC DEP HLTH; DUNN DT, 1992, LANCET, V340, P385; Duong T, 1999, BRIT MED J, V319, P1227, DOI 10.1136/bmj.319.7219.1227; Postma MJ, 1999, BMJ-BRIT MED J, V318, P1656, DOI 10.1136/bmj.318.7199.1656; Simpson WM, 1999, BRIT MED J, V318, P1660, DOI 10.1136/bmj.318.7199.1660	5	5	5	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					934	934		10.1136/bmj.321.7266.934	http://dx.doi.org/10.1136/bmj.321.7266.934			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030683	Green Published, Bronze			2022-12-28	WOS:000089975100024
J	Johanson, U; West, J; Lister, C; Michaels, S; Amasino, R; Dean, C				Johanson, U; West, J; Lister, C; Michaels, S; Amasino, R; Dean, C			Molecular analysis of FRIGIDA, a major determinant of natural variation in Arabidopsis flowering time	SCIENCE			English	Article							THALIANA BRASSICACEAE ECOTYPES; VERNALIZATION; REPRESSOR	Vernalization, the acceleration of flowering by a long period of cold temperature, ensures that many plants overwinter vegetatively and flower in spring. In Arabidopsis, allelic variation at the FRIGIDA (FRI) locus is a major determinant of natural variation in flowering time. Dominant alleles of FRI confer Late flowering, which is reversed to earliness by vernalization. We cloned FRI and analyzed the molecular basis of the allelic variation, Most of the early-flowering ecotypes analyzed carry FRI alleles containing one of two different deletions that disrupt the open reading frame. Loss-of-function mutations at FRI have thus provided the basis for the evolution of many early-flowering ecotypes.	John Innes Ctr Plant Sci Res, Dept Mol Genet, Norwich NR4 7UH, Norfolk, England; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Wisconsin System; University of Wisconsin Madison	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Mol Genet, Norwich NR4 7UH, Norfolk, England.		Michaels, Scott/D-5458-2009; Johanson, Urban/D-4344-2015; Johanson, Urban/AHE-8231-2022	Johanson, Urban/0000-0001-8862-128X; Johanson, Urban/0000-0001-8862-128X				Alonso-Urmeneta B, 1998, CLIN DIAGN LAB IMMUN, V5, P749, DOI 10.1128/CDLI.5.6.749-754.1998; Bergelson J, 1998, GENETICS, V148, P1311; BURN JE, 1993, GENETICA, V90, P145; CLARKE JH, 1994, MOL GEN GENET, V242, P81, DOI 10.1007/BF00277351; HAGENBLAD J, UNPUB; KARLSSON BH, 1993, AM J BOT, V80, P646, DOI 10.2307/2445435; KHURMATOV KK, 1982, ARAB INF SERV, V19, P63; Koomneef M., 1994, PLANT J, V6, P911; Kuittinen H, 1997, THEOR APPL GENET, V95, P573, DOI 10.1007/s001220050598; LEE I, 1993, MOL GEN GENET, V237, P171, DOI 10.1007/BF00282798; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI 10.1111/j.1558-5646.1996.tb04480.x; NAPPZINN K, 1957, Z INDUKT ABSTAMM VER, V88, P253, DOI 10.1007/BF00308342; NAPPZINN K, 1955, NATURWISSENSCHAFTEN, V42, P650, DOI 10.1007/BF00622395; Nordborg M, 1999, AM J BOT, V86, P470, DOI 10.2307/2656807; Sanda S, 1997, J HERED, V88, P69, DOI 10.1093/oxfordjournals.jhered.a023061; Schmidt R, 1996, PLANT J, V9, P755, DOI 10.1046/j.1365-313X.1996.9050755.x; SHARBEL TF, IN PRESS MOL ECOL; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519	21	759	810	12	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					344	347		10.1126/science.290.5490.344	http://dx.doi.org/10.1126/science.290.5490.344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030654				2022-12-28	WOS:000089818100046
J	Charatan, F				Charatan, F			Interferon treatment is beneficial in early multiple sclerosis	BRITISH MEDICAL JOURNAL			English	News Item																		Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 7	2000	321	7265					851	851						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363VC	11021854				2022-12-28	WOS:000089857500011
J	Seddon, B; Legname, G; Tomlinson, P; Zamoyska, R				Seddon, B; Legname, G; Tomlinson, P; Zamoyska, R			Long-term survival but impaired homeostatic proliferation of naive T cells in the absence of p56(lck)	SCIENCE			English	Article							LIGANDS; RECEPTOR; ACTIVATION; MICE; LCK	Interactions between the T cell receptor (TCR) and major histocompatibility complex antigens are essential for the survival and homeostasis of peripheral T lymphocytes, However, little is known about the TCR signaling events that result from these interactions. The peripheral T cell pool of p56(lck) (lck)-deficient mice was reconstituted by the expression of an inducible lck transgene. Continued survival of peripheral naive T cells was observed for long periods after switching off the transgene, Adoptive transfer of T cells from these mice into T lymphopoienic hosts confirmed that T cell survival was independent of lck but revealed its essential role in TCR-driven homeostatic proliferation of naive T cells in response to the T cell-deficient host environment. These data suggest that survival and homeostatic expansion depend on different signals.	Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	MRC National Institute for Medical Research; University of California System; University of California San Francisco	Zamoyska, R (corresponding author), Natl Inst Med Res, Div Mol Immunol, Mill Hill, London NW7 1AA, England.		Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393; Seddon, Benedict/0000-0003-4352-3373; Zamoyska, Rose/0000-0001-9816-2638				Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; CASABO LG, 1994, J IMMUNOL, V152, P397; Chau LA, 1998, J EXP MED, V187, P1699, DOI 10.1084/jem.187.10.1699; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Ferreira C, 2000, J IMMUNOL, V165, P3689, DOI 10.4049/jimmunol.165.7.3689; Freitas AA, 1999, CURR OPIN IMMUNOL, V11, P152, DOI 10.1016/S0952-7915(99)80026-0; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SEDDON B, UNPUB; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355	28	104	110	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					127	131		10.1126/science.290.5489.127	http://dx.doi.org/10.1126/science.290.5489.127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021796				2022-12-28	WOS:000089724800049
J	Kitua, AY; Mashalla, YJS; Shija, JK				Kitua, AY; Mashalla, YJS; Shija, JK			Coordinating health research to promote action: the Tanzanian experience	BRITISH MEDICAL JOURNAL			English	Article							GAMBIAN CHILDREN; MORTALITY; MORBIDITY; BEDNETS; MALARIA	The failure of the malaria eradication programme in some developing countries illustrates the failure of those countries to coordinate their health research activities Coordination is needed to use scarce resources effectively but also to identify priorities and communicate these to policymakers and the public After years of Tanzanian health research institutions failing to collaborate they have now joined in a national health forum Already the forum has identified research priorities and is setting out an ethical framework for research.	Natl Inst Med Res, Dar Es Salaam, Tanzania; Muhimbili Univ, Coll Hlth Sci, Dar Es Salaam, Tanzania	National Institute of Medical Research	Kitua, AY (corresponding author), Natl Inst Med Res, POB 9653, Dar Es Salaam, Tanzania.							ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; BRADLEYJD, 1991, MALARIA WHITING VACC, P11; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; *GLOB FOR HLTH RES, 1999, PROM RES IMPR HLTH P; KITUA AY, 1999, COHRED NEWSLETTER, V17, P7; Lengeler C, 1996, NET GAIN NEW METHOD; *NAT I MED RES, 1999, TANZ ESS NAT HLTH RE; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; SUMMANEN P, 1994, HLTH DIS DEV COUNTRI, V248, P353; *WHO, 1998, WORLD HLTH REP LIF 2	11	9	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 30	2000	321	7264					821	823		10.1136/bmj.321.7264.821	http://dx.doi.org/10.1136/bmj.321.7264.821			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009527	Green Published			2022-12-28	WOS:000089696600031
J	Levchenko, I; Seidel, M; Sauer, RT; Baker, TA				Levchenko, I; Seidel, M; Sauer, RT; Baker, TA			A specificity-enhancing factor for the ClpXP degradation machine	SCIENCE			English	Article							ESCHERICHIA-COLI; DEPENDENT PROTEASES; TAGGING SYSTEM; CLPAP; PROTEINS; CHAPERONE	Events that stall bacterial protein, synthesis activate the ssrA-tagging machinery, resulting in resumption of translation and addition of an 11-residue peptide to the carboxyl terminus of the nascent chain. This ssrA-encoded peptide tag marks the incomplete protein for degradation by the energy-dependent ClpXP protease. Here, a ribosome-associated protein, SspB, was found to bind specifically to ssrA-tagged proteins and to enhance recognition of these proteins by ClpXP. Cells with an sspB mutation are defective in degrading ssrA-tagged proteins, demonstrating that SspB is a specificity-enhancing factor for ClpXP that controls substrate choice.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Dept Biol, Bldg 68,Room 523,77 Massachusetts Ave, Cambridge, MA 02139 USA.			Sauer, Robert/0000-0002-1719-5399	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-16892] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Gonciarz-Swiatek M, 1999, J BIOL CHEM, V274, P13999, DOI 10.1074/jbc.274.20.13999; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Hoskins JR, 1998, P NATL ACAD SCI USA, V95, P12135, DOI 10.1073/pnas.95.21.12135; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Laachouch JE, 1996, EMBO J, V15, P437, DOI 10.1002/j.1460-2075.1996.tb00374.x; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; MILLER MJ, 1974, J BIOL CHEM, V249, P3803; PARCELL DA, 1994, J BIOL CHEM, V269, P4480; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; WILLIAMS MD, 1994, MOL MICROBIOL, V11, P1029, DOI 10.1111/j.1365-2958.1994.tb00381.x; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	20	257	265	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2354	2356		10.1126/science.289.5488.2354	http://dx.doi.org/10.1126/science.289.5488.2354			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009422				2022-12-28	WOS:000089593500054
J	Mao, CD; LaBean, TH; Reif, JH; Seeman, NC				Mao, CD; LaBean, TH; Reif, JH; Seeman, NC			Logical computation using algorithmic self-assembly of DNA triple-crossover molecules	NATURE			English	Article							CRYSTALS	Recent work(1-3) has demonstrated the self-assembly of designed periodic two-dimensional arrays composed of DNA tiles, in which the intermolecular contacts are directed by 'sticky' ends. In a mathematical context, aperiodic mosaics may be formed by the self-assembly of 'Wang' tiles(4), a process that emulates the operation of a Turing machine. Macroscopic self-assembly has been used to perform computations(5); there is also a logical equivalence between DNA sticky ends and Wang tile edges(6,7). This suggests that the self-assembly of DNA-based tiles could be used to perform DNA-based computation(8). Algorithmic aperiodic self-assembly requires greater fidelity than periodic self-assembly, because correct tiles must compete with partially correct tiles. Here we report a one-dimensional algorithmic self-assembly of DNA triple-crossover molecules(9) that can be used to execute four steps of a logical (cumulative XOR) operation on a string of binary bits.	NYU, Dept Chem, New York, NY 10003 USA; Duke Univ, Dept Comp Sci, Durham, NC 27707 USA	New York University; Duke University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.		Mao, Chengde/GPP-1546-2022; LaBean, Thomas H/G-2859-2011	LaBean, Thomas H/0000-0002-6739-2059				ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; GEHANI A, IN PRESS DIMACS SERI; HARADA K, 1993, NUCLEIC ACIDS RES, V21, P2287, DOI 10.1093/nar/21.10.2287; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Liu FR, 1999, J AM CHEM SOC, V121, P917, DOI 10.1021/ja982824a; Liu QH, 2000, NATURE, V403, P175, DOI 10.1038/35003155; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; Pirrung MC, 2000, J AM CHEM SOC, V122, P1873, DOI 10.1021/ja992392j; Reif J., 1997, DNA BASED COMPUTERS, P217; Rothemund PWK, 2000, P NATL ACAD SCI USA, V97, P984, DOI 10.1073/pnas.97.3.984; Sakamoto K, 2000, SCIENCE, V288, P1223, DOI 10.1126/science.288.5469.1223; Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C; Wang H., 1963, P S MATH THEOR AUT, P23; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Winfree E., 1996, DNA BASED COMPUTERS, P199; Winfree E., 1998, THESIS CALTECH; WINFREE E, 1999, DNA BASED COMPUTERS, V2, P217	18	538	571	3	182	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					493	496		10.1038/35035038	http://dx.doi.org/10.1038/35035038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028996	Green Submitted			2022-12-28	WOS:000089727400044
J	Hey, E; Chalmers, I				Hey, E; Chalmers, I			Investigating allegations of research misconduct: the vital need for due process	BRITISH MEDICAL JOURNAL			English	Article									UK Cochrane Ctr, Oxford OX2 7LG, England	Cochrane Centre	Chalmers, I (corresponding author), UK Cochrane Ctr, Summertown Pavil, Oxford OX2 7LG, England.							Armitage P., 1975, SEQUENTIAL MED TRIAL; BLACKHURST D, 2000, SENTINEL        0519, P10; CHALMERS I, 2000, INFORMED CONSENT RES, P267; Jones J, 1999, BRIT MED J, V318, P553, DOI 10.1136/bmj.318.7183.553; *MRC, 1997, MRC ETH SER; *NHS EX W MIDL, 2000, REP REV RES FRAM N S; Samuels MP, 1996, PEDIATRICS, V98, P1154; Smith R, 2000, BMJ-BRIT MED J, V320, P1285, DOI 10.1136/bmj.320.7245.1285; SOUTHALL D, 2000, RESPONSE GRIFFITHS R; STENSON B, 1999, BRIT MED J, V318, P553; 1999, LANCET, V353, P685	11	36	36	2	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					752	755		10.1136/bmj.321.7263.752	http://dx.doi.org/10.1136/bmj.321.7263.752			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999913	Green Published			2022-12-28	WOS:000089546600032
J	Pringle, M				Pringle, M			Clinical governance in primary care - Participating in clinical governance	BRITISH MEDICAL JOURNAL			English	Article									Queens Med Ctr, Dept Gen Practice, Nottingham NH7 2UH, England	University of Nottingham	Pringle, M (corresponding author), Queens Med Ctr, Dept Gen Practice, Nottingham NH7 2UH, England.							*CHEIF MED OFF, 1998, REV CONT PROF DEV GE; *CHIEF MED OFF, 1999, SUPP DOCT PROT PAT; *DEP HLTH, 1998, 1 CLASS SERV QUAL NE; Gillam S, 1999, BUILDING BRIDGES FUT; MORRELL C, 1997, QUAL HEALTH CARE, V6, P9; PRINGLE M, 1995, SIGNIFICANT EVENT AU; *ROYAL COLL GEN PR, 1999, PRACT ADV IMPL CLIN; *ROYAL COLL GEN PR, 1999, QUAL PRACT AW; *ROYAL COLL GEN PR, 2000, FUT PROF LED REG; *ROYAL COLL GEN PR, 2000, REV CLIN GEN PRACT C; *ROYAL COLL GEN PR, 1999, CRIT FELL ASS; *ROYAL COLL NUR, 1998, GUID NURS CLIN GOV; *ROYAL COLL NURS, 1999, CRIT MEMB ASS PERF; *ROYAL COLL NURS, 1998, GUID NURS CLIN GOV; SCRIVENS E, 1998, SCOPING STUDY CLIN G; Secretary of State for Health, 1997, NEW NHS MOD DEP	16	19	19	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					737	740		10.1136/bmj.321.7263.737	http://dx.doi.org/10.1136/bmj.321.7263.737			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999908	Green Published, Bronze			2022-12-28	WOS:000089546600028
J	Bousquet-Antonelli, C; Presutti, C; Tollervey, D				Bousquet-Antonelli, C; Presutti, C; Tollervey, D			Identification of a regulated pathway for nuclear pre-mRNA turnover	CELL			English	Article							MESSENGER-RNA TURNOVER; 5.8S RIBOSOMAL-RNA; HUMAN PM-SCL; SACCHAROMYCES-CEREVISIAE; DECAPPING ENZYME; YEAST-CELLS; GENE; EXOSOME; SPLICEOSOME; MUTATIONS	We have identified a nuclear pathway that rapidly degrades unspliced pre-mRNAs in yeast. This involves 3'-->5' degradation by the exosome complex and 5'-->3' degradation by the exonuclease Rat1p. 3'-->5' degradation is normally the major pathway and is regulated in response to carbon source. Inhibition of pre-mRNA degradation resulted in increased levels of pre-mRNAs and spliced mRNAs. When splicing was inhibited by mutation of a splicing factor, inhibition of turnover resulted in 20- to 50-fold accumulation of pre-mRNAs, accompanied by increased mRNA production. Splicing of a reporter construct with a 3' splice site mutation was also increased on inhibition of turnover, showing competition between degradation and splicing. We propose that nuclear pre-mRNA turnover represents a novel step in the regulation of gene expression.	Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Tollervey, D (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.		Bousquet-Antonelli, Cécile/O-3898-2018; Tollervey, David/AAR-6662-2020	Bousquet-Antonelli, Cécile/0000-0002-3909-7976; Tollervey, David/0000-0003-2894-2772; PRESUTTI, Carlo/0000-0003-3837-2275				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Baker RE, 1998, GENETICS, V149, P73; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; BELTRAME M, 1992, EMBO J, V11, P1531, DOI 10.1002/j.1460-2075.1992.tb05198.x; Benard L, 1998, MOL CELL BIOL, V18, P2688, DOI 10.1128/MCB.18.5.2688; BRANDHORST BP, 1974, J MOL BIOL, V85, P451, DOI 10.1016/0022-2836(74)90444-6; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; CHANFREAU G, 1994, NUCLEIC ACIDS RES, V22, P1981, DOI 10.1093/nar/22.11.1981; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; ENG FJ, 1991, CELL, V65, P797, DOI 10.1016/0092-8674(91)90387-E; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; KADOWAKI T, 1995, MOL BIOL CELL, V6, P1103, DOI 10.1091/mbc.6.9.1103; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Kim SH, 1996, MOL CELL BIOL, V16, P6810; KING DS, 1990, NUCLEIC ACIDS RES, V18, P6556; Klein CJL, 1998, MICROBIOL-SGM, V144, P13, DOI 10.1099/00221287-144-1-13; Lafontaine D, 1996, NUCLEIC ACIDS RES, V24, P3469, DOI 10.1093/nar/24.17.3469; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; LESSER CF, 1993, GENETICS, V133, P851; MAQUAT LE, 1995, RNA, V1, P453; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; PLUMPTON M, 1994, EMBO J, V13, P879, DOI 10.1002/j.1460-2075.1994.tb06331.x; Rain JC, 1997, EMBO J, V16, P1759, DOI 10.1093/emboj/16.7.1759; Shiomi T, 1998, J BIOCHEM-TOKYO, V123, P883; SHOBUIKE T, 1995, NUCLEIC ACIDS RES, V23, P357, DOI 10.1093/nar/23.3.357; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; TUNG KS, 1992, MOL CELL BIOL, V12, P2673, DOI 10.1128/MCB.12.6.2673; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Venema J, 1996, EMBO J, V15, P5701, DOI 10.1002/j.1460-2075.1996.tb00954.x; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; VIJAYRAGHAVAN U, 1986, EMBO J, V5, P1683, DOI 10.1002/j.1460-2075.1986.tb04412.x; VILARDELL J, 1994, GENE DEV, V8, P211, DOI 10.1101/gad.8.2.211; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989	51	316	319	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 15	2000	102	6					765	775		10.1016/S0092-8674(00)00065-9	http://dx.doi.org/10.1016/S0092-8674(00)00065-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355PZ	11030620	Bronze, Green Published			2022-12-28	WOS:000089395200008
J	Yancopoulos, GD; Davis, S; Gale, NW; Rudge, JS; Wiegand, SJ; Holash, J				Yancopoulos, GD; Davis, S; Gale, NW; Rudge, JS; Wiegand, SJ; Holash, J			Vascular-specific growth factors and blood vessel formation	NATURE			English	Article							RECEPTOR TYROSINE KINASE; TUMOR ANGIOGENESIS; CARDIOVASCULAR DEVELOPMENT; DIABETIC-RETINOPATHY; ENDOTHELIAL-CELLS; TRANSGENIC MICE; LUNG-CARCINOMA; TIE2 RECEPTOR; VEGF GENE; PDGF-B	A recent explosion in newly discovered vascular growth factors has coincided with exploitation of powerful new genetic approaches for studying vascular development. An emerging rule is that all of these factors must be used in perfect harmony to form functional vessels. These new findings also demand re-evaluation of therapeutic efforts aimed at regulating blood vessel growth in ischaemia, cancer and other pathological settings.	Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Regeneron	Yancopoulos, GD (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.							ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; DUMONT DJ, 1993, ONCOGENE, V8, P1293; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Eriksson U, 1999, CURR TOP MICROBIOL, V237, P41; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Goede V, 1998, LAB INVEST, V78, P1385; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Henry TD, 1998, J AM COLL CARDIOL, V31, p65A, DOI 10.1016/S0735-1097(97)83989-7; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KORHONEN J, 1992, BLOOD, V80, P2548; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MAISONPIERRE PC, 1993, ONCOGENE, V8, P1631; Miquerol L, 2000, DEVELOPMENT, V127, P3941; O'Reilly MS, 1999, SCIENCE, V285, P1926, DOI 10.1126/science.285.5435.1926; Olofsson B, 1999, CURR OPIN BIOTECH, V10, P528, DOI 10.1016/S0958-1669(99)00024-5; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Persico MG, 1999, CURR TOP MICROBIOL, V237, P31; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Pezzella F, 1997, AM J PATHOL, V151, P1417; Pierce EA, 1997, ARCH OPHTHALMOL-CHIC, V115, P427; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; Ribatti D, 1996, INT J DEV BIOL, V40, P1189; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Springer ML, 1998, MOL CELL, V2, P549, DOI 10.1016/S1097-2765(00)80154-9; Stone J, 1996, INVEST OPHTH VIS SCI, V37, P290; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Stratmann A, 1998, AM J PATHOL, V153, P1459, DOI 10.1016/S0002-9440(10)65733-1; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Taipale J, 1999, CURR TOP MICROBIOL, V237, P85; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; WESSELING P, 1994, J NEUROSURG, V81, P902, DOI 10.3171/jns.1994.81.6.0902; Zagzag D, 1999, EXP NEUROL, V159, P391, DOI 10.1006/exnr.1999.7162	73	3003	3311	7	346	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					242	248		10.1038/35025215	http://dx.doi.org/10.1038/35025215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001067				2022-12-28	WOS:000089241000060
J	Hoppe, T; Matuschewski, K; Rape, M; Schlenker, S; Ulrich, HD; Jentsch, S				Hoppe, T; Matuschewski, K; Rape, M; Schlenker, S; Ulrich, HD; Jentsch, S			Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing	CELL			English	Article							UBIQUITIN-PROTEIN LIGASE; NF-KAPPA-B; CEREVISIAE OLE1 GENE; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL INHERITANCE; TRANSMEMBRANE PROTEIN; INDUCED DEGRADATION; YEAST; PROTEASOME; PROTEOLYSIS	Processing of integral membrane proteins in order to liberate active proteins is of exquisite cellular importance. Examples are the processing events that govern sterol regulation, Notch signaling, the unfolded protein response, and APP fragmentation linked to Alzheimer's disease. In these cases, the proteins are thought to be processed by regulated intramembrane proteolysis, involving site-specific, membrane-localized proteases. Here we show that two homologous yeast transcription factors SPT23 and MGA2 are made as dormant ER/nuclear membrane-localized precursors and become activated by a completely different mechanism that involves ubiquitin/proteasome-dependent processing. SPT23 and MGA2 are relatives of mammalian NF-kappa B and control unsaturated fatty acid levels. Intriguingly, proteasome-dependent processing of SPT23 is regulated by fatty acid pools, suggesting that the precursor itself or interacting partners are sensors of membrane composition or fluidity.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Hoppe, Thorsten/AAC-7880-2020	Matuschewski, Kai/0000-0001-6147-8591; Ulrich, Helle D./0000-0003-0431-2223; Rape, Michael/0000-0003-4849-6343; Hoppe, Thorsten/0000-0002-4734-9352				Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BURKETT TJ, 1994, YEAST, V10, P81, DOI 10.1002/yea.320100108; Choi JY, 1996, J BIOL CHEM, V271, P3581; De Strooper B, 2000, NATURE, V405, P627, DOI 10.1038/35015193; DeHoratius C, 1996, MOL BIOL CELL, V7, P1835, DOI 10.1091/mbc.7.11.1835; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guthrie C, 1991, GUIDE YEAST GENETICS; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; James P, 1996, GENETICS, V144, P1425; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kanda T, 1996, GENES GENET SYST, V71, P75, DOI 10.1266/ggs.71.75; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Knop M, 1997, EMBO J, V16, P1550, DOI 10.1093/emboj/16.7.1550; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; LIU HP, 1992, GENETICS, V132, P665; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; MCCONNELL SJ, 1990, J CELL BIOL, V111, P967, DOI 10.1083/jcb.111.3.967; MCDONOUGH VM, 1992, J BIOL CHEM, V267, P5931; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; Springael JY, 1999, BIOCHEM BIOPH RES CO, V257, P561, DOI 10.1006/bbrc.1999.0505; STEWART LC, 1991, J CELL BIOL, V115, P1249, DOI 10.1083/jcb.115.5.1249; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wang GL, 1999, MOL CELL BIOL, V19, P342; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wolfe D, 1999, MOL CELL BIOL, V19, P8254; Zhang SR, 1999, GENETICS, V151, P473; Zoladek T, 1997, GENETICS, V145, P595	49	466	476	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 1	2000	102	5					577	586		10.1016/S0092-8674(00)00080-5	http://dx.doi.org/10.1016/S0092-8674(00)00080-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007476	hybrid			2022-12-28	WOS:000089105200006
J	Schluenzen, F; Tocilj, A; Zarivach, R; Harms, J; Gluehmann, M; Janell, D; Bashan, A; Bartels, H; Agmon, I; Franceschi, F; Yonath, A				Schluenzen, F; Tocilj, A; Zarivach, R; Harms, J; Gluehmann, M; Janell, D; Bashan, A; Bartels, H; Agmon, I; Franceschi, F; Yonath, A			Structure of functionally activated small ribosomal subunit at 3.3 angstrom resolution	CELL			English	Article							ESCHERICHIA-COLI RIBOSOME; DIRECTED CROSS-LINKING; MESSENGER-RNA ANALOGS; THERMUS-THERMOPHILUS; PROTEIN S20; CRYOELECTRON MICROSCOPY; CONFORMATIONAL SWITCH; CRYSTAL-STRUCTURE; SITE; 16-S	The small ribosomal subunit performs the decoding of genetic information during translation. The structure of that from Thermus thermophilus shows that the decoding center, which positions mRNA and three tRNAs, is constructed entirely of RNA. The entrance to the mRNA channel will encircle the message when a latch-like contact closes and contributes to processivity and fidelity. Extended RNA helical elements that run longitudinally through the body transmit structural changes, correlating events at the particle's far end with the cycle of mRNA translocation at the decoding region. 96% of the nucleotides were traced and the main fold of all proteins was determined. The latter are either peripheral or appear to serve as linkers. Some may assist the directionality of translocation.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Max Planck Res Unit Ribosomal Struct, D-22603 Hamburg, Germany; Weizmann Inst Sci, IL-76100 Rehovot, Israel	Max Planck Society; Max Planck Society; Weizmann Institute of Science	Franceschi, F (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	franceschi@molgen.mpg.de	Schluenzen, Frank/P-9177-2019; Franceschi, Francois/AAF-5860-2021; Harms, Joerg/K-8786-2012; ZARIVACH, RAZ/F-1671-2012; Schluenzen, Frank/H-6274-2014	Schluenzen, Frank/0000-0003-2849-0542; Harms, Joerg/0000-0002-9442-8264; ZARIVACH, RAZ/0000-0001-6543-0296; Schluenzen, Frank/0000-0003-2849-0542; Franceschi, Francois/0000-0002-1554-7944	NIGMS NIH HHS [GM34360] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034360] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; ALKSNE LE, 1993, P NATL ACAD SCI USA, V90, P9538, DOI 10.1073/pnas.90.20.9538; ARAD T, 1987, BIOCHIMIE, V69, P1001, DOI 10.1016/0300-9084(87)90234-3; Auerbach T, 2000, J BIOMOL STRUCT DYN, V17, P617, DOI 10.1080/07391102.2000.10506553; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Baranov PV, 1999, NUCLEIC ACIDS RES, V27, P184, DOI 10.1093/nar/27.1.184; Bashan A, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P21; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bullard JM, 1998, BIOCHEMISTRY-US, V37, P1350, DOI 10.1021/bi9720540; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHOLI T, 1993, BIOL CHEM H-S, V374, P377, DOI 10.1515/bchm3.1993.374.1-6.377; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Culver GM, 1998, RNA, V4, P1471, DOI 10.1017/S1355838298981201; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DONTSOVA O, 1992, EMBO J, V11, P3105, DOI 10.1002/j.1460-2075.1992.tb05383.x; DONTSOVA O, 1991, EMBO J, V10, P2613, DOI 10.1002/j.1460-2075.1991.tb07803.x; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; Gabashvili IS, 1999, J MOL BIOL, V286, P1285, DOI 10.1006/jmbi.1999.2538; GOTZ F, 1990, BIOCHIM BIOPHYS ACTA, V1050, P93, DOI 10.1016/0167-4781(90)90147-T; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GUTELL RR, 1999, COMP SEQUENCE ANAL P; Harms J, 1999, STRUCTURE, V7, P931, DOI 10.1016/S0969-2126(99)80120-8; Helgstrand M, 1999, J MOL BIOL, V292, P1071, DOI 10.1006/jmbi.1999.3122; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kim YC, 1999, P NATL ACAD SCI USA, V96, P14234, DOI 10.1073/pnas.96.25.14234; Leontis NB, 1998, J MOL BIOL, V283, P571, DOI 10.1006/jmbi.1998.2106; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MONTESANORODITIS L, 1993, J BIOL CHEM, V268, P18701; Mueller F, 1997, J MOL BIOL, V271, P566, DOI 10.1006/jmbi.1997.1212; Mueller F, 1997, J MOL BIOL, V271, P524, DOI 10.1006/jmbi.1997.1210; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; MURZINA NV, 1988, NUCLEIC ACIDS RES, V16, P8172, DOI 10.1093/nar/16.16.8172; Muth GW, 2000, BIOCHEMISTRY-US, V39, P4068, DOI 10.1021/bi992362t; Newcomb LF, 1999, RNA, V5, P849, DOI 10.1017/S1355838299990192; Nikulin A, 2000, NAT STRUCT BIOL, V7, P273; OAKES M, 1986, STRUCTURE FUNCTION G, P47; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILIPPSEN A, 2000, DINO VISUALIZING STR; POHL T, 1988, J BIOL CHEM, V263, P4293; Poot RA, 1998, NUCLEIC ACIDS RES, V26, P549, DOI 10.1093/nar/26.2.549; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; POWERS T, 1988, J MOL BIOL, V201, P697, DOI 10.1016/0022-2836(88)90468-8; Ramakrishnan V, 1998, TRENDS BIOCHEM SCI, V23, P208, DOI 10.1016/S0968-0004(98)01214-6; RYDENAULIN M, 1993, MOL MICROBIOL, V7, P983, DOI 10.1111/j.1365-2958.1993.tb01190.x; SCHWEDLER G, 1993, EUR J BIOCHEM, V217, P361, DOI 10.1111/j.1432-1033.1993.tb18254.x; Spickler C, 1997, J MOL BIOL, V273, P586, DOI 10.1006/jmbi.1997.1323; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; STARK H, 1995, STRUCTURE, V3, P815, DOI 10.1016/S0969-2126(01)00216-7; STOFFLER G, 1986, STRUCTURE FUNCTION G, P28; SZEWCZAK AA, 1993, P NATL ACAD SCI USA, V90, P9581, DOI 10.1073/pnas.90.20.9581; Tocilj A, 1999, P NATL ACAD SCI USA, V96, P14252, DOI 10.1073/pnas.96.25.14252; TSIBOLI P, 1994, EUR J BIOCHEM, V226, P169, DOI 10.1111/j.1432-1033.1994.tb20038.x; VANACKEN U, 1975, MOL GEN GENET, V140, P61, DOI 10.1007/BF00268989; VanLoock MS, 1999, J MOL BIOL, V285, P2069, DOI 10.1006/jmbi.1998.2442; Weinstein S, 1999, J STRUCT BIOL, V127, P141, DOI 10.1006/jsbi.1999.4135; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WITTMANNLIEBOLD B, 1978, FEBS LETT, V95, P91, DOI 10.1016/0014-5793(78)80059-3; ZAMIR A, 1971, J MOL BIOL, V60, P347, DOI 10.1016/0022-2836(71)90299-3	69	791	844	2	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					615	623		10.1016/S0092-8674(00)00084-2	http://dx.doi.org/10.1016/S0092-8674(00)00084-2			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007480	Bronze			2022-12-28	WOS:000089105200010
J	Gottlieb, S				Gottlieb, S			Pregnant women with HIV should be started on antiretroviral drugs no later than 28 weeks	BRITISH MEDICAL JOURNAL			English	News Item																		Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Peckham C, 2000, NEW ENGL J MED, V343, P1036, DOI 10.1056/NEJM200010053431408	2	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					915	915						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030668				2022-12-28	WOS:000089975100010
J	Quill, TE; Byock, IR				Quill, TE; Byock, IR			Responding to intractable terminal suffering - Response	ANNALS OF INTERNAL MEDICINE			English	Letter									Genesee Hosp, Rochester, NY 14607 USA; Univ Montana, Missoula, MT 59812 USA	University of Montana System; University of Montana	Quill, TE (corresponding author), Genesee Hosp, Rochester, NY 14607 USA.							Devettere R J, 1990, J Clin Ethics, V1, P268; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099	3	8	9	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					561	562		10.7326/0003-4819-133-7-200010030-00022	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00022			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015176				2022-12-28	WOS:000089678300013
J	Dimmock, PW; Wyatt, KM; Jones, PW; O'Brien, PMS				Dimmock, PW; Wyatt, KM; Jones, PW; O'Brien, PMS			Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review	LANCET			English	Review							RANDOMIZED CONTROLLED TRIAL; PHASE SERTRALINE TREATMENT; DYSPHORIC DISORDER; LUTEAL-PHASE; DOUBLE-BLIND; FLUOXETINE TREATMENT; PLACEBO; CROSSOVER; WOMEN; METAANALYSIS	Background Selective serotonin-reuptake inhibitors (SSRIs) are increasingly being used as first-line therapy for severe premenstrual syndrome (PMS). We undertook a meta-analysis on the efficacy of SSRIs in this disorder. Methods We searched medical and scientific databases, approached pharmaceutical companies, and reviewed citations of relevant articles to identify 29 studies of the use of SSRIs in PMS. 14 were excluded (no placebo group, preliminary report of included trial, or low quality). 15 randomised placebo-controlled trials were included. Information on study design, participants, drugs used and dosing regimens, outcome measures, side-effects, and sources of funding was extracted. Standardised mean differences between treatment and placebo groups were calculated to obtain an overall estimate of efficacy. The primary outcome measure was a reduction in overall PMS symptoms. Findings The primary analysis included data on 904 women (570 assigned active treatment and 435 assigned placebo, including 101 in crossover trials). The overall standardised mean difference was -1.066 (95% CI -1.381 to -0.750), which corresponds to an odds ratio of 6.91 (3.90 to 12.2) in favour of SSRIs. SSRIs were effective in treating physical and behavioural symptoms. There was no significant difference in symptom reduction between continuous and intermittent dosing or between trials funded by pharmaceutical companies and those independently funded. Withdrawal due to side-effects was 2.5 times more likely in the active-treatment group than in the placebo group. Interpretation SSRIs are an effective first-line therapy for severe PMS. The safety of these drugs has been demonstrated in trials of affective disorder, and the side-effects at low doses are generally acceptable.	Keele Univ, Acad Dept Obstet & Gynaecol, Stoke On Trent ST4 6QG, Staffs, England; N Staffordshire Hosp, Stoke On Trent ST4 6QG, Staffs, England; Keele Univ, Dept Math, Keele, Staffs, England	Keele University; Keele University; University Hospital of North Staffordshire NHS Trust; Keele University	Dimmock, PW (corresponding author), Keele Univ, Acad Dept Obstet & Gynaecol, Stoke On Trent ST4 6QG, Staffs, England.	oga03@keele.ac.uk						BRANDENBURG S, 1993, INT CLIN PSYCHOPHARM, V8, P315, DOI 10.1097/00004850-199300840-00018; CHATFIELD C, 1978, STAT TECHNOLOGY; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Diegoli MSC, 1998, INT J GYNECOL OBSTET, V62, P63, DOI 10.1016/S0020-7292(98)00035-6; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELKS ML, 1993, SOUTHERN MED J, V86, P503, DOI 10.1097/00007611-199305000-00003; ERIKSSON E, 1995, NEUROPSYCHOPHARMACOL, V12, P167, DOI 10.1038/sj.npp.1380251; Freeman EW, 1996, J CLIN PSYCHIAT, V57, P7; Freeman EW, 1999, ARCH GEN PSYCHIAT, V56, P932, DOI 10.1001/archpsyc.56.10.932; Freeman EW, 1999, J CLIN PSYCHOPHARM, V19, P3, DOI 10.1097/00004714-199902000-00002; Halbreich U, 1997, J CLIN PSYCHIAT, V58, P399, DOI 10.4088/JCP.v58n0905; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Hedges LV, 2014, STAT METHODS META AN; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jermain DM, 1999, ARCH FAM MED, V8, P328, DOI 10.1001/archfami.8.4.328; Martin JJDL, 1997, ACTAS LUSO-ESP NEUR, V25, P235; MENKES DB, 1993, INT CLIN PSYCHOPHARM, V8, P95, DOI 10.1097/00004850-199300820-00003; MENKES DB, 1992, BRIT MED J, V305, P346, DOI 10.1136/bmj.305.6849.346; OBRIEN PMS, 1987, PREMENSTRUAL SYNDROM; Ozeren S, 1997, EUR J OBSTET GYN R B, V73, P167, DOI 10.1016/S0301-2115(97)02741-3; Pearlstein TB, 1997, J CLIN PSYCHOPHARM, V17, P261, DOI 10.1097/00004714-199708000-00004; PEARLSTEIN TB, 1994, J CLIN PSYCHIAT, V55, P332; RAPKIN AJ, 1987, OBSTET GYNECOL, V70, P533; Rapkin AJ, 1997, OBSTET GYNECOL, V90, P709, DOI 10.1016/S0029-7844(97)00417-1; RICKELS K, 1990, CURR THER RES CLIN E, V48, P161; RUBINOW DR, 1984, AM J PSYCHIAT, V141, P163; SHEN WW, 1995, INT J PSYCHIAT MED, V25, P239, DOI 10.2190/N6C0-DWX2-G4EA-7688; Steiner M, 1997, Int J Psychiatry Clin Pract, V1, P3, DOI 10.3109/13651509709069200; Steiner M, 1997, PSYCHOPHARMACOL BULL, V33, P771; STEINER M, 1995, NEW ENGL J MED, V332, P1529, DOI 10.1056/NEJM199506083322301; STONE AB, 1990, PSYCHOPHARMACOL BULL, V26, P331; STONE AB, 1991, J CLIN PSYCHIAT, V52, P290; Su TP, 1997, NEUROPSYCHOPHARMACOL, V16, P346, DOI 10.1016/S0893-133X(96)00245-X; Sundblad C, 1997, EUR NEUROPSYCHOPHARM, V7, P201, DOI 10.1016/S0924-977X(97)00404-5; VEENINGA AT, 1990, PSYCHOPHARMACOLOGY, V102, P414, DOI 10.1007/BF02244113; Wikander I, 1998, J CLIN PSYCHOPHARM, V18, P390, DOI 10.1097/00004714-199810000-00007; WOOD SH, 1992, OBSTET GYNECOL, V80, P339; WYATT KM, 1999, CLIN EVIDENCE, P286; Yonkers KA, 1996, J CLIN PSYCHOPHARM, V16, P3, DOI 10.1097/00004714-199602000-00002; Yonkers KA, 1997, JAMA-J AM MED ASSOC, V278, P983, DOI 10.1001/jama.278.12.983; Yonkers KA, 1996, PSYCHOPHARMACOL BULL, V32, P41; Young SA, 1998, J CLIN PSYCHIAT, V59, P76, DOI 10.4088/JCP.v59n0206	42	217	232	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2000	356	9236					1131	1136		10.1016/S0140-6736(00)02754-9	http://dx.doi.org/10.1016/S0140-6736(00)02754-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	359CQ	11030291				2022-12-28	WOS:000089594300009
J	Jacobsen, R; Bostofte, E; Engholm, G; Hansen, J; Olsen, JH; Skakkebaek, NE; Moller, H				Jacobsen, R; Bostofte, E; Engholm, G; Hansen, J; Olsen, JH; Skakkebaek, NE; Moller, H			Risk of testicular cancer in men with abnormal semen characteristics: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GERM-CELL TUMORS; EUROPEAN COUNTRIES; CARCINOMA-INSITU; TESTIS CANCER; FERTILITY; ETIOLOGY	Objective To explore the associations between semen characteristics and subsequent risk of testicular cancer. Design Cohort study Participants 32 442 men who had a semen analysis done at the Sperm Analysis Laboratory in Copenhagen during 1963-95. Main outcome measure Standardised incidence ratios of testicular cancer compared with total population of Danish men. Results Men in couples with fertility problems were more likely to develop testicular cancer than other men (89 cases, standardised incidence ratio 1.6; 95% confidence interval 1.3 to 1.9). The risk was relatively constant with increasing time between semen analysis and cancer diagnosis. Analysis according to specific semen characteristics showed that low semen concentration (standardised incidence ratio 2.3), poor motility of the spermatozoa (2.5), and high proportion of morphologically abnormal spermatozoa (3.0) were all associated with an increased risk of testicular cancer. The only other cancer group that showed ina eased incidence was "peritoneum and other digestive organs (six cases; 3.7, 1.3 to 8.0). Of these, two cases were probably and two cases were possibly extragonadal germ cell rumours. Conclusions The results point towards the existence of common aetiological factors for low semen quality and testicular cancer. Low semen quality may also be associated with increased incidence of extragonadal germ cell tumours.	Guys Kings & St Thomas Sch Med, Thames Canc Registry, London SE1 3QD, England; Natl Univ Hosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark; Hlth Serv Phys Org, Sperm Anal, DK-1112 Copenhagen, Denmark; Danish Natl Res Fdn, Ctr Res Hlth & Social Stat, DK-2100 Copenhagen, Denmark	University of London; King's College London; Danish Cancer Society; Danmarks Grundforskningsfond	Jacobsen, R (corresponding author), Univ Copenhagen, Panum Inst, Fac Hlth Sci, Inst Publ Hlth,Dept Epidemiol, DK-2200 Copenhagen, Denmark.	RJacobsen@pubhealth.ku.dk	Lindahl-Jacobsen, Rune/J-2985-2012	Lindahl-Jacobsen, Rune/0000-0002-4622-9826; Moller, Henrik/0000-0001-8200-5929; Olsen, Jorgen Helge/0000-0001-9633-5662				ADAMI HO, 1994, INT J CANCER, V59, P33, DOI 10.1002/ijc.2910590108; Bergstrom R, 1996, J NATL CANCER I, V88, P727, DOI 10.1093/jnci/88.11.727; BERTHELSEN JG, 1983, FERTIL STERIL, V39, P68; BOSTOFTE E, 1984, FERTIL STERIL, V41, P95; BOSTOFTE E, 1990, FERTIL STERIL, V54, P1100; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; CARROLL PR, 1987, J UROLOGY, V137, P420, DOI 10.1016/S0022-5347(17)44054-7; COLEMAN M, 1986, INT J EPIDEMIOL, V15, P134, DOI 10.1093/ije/15.1.134; COLEMAN MP, 1993, IARC SCI PUBLICATION, V121; DAUGAARD G, 1987, LANCET, V2, P528; DAUGAARD G, 1992, ANN ONCOL, V3, P283, DOI 10.1093/oxfordjournals.annonc.a058180; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; FORMAN D, 1994, CANCER SURV, V20, P323; HENDERSON BE, 1979, INT J CANCER, V23, P598, DOI 10.1002/ijc.2910230503; Jacobsen R, 2000, HUM REPROD, V15, P1958, DOI 10.1093/humrep/15.9.1958; James WH, 1997, HUM REPROD, V12, P417; Moller H, 1999, BMJ-BRIT MED J, V318, P559, DOI 10.1136/bmj.318.7183.559; Moller H, 1996, CANCER CAUSE CONTROL, V7, P264, DOI 10.1007/BF00051302; MOLLER H, 1993, EUR UROL, V23, P8; Moller H, 1997, CANCER CAUSE CONTROL, V8, P904, DOI 10.1023/A:1018472530653; Moller H, 1998, APMIS, V106, P232, DOI 10.1111/j.1699-0463.1998.tb01341.x; NIJMAN JM, 1985, ARCH ANDROLOGY, V14, P239, DOI 10.3109/01485018508988306; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x; Storm H H, 1991, IARC Sci Publ, P220; Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228; SWERDLOW AJ, 1989, INT J CANCER, V43, P549, DOI 10.1002/ijc.2910430403; Wanderas EH, 1998, CANCER CAUSE CONTROL, V9, P475, DOI 10.1023/A:1008857702380; World Health Organization, 1999, WHO LAB MAN EX HUM S	29	258	264	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2000	321	7264					789	792		10.1136/bmj.321.7264.789	http://dx.doi.org/10.1136/bmj.321.7264.789			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360ZE	11009515	Green Published, Bronze			2022-12-28	WOS:000089696600020
J	Lane, BF; Kuchner, MJ; Boden, AF; Creech-Eakman, M; Kulkarni, SR				Lane, BF; Kuchner, MJ; Boden, AF; Creech-Eakman, M; Kulkarni, SR			Direct detection of pulsations of the Cepheid star xi Gem and an independent calibration of the period-luminosity relation	NATURE			English	Article							PALOMAR TESTBED INTERFEROMETER; DISTANCES; VARIABLES; RADII	Cepheids are a class of variable (pulsating) stars whose absolute luminosities are related in a simple manner to their pulsational periods. By measuring the period and using the `period-luminosity' relationship, astronomers can use the observed visual brightness to determine the distance to the star. Because these stars are very luminous, they can be observed in other galaxies, and therefore can be used to help determine the expansion rate of the Universe(1) (the Hubble constant). Calibration of the period-luminosity relation is a necessary first step, but the small number of sufficiently nearby Cepheids has forced the use of a number of indirect means, with associated systematic uncertainties. Here we present a distance to the Cepheid zeta Geminorum, determined using a direct measurement (by an optical interferometer) of its changes in diameter as it pulsates. Within our uncertainty of 15 per cent, our distance is in agreement with previous indirect determinations. Planned improvements to the instrument will allow us to calibrate directly the period-luminosity relation to better than a few per cent.	CALTECH, Palomar Observ 105 24, Pasadena, CA 91125 USA; CALTECH, Ctr Infrared Proc & Anal, Pasadena, CA 91125 USA; CALTECH, Jet Prop Lab 171 113, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Lane, BF (corresponding author), CALTECH, Palomar Observ 105 24, Pasadena, CA 91125 USA.	bfl@astro.caltech.edu	Kuchner, Marc/E-2288-2012	Lane, Benjamin/0000-0002-8006-0243				BERSIER D, 1994, ASTRON ASTROPHYS SUP, V108, P25; Boden AF, 1998, ASTROPHYS J, V504, pL39, DOI 10.1086/311560; Claret A, 1995, ASTRON ASTROPHYS SUP, V114, P247; Cohen M, 1999, ASTRON J, V117, P1864, DOI 10.1086/300813; Colavita MM, 1999, ASTROPHYS J, V510, P505, DOI 10.1086/306579; Colavita MM, 1999, PUBL ASTRON SOC PAC, V111, P111, DOI 10.1086/316302; GIEREN WP, 1989, ASTROPHYS J, V342, P467, DOI 10.1086/167606; GIEREN WP, 1993, ASTROPHYS J, V418, P135, DOI 10.1086/173377; HINDSLEY R, 1986, PUBL ASTRON SOC PAC, V98, P881, DOI 10.1086/131839; Kervella P, 1999, ASTR SOC P, V194, P22; Krockenberger M, 1997, ASTROPHYS J, V479, P875, DOI 10.1086/303892; LANEY CD, 1995, MON NOT R ASTRON SOC, V274, P337, DOI 10.1093/mnras/274.2.337; McAlister HA, 1998, P SOC PHOTO-OPT INS, V3350, P947, DOI 10.1117/12.317162; Mould JR, 2000, ASTROPHYS J, V529, P786, DOI 10.1086/308304; Mourard D, 1997, ASTRON ASTROPHYS, V317, P789; NORDGREN T, IN PRESS ASTROPHYSIC; Perryman MAC, 1997, ASTRON ASTROPHYS, V323, pL49; RIDGWAY ST, 1982, ASTRON J, V87, P680, DOI 10.1086/113144; SZABADOS L, 1991, KONKOLY OBSERVATORY, V96, P123; Tanvir NR, 1999, ASTROPHYS SPACE SC L, V237, P17; WELCH DL, 1994, ASTRON J, V108, P1421, DOI 10.1086/117164; WESSELINK AJ, 1969, MON NOT R ASTRON SOC, V144, P297, DOI 10.1093/mnras/144.3.297	22	51	51	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					485	487		10.1038/35035015	http://dx.doi.org/10.1038/35035015			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11028993				2022-12-28	WOS:000089727400041
J	Holmes, SB; Carter, JLB; Metefa, A				Holmes, SB; Carter, JLB; Metefa, A			Lesson of the week - Blunt orbital trauma	BRITISH MEDICAL JOURNAL			English	Review							BLOW-OUT FRACTURES; FLOOR; RADIOGRAPHY; MANAGEMENT	Orbital trauma is common and patients present to a variety of healthcare professionals depending on the type of injury. Clinical examination may reveal gross problems such as diplopia and enophthalmos, which may require radiological confirmation. Most orbital injuries are minor and are managed conservatively. The consequences of an overlooked injury can have profound consequences, with persistent enophthalmos, diplopia, and orbital sepsis representing major morbidity when diagnosis and treatment are delayed.(1) The incidence of isolated blow out fractures of the orbit is unknown. We identified 10 patients with such fractures from 170 patients with bony orbital injuries referred to our department over 20 months. We describe one of those patients.	Royal London Hosp, Dept Oral & Maxillofacial Surg, London E1 1BB, England; Royal London Hosp, Dept Radiol, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Royal London Hospital	Holmes, SB (corresponding author), Royal London Hosp, Dept Oral & Maxillofacial Surg, London E1 1BB, England.			Holmes, Simon/0000-0003-4296-8629				Bhattacharya J, 1997, BRIT J RADIOL, V70, P29, DOI 10.1259/bjr.70.829.9059291; Cope MR, 1999, BRIT J ORAL MAX SURG, V37, P46, DOI 10.1054/bjom.1998.0382; DUTTON JJ, 1991, SURV OPHTHALMOL, V35, P279; HACKNEY DB, 1991, RADIOLOGY, V181, P711, DOI 10.1148/radiology.181.3.1947086; Jenkins CNJ, 1997, CLIN RADIOL, V52, P708, DOI 10.1016/S0009-9260(97)80037-2; KORNEEF L, 1982, ANN PLAST SURG, V9, P185; Millman A L, 1987, Adv Ophthalmic Plast Reconstr Surg, V6, P291; Ng P, 1996, Australas Radiol, V40, P264, DOI 10.1111/j.1440-1673.1996.tb00400.x; Shuttleworth GN, 1999, BMJ-BRIT MED J, V318, P1054, DOI 10.1136/bmj.318.7190.1054; SMITH B, 1957, Am J Ophthalmol, V44, P733	10	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					750	751		10.1136/bmj.321.7263.750	http://dx.doi.org/10.1136/bmj.321.7263.750			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999912	Green Published			2022-12-28	WOS:000089546600031
J	Kormendy, J				Kormendy, J			Astronomy - Galactic rotation in real time	NATURE			English	Editorial Material							SAGITTARIUS-A-ASTERISK; BLACK-HOLE; GALAXY; NUCLEI		Univ Texas, Dept Astron, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Kormendy, J (corresponding author), Univ Texas, Dept Astron, RLM 15308, Austin, TX 78712 USA.							Blandford R.D., 1990, ACTIVE GALACTIC NUCL, P161; Eckart A, 1997, MON NOT R ASTRON SOC, V284, P576, DOI 10.1093/mnras/284.3.576; Genzel R, 1997, MON NOT R ASTRON SOC, V291, P219, DOI 10.1093/mnras/291.1.219; Ghez AM, 2000, NATURE, V407, P349, DOI 10.1038/35030032; Ghez AM, 1998, ASTROPHYS J, V509, P678, DOI 10.1086/306528; Lo KY, 1998, ASTROPHYS J, V508, pL61, DOI 10.1086/311726; Maoz E, 1998, ASTROPHYS J, V494, pL181, DOI 10.1086/311194; Munyaneza F, 1999, ASTROPHYS J, V526, P744, DOI 10.1086/308026; Narayan R., 1998, THEORY BLACK HOLE AC, P148; REES MJ, 1984, ANNU REV ASTRON ASTR, V22, P471, DOI 10.1146/annurev.aa.22.090184.002351; Tsiklauri D, 1998, ASTROPHYS J, V500, P591, DOI 10.1086/305753	11	2	2	1	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					307	309		10.1038/35030274	http://dx.doi.org/10.1038/35030274			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014171				2022-12-28	WOS:000089390700025
J	Wimberly, BT; Brodersen, DE; Clemons, WM; Morgan-Warren, RJ; Carter, AP; Vonrhein, C; Hartsch, T; Ramakrishnan, V				Wimberly, BT; Brodersen, DE; Clemons, WM; Morgan-Warren, RJ; Carter, AP; Vonrhein, C; Hartsch, T; Ramakrishnan, V			Structure of the 30S ribosomal subunit	NATURE			English	Article							THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; BINDING MOTIF; PROTEIN S15; RNA; REVEALS; MODEL; S4	Genetic information encoded in messenger RNA is translated into protein by the ribosome, which is a large nucleoprotein complex comprising two subunits, denoted 30S and 50S in bacteria. Here we report the crystal structure of the 30S subunit from Thermus thermophilus, refined to 3 Angstrom resolution. The final atomic model rationalizes over four decades of biochemical data on the ribosome, and provides a wealth of information about RNA and protein structure, protein-RNA interactions and ribosome assembly. It is also a structural basis for analysis of the functions of the 30S subunit, such as decoding, and for understanding the action of antibiotics. The structure will facilitate the interpretation in molecular terms of lower resolution structural data on several functional states of the ribosome from electron microscopy and crystallography.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA; Global Phasing Ltd, Cambridge CB3 0AX, England; Univ Gottingen, Inst Mikrobiol & Genet, Gottingen Genom Lab, D-37077 Gottingen, Germany	MRC Laboratory Molecular Biology; Utah System of Higher Education; University of Utah; Global Phasing Limited; University of Gottingen	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Clemons, William M/D-1026-2009; Brodersen, Ditlev E./AAQ-5241-2020	Clemons, William M/0000-0002-0021-889X; Ramakrishnan, V/0000-0002-4699-2194; Carter, Andrew/0000-0001-7292-5430; Brodersen, Ditlev/0000-0002-5413-4667	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM019384] Funding Source: NIH RePORTER; NIGMS NIH HHS [F31 GM019384] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1997, ACTA CRYSTALLOGR D, V53, P371, DOI 10.1107/S0907444996015272; Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Allard P, 2000, STRUCT FOLD DES, V8, P875, DOI 10.1016/S0969-2126(00)00177-5; Berglund H, 1997, NAT STRUCT BIOL, V4, P20, DOI 10.1038/nsb0197-20; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPEL MS, 1987, SCIENCE, V238, P1403, DOI 10.1126/science.3317832; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CHOLI T, 1993, BIOL CHEM H-S, V374, P377, DOI 10.1515/bchm3.1993.374.1-6.377; Clemons WM, 1998, STRUCT FOLD DES, V6, P429, DOI 10.1016/S0969-2126(98)00045-8; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Davies C, 1998, EMBO J, V17, P4545, DOI 10.1093/emboj/17.16.4545; Davies C, 1996, STRUCTURE, V4, P1093, DOI 10.1016/S0969-2126(96)00115-3; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 1999, J MOL BIOL, V286, P1285, DOI 10.1006/jmbi.1999.2538; Garrett R. A., 2000, RIBOSOME STRUCTURE F; GLOTZ C, 1987, BIOCHEM INT, V15, P953; GOLDEN BL, 1993, BIOCHEMISTRY-US, V32, P12812, DOI 10.1021/bi00210a033; GUTELL RR, 1996, RIBOSOMAL RNA STRUCT, P111; HARTMANN RK, 1989, J BACTERIOL, V171, P2933, DOI 10.1128/jb.171.6.2933-2941.1989; HELD WA, 1974, J BIOL CHEM, V249, P3103; Helgstrand M, 1999, J MOL BIOL, V292, P1071, DOI 10.1006/jmbi.1999.3122; Hosaka H, 1997, STRUCTURE, V5, P1199, DOI 10.1016/S0969-2126(97)00270-0; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; MALHOTRA A, 1994, J MOL BIOL, V240, P308, DOI 10.1006/jmbi.1994.1448; Markus MA, 1998, EMBO J, V17, P4559, DOI 10.1093/emboj/17.16.4559; Mueller F, 1997, J MOL BIOL, V271, P524, DOI 10.1006/jmbi.1997.1210; Mueller F, 1997, J MOL BIOL, V271, P545, DOI 10.1006/jmbi.1997.1211; Nevskaya N, 1998, J MOL BIOL, V279, P233, DOI 10.1006/jmbi.1998.1758; Nikulin A, 2000, NAT STRUCT BIOL, V7, P273; NOWOTNY V, 1988, BIOCHEMISTRY-US, V27, P7051, DOI 10.1021/bi00418a057; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POWERS SE, 1994, J CONTAM HYDROL, V16, P1, DOI 10.1016/0169-7722(94)90070-1; RAMAKRISHNAN V, 1986, SCIENCE, V231, P1562, DOI 10.1126/science.3513310; RAMAKRISHNAN V, 1992, NATURE, V358, P768, DOI 10.1038/358768a0; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; STERN S, 1988, J MOL BIOL, V204, P447, DOI 10.1016/0022-2836(88)90588-8; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tocilj A, 1999, P NATL ACAD SCI USA, V96, P14252, DOI 10.1073/pnas.96.25.14252; TRAKHANOV SD, 1987, FEBS LETT, V220, P319, DOI 10.1016/0014-5793(87)80838-4; VONBOHLEN K, 1991, J MOL BIOL, V222, P11, DOI 10.1016/0022-2836(91)90730-T; WIMBERLY B, 1993, BIOCHEMISTRY-US, V32, P1078, DOI 10.1021/bi00055a013; Wimberly BT, 1997, STRUCTURE, V5, P1187, DOI 10.1016/S0969-2126(97)00269-4; YONATH A, 1988, J MOL BIOL, V203, P831, DOI 10.1016/0022-2836(88)90216-1; Yonath A, 1998, ACTA CRYSTALLOGR A, V54, P945, DOI 10.1107/S010876739800991X; YUSUPOV MM, 1988, FEBS LETT, V238, P113, DOI 10.1016/0014-5793(88)80237-0	50	1629	1707	7	166	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					327	339		10.1038/35030006	http://dx.doi.org/10.1038/35030006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014182				2022-12-28	WOS:000089390700036
J	Yaalon, DH				Yaalon, DH			Down to earth - Why soil-and soil science-matters.	NATURE			English	Editorial Material									Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Yaalon, DH (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, Givat Ram Campus, IL-91904 Jerusalem, Israel.								0	13	14	1	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					301	301		10.1038/35030260	http://dx.doi.org/10.1038/35030260			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014167	Bronze			2022-12-28	WOS:000089390700021
J	Cash, W; Shipley, A; Osterman, S; Joy, M				Cash, W; Shipley, A; Osterman, S; Joy, M			Laboratory detection of X-ray fringes with a grazing-incidence interferometer	NATURE			English	Article								Starting with Galileo's observations of the Solar System, improvements of an order of magnitude in either the sensitivity or resolution of astronomical instruments have always brought revolutionary discoveries. The X-ray band of the spectrum, where exotic objects can have extremely high surface brightness(1), is ideally suited for significant improvements in imaging, but progress has been impeded by a lack of optics of sufficiently high sensitivity and quality. Here we present an X-ray interferometer design that is practical for adaptation to astronomical observatories. Our prototype interferometer, having just under one millimetre of baseline, creates fringes at 1.25 keV with an angular resolution of 100 milliarcseconds. With a larger version in orbit it will be possible to resolve X-ray sources at 10(-7) arcseconds, three orders of magnitude better than the finest-resolution images ever achieved on the sky (in the radio part of the spectrum) and over one million times better than the current best X-ray images. With such resolutions, we can study the environments of pulsars, resolve and then model relativistic blast waves, image material falling into a black hole, watch the physical formation of astrophysical jets, and study the dynamos of stellar coronae.	Univ Colorado, Boulder, CO 80309 USA; NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA	University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center	Cash, W (corresponding author), Univ Colorado, Boulder, CO 80309 USA.							[Anonymous], 1932, TWT, P5; Baldwin JE, 1996, ASTRON ASTROPHYS, V306, pL13; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Born M., 1999, PRINCIPLES OPTICS, P292; FRANKS A, 1979, Patent No. 4174478; HOLT SS, 1982, ANNU REV ASTRON ASTR, V20, P323, DOI 10.1146/annurev.aa.20.090182.001543; McKee CF, 2000, ASTRONOMY ASTROPHYSI, V352, P353; POLACK F, 1995, REV SCI INSTRUM, V66, P2180, DOI 10.1063/1.1145698; Siarkowski M, 1996, ASTROPHYS J, V473, P470, DOI 10.1086/178159; Weisskopf MC, 1996, PROC SPIE, V2805, P2, DOI 10.1117/12.245079	10	90	92	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2000	407	6801					160	162		10.1038/35025009	http://dx.doi.org/10.1038/35025009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001047				2022-12-28	WOS:000089241000039
J	Hirschberg, JHKK; Brunsveld, L; Ramzi, A; Vekemans, JAJM; Sijbesma, RP; Meijer, EW				Hirschberg, JHKK; Brunsveld, L; Ramzi, A; Vekemans, JAJM; Sijbesma, RP; Meijer, EW			Helical self-assembled polymers from cooperative stacking of hydrogen-bonded pairs	NATURE			English	Article								The double helix of DNA epitomizes this molecule's ability to self-assemble in aqueous solutions into a complex chiral structure using hydrogen bonding and hydrophobic interactions. Noncovalently interacting molecules in organic solvents are used to design systems that similarly form controlled architectures(1-7). Peripheral chiral centres in assemblies(8,9) and chiral side chains attached to a polymer backbone(10,11) have been shown to induce chirality at the supramolecular level, and highly ordered structures stable in water are also known(12-15). However, it remains difficult to rationally exploit non-covalent interactions for the formation of chiral assemblies that are stable in water, where solvent molecules can compete effectively for hydrogen bonds. Here we describe a general strategy for the design of functionalized monomer units and their association in either water or alkanes into non-covalently linked polymeric structures with controlled helicity and chain length. The monomers consist of bifunctionalized ureidotriazine units connected by a spacer and carrying solubilizing chains at the periphery. This design allows for dimerization through self-complementary quadruple hydrogen bonding between the units and solvophobically induced stacking of the dimers into columnar polymeric architectures, whose structure and helicity can be adjusted by tuning the nature of the solubilizing side chains.	Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands; Eindhoven Univ Technol, Dutch Polymer Inst, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Dutch Polymer Institute; Eindhoven University of Technology	Meijer, EW (corresponding author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.	E.W.Meijer@tue.nl	Sijbesma, Rintje Pieter P/D-3551-2012; Meijer, E.W./K-7632-2013	Sijbesma, Rintje Pieter P/0000-0002-8975-636X; Meijer, E.W./0000-0003-4126-7492; Brunsveld, Luc/0000-0001-5675-511X				Appella DH, 1999, J AM CHEM SOC, V121, P2309, DOI 10.1021/ja983918n; Beijer FH, 1998, ANGEW CHEM INT EDIT, V37, P75, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<75::AID-ANIE75>3.0.CO;2-R; BLOKZIJL W, 1993, ANGEW CHEM INT EDIT, V32, P1545, DOI 10.1002/anie.199315451; Castellano RK, 1997, P NATL ACAD SCI USA, V94, P7132, DOI 10.1073/pnas.94.14.7132; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Gottarelli G, 1996, HELV CHIM ACTA, V79, P220, DOI 10.1002/hlca.19960790123; GREEN MM, 1995, SCIENCE, V268, P1860, DOI 10.1126/science.268.5219.1860; KRZYWICKI TG, 1993, P NATL ACAD SCI USA, V90, P163; KUNITAKE T, 1992, ANGEW CHEM INT EDIT, V31, P709, DOI 10.1002/anie.199207091; Lydon J, 1998, CURR OPIN COLLOID IN, V3, P458, DOI 10.1016/S1359-0294(98)80019-8; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Palmans ARA, 1997, ANGEW CHEM INT EDIT, V36, P2648, DOI 10.1002/anie.199726481; Prince RB, 2000, ANGEW CHEM INT EDIT, V39, P228, DOI 10.1002/(SICI)1521-3773(20000103)39:1<228::AID-ANIE228>3.0.CO;2-B; Prins LJ, 1999, NATURE, V398, P498, DOI 10.1038/19053; Seebach D, 1996, HELV CHIM ACTA, V79, P913, DOI 10.1002/hlca.19960790402; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191	17	598	611	8	399	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					167	170		10.1038/35025027	http://dx.doi.org/10.1038/35025027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001050				2022-12-28	WOS:000089241000042
J	Nguyen-Tran, VTB; Kubalak, SW; Minamisawa, S; Fiset, C; Wollert, KC; Brown, AB; Ruiz-Lozano, P; Barrere-Lemaire, S; Kondo, R; Norman, LW; Gourdie, RG; Rahme, MM; Feld, GK; Clark, RB; Giles, WR; Chien, KR				Nguyen-Tran, VTB; Kubalak, SW; Minamisawa, S; Fiset, C; Wollert, KC; Brown, AB; Ruiz-Lozano, P; Barrere-Lemaire, S; Kondo, R; Norman, LW; Gourdie, RG; Rahme, MM; Feld, GK; Clark, RB; Giles, WR; Chien, KR			A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages	CELL			English	Article							LONG-QT SYNDROME; HEART-FAILURE; POTASSIUM CHANNEL; OUTWARD CURRENT; ALPHA-SUBUNIT; MICE; CONNEXIN40; MUSCLE; EXPRESSION; MYOCYTES	HF-1b, an SP1-related transcription factor, is preferentially expressed in the cardiac conduction system and ventricular myocytes in the heart. Mice deficient for HF-1b survive to term and exhibit normal cardiac structure and function but display sudden cardiac death and a complete penetrance of conduction system defects, including spontaneous ventricular tachycardia and a high incidence of AV block. Continuous electrocardiographic recordings clearly documented cardiac arrhythmogenesis as the cause of death. Single-cell analysis revealed an anatomic substrate for arrhythmogenesis, including a decrease and mislocalization of connexins and a marked increase in action potential heterogeneity. Two independent markers reveal defects in the formation of ventricular Purkinje fibers. These studies identify a novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages.	Univ Calif San Diego, Salk Program Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; Univ Calgary, Calgary, AB T2N 4N1, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Medical University of South Carolina; University of Calgary	Chien, KR (corresponding author), Univ Calif San Diego, Salk Program Mol Med, La Jolla, CA 92093 USA.	kchein@ucsd.edu		Fiset, Celine/0000-0003-2309-4823; Nguyen-Tran, Van/0000-0001-5678-1908; Barrere-Lemaire, Stephanie/0000-0002-3742-6975; Minamisawa, Susumu/0000-0003-4728-2116				Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Angst BD, 1997, CIRC RES, V80, P88, DOI 10.1161/01.RES.80.1.88; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Charpentier F, 1998, BIOCHEM BIOPH RES CO, V251, P806, DOI 10.1006/bbrc.1998.9554; Chen J, 1998, DEVELOPMENT, V125, P1943; Cheng G, 1999, DEVELOPMENT, V126, P5041; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; CHIEN KR, 2000, IN PRESS NATURE, V406; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; CURRAN ME, 1999, MOL BASIS CARDIOVASC, P302; DELORME B, 1995, DEV DYNAM, V204, P358, DOI 10.1002/aja.1002040403; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Folco E, 1997, J BIOL CHEM, V272, P26505, DOI 10.1074/jbc.272.42.26505; Gourdie RG, 1999, TRENDS CARDIOVAS MED, V9, P18, DOI 10.1016/S1050-1738(98)00035-8; GOURDIE RG, 1993, J CELL SCI, V105, P985; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Jalife J, 1999, TRENDS CARDIOVAS MED, V9, P119, DOI 10.1016/S1050-1738(99)00019-5; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; KUBALAK SW, 1996, METH MOL G, V8, P470; Kupershmidt S, 1999, CIRC RES, V84, P146, DOI 10.1161/01.RES.84.2.146; Litchenberg WH, 2000, CARDIOVASC RES, V45, P379, DOI 10.1016/S0008-6363(99)00363-6; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; MARBAN E, 1999, MOL BASIS CARDIOVASC; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Roden DM, 1999, J CARDIOVASC ELECTR, V10, P1664, DOI 10.1111/j.1540-8167.1999.tb00231.x; Ross RS, 1996, DEVELOPMENT, V122, P1799; Ruiz-Lozano P, 1998, DEVELOPMENT, V125, P533; Simon AM, 1998, CURR BIOL, V8, P295, DOI 10.1016/S0960-9822(98)70113-7; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; van der Velden HMW, 1998, J CARDIOVASC ELECTR, V9, P596; Ward CA, 1997, J PHYSIOL-LONDON, V500, P631, DOI 10.1113/jphysiol.1997.sp022048; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623; Zhou J, 1998, CIRC RES, V83, P806, DOI 10.1161/01.RES.83.8.806; ZHU H, 1993, MOL CELL BIOL, V13, P4432, DOI 10.1128/MCB.13.7.4432; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	38	103	111	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					671	682		10.1016/S0092-8674(00)00089-1	http://dx.doi.org/10.1016/S0092-8674(00)00089-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007485	Bronze			2022-12-28	WOS:000089105200015
J	Glogowska, M; Roulstone, S; Enderby, P; Peters, TJ				Glogowska, M; Roulstone, S; Enderby, P; Peters, TJ			Randomised controlled trial of community based speech and language therapy in preschool children	BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; YOUNG-CHILDREN; INTERVENTION; TODDLERS; SKILLS	Objective To compare routine speech and language therapy in preschool children with delayed speech and language against 12 months of "watchful waiting. Design Pragmatic randomised controlled trial. Setting 16 community clinics in Bristol. Participants 159 preschool children with appreciable speech or language difficulties who fulfilled criteria for admission to speech and language therapy. Main outcome measures Four quantitative measures of speech and language, assessed at 6 and 12 months; a binary variable indicating improvement by 12 months, on the trial entry criterion. Results Improvement in auditory comprehension was significant in favour of therapy (adjusted difference in means 4.1, 95% confidence interval 0.5 to 7.6; P = 0.025). No significant differences were observed for expressive language (1.4, - 2.1 to 4.8; P = 0.44); phonology error rate (- 4.4, - 12.0 to 3.3; P = 0.26); language development (0.1, - 0.4 to 0.6; P = 0.73); or improvement on entry criterion (odds ratio 1.3, 0.67 to 2.4; P = 0.46). At the end of the trial, 70% of all children still had substantial speech and language deficits. Conclusions This study provides little evidence for the effectiveness of speech and language therapy compared with watchful waiting over 12 months. Providers of speech and language therapy should reconsider the appropriateness, timing, nature, and intensity of such therapy in preschool children. Continued research into more specific provision to subgroups of children is also needed to identify better treatment methods. The lack of resolution of difficulties for most of the children suggests that further research is needed to identify effective ways of helping this population of children.	Frenchay Hosp, Speech & Language Therapy Res Unit, Bristol BS16 1LE, Avon, England; Univ Sheffield, No Gen Hosp, Sch Hlth & Related Studies, Ctr Ageing & Rehabil Studies, Sheffield S5 7AU, S Yorkshire, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	Northern General Hospital; University of Sheffield; University of Bristol	Roulstone, S (corresponding author), Frenchay Hosp, Speech & Language Therapy Res Unit, Bristol BS16 1LE, Avon, England.			Peters, Tim/0000-0003-2881-4180; Enderby, Pamela/0000-0002-4371-9053				Almost D, 1998, DEV MED CHILD NEUROL, V40, P319; COOPER J, 1978, HELPING LANGUAGE DEV; Enderby P., 2009, THERAPY OUTCOME MEAS; ENDERBY PM, 1997, THRAPY OUTCOME MEASU; FELSENFELD S, 1992, J SPEECH HEAR RES, V35, P1114, DOI 10.1044/jshr.3505.1114; FEY ME, 1993, J SPEECH HEAR RES, V36, P141, DOI 10.1044/jshr.3601.141; GIBBARD D, 1994, EUR J DISORDER COMM, V29, P131; GLOGOWSKA M, 1999, THESIS U BRISTOL BRI; GLOGOWSKA M, IN PRESS INT J LANG; Gutfreund M., 1989, BRISTOL LANGUAGE DEV; HALL DMB, 1996, HLTH ALL CHILDREN RE; Johnson CJ, 1999, J SPEECH LANG HEAR R, V42, P744, DOI 10.1044/jslhr.4203.744; Law J, 1998, Health Technol Assess, V2, P1; LAW J, 1992, EARLY IDENTIFICATION; McConkey R, 1979, Spec Educ Forward Trends, V6, P13; PADEN EP, 1987, J SPEECH HEAR DISORD, V52, P232, DOI 10.1044/jshd.5203.232; PAUL R, 1991, J SPEECH HEAR RES, V34, P858, DOI 10.1044/jshr.3404.858; RESCORLA L, 1990, APPL PSYCHOLINGUIST, V11, P393, DOI 10.1017/S0142716400009644; Robertson SB, 1999, J SPEECH LANG HEAR R, V42, P1234, DOI 10.1044/jslhr.4205.1234; Roulstone S, 1999, CHILD CARE HLTH DEV, V25, P141, DOI 10.1046/j.1365-2214.1999.25220119.x; Sparrow S.S., 2005, VINELAND 2 ADAPTIVE; Steiner V. G., 1992, PRESCHOOL LANGUAGE S; Stothard SE, 1998, J SPEECH LANG HEAR R, V41, P407, DOI 10.1044/jslhr.4102.407	23	91	91	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					923	926		10.1136/bmj.321.7266.923	http://dx.doi.org/10.1136/bmj.321.7266.923			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	365XE	11030677	Green Published, Bronze			2022-12-28	WOS:000089975100019
J	Jones, M				Jones, M			Walk-in primary medical care centres: lessons from Canada	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FAMILY-PRACTICE PATIENTS; CLINICS; EMERGENCY		UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, London NW3 2PF, England	University of London; University College London	Jones, M (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, Royal Free Campus, London NW3 2PF, England.	melvyn.jones@ucl.ac.uk	Jones, Melvyn/C-2300-2008	Jones, Melvyn/0000-0002-8766-7443				BELL NR, 1992, CAN FAM PHYSICIAN, V38, P507; Borkenhagen RH, 1996, CAN FAM PHYSICIAN, V42, P1879; BURA, 1988, CMAJ, V139, P63; BURAK AJ, 1994, BC COLL FAM PHYSICIA, P5; Burnett MG, 1996, CAN MED ASSOC J, V154, P1345; *DEP HLTH, 1999, 199916 HSC DEP HLTH; FELDMAN W, 1984, CAN MED ASSOC J, V130, P1003; Grad R, 1998, CAN FAM PHYSICIAN, V44, P2666; MAKIN M, 1993, BC MED J, V35, P151; MILLER GB, 1989, CAN FAM PHYSICIAN, V35, P2013; MILLER GB, 1989, CAN FAM PHYSICIAN, V35, P2019; MILNE M, 1987, CAN MED ASSOC J, V137, P532; MILNE P, 1987, CMAJ, V136, P354; RACHLIS V, 1993, CAN FAM PHYSICIAN, V39, P266; RIZOS J, 1991, CAN MED ASSOC J, V144, P631; RIZOS J, 1999, CMAJ, V143, P745; ROWLANDS J, 1988, ONTARIO MED REV, V55, P10; SHAH CP, 1994, PUBLIC HLTH PREVENTI; Szafran O, 2000, CAN FAM PHYSICIAN, V46, P114; TOWES B, 1992, BR COLUMBIA MED J, V34, P202; WEINKAUF DJ, 1968, CAN PUBLIC POL, V24, P471; Wilkie P, 1999, BRIT J GEN PRACT, V49, P1017; WISHART D, 1987, CAN MED ASSOC J, V137, P535	23	29	29	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2000	321	7266					928	931		10.1136/bmj.321.7266.928	http://dx.doi.org/10.1136/bmj.321.7266.928			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030681	Bronze, Green Published			2022-12-28	WOS:000089975100022
J	Kraynov, VS; Chamberlain, C; Bokoch, GM; Schwartz, MA; Slabaugh, S; Hahn, KM				Kraynov, VS; Chamberlain, C; Bokoch, GM; Schwartz, MA; Slabaugh, S; Hahn, KM			Localized Rac activation dynamics visualized in living cells	SCIENCE			English	Article							GTP-BINDING-PROTEIN; RHO-GTPASES; FLUORESCENCE; CDC42; EXCHANGE; KINASE	Signaling proteins are thought to be tightly regulated spatially and temporally in order to generate specific and Localized effects. For Rac and other small guanosine triphosphatases, binding to guanosine triphosphate Leads to interaction with downstream targets and regulates subcellular localization. A method called FLAIR (fluorescence activation indicator for Rho proteins) was developed to quantify the spatio-temporal dynamics of the Rad nucleotide state in Living cells. FLAIR revealed precise spatial control of growth factor-induced Rac activation, in membrane ruffles and in a gradient of activation at the leading edge of motile cells. FLAIR exemplifies a generally applicable approach for examining spatio-temporal control of protein activity.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Hahn, KM (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.			schwartz, martin/0000-0002-2071-1243; Hahn, Klaus/0000-0002-1970-7562	NIA NIH HHS [AG15430] Funding Source: Medline; NIGMS NIH HHS [GM39434, R01 GM-57464] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039434, R01GM057464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015430] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; CASTLEMAN K. R., 1996, DIGITAL IMAGE PROCES, P207; CHAMBERLAIN CE, IN PRESS METHODS ENZ; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; DEBIASIO R, 1987, J CELL BIOL, V105, P1613, DOI 10.1083/jcb.105.4.1613; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Joneson T, 1999, MOL CELL BIOL, V19, P5892; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Lakowicz J. R., 1983, PRINCIPLES FLUORESCE, P305; Leonard DA, 1997, BIOCHEMISTRY-US, V36, P1173, DOI 10.1021/bi9622837; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MENARD L, 1992, EUR J BIOCHEM, V206, P537, DOI 10.1111/j.1432-1033.1992.tb16957.x; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nomanbhoy TK, 1996, BIOCHEMISTRY-US, V35, P4602, DOI 10.1021/bi951743d; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Zhou KM, 1998, J BIOL CHEM, V273, P16782, DOI 10.1074/jbc.273.27.16782	24	540	558	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					333	337		10.1126/science.290.5490.333	http://dx.doi.org/10.1126/science.290.5490.333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11030651				2022-12-28	WOS:000089818100043
J	Fagarasan, S; Honjo, T				Fagarasan, S; Honjo, T			T-independent immune response: New aspects of B cell biology	SCIENCE			English	Editorial Material							MEMBER; MICE; PD-1	Recent results emphasize the roles of T-independent antibody response in humoral defenses, for which B1 cells and marginal zone B cells are mostly responsible. We discuss how these cells are activated, migrate, and differentiate into antibody-producing cells in various Lymphoid tissues. Based on recent findings in each of these areas of B cell biology, we propose a possible mechanism for peripheral tolerance of autoreactive B cells at target organs.	Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.		Honjo, Tasuku/N-4470-2016; Fagarasan, Sidonia/A-5258-2016	Fagarasan, Sidonia/0000-0003-2086-6402				Bos NA, 1996, INFECT IMMUN, V64, P616, DOI 10.1128/IAI.64.2.616-623.1996; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Fagarasan S, 2000, IMMUNOL REV, V176, P205; FREEMAN GJ, IN PRESS J EXP MED; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; KASAIAN MT, 1993, AUTOIMMUNITY, V15, P315, DOI 10.3109/08916939309115755; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; NISHIMURA H, UNPUB; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; OKAZAKI T, UNPUB; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Watanabe N., UNPUB; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889	28	299	311	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					89	92		10.1126/science.290.5489.89	http://dx.doi.org/10.1126/science.290.5489.89			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11021805				2022-12-28	WOS:000089724800038
J	Davidoff, F				Davidoff, F			Publication of papers on assisted suicide and terminal sedation - Response	ANNALS OF INTERNAL MEDICINE			English	Letter																		Quill TE, 2000, ANN INTERN MED, V132, P488, DOI 10.7326/0003-4819-132-6-200003210-00011; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; 2000, ANN INTERN MED, V132, P1011	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					566	566		10.7326/0003-4819-133-7-200010030-00029	http://dx.doi.org/10.7326/0003-4819-133-7-200010030-00029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360QG	11015183				2022-12-28	WOS:000089678300020
J	Kikyo, N; Wade, PA; Guschin, D; Ge, H; Wolffe, AP				Kikyo, N; Wade, PA; Guschin, D; Ge, H; Wolffe, AP			Active remodeling of somatic nuclei in egg cytoplasm by the nucleosomal ATPase ISWI	SCIENCE			English	Article							RNA-POLYMERASE-II; XENOPUS-LAEVIS; HISTONE DEACETYLASE; CHROMATIN; PROTEIN; TRANSCRIPTION; BINDING; CELLS; NUCLEOPLASMIN; EXTRACTS	Cloning by the transplantation of somatic nuclei into unfertilized eggs requires a dramatic remodeling of chromosomal architecture. Many proteins are specifically Lost from nuclei, and others are taken up from the egg cytoplasm. Recreating this exchange in vitro, we identified the chromatin-remodeling nucleosomal adenosine triphosphatase (ATPase) ISWI as a key molecule in this process. ISWI actively erases the TATA binding protein from association with the nuclear matrix. Defining the biochemistry of global nuclear remodeling may facilitate the efficiency of cloning and other dedifferentiation events that establish new stem cell lineages.	NIH, Mol Embryol Lab, Bethesda, MD 20892 USA; Sangarno BioSci, Point Richmond Tech Ctr, Richmond, CA 94804 USA	National Institutes of Health (NIH) - USA	Wolffe, AP (corresponding author), Sangarno BioSci, Point Richmond Tech Ctr, Richmond, CA 94804 USA.	awolffe@sangamo.com	Wade, Paul A/D-2374-2019; Guschin, Dmitry/U-3731-2019; Guschin, Dmitry/O-7594-2018	Wade, Paul A/0000-0002-6042-357X; Guschin, Dmitry/0000-0002-4184-0001; Guschin, Dmitry/0000-0002-4184-0001				ADAM SA, 1992, METHOD ENZYMOL, V219, P97; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Dimitrov S, 1996, EMBO J, V15, P5897, DOI 10.1002/j.1460-2075.1996.tb00976.x; Gurdon J.B., 1979, International Review of Cytology Supplement, P161; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Gurdon JB, 1999, NATURE, V402, P743, DOI 10.1038/45429; Guschin D, 2000, BIOCHEMISTRY-US, V39, P5238, DOI 10.1021/bi000421t; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kimura H, 1999, MOL CELL BIOL, V19, P5383; Li W, 1996, BIOCHEM J, V314, P631, DOI 10.1042/bj3140631; NEWMEYER DD, 1986, J CELL BIOL, V103, P2091, DOI 10.1083/jcb.103.6.2091; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; SEALY L, 1989, METHOD ENZYMOL, V170, P612; SPECTOR DL, 1997, CELLS LAB MANUAL, P105; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weitzel JM, 1997, MOL CELL BIOL, V17, P5656, DOI 10.1128/MCB.17.9.5656; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	28	185	205	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2000	289	5488					2360	2362		10.1126/science.289.5488.2360	http://dx.doi.org/10.1126/science.289.5488.2360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11009424				2022-12-28	WOS:000089593500056
J	Altshuler, D; Pollara, VJ; Cowles, CR; Van Etten, WJ; Baldwin, J; Linton, L; Lander, ES				Altshuler, D; Pollara, VJ; Cowles, CR; Van Etten, WJ; Baldwin, J; Linton, L; Lander, ES			An SNP map of the human genome generated by reduced representation shotgun sequencing	NATURE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CANDIDATE GENES; IDENTIFICATION; DIVERSITY; DISCOVERY	Most genomic variation is attributable to single nucleotide polymorphisms (SNPs), which therefore offer the highest resolution for tracking disease genes and population history(1-3). It has been proposed that a dense map of 30,000-500,000 SNPs can be used to scan the human genome for haplotypes associated with common diseases(4-6). Here we describe a simple but powerful method, called reduced representation shotgun (RRS) sequencing, for creating SNP maps. RRS re-samples specific subsets of the genome from several individuals, and compares the resulting sequences using a highly accurate SNP detection algorithm. The method can be extended by alignment to available genome sequence, increasing the yield of SNPs and providing map positions. These methods are being used by The SNP Consortium, an international collaboration of academic centres, pharmaceutical companies and a private foundation, to discover and release at least 300,000 human SNPs. We have discovered 47,172 human SNPs by RRS, and in total the Consortium has identified 148,459 SNPs. More broadly, RRS facilitates the rapid, inexpensive construction of SNP maps in biomedically and agriculturally important species. SNPs discovered by RRS also offer unique advantages for large-scale genotyping.	MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Diabet Unit, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), MIT, Whitehead Inst, Ctr Genome Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gu ZJ, 1998, HUM MUTAT, V12, P221, DOI 10.1002/(SICI)1098-1004(1998)12:4<221::AID-HUMU1>3.0.CO;2-I; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Landegren U, 1998, GENOME RES, V8, P769, DOI 10.1101/gr.8.8.769; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Li W. H, 1997, MOL EVOLUTION; LI WH, 1991, GENETICS, V129, P513; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401	22	525	579	2	96	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 28	2000	407	6803					513	516		10.1038/35035083	http://dx.doi.org/10.1038/35035083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029002				2022-12-28	WOS:000089727400050
J	Hibbett, DS; Gilbert, LB; Donoghue, MJ				Hibbett, DS; Gilbert, LB; Donoghue, MJ			Evolutionary instability of ectomycorrhizal symbioses in basidiomycetes	NATURE			English	Article							HOST SPECIFICITY; YUCCA MOTHS; FUNGI; EUCALYPTUS; PLANTS	Mycorrhizae, the symbiotic associations of plant roots and fungal hyphae, are classic examples of mutualisms. In these ecologically important associations, the fungi derive photosynthetic sugars from their plant hosts, which in turn benefit from fungus-mediated uptake of mineral nutrients. Early views on the evolution of symbioses suggested that all long-term, intimate associations tend to evolve toward mutualism. Following this principle, it has been suggested that mycorrhizal symbioses are the stable derivatives of ancestral antagonistic interactions involving plant parasitic fungi(1). Alternatively, mutualisms have been interpreted as inherently unstable reciprocal parasitisms, which can be disrupted by conflicts of interest among the partners(2-5). To determine the number of origins of mycorrhizae, and to assess their evolutionary stability, it is necessary to understand the phylogenetic relationships of the taxa involved. Here we present a broad phylogenetic analysis of mycorrhizal and free-living homobasidiomycetes (mushroom-forming fungi). Our results indicate that mycorrhizal symbionts with diverse plant hosts have evolved repeatedly from saprotrophic precursors, but also that there have been multiple reversals to a free-living condition. These findings suggest that mycorrhizae are unstable, evolutionarily dynamic associations.	Harvard Univ Herbaria, Cambridge, MA 02138 USA	Harvard University	Hibbett, DS (corresponding author), Clark Univ, Dept Biol, 950 Main St, Worcester, MA 01610 USA.	dhibbett@black.clarku.edu						ASHTON DH, 1976, AUST J BOT, V24, P723, DOI 10.1071/BT9760723; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; BRUNS TD, 1995, PLANT SOIL, V170, P63, DOI 10.1007/BF02183055; COOKE RC, 1984, ECOLOGY SAPROTROPHIC; DANIELSON RM, 1984, CAN J BOT, V62, P932, DOI 10.1139/b84-132; Fitter AH, 1996, PHILOS T R SOC B, V351, P1367, DOI 10.1098/rstb.1996.0120; HAWKSWORTH DL, 1996, DICT FUNGI; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; HIBBETT DS, MYCOTA, V7; KROPP BR, 1982, MYCOLOGIA, V74, P479, DOI 10.2307/3792970; LAMB RJ, 1974, T BRIT MYCOL SOC, V63, P295, DOI 10.1016/S0007-1536(74)80176-2; Maddison WP, 1992, MACCLADE VERSION 3 A; MALAJCZUK N, 1982, NEW PHYTOL, V91, P467, DOI 10.1111/j.1469-8137.1982.tb03325.x; MALLOCH DW, 1980, P NATL ACAD SCI-BIOL, V77, P2113, DOI 10.1073/pnas.77.4.2113; MOLINA R, 1982, FOREST SCI, V28, P423; NUHAMARA ST, 1985, P 6 N AM C MYC, P439; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; Price P.W., 1991, SYMBIOSIS SOURCE EVO, P262; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; SMITS WTM, 1994, DIPTEROCARPACEAE MYC; SWANN EC, 1993, MYCOLOGIA, V85, P923, DOI 10.2307/3760675; SWOFFORD DL, 1999, PAUP; Thompson JD., 1994, COEVOLUTIONARY PROCE; TRAPPE JM, 1962, BOT REV, V28, P538, DOI 10.1007/BF02868758; [No title captured]; [No title captured]	29	290	309	1	116	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 28	2000	407	6803					506	508		10.1038/35035065	http://dx.doi.org/10.1038/35035065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361MT	11029000				2022-12-28	WOS:000089727400048
J	Mathias, CJ				Mathias, CJ			A 21st century water cure	LANCET			English	Editorial Material							POSTURAL HYPOTENSION; AUTONOMIC FAILURE; DRINKING		UCL, Natl Hosp Neurol & Neurosurg, Univ Dept Clin Neurol, Autonom Unit, London WC1E 6BT, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Mathias, CJ (corresponding author), St Marys, Imperial Coll Sch Med, Neurovasc Med Unit, London W2 1NY, England.							Cariga P, 2000, CLIN AUTON RES, V10, P89; CORBETT JL, 1971, J PHYSIOL-LONDON, V215, P395, DOI 10.1113/jphysiol.1971.sp009476; DIBONA GF, 1999, AUTONOMIC FAILURE TX, P143; Jordan J, 1999, LANCET, V353, P723, DOI 10.1016/S0140-6736(99)99015-3; Jordan J, 2000, CIRCULATION, V101, P504, DOI 10.1161/01.CIR.101.5.504; KOONER JS, 1987, J HYPERTENS       S5, V5, P327; Mathias CJ, 1998, J NEUROL NEUROSUR PS, V65, P285, DOI 10.1136/jnnp.65.3.285; MATHIAS CJ, 1991, J NEUROL NEUROSUR PS, V54, P726, DOI 10.1136/jnnp.54.8.726; MATHIAS CJ, 1986, BRIT MED J, V293, P353, DOI 10.1136/bmj.293.6543.353; PUVIRAJASINGHAM S, 1997, J PHYSL, V505, P481; Rossi P, 1998, J NEUROL SCI, V161, P148, DOI 10.1016/S0022-510X(98)00276-7; Senard JM, 1999, LANCET, V353, P1971, DOI 10.1016/S0140-6736(05)77182-8	12	23	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 23	2000	356	9235					1046	1048		10.1016/S0140-6736(00)02723-9	http://dx.doi.org/10.1016/S0140-6736(00)02723-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356EC	11009136				2022-12-28	WOS:000089430500004
J	van der Wiel, WG; De Franceschi, S; Fujisawa, T; Elzerman, JM; Tarucha, S; Kouwenhoven, LP				van der Wiel, WG; De Franceschi, S; Fujisawa, T; Elzerman, JM; Tarucha, S; Kouwenhoven, LP			The Kondo effect in the unitary limit	SCIENCE			English	Article							NUMERICAL RENORMALIZATION-GROUP; SINGLE-ELECTRON TRANSISTOR; QUANTUM-DOT; ANDERSON MODEL; TRANSPORT; EQUILIBRIUM	We observe a strong Kondo effect in a semiconductor quantum dot when a small magnetic field is applied. The Coulomb blockade for electron tunneling is overcome completely by the Kondo effect, and the conductance reaches the unitary Limit value. We compare the experimental Kondo temperature with the theoretical predictions for the spin-1/2 Anderson impurity model. Excellent agreement is found throughout the Kondo regime. Phase coherence is preserved when a Kondo quantum dot is included in one of the arms of an Aharonov-Bohm ring structure, and the phase behavior differs from previous results on a non-Kondo dot.	Delft Univ Technol, Dept Appl Phys, NL-2600 GA Delft, Netherlands; Delft Univ Technol, Delft Inst Microelect & Submicron Technol, NL-2600 GA Delft, Netherlands; Delft Univ Technol, ERATO, Mesoscop Correlat Project, NL-2600 GA Delft, Netherlands; NTT, Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; Univ Tokyo, ERATO, Mesoscop Correlat Project, Bunkyo Ku, Tokyo 1130033, Japan	Delft University of Technology; Delft University of Technology; Delft University of Technology; Nippon Telegraph & Telephone Corporation; University of Tokyo	van der Wiel, WG (corresponding author), Delft Univ Technol, Dept Appl Phys, POB 5046, NL-2600 GA Delft, Netherlands.		Elzerman, Jeroen M/J-3551-2012; van der Wiel, Wilfred/F-8812-2014; TARUCHA, SEIGO/I-7030-2012; Fujisawa, Toshimasa/M-2428-2013	Elzerman, Jeroen M/0000-0002-4596-8483; van der Wiel, Wilfred/0000-0002-3479-8853; Fujisawa, Toshimasa/0000-0002-0451-6579				BUTTIKER M, 1986, PHYS REV LETT, V57, P176; COSTI TA, 1994, J PHYS-CONDENS MAT, V6, P2519, DOI 10.1088/0953-8984/6/13/013; Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; Gerland U, 2000, PHYS REV LETT, V84, P3710, DOI 10.1103/PhysRevLett.84.3710; Glazman LI, 1999, PHYS REV LETT, V83, P1830, DOI 10.1103/PhysRevLett.83.1830; GLAZMAN LI, 1988, JETP LETT+, V47, P452; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Goldhaber-Gordon D, 1998, PHYS REV LETT, V81, P5225, DOI 10.1103/PhysRevLett.81.5225; HALDANE FDM, 1978, PHYS REV LETT, V40, P416, DOI 10.1103/PhysRevLett.40.416; Izumida W, 1998, J PHYS SOC JPN, V67, P2444, DOI 10.1143/JPSJ.67.2444; KAWABATA A, 1991, J PHYS SOC JPN, V60, P3222, DOI 10.1143/JPSJ.60.3222; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Maurer SM, 1999, PHYS REV LETT, V83, P1403, DOI 10.1103/PhysRevLett.83.1403; MEIR Y, 1993, PHYS REV LETT, V70, P2601, DOI 10.1103/PhysRevLett.70.2601; NG TK, 1988, PHYS REV LETT, V61, P1768, DOI 10.1103/PhysRevLett.61.1768; Sasaki S, 2000, NATURE, V405, P764, DOI 10.1038/35015509; Schmid J, 2000, PHYS REV LETT, V84, P5824, DOI 10.1103/PhysRevLett.84.5824; Schmid J, 1998, PHYSICA B, V256, P182, DOI 10.1016/S0921-4526(98)00533-X; Simmel F, 1999, PHYS REV LETT, V83, P804, DOI 10.1103/PhysRevLett.83.804; Stewart DR, 1997, SCIENCE, V278, P1784, DOI 10.1126/science.278.5344.1784; STOPA M, COMMUNICATION; WINGREEN NS, 1994, PHYS REV B, V49, P11040, DOI 10.1103/PhysRevB.49.11040; YACOBY A, 1995, PHYS REV LETT, V74, P4047, DOI 10.1103/PhysRevLett.74.4047; [No title captured]	25	683	684	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2105	2108		10.1126/science.289.5487.2105	http://dx.doi.org/10.1126/science.289.5487.2105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000108	Green Submitted			2022-12-28	WOS:000089430900038
J	Akhtar, A; Zink, D; Becker, PB				Akhtar, A; Zink, D; Becker, PB			Chromodomains are protein-RNA interaction modules	NATURE			English	Article							MALE X-CHROMOSOME; DOSAGE COMPENSATION; DROSOPHILA-MELANOGASTER; CHROMATIN; GENES; COMPLEX; DOMAIN; ASSOCIATION; YEAST; ROX1	In Drosophila, compensation for the reduced dosage of genes located on the single male X chromosome involves doubling their expression in relation to their counterparts on female X chromosomes(1). Dosage compensation is an epigenetic process involving the specific acetylation of histone H4 at lysine 16 by the histone acetyltransferase MOF2-5. Although MOF is expressed in both sexes, it only associates with the X chromosome in males. Its absence causes male-specific lethality(6). MOF is part of a chromosome-associated complex comprising male-specific lethal (MSL) proteins and at least one non-coding roX RNA(7). How MOF is integrated into the dosage compensation complex is unknown. Here we show that association of MOF with the male X chromosome depends on its interaction with RNA. MOF specifically binds through its chromodomain to roX2 RNA in vivo. In vitro analyses of the MOF and MSL-3 chromodomains indicate that these chromodomains may function as RNA interaction modules. Their interaction with non-coding RNA may target regulators to specific chromosomal sites.	Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; Univ Munich, Inst Anthropol & Humangenet, D-80336 Munich, Germany	University of Munich; University of Munich	Becker, PB (corresponding author), Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany.		Zink, Daniele/A-8181-2015	Becker, Peter/0000-0001-7186-0372				Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Eddy SR, 1999, CURR OPIN GENET DEV, V9, P695, DOI 10.1016/S0959-437X(99)00022-2; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Gu WG, 1998, DEV GENET, V22, P56, DOI 10.1002/(SICI)1520-6408(1998)22:1<56::AID-DVG6>3.0.CO;2-6; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lucchesi JC, 1999, CURR BIOL, V9, pR807, DOI 10.1016/S0960-9822(99)80495-3; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Richter L, 1996, GENES CELLS, V1, P325, DOI 10.1046/j.1365-2443.1996.26027.x; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stuckenholz C, 1999, TRENDS GENET, V15, P454, DOI 10.1016/S0168-9525(99)01855-7; Turner BM, 1998, CELL MOL LIFE SCI, V54, P21, DOI 10.1007/s000180050122; Weeks KM, 1997, CURR OPIN STRUC BIOL, V7, P336, DOI 10.1016/S0959-440X(97)80048-6	30	299	310	2	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					405	409		10.1038/35030169	http://dx.doi.org/10.1038/35030169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014199				2022-12-28	WOS:000089390700053
J	Macilwain, C				Macilwain, C			World Bank is urged to give greater priority to science	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 21	2000	407	6802					276	276		10.1038/35030373	http://dx.doi.org/10.1038/35030373			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355NA	11014153	Bronze			2022-12-28	WOS:000089390700006
J	Chhowalla, M; Amaratunga, GAJ				Chhowalla, M; Amaratunga, GAJ			Thin films of fullerene-like MoS2 nanoparticles with ultra-low friction and wear	NATURE			English	Article							BEAM-ASSISTED DEPOSITION; APPARATUS	The tribological properties of solid lubricants such as graphite and the metal dichalcogenides MX2 (where M is molybdenum or tungsten and X is sulphur or selenium)(1-13) are of technological interest for reducing wear in circumstances where liquid lubricants are impractical, such as in space technology, ultra-high vacuum or automotive transport. These materials are characterized by weak interatomic interactions (van der Waals forces) between their layered structures, allowing easy, low-strength shearing(14,15). Although these materials exhibit excellent friction and wear resistance and extended lifetime in vacuum, their tribological properties remain poor in the presence of humidity or oxygen(16-19), thereby limiting their technological applications in the Earth's atmosphere. But using MX2 in the form of isolated inorganic fullerene-like hollow nanoparticles similar to carbon fullerenes and nanotubes can improve its performance(1). Here we show that thin films of hollow MoS2 nanoparticles, deposited by a localized high-pressure arc discharge method, exhibit ultra-low friction (an order of magnitude lower than for sputtered MoS2 thin films) and wear in nitrogen and 45% humidity. We attribute this `dry' behaviour in humid environments to the presence of curved S-Mo-S planes that prevent oxidation and preserve the layered structure.	Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	University of Cambridge	Amaratunga, GAJ (corresponding author), Univ Cambridge, Dept Engn, Trumington St, Cambridge CB2 1PZ, England.	ga@eng.cam.ac.uk	Cao, Ming/U-3495-2017					Amaratunga GAJ, 1996, NATURE, V383, P321, DOI 10.1038/383321a0; Arnell R. D., 1991, TRIBOLOGY PRINCIPLES, P105; BELL ME, 1941, PHYS REV, V59, P922; Bilek MMM, 1998, J APPL PHYS, V83, P2965, DOI 10.1063/1.367052; Bragg W, 1925, NATURE, V115, P266, DOI 10.1038/115266a0; BRAITHWAITE ER, 1957, SCI LUBR, V15, P92; BUCK V, 1983, WEAR, V91, P281, DOI 10.1016/0043-1648(83)90073-X; Chhowalla M, 1997, PHIL MAG LETT, V75, P329, DOI 10.1080/095008397179598; Dickinson RG, 1923, J AM CHEM SOC, V45, P1466, DOI 10.1021/ja01659a020; Dunn DN, 1998, J MATER RES, V13, P3001, DOI 10.1557/JMR.1998.0410; Dunn DN, 1997, J MATER RES, V12, P1191, DOI 10.1557/JMR.1997.0167; FELDMAN Y, 1995, SCIENCE, V267, P222, DOI 10.1126/science.267.5195.222; FLEISCHAUER PD, 1984, ASLE TRANS, V27, P82, DOI 10.1080/05698198408981548; Fox VC, 1999, SURF COAT TECH, V116, P492, DOI 10.1016/S0257-8972(99)00193-0; HOLINSKI R, 1972, WEAR, V19, P329, DOI 10.1016/0043-1648(72)90124-X; JoseYacaman M, 1996, APPL PHYS LETT, V69, P1065, DOI 10.1063/1.116932; Killeffer D. H., 1952, MOLYBDENUM COMPOUNDS; MATSUMOTO K, 1996, P INT TRIB C YOK, P1165; Mattern N, 1997, MATER SCI FORUM, V235-2, P613, DOI 10.4028/www.scientific.net/MSF.235-238.613; MIYOSHI K, 1993, TRIBOL T, V36, P351, DOI 10.1080/10402009308983169; Rapoport L, 1997, NATURE, V387, P791, DOI 10.1038/42910; ROBERTS EW, 1990, TRIBOL INT, V23, P95, DOI 10.1016/0301-679X(90)90042-N; SAVAGE RH, 1948, J APPL PHYS, V19, P1, DOI 10.1063/1.1697867; SPALVINS T, 1982, THIN SOLID FILMS, V96, P17, DOI 10.1016/0040-6090(82)90208-5; SROLOVITZ DJ, 1995, PHYS REV LETT, V74, P1779, DOI 10.1103/PhysRevLett.74.1779; Suzuki M, 1998, WEAR, V218, P110, DOI 10.1016/S0043-1648(98)00143-4; Wang DY, 1999, SURF COAT TECH, V120, P629, DOI 10.1016/S0257-8972(99)00431-4; WESTERGARD R, 1998, FINN J TRIBOL, V17, P14; WILLIAMS JA, 1994, ENG TRIBOLOGY, P368	30	719	769	15	716	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2000	407	6801					164	167		10.1038/35025020	http://dx.doi.org/10.1038/35025020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352VX	11001049				2022-12-28	WOS:000089241000041
J	Neuberger, MS; Scott, J				Neuberger, MS; Scott, J			Immunology - RNA editing AIDs antibody diversification?	SCIENCE			English	Editorial Material									MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Med, London W12 0NN, England	MRC Laboratory Molecular Biology; Imperial College London	Neuberger, MS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; MUTO T, IN PRESS GENOMICS; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9	7	9	9	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1705	1706		10.1126/science.289.5485.1705	http://dx.doi.org/10.1126/science.289.5485.1705			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	11001738				2022-12-28	WOS:000089195200035
J	Minor, DL; Lin, YF; Mobley, BC; Avelar, A; Jan, YN; Jan, LY; Berger, JM				Minor, DL; Lin, YF; Mobley, BC; Avelar, A; Jan, YN; Jan, LY; Berger, JM			The polar T1 interface is linked to conformational changes that open the voltage-gated potassium channel	CELL			English	Article							SHAKER K+ CHANNEL; ALANINE-SCANNING MUTAGENESIS; GCN4 LEUCINE-ZIPPER; CRYSTAL-STRUCTURE; ACETYLCHOLINE-RECEPTOR; TETRAMERIZATION DOMAIN; PROTEIN STABILITY; MOLECULAR-BASIS; N-TERMINUS; ACTIVATION	Kv voltage-gated potassium channels share a cytoplasmic assembly domain, T1. Recent mutagenesis of two T1 C-terminal loop residues implicates T1 in channel gating. However, structural alterations of these mutants leave open the question concerning direct involvement of T1 in gating. We find in mammalian Kv1.2 that gating depends critically on residues at complementary T1 surfaces in an unusually polar interface. An isosteric mutation in this interface causes surprisingly little structural alteration while stabilizing the dosed channel and increasing the stability of T1 tetramers. Replacing T1 with a tetrameric coiled-coil destabilizes the closed channel. Together, these data suggest that structural changes involving the buried polar T1 surfaces play a key role in the conformational changes leading to channel opening.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Minor, DL (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	minor@itsa.ucsf.edu		Lin, Yu-Fung/0000-0003-1471-949X; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; ASCHER P, 1992, CURR OPIN NEUROBIOL, V2, P241; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Cachero TG, 1998, CELL, V93, P1077, DOI 10.1016/S0092-8674(00)81212-X; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; CHANDY KG, 1995, HDB RECEPTORS CHANNE, P1; Chiara MD, 1999, J NEUROSCI, V19, P6865, DOI 10.1523/JNEUROSCI.19-16-06865.1999; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Creighton T. E., 1993, PROTEINS STRUCTURES; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Elkes DA, 1997, NEURON, V19, P165, DOI 10.1016/S0896-6273(00)80356-6; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hille B., 1992, IONIC CHANNELS EXCIT; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; HUANG XY, 1994, P NATL ACAD SCI USA, V91, P624, DOI 10.1073/pnas.91.2.624; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Johnstone DB, 1997, NEURON, V19, P151, DOI 10.1016/S0896-6273(00)80355-4; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; McPherson A., 1999, CRYSTALLIZATION BIOL; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; SHEN NV, 1993, NEURON, V11, P67; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	68	160	166	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2000	102	5					657	670		10.1016/S0092-8674(00)00088-X	http://dx.doi.org/10.1016/S0092-8674(00)00088-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	350ML	11007484	Bronze			2022-12-28	WOS:000089105200014
J	Thompson, LG; Yao, T; Mosley-Thompson, E; Davis, ME; Henderson, KA; Lin, PN				Thompson, LG; Yao, T; Mosley-Thompson, E; Davis, ME; Henderson, KA; Lin, PN			A high-resolution millennial record of the South Asian Monsoon from Himalayan ice cores	SCIENCE			English	Article							EURASIAN SNOW COVER; SURFACE AIR-TEMPERATURE; TROPICAL CLIMATE; NORTH PACIFIC; RAINFALL; TRANSPORT; ENSO; DUST	A high-resolution ice core record from Dasuopu, Tibet, reveals that this site is sensitive to fluctuations in the intensity of the South Asian Monsoon. Reductions in monsoonal intensity are recorded by dust and chloride concentrations. The deeper, older sections of the Dasuopu cores suggest many other periods of drought in this region, but none have been of greater intensity than the greatest recorded drought, during 1790 to 1796 A.D. of the Last millennium. The 20th century increase in anthropogenic activity in India and Nepal, upwind from this site, is recorded by a doubling of chloride concentrations anti a fourfold increase in dust. Like other ice cores from the Tibetan Plateau, Dasuopu suggests a Large-scale, plateau-wide 20th-century warming trend that apl,ears to be amplified at higher elevations.	Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; Chinese Acad Sci, Cold & Arid Reg Environm & Engn Inst, Lanzhou, Peoples R China; Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; Ohio State Univ, Dept Geol Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Thompson, LG (corresponding author), Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA.		Mosley-Thompson, Ellen S/Z-2100-2018					BARNETT TP, 1988, SCIENCE, V239, P504, DOI 10.1126/science.239.4839.504; BOLZAN JF, 1985, J GEOPHYS RES-ATMOS, V90, P8111, DOI 10.1029/JD090iD05p08111; Charles CD, 1997, SCIENCE, V277, P925, DOI 10.1126/science.277.5328.925; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Cole JE, 2000, SCIENCE, V287, P617, DOI 10.1126/science.287.5453.617; DICKSON RR, 1984, J CLIM APPL METEOROL, V23, P171, DOI 10.1175/1520-0450(1984)023<0171:ESCVIM>2.0.CO;2; GAO Y, 1992, J GEOPHYS RES-ATMOS, V97, P9867, DOI 10.1029/92JD00714; GREGORY S, 1986, THEOR APPL CLIMATOL, V37, P194, DOI 10.1007/BF00867577; Grove RH, 1998, NATURE, V393, P318, DOI 10.1038/30636; HAHN DG, 1976, J ATMOS SCI, V33, P2461, DOI 10.1175/1520-0469(1976)033<2461:AARBES>2.0.CO;2; Henderson KA, 1999, J GEOPHYS RES-ATMOS, V104, P31053, DOI 10.1029/1999JD900966; JONES PD, 1994, J CLIMATE, V7, P1794, DOI 10.1175/1520-0442(1994)007<1794:HSATVA>2.0.CO;2; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Liu T.-S., 1981, GEOLOGICAL SOC AM SP, V186, P149; LIU X, IN PRESS INT J CLIMA; MERRILL JT, 1989, J GEOPHYS RES-ATMOS, V94, P8584, DOI 10.1029/JD094iD06p08584; Ortlieb L., 2000, EL NINO SO OSCILLATI, P207; PARRINGTON JR, 1983, SCIENCE, V220, P195, DOI 10.1126/science.220.4593.195; QUINN WH, 1992, NINO HIST PALEOCLIMA, P119; REEH N, 1988, J GLACIOL, V34, P46, DOI 10.3189/S0022143000009059; SIROCKO F, 1993, NATURE, V364, P322, DOI 10.1038/364322a0; SONTAKKE NA, 1993, J CLIMATE, V6, P1807, DOI 10.1175/1520-0442(1993)006<1807:COAISM>2.0.CO;2; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; THOMPSON LG, 1989, SCIENCE, V246, P474, DOI 10.1126/science.246.4929.474; THOMPSON LG, 1993, GLOBAL PLANET CHANGE, V7, P145, DOI 10.1016/0921-8181(93)90046-Q; Thompson LG, 2000, QUATERNARY SCI REV, V19, P19, DOI 10.1016/S0277-3791(99)00052-9; THOMPSON LG, 1985, SCIENCE, V229, P971, DOI 10.1126/science.229.4717.971; THOMPSON LG, 1995, SCIENCE, V269, P47; THOMPSON LG, 1997, SCIENCE, V276, P1757; TOURRE YM, 1995, J PHYS OCEANOGR, V25, P1317, DOI 10.1175/1520-0485(1995)025<1317:ESIGUO>2.0.CO;2; WALLACE JM, 1998, J GEOPHYS RES, V103, P14167; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; Yao TD, 1996, J GEOPHYS RES-ATMOS, V101, P29531, DOI 10.1029/96JD02683	33	685	806	16	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1916	1919		10.1126/science.289.5486.1916	http://dx.doi.org/10.1126/science.289.5486.1916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	11001720				2022-12-28	WOS:000089355800040
J	Winett, RA; Carpinelli, RN				Winett, RA; Carpinelli, RN			Exercise intensity and risk of chronic disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Virginia Tech, Dept Psychol, Blacksburg, VA 24061 USA; Adelphi Univ, Human Performance Lab, Garden City, NY 11530 USA	Virginia Polytechnic Institute & State University; Adelphi University	Winett, RA (corresponding author), Virginia Tech, Dept Psychol, Blacksburg, VA 24061 USA.		Hu, Frank/C-1919-2013					Hu FB, 2000, JAMA-J AM MED ASSOC, V283, P2961, DOI 10.1001/jama.283.22.2961; McArdle WD, 1996, EXERCISE PHYSL ENERG; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; WINETT RA, IN PRESS ANN BEHAV M	4	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1784	1785		10.1001/jama.284.14.1784	http://dx.doi.org/10.1001/jama.284.14.1784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025819				2022-12-28	WOS:000089622100017
J	Perez-Molina, JA; Fernandez, RA				Perez-Molina, JA; Fernandez, RA			The role of genotypic resistance testing in selecting therapy for HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Hosp Gen Univ Gregorio Maranon, Madrid, Spain	General University Gregorio Maranon Hospital	Perez-Molina, JA (corresponding author), Hosp Gen Univ Gregorio Maranon, Madrid, Spain.			Perez-Molina, Jose Antonio/0000-0001-8735-4124				Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417	1	15	16	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2000	284	13					1649	1650		10.1001/jama.284.13.1649	http://dx.doi.org/10.1001/jama.284.13.1649			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357KY	11015790				2022-12-28	WOS:000089501900019
J	Wilt, TJ				Wilt, TJ			Quality of evidence for treatment of prostate cancer - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Minneapolis Vet Affairs Ctr Chron Dis Outcomes Re, Minneapolis, MN 55417 USA; Cochrane Review Grp Prostate Dis & Urol Malignanc, Minneapolis, MN USA		Wilt, TJ (corresponding author), Minneapolis Vet Affairs Ctr Chron Dis Outcomes Re, Minneapolis, MN 55417 USA.							Glanville J, 2000, ACP J Club, V132, pA11; MULROW CD, 1999, BRIT MED J, V309, P597	2	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1785	1786		10.1001/jama.284.14.1785	http://dx.doi.org/10.1001/jama.284.14.1785			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025820				2022-12-28	WOS:000089622100020
J	Clarke, M				Clarke, M			Quality of evidence for treatment of prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									UK Cochrane Ctr, Natl Hlth Serv Res & Dev Programme, Oxford, England	Cochrane Centre	Clarke, M (corresponding author), UK Cochrane Ctr, Natl Hlth Serv Res & Dev Programme, Oxford, England.							Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; Dalesio O, 2000, LANCET, V355, P1491; Wilt TJ, 2000, JAMA-J AM MED ASSOC, V283, P3258, DOI 10.1001/jama.283.24.3258	3	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2000	284	14					1785	1785		10.1001/jama.284.14.1785	http://dx.doi.org/10.1001/jama.284.14.1785			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359PW	11025820				2022-12-28	WOS:000089622100019
